{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_intra_doc",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 750,
    "successful_questions_in_experiment": 750,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 750,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-120b/e5_page_window_relevance_asc/qualitative_2hop_intra_doc.json",
    "timestamp": "2026-02-05T02:22:03.395284"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "What was the total amount of Chevron's outstanding loan to Petroboscan, and what percentage of ownership in Petroboscan did Chevron hold as of the 2022 reporting period?",
      "original_answer": "Chevron had an outstanding long-term loan of $560 to Petroboscan, and Chevron held a 39.2 percent interest in Petroboscan as of the 2022 reporting period.",
      "llm_answer": "Chevron’s 2022 filing shows it had an outstanding long‑term loan to Petroboscan of **$560 million** (fully provisioned at year‑end 2021).  At the same time, Chevron owned **approximately 39.2 %** of Petroboscan.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both key pieces of information: the $560 million loan amount and the 39.2% ownership interest in Petroboscan as of 2022. The only discrepancy is the inclusion of additional context — that the loan was 'fully provisioned at year-end 2021' — which is not in the ground truth but does not contradict it and may reflect accurate filing details. (2) Quantitatively, the numbers match: $560 million is equivalent to $560 in the context of the original answer (assuming unit is million, as standard in SEC filings), and 39.2% is reported exactly. The formatting variation ($560 million vs $560) is acceptable under the evaluation criteria. (3) The multi-hop reasoning is sound — the model correctly synthesizes two distinct pieces of information (loan amount and ownership percentage) about Chevron's relationship with Petroboscan from the 2022 reporting period. (4) Scores reflect near-perfect factual accuracy, with a minor deduction in quantitative accuracy only because the original ground truth does not specify 'million', though industry context supports this interpretation. No substantive errors in entities, years, or metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1097,
        "completion_tokens": 333,
        "total_tokens": 1430
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total financial impact on Target Corporation from the sale of Dermstore LLC, including both the cash received and the pretax gain recognized?",
      "original_answer": "Target Corporation received $356 million in cash and recognized a $335 million pretax gain from the sale of Dermstore LLC, resulting in a total financial impact of $691 million.",
      "llm_answer": "Target’s sale of Dermstore generated $356 million of cash proceeds and produced a $335 million pretax gain. Together, the transaction contributed roughly $691 million of financial impact to the company. (Sources: cash proceeds $356 M and pretax gain $335 M reported in the 2021 Form 10‑K.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $356 million in cash proceeds and a $335 million pretax gain are correctly reported, and their sum—$691 million total financial impact—is accurately calculated. Minor formatting differences (e.g., 'million' vs 'M', use of thin space) do not affect correctness. (2) The answer is complete, addressing both components of the question: cash received and pretax gain, and correctly synthesizing them into the total financial impact. (3) Entity accuracy is correct: Target Corporation and Dermstore LLC are properly identified, and the financial figures are attributed to the correct transaction. The mention of the 2021 Form 10-K as the source aligns with the expected data provenance. (4) The reasoning is sound: the model correctly performs the multi-hop synthesis by combining two distinct financial metrics from the same transaction and summing them to determine total impact. (5) The semantic meaning is equivalent to the original answer, with slightly different phrasing but identical factual content. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 332,
        "total_tokens": 1450
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was Amgen's total recorded Product Sales revenue from sales to BeiGene over the three-year period from 2021 to 2023 under their collaboration agreement?",
      "original_answer": "Amgen recorded $72 million in 2021, $64 million in 2022, and $125 million in 2023 in Product Sales revenue from sales to BeiGene under the collaboration agreement, totaling $261 million over the three-year period.",
      "llm_answer": "Amgen recorded product‑sale revenue from its collaboration with BeiGene of **$125 million in 2023, $64 million in 2022 and $72 million in 2021**.  Adding the three years together, the total product‑sales amount to **$261 million** for the 2021‑2023 period【page_131】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $72 million in 2021, $64 million in 2022, and $125 million in 2023 — matching the original answer exactly. The total sum of $261 million is correctly calculated. (2) The answer is complete, addressing each year's revenue and the three-year total as required by the question. (3) Entities are correctly identified: Amgen, BeiGene, and the collaboration agreement context are accurately referenced. (4) The reasoning is sound — the model correctly synthesizes multi-hop information across years and performs accurate addition to arrive at the correct total. Minor reordering of years (listing 2023 first) does not affect correctness, and the semantic meaning remains identical. Number formatting ($125 million vs $125 million) is equivalent. The citation [page_131] adds contextual support. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 273,
        "total_tokens": 1396
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and how many remained available for issuance as of December 31, 2021?",
      "original_answer": "A total of 127 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and approximately 50 million shares remained available for issuance as of December 31, 2021.",
      "llm_answer": "The 2007 Omnibus Incentive Plan authorizes roughly **127 million shares** of Danaher common stock. As of December 31 2021, about **50 million of those shares** remained available for issuance under the plan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers '127 million shares' authorized and '50 million shares' remaining available as of December 31, 2021, are exactly correct, with only minor formatting differences (e.g., use of 'roughly' and 'about', which are acceptable given the original answer uses 'approximately'). (2) The answer is complete, addressing both parts of the question: total authorized shares and shares remaining available. (3) Entity accuracy is correct—'Danaher common stock', '2007 Omnibus Incentive Plan', and the date 'December 31, 2021' are all accurately referenced. (4) The reasoning is sound, demonstrating correct synthesis of multi-hop information from the 10-K filing, even though the answer is concise. (5) Semantic equivalence is preserved—the LLM conveys the same factual content as the original answer using slightly different phrasing. No errors in calculation, logic, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 279,
        "total_tokens": 1392
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, and how was this amount distributed across the years 2023 and 2024?",
      "original_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio to Cheplapharm, with $1.05 billion received in 2023 and an additional $305.0 million received in 2024.",
      "llm_answer": "Lilly received a total of **$1.355 billion** in cash from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm. The cash was received in two installments: **$1.05 billion in 2023** and **$305 million in 2024** (both amounts were included in the transaction price in 2023).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total cash received is accurately stated as $1.355 billion, with $1.05 billion in 2023 and $305 million in 2024—these figures exactly match the original answer. Minor formatting differences ($305.0 million vs $305 million) are acceptable and do not affect accuracy. (2) The answer is complete, addressing both the total amount and its distribution across 2023 and 2024 as required by the question. (3) Entities are correct: LLY (Lilly), olanzapine portfolio, Zyprexa, and Cheplapharm are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—the LLM correctly identifies that while the full amount was agreed upon in 2023, the cash receipts were distributed across two years. The additional detail about both amounts being included in the transaction price in 2023 adds contextual accuracy without contradicting the cash flow timing. Overall, the answer is factually precise, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 305,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What was the total amount of goodwill recorded by Lockheed Martin as a result of its acquisition of Terran Orbital, and how much of the purchase consideration was paid in cash?",
      "original_answer": "Lockheed Martin recorded $298 million in goodwill as a result of the acquisition of Terran Orbital, and $231 million of the total $314 million purchase consideration was paid in cash.",
      "llm_answer": "Lockheed Martin recorded **$298 million of goodwill** related to the Terran Orbital acquisition, and **$231 million of the $314 million purchase price was paid in cash** (the balance of $83 million represented previously‑held equity that was rolled into the consideration).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $298 million in goodwill, $231 million in cash paid, and the total purchase consideration of $314 million are all correctly reported. The breakdown of the non-cash portion ($83 million as previously-held equity) is an accurate inference and consistent with the total. (2) The answer is complete, addressing both parts of the question: the amount of goodwill recorded and the cash component of the purchase consideration. (3) Entities are correct—Lockheed Martin and Terran Orbital are accurately identified, and the financial metrics (goodwill, purchase consideration, cash payment) are appropriate and correctly used. (4) The reasoning is sound and demonstrates proper multi-hop synthesis: the model correctly associates the acquisition event with the resulting goodwill and decomposes the purchase price into cash and non-cash components, even adding context (rolled equity) that enhances clarity without introducing error. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced detail that does not deviate from the truth. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 342,
        "total_tokens": 1464
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is Chevron's (CVX) carrying value of its investment in GS Caltex Corporation at the end of 2021, and how does this compare to Chevron's equity ownership percentage in the company?",
      "original_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, and Chevron owns a 50% equity interest in GS Caltex Corporation.",
      "llm_answer": "Chevron’s carrying value for its investment in GS Caltex Corporation at December 31 2021 was **$3.6 billion** (shown as $3,616 million in Note 15).  Chevron owns **50 %** of GS Caltex Corporation, as disclosed in the same note.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the carrying value of Chevron's investment in GS Caltex Corporation at the end of 2021 is correctly stated as $3,616 million, which the model accurately reports as $3.6 billion (a valid rounding and format variation). The equity ownership percentage is correctly identified as 50%. (2) Quantitative accuracy is perfect: the dollar amount and percentage match the original data exactly, with acceptable formatting differences ($3.6 billion vs $3,616 million). (3) The reasoning is sound and reflects proper multi-hop synthesis—tying the carrying value and ownership percentage to the same source (Note 15) demonstrates correct use of document-level context. (4) The answer is semantically equivalent to the ground truth, complete, and directly addresses both parts of the question. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 273,
        "total_tokens": 1382
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "By how much did the total revenue from Forest Products change in dollars from 2020 to 2021, and what was the corresponding change in average revenue per car for this product category during the same period?",
      "original_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021, and the average revenue per car increased by $155 during the same period.",
      "llm_answer": "The Forest Products segment generated **$197 million more revenue in 2021 than in 2020** ( $1,357 million vs. $1,160 million ).  During the same period, **average revenue per car rose by $155** ( $5,424 per car in 2021 vs. $5,269 per car in 2020).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $197 million increase in total revenue from Forest Products is accurate, with exact figures provided for 2020 ($1,160 million) and 2021 ($1,357 million), which correctly differ by $197 million. The average revenue per car increased from $5,269 in 2020 to $5,424 in 2021, a difference of $155, which is correctly reported. (2) The answer is complete, addressing both parts of the question: the dollar change in total revenue and the change in average revenue per car. (3) All entities—Forest Products as the product category, the years 2020 and 2021—are correctly identified and used. (4) The multi-hop reasoning is sound: the model correctly synthesized data across years and metrics (total revenue and per-unit revenue), demonstrating proper calculation and contextual understanding. The additional detail (exact revenue values and per-car amounts) enhances clarity without introducing error. Semantic equivalence is maintained with the original answer, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 308,
        "total_tokens": 1424
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total net revenue contribution of Restasis in 2024, and by what percentage did it decline compared to 2023 based on actual currency rates?",
      "original_answer": "The total net revenue contribution of Restasis in 2024 was $224 million, representing a decline of 48.7% compared to 2023 based on actual currency rates.",
      "llm_answer": "Restasis generated **$224 million** in net revenue in 2024. Compared with 2023’s $436 million, that represents a **48.7 % decline** on an actual‑currency‑rates basis【page_102】【page_43】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the net revenue for Restasis in 2024 is correctly stated as $224 million, and the percentage decline of 48.7% compared to 2023 is accurate. The implied 2023 revenue of $436 million is consistent with the 48.7% decline from $436M to $224M: (436 - 224) / 436 ≈ 0.487 or 48.7%. (2) The answer addresses both parts of the question: total net revenue in 2024 and the year-over-year percentage decline based on actual currency rates. (3) Entities are correct—'Restasis', '2024', '2023', 'net revenue', and 'actual currency rates' are all accurately referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly inferred or retrieved both 2023 and 2024 figures and computed the correct decline percentage, confirming internal consistency. The citation of page references further supports accurate sourcing. Semantic equivalence is maintained with the ground truth, with only minor formatting differences (e.g., spacing in '$224 million') that do not affect meaning. All criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1085,
        "completion_tokens": 315,
        "total_tokens": 1400
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2023?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 8.4%. This is calculated by subtracting the Minimum Capital Adequacy requirement of 4.5% from Capital One Financial Corp's ratio of 12.9%.",
      "llm_answer": "As of December 31 2023, Capital One Financial Corp reported a Common Equity Tier 1 (CET1) capital ratio of **12.9 %**. The regulatory minimum capital‑adequacy requirement for CET1 is **4.5 %**. Thus, the company’s CET1 ratio exceeds the minimum by **about 8.4 percentage points**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key numbers — Capital One's CET1 ratio of 12.9% and the minimum requirement of 4.5% — are accurately reported. The difference is correctly calculated as 8.4 percentage points (12.9% - 4.5% = 8.4%), which matches the ground truth. Minor phrasing differences (e.g., 'about 8.4 percentage points' vs. '8.4%') are semantically equivalent in this context, as both refer to a percentage point difference in capital ratios. (2) The answer is complete, addressing both the company's ratio, the regulatory minimum, and the difference between them — all required components of the multi-part question. (3) Entity accuracy is correct: 'Capital One Financial Corp', 'Common Equity Tier 1 capital ratio', 'Minimum Capital Adequacy requirement', and 'December 31, 2023' are all properly identified. (4) The reasoning is sound and demonstrates correct multi-hop synthesis: it retrieves the firm-specific metric from its filing, identifies the regulatory standard, and computes the gap — a core multi-hop financial analysis task. The conclusion logically follows from the data. All criteria are met with high precision and clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 341,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023, and how did it compare to the amounts recognized in the two prior years?",
      "original_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million. This amount decreased from $81 million in 2022 but increased compared to $56 million in 2021.",
      "llm_answer": "Lockheed Martin recorded **$64 million** of pretax pension expense for its non‑qualified defined‑benefit pension plans in 2023. That amount was **down from $81 million** recognized in 2022, but **up from the $56 million** recorded in 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $64 million for 2023, $81 million for 2022, and $56 million for 2021. The comparisons (decrease from 2022, increase from 2021) are correctly stated. (2) The answer is complete, addressing both parts of the question: the 2023 expense and the comparison to the two prior years. (3) Entities are accurate—Lockheed Martin, nonqualified defined benefit pension plans, and the correct fiscal years (2021, 2022, 2023) are properly identified. (4) The reasoning is sound: the multi-hop synthesis across three years of data is correctly executed, with accurate directional comparisons. (5) The semantic meaning is equivalent to the original answer, with only minor wording differences (e.g., 'non-qualified' vs 'nonqualified') that do not affect accuracy. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 260,
        "total_tokens": 1385
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the change in the net carrying amount of BlackRock's investor/customer relationships between December 31, 2022, and December 31, 2023, and how does the difference in accumulated amortization over this period contribute to this change?",
      "original_answer": "The net carrying amount of investor/customer relationships decreased from $492 million at December 31, 2022, to $447 million at December 31, 2023, resulting in a $45 million decline. This change is due to an increase in accumulated amortization from $254 million in 2022 to $338 million in 2023, which reduced the net carrying value despite a slight increase in the gross carrying amount from $746 million to $785 million.",
      "llm_answer": "The net carrying amount of BlackRock’s investor‑customer relationships fell from **$492 million at 12/31/2022 to $447 million at 12/31/2023**, a decline of **$45 million**.  \n\nDuring the same period the accumulated amortization on this asset rose from **$254 million to $338 million**, an increase of **$84 million**; this higher amortization more than offset the $39 million rise in the gross carrying amount (from $746 million to $785 million), producing the $45 million net reduction.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the net carrying amount decreased from $492 million to $447 million, a $45 million decline; accumulated amortization increased from $254 million to $338 million ($84 million increase); gross carrying amount rose from $746 million to $785 million ($39 million increase). These values exactly match the original answer. (2) The calculations are correct: the $84 million increase in amortization more than offsets the $39 million increase in gross carrying amount, resulting in a net $45 million reduction in carrying value (84 - 39 = 45), which is logically sound. (3) The multi-hop reasoning is accurate—synthesizing changes in gross carrying amount, accumulated amortization, and their impact on net carrying amount across two fiscal years (2022 to 2023) for BlackRock. (4) All entities (BlackRock, investor/customer relationships, amortization, carrying amounts) are correctly identified and contextualized. The answer fully addresses both parts of the question: the change in net carrying amount and the contribution of accumulated amortization. Wording differs slightly but maintains semantic equivalence. No errors in facts, logic, or synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 355,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What is the total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, and how does UPS classify this debt on its consolidated balance sheet despite its 2024 maturity?",
      "original_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is $400 million. Despite its 2024 maturity, UPS classifies this debt as long-term on its consolidated balance sheet based on its intent and ability to refinance the debt.",
      "llm_answer": "UPS had $400 million of 2.200% senior notes outstanding at December 31, 2023.  Although the notes mature in September 2024, UPS classifies them as **long‑term debt** (a non‑current liability) on its consolidated balance sheet because it intends and is able to refinance the obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the principal amount of $400 million is accurate, and the maturity in September 2024 (implied by the 2024 maturity in the original answer) is consistent with the context. The percentage (2.200%) and date (December 31, 2023) are correctly stated. (2) The answer completely addresses both parts of the question: it specifies the total principal amount and explains how UPS classifies the debt despite its 2024 maturity. (3) Entity accuracy is correct—UPS is the right company, the financial instrument is accurately identified as 2.200% senior notes, and the classification is correctly attributed to the consolidated balance sheet. (4) The reasoning is sound: the answer correctly applies the accounting principle that debt maturing within a year can still be classified as long-term if the company has both the intent and ability to refinance, which is the key multi-hop logic required. (5) The LLM answer is semantically equivalent to the original, with slightly more detail (specifying September 2024) but without contradicting or distorting the ground truth. All scores are maximized due to full factual accuracy, completeness, and correct synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 349,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "By how much did Cisco's available-for-sale debt investments decrease in the fiscal year ending July 27, 2024, and what was the impact on the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities?",
      "original_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million in the fiscal year ending July 27, 2024. This decrease, combined with a $2,615 million decrease in cash and cash equivalents and a $50 million increase in marketable equity securities, resulted in a total decrease of $8,292 million in the sum of these financial assets.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments fell by **$5.7 billion** (down from $15.592 billion to $9.865 billion) in the year ended July 27 2024. That decline, together with the drop in cash and cash equivalents, reduced the combined total of cash, available‑for‑sale debt investments and marketable equity securities from **$26.146 billion to $17.854 billion**, a **$8.3 billion** decrease.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cisco's available-for-sale debt investments decreased by $5.7 billion, which matches the ground truth decrease of $5,727 million (rounded to $5.7 billion). The total decrease in the combined financial assets is reported as $8.3 billion, which aligns with the ground truth total decrease of $8,292 million (rounded). The LLM also correctly references the fiscal year ending July 27, 2024. (2) The specific values cited—$15.592 billion to $9.865 billion—imply a decrease of $5.727 billion, which is accurate. The combined total decrease from $26.146 billion to $17.854 billion equals $8.292 billion, matching the ground truth calculation. Minor rounding in presentation ($8.3 billion vs $8,292 million) is acceptable. (3) The multi-hop reasoning is sound: the model synthesizes changes across cash, available-for-sale debt investments, and marketable equity securities, correctly aggregating their impact. It infers the total change from component changes even if not explicitly stating each one, but the net effect is accurate. (4) The answer is highly factually accurate, complete, and relevant. The only minor limitation is that it does not explicitly break down the $2,615 million decrease in cash and $50 million increase in marketable equity securities mentioned in the ground truth, but it captures their net effect correctly. Thus, a score of 9 is justified—excellent accuracy with negligible omission in granular detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 409,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How many shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan as of December 31, 2023, and how many of those shares could be granted as awards other than options or stock appreciation rights?",
      "original_answer": "As of December 31, 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan, of which 2,452,443 shares could be granted as awards other than options or stock appreciation rights.",
      "llm_answer": "As of December 31 2023, the 2021 Linde plc Long‑Term Incentive Plan had **7,661,431 shares** still available for equity grants. Of those, **2,452,443 shares** could be issued as awards other than stock options or stock‑appreciation rights.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The numbers provided—7,661,431 total shares available and 2,452,443 shares available for awards other than options or stock appreciation rights—are identical to the original answer. Minor formatting differences (e.g., use of en-dash, spacing) do not affect accuracy. (2) Both numeric values are factually correct and correctly attributed to the 2021 Linde plc Long-Term Incentive Plan as of December 31, 2023. (3) The reasoning is sound and reflects proper synthesis of multi-hop information: identifying the correct incentive plan, the correct date, and the distinction between total available shares and those eligible for non-option awards. (4) The answer is semantically equivalent to the original, with clear, precise language that conveys the same information without omissions or distortions. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 272,
        "total_tokens": 1411
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total payment received by the company from the settlement of forward interest rate swap contracts associated with the issuance of the 2023 Notes, March 2022 Notes, and September 2022 Notes, and how does this reflect the financial impact of these settlements on the company's cash flow?",
      "original_answer": "The company received a total payment of $526 million from the settlement of forward interest rate swap contracts: $247 million from the 2023 Notes, $143 million from the March 2022 Notes, and $136 million from the September 2022 Notes. These settlements directly contributed to the company's cash flows, as the cash flows related to the settlement of hedging derivatives are classified in the consolidated statements of cash flows based on the nature of the underlying hedged items.",
      "llm_answer": "The company received **$247 million** from the forward‑interest‑rate‑swap settlement tied to the 2023 Notes, **$143 million** for the March 2022 Notes, and **$136 million** for the September 2022 Notes – a combined cash receipt of **$526 million**.  This inflow is recorded in the cash‑flow statement as a financing‑activity cash receipt, indicating that the swap settlements provided a net boost of roughly $0.5 billion to the company’s cash resources in the periods in which the notes were issued.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all individual and total cash payments: $247 million (2023 Notes), $143 million (March 2022 Notes), $136 million (September 2022 Notes), and the sum of $526 million — all match the ground truth exactly. Minor formatting differences (e.g., use of thin spaces, 'million' vs 'M') are acceptable and do not affect accuracy. (2) The calculation of the total ($247M + $143M + $136M = $526M) is correct and explicitly stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three separate note issuances and their associated swap settlements. (4) The qualitative description of the financial impact is mostly accurate — it correctly states the settlements boosted cash flow and were recorded as cash inflows. However, the LLM specifies the inflow was classified as a 'financing-activity cash receipt', while the ground truth states that classification is 'based on the nature of the underlying hedged items' without specifying the exact category. This is a minor overprecision but does not contradict the truth, as hedging activities related to debt issuance are often classified under financing activities. Thus, the reasoning and synthesis remain strong. (5) The answer fully addresses both parts of the question: total payment received and the financial impact on cash flow. Semantic equivalence is maintained. Only a minor deduction in qualitative accuracy due to the slightly more specific classification claim without explicit support in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 424,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the approximate range of NextEra Energy's ownership interest in XPLR, and what type of assets do the principal equity method investees, including XPLR, primarily own according to NEE's 2024 10-K filing?",
      "original_answer": "NextEra Energy's ownership interest in XPLR ranges from approximately 33.3% to 85.0%, and the principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "llm_answer": "NextEra Energy’s stake in XPLR falls within the same broad band it holds for its other equity‑method investees – roughly **33 % to 85 %** of the partnership (the exact percentage for XPLR is not disclosed, but it is within this range)【page_96】.  \n\nAll of the principal equity‑method investees, XPLR included, **primarily own electric‑generation assets (wind, solar, battery storage and other generation facilities) and natural‑gas pipelines**【page_96】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the ownership interest range in XPLR as approximately 33% to 85%, which matches the ground truth of 33.3% to 85.0% — minor rounding difference (33% vs 33.3%) is acceptable under semantic equivalence and format variation. The answer acknowledges that the exact percentage for XPLR is not disclosed but falls within the range used for other equity-method investees, which is consistent with the source. (2) Quantitatively, all numbers are accurate: the 33% to 85% range aligns with the reported data, and no calculations are required beyond correct interpretation. (3) The LLM correctly states that principal equity method investees, including XPLR, primarily own electric generation facilities (specifying wind, solar, battery storage) and natural gas pipelines, which is semantically equivalent to the ground truth. The added specificity (e.g., battery storage) enhances clarity without introducing error. (4) Multi-hop reasoning is sound: the model synthesizes ownership range and asset type from the same context (page 96), correctly attributing both pieces of information to NEE’s 2024 10-K. The only minor shortcoming is the lack of explicit mention of '33.3%' (cited in ground truth), but '33%' is a reasonable approximation in financial reporting context. All parts of the question are addressed with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 380,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total fair value of Corporate notes and obligations as reported in the fair value hierarchy table, and how does this compare to their amortized cost in terms of unrealized losses?",
      "original_answer": "The total fair value of Corporate notes and obligations is $3,354 million as reported in the fair value hierarchy table. This is $92 million less than their amortized cost of $3,442 million, indicating an unrealized loss of $92 million.",
      "llm_answer": "The fair‑value hierarchy table shows that the Company’s corporate notes and obligations had a **fair value of $2,978 million**. Their amortized‑cost amount was **$3,014 million**, so the fair value is about **$45 million lower**, reflecting an unrealized loss of $45 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers. The ground truth states the fair value is $3,354 million and amortized cost is $3,442 million, resulting in an unrealized loss of $92 million. The LLM reports $2,978 million (fair value) and $3,014 million (amortized cost), with a $45 million difference—both values and the resulting calculation are wrong. (2) Quantitative accuracy is severely lacking: the fair value is off by $376 million, amortized cost by $428 million, and the unrealized loss by $47 million. These are not rounding or formatting differences but significant factual errors. (3) While the reasoning structure is sound—comparing fair value to amortized cost to derive unrealized loss—the multi-hop synthesis fails because it uses incorrect source data, suggesting the model pulled figures from a different company, year, or context. (4) Contextual relevance is high because the answer addresses the right concepts (fair value hierarchy, amortized cost, unrealized losses) and follows the correct logical flow, but the incorrect numbers render the answer misleading. Correctness and quantitative accuracy are therefore very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 331,
        "total_tokens": 1470
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total number of locomotives operated by UNP in 2024, and how does the combination of owned and leased locomotives contribute to this figure?",
      "original_answer": "The total number of locomotives operated by UNP in 2024 is 7,026. This total is derived from 6,106 owned locomotives and 920 leased locomotives.",
      "llm_answer": "In 2024 Union Pacific operated **7,026 locomotives**. This total consists of **6,106 owned locomotives** (5,973 multiple‑purpose units, 122 switching units and 11 other units) plus **920 leased locomotives**, which together make up the full fleet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total number of locomotives operated by UNP in 2024 is correctly stated as 7,026, composed of 6,106 owned and 920 leased locomotives. (2) Quantitative accuracy is perfect—6,106 + 920 = 7,026, and the breakdown of owned units (though more detailed than the original) does not contradict the ground truth and adds context without error. (3) The multi-hop reasoning is sound: the model correctly synthesizes the total fleet size from owned and leased components, directly addressing how each contributes to the total. (4) The answer is semantically equivalent to the original, with slightly more detail on the types of owned locomotives, which enhances completeness without introducing inaccuracies. All entities (UNP, 2024, locomotive ownership categories) are correctly identified and used. The response fully addresses both parts of the question: the total number and the contribution of owned and leased units.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 291,
        "total_tokens": 1390
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the net change in the value of Brands/Tradenames for LIN in 2024, and how did foreign currency translation and amortization expense specifically contribute to this change?",
      "original_answer": "The net value of Brands/Tradenames for LIN decreased from $2,609 million in 2023 to $2,239 million in 2024, a reduction of $370 million. This decrease was primarily driven by a foreign currency translation reduction of $107 million and an amortization expense of $36 million. Together, these two factors contributed a total decline of $143 million, which is more than the total additions (which were $0 million) and partially offset by a small positive adjustment of $4 million under 'Other'.",
      "llm_answer": "The net carrying amount of Brands/Tradenames fell from $2,376 million at 12/31/2023 to $2,239 million at 12/31/2024 – a net decrease of **$137 million**.  \n\nIn 2024, **amortization expense** on Brands/Tradenames was **$36 million**, which reduced the net balance, while **foreign‑currency translation** added **$5 million** (a modest offset), together accounting for a $31 million portion of the overall $137 million decline.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers and direction of effects. The starting value for Brands/Tradenames in 2023 is incorrect: LLM states $2,376 million vs. the ground truth of $2,609 million. The net change is reported as $137 million decrease, but the correct net change is $370 million. Additionally, the LLM incorrectly states that foreign currency translation had a positive impact of $5 million, whereas the ground truth shows a negative impact (reduction) of $107 million due to foreign currency translation. The amortization expense of $36 million is correct. (2) Calculations: The LLM computes a $137 million decrease from $2,376M to $2,239M, which is mathematically correct based on its numbers, but the inputs are factually wrong. The correct calculation is $2,609M - $2,239M = $370M decrease. The LLM also incorrectly combines a $36M amortization and +$5M FX effect to explain part of the decline, while in reality, FX translation reduced value by $107M and amortization by $36M, totaling $143M in reductions. (3) Multi-hop reasoning: The model fails to correctly synthesize the components of change in the asset value. It misrepresents the direction and magnitude of foreign currency translation, misses the total additions of $0, and omits the 'Other' adjustment of +$4M. It does not account for the full $370M decline or explain the discrepancy, indicating flawed reasoning. (4) Justification: The correctness score is low (2) due to major factual and directional errors in core financial figures. Quantitative accuracy is severely compromised (2) because the key dollar amounts and changes are incorrect. Qualitative accuracy is slightly higher (3) because the model recognizes amortization as a reducing factor and attempts to break down components, though with errors. Contextual relevance is high (8) because the structure and intent align with the question, discussing the right metric, company, year, and relevant factors like amortization and FX.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 541,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities at the end of 2021 and how did it compare to the previous year in terms of dollar value change?",
      "original_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities was $1,023 million at the end of 2021. This represents a decrease of $19 million compared to the previous year's value of $1,042 million.",
      "llm_answer": "At December 31 2021 Coca‑Cola reported corporate bonds and debt securities at a fair‑value total of **$1,023 million** (Level 2 $994 m + Level 3 $29 m). The prior‑year total (December 31 2020) was **$1,042 million** (Level 2 $1,011 m + Level 3 $31 m), so the fair‑value amount fell by **$19 million** year‑over‑year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the LLM correctly reports the total fair value of Coca-Cola's Corporate Bonds and Debt Securities at $1,023 million for 2021 and $1,042 million for 2020, with a year-over-year decrease of $19 million—this matches the original answer exactly. The breakdown into Level 2 and Level 3 values, while additional detail not required by the question, is accurate and consistent with the knowledge graph. (2) The calculation of the $19 million decrease is correct: $1,042M - $1,023M = $19M. (3) The reasoning is sound and demonstrates proper multi-hop synthesis across two fiscal years and components of fair value. (4) All entities—Coca-Cola (KO), the financial instrument (Corporate Bonds and Debt Securities), and the time periods (2021 and 2020)—are correctly identified. The answer is semantically equivalent to the ground truth, with slightly more detail but no factual deviation. All scoring categories warrant the highest rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 293,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program, and why are these units not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023?",
      "original_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is $42.5 million. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because, although LTIP units are potentially dilutive securities, they have not yet met the performance conditions necessary to be considered earned, and no securities had a material dilutive effect during the reporting period.",
      "llm_answer": "The 2023 Long‑Term Incentive (LTI) Program states that the performance‑based portion of the LTIP awards has a **maximum potential grant‑date fair value of $42.5 million**【page_129】.  \n\nThese units are not shown as a material dilutive effect on net income attributable to common stockholders for 2023 because, although they are potentially dilutive securities, they have not yet been earned or vested and the company determined that their inclusion would have **no material impact on diluted earnings per share**; consequently, no adjustment to net income or share count was made【page_111】【page_112】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the maximum potential fair value at grant date as $42.5 million, matching the ground truth exactly. This satisfies the quantitative requirement with no discrepancies in dollar amount or formatting. (2) The explanation for why these units are not reflected as a material dilutive effect is substantively correct: the units are potentially dilutive but have not been earned due to unmet performance conditions, and no adjustment was made because they had no material impact on diluted EPS. The LLM cites pages 111 and 112 for this reasoning, aligning with disclosure practices in 10-K filings. (3) The multi-hop reasoning is sound—linking the grant-date fair value from the LTI program description to the accounting treatment in earnings per share calculations. The only minor shortcoming is that the LLM slightly rephrases the reason as 'no material impact on diluted earnings per share' rather than explicitly stating that performance conditions have not been met (which is the root cause). However, this is implied in the 'not yet earned or vested' phrasing. (4) All entities—2023 LTI Program, performance-based LTIP units, net income attributable to common stockholders, and the reporting period—are correctly identified and contextually appropriate. The answer is fully relevant and conveys semantically equivalent information to the ground truth, warranting a high correctness score with only a slight deduction in qualitative accuracy for less precise emphasis on performance conditions as the determining factor.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 431,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the difference between the amortized cost and fair value of Covered Bonds held by CRM in 2023, and what is the unrealized loss on these bonds?",
      "original_answer": "The amortized cost of Covered Bonds held by CRM in 2023 is $105 million, while the fair value is $101 million, resulting in an unrealized loss of $4 million.",
      "llm_answer": "In 2023 the Company held covered bonds with an amortized‑cost carrying amount of **$105 million** and a fair‑value measurement of **$101 million**, a gap of **$4 million**. That $4 million shortfall is recorded as an **unrealized loss of $4 million** on the covered‑bond portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the amortized cost ($105 million), fair value ($101 million), and the resulting unrealized loss ($4 million) are correctly reported. (2) Quantitative accuracy is perfect — the difference between amortized cost and fair value is correctly calculated as $4 million, and all values match the original answer exactly. Minor formatting differences (e.g., en-dash in $105 million) do not affect meaning or accuracy. (3) The multi-hop reasoning is sound: the model correctly identifies the two valuation metrics (amortized cost and fair value), computes the difference, and correctly interprets this difference as an unrealized loss, which requires synthesis across accounting concepts and data points. (4) The answer is contextually relevant, directly addressing both parts of the question — the difference between amortized cost and fair value, and the unrealized loss. Semantic equivalence is maintained with the original answer, with slightly expanded wording for clarity but no deviation in meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 315,
        "total_tokens": 1426
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What percentage of Union Pacific's Multiple Purpose locomotives are leased rather than owned, and how does this compare to the proportion of leased locomotives in the 'Switching' and 'Other' categories combined?",
      "original_answer": "13.35% of Union Pacific's Multiple Purpose locomotives are leased. Since there are no leased locomotives in the 'Switching' and 'Other' categories, the percentage of leased locomotives in these categories combined is 0%.",
      "llm_answer": "Union Pacific’s Multiple‑purpose locomotives are about 13 percent leased (920 leased ÷ 6,893 total ≈ 13.4%). In contrast, none of the locomotives classified as “Switching” or “Other” are leased – the combined 133 units in those categories are all owned, giving a 0 percent lease rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth. (1) Quantitatively, the percentage of leased Multiple Purpose locomotives is correctly calculated as approximately 13.4% (920 leased ÷ 6,893 total), which rounds to the ground truth value of 13.35%—a negligible difference due to rounding, which is acceptable. The answer correctly states that there are no leased locomotives in the 'Switching' and 'Other' categories, resulting in a 0% lease rate, matching the ground truth. (2) The calculation is sound and explicitly shown, demonstrating correct reasoning. (3) The multi-hop reasoning is accurate: the model correctly identifies Union Pacific's leasing data across locomotive categories and synthesizes the information to compare Multiple Purpose with the combined Switching and Other categories. (4) All entities (Union Pacific, locomotive types) are correct, and the answer fully addresses both parts of the question. The only minor point preventing a perfect 10 is the slight rounding of 13.35% to 13.4%, though this does not affect factual correctness. Wording differs but maintains semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 323,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "By how much did the combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 increase compared to the end of 2020, and what was the total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023?",
      "original_answer": "The natural gas liquids (NGLs) volume in the Lower 48 increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, a difference of 567 million barrels. In 2023, the total depreciation, depletion, amortization, and impairments for the Lower 48 was $5,729 million.",
      "llm_answer": "The combined NGL volume in the Lower 48 grew from **230 million barrels at the end of 2020 to 797 million barrels at the end of 2023**, an increase of **567 million barrels**.  \n\nFor 2023, the Lower 48 segment recorded **$5.729 billion** in depreciation, depletion, amortization and impairments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the NGL volume increase is accurately calculated: 797 million barrels (end of 2023) minus 230 million barrels (end of 2020) equals 567 million barrels, which is correctly reported. The total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023 is stated as $5.729 billion, which is equivalent to $5,729 million in the ground truth—this is a valid format variation (billion vs million) and numerically accurate. (2) The answer is complete, addressing both parts of the multi-part question: the volume increase and the 2023 DDA&I total. (3) Entity accuracy is correct: 'Lower 48', 'NGLs', '2020', '2023', and the financial metric are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across time periods and financial metrics. (5) Semantic equivalence is maintained—wording differs slightly but conveys the same factual content. No errors in logic, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 295,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How much total cash did Walmart spend in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation, and what was the subsequent financial treatment of Alert Innovation in fiscal 2025 as reflected in the consolidated financial statements?",
      "original_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation ($0.4 billion for each). Alert Innovation was subsequently sold and deconsolidated in fiscal 2025.",
      "llm_answer": "Walmart spent $0.4 billion to buy out the non‑controlling interest in Massmart and another $0.4 billion to acquire the remaining interest in Alert Innovation, for a total cash outlay of approximately $0.8 billion in fiscal 2023.  In fiscal 2025 the Alert Innovation entity was sold and consequently deconsolidated, so it was removed from Walmart’s consolidated balance sheet and results of operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the answer correctly states that Walmart spent $0.4 billion on Massmart and $0.4 billion on Alert Innovation, totaling $0.8 billion in fiscal 2023—this aligns exactly with the original answer, including the breakdown and sum. Minor phrasing like 'approximately $0.8 billion' is acceptable as the exact sum of $0.4B + $0.4B is $0.8B. (2) The answer is complete, addressing both parts of the question: total cash spent in fiscal 2023 and the financial treatment of Alert Innovation in fiscal 2025. (3) Entity accuracy is perfect: Walmart, Massmart, Alert Innovation, fiscal 2023, and fiscal 2025 are all correctly identified and contextually used. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly links the acquisition costs across two entities in one fiscal year and separately identifies the subsequent deconsolidation due to sale in fiscal 2025. (5) The semantic meaning is equivalent to the ground truth—the phrasing 'sold and consequently deconsolidated' accurately reflects 'subsequently sold and deconsolidated', and the financial implication (removal from consolidated statements) is correctly explained. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 359,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total revenue generated from Metals & minerals shipments for UNP in 2021, combining the number of carloads with the average revenue per car for that category?",
      "original_answer": "$1,810,806,000",
      "llm_answer": "In 2021 Union Pacific shipped 697 thousand carloads of metals & minerals, and the average revenue per car was $2,598. Multiplying the two gives:\n\n\\(697,000 \\text{ carloads} \\times \\$2,598 \\approx \\$1,810,806,000\\),\n\nor roughly **$1.81 billion** in freight revenue from metals & minerals shipments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the number of carloads (697,000) and average revenue per car ($2,598) are correctly stated. (2) The calculation is precise: 697,000 × $2,598 = $1,810,806,000, which matches the original answer exactly. The answer also appropriately rounds to $1.81 billion, preserving semantic equivalence. (3) The multi-hop reasoning—combining carload volume with per-unit revenue to compute total revenue—is sound and correctly executed. (4) The entities (UNP, 2021, Metals & Minerals category) are correctly identified and contextualized. The response is complete, factually accurate, and directly addresses the question with proper synthesis of data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 222,
        "total_tokens": 1306
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization, and how does this compare to the amount of the Series 2013-2A Securities that were repaid in March 2023?",
      "original_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization is $1.3 billion. This matches the amount of the Series 2013-2A Securities that were repaid in March 2023, indicating a direct refinancing of the older securities with the new issuance.",
      "llm_answer": "The 2023 Securitization issued **$1.3 billion** of Series 2023‑1A Securities. In March 2023 the Company repaid the entire **$1.3 billion** principal amount of the Series 2013‑2A Securities. Thus, the amount issued for the 2023‑1A securities is equal to the amount repaid for the 2013‑2A securities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts are accurate: $1.3 billion is correctly reported for both the Series 2023-1A issuance and the repayment of the Series 2013-2A securities in March 2023. The format variation (using 'billion' instead of 'M' or numeric form) is acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the question: the principal amount issued in 2023 and the comparison to the amount repaid. (3) Entity accuracy is correct—Series 2023-1A and Series 2013-2A are properly identified with their respective years and actions (issuance vs. repayment). (4) The reasoning is sound and reflects correct multi-hop synthesis: the model infers the equivalence of the two amounts, indicating a refinancing, which aligns with the ground truth's interpretation. The conclusion that the amounts are equal is logically derived and clearly stated. All criteria for correctness, accuracy, and relevance are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 296,
        "total_tokens": 1455
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the facility's total borrowing capacity?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. This compares to a total borrowing capacity of $6.0 billion under the facility as of December 31, 2023.",
      "llm_answer": "During 2023 the company drew $3.0 billion on the 2021 Multicurrency Credit Facility and repaid $6.1 billion of revolving indebtedness (including €842.6 million). The facility’s total borrowing capacity is $6.0 billion, so the amount repaid alone already exceeds the full $6 billion limit and the combined borrow‑and‑repay activity ($9.1 billion) is well above the facility’s available borrowing amount.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3.0 billion borrowed and $6.1 billion repaid under the 2021 Multicurrency Credit Facility during 2023, matching the ground truth. It also correctly states the total borrowing capacity as $6.0 billion. However, it introduces an error by claiming that the amount repaid ($6.1 billion) exceeds the $6.0 billion capacity, implying a violation or inconsistency, which is misleading—credit facilities allow for multiple draws and repayments over time, so cumulative repayments can exceed the committed capacity. Additionally, the LLM incorrectly calculates 'combined borrow-and-repay activity' as $9.1 billion, treating borrowing and repayment as additive flows, which is not a standard or relevant metric in this context and misrepresents the facility usage. (2) All individual numbers are accurate: $3.0 billion borrowed, $6.1 billion repaid, $6.0 billion capacity. The calculation of $3.0 + $6.1 = $9.1 billion is mathematically correct but conceptually flawed. (3) The multi-hop reasoning is partially sound—information about borrowings, repayments, and capacity is correctly retrieved and attributed to the correct facility and time period. However, the synthesis and interpretation are flawed due to the incorrect implication that repayments exceeding capacity is anomalous or indicative of overuse. (4) The answer is factually mostly correct but includes a significant misinterpretation that affects the qualitative correctness. Hence, correctness score is 6 due to accurate data but flawed reasoning and misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 433,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "By how much did the total Intermodal revenue increase for UNP in 2021 compared to 2020, and how did this growth compare to the increase in average revenue per car for Intermodal during the same period?",
      "original_answer": "The total Intermodal revenue for UNP increased by $515 million in 2021 compared to 2020, and the average revenue per car for Intermodal increased by $136 during the same period.",
      "llm_answer": "UNP’s Intermodal freight revenue rose from $3.989 billion in 2020 to $4.504 billion in 2021 – an increase of **about $515 million (≈13 %)**.  During the same period, average revenue per Intermodal car grew from $1,267 to $1,403, a **rise of roughly $136 per car (≈11 %)**.  Thus, while total Intermodal revenue jumped by over half a billion dollars, the per‑car revenue increase was $136 per car.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the increase in total Intermodal revenue is accurately calculated as $515 million ($4.504B - $3.989B), which aligns with the ground truth. The average revenue per car increase is correctly reported as $136 ($1,403 - $1,267), also matching the original answer. Minor percentage figures (13%, 11%) are approximate but reasonable and not part of the ground truth requirement. (2) The answer is complete, addressing both parts of the question: the total revenue increase and the per-car revenue increase. (3) Entities are accurate: UNP is correctly identified, time period is 2020 to 2021, and the metric 'Intermodal' is consistently used. (4) The reasoning is sound and demonstrates multi-hop synthesis by combining revenue figures and per-car metrics across two years from likely different parts of the 10-K filings. The conclusion that both total revenue and per-car revenue increased is logically derived. (5) Semantic equivalence is achieved: while the LLM provides more granular data (exact revenue figures and per-car amounts), the core facts match the ground truth exactly. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 344,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021, and how does this compare to the net gain or loss reported from operations in the same region for the same year?",
      "original_answer": "The total capital expenditure in the EMENA region in 2021 was $534 million, while the net loss reported from operations in the same region was $24 million. This indicates that despite significant investment in the region, operations resulted in a net loss.",
      "llm_answer": "In 2021 ConocoPhillips spent **$534 million** on capital projects in the Europe, Middle East and North Africa (EMENA) region.  For the same year the company reported a **$24 million credit (gain)** from operations in EMENA, reflecting a reduction in asset‑retirement‑obligation estimates.  Thus, the region’s capital outlay far exceeded the modest operational gain – about 22 times larger.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies the capital expenditure in the EMENA region in 2021 as $534 million, matching the ground truth. However, it incorrectly states that the net gain from operations was $24 million, whereas the ground truth specifies a net *loss* of $24 million. This is a critical factual error in interpretation. 2) Quantitatively, all numbers are accurate in value and format ($534 million, $24 million), and the comparison of scale (22 times larger) is mathematically correct (534 / 24 ≈ 22.25). 3) The reasoning is partially sound: the model correctly synthesizes capital expenditure and operational results for EMENA in 2021, but mischaracterizes the nature of the operational outcome—reporting a 'credit (gain)' instead of a 'net loss'—which undermines the multi-hop conclusion. The mention of 'reduction in asset-retirement-obligation estimates' introduces a plausible source for the credit but contradicts the ground truth's explicit statement of a net loss, suggesting a failure in correctly interpreting or retrieving the financial result. 4) Despite accurate numbers and good contextual framing, the reversal of a loss into a gain significantly affects the qualitative accuracy and overall correctness, as it misrepresents the financial performance. Contextual relevance is high as the answer directly addresses both parts of the question with appropriate detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 382,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Microsoft position Copilot Pro within its AI-driven productivity strategy as described in its strategic ambitions, and in which specific revenue category is Copilot Pro classified in the financial reporting?",
      "original_answer": "Microsoft positions Copilot Pro as a consumer subscription service that offers faster and more powerful AI assistance in Microsoft 365 apps and on the web, aligning with its ambition to reinvent productivity and business processes. In the financial reporting, Copilot Pro is classified under 'Office Consumer products and cloud services revenue,' which includes Microsoft 365 Consumer and Copilot Pro subscriptions, Office licensed on-premises, and other Office services.",
      "llm_answer": "Microsoft frames Copilot Pro as a consumer‑focused AI subscription that delivers faster, more powerful assistance inside Microsoft 365 apps and on the web, reinforcing its “Reinvent productivity and business processes” ambition to embed AI across its productivity suite. In its financial reporting, Copilot Pro revenue is grouped under the **Office Consumer products and cloud services** revenue line.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes Microsoft's positioning of Copilot Pro as a consumer-focused AI subscription that enhances productivity in Microsoft 365 apps and on the web, aligning with the 'Reinvent productivity and business processes' strategic ambition. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable but not deficient. (3) The multi-hop reasoning is sound: the answer correctly links Copilot Pro’s strategic role with its financial classification, synthesizing information across strategic and financial reporting domains. (4) The revenue category is correctly identified as 'Office Consumer products and cloud services,' matching the original answer exactly in substance. Minor wording differences (e.g., 'consumer-focused' vs 'consumer subscription service') do not affect factual accuracy. All entities—Copilot Pro, Microsoft 365, Office Consumer products and cloud services—are correctly named and contextualized. The answer is concise, complete, and fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 329,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment, and how was this increase determined based on the Nasdaq stock price movement?",
      "original_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan was 128,000. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan in response to the 2024 special dividend, which was calculated using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the Nasdaq opening price of $662.70 on December 27, 2023 (the ex-dividend date), resulting in an adjustment factor of 1.018.",
      "llm_answer": "The 2024 special‑dividend adjustment added **128,000 RSU shares** to the pool of shares that could be granted under the 2019 Incentive Plan. The increase was calculated by applying a **1.018 adjustment factor** – the ratio of the Nasdaq closing price of **$674.62** on December 26, 2023 to the Nasdaq opening price of **$662.70** on December 27, 2023 – to the plan’s maximum issuable share count, which proportionally raised the grant‑available RSU shares by 128,000.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the increase of 128,000 RSU shares, the Nasdaq closing price of $674.62 on December 26, 2023, the opening price of $662.70 on December 27, 2023, and the resulting adjustment factor of 1.018 are all correctly reported. The calculation logic—using the ratio of closing to opening prices to determine the adjustment factor—is accurately described. (2) The answer is complete, addressing both parts of the question: the total increase in shares and how it was determined based on Nasdaq stock price movement. (3) Entity accuracy is correct: the 2019 Incentive Plan, 2024 special dividend, and relevant dates and prices are properly identified. (4) The multi-hop reasoning is sound—the model correctly synthesizes the cause (special dividend), the mechanism (price-based proportional adjustment), and the outcome (128,000 additional shares). The explanation conveys the same semantic meaning as the original answer, with clear and precise wording. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 312,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the headwinds from PFAS manufactured products quantitatively affect the 2024 sales performance of 3M's Transportation and Electronics segment when comparing reported sales to non-GAAP adjusted sales?",
      "original_answer": "The headwinds from PFAS manufactured products caused a 4.5 percentage point difference in the 2024 sales performance of 3M's Transportation and Electronics segment. Reported sales decreased by 1.4%, but when adjusted for PFAS-related special items, sales increased by 3.1%. This implies that the PFAS-related headwinds reduced sales growth by 4.5 percentage points (from +3.1% to -1.4%).",
      "llm_answer": "In 2024 the Transportation and Electronics segment reported sales of **$8.38 billion**, a **1.4 % decline** versus the prior year. When the PFAS‑related headwinds are removed (the non‑GAAP “adjusted sales” measure), sales are shown as **$7.44 billion**, reflecting a **3.1 % increase** year‑over‑year. Thus, the PFAS exit pressures turned what would have been a 3.1 % sales gain into a 1.4 % decline—a swing of roughly **4.5 percentage points** attributable to those headwinds.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical quantitative error in the reported dollar amounts, which undermines factual accuracy. While the percentage changes (1.4% decline, 3.1% increase, and 4.5 percentage point swing) are correctly stated and align with the ground truth, the absolute sales figures provided—$8.38 billion (reported) and $7.44 billion (adjusted)—are inconsistent with each other and with the stated growth rates. If adjusted sales are $7.44 billion and represent a 3.1% increase over the prior year, then prior-year sales would be approximately $7.22 billion. Applying a 1.4% decline to that base would yield reported 2024 sales of about $7.12 billion, not $8.38 billion. Alternatively, if reported 2024 sales are $8.38 billion (down 1.4%), prior-year sales were ~$8.50 billion, so adjusted sales (up 3.1%) should be ~$8.76 billion, not $7.44 billion. Thus, the dollar figures contradict the percentages, indicating a major factual inconsistency. The reasoning structure is sound—correctly identifying the 4.5 percentage point impact as the difference between +3.1% and -1.4%—and the entities (3M, Transportation and Electronics segment, PFAS headwinds, 2024) are accurate. The answer addresses the core question about the quantitative impact of PFAS headwinds on sales performance and correctly computes the 4.5 pp swing. However, the inclusion of fabricated or mismatched absolute sales figures introduces significant inaccuracy, warranting a moderate correctness score. Semantic equivalence fails on numerical consistency, though directional and relative impacts are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 433,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the total recognized gain on equity method investment contracts in 2021, and what was the fair value of these contracts as of December 31, 2021?",
      "original_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31, 2021, was $(3) million.",
      "llm_answer": "- The company recorded a **$2 million pre‑tax gain** on its equity‑method investment contracts for 2021.  \n- The **fair‑value of those contracts at December 31 2021 was a $3 million liability** (i.e., a net fair‑value of –$3 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, it accurately reports the $2 million recognized gain in 2021 and the $(3) million fair value (expressed as a $3 million liability or –$3 million), matching the original answer exactly in substance. Minor formatting differences (e.g., '–$3 million' vs. '$(3) million') are acceptable and common in financial reporting. (2) The answer addresses both parts of the multi-part question completely: the total recognized gain for 2021 and the fair value as of December 31, 2021. (3) Entity and metric identification is accurate—'equity-method investment contracts', '2021', and 'December 31, 2021' are all correctly referenced. (4) The reasoning is sound; the LLM correctly interprets a negative fair value as a liability, demonstrating proper financial understanding. No calculation errors or factual inaccuracies are present. The answer is contextually precise and fully aligned with the question's requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1102,
        "completion_tokens": 289,
        "total_tokens": 1391
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does Abbott Laboratories' use of interest rate hedge contracts with a total notional value of $2.2 billion as of December 31, 2024, impact the fair value of its long-term debt, which stood at $13.7 billion on that date?",
      "original_answer": "Abbott Laboratories uses interest rate hedge contracts totaling $2.2 billion to convert fixed-rate debt into variable-rate debt, directly affecting the fair value of its long-term debt. This hedging strategy reduces the volatility in the fair value of the $13.7 billion long-term debt caused by changes in long-term benchmark interest rates. Without these hedges, the fair value of the debt would fluctuate more significantly with market interest rate changes, potentially impacting Abbott's financial position and earnings.",
      "llm_answer": "Abbott uses interest‑rate swap contracts (notional ≈ $2.2 billion) as fair‑value hedges that convert the fixed‑rate portion of its debt to a variable rate; the swaps are recorded at fair value and an offsetting adjustment is made to the carrying amount of the hedged debt【page_40】.  As a result, about $2.1 billion of the $13.7 billion fair‑value of long‑term debt as of 31 Dec 2024 reflects the fair‑value impact of these hedges【page_65】, effectively incorporating the hedge‑related valuation change into the overall debt fair value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: the $2.2 billion notional value of interest rate hedges and the $13.7 billion fair value of long-term debt as of December 31, 2024, are accurately reported. The LLM adds a specific detail—$2.1 billion of the debt reflects the fair-value impact of hedges—which is not in the original answer but is plausible and consistent with hedging mechanics; this level of granularity enhances rather than contradicts the ground truth. (2) Quantitative accuracy is perfect: values match, dates are correct, and the slight variation in the $2.1 billion figure (vs. $2.2 billion notional) likely reflects fair value vs. notional difference, which is financially sound. (3) Reasoning is strong: the LLM correctly identifies the hedges as fair-value hedges that convert fixed-rate debt to variable, explains the accounting treatment (offsetting adjustment to debt carrying amount), and links this to the fair value of the total debt. This demonstrates proper multi-hop synthesis of hedging mechanics and financial reporting impact. (4) The answer is contextually fully relevant, directly addressing how the hedges impact the fair value of debt. The only minor gap is that the original emphasizes the *reduction in volatility* of fair value due to hedges, a risk management perspective slightly underemphasized in the LLM response, but the core financial impact is correctly conveyed. Thus, the answer earns a 9/10 overall for factual precision and completeness, missing only slight depth in explaining volatility mitigation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 440,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the total oil-equivalent proved reserves (in million barrels) for equity companies in Asia, and how does this compare to the total proved reserves for consolidated subsidiaries in Asia, based on the data from ExxonMobil's 2024 10-K filing?",
      "original_answer": "The total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 2,286 million barrels. This means that the consolidated subsidiaries in Asia hold approximately 1.8 times more oil-equivalent reserves than the equity companies in the same region.",
      "llm_answer": "ExxonMobil reports **2,779 million barrels of oil‑equivalent proved reserves for its equity‑company interests in Asia** (1,276 m bbl developed + 1,503 m bbl undeveloped).  \n\nThe **consolidated‑subsidiary interests in Asia hold 3,601 million barrels** (2,286 m bbl developed + 1,315 m bbl undeveloped), which is **about 822 million barrels more** than the equity‑company total.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported numbers. According to the ground truth, the total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, and for consolidated subsidiaries, 2,286 million barrels. However, the LLM incorrectly reports equity-company reserves as 2,779 million barrels (sum of 1,276 + 1,503) and consolidated subsidiaries as 3,601 million barrels (2,286 + 1,315), which are not supported by the original answer. These totals do not appear in the ground truth and represent a misinterpretation or miscalculation of the data. (2) The calculation of the difference (822 million barrels more) is based on incorrect totals and is therefore invalid. The correct difference is 2,286 - 1,276 = 1,010 million barrels, and the correct ratio is approximately 1.8 times, not addressed in the LLM answer. Instead, the LLM introduces a comparison not in the original answer (absolute difference), while missing the relative comparison (1.8x) that was central to the ground truth. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize developed and undeveloped reserves, but it does so using incorrect data or misattributed breakdowns. The original answer does not provide a split between developed and undeveloped reserves, so including these figures appears to be fabrication or sourcing from outside the provided truth. (4) Contextually, the answer addresses the right region (Asia), entities (equity companies vs. consolidated subsidiaries), and metric (oil-equivalent proved reserves), so relevance is high. However, due to major quantitative inaccuracies and incorrect synthesis, the correctness score is low despite appropriate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 477,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the Swiss Tax Reform impact Mondelēz International's effective tax rate in 2019, and what was the net financial benefit recorded in that year as a result of this reform?",
      "original_answer": "The Swiss Tax Reform reduced Mondelēz International's effective tax rate in 2019 by 22.3 percentage points, contributing to a net financial benefit of $767 million recorded during that year.",
      "llm_answer": "The Swiss tax reform caused Mondelēz’s 2019 effective tax rate to collapse to **about 0.1 %** (versus roughly 22 % when the reform impact is excluded).  The reform generated a **net tax benefit of roughly $767 million** (a $769 million reduction in deferred‑tax expense offset by a $2 million indirect‑tax charge).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net financial benefit as $767 million, matching the ground truth exactly. It also accurately describes the impact on the effective tax rate by stating it dropped to about 0.1% from approximately 22%, which implies a reduction of roughly 21.9 percentage points. While this is very close to the ground truth reduction of 22.3 percentage points, it is not exact—likely due to rounding or estimation in the LLM's source. However, the core quantitative impact is effectively captured. (2) All numbers are correct within acceptable rounding: $767 million is explicitly stated and matches the ground truth; the breakdown into a $769 million deferred-tax reduction and $2 million indirect-tax charge adds up correctly and provides additional accurate context not in the original answer but consistent with it. (3) The multi-hop reasoning is sound: the model connects the Swiss Tax Reform to both the change in effective tax rate and the net financial benefit in 2019, correctly attributing both effects to the same event and company. (4) The answer is semantically equivalent and highly relevant, with slightly more detail than the ground truth. The minor deviation in the precise percentage point reduction (21.9 vs 22.3) prevents a perfect 10, but the overall correctness, especially on the key financial figure, warrants a 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 383,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What was the total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG?",
      "original_answer": "The total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG was $665 million.",
      "llm_answer": "PepsiCo transferred pension and retiree‑medical obligations worth **$145 million** to TBG in connection with the Juice Transaction, and it recognized a **$520 million** gain from the fair‑value remeasurement of its 39 % stake in TBG. Combined, these two items produced a total 2022 financial impact of roughly **$665 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key facts are accurate: the $145 million pension obligation transfer to TBG and the $520 million gain from remeasurement of PepsiCo's 39% stake in TBG are correctly stated. The combined total impact of $665 million is accurate and properly calculated ($145M + $520M = $665M). (2) Quantitative accuracy is perfect: both individual figures match the source data, the percentage ownership (39%) is correct, and the final sum is mathematically sound. Minor formatting like bolding and spacing (e.g., '39 %' vs '39%') does not affect meaning. (3) The multi-hop reasoning is sound—information about two distinct financial events (obligation transfer and equity remeasurement) is correctly synthesized into a single net impact, as required by the question. (4) The answer is semantically equivalent to the original, providing the same conclusion with additional contextual clarity (e.g., specifying 'retiree-medical obligations' and 'Juice Transaction', which are consistent with the knowledge graph). All entities (PepsiCo, TBG, 2022 time frame) are correctly identified. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 334,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total amount of sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and how does this compare to the accrued but unpaid sales-based milestone payments as of December 31, 2021?",
      "original_answer": "Merck made $200 million in sales-based milestone payments to Eisai for Lenvima in 2021. As of December 31, 2021, $600 million in sales-based milestone payments were accrued but not yet paid. This indicates that the accrued but unpaid amount was three times the amount paid in 2021.",
      "llm_answer": "In 2021 Merck paid **$200 million** in sales‑based milestone payments to Eisai for Lenvima.  As of December 31 2021, sales‑based milestone payments that had accrued but remained unpaid totaled **$600 million**, i.e., **$400 million more** than the amount actually paid during the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $200 million in sales-based milestone payments made by Merck to Eisai for Lenvima in 2021 and the $600 million accrued but unpaid as of December 31, 2021, matching the ground truth exactly. These values are factually accurate and properly attributed. (2) The quantitative comparison is correct: $600 million is indeed $400 million more than $200 million, and this difference is accurately stated. While the original answer uses a multiplicative comparison (three times), the LLM uses an additive one ($400 million more), which is mathematically correct and semantically valid. No calculation errors are present. (3) The multi-hop reasoning is sound—information about payments made during the year and accrued but unpaid balances at year-end is correctly synthesized from different aspects of the financial arrangement. (4) The answer is fully contextually relevant and conveys the same core information as the ground truth, though it expresses the comparison differently. The slight difference in framing (additive vs. multiplicative) does not reduce factual accuracy, hence a 9/10 on correctness and qualitative accuracy to reflect equivalent but non-identical reasoning expression.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 347,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How much cash did PepsiCo receive from the sale of the Naked brand and other juice brands to PAI Partners, and what percentage ownership interest in TBG did PepsiCo retain as part of the transaction?",
      "original_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and retained a 39% noncontrolling ownership interest in TBG.",
      "llm_answer": "PepsiCo received roughly **$3.5 billion in cash** from the sale of the Naked brand and other juice brands to PAI Partners, and it retained a **39 % ownership (non‑controlling) interest in TBG** as part of that transaction.【page_111】【page_6】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the cash amount of $3.5 billion and the retained ownership interest of 39% are accurately reported, with acceptable formatting variations (e.g., '3.5 billion' vs. '$3.5 billion', '39%' vs. '39 %'). (2) The answer is complete, addressing both parts of the question: the cash received and the percentage ownership retained. (3) Entity accuracy is correct—PepsiCo, PAI Partners, and TBG are all properly identified, and the transaction context is accurate. (4) The reasoning is sound, demonstrating correct multi-hop synthesis by linking the sale of the Naked and other juice brands to the financial proceeds and the retained stake in TBG. (5) The semantic meaning is equivalent to the original answer, with only minor stylistic differences (e.g., bolding, spacing) that do not affect factual content. The cited page references add contextual support. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 284,
        "total_tokens": 1403
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does Southern Company's adoption of the fair value approach for liability-hedging securities, as opposed to the calculated value approach, affect the recognition of changes in the market value of plan assets in relation to the measurement of net periodic pension cost?",
      "original_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities results in the immediate recognition of changes in the market value of these plan assets, as opposed to amortizing these changes over five years under the calculated value approach. This change leads to a more current reflection of asset value changes in the measurement of net periodic pension cost, aligning it more closely with the changes in the related pension obligations.",
      "llm_answer": "By switching to the fair‑value method for the liability‑hedging portion of its pension assets, Southern Company now records any change in the market value of those securities **immediately** in the market‑related value used to compute the expected return on plan assets. Under the prior calculated‑value approach the gains and losses were smoothed and amortized over five years, deferring their impact on net periodic pension cost. The fair‑value approach therefore makes the measurement of net periodic pension cost reflect current asset‑value changes more directly and in line with the related benefit‑obligation changes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Southern Company's adoption of the fair value approach leads to immediate recognition of market value changes in liability-hedging securities, as opposed to the five-year amortization under the calculated value approach. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the temporal period 'five years' is correctly cited and matches the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes the accounting implications of two different valuation methods and links them to the impact on net periodic pension cost. (4) The answer fully addresses the question by explaining how the change in accounting approach affects the timing and alignment of asset value recognition with pension obligations. Wording differs slightly but meaning is preserved with high precision. All entities—Southern Company, liability-hedging securities, fair value vs. calculated value approaches, and net periodic pension cost—are accurately referenced and logically connected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 324,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total increase in Netflix's content spending from 2019 to 2021, and how did the growth in produced content compare to the growth in licensed content over this period?",
      "original_answer": "Netflix's total content spending increased by $3,014,120,000 from 2019 to 2021. During this period, produced content spending grew by $2,201,108,000, which was a significantly faster rate of growth compared to the $813,012,000 increase in licensed content spending.",
      "llm_answer": "Netflix’s total content spending rose from $9.216 billion in 2019 to $12.230 billion in 2021 – an increase of roughly $3.0 billion【page_53】.  During the same period, produced‑content costs grew from $1.973 billion to $4.175 billion (≈ $2.2 billion), while licensed‑content costs rose from $7.243 billion to $8.056 billion (≈ $0.8 billion)【page_53】.  Thus, the increase in produced‑content spending was about three times larger than the increase in licensed‑content spending.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively, the total spending increase is correctly calculated: $12.230B - $9.216B = $3.014B ($3,014,000,000), which aligns with the ground truth of $3,014,120,000 (the $120,000 difference is negligible and likely due to rounding). Produced content spending increased from $1.973B to $4.175B, a rise of $2.202B ($2,202,000,000), matching closely with the ground truth $2,201,108,000. Licensed content rose from $7.243B to $8.056B, an increase of $813M ($813,000,000), nearly identical to the ground truth $813,012,000. Minor rounding differences are acceptable. (2) The answer fully addresses both parts of the question: total spending increase and comparative growth between produced and licensed content. (3) All entities—Netflix, years (2019–2021), and content spending categories—are correctly identified. (4) The reasoning is sound: the LLM correctly computes differences, compares growth rates, and concludes that produced content spending grew about three times faster, which is consistent with the data. The use of approximate values (e.g., ≈$2.2B, ≈$0.8B) is appropriate and semantically equivalent to the precise figures. Only a minor deduction in quantitative accuracy due to slight rounding discrepancies, but these do not affect the correctness of the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 378,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total pre-tax impairment charge recorded by PepsiCo in 2023 related to its 39% noncontrolling interest in TBG, and how does this compare to the gain recognized in 2022 from the remeasurement of the same investment?",
      "original_answer": "PepsiCo recorded a pre-tax impairment charge of $321 million in 2023 related to its 39% noncontrolling interest in TBG. In contrast, in 2022, the company recognized a gain of $520 million from the remeasurement of this investment at fair value. This results in a net pre-tax difference of -$199 million over the two-year period.",
      "llm_answer": "PepsiCo recorded a **pre‑tax impairment charge of $321 million in 2023** for its 39 % non‑controlling interest in TBG (recorded in PBNA SG&A). In contrast, the **2022 remeasurement of the same investment produced a pre‑tax gain of $520 million**. Thus, the 2023 impairment is about $199 million less (and opposite in direction) than the gain recognized in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the pre-tax impairment charge of $321 million in 2023 and the $520 million gain in 2022 from the remeasurement of PepsiCo's 39% noncontrolling interest in TBG, matching the ground truth exactly. These numbers are accurate and properly attributed to the correct years and context. (2) The comparison states that the 2023 impairment is 'about $199 million less (and opposite in direction)' than the 2022 gain. This is semantically equivalent to the ground truth's 'net pre-tax difference of -$199 million,' as $520M - $321M = $199M, and the reversal in sign (gain to loss) is correctly implied. The phrasing 'about $199 million less' is slightly less precise than stating the net difference as -$199 million, but it captures the economic impact accurately. (3) The multi-hop reasoning is sound: the model synthesizes data across two years, correctly identifies the nature of the items (impairment vs. remeasurement gain), and draws a valid comparison. The mention of 'PBNA SG&A' adds contextual detail not required but factually consistent. (4) Scores reflect near-perfect factual accuracy, with only a minor deduction in qualitative accuracy due to slightly less formal framing of the net difference. All entities (PepsiCo, TBG, 39% noncontrolling interest, 2022/2023) are correct, and the answer is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 384,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Netflix's increased investment in original programming in 2021 affect content amortization and cost of revenues as a percentage of revenue?",
      "original_answer": "Netflix's increased investment in original programming in 2021 led to a $1,423 million increase in content amortization. Despite this rise in amortization, the cost of revenues as a percentage of revenue decreased from 61% to 58%, primarily due to delays in content releases caused by the COVID-19 pandemic, which slowed the rate of amortization growth relative to revenue growth.",
      "llm_answer": "Netflix’s larger spend on original programming pushed content‑amortization up by about $1.4 billion in 2021. Even with that rise, cost of revenues fell to 58 % of total revenue, down from 61 % in 2020, because revenue grew faster than the amortization expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.4 billion increase in content amortization (matching the ground truth $1,423 million, with acceptable rounding). The cost of revenues as a percentage of revenue is accurately reported as decreasing from 61% to 58%. (2) All numeric values are correct or acceptably rounded: $1.4 billion ≈ $1,423 million, and percentages (61% to 58%) match exactly. (3) The reasoning is mostly sound—correctly noting that amortization increased but cost of revenues as a percentage decreased due to revenue growing faster. However, the LLM omits the specific cause mentioned in the ground truth: delays in content releases due to the COVID-19 pandemic, which slowed amortization growth relative to revenue. This is a minor omission in qualitative reasoning but does not invalidate the conclusion. (4) The answer is contextually complete and relevant, addressing both parts of the question—impact on amortization and cost of revenues as a percentage. The omission of the pandemic-related context slightly affects qualitative accuracy but not overall correctness. Hence, high scores across all dimensions with a 9 in correctness due to missing nuance in causal explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 342,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the combined total net revenue from Ozurdex in 2024, and how did its international revenue growth compare to the previous year in terms of percentage change at actual currency rates?",
      "original_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Its international revenue grew by 8.3% compared to the previous year at actual currency rates.",
      "llm_answer": "In 2024 Ozurdex generated **$494 million** in net revenue (U.S. $138 million + International $356 million). Its international sales rose **about 8.3 %** versus 2023 when measured at actual currency rates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the combined total net revenue for Ozurdex in 2024 as $494 million, which matches the ground truth. It breaks this down into U.S. ($138 million) and International ($356 million) components, and their sum (138 + 356 = 494) is accurate. The international revenue growth is reported as 'about 8.3%' compared to the previous year at actual currency rates, which aligns exactly with the ground truth of 8.3%. (2) All numeric values are correct and consistent with the original answer. The calculation of total revenue from the components is valid and matches the stated total. Percentage change is reported accurately with appropriate rounding ('about 8.3%'). (3) The multi-hop reasoning is sound: the model correctly synthesized U.S. and international figures to compute the total and accurately compared international revenue across years at actual currency rates. (4) All aspects of the question are addressed completely and accurately. The answer is factually correct, semantically equivalent to the ground truth, and provides additional helpful breakdown without introducing errors. Hence, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1103,
        "completion_tokens": 329,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total pretax gain Target Corporation recognized from the sale of Dermstore LLC, and how was this gain treated in the financial statements according to the notes?",
      "original_answer": "Target Corporation recognized a total pretax gain of $335 million from the sale of Dermstore LLC, and this gain was included in Net Other Income in the financial statements.",
      "llm_answer": "Target recorded a **$335 million pretax gain** on the February 2021 sale of Dermstore LLC.  The gain was **included in “Net Other (Income) / Expense”** (i.e., non‑operating income) and appears as a “gain on Dermstore sale” adjustment in the reconciliation of net earnings to cash provided by operating activities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the pretax gain of $335 million is accurately reported, and the date of the sale (February 2021) is consistent with the source data. (2) The treatment of the gain in the financial statements is correctly described: it was included in 'Net Other Income' (or 'Net Other (Income) / Expense'), which aligns with the ground truth's 'Net Other Income'. The additional detail that it appears as a 'gain on Dermstore sale' in the cash flow reconciliation enhances accuracy without contradicting the original. (3) Entity accuracy is correct: Target Corporation and Dermstore LLC are properly identified. (4) The reasoning is sound and reflects proper synthesis across financial statement notes and income statement classification. (5) Semantic equivalence is maintained—though the LLM provides slightly more context, all information is factually aligned with the ground truth. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 289,
        "total_tokens": 1417
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What is the difference between the amortized cost and fair value of Salesforce's (CRM) mortgage-backed obligations as reported in their 2024 10-K, and what percentage of the total marketable securities at fair value does this difference represent?",
      "original_answer": "The difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations is $8 million ($244 million amortized cost - $236 million fair value). This $8 million difference represents approximately 0.14% of the total marketable securities at fair value ($5,722 million).",
      "llm_answer": "Salesforce’s mortgage‑backed obligations were carried at an amortized cost of **$244 million** versus a fair‑value of **$236 million**, a **$8 million** gap. That $8 million equals roughly **0.14 %** of the company’s total marketable‑securities fair value of **$5,722 million** reported in the 2024 10‑K.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: amortized cost ($244 million), fair value ($236 million), difference ($8 million), total marketable securities at fair value ($5,722 million), and percentage (0.14%). Minor formatting differences (e.g., use of en dashes, spacing in numbers like '244 million') do not affect accuracy. (2) Calculations are correct: $244M - $236M = $8M; ($8M / $5,722M) ≈ 0.14%. (3) The multi-hop reasoning is sound—information about mortgage-backed obligations and total marketable securities comes from different parts of the 10-K and must be correctly synthesized, which the model did. (4) The entities are correctly identified: Salesforce (CRM), 2024 10-K, mortgage-backed obligations, and marketable securities. The answer is semantically equivalent to the original, with clear, concise restatement of the same facts. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 281,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of adopting the new LDTI accounting guidance, and what time periods do these adjustments cover according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statements of comprehensive income and its consolidated balance sheet as a result of adopting the new LDTI accounting guidance. The adjustments to the consolidated statements of comprehensive income reflect the effects of the guidance as of December 31, while the balance sheet adjustments were applied to the financials as of December 31, 2022.",
      "llm_answer": "MetLife applied the new LDTI guidance retrospectively to all of its consolidated financial statements – the statement of comprehensive income, the balance sheet, the statement of operations, the statement of equity and the statement of cash flows 【page_164】【page_162】【page_163】【page_165】【page_166】. The adjustments were made to the previously reported figures for the two most recent fiscal years, 2022 and 2021 (the equity tables also show the cumulative effect on balances as of the end‑of‑year dates for 2020‑2022).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies compared to the ground truth. (1) It incorrectly states that *all* consolidated financial statements were retrospectively adjusted, including the statement of operations, statement of equity, and statement of cash flows, while the original answer specifies only the consolidated statements of comprehensive income and the consolidated balance sheet were adjusted. This overstatement misrepresents the scope of the adjustment. (2) Regarding time periods, the LLM claims adjustments were made for 2022 and 2021, with cumulative effects going back to 2020, but the ground truth specifies that balance sheet adjustments were applied as of December 31, 2022, and income statement effects as of December 31 (without specifying prior years). The mention of 2020–2022 equity adjustments is not supported in the original answer. (3) The multi-hop reasoning is flawed because the model extrapolates adjustments to financial statements not mentioned in the ground truth, suggesting a failure to precisely extract and synthesize the correct information from the filing. (4) While the mention of retrospective application and some correct statements (e.g., comprehensive income and balance sheet) provide partial alignment, the inclusion of extra statements and incorrect time period coverage reduces factual accuracy. Quantitative accuracy is moderate due to correct mention of 2022 but incorrect extension to 2021 and 2020. Qualitative accuracy suffers from overgeneralization and incorrect entity (financial statement) identification. Contextual relevance is fair as the response addresses the topic and cites pages, but with factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 463,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total potential financing commitment Disney has through its two cruise ship credit facilities, and how does the interest rate structure differ between the Disney Treasure and the Disney Destiny borrowings?",
      "original_answer": "Disney has a total potential financing commitment of $2.2 billion through its two cruise ship credit facilities. The Disney Treasure borrowing carries a fixed interest rate of 3.80%, while the Disney Destiny borrowing, if utilized, will have a fixed interest rate of 3.74%.",
      "llm_answer": "Disney’s two cruise‑ship credit facilities provide a combined financing commitment of **$2.2 billion** ($1.1 billion for each ship). The loan taken for the **Disney Treasure** carries a **fixed 3.80 % rate**, payable semi‑annually over 12 years, whereas the facility that could be used for the **Disney Destiny** would bear a **slightly lower fixed rate of 3.74 %**, also payable semi‑annually over 12 years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total financing commitment of $2.2 billion is accurately stated, with correct attribution of $1.1 billion per ship (implied in the original answer). The interest rates—3.80% for Disney Treasure and 3.74% for Disney Destiny—are exactly correct. Minor additional details (semi-annual payments, 12-year term) are consistent with typical financing structures and do not contradict the ground truth. (2) The answer addresses both parts of the question: total commitment and interest rate differences. (3) Entities—Disney, Disney Treasure, Disney Destiny—are correctly identified. (4) The reasoning is sound: the model correctly synthesizes that there are two facilities totaling $2.2 billion and differentiates the fixed rates between the two ships. The slight expansion on payment frequency and term does not introduce error and may reflect knowledge from the source documents. Semantic equivalence is maintained, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 297,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How much did Chevron's equity in earnings from Angola LNG Limited contribute to its total upstream equity earnings in 2024, and what does this indicate about Chevron's production involvement in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings of $3,580 million in 2024. This indicates that Chevron has a significant production involvement in Angola, as Angola LNG is one of its equity method affiliates contributing directly to upstream earnings, and Chevron's production volumes include its share from Angola LNG operations.",
      "llm_answer": "In 2024 Chevron recorded $405 million of equity‑in‑earnings from its 36.4 % interest in Angola LNG Limited, which made up roughly 11 % of the company’s total upstream equity earnings of $3.58 billion. This sizable share shows that Chevron’s upstream portfolio includes a material production stake in Angola’s natural‑gas‑to‑LNG operations, contributing directly to its overall upstream earnings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $405 million equity earnings from Angola LNG Limited and the total upstream equity earnings of $3.58 billion (equivalent to $3,580 million) are accurate, with the 11% proportion being a correct approximation (405 / 3580 ≈ 0.113, or 11.3%, rounded to 11%). The 36.4% ownership interest, while not in the original answer, is plausible supplemental detail that does not contradict the ground truth. (2) The answer addresses both parts of the question: the dollar contribution ($405 million) and what it indicates about Chevron's production involvement in Angola. (3) All entities—Chevron, Angola LNG Limited, upstream equity earnings—are correctly identified and contextualized. (4) The reasoning is sound: the LLM correctly infers that a significant equity earnings contribution indicates material production involvement, aligning with the ground truth's conclusion about Chevron's direct contribution from Angola LNG operations. The answer demonstrates proper multi-hop synthesis by linking equity earnings to production involvement via ownership in an affiliate. Semantic equivalence is maintained throughout, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 347,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, and how much of this amount was converted into U.S. dollar denominated borrowings through cross-currency swaps?",
      "original_answer": "The total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, was Canadian $2.6 billion (CAD $1.3 billion + CAD $1.3 billion). Of this, Canadian $1.3 billion ($1.0 billion USD) remained outstanding and was converted into U.S. dollar denominated borrowings through cross-currency swaps, while the other Canadian $1.3 billion ($0.9 billion USD) was paid in October 2024.",
      "llm_answer": "Disney had Canadian‑dollar senior notes totaling **C$2.6 billion** outstanding as of September 28, 2024 (two C$1.3 billion issues). The company entered into cross‑currency swaps that **converted the entire C$2.6 billion** into variable‑rate U.S.‑dollar borrowings indexed to SOFR.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total Canadian dollar denominated notes outstanding as C$2.6 billion as of September 28, 2024, which matches the ground truth (C$1.3 billion + C$1.3 billion). However, it incorrectly states that the *entire* C$2.6 billion was converted into U.S. dollar denominated borrowings via cross-currency swaps. According to the ground truth, only C$1.3 billion (equivalent to $1.0 billion USD) was converted through swaps, while the other C$1.3 billion was paid off in October 2024 and thus not swapped. This is a critical factual error affecting the core of the second part of the question. (2) Quantitatively, the total note amount is correct, but the breakdown of how much was swapped is wrong. The LLM reports full conversion, whereas only half was swapped. The absence of the $0.9 billion USD figure (related to the repaid portion) further reduces quantitative accuracy. (3) The reasoning fails on the multi-hop synthesis: the model must recognize that not all outstanding debt as of September 28 remained beyond that date, and only a portion was hedged via swaps. The answer reflects a failure to distinguish between outstanding debt and hedged debt, indicating flawed logic. (4) Despite the significant error in the key financial conclusion, the context and entities (Disney, Canadian dollar notes, cross-currency swaps, SOFR) are relevant and correctly framed, warranting a high contextual relevance score. However, due to the major inaccuracy in the swap amount, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 423,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023?",
      "original_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,380 million. This is calculated by summing the $1,265 million in private funds from the U.S. Plans and the $115 million in private funds from the Non-U.S. Plans.",
      "llm_answer": "Honeywell reported **$1,265 million** of private‑fund investments in its U.S. pension plans and **$115 million** in its non‑U.S. pension plans for a combined fair‑value total of **approximately $1.38 billion** as of December 31, 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: $1,265 million for U.S. Plans and $115 million for Non-U.S. Plans are correctly reported. The total fair value is stated as approximately $1.38 billion, which is numerically equivalent to $1,380 million (since $1.38 billion = $1,380 million). Minor formatting differences (e.g., 'billion' vs 'million') are acceptable and common in financial reporting. (2) The calculation is accurate: 1,265 + 115 = 1,380 million. The use of 'approximately' is reasonable given the rounding to $1.38 billion. (3) The multi-hop reasoning is sound—information from both U.S. and Non-U.S. Plans is correctly synthesized to arrive at the total. (4) Entities (Honeywell, private funds, U.S. and Non-U.S. Plans, December 31, 2023) are correctly identified and contextualized. The answer is concise, relevant, and fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 270,
        "total_tokens": 1403
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, impact the structure of its revenue recognition for cloud versus license-based offerings?",
      "original_answer": "Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, leads to a distinct revenue recognition pattern where cloud services revenues are generally recognized ratably over the contractual period, while on-premise and cloud license revenues are recognized up front at the point of delivery. This difference results in more predictable and stable revenue streams from Oracle Cloud Services compared to the point-in-time recognition of license revenues, which can be significantly affected by the timing of large license transactions.",
      "llm_answer": "Oracle’s “choice‑and‑flexibility” strategy creates two distinct revenue‑recognition patterns. Cloud‑based offerings—including SaaS, IaaS and subscription‑based license‑support—are billed in advance but are recorded ratably over the contract term (or as usage is consumed), while perpetual cloud or on‑premise software licenses are recognized at the point the software is made available to the customer, with any accompanying support contracts recognized ratably over their one‑year term. Thus, as more customers move to Oracle Cloud Services, a larger share of total revenue is spread over time, whereas traditional license sales remain a point‑in‑time revenue stream.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the two distinct revenue recognition patterns: ratable recognition for cloud services (SaaS, IaaS, subscription-based) and point-in-time recognition for perpetual on-premise and cloud licenses. This aligns with the original answer's emphasis on ratable vs. up-front recognition. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes how deployment models (cloud vs. on-premise) map to different revenue recognition treatments under accounting standards, and infers the financial impact—increasing cloud adoption leads to more revenue being recognized over time rather than upfront. (4) Minor deduction in qualitative accuracy due to slight over-specification: the mention of 'usage is consumed' and 'billed in advance' is not in the original and, while plausible, introduces nuances not confirmed in the ground truth. Also, 'perpetual cloud' license is an ambiguous term not clearly defined in the context. However, these do not undermine the overall correctness. The answer is fully contextually relevant and directly addresses how Oracle's flexible deployment strategy impacts revenue recognition structure between cloud and license offerings.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 392,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total worldwide sales growth percentage of ERLEADA from 2021 to 2023, and how did this growth contribute to the overall performance of the Oncology segment in 2023 compared to 2022?",
      "original_answer": "ERLEADA's worldwide sales grew from $1,291 million in 2021 to $2,387 million in 2023, representing an 84.9% increase over the two-year period. In 2023, ERLEADA's sales increased by 26.9% compared to 2022, contributing significantly to the overall Oncology segment's 10.5% total sales growth in 2023. ERLEADA was the third-largest contributor to the Oncology segment's growth after DARZALEX (22.2% growth) and TREMFYA (17.9% growth), highlighting its strong performance within the portfolio.",
      "llm_answer": "ERLEADA’s worldwide sales rose from $1.291 billion in 2021 to $2.387 billion in 2023 – an increase of about **84.9 %**.  The Oncology segment’s total sales grew 10.5 % year‑over‑year (from $15.983 billion in 2022 to $17.661 billion in 2023), and ERLEADA’s 26.9 % growth (≈ $506 million) was a major contributor to that overall segment improvement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: ERLEADA's sales growth from $1.291 billion in 2021 to $2.387 billion in 2023 (84.9% increase), the 26.9% year-over-year growth in 2023, and the Oncology segment’s 10.5% growth. The dollar amounts and percentages match the ground truth exactly, with acceptable format variations (e.g., $1.291 billion = $1,291 million). (2) Calculations are accurate: the 84.9% two-year growth and 26.9% YoY growth are correct based on the provided figures. The LLM even adds a precise incremental sales increase of ~$506 million (from ~$1.881B to ~$2.387B), which is consistent with the data. (3) The multi-hop reasoning is sound: the answer links ERLEADA’s performance to the broader Oncology segment growth, correctly identifying its role as a major contributor. However, it omits a specific detail from the ground truth: ERLEADA was the third-largest contributor after DARZALEX and TREMFYA, which provides additional context about its relative impact. While not critical, this nuance enhances completeness. (4) The answer is semantically equivalent and highly relevant, with excellent quantitative precision and strong qualitative reasoning. The minor omission prevents a perfect 10, but the core facts, calculations, and synthesis are fully correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 367,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, and how does this compare to the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date?",
      "original_answer": "As of December 31, 2023, the notional amount of net investment hedge derivative contracts was $7,456 million, and the notional amount of non-U.S. dollar denominated debt used as net investment hedges totaled $4,355 million (comprising $3,516 million in Euro notes, $386 million in Swiss franc notes, and $453 million in Canadian dollar notes), for a combined total of $11,811 million. Meanwhile, the total fair value of derivative assets recorded in other current assets and other assets was $1,347 million and $250 million, respectively, for a total of $1,597 million. This indicates that the notional amount of the hedges significantly exceeds the fair value of the derivative assets.",
      "llm_answer": "- The 2023 derivative‑volume table shows a notional $7.456 billion in net‑investment‑hedge derivative contracts and $4.355 billion in non‑U.S.‑dollar debt designated as net‑investment hedges (Euro $3.516 bn + Swiss‑franc $0.386 bn + Canadian‑dollar $0.453 bn), for a combined notional amount of **≈ $11.8 billion**.\n\n- On the consolidated balance sheet, MDLZ records the fair value of derivative **assets** of **$1.347 billion** in other current assets and **$0.250 billion** in other assets, totaling **≈ $1.6 billion** of derivative‑asset fair value.  \n\nThus, the notional amount of net‑investment‑hedge contracts and debt (~$11.8 bn) is roughly **seven‑times larger** than the $1.6 bn fair‑value of derivative assets shown on the balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $7.456 billion (notional of derivative contracts), $4.355 billion (non-USD debt), broken down into $3.516B (Euro), $0.386B (Swiss franc), and $0.453B (Canadian dollar), summing to a combined notional of $11.811 billion, which the LLM correctly rounds to ≈$11.8 billion. The fair values of derivative assets are correctly reported as $1.347 billion (other current assets) and $0.250 billion (other assets), totaling $1.597 billion, rounded appropriately to ≈$1.6 billion. (2) Calculations are accurate: the sum of the notional amounts and fair values are correct, and the comparison (notional being ~7x the fair value) is a reasonable approximation (11.8 / 1.6 ≈ 7.375), which is semantically valid. (3) The multi-hop reasoning is sound—information is synthesized across derivative contracts, debt instruments, and balance sheet line items, all tied to MDLZ as of December 31, 2023. (4) The answer addresses both parts of the question: total notional of hedges and comparison to fair value of derivative assets. All entities (MDLZ, net investment hedges, derivative assets, balance sheet categories) are correctly identified. Wording differs slightly but maintains full semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 378,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023?",
      "original_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $686 million. This is calculated by adding $676 million from the U.S. Plans and $10 million from the Non-U.S. Plans.",
      "llm_answer": "Honeywell’s pension plans held **$676 million** of mortgage/asset‑backed securities in the U.S. plans and **$10 million** in the non‑U.S. plans at December 31 2023, for a combined total of **approximately $686 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: $676 million for U.S. Plans and $10 million for Non-U.S. Plans are correctly reported. The combined total of $686 million is accurate and properly calculated. (2) Quantitative accuracy is perfect—numbers match exactly, with only minor formatting differences (e.g., 'approximately $686 million' vs. exact $686 million), which is semantically acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesized data from both U.S. and Non-U.S. plans and performed the correct summation. (4) Entity accuracy is correct—Honeywell, mortgage/asset-backed securities, and the date December 31, 2023, are all properly identified. The answer is concise, relevant, and conveys the same information as the original answer with equivalent wording. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 265,
        "total_tokens": 1386
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How much total prepaid royalty revenue from Nestlé is remaining to be recognized by Starbucks as of September 29, 2024, and how does this relate to the Global Coffee Alliance's 40-year arrangement?",
      "original_answer": "As of September 29, 2024, Starbucks had $177.0 million (current) and $5.8 billion (long-term) of deferred revenue remaining to be recognized from the $7 billion up-front prepaid royalty received from Nestlé. This recognition schedule is based on the 40-year estimated economic life of the Global Coffee Alliance arrangement, over which the payment is being recognized on a straight-line basis as other revenue.",
      "llm_answer": "As of September 29 2024 Starbucks had $177 million of current deferred revenue and $5.8 billion of long‑term deferred revenue tied to the Nestlé up‑front payment – a total of roughly **$5.98 billion** of prepaid royalty revenue still to be recognized.  That balance is being amortized on a straight‑line basis over the estimated 40‑year economic life of the Global Coffee Alliance licensing arrangement, so the remaining amount will be recognized gradually over the remaining years of that 40‑year term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the current deferred revenue ($177 million) and long-term deferred revenue ($5.8 billion) as of September 29, 2024, matching the ground truth. The total prepaid royalty revenue to be recognized is accurately calculated as approximately $5.98 billion ($177 million + $5.8 billion), which is consistent with the $7 billion up-front payment with partial recognition already occurred. The mention of straight-line amortization over the 40-year economic life of the Global Coffee Alliance is factually correct and aligns with the original answer.\n\n2) Quantitative accuracy is perfect: $177 million (current) and $5.8 billion (long-term) are correctly reported. The sum of $5.98 billion is accurate and appropriately labeled as 'roughly' $5.98 billion, acknowledging rounding. The date (September 29, 2024) is correct. No calculation or numeric errors.\n\n3) The multi-hop reasoning is sound: the model correctly links the deferred revenue components to the original $7 billion Nestlé payment, recognizes that the remaining balance is being amortized, and ties this to the 40-year term of the Global Coffee Alliance. It synthesizes the financial structure with the contractual arrangement correctly.\n\n4) The only minor shortcoming is that the LLM does not explicitly state that the $7 billion was an 'up-front prepaid royalty' in the opening sentence (though it refers to it later as such), and slightly condenses the explanation of the revenue recognition policy. However, all key facts and relationships are preserved, and the semantic meaning fully matches the ground truth. Wording differences do not affect factual equivalence.\n\nThus, the answer is excellent, with full quantitative accuracy and high qualitative and contextual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 481,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K filing?",
      "original_answer": "The total fair value of long-term obligations to equity companies is $1,896 million, and the total guarantees related to equity company obligations amount to $1,862 million. Adding these together results in a total of $3,758 million.",
      "llm_answer": "ExxonMobil reported a fair‑value amount of **$2.467 billion** for its long‑term obligations to equity‑company affiliates, and guarantees related to equity‑company obligations of **$1.862 billion**.  Combined, the total fair value is **approximately $4.33 billion**【page_102】【page_106】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the fair value of long-term obligations to equity companies is $1,896 million, but the LLM reports $2.467 billion ($2,467 million), which is incorrect. The guarantee amount of $1.862 billion is correctly reported. However, due to the incorrect first value, the combined total is also wrong: LLM reports ~$4.33 billion, while the correct sum is $3,758 million (~$3.758 billion). (2) Number verification: $1,896 million (correct) vs. $2,467 million (LLM) = $571 million overstatement; $1,862 million matches exactly; sum should be $3,758 million, not $4,329 million. (3) Multi-hop reasoning is structurally sound—the model attempts to sum two disclosed values—but fails due to reliance on an incorrect base figure. It correctly identifies that the total requires combining obligations and guarantees. (4) Contextual relevance is high as the model cites appropriate items (obligations and guarantees) from XOM’s 2023 10-K and provides page references. However, the use of an incorrect number for long-term obligations severely undermines factual accuracy. The error likely stems from misreading or misextracting the obligation amount, possibly confusing it with another line item. Thus, while the approach and structure are reasonable, the core quantitative data are flawed, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 391,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the total value of Mortgage/Asset-backed securities investments made by Honeywell's U.S. and Non-U.S. plans as of December 31, 2023, and how does this allocation compare between the two plans?",
      "original_answer": "Honeywell's U.S. plans have $676 million invested in Mortgage/Asset-backed securities, while the Non-U.S. plans have $10 million invested in the same category. This results in a total investment of $686 million in Mortgage/Asset-backed securities across both U.S. and Non-U.S. plans. The U.S. plans account for 98.5% of this total, highlighting a significantly larger allocation to Mortgage/Asset-backed securities in U.S. plans compared to Non-U.S. plans.",
      "llm_answer": "As of December 31 2023, Honeywell’s U.S. pension plans held **$676 million** in mortgage‑ and asset‑backed securities, while the non‑U.S. plans held **$10 million** of the same asset class. Thus, the U.S. allocation is roughly 68 times larger than the non‑U.S. allocation, representing the overwhelming share of these investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: $676 million for U.S. plans and $10 million for Non-U.S. plans in Mortgage/Asset-backed securities as of December 31, 2023, matching the ground truth exactly. The total investment of $686 million is implied through the individual figures, though not explicitly stated. (2) Quantitative accuracy is perfect—both dollar amounts are correct, and the statement that the U.S. allocation is 'roughly 68 times larger' is accurate (676 / 10 = 67.6, which rounds to ~68). This conveys the same comparative insight as the ground truth's 98.5% attribution. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across U.S. and Non-U.S. plans and makes a valid comparison. While the ground truth uses percentage share (98.5%) and the LLM uses a ratio (68x), both are valid and semantically equivalent ways to express the disparity. (4) The only minor shortcoming is the omission of the explicit total value ($686 million), which was asked for in the question. However, since it can be easily derived and both components are provided, this does not significantly detract from correctness. All entities (Honeywell, Mortgage/Asset-backed securities, U.S./Non-U.S. plans, date) are accurate. The answer is highly relevant and conveys the same core information with slightly different framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 382,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022?",
      "original_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022 was $185 million. This includes $83 million in fiscal year 2021 and $102 million in fiscal year 2022.",
      "llm_answer": "The “Medical device regulations” adjustments added **$102 million** to Non‑GAAP income before income taxes in fiscal 2022 and **$83 million** in fiscal 2021. Combined, these adjustments represent a total pre‑tax impact of **$185 million** on Medtronic’s Non‑GAAP income before taxes for the two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the individual adjustments—$83 million in fiscal year 2021 and $102 million in fiscal year 2022—are accurately reported, and their sum ($185 million) is correctly calculated. Minor formatting differences (e.g., using ' ' as a thousands separator) do not affect accuracy. (2) The answer is complete, addressing both the individual yearly impacts and the total pre-tax financial impact across the two years, as required by the multi-part question. (3) Entity accuracy is correct: Medtronic is the subject company, the fiscal years 2021 and 2022 are properly referenced, and the financial metric 'Non-GAAP income before income taxes' is correctly used. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by aggregating data from two separate fiscal years and correctly interpreting the cumulative impact of 'Medical device regulations' adjustments. (5) The semantic meaning is equivalent to the original answer, with clear, rephrased presentation that preserves all factual content. No errors in logic, calculation, or fact are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 324,
        "total_tokens": 1472
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How much goodwill impairment was recognized for the OpenTable and KAYAK reporting unit in total during 2020, and what was the key factor that led to the continued impairment in the annual test as of September 30, 2020?",
      "original_answer": "A total goodwill impairment of $1.062 billion was recognized for the OpenTable and KAYAK reporting unit in 2020. This includes $489 million recognized during the interim test in March 2020 and an additional $573 million during the annual test in September 2020. The key factor that led to the continued impairment in the annual test was the lowered outlook for monetization opportunities in restaurant reservation services and slower recovery trends in airline travel, which is a key vertical for KAYAK.",
      "llm_answer": "Booking Holdings recorded a $489 million goodwill impairment for the OpenTable & KAYAK reporting unit in the March 31 2020 interim test and a further $573 million in the September 30 2020 annual test, for a total of about $1.06 billion of goodwill impairment in 2020. The continued impairment was driven primarily by the material adverse impact of the COVID‑19 pandemic, which forced the company to lower its cash‑flow forecasts and assume a longer recovery period for OpenTable and KAYAK (notably the hit to KAYAK’s flight vertical and weaker monetization prospects for restaurant‑reservation services).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: $489 million in the interim test (March 2020), $573 million in the annual test (September 30, 2020), and a total of $1.062 billion (rounded to $1.06 billion, which is acceptable). These match the ground truth exactly. (2) Quantitative accuracy is perfect—each dollar amount and date is correct, and the sum ($489M + $573M = $1,062M) is accurate. The LLM uses 'about $1.06 billion', which is a reasonable rounding. (3) The reasoning is sound and captures the multi-hop nature: it links the continued impairment in the annual test to the ongoing impact of the pandemic, specifically citing weaker monetization in restaurant reservations (affecting OpenTable) and slower recovery in airline travel (affecting KAYAK’s flight vertical). While the original answer explicitly names 'slower recovery trends in airline travel' and 'lowered outlook for monetization', the LLM paraphrases this accurately using 'weaker monetization prospects' and 'longer recovery period', preserving semantic equivalence. (4) The only minor gap is that the LLM attributes the impairment more broadly to the 'material adverse impact of the COVID-19 pandemic' without explicitly stating that the *continued* impairment was due to *updated assumptions* in the September test—though this is implied. This slight omission in nuance prevents a perfect 10, but the core facts, synthesis, and logic are fully correct. All entities (OpenTable, KAYAK, Booking Holdings, reporting unit, interim and annual tests) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 438,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "By how much did Walmart's ownership stake in Flipkart increase between fiscal 2023 and fiscal 2024, and what financial transaction supported this change?",
      "original_answer": "Walmart's ownership stake in Flipkart increased by 10% (from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024). This increase was supported by a $3.5 billion transaction during fiscal 2024, where the company acquired shares from certain Flipkart noncontrolling interest holders.",
      "llm_answer": "Walmart’s stake in Flipkart rose from roughly 75 % at the end of fiscal 2023 to about 85 % at the end of fiscal 2024 – an increase of roughly 10 percentage points.  This gain was driven by a $3.5 billion cash payment in fiscal 2024 to buy out certain Flipkart non‑controlling‑interest shareholders (and settle related PhonePe liabilities).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the 10 percentage point increase in Walmart's ownership stake in Flipkart from approximately 75% to 85%, aligning with the ground truth. The $3.5 billion transaction amount is accurately reported. 2) All numeric values—percentages (75%, 85%, 10 percentage point increase) and dollar amount ($3.5 billion)—are correct and match the original answer. Minor phrasing differences (e.g., 'roughly' vs 'approximately') are semantically equivalent and acceptable. 3) The reasoning is sound: the model correctly attributes the ownership increase to a transaction with noncontrolling interest holders. However, the addition of 'settle related PhonePe liabilities' introduces information not present in the ground truth, which may be contextually relevant but is unsupported by the provided answer and could imply an expanded scope. This does not contradict core facts but adds unverified detail. 4) The answer addresses both parts of the question: the magnitude of stake increase and the financial transaction. Entity names (Walmart, Flipkart, non-controlling interest holders), fiscal years (2023 to 2024), and financial terms are accurate. The extra detail about PhonePe slightly affects qualitative precision but does not undermine correctness. Overall, the answer is factually accurate, complete, and contextually appropriate with only minor over-specification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 385,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What percentage of Procter & Gamble's total net sales does the Baby, Feminine & Family Care segment represent, and within this segment, what is the North American market share of the Bounty brand in the paper towel category?",
      "original_answer": "The Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds over 40% North American market share in the paper towel category.",
      "llm_answer": "The Baby, Feminine & Family Care segment accounts for **about 24 % of Procter & Gamble’s total net sales**. Within that segment, the Bounty paper‑towel brand enjoys **a North‑American market share of over 40 %** in the paper‑towel category.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages are accurate: 'about 24%' aligns with the exact 24% from the original answer, and 'over 40%' matches the stated market share for Bounty. Minor wording variations like 'about' and formatting (e.g., spacing around %) do not affect factual accuracy. (2) The answer is complete, addressing both sub-questions: the segment's contribution to total net sales and Bounty's North American market share within the paper towel category. (3) Entity accuracy is correct—Procter & Gamble, Baby, Feminine & Family Care segment, and the Bounty brand are all properly identified. (4) The multi-hop reasoning is sound, as the model correctly synthesizes data across the corporate structure (segment sales as % of total) and brand-level market performance (Bounty in the paper towel category). (5) Semantic equivalence is maintained—despite rephrasing (e.g., 'enjoys a market share'), the meaning is identical to the original. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 303,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving Thales-Raytheon Systems and Related Matters, and how does this resolution connect to the SEC Administrative Order?",
      "original_answer": "RTX recorded a pre-tax charge of $364 million in 2024 related to Thales-Raytheon Systems and Related Matters. This resolution is directly connected to the SEC Administrative Order, which was issued as part of the settlement of investigations into improper payments made by Raytheon Company and its joint venture TRS in connection with certain Middle East contracts since 2012. The SEC Administrative Order requires RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for a period of three years from the monitor's engagement.",
      "llm_answer": "RTX recorded a pre‑tax charge of **$364 million** in 2024 for the Thales‑Raytheon Systems and Related Matters. This charge arose because the company settled the investigations that had been addressed through the **SEC Administrative Order** (issued to resolve the criminal and civil probes into payments made by Raytheon and its joint‑venture), and the charge reflects the costs associated with that SEC‑order‑driven resolution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the pre-tax charge of $364 million in 2024, matching the ground truth exactly. The amount is presented accurately with acceptable formatting ($364 million). (2) All numeric values and dates are correct—specifically, the $364 million charge and the year 2024 are both factually accurate and align with the original answer. (3) The multi-hop reasoning is largely sound: the LLM correctly links the pre-tax charge to the resolution of investigations addressed by the SEC Administrative Order, and notes that the charge stems from the settlement of probes into improper payments by Raytheon and its joint venture (TRS). However, the LLM omits specific details about the SEC Administrative Order requiring RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for three years—this is a minor but relevant omission affecting completeness. (4) Despite this omission, the core factual content—especially the financial figure and causal connection to the SEC order—is correct and well-reasoned. The answer is semantically equivalent in key aspects and highly contextually relevant. The qualitative accuracy is slightly reduced due to the missing compliance monitor requirement, but the main logic and synthesis across entities (RTX, TRS, SEC) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 373,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "What is the total number of approved indications for Trodelvy as of April 2021, and in which specific countries was the drug approved for the treatment of metastatic triple-negative breast cancer by September 2021?",
      "original_answer": "As of April 2021, Trodelvy had two approved indications: one for locally advanced or metastatic urothelial cancer and another for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC). By September 2021, Trodelvy was approved for TNBC in Australia, Great Britain, Switzerland, the United States, and Canada.",
      "llm_answer": "- As of April 2021, Trodelvy had **two approved indications** – metastatic urothelial cancer (accelerated approval) and metastatic triple‑negative breast cancer (full approval)【page_39】.  \n\n- By September 2021, the metastatic‑TNBC indication had been approved in **five countries**: **Canada, Australia, Great Britain, Switzerland and the United States** (the latter four were already approved under the Project Orbis collaborative review)【page_39】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of approved indications as of April 2021 is correctly stated as two, and the five countries where Trodelvy was approved for metastatic TNBC by September 2021—Canada, Australia, Great Britain, Switzerland, and the United States—are accurately listed. (2) The answer addresses both parts of the multi-hop question completely: first, the total number of approved indications by April 2021, and second, the specific countries of approval for metastatic TNBC by September 2021. (3) Entity accuracy is perfect: the drug name (Trodelvy), indications (metastatic urothelial cancer and metastatic triple-negative breast cancer), and country names are all correct. The mention of Project Orbis adds contextual accuracy, aligning with regulatory details in the source. (4) The reasoning is sound and demonstrates proper synthesis across time points and indications. Semantic equivalence is maintained despite slightly different phrasing (e.g., 'full approval' vs. 'approved'). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 318,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, and how does this compare to the amount expected to be reclassified from AOCI into earnings within 12 months?",
      "original_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is $11.5 million, and $9.5 million of this amount is expected to be reclassified from AOCI into earnings within 12 months.",
      "llm_answer": "The “Foreign currency – other” cash‑flow hedge shows a **$11.5 million net gain (after tax) recorded in AOCI** as of September 29, 2024. Of that amount, **$9.5 million is expected to be re‑classified from AOCI into earnings within the next 12 months**, i.e., the re‑classification amount is about $2 million less than the total balance currently sitting in AOCI.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $11.5 million (total net gain in AOCI) and $9.5 million (expected reclassification within 12 months) are accurately reported, with correct dates (September 29, 2024). The minor wording difference—'net gain (after tax)'—adds clarification but does not contradict the original. (2) The answer addresses both parts of the question: the total AOCI balance and the portion expected to be reclassified. (3) The entity 'Foreign currency - other' derivatives is correctly identified, and the context of cash flow hedges and AOCI is appropriately applied. (4) The reasoning is sound: the comparison between the total gain and the reclassification amount is logically presented, including the observation that the reclassification is $2 million less, which is a valid inference ($11.5M - $9.5M = $2M) and adds value without introducing error. All information is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 288,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What is the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of the end of fiscal 2024, and how do these facilities differ in terms of maturity dates and interest rate margins?",
      "original_answer": "The total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of September 29, 2024, is $103.6 million (¥5.0 billion at $34.5 million and ¥10.0 billion at $69.1 million). The first facility matures on December 30, 2024, and carries an interest rate margin of 0.400% over TIBOR, while the second facility matures later, on March 27, 2025, and has a lower margin of 0.300% over TIBOR.",
      "llm_answer": "Starbucks had two yen‑denominated facilities available at fiscal‑2024 year‑end, together providing about **$103.6 million** of borrowing capacity (¥5 billion ≈ $34.5 million plus ¥10 billion ≈ $69.1 million).  \n\n- The **¥5 billion** facility matures on **December 30, 2024** and bears interest at **TIBOR + 0.40 %**.  \n- The **¥10 billion** facility matures on **March 27, 2025** and bears interest at **TIBOR + 0.30 %**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the total dollar value is correctly calculated as $103.6 million, composed of ¥5.0 billion ≈ $34.5 million and ¥10.0 billion ≈ $69.1 million. The maturity dates (December 30, 2024, and March 27, 2025) and interest rate margins (0.400% and 0.300% over TIBOR) are exactly as stated in the original answer. Minor formatting differences (e.g., '0.40%' vs '0.400%') do not affect meaning. (2) The answer is complete, addressing both the total value and the differences in maturity and interest rates. (3) Entities are correct: Starbucks, Japanese yen-denominated facilities, TIBOR as the reference rate, and the fiscal year-end context (implied as September 29, 2024, consistent with Starbucks' fiscal calendar). (4) The multi-hop reasoning—aggregating two separate credit facilities across currencies and terms—is sound and accurately synthesized. The answer conveys the same information as the ground truth with equivalent wording and structure. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 312,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans or programs, and what was the average price paid per share under the open-market program?",
      "original_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,263 — consisting of 2,000,308 shares purchased under the publicly announced open-market share purchase program and 72,255 shares acquired through transactions unrelated to publicly announced share plans. The average price paid per share under the open-market program was approximately $302.45, calculated by dividing the aggregate purchase price of $605 million by the 2,000,308 shares acquired.",
      "llm_answer": "Accenture purchased **2,072,563 Class A ordinary shares** in the fourth quarter of fiscal 2024 – 2,000,308 shares under the publicly announced open‑market repurchase program and 72,255 shares in transactions unrelated to any announced plan. The open‑market purchases were made at an average price of **approximately $302 – $303 per share** (about $302.5 per share based on the $605 million total outlay).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor quantitative error in the total number of shares purchased: it reports 2,072,563 instead of the correct 2,072,263 (a discrepancy of 300 shares). This appears to be a typo, as the component numbers (2,000,308 + 72,255) sum to 2,072,563 in the LLM answer, but the ground truth sum is 2,072,263. The breakdown of shares under the open-market program (2,000,308) and unrelated transactions (72,255) is accurate. The average price is correctly derived from $605 million divided by 2,000,308 shares, which is approximately $302.45. The LLM rounds this to 'approximately $302–$303' and notes '$302.5', which is semantically acceptable and within reasonable rounding.\n\n2) Quantitative verification: 2,000,308 + 72,255 = 2,072,563 (LLM total), but ground truth total is 2,072,263 — so the total is off by 300 shares. The $605 million aggregate cost and 2,000,308 shares yield $302.45 average price (605,000,000 / 2,000,308 ≈ 302.45). LLM’s approximation of $302.5 is acceptable.\n\n3) Multi-hop reasoning is sound: the model correctly separates two types of share purchases, identifies the relevant figures for each, and computes or references the average price using the aggregate cost. It synthesizes information across components (total shares, program shares, price calculation) appropriately.\n\n4) Scores justified: correctness is 8 due to the small but factual error in total shares; quantitative accuracy is 8 due to the incorrect total despite correct components and reasonable price approximation; qualitative accuracy is 9 due to strong reasoning and entity identification; contextual relevance is 10 as all parts of the question are addressed with relevant, focused information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 471,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the total carrying value of the 6.375% 2037 Notes and how much principal amount of these notes was exchanged according to the information provided in the respective sections?",
      "original_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and the principal amount of these notes that was exchanged is $74 million.",
      "llm_answer": "The 6.375 % notes due 2037 have a total carrying value of **$478 million**, and **$74 million** of principal from those notes was exchanged in the 2020 debt‑exchange offer.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The total carrying value of the 6.375% 2037 Notes is accurately stated as $478 million, and the principal amount exchanged is correctly reported as $74 million. (2) Both numeric values match the original answer exactly, with acceptable formatting (e.g., $478 million vs $478 million). (3) The reasoning is sound and reflects proper synthesis of information from the relevant SEC filing sections, correctly identifying the notes, their carrying value, and the exchange transaction in context. (4) The answer is semantically equivalent to the ground truth, addresses both parts of the multi-part question, and includes appropriate contextual detail (e.g., reference to the 2020 debt-exchange offer), demonstrating accurate multi-hop understanding without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1087,
        "completion_tokens": 246,
        "total_tokens": 1333
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the expected average amortization period for Netflix's content assets, and how does the accelerated amortization policy impact the distribution of amortization expense over the life of a content asset, particularly within the first four years?",
      "original_answer": "Netflix expects over 90% of a licensed or produced content asset to be amortized within four years after its month of first availability. The accelerated amortization policy results in a higher proportion of the asset's cost being expensed earlier, particularly in the initial months following availability, reflecting the expectation of more upfront viewing, especially for films compared to TV series.",
      "llm_answer": "Netflix expects to amortize its content assets over the shorter of each title’s contractual window or an estimated useful‑life period that does not exceed ten years. Because the company uses an accelerated‑amortization policy—reflecting higher upfront viewing—it front‑loads the expense so that **more than 90 % of a licensed or produced title is amortized within the first four years after it becomes available**. This policy therefore concentrates the bulk of amortization expense in the early years of a content asset’s life rather than spreading it evenly over the full ten‑year horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the key figure of 'more than 90% of a licensed or produced title amortized within the first four years' matches the original answer's 'over 90%...within four years after its month of first availability'—this is semantically equivalent and correctly reported. (2) The explanation of the accelerated amortization policy correctly captures that expenses are front-loaded due to higher upfront viewing, especially for films, which is consistent with the original reasoning. (3) The LLM adds contextual detail not in the original—mentioning the 'shorter of contractual window or ten-year useful life'—which is accurate based on Netflix's accounting policies and enhances completeness without introducing error. (4) While the original emphasizes the contrast between films and TV series, the LLM omits this nuance but still correctly explains the policy’s impact on expense distribution. All entities (Netflix, content assets, amortization) are correct, and the multi-hop synthesis of policy and financial impact is sound. The answer is slightly more generalized in its explanation of viewing patterns but remains factually and contextually accurate. Minor deduction in qualitative accuracy for not explicitly mentioning the film vs. TV series distinction, but core reasoning is intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 379,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 if all investments experience a -10% change in exchange rates, based on the disclosed exposure?",
      "original_answer": "The total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 from a -10% change in exchange rates would be $112 million, as calculated from the disclosed exposure of $1,125 million.",
      "llm_answer": "Based on the 2023 disclosure, BlackRock’s foreign‑exchange‑rate‑risk investments had an exposure of $1.125 billion, and a 10% adverse move would affect them by approximately **$112 million**. This $112 million figure represents the total potential financial impact if all such investments experienced a –10% change in exchange rates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the exposure amount ($1.125 billion, equivalent to $1,125 million), the -10% exchange rate change, and the resulting financial impact of $112 million. These match the ground truth exactly in both value and meaning. (2) Quantitatively, the numbers are accurate with acceptable format variation ($1.125 billion = $1,125 million); the 10% of $1.125 billion is correctly calculated as $112.5 million, and the answer appropriately rounds to $112 million as stated in the original answer. (3) The reasoning is sound and reflects proper multi-hop synthesis: it links BLK’s disclosed exposure in 2023 to the hypothetical -10% exchange rate movement and computes the financial impact, which requires combining two pieces of information (exposure value and sensitivity). (4) The answer is semantically equivalent to the ground truth, uses precise terminology, and fully addresses the question with no omissions or inaccuracies. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 301,
        "total_tokens": 1450
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How many amendments to the Target Corporation Deferred Compensation Trust Agreement are listed in the 2022 10-K filing, and what are their effective dates?",
      "original_answer": "There are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K filing. Their effective dates are June 8, 2011; October 25, 2017; and December 18, 2020.",
      "llm_answer": "The filing lists **three amendments** to the Target Corporation Deferred Compensation Trust Agreement. Their amendment dates (effective dates) are:\n\n- **June 8, 2011** – Amendment dated June 8, 2011 (Exhibit 22)  \n- **October 25, 2017** – Amendment dated October 25, 2017 (Exhibit 23)  \n- **December 18, 2020** – Amendment dated December 18, 2020 (Exhibit 24)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It correctly identifies that there are three amendments to the Target Corporation Deferred Compensation Trust Agreement, which matches the original answer. (2) The effective dates provided—June 8, 2011; October 25, 2017; and December 18, 2020—are exactly the same as in the ground truth, with no discrepancies in formatting or content. (3) The multi-hop reasoning is sound: the model correctly extracted and synthesized information from the 2022 10-K filing, identifying the number of amendments and their respective effective dates. (4) The answer is contextually precise, directly addressing both parts of the question (quantity and dates), and includes additional but accurate reference to exhibit numbers, which enhances clarity without introducing error. Semantic equivalence is maintained, and all factual elements are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 265,
        "total_tokens": 1408
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total carrying value of the 6.90% 2038 Notes and how much principal amount of these notes was exchanged according to the debt exchange transactions disclosed?",
      "original_answer": "The total carrying value of the 6.90% 2038 Notes is $254 million, and the principal amount exchanged in the debt exchange transactions was $37 million.",
      "llm_answer": "The 6.90 % notes due 2038 are shown with a total carrying value of **$254 million** (see the debt‑carrying‑value table). In the 2020 debt‑exchange transaction, **$37 million** of principal of these 6.90 % 2038 notes was tendered and cancelled.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total carrying value of the 6.90% 2038 Notes is correctly stated as $254 million, and the principal amount exchanged is accurately reported as $37 million. (2) Quantitative accuracy is perfect—both dollar amounts match the original answer exactly, with acceptable formatting (e.g., $254 million). (3) The multi-hop reasoning is sound: the model correctly identifies the relevant debt instrument (6.90% 2038 Notes), retrieves its carrying value from the appropriate financial table, and links it to the debt exchange transaction in 2020 where $37 million of principal was tendered and cancelled. (4) The answer is contextually precise, directly addressing both parts of the question with clear, concise, and semantically equivalent information. No errors in entities, metrics, or synthesis across disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 265,
        "total_tokens": 1370
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "By how much did the Fleet Ballistic Missile (FBM) program contribute to the increase in both product sales and product costs at Space in 2023, and what was the net financial impact on Lockheed Martin's operations from these changes?",
      "original_answer": "The Fleet Ballistic Missile (FBM) program contributed to a $940 million increase in product sales and an $815 million increase in product costs at the Space business segment in 2023. The net financial impact from these changes was an increase in gross profit of $125 million ($940M - $815M) for the Space segment related to the FBM program.",
      "llm_answer": "The 2023 filing says that the Space segment’s product‑sales rise of about **$940 million** was “largely due to … higher volume in the Fleet Ballistic Missile (FBM) program,” and that the same segment’s product‑cost increase of about **$815 million** was “primarily attributable to … higher volume in the FBM program.”  \n\nBecause the FBM‑related cost increase was slightly larger than the FBM‑related sales increase, the net effect on Lockheed Martin’s overall operating results was modest – roughly **$125 million of additional operating profit** (the $940 million of extra sales less the $815 million of extra costs).  In other words, the FBM program boosted Space sales but was almost fully offset by higher FBM‑related costs, leaving only a small positive contribution to the company’s operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key quantitative figures: $940 million increase in product sales and $815 million increase in product costs due to the FBM program in 2023, and accurately calculates the net financial impact as $125 million ($940M - $815M). These match the ground truth exactly. (2) All numbers are correct and properly formatted; the calculation of gross profit impact is accurate and clearly explained. (3) The reasoning is sound: the LLM correctly synthesizes the information from the 2023 filing, linking the FBM program to both sales and cost increases in the Space segment and deriving the net operating profit impact. It correctly infers that the net effect is positive but modest, which aligns with the ground truth's implication of a $125M gross profit increase. (4) The only minor issue is semantic: the LLM refers to 'operating profit' while the ground truth specifies 'gross profit.' While closely related, these are not identical metrics—gross profit is sales minus cost of goods sold, whereas operating profit includes additional operating expenses. However, given the context and the fact that the calculation is based on sales and product costs only, 'gross profit' would be more precise. This does not invalidate the answer but introduces slight imprecision in financial terminology. Despite this, the core facts, numbers, and multi-hop logic (linking FBM → sales ↑ → costs ↑ → net profit impact) are fully correct and complete. Hence, high scores across all categories with a 9 in correctness due to terminology nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 433,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total carrying value of the 5.375% 2043 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged during the period?",
      "original_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, which represents approximately 0.555% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $76 million in principal of these notes was exchanged during the period.",
      "llm_answer": "The 5.375 % 2043 Notes had a carrying value of **$185 million**, which is roughly **0.56 %** of Amgen’s total reported debt of **$33,309 million** (185 ÷ 33,309 ≈ 0.0056).  \n\nDuring the exchange‑offer period, **$76 million** of principal of these 5.375 % 2043 Notes was tendered and cancelled.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value of the 5.375% 2043 Notes is correctly stated as $185 million, the total debt as $33,309 million, and the exchanged principal as $76 million. The percentage is calculated as approximately 0.56%, which is a correctly rounded version of 0.555% (185 / 33,309 ≈ 0.005555 ≈ 0.56%), so this is semantically equivalent and acceptable. (2) The answer is complete, addressing both parts of the question: the percentage of total debt and the amount of principal exchanged. (3) Entities are accurate: AMGN (Amgen) is correctly identified, the 5.375% 2043 Notes are precisely referenced, and the year 2022 is contextually implied as the reporting period. (4) The reasoning is sound, demonstrating correct multi-hop synthesis: it combines the specific note's carrying value with total debt to compute a percentage and correctly reports the exchanged principal from the same instrument. The explanation includes the calculation (185 ÷ 33,309 ≈ 0.0056), showing transparent and correct logic. (5) The wording differs slightly (e.g., 'tendered and cancelled' vs 'exchanged'), but this is semantically equivalent in the context of debt exchange offers. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 376,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total value of securities on loan subject to indemnification, and how much collateral was held against these securities as of December 31, 2023, and what is the potential financial impact if significant borrower defaults occur simultaneously with rapid declines in collateral value?",
      "original_answer": "As of December 31, 2023, the total value of securities on loan subject to indemnification was approximately $259 billion, and BlackRock held approximately $276 billion in cash and securities as collateral against these loans. If significant borrower defaults were to occur simultaneously with rapid declines in the value of pledged collateral, there could be collateral shortfalls, which may result in material liabilities under these indemnities and could cause BlackRock's revenue and earnings to decline.",
      "llm_answer": "BlackRock reported that, at December 31 2023, the amount of securities it had on loan that are covered by borrower‑default indemnifications was about $259 billion, and the cash and securities it held as collateral for those loans totaled roughly $276 billion. If a large number of borrowers were to default at the same time that the pledged collateral fell sharply (or the loaned securities rose in value), the shortfall could trigger material indemnity liabilities, which would likely depress BlackRock’s revenue and earnings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the total value of securities on loan subject to indemnification is correctly stated as $259 billion, and the collateral held is accurately given as $276 billion as of December 31, 2023. (2) Quantitative accuracy is perfect—both figures match the original answer exactly, with acceptable formatting variations (e.g., 'about $259 billion' = 'approximately $259 billion'). (3) The reasoning regarding potential financial impact is sound and captures the multi-hop risk scenario: simultaneous borrower defaults and rapid declines in collateral value (or increases in loaned securities' value) could lead to shortfalls, triggering material indemnity liabilities. The conclusion that this could depress BlackRock’s revenue and earnings aligns precisely with the original answer. (4) Entity accuracy is correct—BlackRock is properly identified, and the financial terms (indemnification, collateral, securities on loan) are used appropriately. The answer addresses all parts of the multi-part question completely and contextually. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 337,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. as documented in the 2022 10-K filing?",
      "original_answer": "The total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. is two.",
      "llm_answer": "The filing lists a Pharmacy Operating Agreement (dated December 16, 2015) and then shows **two amendments** to that agreement—a First Amendment (Nov 30, 2016) and a Second Amendment (Jan 9, 2018)【page_69】. Thus, the agreement was amended **twice**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are two amendments to the Pharmacy Operating Agreement, which aligns with the original answer. (2) The dates provided—First Amendment on Nov 30, 2016, and Second Amendment on Jan 9, 2018—are factually correct and match the documented filings. The reference to the original agreement date (December 16, 2015) adds contextual accuracy. (3) The reasoning is sound: the model correctly identifies the base agreement and traces the two subsequent amendments, demonstrating proper multi-hop synthesis within the same document (2022 10-K). (4) The answer is semantically equivalent to the ground truth, using 'two amendments' and 'amended twice' to convey the same meaning. All entities—Target Corporation, CVS Pharmacy, Inc., and the agreement—are correctly identified. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 267,
        "total_tokens": 1366
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What is the change in the net carrying amount of Technology-related finite-lived intangible assets from December 31, 2022, to December 31, 2023, and how does this compare to the change in the accumulated amortization for the same category over the same period?",
      "original_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from $180 million in 2022 to $142 million in 2023. Over the same period, the accumulated amortization increased by $37 million from $81 million in 2022 to $118 million in 2023. This indicates that the decline in net carrying amount is primarily due to the increase in accumulated amortization.",
      "llm_answer": "The net carrying amount of Technology‑related finite‑lived intangible assets fell from **$180 million at 12/31/2022 to $142 million at 12/31/2023**, a decrease of **$38 million**.  Over the same period, accumulated amortization for this category rose from **$81 million to $118 million**, an increase of **$37 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: the net carrying amount decreased from $180 million to $142 million, a $38 million decrease; accumulated amortization increased from $81 million to $118 million, a $37 million increase. These figures exactly match the original answer. (2) Calculations are correct: $180M - $142M = $38M decrease; $118M - $81M = $37M increase. (3) The multi-hop reasoning is sound—though the LLM did not explicitly state the interpretive conclusion (that the decline is primarily due to amortization), it provided all necessary data for the comparison, fulfilling the question's requirement to report both changes and enabling the implied comparison. (4) Entities (Technology-related finite-lived intangible assets, net carrying amount, accumulated amortization, and dates) are correctly identified and contextualized. The answer is semantically equivalent to the ground truth, with only minor formatting differences (e.g., use of bold, spacing). No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 312,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and how does this compare to the change in the same category in the Americas region?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million, while in the Americas region, the increase was $7,048 million. This means the growth in the Americas was significantly higher compared to the Asia Pacific region.",
      "llm_answer": "In fiscal 2024 the “Subscriptions and services” line grew to $2,203 million in Asia Pacific versus $657 million in fiscal 2023 – an increase of **$1.546 billion** year‑over‑year.  In the same period the Americas segment rose to $12,726 million from $5,678 million, a **$7.048 billion** increase, which is roughly **$5.5 billion larger** than the growth seen in Asia Pacific.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the year-over-year increase in Subscriptions and Services revenue for the Asia Pacific region is correctly calculated as $1.546 billion ($2,203M - $657M = $1,546M), and for the Americas region as $7.048 billion ($12,726M - $5,678M = $7,048M). These values match the ground truth exactly, with acceptable format variation ($1.546 billion = $1,546 million). (2) The comparison stating the Americas growth was 'roughly $5.5 billion larger' is accurate ($7.048B - $1.546B = $5.502B), and this correctly highlights the significant difference in growth between regions. (3) The multi-hop reasoning is sound: the model correctly identified the relevant metric (Subscriptions and Services revenue), extracted data for two regions (Asia Pacific and Americas), computed year-over-year increases using correct fiscal years (2023 to 2024), and synthesized the comparison. (4) All entities (regions, financial category, time period) are accurate, and the answer fully addresses both parts of the question. Semantic equivalence is maintained with enhanced clarity and precise numerical formatting. No factual, computational, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 347,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What is the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, and how much of the unrealized loss on these securities has been recognized in fair value as of the same date?",
      "original_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million. Of the total unrealized loss of $1 million on these securities, $1 million has been recognized in fair value as there are no unrealized losses in the 'Less than 12 months' category and the entire unrealized loss of $1 million is in the 'Greater than 12 months' category.",
      "llm_answer": "As of December 31 2023, CVS held redeemable preferred securities with a **fair‑value total of $20 million**. The securities carried a **$1 million unrealized loss that has been reflected in that fair‑value amount**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, at $20 million and accurately states that a $1 million unrealized loss has been reflected in that fair value. All numeric values match the ground truth exactly, satisfying quantitative accuracy. The answer is contextually relevant and addresses both parts of the question: the fair value and the amount of unrealized loss recognized. While the LLM does not explicitly mention the breakdown between 'Less than 12 months' and 'Greater than 12 months' categories for the unrealized loss, it correctly conveys that the full $1 million loss is reflected in fair value, which is the key inference from that categorization. This omission slightly affects completeness but does not undermine the factual correctness or the core reasoning. The multi-hop synthesis—linking the unrealized loss to its recognition in fair value—is sound and semantically equivalent to the original answer. Therefore, the response is highly accurate with only minor reduction in qualitative completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 312,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What was the total amount of borrowings under HD's commercial paper programs at January 30, 2022, and how does this compare to the combined capacity of their back-up credit facilities at that date?",
      "original_answer": "The total amount of borrowings under HD's commercial paper programs at January 30, 2022, was $1.0 billion. The combined capacity of their back-up credit facilities at that date was $3.0 billion, consisting of a five-year $2.0 billion credit facility and a 364-day $1.0 billion credit facility. Therefore, HD had $1.0 billion in outstanding borrowings, which was fully covered by the $3.0 billion in available back-up credit facilities.",
      "llm_answer": "At January 30 2022 Home Depot had **$1.0 billion of outstanding borrowings** under its commercial‑paper programs. Its back‑up credit facilities – a $2.0 billion five‑year facility plus a $1.0 billion 364‑day facility – provided a **combined borrowing capacity of $3.0 billion**, meaning the commercial‑paper borrowings represented roughly one‑third of the available backup capacity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1.0 billion in commercial paper borrowings and the $3.0 billion combined backup credit capacity (from a $2.0 billion five-year facility and a $1.0 billion 364-day facility) are accurately reported. The comparison stating that borrowings represent roughly one-third of available backup capacity is a valid interpretation of $1.0B / $3.0B. (2) All numbers match the original answer exactly, with acceptable formatting variations (e.g., 'billion' vs 'B'). (3) The multi-hop reasoning is sound: the model correctly identifies the amount borrowed under commercial paper programs and synthesizes the two credit facilities to compute total backup capacity. (4) The answer addresses both parts of the question: the total borrowings and how they compare to backup capacity. Semantic equivalence is maintained, with slightly different but accurate phrasing. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 287,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What was Amgen's total revenue from sales to BeiGene in 2023, and how much did Amgen pay in profit and loss sharing expenses related to these products during the same year?",
      "original_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and Amgen paid $40 million in profit and loss sharing expenses related to these products during the same year.",
      "llm_answer": "Amgen recorded **$125 million** of product sales to BeiGene in 2023, and it incurred **$40 million** of profit‑and‑loss‑sharing expenses for those products during the same year【page_131】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both key financial figures—$125 million in product sales revenue from Amgen to BeiGene and $40 million in profit-and-loss-sharing expenses—all matching the ground truth. (2) Quantitatively, both dollar amounts are accurate and presented in a semantically equivalent format (e.g., $125 million = $125 million), with no calculation errors. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly associates Amgen’s revenue from BeiGene with the corresponding P&L sharing expenses, indicating understanding of the financial relationship between the two entities in 2023. (4) All entities—Amgen, BeiGene, the year 2023, and the financial metrics—are accurately identified and correctly contextualized. The answer is fully aligned with the question and source data, earning top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1098,
        "completion_tokens": 261,
        "total_tokens": 1359
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024, and how does this relate to the valuation method used for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023?",
      "original_answer": "The year-over-year increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million ($2,886 million in 2024 - $1,241 million in 2023). This increase corresponds to the valuation method used for the Crypto Asset Safeguarding Asset, which, as of December 31, 2023, was valued at $1,241 million and categorized under 'Significant Other Observable Inputs (Level 2)'—indicating that the liability tracks the asset's valuation, which is not based on active market quotes but on other observable market data.",
      "llm_answer": "The crypto‑asset safeguarding liability grew from $1.241 billion in 2023 to $2.886 billion in 2024 – a year‑over‑year increase of **$1.645 billion**. The matching safeguarding asset is not quoted in an active market; instead, as disclosed for the 2023 balance sheet, it is measured at fair value using **quoted prices on the identified principal exchange for the underlying crypto assets (a Level 2 valuation)**. This same Level 2 approach is applied to both the liability and its corresponding asset.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key numerical values: the 2023 liability ($1.241 billion), 2024 liability ($2.886 billion), and the year-over-year increase ($1.645 billion), which matches the ground truth calculation ($2,886M - $1,241M = $1,645M). Number formats are consistent and acceptable (billion vs million with correct magnitude). (2) The answer addresses both parts of the question: the dollar increase and the valuation method for the corresponding asset as of December 31, 2023. It correctly states that the asset is measured using Level 2 inputs, specifically 'quoted prices on the identified principal exchange,' which aligns with the ground truth's 'Significant Other Observable Inputs (Level 2).' (3) The multi-hop reasoning is sound—linking the liability increase to the valuation method of the corresponding asset, noting that both are valued using the same Level 2 approach. This reflects proper synthesis across financial statements and accounting disclosures. (4) The only minor shortcoming is that the LLM slightly rephrases the valuation method in operational terms ('quoted prices on the identified principal exchange') rather than using the formal fair value hierarchy label as emphasized in the original answer. However, this detail is still accurate and consistent with Level 2. All entities (PYPL, crypto safeguarding liability/asset, 2023–2024 timeframe) are correct. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 412,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How many shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, and what types of share-based awards are explicitly referenced in the plan documentation?",
      "original_answer": "As of December 31, 2024, UnitedHealth Group had 48 million shares available for future grants under the 2020 Stock Incentive Plan. The plan documentation explicitly references several types of share-based awards, including Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards, as evidenced by the various form agreements listed in the filing.",
      "llm_answer": "As of December 31 2024, UnitedHealth Group had **48 million shares** available for future grants under its 2020 Stock Incentive Plan. The plan’s documentation states that those shares may be used for **stock options, stock‑appreciation rights, restricted stock, restricted stock units, performance awards, and other stock‑based awards**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that 48 million shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. (2) The types of share-based awards listed in the LLM answer — stock options, stock-appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards — are broader than the specific types explicitly referenced in the ground truth (Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards). However, the LLM's list is consistent with the general categories permitted under the plan as typically described in such filings, and the more specific award types mentioned in the ground truth fall within the broader categories cited by the LLM. While the LLM does not name the exact award types listed in the form agreements (e.g., Non-Qualified Stock Option Awards), it captures the essential scope of allowable awards. (3) The multi-hop reasoning is sound: the model correctly identifies the company, plan, date, share availability, and links to relevant award types from the plan documentation. It synthesizes information appropriately, though with slightly less specificity on the exact award types referenced in the filing. (4) The answer is factually correct in number and substantially accurate in content, with only minor loss of specificity on the award types. Hence, a correctness score of 9 is warranted — highly accurate but not fully precise in reflecting the exact named award types from the source documentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 463,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How much remaining contracted revenue for Paxlovid is expected to be recognized from deliveries between 2025 and 2028, and how does this compare to the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner?",
      "original_answer": "Pfizer has approximately $1 billion in remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028. This is significantly higher than the $129 million recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner.",
      "llm_answer": "Pfizer says that, as of December 31 2024, about **$1 billion** of Paxlovid contract revenue is still to be recognized from deliveries scheduled for **2025‑2028**. In contrast, the 2024 financials include a **$129 million** one‑time sales‑true‑up settlement with a commercialization partner. Thus, the future Paxlovid contract revenue is roughly eight times the amount recognized from the 2024 true‑up settlement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1 billion in remaining contracted revenue for Paxlovid from 2025–2028 and the $129 million one-time true-up settlement in 2024 are accurately reported, with acceptable formatting (e.g., $1 billion, $129 million). (2) The comparison stating that the future revenue is 'roughly eight times' the 2024 amount is logically sound: $1,000M / $129M ≈ 7.75, which rounds to 'roughly eight times'—a reasonable approximation. (3) The multi-hop reasoning is correct: the model synthesizes future expected revenue (forward-looking contractual obligation) with a past one-time settlement (historical 2024 event), correctly distinguishing timing and nature of the two revenue components. (4) All entities—Pfizer, Paxlovid, commercialization partner, and the years 2024, 2025–2028—are accurately referenced. (5) The answer fully addresses both parts of the question: the amount of future contracted revenue and its comparison to the 2024 true-up. Semantic equivalence is maintained with enhanced clarity. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 323,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How much of AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were covered by the parental guarantee from Berkshire Hathaway Inc. as of December 31, 2023?",
      "original_answer": "As of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, which was secured by a parental guarantee from Berkshire Hathaway Inc.",
      "llm_answer": "AIG’s 2017 adverse‑development retro‑reinsurance agreement with National Indemnity Company (NICO) had **$12.4 billion of ceded loss reserves** outstanding at December 31 2023, and Berkshire Hathaway’s parental guarantee was provided to fully secure NICO’s obligations under that agreement. 【page 184】 【page 184】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO as of December 31, 2023, matching the original answer exactly in amount and date. (2) The quantitative accuracy is perfect: the dollar amount ($12.4 billion) and year (2023) are correct, with no calculation errors. (3) The qualitative accuracy is strong: the entities—AIG, NICO (National Indemnity Company), and Berkshire Hathaway Inc.—are correctly identified, and the role of the parental guarantee from Berkshire Hathaway is accurately described as securing NICO’s obligations, which aligns with the guarantee covering the ceded reserves. (4) The reasoning is sound and reflects proper multi-hop synthesis: the answer links the reinsurance agreement, the ceded reserves, the date, and the guarantee from Berkshire Hathaway, all of which are required to answer the question. The inclusion of a citation (page 184) adds contextual support. Wording differs slightly but meaning is preserved: 'secured by a parental guarantee' vs 'parental guarantee was provided to fully secure' convey the same factual relationship. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 358,
        "total_tokens": 1500
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What was the total amount of credit receivables purchased by PayPal for its merchant finance offerings in the years ended December 31, 2021 and 2020, and how does this relate to the outstanding balance of merchant loans, advances, and interest and fees receivable as of December 31, 2021?",
      "original_answer": "PayPal purchased approximately $1.8 billion in credit receivables for both the years ended December 31, 2021 and 2020. As of December 31, 2021, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of the participation interest sold to WebBank of $63 million. This indicates that PayPal maintains a significant portion of the credit risk on the receivables it purchases, as only a small fraction is sold to third parties.",
      "llm_answer": "PayPal bought roughly **$1.8 billion of merchant‑finance credit receivables in each of the years ended December 31 2021 and 2020**.  As of December 31 2021, the **net outstanding balance of merchant loans, advances and interest‑and‑fees receivable was about $1.4 billion** (net of participation interest sold), meaning the amount purchased each year exceeds the net balance by roughly $0.4 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PayPal purchased approximately $1.8 billion in credit receivables in both 2021 and 2020, matching the ground truth. It also accurately reports the net outstanding balance as $1.4 billion as of December 31, 2021. The mention of the $63 million participation interest sold to WebBank is omitted in the LLM answer, but the net figure is correctly used, implying awareness of the deduction. (2) All numeric values are correct: $1.8 billion for each year and $1.4 billion net balance. The observation that annual purchases exceed the net balance by ~$0.4 billion is a valid inference and adds analytical value without contradicting facts. (3) The multi-hop reasoning is sound—linking annual purchases over two years to the year-end outstanding balance demonstrates synthesis across time periods and financial concepts. The only minor gap is not explicitly mentioning that the $1.4 billion is net of the $63 million sale to WebBank, though the use of 'net' implies it. (4) The answer is contextually fully relevant, directly addressing both parts of the question with accurate data and meaningful comparison. The omission of WebBank’s name and exact participation amount slightly affects qualitative completeness but does not impair factual correctness. Overall, this is a highly accurate and well-reasoned response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 379,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023, and how much of this debt was repaid by July 2024?",
      "original_answer": "The Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million of this debt had been repaid.",
      "llm_answer": "Costco’s Japanese subsidiary issued four Guaranteed Senior Notes in November 2023 for a total of roughly **$500 million**. By July 2024 it had **repaid about $77 million** of that issuance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the issuance of $500 million in Guaranteed Senior Notes by Costco's Japanese subsidiary in November 2023, and the repayment of $77 million by July 2024. (2) The numeric values match exactly in amount and context—$500 million issued, $77 million repaid—with only minor formatting differences (e.g., 'roughly' and 'about' used, but no impact on accuracy as these do not misrepresent precision). (3) The multi-hop reasoning is sound: the model correctly identifies the subsidiary, the financial instrument, the timing of issuance and repayment, and synthesizes information across time points and entities. (4) The answer is contextually complete and directly addresses both parts of the question. All scores are maximized due to full factual correctness, proper entity identification, accurate numbers, and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1090,
        "completion_tokens": 273,
        "total_tokens": 1363
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "By how much did the decrease in the value of available-for-sale debt investments from 2021 to 2022 exceed the net gains realized from these investments during the same period?",
      "original_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 million, while the net gains from these investments decreased by $44 million. Therefore, the decrease in investment value exceeded the change in net gains by $3,215 million.",
      "llm_answer": "The portfolio of available‑for‑sale debt investments fell by **$3.259 billion** (from $15.206 billion in 2021 to $11.947 billion in 2022)【page_50】, while the company recorded only **$9 million** of net gains on those investments in 2022【page_49】. Thus, the decrease exceeded the realized net gains by roughly **$3.25 billion**.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and calculations. While it correctly identifies the decrease in available-for-sale debt investments as $3.259 billion (matching the ground truth $3,259 million), it incorrectly states the net gains realized in 2022 as $9 million, whereas the ground truth indicates a decrease in net gains of $44 million (i.e., a negative change of $44 million). This misrepresents both the magnitude and nature of the gain/loss. (2) The calculation of how much the decrease exceeded the net gains is flawed: the LLM computes $3.259 billion - $9 million ≈ $3.25 billion, but the correct calculation per ground truth is $3,259 million - (-$44 million) = $3,259 + $44 = $3,303 million decrease exceeding gains — however, the original answer states $3,215 million, implying the net gains may have been +$44 million reduction (i.e., from +X to +X-44), so the excess decrease is $3,259 - $44 = $3,215 million. The LLM uses $9 million instead of $44 million, leading to a major error. (3) The multi-hop reasoning is partially sound — the model correctly pulls investment values from two years to compute a decrease and attempts to compare it with realized gains — but fails in synthesizing the correct gain figure from the same period. (4) Contextually, the answer is relevant and addresses the right entities (available-for-sale debt investments, two-year comparison, net gains), but the incorrect use of $9 million (possibly mistaking a subtotal or unrelated figure) undermines factual correctness. Wording and structure are clear, but quantitative errors are severe enough to make the conclusion misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 457,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, combining both its unsecured revolving credit facility and unused letters of credit?",
      "original_answer": "The total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, is $14.2 billion. This includes the full $7.0 billion unsecured revolving credit facility, as there were no borrowings outstanding under the Credit Agreement, and $7.2 billion of unused letters of credit.",
      "llm_answer": "As of December 31 2021 Amazon had the entire $7.0 billion unsecured revolving credit facility available (no borrowings were outstanding) and $7.2 billion of unused letters of credit, giving it a total of **$14.2 billion** of unused short‑term credit capacity.【page_57】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the $7.0 billion unsecured revolving credit facility was fully available with no borrowings outstanding, and $7.2 billion in unused letters of credit are correctly reported. The total unused short-term credit capacity is accurately calculated as $14.2 billion. (2) Quantitative accuracy is perfect: all dollar amounts and the final sum are correct, with acceptable formatting variations (e.g., $7.0 billion vs $7.0 billion). The addition of $7.0B + $7.2B = $14.2B is mathematically sound. (3) Multi-hop reasoning is correctly applied: the model synthesizes data from two sources—availability of the revolving credit facility and unused letters of credit—and combines them appropriately to answer the total capacity question. (4) Entity accuracy is maintained: Amazon, the correct date (December 31, 2021), and the relevant financial instruments (revolving credit facility, letters of credit) are all correctly identified. (5) The answer is semantically equivalent to the original, conveying the same information with slightly different phrasing but no loss or distortion of meaning. The citation of 'page_57' adds contextual support. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 361,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the total cash outflow for acquisitions made by TMO in 2023, including its acquisition of The Binding Site Group, and how much of this total was specifically allocated to The Binding Site Group?",
      "original_answer": "The total cash outflow for acquisitions made by TMO in 2023 was $3.61 billion, with $2.70 billion specifically allocated to the acquisition of The Binding Site Group.",
      "llm_answer": "In 2023 Thermo Fisher spent $2.70 billion on its acquisition of The Binding Site Group and $0.91 billion on its acquisition of CorEvitas, LLC, for a total acquisition‑related cash outflow of roughly $3.61 billion. All of the cash allocated to The Binding Site Group was $2.70 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total cash outflow for acquisitions by TMO (Thermo Fisher) in 2023 was $3.61 billion, with $2.70 billion allocated to The Binding Site Group. The LLM correctly identifies Thermo Fisher (TMO) and the two acquisitions, including CorEvitas, LLC, which contributes the remaining $0.91 billion ($2.70B + $0.91B = $3.61B), confirming the calculation is accurate. (2) Quantitatively, all numbers match the ground truth exactly, with correct formatting and precise values. The sum is mathematically correct. (3) The multi-hop reasoning is sound: the model synthesizes information about multiple acquisitions in 2023, correctly attributes amounts to each, and aggregates them appropriately. (4) The answer addresses both parts of the question: total cash outflow and the portion allocated to The Binding Site Group. Semantic equivalence is maintained, and no irrelevant or incorrect details are introduced. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 294,
        "total_tokens": 1421
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What percentage of Union Pacific's chassis units are leased rather than owned, and how does this compare to the much smaller leased proportion of containers in their highway revenue equipment fleet?",
      "original_answer": "Union Pacific owns 30,635 chassis units and leases 17,705, meaning 36.6% (17,705 / 48,340) of chassis are leased. In contrast, only 1.1% (545 / 47,984) of containers are leased. This shows a significantly higher reliance on leasing for chassis compared to containers.",
      "llm_answer": "Union Pacific leases roughly **36‑37 % of its chassis units** (17,705 leased of 48,340 total). By contrast, only about **1 % of its containers are leased** (545 leased of 47,984 total).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the number of leased chassis (17,705) and total chassis (48,340) are correct, leading to the accurate percentage of ~36.6%, which the model correctly rounds to '36-37%'. Similarly, the number of leased containers (545) and total containers (47,984) are correctly cited, yielding ~1.1%, which the model appropriately rounds to 'about 1%'. (2) Calculations are accurate: 17,705 / 48,340 ≈ 36.6% and 545 / 47,984 ≈ 1.1% — minor rounding is acceptable and common. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across two different equipment types (chassis and containers), compares their leased proportions, and implicitly highlights the stark contrast in leasing reliance. (4) Entity accuracy is perfect: Union Pacific is correctly identified, and the metrics (leased vs. total units) are properly attributed. (5) The answer addresses both parts of the question: the percentage of leased chassis and the comparison to leased containers. Wording is concise but preserves all key information. No errors in reasoning, numbers, or relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 332,
        "total_tokens": 1458
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How many different supplemental indentures related to Senior Notes that include the 2035 Note were identified across the referenced exhibits, and which trustee was involved in the most recent of these agreements?",
      "original_answer": "Two supplemental indentures related to Senior Notes that include the 2035 Note were identified: the Fifth Supplemental Indenture dated September 14, 2015, and the Tenth Supplemental Indenture dated November 20, 2024. The trustee involved in the most recent of these agreements was Computershare Trust Company, National Association, as successor to Wells Fargo Bank.",
      "llm_answer": "Two supplemental indentures listed in the exhibits contain a Form of the 2035 Note – the Fifth Supplemental Indenture (Sept. 14 2015) and the Tenth Supplemental Indenture (Nov. 20 2024). The most recent of these was the Tenth Supplemental Indenture, which was executed with **Computershare Trust Company, National Association** as the trustee.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively, the numbers and dates are correct: two supplemental indentures are identified — the Fifth Supplemental Indenture on September 14, 2015, and the Tenth Supplemental Indenture on November 20, 2024. These match the ground truth exactly. (2) The trustee for the most recent agreement (Tenth Supplemental Indenture) is correctly identified as Computershare Trust Company, National Association. (3) The only minor omission is that the LLM answer does not explicitly mention that Computershare is 'as successor to Wells Fargo Bank,' which is included in the original answer. While this detail adds context about the trustee's succession, it does not change the core factual correctness of naming Computershare as the involved trustee. (4) The reasoning is sound: the model correctly identified the two relevant indentures involving the 2035 Note and determined the most recent one, demonstrating proper multi-hop synthesis across dates and documents. (5) The answer is contextually relevant and directly addresses both parts of the question — the count of indentures and the trustee in the most recent. Wording differences are acceptable under semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to the minor omission, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 392,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the expensing methodology for non-employee director deferred stock units granted in 2023 differ from those granted prior to 2022, and what is the vesting timeline for the 2023 awards?",
      "original_answer": "Deferred stock units granted to non-employee directors in 2023 are expensed on a straight-line basis over the requisite service period, whereas awards granted prior to 2022 were expensed in full on the grant date because they vested immediately. The 2023 awards vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "llm_answer": "For non‑employee directors, the 2023 deferred‑stock‑unit awards are expensed on a straight‑line basis over the required service period, whereas awards granted before 2022 vested immediately and the entire expense was recognized on the grant date. The 2023 awards vest on the earlier of (i) the first anniversary of the grant date or (ii) the day immediately preceding the next Annual Meeting of Shareholders (subject to certain acceleration provisions).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually and semantically equivalent to the ground truth. (1) All key elements are correct: the expensing methodology for 2023 awards (straight-line over service period) vs. pre-2022 awards (full expensing on grant date due to immediate vesting) is accurately described. (2) The vesting timeline for 2023 awards — 'the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders' — matches the original exactly, including the conditional phrasing and subject to acceleration. (3) Multi-hop reasoning is sound: the model correctly contrasts two different time periods (2023 vs. prior to 2022), identifies the change in accounting treatment, and specifies the vesting conditions for the newer awards. (4) No numerical inaccuracies; while no specific dollar amounts or percentages are involved, the temporal references (2023, prior to 2022) are correct. Wording differs slightly (e.g., 'required service period' vs. 'requisite service period'), but this does not affect meaning. All parts of the question are fully addressed with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 322,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, and what percentage of the total identifiable assets in that same region and business unit did this profit represent?",
      "original_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million. The identifiable assets in that same region and business unit were $698 million. Therefore, the operating profit represented approximately 36.4% of the identifiable assets.",
      "llm_answer": "The Oral, Personal and Home Care business generated **$254 million of operating profit in the Africa/Eurasia region in 2023** (see the “Operating profit” table on page 117).  \n\nThe filing does not disclose the amount of **identifiable assets** for that same region and business unit, so the percentage that the $254 million profit represents of those assets cannot be calculated from the pages provided.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the operating profit of $254 million for the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, which matches the ground truth. However, it incorrectly stated that the identifiable assets for that region and business unit were not disclosed, when in fact the ground truth specifies that identifiable assets were $698 million. This led to the failure to compute the correct percentage. (2) The quantitative accuracy is perfect for the profit figure, and the format ($254 million) is equivalent to the ground truth. The calculation of 254 / 698 ≈ 36.4% is straightforward and verifiable, but the LLM did not perform it due to the incorrect claim of missing data. (3) The multi-hop reasoning failed at the second hop: while the model correctly retrieved operating profit, it erroneously concluded that identifiable assets were not disclosed, preventing synthesis of the two figures to compute the percentage. This breaks the chain of reasoning required for full correctness. (4) The contextual relevance is high because the answer addresses the right business, region, year, and metric, but the qualitative accuracy is low due to the critical omission and incorrect assertion about data availability, which undermines the completeness and correctness of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 372,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "What was the total amount of AMD's purchases from and resales to the ATMP JV in fiscal year 2024, and how does this compare to the amount of the loan AMD provided to the ATMP JV during the same year?",
      "original_answer": "In fiscal year 2024, AMD's purchases from the ATMP JV amounted to $1.7 billion, and its resales to the ATMP JV totaled $121 million, resulting in a combined total of $1.821 billion. This is significantly higher than the $100 million loan AMD provided to one of the ATMP JVs in October 2024.",
      "llm_answer": "In fiscal 2024 AMD bought inventory from the ATMP joint venture for **$1.7 billion** and sold inventory back to it for **$121 million**, for a combined **$1.821 billion** of purchases + resales. During the same year AMD also made a **$100 million** term loan to the ATMP JV. Thus, the purchase‑and‑resale activity was roughly **18 times larger** than the loan amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1.7 billion in purchases, $121 million in resales, and a $100 million loan are correctly reported. The combined total of $1.821 billion is correctly calculated ($1.7B + $0.121B = $1.821B). The comparison stating that purchase-and-resale activity was roughly 18 times larger than the loan is logically sound (1.821B / 0.1B ≈ 18.21). (2) The answer is complete, addressing both parts of the question: total purchases and resales, and their comparison to the loan amount. (3) Entities are accurate—AMD, ATMP JV, fiscal year 2024, and the October 2024 loan timing (implied within fiscal 2024) are correctly referenced. (4) Multi-hop reasoning is properly executed: the model synthesizes purchase, resale, and loan data from the same fiscal year and draws a valid comparative conclusion. (5) Semantic equivalence is maintained—wording differs slightly but conveys the same factual content with added clarity (e.g., 'term loan' is a reasonable specification). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 319,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021, and how does this growth compare to the increase in the Research and medical products segment over the same period?",
      "original_answer": "The revenue for the Analytical and physical instrumentation product line increased by $156 million from 2019 to 2021 ($2,620 million in 2021 vs. $2,464 million in 2019). The Research and medical products segment increased by $11,290 million over the same period ($24,802 million in 2021 vs. $13,512 million in 2019). The increase in Analytical and physical instrumentation revenue was relatively modest compared to the significant growth in Research and medical products.",
      "llm_answer": "The Analytical and physical instrumentation product line grew from $2.464 billion in 2019 to $2.620 billion in 2021 – an increase of **$156 million**. In contrast, the Research and medical products segment rose from $13.512 billion to $24.802 billion, a **$11.29 billion** increase, which is dramatically larger than the modest growth in analytical instrumentation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the Analytical and physical instrumentation revenue increased from $2,464 million ($2.464 billion) in 2019 to $2,620 million ($2.620 billion) in 2021, resulting in a $156 million increase, which is correctly reported. The Research and medical products segment grew from $13,512 million ($13.512 billion) to $24,802 million ($24.802 billion), a difference of $11,290 million ($11.29 billion), which the LLM correctly rounds to $11.29 billion—this is within acceptable rounding precision. (2) The answer is complete, addressing both parts of the question: the revenue increase for the Analytical and physical instrumentation product line and the comparison with the Research and medical products segment. (3) Entities are correctly identified: both product lines and the 2019–2021 time frame are accurate. (4) The reasoning is sound: the LLM correctly performs the multi-hop calculation across years and segments, and the qualitative comparison—describing the instrumentation growth as 'modest' versus the 'dramatically larger' increase in research and medical products—accurately reflects the magnitude difference and aligns with the ground truth's interpretation. (5) Semantic equivalence is maintained despite format differences (e.g., using billions instead of millions), which does not affect factual accuracy. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 405,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Microsoft's SQL Server product line contribute to its Intelligent Cloud segment's financial performance, given the segment's reported structure and revenue drivers?",
      "original_answer": "Microsoft's SQL Server is a core component of the Intelligent Cloud segment, which includes server products and cloud services. SQL Server contributes to the segment's revenue through volume licensing programs, OEM licenses, and retail packaged products. As part of the server products category, SQL Server also drives revenue through Client Access Licenses (CALs), which provide access rights to the server product and are reported alongside the associated server product revenue. This aligns with the Intelligent Cloud segment's primary revenue drivers, which include server product licensing and cloud services like Azure.",
      "llm_answer": "SQL Server is part of the “Server products and cloud services” line that makes up the Intelligent Cloud segment. As the filing explains, server‑product revenue – which includes SQL Server licenses and the associated Client Access Licenses – is driven primarily by volume‑licensing, OEM and retail sales (page 13). In fiscal 2022 the entire Server products and cloud services category generated $67.3 billion of revenue, feeding directly into the Intelligent Cloud segment’s total of $75.3 billion (page 96).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies SQL Server as part of the 'Server products and cloud services' category within the Intelligent Cloud segment and accurately describes its revenue streams (volume licensing, OEM, retail) and the role of Client Access Licenses. This aligns with the ground truth and shows correct entity identification and conceptual understanding. (2) However, the quantitative accuracy is flawed: the LLM states that 'Server products and cloud services' generated $67.3 billion in fiscal 2022 and that Intelligent Cloud totaled $75.3 billion. These figures are incorrect or unverifiable from the ground truth provided, which does not include any specific revenue numbers. Since the original answer (ground truth) contains no dollar amounts or fiscal year data, the inclusion of precise figures like $67.3B and $75.3B constitutes a hallucination. This significantly undermines factual correctness. (3) The multi-hop reasoning is partially sound—linking SQL Server to server product licensing and then to the Intelligent Cloud segment is valid—but the addition of unsupported numerical data breaks the chain of accurate synthesis. The model introduces external data not present in the ground truth, failing the core requirement of fidelity to provided information. (4) Despite the hallucinated numbers, the qualitative explanation of how SQL Server contributes to revenue (via licensing models and CALs) is consistent with the original answer, and the response remains highly relevant to the question. Thus, while the reasoning and structure are strong, the incorrect figures severely reduce overall correctness, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 457,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What is the total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, and how does this reflect in both the 2023 and 2024 year-end balances?",
      "original_answer": "The value of Insurance Buy-in Contracts increased from $950 million at December 31, 2022, to $1,605 million at December 31, 2023, and then decreased to $1,390 million at December 31, 2024. This results in a net increase of $440 million over the two-year period ($1,390 million - $950 million = $440 million).",
      "llm_answer": "The non‑U.S. pension plans held Insurance Buy‑in Contracts valued at **$950 million at December 31, 2022** and **$1,390 million at December 31, 2024**, a net increase of **$440 million** over the two‑year period.  The year‑end balance rose to **$1,605 million in 2023** and then fell to **$1,390 million in 2024**, reflecting a $215 million decline from the 2023 peak.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $950 million (2022), $1,605 million (2023), and $1,390 million (2024) are correctly reported. The net increase of $440 million ($1,390M - $950M) is correctly calculated. The $215 million decline from 2023 to 2024 ($1,605M - $1,390M) is also accurate. (2) The answer addresses all parts of the question: total change over the period, and the reflection in both 2023 and 2024 year-end balances. (3) Entities are correct—'Insurance Buy-in Contracts' and the specified dates are properly referenced. (4) The multi-hop reasoning is sound: the model correctly synthesizes values across three time points, computes the net change, and explains the fluctuation between 2023 and 2024. Wording differs slightly from the original answer but maintains full semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 272,
        "total_tokens": 1450
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and how much in dividends was paid on those shares during 2024?",
      "original_answer": "$886 million was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and $26 million in dividends was paid on those shares during 2024.",
      "llm_answer": "As of December 31 2024 Texas Instruments’ defined‑contribution plans held TI common stock worth **$852 million in the U.S. plans plus $34 million in the non‑U.S. plans – a combined value of about $886 million**.  Dividends paid on those shares in 2024 were **$26 million (the U.S. portion); dividends on the non‑U.S. holdings were not material**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as $886 million as of December 31, 2024, matching the ground truth. It breaks this down into $852 million (U.S.) and $34 million (non-U.S.), which sum correctly to $886 million. The dividends paid on those shares during 2024 are reported as $26 million, which matches the ground truth. The note that non-U.S. dividends were 'not material' is a minor addition but does not contradict the ground truth, which states the total dividend amount without specifying geography. (2) All numeric values are accurate: $852M + $34M = $886M is correct; $26M in dividends is exactly as in the original answer. Format variations (e.g., $886 million vs $886M) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across U.S. and non-U.S. plans for both stock value and dividends, demonstrating proper aggregation. The slight elaboration on dividend breakdown does not introduce error but adds context. (4) The answer is fully factually correct, complete, and contextually appropriate. The only reason for not scoring a perfect 10 is the slight over-elaboration on dividend materiality, which, while not inaccurate, is not present in the ground truth and could imply a nuance not confirmed. However, it does not detract from correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 396,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What was the principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in their 2022 10-K, and how does this amount compare to the combined principal of their 3.900%, 4.450%, and 5.200% Senior Notes from the same filing?",
      "original_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 was $1,250 million. The combined principal of their 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes totals $2,250 million. Therefore, the 5.300% Senior Notes due 2050 represent approximately 55.6% of the combined principal of the other three notes.",
      "llm_answer": "The 2022 Form 10‑K shows that UPS issued $1.25 billion of 5.300 % senior notes (due 2050)【page_53】.  \nThe three earlier series total $1.0 billion + $750 million + $500 million = $2.25 billion of principal (3.900 %, 4.450 % and 5.200 % senior notes)【page_53】.  \n\nThus, the 5.300 % notes represent $1.0 billion less principal than the combined amount of the other three series.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the principal amount of the 5.300% Senior Notes due 2050 as $1.25 billion ($1,250 million), matching the ground truth. It also accurately reports the individual principal amounts for the 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) notes and correctly calculates their combined total as $2.25 billion ($2,250 million). These numeric values and the sum are all factually correct, supporting a high quantitative accuracy score. (2) However, the LLM's comparison statement — that the 5.300% notes represent '$1.0 billion less principal' than the combined amount — while mathematically accurate ($2.25B - $1.25B = $1.0B), does not fully address the comparative aspect requested in the question. The original answer computes the relative proportion (55.6%), which provides a more meaningful comparison. The LLM omits this percentage-based synthesis, which is a key part of the multi-hop reasoning required. (3) The reasoning is partially sound: it correctly aggregates the three notes and performs a subtraction, but fails to compute or mention the percentage relationship explicitly, which is central to the comparative analysis. This represents a gap in qualitative reasoning despite correct inputs and arithmetic. (4) Contextual relevance is perfect — the answer draws from the correct document (2022 10-K), correct page, and correct notes. Overall, the answer is factually strong but incomplete in its analytical depth, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 421,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What is the total weighted-average grant-date fair value of all Service-Based RSUs that were both outstanding at the beginning of the year and still outstanding at the end of 2024, after accounting for grants, vesting, and forfeitures?",
      "original_answer": "The total weighted-average grant-date fair value of Service-Based RSUs that remained outstanding throughout 2024 is $183.41 million.",
      "llm_answer": "The Service‑Based RSUs that were outstanding on December 31, 2023 and still outstanding on December 31, 2024 total **885 thousand units**. After removing the RSUs that vested (844 k) and were forfeited (98 k), the remaining units represent an **aggregate grant‑date fair value of roughly $143 million**, which works out to a **weighted‑average grant‑date fair value of about $161 per RSU**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its final dollar value. The ground truth states the total weighted-average grant-date fair value is $183.41 million, but the LLM reports approximately $143 million, which is off by over $40 million. This is a major quantitative error. Additionally, the LLM introduces a per-RSU value of $161 and unit counts (885k, 844k, 98k) that are not present in the original answer and cannot be verified against the ground truth, suggesting incorrect decomposition or sourcing. (2) The calculation logic implied—subtracting vested and forfeited units from beginning outstanding to get ending outstanding—is reasonable, but the resulting aggregate fair value does not match the ground truth. Without access to the actual filings, we judge based on alignment with the known correct answer, and the $143 million figure is factually wrong. (3) The reasoning attempts multi-hop synthesis (tracking RSUs over time with vesting and forfeitures), but the model appears to have used incorrect input data or miscalculated the final value. It also shifts focus to per-unit metrics not requested, indicating a misalignment in reasoning. (4) Despite the incorrect final number, the answer is contextually relevant—it addresses the right concept (Service-Based RSUs outstanding throughout 2024), references correct time points (Dec 31, 2023 and 2024), and attempts proper financial logic. However, the core factual output is wrong, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 420,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does UPS's estimation process for uncertain tax positions, as described in both the notes to the financial statements and the management discussion section, influence the potential recognition of tax benefits or additional charges to the tax provision, and what specific criteria determine the measurement of these benefits?",
      "original_answer": "UPS evaluates uncertain tax positions using a two-step process that directly affects the recognition of tax benefits or additional charges to the tax provision. First, it determines whether a tax position is more likely than not to be sustained on audit, based on available evidence. Second, it measures the largest amount of tax benefit that is more likely than not to be realized upon settlement. The difference between this recognizable benefit and the total benefit claimed or to be claimed is recorded as a liability. This process, detailed in both the financial statement notes and the management discussion, leads to quarterly reevaluations based on changes in facts, tax law, audit outcomes, or new activity, which can result in either recognizing a tax benefit or recording an additional charge to the tax provision.",
      "llm_answer": "UPS evaluates uncertain tax positions using a two‑step approach. First, it determines whether the “weight of available evidence” shows that the position is **more likely than not** to be sustained on audit (including any appeals or litigation). If that threshold is met, UPS then measures the **largest amount of tax benefit that is also more likely than not** to be realized; the difference between that amount and the total benefit claimed is recorded as a liability for uncertain tax benefits. Because the positions are re‑examined each quarter, any change in the recognition or measurement under these criteria can either add a tax benefit to earnings or increase the tax provision by an additional charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: UPS uses a two-step process for uncertain tax positions—first assessing whether a position is more likely than not to be sustained, and second measuring the largest amount of benefit that is more likely than not to be realized. The liability is based on the difference between the recognizable benefit and the total claimed benefit. These criteria directly influence whether tax benefits are recognized or additional charges are made to the tax provision. (2) There are no numeric values, dates, or financial figures in the question or answer that require verification; thus, quantitative accuracy is not applicable but assumed perfect as no errors exist. (3) The multi-hop reasoning is sound—synthesizing the recognition and measurement criteria with their impact on the tax provision and noting quarterly reevaluation (implied through 're-examined each quarter'), which aligns with the original answer’s mention of changes in facts, law, or audit outcomes triggering adjustments. (4) The only minor shortcoming is that the LLM answer does not explicitly name the sources (notes to financial statements and management discussion) as emphasized in the question and present in the original answer, slightly reducing completeness in contextual framing. However, the substance and logic are fully aligned. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 430,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What was the total capital expenditure in Africa/Eurasia in 2021, and by what percentage did organic sales in this region increase during the same year?",
      "original_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0% during the same year.",
      "llm_answer": "In 2021 Colgate‑Palmolive recorded **$33 million** of capital expenditures for the Africa/Eurasia segment, and **organic sales in that region grew 7.0 %** year‑over‑year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both the total capital expenditure in Africa/Eurasia in 2021 as $33 million and the organic sales growth in the region as 7.0%, matching the ground truth exactly. (2) All numeric values are accurate: $33 million in capital expenditures and 7.0% year-over-year organic sales growth are factually correct and consistent with the original answer. Format variations (e.g., '7.0 %' vs '7.0%') are acceptable and do not affect meaning. (3) The reasoning is sound and reflects proper multi-hop synthesis—linking the financial metric (capital expenditure) and performance metric (organic sales growth) to the correct geographic segment (Africa/Eurasia) and fiscal year (2021). (4) The answer is fully complete, addressing both parts of the question with precise data, correct entities, and appropriate context. All scores are maximized due to perfect factual alignment, accurate synthesis, and semantic equivalence to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1080,
        "completion_tokens": 284,
        "total_tokens": 1364
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What was the increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021, and how did this growth contribute to the overall increase in Vision segment sales during the same period?",
      "original_answer": "Johnson & Johnson's Contact Lenses/Other sales increased by $446 million (from $2,994 million in 2020 to $3,440 million in 2021). Vision segment sales grew by $769 million (from $3,919 million in 2020 to $4,688 million in 2021). Therefore, the increase in Contact Lenses/Other sales accounted for approximately 58% of the total growth in Vision segment sales from 2020 to 2021.",
      "llm_answer": "Johnson & Johnson’s Contact Lenses/Other line grew from **$2.994 billion in 2020 to $3.440 billion in 2021**, a rise of **$446 million (about 14.9%)**【page_33】.  \n\nThe Vision franchise overall rose 19.6% year‑over‑year, increasing roughly **$770 million** (from about $3.92 billion in 2020 to $4.69 billion in 2021). The $446 million gain in Contact Lenses/Other therefore supplied more than half of the Vision segment’s total growth, making it a principal contributor to the Vision sales increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: Contact Lenses/Other sales increased from $2,994 million to $3,440 million, a $446 million increase — matching the ground truth exactly. Vision segment sales grew from $3,919 million to $4,688 million, a $769 million increase; the LLM reports this as approximately $770 million, which is an acceptable rounding. The percentage contribution of Contact Lenses/Other to total Vision growth is calculated in the ground truth as ~58% ($446M / $769M), and while the LLM does not state the exact percentage, it correctly concludes that the increase 'supplied more than half' and was a 'principal contributor,' which is semantically equivalent and accurate. (2) All calculations are correct: the $446M increase is accurate, and the ~14.9% growth rate is correctly derived. The Vision segment’s 19.6% growth aligns with the reported figures (from $3.92B to $4.69B). (3) Multi-hop reasoning is sound: the model synthesizes data across two financial line items (Contact Lenses/Other and total Vision sales) across two years, correctly isolates the growth components, and draws a valid comparative conclusion about contribution. (4) The only minor shortcoming is the lack of explicit percentage attribution (58%), which slightly reduces qualitative precision, but the conclusion 'more than half' is logically sound and contextually sufficient. All entities (Johnson & Johnson, Contact Lenses/Other, Vision segment, years 2020–2021) are correct. Overall, the answer is factually accurate, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 436,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What was the impact of AspenTech's consolidation into Emerson's financial statements on the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022?",
      "original_answer": "The consolidation of AspenTech into Emerson's financial statements significantly reduced the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022. In 2022, AspenTech contributed $12 million in earnings, but in 2023, it reported a loss of $107 million. This $119 million deterioration directly impacted the overall segment earnings, which remained flat at $529 million in 2023 despite revenue growth, compared to $437 million in 2022. Additionally, the segment margin declined from 14.7% in 2022 to 11.6% in 2023, a 3.1 percentage point decrease, largely driven by AspenTech's poor performance.",
      "llm_answer": "After Emerson folded Heritage AspenTech into its books, the Control Systems & Software segment reported earnings of **$529 million in 2023 versus $437 million in 2022** – a rise of roughly **21 %**.  However, the segment’s margin slipped to **11.6 % in 2023 from 14.7 % in 2022**, a decline of **about 3.1 percentage points**, mainly because the AspenTech acquisition added roughly **$249 million of incremental intangibles amortization** that pressured profitability.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect information. It correctly reports the segment earnings ($529M in 2023 vs $437M in 2022), the margin decline (14.7% to 11.6%), and the 3.1 percentage point decrease. However, it incorrectly states that segment earnings increased by 21%, when in fact the ground truth indicates that earnings were flat in 2023 compared to 2022 *despite* revenue growth — this is a critical error because the $529M in 2023 is only a nominal increase from $437M in 2022, but the ground truth emphasizes that this increase was fully offset by AspenTech's deterioration, implying the core business may have grown, but the segment earnings did not meaningfully improve. More critically, the LLM claims AspenTech added $249M in intangibles amortization, which is not in the ground truth; instead, the truth states AspenTech contributed $12M in earnings in 2022 and a $107M loss in 2023 — a $119M year-over-year deterioration. The $249M figure is unsupported and materially inaccurate. (2) Number verification: $529M (2023 earnings) — correct; $437M (2022) — correct; 11.6% and 14.7% margins — correct; 3.1 pp decline — correct; 21% earnings growth — incorrect (misleading, as the truth frames earnings as flat relative to the prior year given the AspenTech drag); $249M amortization — not in ground truth, likely fabricated. (3) Multi-hop reasoning: The model correctly identifies the impact of AspenTech on margins and earnings but misattributes the cause. Instead of citing the actual $119M swing from positive to negative earnings, it invents an amortization explanation, failing to synthesize the correct causal link. (4) Correctness score is 5 due to significant factual error in explaining AspenTech's impact despite some correct numbers. Quantitative accuracy is 5 because half the numbers are correct but key ones (amortization, earnings change interpretation) are wrong. Qualitative accuracy is 6 because reasoning is partially sound but based on incorrect data. Contextual relevance is 9 — the answer addresses the right segment, company, and year, and focuses on earnings and margin as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 574,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How much total monetary liability did Visa record in fiscal 2022 for U.S. covered litigation, and how is this liability recovered under the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of class B common stock to class A common stock.",
      "llm_answer": "In fiscal 2022 Visa recorded a U.S.‑covered‑litigation liability of **$1.441 billion** (the ending balance of the U.S. covered‑litigation accrual).  Under the U.S. Retrospective Responsibility Plan, this liability is **recovered by a downward adjustment to the conversion rate at which Visa’s Class B common‑stock shares are converted into Class A common‑stock shares**.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a significant factual error in the monetary amount: it reports $1.441 billion instead of the correct $861 million from the ground truth. This is a major quantitative discrepancy that undermines the correctness of the answer. However, the description of how the liability is recovered — via a downward adjustment to the conversion rate of Class B to Class A common stock — is factually accurate and matches the original answer. (2) The dollar amount is incorrect: $1.441 billion (LLM) vs $861 million (ground truth), a difference of over $580 million. This error likely stems from confusing the ending accrual balance with the fiscal year liability recorded, but regardless, it does not align with the documented liability for fiscal 2022. No calculation is required in the question, but the reported figure must match the recorded liability, which it does not. (3) The reasoning regarding the recovery mechanism is sound and reflects proper multi-hop understanding of Visa’s U.S. Retrospective Responsibility Plan and its impact on stock conversion — this part of the synthesis is correct. (4) Due to the severe inaccuracy in the key numeric figure, the correctness score is low (4), though not lower because the qualitative mechanism is right. Quantitative accuracy is scored very low (3) due to the wrong number. Qualitative accuracy is moderate (7) because the conceptual explanation is correct. Contextual relevance is high (9) as the response directly addresses both parts of the question with relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 423,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "What was the total financial impact on Pfizer from its historical ownership of Meridian in 2021, including both operational results and post-closing adjustments?",
      "original_answer": "The total financial impact on Pfizer from its historical ownership of Meridian in 2021 was a $512 million negative impact, which includes a $345 million pre-tax legal charge in the second quarter and an after-tax loss of $167 million related to the sale of Meridian in the fourth quarter.",
      "llm_answer": "Pfizer said that its historic Meridian ownership cost it a $345 million pre‑tax charge in Q2 2021 to settle a legal matter and a $167 million after‑tax loss in Q4 2021 on the sale – a combined impact of roughly **$512 million** for 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $345 million pre-tax legal charge in Q2 2021 and $167 million after-tax loss in Q4 2021, with a correctly summed total impact of $512 million. The format variations (e.g., using 'million' and 'M') are acceptable and semantically equivalent. (2) The answer is complete, addressing both components of the financial impact—operational results (legal charge) and post-closing adjustments (loss on sale)—as required by the question. (3) Entity accuracy is correct: Pfizer, Meridian, and the year 2021 are properly identified, with accurate time periods (Q2 and Q4). (4) The multi-hop reasoning is sound—information from two separate events (a legal charge and a sale-related loss) is correctly synthesized into a single total financial impact. The conclusion of a $512 million total impact is logically derived and matches the ground truth. (5) The semantic meaning is equivalent to the original answer, with slightly different phrasing but no loss or distortion of factual content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 312,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "What is the minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, and how does this requirement differ from the SLR requirement for its insured depository institution subsidiaries?",
      "original_answer": "Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of 3.0 percent plus a leverage buffer of 2.0 percent, totaling 5.0 percent, to avoid restrictions on capital distributions and discretionary bonus payments. In contrast, its insured depository institution subsidiaries are required to maintain a higher minimum SLR of 6.0 percent to be considered well capitalized under the PCA framework.",
      "llm_answer": "Bank of America Corporation must keep a supplementary leverage ratio of **3 % plus a 2 % leverage buffer – a total regulatory minimum of 5 %** under Basel III. By contrast, its insured depository‑institution subsidiaries must meet a **6 % SLR** to be deemed well‑capitalized, which is higher than the corporation’s 5 % requirement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Bank of America Corporation must maintain a 3% minimum SLR plus a 2% leverage buffer, totaling 5%, which aligns with Basel III requirements to avoid restrictions. The subsidiaries' requirement of 6% is correctly stated as higher. (2) The answer is complete, addressing both parts of the question: the consolidated corporate requirement (5%) and the higher requirement for insured depository institution subsidiaries (6%). (3) Entity accuracy is correct—'Bank of America Corporation' and its 'insured depository institution subsidiaries' are properly distinguished. (4) The reasoning is sound and reflects proper multi-hop synthesis: it contrasts the Basel III leverage ratio framework (applying to the holding company) with the PCA (Prompt Corrective Action) framework (applying to insured depository institutions), which is essential context implied in the question. (5) Semantic equivalence is maintained—though wording differs slightly, all key facts, comparisons, and implications are preserved. No errors in calculation, logic, or factual representation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 332,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact MetLife's accounting treatment for mortgage loans, specifically in terms of the allowance for credit losses and the timing of credit loss recognition?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed MetLife's accounting treatment for mortgage loans by requiring the establishment of an allowance for credit losses (ACL) at the time of purchase based on expected lifetime credit losses, rather than recognizing credit loss only when it was probable that amounts due would not be collected. This shift moved the company from an incurred loss model to an expected loss model, resulting in earlier recognition of credit losses and presenting mortgage loans at the net amount expected to be collected.",
      "llm_answer": "When MetLife adopted the new credit‑loss guidance on 1 January 2020, it began recording an **allowance for credit losses (ACL)** on its mortgage‑loan portfolio at the time the loans were purchased.  The ACL reflects the portion of the amortized‑cost basis that the company does not expect to collect over the life of the loan, so the loans are presented net of that allowance.  Under the prior incurred‑loss model, credit losses were recognized in earnings only when a loss became probable; the new guidance shifts recognition to an expected‑lifetime loss at acquisition rather than waiting for an incurred loss.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correct: the adoption date (January 1, 2020), the shift from an incurred loss to an expected loss model, the establishment of an allowance for credit losses (ACL) at purchase, and the presentation of mortgage loans at net amount expected to be collected. (2) There are no numeric values requiring calculation, but the date 'January 1, 2020' is correctly stated. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the change in accounting treatment by linking the timing of loss recognition (from probable to expected at acquisition) with its impact on financial reporting (ACL and net presentation). (4) The answer fully addresses both parts of the question: impact on allowance for credit losses and timing of credit loss recognition. Wording differs slightly but meaning is preserved with high precision. All scores are 10 due to complete factual correctness, accurate entities, logical reasoning, and full relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 297,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, change the timing and methodology of recognizing credit losses on leveraged lease receivables and mortgage loans, and what specific models and inputs were used under the new guidance?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition of credit losses from an incurred loss model to an expected lifetime credit loss model for both leveraged lease receivables and mortgage loans. For leveraged lease receivables, the Company now uses a probability of default and loss given default model to estimate expected lifetime credit loss, incorporating third-party credit ratings and historical default data. For mortgage loans, the Company applies significant judgment to estimate expected lifetime credit loss over the contractual term adjusted for prepayments and extensions, considering past events and current and forecasted economic conditions. This represents a shift from recognizing credit losses only when incurred to proactively accounting for expected losses over the life of the asset.",
      "llm_answer": "The adoption of the new credit‑loss guidance on 1 January 2020 moved MetLife from an “incurred‑loss/other‑than‑temporary‑impairment” approach—where a loss was recorded only when it became probable that the full contractual amount would not be collected—to an “expected‑lifetime‑credit‑loss” (ACL) approach that requires an allowance to be recorded at the time the asset is recognized (or each reporting period thereafter).  \n\n* **Leveraged‑lease receivables:**  Under the new guidance MetLife records an ACL in earnings for the portion of the lease investment it does not expect to collect.  The allowance is calculated with a **probability‑of‑default (PD) / loss‑given‑default (LGD) model** that (i) pools leases with similar risk characteristics, (ii) uses third‑party credit ratings of the lessee together with historical default data to derive PD, and (iii) incorporates LGD assumptions, residual‑value fair‑value estimates, and other market information (e.g., third‑party forecasts, brokerage reports).  \n\n* **Mortgage loans:**  The company now estimates an **expected‑lifetime credit loss** for each loan or pool of loans.  The model projects cash‑flows over the contractual term, adjusts them for **expected pre‑payments and extensions**, and discounts them using appropriate rates.  Key inputs are **historical default experience, current and forecasted macro‑economic conditions, credit‑rating information, and assumptions about pre‑payment behavior**.  \n\nThus, the guidance changed loss recognition from an event‑driven timing to a forward‑looking, lifetime‑based allowance, and the new methodology relies on PD/LGD models for leveraged leases and an expected‑cash‑flow‑discount model with macro‑economic and pre‑payment inputs for mortgage loans.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: the adoption date of January 1, 2020, and the shift from an incurred loss model to an expected lifetime credit loss model are accurately stated. (2) The methodology for leveraged lease receivables correctly identifies the use of a probability of default (PD) and loss given default (LGD) model, with inputs including third-party credit ratings and historical default data—matching the original answer. The mention of pooling leases with similar risk characteristics and using residual-value estimates and market data adds appropriate detail without introducing inaccuracies. (3) For mortgage loans, the LLM correctly describes the estimation of expected lifetime credit losses over the contractual term adjusted for prepayments and extensions, and includes the use of historical default experience, current and forecasted economic conditions, credit ratings, and prepayment assumptions—fully aligning with the ground truth. (4) The reasoning is sound and reflects proper multi-hop synthesis: it distinguishes between the two asset types, applies the correct models and inputs to each, and explains the forward-looking nature of the new guidance. (5) There are no numerical inaccuracies (dates are correct, no incorrect figures), and while the LLM adds slight elaboration (e.g., 'discounts them using appropriate rates'), these do not deviate from the original meaning but enhance clarity. The answer fully addresses all parts of the question: timing (change from event-driven to forward-looking), methodology (ACL model), and specific models and inputs for each asset class. Thus, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1675,
        "completion_tokens": 470,
        "total_tokens": 2146
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does Texas Instruments' (TXN) structural cost advantage in manufacturing analog products using 300-millimeter wafers contribute to its ability to generate and return significant amounts of cash, as highlighted in its business model and competitive advantages?",
      "original_answer": "Texas Instruments achieves a 40% cost reduction per unpackaged chip by using 300-millimeter wafers instead of 200-millimeter wafers, which directly supports its competitive advantage in manufacturing and technology. This cost advantage enables greater control over the supply chain and lowers production costs, contributing to higher gross margins. As a result, TI is positioned to generate significant free cash flow, which aligns with its stated objective of maximizing long-term free cash flow per share growth and returning substantial amounts of cash to shareholders.",
      "llm_answer": "Texas Instruments’ investment in 300‑millimeter wafer capacity gives its analog products a structural cost advantage—an unpackaged chip on a 300‑mm wafer costs roughly 40 % less than one on a 200‑mm wafer【page_8】.  That lower‑cost, higher‑margin manufacturing base lifts gross margins (67.5 % in 2021) and operating profit, producing $8.76 billion of cash flow from operations and $6.29 billion of free cash flow, which the company then returns to shareholders ($4.41 billion in 2021)【page_21】【page_20】.  In short, the 300‑mm cost advantage underpins the “strong foundation of manufacturing and technology” that enables TI to generate and return large amounts of cash.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the 40% cost reduction per unpackaged chip using 300-mm wafers vs. 200-mm wafers, matching the original answer. (2) It adds specific financial figures: $8.76 billion in cash flow from operations, $6.29 billion in free cash flow, and $4.41 billion returned to shareholders in 2021. These numbers are consistent with typical disclosures in TI's 10-K filings and enhance the answer with concrete data not in the ground truth, but do not contradict it. The gross margin of 67.5% in 2021 is accurate and contextually relevant. (3) The reasoning is sound and multi-hop: it connects wafer size → cost advantage → higher margins → increased cash flow → shareholder returns, which directly addresses the causal chain in the question. (4) Minor deduction in quantitative accuracy is due to the lack of explicit sourcing for the 2021 financial figures in the ground truth; while plausible and likely correct, the original answer does not include them, so their precision cannot be fully verified against the provided knowledge graph. However, they do not appear erroneous. The answer is semantically equivalent and adds valuable context. No entity errors—correct company (Texas Instruments/TI), correct technology (300-mm wafers), correct financial concepts. The answer is fully relevant and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 391,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What is the total value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes issued by TMO as of December 31, 2021, and how does this compare to the value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of the same date?",
      "original_answer": "The total value of the Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes issued by TMO as of December 31, 2021, is $1,000 million. The value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of December 31, 2021, is $500 million. Therefore, the 1.5-Year Senior Notes are valued at twice the amount of the 2-Year Senior Notes as of December 31, 2021.",
      "llm_answer": "As of December 31 2021, Thermo Fisher had **$1.0 billion** of the 1.5‑year floating‑rate senior notes (SOFR + 0.35%, due 4/18/2023) outstanding, compared with **$0.5 billion** of the 2‑year floating‑rate senior notes (SOFR + 0.39%, due 10/18/2023). Thus, the 1.5‑year notes were twice the size of the 2‑year notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes value is correctly stated as $1.0 billion (i.e., $1,000 million), and the 2-Year Floating Rate (SOFR + 0.39%) Senior Notes value is correctly given as $0.5 billion (i.e., $500 million). (2) The due dates are consistent with the original context (April 18, 2023, and October 18, 2023), and while the question only asked about the latter's maturity, the inclusion of the former is accurate and adds context. (3) The comparison 'twice the size' correctly reflects the 2:1 ratio between $1,000 million and $500 million. (4) The entity 'Thermo Fisher' (TMO) is correctly identified. (5) The multi-hop reasoning—comparing two different notes by value, rate, term, and maturity—is sound and well-synthesized. All formatting variations (e.g., $1.0 billion vs $1,000 million) are acceptable and numerically equivalent. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 296,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How many shares of UnitedHealth Group common stock were available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, and which plan had more shares available?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan and 17 million shares were available under the ESPP, making a total of 70 million shares available for future issuance combined. The 2020 Stock Incentive Plan had more shares available than the ESPP.",
      "llm_answer": "As of December 31 2023, UnitedHealth Group had **70 million shares of common stock** available for future issuance under its equity‑compensation plans – 53 million under the **2020 Stock Incentive Plan** and 17 million under the **1993 Employee Stock Purchase Plan (ESPP)**【page_72†L13-L19】. The 2020 Stock Incentive Plan therefore had the larger pool of shares available.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 53 million shares under the 2020 Stock Incentive Plan and 17 million under the ESPP, totaling 70 million shares available as of December 31, 2023. The sum (53M + 17M = 70M) is correct. (2) The answer is complete, addressing both parts of the question: the total number of shares available for future issuance (70 million) and which plan had more shares available (the 2020 Stock Incentive Plan). (3) Entity accuracy is perfect: UnitedHealth Group, the 2020 Stock Incentive Plan, the 1993 Employee Stock Purchase Plan (ESPP), and the date December 31, 2023 are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly aggregated data from two different plans, computed the total, and made a valid comparison between the two plans. (5) The semantic meaning is equivalent to the original answer, with only minor rephrasing (e.g., 'larger pool' instead of 'more shares available'). The citation reference 【page_72†L13-L19】 adds contextual support. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 331,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "What was the total liability for postemployment benefits reported by CAT in 2023, and how did the pension benefits freeze impact the assumptions used in their financial reporting?",
      "original_answer": "The total liability for postemployment benefits reported by CAT in 2023 was $621 million, which includes $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans. The pension benefits freeze, which became effective December 31, 2019, resulted in the elimination of service cost and rendered certain actuarial assumptions no longer applicable to the pension reporting.",
      "llm_answer": "Caterpillar reported a total post‑employment‑benefits liability of **$621 million for 2023** (the $56 million liability for other post‑retirement benefits plus the $565 million liability for non‑qualified deferred‑compensation plans). Because all U.S. pension benefits were frozen on December 31 2019, the company no longer uses a compensation‑increase rate (and consequently records no service cost) for U.S. pension plans, and those related actuarial assumptions are omitted from its financial‑reporting calculations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total liability of $621 million is accurately broken down into $56 million for other post-retirement benefits and $565 million for non-qualified deferred compensation plans, which sum correctly to $621 million. The date of the pension freeze, December 31, 2019, is correctly stated. (2) The answer addresses both parts of the multi-hop question: it reports the 2023 total liability and explains the impact of the pension freeze on financial reporting assumptions. (3) Entities are accurate—Caterpillar (CAT), correct fiscal year (2023), and proper identification of benefit types and reporting terms (e.g., service cost, compensation-increase rate). (4) The reasoning is sound: the freeze led to the elimination of service cost and the discontinuation of certain actuarial assumptions (like compensation growth), which the LLM correctly links to changes in financial reporting. The phrasing differs slightly from the original (e.g., 'compensation-increase rate' instead of 'certain actuarial assumptions'), but the meaning is semantically equivalent and technically precise. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 344,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "What was the total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans, and how does this compare to the prior year?",
      "original_answer": "The total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was $2,555 million for investment funds and $2,171 million for equity securities, totaling $4,726 million. In 2023, the fair value was $2,797 million for investment funds and $2,071 million for equity securities, totaling $4,868 million. This represents a decrease of $142 million from 2023 to 2024.",
      "llm_answer": "In the U.S. pension plans, Merck reported $2,555 million of developed‑market equity **investment‑fund** assets and $2,171 million of developed‑market **equity‑security** assets at December 31, 2024 – a combined fair‑value total of **$4,726 million**. For the prior year, the same categories totaled $2,797 million (investment funds) + $2,071 million (equity securities) = **$4,868 million**. Thus, the 2024 total was about **$142 million lower** than in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: $2,555 million (2024 investment funds), $2,171 million (2024 equity securities), $2,797 million (2023 investment funds), and $2,071 million (2023 equity securities) are correctly reported. The totals are also correct: $4,726 million in 2024 ($2,555 + $2,171) and $4,868 million in 2023 ($2,797 + $2,071). The year-over-year difference is accurately calculated as $142 million decrease ($4,868 - $4,726). (2) The answer addresses both parts of the question: the total fair value in 2024 and the comparison to the prior year. (3) Entities are correctly identified: Merck, U.S. Pension Plans, developed markets equities, investment funds, equity securities, and the correct years (2024 and 2023). (4) The multi-hop reasoning—aggregating across two asset categories and two years, then computing the change—is sound and clearly presented. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of en-dashes, spacing) that do not affect accuracy. All criteria for a perfect score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 324,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and how many remain available for issuance as of December 31, 2024, considering the plan's role in issuing stock options, RSUs, and PSUs as stated in the plan documentation and stock-based compensation disclosures?",
      "original_answer": "A total of 135 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and approximately 47 million shares remain available for issuance as of December 31, 2024, after accounting for shares issued through stock options, RSUs, and PSUs under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan was established with authority to issue roughly **135 million shares of Danaher common stock** in total. As of December 31 2024, about **47 million of those shares** were still available for issuance (excluding the shares already underlying outstanding awards)【page_96】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total authorized shares (135 million) and the remaining available shares (47 million) as of December 31, 2024), which matches the ground truth exactly. These numbers are factually accurate and properly attributed to the 2007 Omnibus Incentive Plan. (2) Quantitative accuracy is perfect: both key figures (135 million authorized, 47 million available) are correct, and the date (December 31, 2024) aligns with the question. Format variations (e.g., '135 million' vs '135 million') are acceptable and do not affect meaning. (3) The reasoning is sound and reflects multi-hop synthesis—combining the plan’s initial authorization with cumulative usage over time to determine remaining availability. The mention of 'excluding shares already underlying outstanding awards' adds nuance consistent with stock plan accounting practices, though it slightly diverges in emphasis from the original answer, which explicitly references stock options, RSUs, and PSUs. This minor omission in detailing the types of awards does not detract from the core correctness but prevents a perfect qualitative score. (4) Contextual relevance is excellent—the response directly addresses both parts of the question (total authorized and remaining shares), stays focused on Danaher’s 2007 plan, and cites a specific document page (【page_96】), indicating proper sourcing from disclosures. Overall, the answer is semantically equivalent to the ground truth with only minor differences in elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 420,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the growth in Google Play's revenue contribution, as part of non-advertising revenues, potentially affect Google's overall profit margins, given the differing margin profiles between advertising and non-advertising revenue streams?",
      "original_answer": "Google Play generates revenues from app sales, in-app purchases, and digital content, and is a growing component of Google's non-advertising revenues. According to the 2022 10-K filing, non-advertising revenues—including those from Google Play, hardware, and Google Cloud—are increasing and may adversely affect overall profit margins because the margins on these revenues vary significantly and may be lower than those on advertising revenues. As Google Play's revenue contribution grows, if its margins remain lower than those of advertising, the overall profit margin of Google could decrease unless offset by efficiencies or higher-margin offerings.",
      "llm_answer": "The 10‑K notes that Google Play is classified under “Google other” (non‑advertising) revenues 【page 31】, and that the share of non‑advertising revenues – which include Google Play, hardware, and YouTube subscriptions – is rising 【page 30】. Because the margins on these non‑advertising streams are “significantly lower” than the high‑margin advertising business 【page 30】, a larger contribution from Google Play will shift the revenue mix toward lower‑margin items and therefore can pull down Alphabet’s overall profit margin.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the original answer from the knowledge graph. (1) It correctly identifies Google Play as part of non-advertising revenues (labeled as 'Google other' in the 10-K), accurately citing page 31 for classification and page 30 for the rising share and margin comparison. (2) There are no numeric values or calculations in the question or ground truth, so quantitative accuracy is not applicable in terms of numbers, but the LLM correctly references the qualitative financial characterization (lower margins in non-advertising vs. advertising). (3) The multi-hop reasoning is sound: it connects Google Play's inclusion in non-advertising revenues, the growth of that segment, and the implication of lower margins relative to advertising—leading to the conclusion that increasing Google Play revenue could reduce overall profit margins. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Google Cloud or hardware as part of non-advertising revenues (though it does mention hardware and YouTube subscriptions, which is consistent with the 10-K), and slightly narrows the scope by not acknowledging potential offsets like efficiencies or higher-margin offerings in the future, which the original answer includes. However, the core logic and factual basis are correct, and the answer is semantically equivalent in intent and substance. Thus, the correctness score is 9 due to high accuracy with a small omission in completeness regarding mitigating factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 420,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What specific financial instruments does CVS use to hedge against credit quality risk, and how does the company expect these instruments to impact its overall risk exposure?",
      "original_answer": "CVS uses derivative financial instruments such as interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps to hedge against credit quality risk. The company expects these instruments, when used for hedging, to reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately.",
      "llm_answer": "CVS hedges its credit‑quality risk primarily with **credit‑default swaps** (along with other derivatives such as interest‑rate swaps, treasury rate locks, forwards, futures, warrants and put options that are also used for hedging).  The company states that, when employed for hedging, these instruments are expected to **offset or reduce the overall credit‑quality risk exposure** of its investment portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All financial instruments listed—credit default swaps, interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, and put options—are correctly identified, matching the original answer. The LLM emphasizes credit-default swaps as primary for credit quality risk, which is contextually reasonable though the original does not prioritize one instrument over others. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable but assumed correct by absence. (3) The reasoning is sound: the LLM correctly states that these instruments are used for hedging and are expected to reduce overall credit-quality risk exposure, which aligns with the original statement that hedging reduces overall risk despite introducing other individual risks. The only minor shortcoming is that the LLM omits explicit mention of the trade-off—'subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately'—which slightly weakens the completeness of the risk perspective. (4) Despite this omission, the answer remains semantically equivalent in intent and factual content, with excellent contextual relevance and entity accuracy. Thus, the correctness score is 9 due to a minor omission in risk nuance, but all other dimensions are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 401,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021?",
      "original_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $691 million. This is calculated by summing $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans.",
      "llm_answer": "In 2021 the company held **$682 million** of hedge‑fund/limited‑partnership assets in its U.S. pension plans and **$9 million** in its other post‑retirement benefit plans, for a combined total of **approximately $691 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans are correctly reported. The combined total of $691 million is accurate and properly calculated. (2) Quantitative accuracy is perfect—numbers match exactly, with acceptable formatting (e.g., 'million' used consistently, bold formatting does not affect meaning). The sum (682 + 9 = 691) is correct. (3) Multi-hop reasoning is sound: the model correctly synthesized data from two distinct plans (U.S. Pension Plans and Other Postretirement Benefit Plans) for the year 2021, as required by the question. (4) The answer is semantically equivalent to the original, using slightly different phrasing ('approximately $691 million' is acceptable given exact numbers are provided earlier) without losing precision. All entities (plan types, asset class, year) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 284,
        "total_tokens": 1411
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total number of freight cars UNP both owns and leases as of 2024, and how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?",
      "original_answer": "UNP owns or leases a total of 56,176 freight cars as of 2024. Based on the capital plan and lease buyout figures, they spent $143 million on acquiring freight cars in 2024.",
      "llm_answer": "- UNP reported owning 33,704 freight cars and leasing 22,472 freight cars at December 31 2024, for a combined fleet of 56,176 freight cars【page_19】.  \n- In 2024 the company’s capital program included $788 million for locomotives and freight cars, of which $143 million was specifically identified as lease‑buyout spending for freight cars【page_33】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, all numbers are accurate: the total number of freight cars (56,176) is correctly derived from the sum of owned (33,704) and leased (22,472) units, and the $143 million spent on acquiring freight cars via lease buyouts in 2024 is explicitly stated. (2) The answer addresses both parts of the question: total freight car fleet size (owned + leased) as of 2024 and the acquisition spending based on capital plan and lease buyouts. (3) Entities are correct—UNP is the subject, all figures are tied to 2024, and the financial metric ($143 million for freight car lease buyouts) is accurately extracted. (4) The reasoning is sound: the LLM correctly synthesizes data from two different pages (fleet count from page 19, capital spending breakdown from page 33), demonstrating proper multi-hop logic. The $143 million is correctly interpreted as the amount spent on acquiring freight cars through lease buyouts, which aligns with the definition of acquisition in this context. Minor wording differences (e.g., 'lease-buyout spending for freight cars' vs. 'spent on acquiring freight cars') do not affect semantic equivalence—the meaning is identical. All criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 351,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "By how much did changes in non-marketable equity securities contribute to the overall increase in other income (expense), net, from 2020 to 2021, given the role of these investments in Google's equity portfolio?",
      "original_answer": "The changes in non-marketable equity securities contributed $6.9 billion to the overall increase in other income (expense), net, from 2020 to 2021. This was the primary driver behind the $5.2 billion net increase in other income, despite being partially offset by a $1.3 billion increase in accrued performance fees.",
      "llm_answer": "The net unrealized gain on Google’s non‑marketable equity securities grew from $1.5 billion in 2020 to $9.85 billion in 2021 – an increase of roughly **$8.3 billion**. This rise in the value of its non‑marketable equity portfolio accounted for the bulk of the $5.2 billion jump in other income (expense), net, between the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The ground truth states that changes in non-marketable equity securities contributed $6.9 billion to the increase in other income, net. However, the LLM claims an $8.3 billion increase in net unrealized gains ($9.85B in 2021 vs $1.5B in 2020), which does not align with the ground truth. This overstates the contribution by $1.4 billion. Additionally, while the LLM correctly notes a $5.2 billion overall increase in other income, it fails to mention the offsetting $1.3 billion increase in accrued performance fees, which is critical context for understanding why a $6.9B gain led to only a $5.2B net increase. (2) The calculation of $9.85B - $1.5B = $8.35B (rounded to $8.3B) is mathematically correct based on the numbers provided, but the underlying figures are factually wrong per the knowledge graph. The correct contribution is $6.9B, not $8.3B. (3) The reasoning partially captures the multi-hop nature of the question—linking non-marketable equity gains to the change in other income—but misses the full synthesis by omitting the offsetting fees, leading to an incomplete and misleading explanation. (4) Scores reflect major quantitative error (factual dollar amounts incorrect), partial qualitative accuracy (correct direction and general logic), and high contextual relevance (addresses the right metric, company, and time period).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 396,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023, and how were these contracts classified in the company's financial statements upon final settlement?",
      "original_answer": "The total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 was $0.7 billion ($0.3 billion in 2022 and $0.4 billion in 2023). These forward contracts were initially classified as equity instruments and recorded within capital surplus. Upon final settlement, the forward contracts were reclassified from capital surplus to treasury stock.",
      "llm_answer": "The forward contracts tied to the ASR transactions amounted to **$0.3 billion for the 2022 Barclays ASR and $0.4 billion for the 2023 Citibank ASR – a combined total of $0.7 billion**【page_92†L22-L30】【page_70†L1-L8】.  In each case the forward contract was initially recorded as an equity instrument in capital surplus, and **upon final settlement it was re‑classified from capital surplus to treasury stock**【page_92†L24-L30】【page_70†L5-L8】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all factual components of the ground truth. The total value of the forward contracts is accurately stated as $0.7 billion, with correct breakdowns of $0.3 billion in 2022 and $0.4 billion in 2023. These figures match the original answer exactly, and the combined total is correctly calculated. (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and the sum ($0.3B + $0.4B = $0.7B) is accurate. Format variations (e.g., $0.7 billion vs $700 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—information is synthesized across two years and two ASR transactions (Barclays 2022, Citibank 2023), and the classification treatment over time (initial recording in capital surplus, reclassification to treasury stock upon settlement) is correctly described, demonstrating proper understanding of the accounting treatment. (4) The answer is contextually fully relevant, addressing both parts of the question: total value and accounting classification upon settlement. Wording differs slightly (e.g., naming counterparties Barclays and Citibank, which adds detail not in the ground truth but does not contradict it), but the semantic meaning and factual content are identical. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 368,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, relate to the defined contribution retirement plan in terms of addressing restrictions under the Internal Revenue Code of 1986 for eligible employees?",
      "original_answer": "The Benefit Restoration Plan supplements benefits provided under the defined contribution retirement plan (401(k) Plan) for participants whose benefits are restricted due to provisions in the Internal Revenue Code of 1986. The Company Match under the 401(k) Plan varies up to a maximum of 4.25% of eligible compensation, and this matching contribution is mirrored in the Benefit Restoration Plan for affected participants.",
      "llm_answer": "The Benefit Restoration Plan is a supplemental “restoration” vehicle that sits on top of Lowe’s defined‑contribution 401(k) plan. It is used only for participants whose 401(k) benefits are limited by certain provisions of the Internal Revenue Code of 1986, and it provides additional employee salary deferrals together with an employer “Company Match” to offset those statutory restrictions 【page_64】.  In this way the plan restores or augments the retirement benefits that would otherwise be constrained for eligible employees under the IRC 1986 rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly explains that the Benefit Restoration Plan serves as a supplemental plan for employees whose benefits under the 401(k) Plan are limited by the Internal Revenue Code of 1986, and that it restores those benefits through additional deferrals and matching contributions. The explanation aligns semantically with the ground truth. Quantitatively, while the LLM does not explicitly state the '4.25%' maximum Company Match mentioned in the original answer, it correctly references the concept of a mirrored employer match without introducing any incorrect numbers—thus no factual inaccuracy, but a minor omission. The entity identification (Lowe’s, Benefit Restoration Plan, 401(k) Plan, Internal Revenue Code of 1986) is accurate. The reasoning is sound and reflects proper multi-hop synthesis between the defined contribution plan and the restoration mechanism. The contextual relevance is high, directly addressing the relationship between the two plans and the IRC restrictions. The lack of the specific percentage prevents a perfect 10, but the answer remains substantially correct and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 317,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, including both CS&Co and TDAC, and how does this compare to the total borrowing capacity under these facilities?",
      "original_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, which includes $950 million outstanding under CS&Co's secured uncommitted lines of credit and $700 million outstanding under TDAC's secured uncommitted lines of credit. This represents a utilization rate of approximately 91.7% of the total borrowing capacity of $1.8 billion.",
      "llm_answer": "At December 31 2023 the Company had $950 million outstanding under CS & Co’s secured, uncommitted lines of credit and $700 million outstanding under TDAC’s secured, uncommitted lines of credit – a combined total of **$1.65 billion**.  The disclosed borrowing capacity for these facilities is **$1.8 billion**, so the amount actually drawn was modestly below the total capacity available.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numbers: $950 million outstanding under CS&Co, $700 million under TDAC, and a total of $1.65 billion outstanding at December 31, 2023. The total borrowing capacity of $1.8 billion is also accurately reported. These match the ground truth exactly. (2) Quantitative accuracy is perfect: the sum ($950M + $700M = $1.65B) is correct, and the borrowing capacity is correctly stated. While the original answer includes a utilization rate of 91.7% (=$1.65B / $1.8B), the LLM answer omits this percentage but correctly states that the drawn amount was 'modestly below' the total capacity, which is semantically reasonable. (3) The multi-hop reasoning is sound—information from both CS&Co and TDAC is correctly synthesized across entities and summed appropriately. The date (December 31, 2023) is correct. (4) The only minor shortcoming is the lack of explicit calculation or mention of the 91.7% utilization rate, which was part of the original answer. However, the conclusion that the drawn amount was 'modestly below' capacity is qualitatively accurate and contextually appropriate. Thus, the answer is factually complete and highly accurate, warranting a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 368,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021, and how does this compare to the total value of hedge funds/limited partnerships and real estate investments combined in the same year?",
      "original_answer": "The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87. This is greater than the combined total of hedge funds/limited partnerships ($9) and real estate investments ($5), which together amounted to $14. Thus, mutual, pooled, and commingled funds represented a significantly larger portion of the investment portfolio than the other two categories combined.",
      "llm_answer": "At December 31 2021 Coca‑Cola’s pension plans held **$850 million** in mutual, pooled and commingled funds (U.S. $290 million + non‑U.S. $560 million).  \n\nThe same pension plans held **$1,109 million** in hedge‑fund/limited‑partnership and real‑estate investments (hedge funds $720 million + real estate $389 million).  \n\nThus, the mutual‑fund holdings were about **$259 million lower** than the combined hedge‑fund and real‑estate holdings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) The numbers are completely wrong: the ground truth states that Coca-Cola's investments in mutual, pooled, and commingled funds were $87 million (not $850 million), and hedge funds/limited partnerships were $9 million and real estate $5 million (combined $14 million), not $1,109 million. The LLM reports values over 10 times higher, likely confusing the data with pension plan holdings from a different context or company. (2) Calculations are based on incorrect inputs: claiming mutual fund holdings were $259 million lower than the others is false—correctly, mutual fund investments ($87M) were significantly higher than the combined $14M. (3) Multi-hop reasoning fails: the model incorrectly synthesizes non-existent or misattributed data, possibly pulling figures from unrelated pension disclosures. (4) Entity and metric confusion: the answer references 'pension plans' which are not mentioned in the original question or ground truth, introducing a misleading context. The original answer focuses on Coca-Cola's corporate investments, not pension assets. (5) Despite addressing all parts of the question structurally, the factual foundation is entirely inaccurate, making the response highly misleading. Minor credit is given for attempting comparison and structure, but core data is invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 383,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the treatment of LTIP units as participating securities impact Simon Property Group's earnings per share calculation, based on the disclosure regarding distributions equal to 10% of the regular quarterly distributions on Operating Partnership units?",
      "original_answer": "LTIP units are treated as participating securities under the two-class method of computing earnings per share because they entitle participants to receive distributions equal to 10% of the regular quarterly distributions paid on a unit of the Operating Partnership. This impacts earnings per share because participating securities must be included in the computation of earnings per share using the two-class method, which allocates earnings to both common shares and participating securities. Although the LTIP units do not have full parity with common units in terms of distributions, their participation in a portion of the distributions affects the allocation of earnings and thus the resulting earnings per share figure.",
      "llm_answer": "Simon Property Group’s LTIP units receive a distribution equal to **10 % of the regular quarterly distribution paid on an Operating‑Partnership unit**. Because of that entitlement, the company classifies the LTIP units as **participating securities** and therefore includes them in the **two‑class method used to compute earnings per share** (both basic and diluted EPS). However, the filing notes that these potentially dilutive securities had **no material dilutive effect** on EPS for 2023 (and the prior two years).【page_127】【page_111】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that LTIP units receive distributions equal to 10% of the regular quarterly distributions on Operating Partnership units, which is the key criterion for classification as participating securities—this matches the original answer exactly. (2) All quantitative elements are correct: the 10% distribution rate is accurately stated, and there are no numerical errors. The mention that these securities had no material dilutive effect in 2023 and the prior two years adds contextual detail supported by the filing (pages 127 and 111), though this specific point is not in the ground truth; however, it does not contradict it and provides additional relevant context. (3) The reasoning is sound: the LLM correctly links the distribution entitlement to the classification as participating securities, explains the use of the two-class method for EPS computation, and acknowledges the impact (or lack of material impact) on EPS. The multi-hop logic—connecting the economic feature (10% distribution) to accounting treatment (participating security) to financial reporting impact (EPS calculation)—is well executed. (4) The only minor shortcoming is that the original answer emphasizes how even partial distribution rights affect earnings allocation under the two-class method, which the LLM implies but does not explicitly elaborate. Still, the core conceptual and factual content is preserved. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 447,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, and how is this entity classified in NEE's financial reporting structure based on its control and governance characteristics?",
      "original_answer": "NEE's noncontrolling interest investment in XPLR OpCo totaled $3,315 million as of December 31, 2024. XPLR OpCo is classified as a variable interest entity (VIE) in which NEE is not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest, and therefore it is accounted for under the equity method.",
      "llm_answer": "- **Amount:** As of December 31 2024, NEE’s non‑controlling‑interest investment in XPLR OpCo was approximately $3.3 billion (the amount reported for NEE’s non‑controlling‑interest stakes in its equity‑method VIEs, which includes XPLR OpCo).  \n\n- **Classification:** XPLR OpCo is treated as a **Variable‑Interest Entity (VIE)** that NEE accounts for under the equity‑method of accounting.  Because the limited‑partner members (including NEE’s non‑controlling interest) do not have substantive rights over the entity’s significant activities, NEE is not the primary beneficiary and therefore does not consolidate the entity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in substance but slightly imprecise in the numerical value. The ground truth states $3,315 million, while the LLM reports 'approximately $3.3 billion'. This is a reasonable rounding ($3.315B ≈ $3.3B) and format variation (billion vs million), so it does not constitute a material error. (2) All other key facts are accurate: XPLR OpCo is correctly identified as a VIE, NEE is not the primary beneficiary, control is lacking due to insufficient rights over significant activities, and the entity is accounted for under the equity method. (3) The multi-hop reasoning is sound—LLM correctly synthesizes control, governance, and accounting treatment based on VIE framework and noncontrolling interest status. It appropriately links lack of substantive rights to non-consolidation, which reflects accurate understanding of ASC 810. (4) The answer fully addresses both parts of the question: the investment amount and the classification with rationale. Wording differs slightly but maintains semantic equivalence. Minor deduction in quantitative accuracy due to rounding without explicit 'approximation' qualifier in original data; otherwise, all elements are correct and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 349,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the total number of distribution methods Linde uses to supply process gases, and how does the company's on-site delivery method differ from the other methods in terms of contract duration and customer volume requirements?",
      "original_answer": "Linde uses three distribution methods to supply process gases: on-site, merchant, and packaged. The on-site delivery method differs significantly from the others in that it serves customers with the largest volume requirements and typically involves contracts ranging from 10 to 20 years in duration, often containing minimum purchase requirements. In contrast, merchant and packaged gas contracts are generally shorter, ranging from three to seven years and one to three years respectively, and do not typically include minimum purchase requirements or volume commitments.",
      "llm_answer": "Linde supplies process gases through **three distribution methods** – on‑site (tonnage), merchant (bulk liquid) and packaged (cylinder) delivery. The on‑site method is reserved for the highest‑volume customers and is governed by long‑term “total‑requirement” contracts that typically run **10‑20 years**, include **minimum purchase requirements** and price‑escalation clauses. In contrast, merchant agreements are usually **3‑7 year** contracts and packaged‑gas contracts are **1‑3 year** agreements, both of which **do not contain minimum‑purchase or volume‑commitment provisions**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that Linde uses three distribution methods: on-site, merchant, and packaged—using equivalent terminology (on-site/tonnage, merchant/bulk liquid, packaged/cylinder). (2) Quantitative accuracy is perfect: the contract durations (10–20 years for on-site, 3–7 years for merchant, 1–3 years for packaged) are correctly reported with matching ranges. The presence of minimum purchase requirements for on-site and their absence in the other two methods is correctly noted. (3) The multi-hop reasoning is sound—differences in contract duration and volume commitments are properly contrasted across methods, demonstrating synthesis of comparative information. (4) Semantic equivalence is maintained: although the LLM uses slightly more detailed phrasing (e.g., 'total-requirement contracts', 'price-escalation clauses'), these additions are consistent with and enrich the ground truth without introducing inaccuracies. All parts of the question are addressed: total number of methods, and the differences in contract duration and volume requirements. No factual errors, omissions, or misstatements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 334,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relate to the Board of Directors' prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock, and what condition was required for the stock split to proceed?",
      "original_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relates to the prior $50.0 billion Class C stock repurchase authorization from April 2021 because the stock split required an increase in the number of authorized shares of Class C stock to accommodate the split. This condition was necessary to ensure that the company had enough authorized shares post-split for both ongoing operations and the repurchase program. The stock split was subject to stockholder approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A, Class B, and Class C stock.",
      "llm_answer": "The board’s February 1 2022 announcement of a 20‑for‑1 split of Alphabet’s Class C capital stock (and the same split for Class A and B) came after the board’s April 2021 resolution that authorized the company to repurchase up to **$50 billion** of Class C shares. The split could be effected only if **stockholders approved an amendment to the Amended and Restated Certificate of Incorporation to increase the number of authorized shares** of each class, thereby providing the shares needed for the split.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately stated: the 20-for-1 stock split was announced on February 1, 2022; it followed the April 2021 $50.0 billion Class C stock repurchase authorization; and the condition for the split was stockholder approval of an amendment to increase authorized shares. (2) Quantitative accuracy is perfect: the $50 billion repurchase amount and the February 2022 announcement date match the original answer. The term 'up to $50 billion' is correctly represented as '$50 billion'. (3) The multi-hop reasoning is sound—the LLM correctly links the stock split to the prior repurchase authorization by explaining that the split required an increase in authorized shares to accommodate both the split and the ongoing repurchase program, even though the latter is implied rather than explicitly restated. (4) The answer is contextually relevant, directly addressing both the relationship between the two corporate actions and the required condition for the split. Minor wording differences (e.g., 'could be effected only if' vs 'was subject to') do not affect factual meaning. All entities—Alphabet, Class A/B/C stock, Board of Directors, stockholders, Certificate of Incorporation—are correctly identified and used appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 367,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023, and how much in committed capital contributions did GM have outstanding to the same entity as of December 31, 2023?",
      "original_answer": "GM's equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, and GM had $0.8 billion in committed capital contributions outstanding to the same entity as of December 31, 2023.",
      "llm_answer": "GM reported equity earnings from its investment in Ultium Cells Holdings LLC of **$293 million for 2023**. At December 31 2023, GM still had **about $0.8 billion (≈ $800 million) of committed‑capital contributions** outstanding to Ultium Cells Holdings LLC.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the equity earnings contribution of $293 million in 2023 and the $0.8 billion ($800 million) in committed capital contributions outstanding as of December 31, 2023 are accurately reported, with acceptable formatting variations (e.g., '≈ $800 million' correctly represents $0.8 billion). (2) The answer is complete, addressing both parts of the multi-part question: the 2023 equity earnings and the committed capital as of year-end. (3) Entity accuracy is correct—GM and Ultium Cells Holdings LLC are properly identified, and the time frame (2023, specifically December 31, 2023) is precise. (4) The reasoning is sound, demonstrating correct synthesis of financial data from GM's 10-K or related SEC filings, indicating proper multi-hop understanding of equity method investments and capital commitments. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced clarity due to explanatory phrasing (e.g., 'about $0.8 billion (≈ $800 million)'). No factual, numerical, or contextual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 318,
        "total_tokens": 1448
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 as reported in both its consolidated financial statements and its other postretirement benefit plan assets, and how does this dual reporting reflect the company's overall exposure to such investment vehicles?",
      "original_answer": "The Coca-Cola Company reported $720 million in hedge funds and limited partnerships within its consolidated financial statements and $9 million in such investments within its other postretirement benefit plan assets for 2021. This totals $729 million in exposure to hedge funds and limited partnerships across both reporting categories.",
      "llm_answer": "In the 2021 consolidated balance sheet the Company reported **$720 million** invested in hedge‑funds and limited‑partnerships (U.S. pension plans $682 million + non‑U.S. pension plans $38 million). The same year the assets of its other post‑retirement benefit plan (the VEBA trust) included **$9 million** of hedge‑fund/limited‑partnership holdings. Together, the dual disclosure shows that virtually all of Coca‑Cola’s exposure to these alternative‑investment vehicles resides in its pension‑plan assets, with only a modest amount held in its other post‑retirement benefit plan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $720 million in hedge funds and limited partnerships from the consolidated financial statements and $9 million from the other postretirement benefit plan assets are accurately reported. The total exposure of $729 million is implied through correct individual figures, even though the sum is not explicitly stated. (2) The breakdown of the $720 million into U.S. pension plans ($682 million) and non-U.S. pension plans ($38 million) provides additional detail not in the original answer but consistent with plausible sourcing and does not contradict the ground truth. (3) Entity accuracy is correct: The Coca-Cola Company, 2021 reporting year, and proper categorization of investment types (hedge funds, limited partnerships) and benefit plans (pension vs. other postretirement) are all accurate. (4) The reasoning is sound: the LLM correctly synthesizes data from two distinct reporting categories—consolidated financial statements and postretirement benefit plan assets—and draws a logical conclusion about the concentration of exposure in pension plans. (5) The semantic meaning fully aligns with the original answer, with added contextual insight that enhances relevance without introducing error. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 378,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the increased use of e-commerce by retail tenants, as mentioned in the risk factors, contribute to the difficulty Simon Property Group (SPG) faces in leasing spaces and maintaining rental rates at its properties?",
      "original_answer": "The increased use of e-commerce by retail tenants has led to lower demand for physical retail space, which directly contributes to higher vacancy rates at SPG's properties. This oversupply of vacant space, combined with the increased bargaining power of creditworthy retail tenants, results in downward pressure on rental rates and occupancy levels. Additionally, SPG may need to increase spending on tenant improvements and offer more lease modifications to attract or retain tenants, all of which materially and adversely affect SPG's financial performance and leasing strategy.",
      "llm_answer": "The risk‑factor discussion notes that as more retailers shift sales to e‑commerce, they are closing or right‑sizing under‑performing brick‑and‑mortar stores. That reduces the overall demand for lease space, creates higher vacancy and gives the remaining, credit‑worthy tenants greater bargaining power, which “downward[s] pressure on our rental rates and occupancy levels” and makes it harder for Simon to re‑let or renew space at attractive rents. Consequently, the growth of online shopping directly hampers SPG’s ability to lease space and maintain existing rental rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core causal chain described in the original answer. It correctly identifies that e-commerce adoption leads retailers to close or downsize physical stores, reducing demand for retail space, increasing vacancy, and giving remaining tenants greater bargaining power—resulting in downward pressure on rental rates and occupancy levels. The quote 'downward[s] pressure on our rental rates and occupancy levels' is accurately attributed (likely from the 10-K), and the conclusion that this makes it harder to lease space at attractive rents aligns with the ground truth. The only minor omission is that the LLM answer does not mention SPG's potential need to increase spending on tenant improvements or lease modifications, which is part of the full financial impact described in the original. However, all key entities (Simon Property Group, retail tenants, e-commerce), reasoning steps, and financial implications are correctly synthesized. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The answer is contextually precise and directly addresses how e-commerce affects leasing and rental rate challenges.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 340,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the cumulative impact on UNP's deferred tax expense in 2024 and 2023 from corporate income tax legislation enacted in Arkansas, and how does this compare to the 2022 impact from Arkansas legislation?",
      "original_answer": "The cumulative impact on UNP's deferred tax expense from Arkansas tax legislation was $34 million in 2024 and $114 million in 2023, totaling $148 million over the two years. In 2022, Arkansas legislation contributed to a $95 million reduction in deferred tax expense. Therefore, the reduction in 2024 and 2023 was greater than the 2022 impact by $53 million.",
      "llm_answer": "The filing says that the corporate‑income‑tax statutes that were enacted in Arkansas (together with other states) cut UNP’s deferred‑tax expense by **$34 million in 2024** and by **$114 million in 2023**, for a combined reduction of **$148 million** over the two years. By contrast, the Arkansas‑related legislation in 2022 produced a **$95 million** reduction in deferred‑tax expense, so the 2024‑23 cumulative impact was **about $53 million larger** than the 2022 impact.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $34 million in 2024, $114 million in 2023, and $95 million in 2022 are correctly reported. The combined reduction of $148 million (34 + 114) is accurate, and the comparison showing a $53 million larger impact in 2023-2024 versus 2022 (148 - 95 = 53) is correct. (2) The answer is complete, addressing both parts of the question: the cumulative impact in 2024 and 2023, and the comparison to the 2022 impact. (3) Entities are correctly identified: UNP is the company, deferred tax expense is the metric, and the years 2022, 2023, and 2024 are properly referenced. (4) The multi-hop reasoning is sound—information from multiple years and legislative impacts is synthesized correctly to derive the comparative conclusion. (5) The semantic meaning is equivalent to the original answer, with only minor rephrasing (e.g., 'about $53 million larger' vs. 'greater by $53 million'), which does not affect factual accuracy. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 303,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does NEE's limited partner interest in XPLR OpCo potentially impact its financial obligations and liquidity, particularly if XPLR is unable to access capital on commercially reasonable terms?",
      "original_answer": "NEE's limited partner interest in XPLR OpCo could negatively affect its liquidity and financial obligations if XPLR is unable to access capital on commercially reasonable terms. This is because XPLR's inability to secure capital would hinder its ability to complete acquisitions or meet growth opportunities, reducing its cash distributions to unitholders, including NEE. Additionally, if XPLR issues more common units or converts existing securities into common units, NEE's share of future distributions could be diluted. This directly impacts NEE’s cash flows, which are crucial for meeting its financial obligations and paying dividends.",
      "llm_answer": "NEE’s ownership of a limited‑partner interest in XPLR OpCo means that the company relies on XPLR to generate cash distributions that flow back to NEE.  If XPLR cannot obtain financing on commercially reasonable terms, it may be unable to fund acquisitions, meet capital‑needs or make those cash distributions, which would diminish the value of NEE’s limited‑partner stake and could force NEE to absorb or guarantee XPLR‑related obligations – thereby pressuring NEE’s own liquidity and its ability to meet other financial commitments.【page_34】",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core financial risk to NEE from its limited partner interest in XPLR OpCo if XPLR cannot access capital on commercially reasonable terms. It accurately explains that NEE relies on cash distributions from XPLR, and if XPLR cannot secure financing, it may fail to fund acquisitions or make distributions, thereby negatively impacting NEE’s liquidity and ability to meet financial obligations. This aligns with the ground truth. The answer also goes further by suggesting NEE might 'absorb or guarantee XPLR-related obligations,' which is a plausible but not explicitly stated risk in the original answer; this is a reasonable inference but not directly supported, slightly reducing qualitative accuracy. The LLM does not mention the dilution risk from potential future issuance of common units by XPLR, which is a key point in the original answer and represents a missed element in completeness. However, no numbers, dates, or financial metrics are incorrect (quantitative accuracy is perfect), and the response is highly relevant to the question. The reasoning is logically sound and contextually appropriate, but the omission of distribution dilution slightly weakens the multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 344,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the difference between the fair value of mortgage-backed obligations reported in the 'Marketable securities' section and the 'Fair Value' column of the marketable securities table?",
      "original_answer": "The difference between the fair value of mortgage-backed obligations reported in the two sections is $58. In the 'Marketable securities' section, the fair value is $178, while in the 'Fair Value' column of the marketable securities table, it is $236.",
      "llm_answer": "Both places show the same amount – the mortgage‑backed obligations are reported at a fair value of **$236 million** (for 2024, $178 million for 2023). Thus, the difference between the two figures is **$0**.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states that the fair value in the 'Marketable securities' section is $178 and in the 'Fair Value' column it is $236, resulting in a difference of $58. The LLM incorrectly claims both values are the same ($236 million for 2024, $178 million for 2023), implying a difference of $0, which contradicts the ground truth. The introduction of different years (2024 and 2023) is unsupported and confuses the comparison, as the question does not mention or imply a year-based distinction. (2) Quantitatively, the numbers $178 and $236 appear in the correct context in the LLM answer but are misattributed across years rather than sections, and the calculated difference of $0 is wrong—the correct difference is $236 - $178 = $58. (3) The reasoning is flawed: the model fails to perform the correct multi-hop comparison between two reporting sections in the same document and instead invents a temporal distinction not present in the question or ground truth. (4) Scores are low because the core factual claim (difference of $0 vs. $58) is incorrect, and the model misrepresents the data structure. Contextual relevance is moderate because it addresses the right topic and metric but with incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 356,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the revenue recognition method for Google Play impact the financial reporting of non-advertising revenues, given the increasing portion of these revenues and their effect on margins?",
      "original_answer": "Google Play's revenue is reported on a net basis because Google's performance obligation is to facilitate a transaction between app developers and end users, for which it earns a service fee. This method reduces the total revenue amount reported for Google Play sales. As non-advertising revenues, which include Google Play, are increasing and have varying margins that may be lower than advertising revenues, this trend could adversely affect overall margins.",
      "llm_answer": "Alphabet treats Google Play sales as a net‑basis transaction: it determines whether it is the principal or agent and, because its performance obligation is only to facilitate the sale, it records only the service‑fee portion of app and in‑app‑purchase revenues. As the share of Google Play (a non‑advertising revenue) continues to rise, this net‑recognition means a smaller amount is reported as revenue and the associated margins are lower than the higher‑margin advertising business, thereby pulling overall non‑advertising margins down.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Google Play revenue is recognized on a net basis because Google acts as an agent facilitating transactions, and only the service fee is recorded—this aligns with the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all financial concepts (net reporting, margin impact) are correctly represented. (3) The multi-hop reasoning is sound: the model connects revenue recognition method (net basis) → lower reported revenue → increasing weight of lower-margin non-advertising revenues (like Google Play) → downward pressure on overall margins. This synthesis across accounting policy and financial performance is accurate. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of 'overall margins' (the original specifies 'overall margins' while LLM says 'non-advertising margins'), but the implication for consolidated margins is reasonably inferred. Wording differs slightly but meaning is preserved. Contextual relevance is perfect—directly addresses all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 342,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023, and how does this compare to the previous year's commitment?",
      "original_answer": "General Motors committed $0.8 billion to Ultium Cells Holdings LLC in 2023, which is a decrease from $1.4 billion in 2022. This indicates a reduction in GM's capital commitment to the joint venture by $0.6 billion year-over-year.",
      "llm_answer": "In 2023 General Motors had **$0.8 billion** of committed capital contributions outstanding for Ultium Cells Holdings LLC. The prior year’s commitment was **$1.4 billion**, so the 2023 commitment was **$0.6 billion lower** than in 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $0.8 billion for 2023 and $1.4 billion for 2022 are correctly reported. The year-over-year decrease of $0.6 billion is accurately calculated ($1.4B - $0.8B = $0.6B). (2) The answer is complete, addressing both parts of the question: the 2023 committed capital and the comparison to the previous year. (3) Entity accuracy is correct—General Motors, Ultium Cells Holdings LLC, and the years 2023 and 2022 are all properly identified. (4) The reasoning is sound: the LLM correctly infers a decrease in commitment and quantifies the difference, demonstrating proper multi-hop synthesis between the two years' commitments. (5) The semantic meaning is equivalent to the original answer, with clear, concise phrasing that preserves all factual content. Minor formatting differences (e.g., use of 'billion' vs 'B') are acceptable and do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 280,
        "total_tokens": 1404
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total cash consideration paid by Mastercard in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc., and how much of this amount was attributed to goodwill?",
      "original_answer": "Mastercard paid a total cash consideration of $2.8 billion in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc. Out of this, $1.7 billion was attributed to goodwill.",
      "llm_answer": "In 2024 Mastercard paid **$2.8 billion in cash** for all of its acquisitions, which includes the **$2.7 billion cash purchase of RF UlEmate Parent, Inc.** (Recorded Future).  Of the total purchase price, **$1.7 billion was allocated to goodwill**.【page_79】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the total cash consideration paid by Mastercard in 2024 as $2.8 billion and the goodwill amount as $1.7 billion, matching the ground truth exactly. The mention of RF UlEmate Parent, Inc. being acquired for $2.7 billion in cash is consistent with the total acquisition spending when combined with other smaller acquisitions, though the question did not ask for the breakdown per company. (2) All numeric values are accurate: $2.8 billion total cash consideration and $1.7 billion attributed to goodwill are correct. The $2.7 billion figure for RF UlEmate is plausible within the total and does not contradict the total cash outlay. (3) The multi-hop reasoning is sound—LLM correctly synthesizes that the total cash consideration includes the RF UlEmate acquisition and correctly allocates the goodwill amount from the total purchase price. (4) The only minor issue is the introduction of a specific $2.7 billion figure for RF UlEmate, which, while likely accurate, is not present in the ground truth and slightly over-specifies beyond the provided answer. However, it does not contradict the total and may reflect additional data from the cited page 79. This does not detract significantly from correctness. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 373,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total amount spent by UNP on freight car lease buyouts over the three-year period from 2022 to 2024, and how does this relate to the company's capital plan for acquiring freight cars in 2025?",
      "original_answer": "UNP spent a total of $270 million on freight car lease buyouts from 2022 to 2024 ($70 million in 2022, $57 million in 2023, and $143 million in 2024). This spending trend aligns with the company's 2025 capital plan, which includes acquiring freight cars to support asset replacement and growth opportunities, as part of a broader $3.4 billion investment strategy.",
      "llm_answer": "UNP spent $70 million in 2022, $57 million in 2023 and $143 million in 2024 on freight‑car lease buyouts – a three‑year total of roughly $270 million. The company’s 2025 capital plan is about $3.4 billion, which includes funding to acquire freight cars; thus the lease‑buyout spend represents only a modest portion of the overall capital budget earmarked for freight‑car acquisition in 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar amounts: $70 million in 2022, $57 million in 2023, and $143 million in 2024, summing to $270 million over the three-year period—this matches the ground truth exactly. Number formats are consistent and acceptable. (2) The calculation of the total ($70M + $57M + $143M = $270M) is accurate and correctly presented as 'roughly $270 million,' which is semantically acceptable. (3) The LLM correctly identifies the connection between past lease buyout spending and the 2025 capital plan, noting that the $3.4 billion capital budget includes funding for freight car acquisition. While the original answer specifies that the 2025 plan supports 'asset replacement and growth opportunities,' the LLM captures the essence by linking lease buyouts to broader acquisition goals, though this nuance is slightly underdeveloped. (4) All entities—UNP, freight car lease buyouts, correct years, and the $3.4 billion capital plan—are accurately referenced. The reasoning is sound and synthesizes multi-hop information across time periods and strategic planning. The only minor shortcoming is the lack of explicit mention of 'asset replacement and growth opportunities,' which slightly reduces qualitative accuracy, but the core logic and context are preserved. Overall, the answer is factually correct, complete, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 382,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023?",
      "original_answer": "The total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $3.5 billion. This is calculated by summing the $2.0 billion notional amount from the ASR disclosed in the 2023 transaction and the $1.5 billion notional amount from the ASR disclosed in the 2022 transaction.",
      "llm_answer": "CVS Health entered into two ASR transactions under the 2021 Repurchase Program in the 2022‑2023 period—a $1.5 billion ASR with Barclays (initial treasury stock $1.2 billion + forward contract $0.3 billion) and a $2.0 billion ASR with Citibank (initial treasury stock $1.6 billion + forward contract $0.4 billion). Together, these represent a total notional ASR amount of **$3.5 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total notional amount of $3.5 billion, matching the ground truth. It accurately breaks this down into a $1.5 billion ASR in 2022 and a $2.0 billion ASR in 2023, which aligns with the disclosed forward contract amounts and initial treasury stock transactions. All numeric values—$1.5B, $2.0B, and the sum—are factually correct and properly formatted. (2) The calculations are accurate: $1.5B + $2.0B = $3.5B. The additional detail about the split between initial treasury stock and forward contracts (e.g., $1.2B + $0.3B) is consistent with typical ASR structures and does not contradict the ground truth, though this level of detail was not required by the question. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years (2022 and 2023), identifies the correct program (2021 Repurchase Program), and aggregates the notional amounts from two separate ASR agreements. The mention of counterparties (Barclays, Citibank) adds contextual detail but is not part of the ground truth; however, it does not detract from accuracy as such details may be present in the source filings. (4) The answer is semantically equivalent to the original and fully addresses the question. The only reason for not scoring a perfect 10 is that the ground truth does not specify bank names or the internal split of payments (treasury vs. forward), so including them, while plausible, introduces elements not confirmed in the verified answer—this is a minor over-specification but does not affect factual correctness. Hence, correctness, quantitative accuracy, and relevance are excellent; qualitative accuracy is slightly reduced due to unverified specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 472,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Given GM's dependency on full-size ICE pickup trucks for near-term profitability and the risks outlined in the forward-looking statements, how does the company's reliance on these vehicles interact with its strategic shift toward electric vehicles (EVs) to impact long-term financial stability?",
      "original_answer": "GM's near-term profitability is heavily dependent on the success of its full-size ICE pickup trucks, which currently generate the highest profit margins and fund the company's strategic shift toward EVs. However, the forward-looking statements highlight that any shift in consumer preferences toward smaller, more fuel-efficient vehicles could weaken demand for these high-margin ICE vehicles. This would reduce the cash flow available to invest in EV development, which is critical to GM's long-term strategy. Therefore, a decline in ICE truck sales could jeopardize both short-term financial performance and the funding necessary to transition to an all-electric future, creating a dual risk that threatens both immediate and long-term financial stability.",
      "llm_answer": "GM’s 2023 filing makes clear that the cash and earnings generated by its full‑size ICE SUVs and pickup trucks are the primary source of near‑term profit and the funding engine for its EV and autonomous‑vehicle programs.  Because those ICE models fund the costly EV rollout, any slowdown in their sales or margins—highlighted in the forward‑looking risk factors as a possible result of shifting consumer preferences, stricter emissions rules, or higher EV‑related costs—could erode the cash flow needed to sustain the transition and jeopardize long‑term financial stability.  Conversely, a successful EV launch that quickly replaces ICE revenue would solidify GM’s balance sheet, but the company’s current dependence on high‑margin trucks makes the transition period a critical financial risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GM's reliance on ICE SUVs and pickup trucks for near-term profits and as a funding source for EV development is accurately stated. The risks tied to shifting consumer preferences, regulatory changes, and margin pressures are properly identified from forward-looking statements. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that ICE vehicle profits fund EV investments, and a decline in those profits could impair long-term stability. It also adds value by noting the balancing possibility of successful EV adoption stabilizing finances, which is logically consistent and enhances the response without contradicting the ground truth. (4) The only reason for not scoring a 10 in qualitative accuracy is that the LLM slightly broadens the scope to include 'autonomous-vehicle programs' and 'stricter emissions rules,' which are not explicitly mentioned in the original answer. While plausible and potentially present in the actual filing, they slightly extend beyond the provided ground truth. Otherwise, the semantic meaning, completeness, and contextual relevance are excellent, fully addressing the interaction between ICE dependency and EV transition risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 392,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the uncertainty around the pace of the energy transition, as influenced by changing commodity prices and regulatory developments, affect Chevron's asset impairment assessments and upstream investment decisions?",
      "original_answer": "Chevron evaluates the pace of the energy transition as a key factor in its commodity price forecasting and asset impairment assessments. Due to the uncertainty around the energy transition, Chevron may face reduced demand for traditional oil and gas products, which directly affects upstream earnings, cash flows, and capital expenditure programs. This uncertainty complicates impairment evaluations, as future cash flows from upstream assets depend on long-term assumptions about commodity prices, carbon costs, production profiles, and regulatory changes. If the energy transition accelerates or commodity prices remain low, Chevron may be forced to impair upstream assets, particularly those tied to crude oil, which could negatively impact its financial condition and reduce its ability to invest in new business lines such as lower-carbon energy solutions.",
      "llm_answer": "Chevron says that because the speed of the energy transition is uncertain—and because commodity prices and new climate‑related regulations can change rapidly—it must treat those variables as “highly uncertain matters” when it tests the recoverability of its upstream assets.  A downward shift in oil‑ or gas‑price forecasts, higher carbon costs, or stricter environmental rules can trigger an impairment review and, if the cash‑flow model no longer supports the carrying value, a write‑down of the property (see page 52).  That same uncertainty is built into its capital‑budget process, causing the company to be more selective and to align new upstream investments with long‑term price, demand and regulatory assumptions rather than proceeding on a “business‑as‑usual” basis (see page 21).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that uncertainty in the energy transition—driven by changing commodity prices and regulatory developments—affects Chevron's asset impairment assessments and upstream investment decisions. The key elements from the original answer, including the impact on cash flows, capital expenditures, and potential impairments due to lower demand or prices, are all addressed. (2) There are no specific numbers (e.g., dollar amounts, dates, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is sound: the LLM connects uncertainty in the energy transition to commodity price forecasting, regulatory risk, impairment testing, and capital budgeting decisions—correctly synthesizing cause-effect relationships across these domains. It even references specific pages (52 and 21), suggesting grounding in source material, though these are not required for correctness. (4) The wording differs slightly but maintains semantic equivalence: 'highly uncertain matters', 'impairment review', 'write-down', and 'selective capital budgeting' mirror the original's emphasis on financial risk and strategic caution. The only minor shortcoming is that the LLM does not explicitly mention the potential impact on Chevron’s ability to invest in lower-carbon energy solutions—a point included in the original—but this does not undermine the core accuracy. Overall, the response is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 453,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Mastercard's provision of Consumer Engagement Services, as part of its broader payment solutions, support its global payments network operations and financial performance?",
      "original_answer": "Mastercard's provision of Consumer Engagement Services enhances its global payments network by drawing on the company's principled and responsible use of secure data, which helps attract and retain consumers and merchants. This, in turn, strengthens the network's utility and drives additional payment flows, contributing to the company's financial performance. These services are part of a suite of offerings that are fundamentally interdependent and support the overall efficiency and attractiveness of Mastercard's global payments network.",
      "llm_answer": "Mastercard’s consumer‑acquisition and engagement services are classified as “value‑added” offerings that are bundled with, or sold separately from, its core switching platform. By giving issuers and merchants tools to attract, retain and activate card‑holders, these services increase the number of transactions that flow through Mastercard’s proprietary global network, which in turn boosts the gross‑dollar‑volume‑based fees that drive the company’s net‑revenue growth and profitability (see the overview of services on page 6, the strategic‑priority discussion on page 8, and the revenue‑recognition description on page 73).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key elements are accurately represented: Mastercard's Consumer Engagement Services are positioned as value-added offerings that support the core network by increasing transaction volume through enhanced consumer and merchant engagement. The link to financial performance via gross-dollar-volume-based fees driving net revenue and profitability aligns with the original answer's claim about contributing to financial performance. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly infers that these services increase transaction flows, which directly supports network utility and generates fee-based revenue—this reflects proper synthesis of the interdependence between service offerings, network effects, and revenue mechanics. (4) The only reason for not scoring a perfect 10 is that the LLM answer emphasizes the revenue mechanism (fees tied to transaction volume) more than the original’s focus on 'principled use of secure data' and 'interdependence' of services. However, this does not make it incorrect—rather, it provides complementary detail. The answer remains contextually precise, fully relevant, and factually aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 394,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025, considering the initial acquisition cost and the deconsolidation in the final year?",
      "original_answer": "The total net cash outflow impact from Walmart's acquisition and deconsolidation of Alert Innovation was $0.4 billion, as the company initially spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no net cash inflow from its deconsolidation in fiscal 2025.",
      "llm_answer": "Walmart spent about **$0.4 billion** to acquire Alert Innovation in fiscal 2023. The company later sold and de‑consolidated Alert Innovation in fiscal 2025, but the filing does not disclose the cash proceeds from that sale, so the only quantified cash‑outflow related to the transaction is the $0.4 billion acquisition cost.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion acquisition cost in fiscal 2023, which matches the ground truth. However, it fails to state the key conclusion from the original answer — that the total net cash outflow is $0.4 billion because there was no cash inflow from the deconsolidation in fiscal 2025. Instead, the LLM states that the sale proceeds are 'not disclosed,' which implies uncertainty, whereas the ground truth affirms there was no net cash inflow. This misrepresents the reasoning and omits a critical synthesis step. (2) Quantitatively, the $0.4 billion figure is accurate and correctly attributed to fiscal 2023. The lack of a disclosed sale amount is factually consistent with typical filing disclosures, but the inference should have been that no value was realized, not that it is unknown. (3) The multi-hop reasoning is partially sound — the model connects acquisition and deconsolidation events across fiscal years — but fails to synthesize the final net impact correctly. It stops short of concluding the net outflow due to lack of inflow, which is the core of the original answer. (4) Scores reflect high quantitative and contextual accuracy, but lower qualitative accuracy due to flawed reasoning in the synthesis step. Correctness is reduced because the final net impact — the central question — is not fully and correctly answered.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 382,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Considering the information provided about LTIP Units in both disclosures, what is the combined total of potentially dilutive securities for the year ended December 31, 2023, and why was no adjustment made to net income attributable to common stockholders?",
      "original_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes units exchangeable for common stock and LTIP Units. No adjustment was made to net income attributable to common stockholders because these securities had no material dilutive effect during the reporting period.",
      "llm_answer": "The two notes both state that the only potentially dilutive securities for 2023 are the LTIP units (and other exchangeable units), but **none of those securities had a material dilutive effect**. Consequently, the combined total of potentially dilutive securities for the year ended December 31 2023 is effectively **zero** (i.e., no material dilutive securities).  \n\nBecause the LTIP units and other exchangeable units would not have changed earnings per share, Simon Property Group did **not adjust net income attributable to common stockholders** (or the weighted‑average share count), since doing so would have had no dilutive impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the potentially dilutive securities (LTIP Units and other exchangeable units) had no material dilutive effect, aligning with the ground truth that no adjustment was made to net income attributable to common stockholders for the year ended December 31, 2023. The conclusion that the combined total is effectively zero due to immateriality matches the semantic meaning of the original answer, which states there were no material dilutive effects. (2) There are no explicit numerical values to verify (e.g., exact unit counts), but the reasoning around materiality and dilutive impact is consistent with financial reporting standards and the ground truth. The date (December 31, 2023) is correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes information about LTIP Units and exchangeable units from both disclosures, correctly infers their lack of material dilutive impact, and links this to the absence of adjustment in net income and share count. The logic that no adjustment was made because there was no dilutive effect is accurate. (4) The only minor deviation is the phrasing 'combined total... is effectively zero'—while semantically acceptable and conveying the right intent (no material dilution), the original answer does not state the total is zero but rather describes the composition and effect. This is a nuance in framing, not a factual error. All key entities—LTIP Units, exchangeable units, net income attributable to common stockholders, and the reporting period—are correctly identified and used. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 455,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ, and how does this compare to the total investments at fair value in each category?",
      "original_answer": "The total value of Investments measured at NAV across both asset categories in the 2023 10-K filing for VZ is $14 million ($9 million from the first category and $5 million from the second). This represents 3.1% of the total investments at fair value, which sum to $902 million ($441 million in the first category and $461 million in the second).",
      "llm_answer": "The 2023 filing shows $4,432 million of pension‑plan investments measured at NAV and $5 million of health‑care‑and‑life‑plan investments measured at NAV, for a combined NAV total of **$4,437 million**. By contrast, the same filing reports **$9,104 million** of pension‑plan investments at fair value and **$461 million** of health‑care‑and‑life‑plan investments at fair value.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of factual content and fails to match the ground truth. (1) Quantitative Accuracy: The reported NAV values are wrong—LLM states $4,432 million and $5 million (total $4,437 million), while the ground truth is $9 million and $5 million (total $14 million). Similarly, fair value figures are incorrect: LLM reports $9,104 million (pension) and $461 million (health), but ground truth is $441 million and $461 million, respectively. The total fair value should be $902 million, not $9,565 million. The percentage comparison (3.1% in ground truth) is missing entirely. (2) Completeness: The answer fails to compute or mention the key comparative metric—NAV as a percentage of total fair value investments—which is central to the question. (3) Entity Accuracy: While the company (VZ) and year (2023) are implied correctly, the investment categories appear misidentified—'pension-plan' and 'health-care-and-life-plan' may be contextually relevant but are not confirmed in the ground truth, and their assigned values are factually wrong. (4) Reasoning: The multi-hop synthesis is flawed—no correct aggregation or comparison between NAV and fair value totals across categories was performed. The LLM appears to have hallucinated large numbers inconsistent with the actual data. (5) Semantic Equivalence: The structure of the response mirrors the question format, but the factual content is wildly divergent. Even allowing for format variation, the numbers are off by orders of magnitude. The answer lacks basic quantitative fidelity and thus fails the primary correctness criterion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 442,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much in equity earnings did GM report from Ultium Cells Holdings LLC in 2023, and in what financial statement category were these earnings disclosed?",
      "original_answer": "General Motors reported $293 million in equity earnings from Ultium Cells Holdings LLC in the year ended December 31, 2023, and these earnings were disclosed under 'Automotive and other cost of sales' in the financial statements.",
      "llm_answer": "GM reported **$293 million** of equity earnings from Ultium Cells Holdings LLC for 2023. These earnings are shown in the **equity‑income (equity earnings) line of the consolidated statement of income**, noted that they are presented in “Automotive and other cost of sales” because the entity is integral to GM’s EV battery‑cell operations【page_76†L31-L38】【page_101†L49-L55】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the equity earnings amount as $293 million from Ultium Cells Holdings LLC in 2023, matching the ground truth exactly. The financial statement category is also accurately reported as 'Automotive and other cost of sales', with proper contextual explanation. (2) Quantitatively, the dollar amount and year are correct with no calculation errors. Format variation ($293 million) is acceptable and semantically equivalent. (3) The reasoning is sound: the LLM correctly synthesizes that while equity earnings are typically reported in a standalone income line, in this case they are reclassified into 'Automotive and other cost of sales' due to the operational integration of Ultium Cells, which aligns with the multi-hop logic required. The citation of specific pages supports this synthesis. (4) The only minor discrepancy is the mention of 'equity-income (equity earnings) line' as the presentation location, which may confuse readers—while such a line exists, the ground truth clarifies that the earnings are *disclosed under* 'Automotive and other cost of sales', meaning they are embedded there rather than appearing as a separate line. This nuance slightly affects qualitative accuracy but does not invalidate the core correctness. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 379,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the change in equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) from 2023 to 2024, and how does this shift reflect in the overall ownership structure of MA?",
      "original_answer": "The equity ownership of Principal or Affiliate Customers (Class B stockholders) decreased from 0.8% in 2023 to 0.7% in 2024, a reduction of 0.1 percentage points. This shift indicates a minor decline in the relative ownership stake of this group within MA's overall ownership structure.",
      "llm_answer": "Principal or Affiliate Customers (the Class B stockholders) owned **0.8 % of equity in 2023 and 0.7 % in 2024**, a decline of **0.1 percentage point**. This modest drop helped push the share held by public investors (Class A) up from **88.8 % to 89.9 %**, while the Mastercard Foundation’s stake fell from **10.4 % to 9.3 %**, leaving the overall ownership structure essentially unchanged aside from a slight re‑allocation away from Class B and the foundation toward public shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the equity ownership percentages of Principal or Affiliate Customers (Class B stockholders) as 0.8% in 2023 and 0.7% in 2024, with a decline of 0.1 percentage point, matching the ground truth exactly. This satisfies the primary quantitative requirement.\n\n2) All numeric values are accurate: 0.8%, 0.7%, and the 0.1 percentage point decrease are correct. The additional context about public investors (Class A) increasing from 88.8% to 89.9% and the Mastercard Foundation decreasing from 10.4% to 9.3% is consistent with the overall ownership structure and implies correct cross-verification across ownership segments. These numbers sum appropriately (0.8+88.8+10.4=100; 0.7+89.9+9.3=100), confirming calculation accuracy.\n\n3) The multi-hop reasoning is sound: the model synthesizes changes across multiple stakeholder groups (Class B, Class A, Foundation) and correctly infers that the decrease in Class B ownership contributed to a shift toward public shareholders. While the original answer only mentions the Class B change, the LLM provides enriched but accurate context about where the ownership shift likely went, without contradicting the ground truth.\n\n4) The answer is semantically equivalent and adds minor but relevant context. The conclusion that the overall structure is 'essentially unchanged' aside from a slight reallocation is a reasonable qualitative interpretation. The only reason for not scoring a 10 is that the original answer does not mention the other ownership groups, so while the added details are accurate, they slightly exceed the scope of the verified ground truth. However, they do not detract from correctness.\n\nOverall, the response is factually precise, logically sound, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 481,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total financial impact on Walmart (WMT) in terms of cash outflows related to Alert Innovation during fiscal 2023, and what happened to this entity in the following fiscal year?",
      "original_answer": "Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023, and then subsequently sold and deconsolidated the entity in fiscal 2025.",
      "llm_answer": "Walmart spent about **$0.4 billion** to acquire Alert Innovation in fiscal 2023.  The company later **sold the business and de‑consolidated it in fiscal 2025**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately stated: Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023, and the entity was sold and deconsolidated in fiscal 2025. (2) The numeric value ($0.4 billion) matches the original answer exactly, with acceptable formatting (e.g., '0.4 billion' = '$400 million'). (3) The multi-hop reasoning is sound—correctly linking Walmart's acquisition cash outflow in fiscal 2023 to the subsequent divestiture and deconsolidation in fiscal 2025. (4) Entities (Walmart, Alert Innovation), fiscal years (2023, 2025), and financial actions (acquire, sell, de-consolidate) are all correctly identified and synthesized. The answer is concise, factually precise, and fully addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1086,
        "completion_tokens": 242,
        "total_tokens": 1329
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much total principal was repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024, and what was the impact on the facility's remaining borrowing capacity as of December 31, 2023?",
      "original_answer": "The company repaid a total principal of $1.5 billion using borrowings from the 2021 Multicurrency Credit Facility in early 2024 ($500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes). As of December 31, 2023, the company still had the ability to borrow up to $6.0 billion under the facility, which includes a $3.5 billion sublimit for multicurrency borrowings, a $200.0 million sublimit for letters of credit, and a $50.0 million sublimit for swingline loans.",
      "llm_answer": "In January 2024 the Company repaid $500 million of its 0.600 % senior notes, and in February 2024 it repaid $1.0 billion of its 5.00 % senior notes – a total of **$1.5 billion of principal** that was funded with borrowings under the 2021 Multicurrency Credit Facility【page_50†L22-L30】【page_136†L1-L8】.  \n\nAs disclosed in the 2023 filing, the facility provides **up to $6.0 billion of borrowing capacity** (including its sub‑limits) as of December 31, 2023, so the early‑2024 repayments left the full $6.0 billion still available for future borrowing【page_52†L9-L14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total principal repaid ($1.5 billion), broken down into $500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes, matching the ground truth exactly. The timing (January and February 2024) is consistent with 'early 2024' in the question and source. The borrowing capacity under the 2021 Multicurrency Credit Facility as of December 31, 2023, is accurately stated as $6.0 billion. (2) All numeric values—$500 million, $1.0 billion, $1.5 billion total, and $6.0 billion capacity—are factually correct and properly formatted. Calculations (summing to $1.5 billion) are accurate. (3) The multi-hop reasoning is sound: the model correctly links the early 2024 repayments to funding via the credit facility and correctly infers that since the repayments occurred in 2024, the borrowing capacity as of December 31, 2023, was still fully available. However, the LLM omits mention of the sublimits (e.g., $3.5 billion multicurrency sublimit, $200 million for letters of credit, $50 million for swingline loans), which are part of the original answer and provide important structural detail about the facility. This is a minor omission affecting completeness but not the core correctness. (4) The answer is highly relevant, directly addressing both parts of the question with precise, contextually supported information. The omission of sublimits prevents a perfect 10, but all key facts and logic are correct, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 421,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Intel's use of EUV in its Intel 4 and Intel 3 process nodes relate to its broader roadmap for advanced transistor architectures, and what future node is expected to introduce High Numerical Aperture EUV as part of this progression?",
      "original_answer": "Intel uses EUV in its Intel 4 process node to print small features using ultra-short wavelength light, which is critical for improving performance-per-watt and enabling future client processors like Meteor Lake. Intel 3 builds on this by leveraging further FinFET optimizations and increased EUV usage to deliver additional area and efficiency improvements. This progression sets the stage for Intel 20A, which will introduce RibbonFET (Intel's implementation of gate-all-around transistor architecture) and PowerVia (backside power delivery). Beyond Intel 20A, Intel is developing Intel 18A, which will refine RibbonFET performance and incorporate next-generation High Numerical Aperture EUV in its process technology roadmap.",
      "llm_answer": "Intel is deploying extreme‑ultraviolet (EUV) lithography first in its Intel 4 node and then in Intel 3, using EUV to shrink critical features and boost performance‑per‑watt as it advances toward the next‑generation transistor architecture (Ribbon FET) slated for the Intel 20A node.  The roadmap’s subsequent node, Intel 18A, is the one slated to incorporate next‑generation High‑Numerical‑Aperture EUV as part of that continued evolution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key elements of the ground truth. (1) It correctly identifies that EUV is first used in Intel 4 and further deployed in Intel 3, linking this to performance-per-watt improvements and the progression toward RibbonFET at Intel 20A. It accurately states that High Numerical Aperture EUV will be introduced at Intel 18A. (2) There are no numeric values requiring calculation, but all process node names (Intel 4, Intel 3, Intel 20A, Intel 18A) are correct and consistent with the original answer. (3) The multi-hop reasoning is sound: the answer connects EUV adoption in current nodes to future transistor architecture evolution (RibbonFET and PowerVia implied via roadmap progression) and correctly positions High NA EUV in the next phase at Intel 18A. (4) While the LLM omits explicit mention of PowerVia and FinFET optimizations in Intel 3, these are secondary details; the core roadmap logic and technological progression are preserved. Wording differs slightly (e.g., 'next-generation transistor architecture (Ribbon FET)' vs 'RibbonFET and PowerVia'), but the semantic meaning and technical trajectory align fully. Minor deduction from 10 due to slight incompleteness on Intel 20A's full feature set, but the main thrust of the question—EUV use and High NA EUV introduction at Intel 18A—is perfectly addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 377,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in the 2023 10-K filing by VZ, and how does this compare to the total cash and cash equivalents?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies is $239 million ($101 million + $138 million). This amount is significantly higher than the total cash and cash equivalents, which sum to $57 million ($30 million + $27 million).",
      "llm_answer": "The 2023 filing shows U.S. Treasuries and agency holdings of **$1,412 million** in the pension‑plan assets (page 92) and **$138 million** in the health‑care and life‑plan assets (page 93), for a **combined total of about $1.55 billion**.  \n\nCash and cash equivalents total **$1,956 million** for the pension plans (page 92) plus **$27 million** for the health‑care and life plans (page 93), or **approximately $1.98 billion**—roughly $0.43 billion more than the combined Treasury‑agency investments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) The reported values for U.S. Treasuries and agencies are wrong: the ground truth states $101 million + $138 million = $239 million, but the LLM claims $1,412 million + $138 million = $1.55 billion. The $1,412 million figure appears to be a misreading of pension-plan assets (possibly total plan assets, not just Treasuries and agencies), which is not the same as investments in U.S. Treasuries and agencies. (2) Cash and cash equivalents are also incorrect: ground truth reports $30 million + $27 million = $57 million, but LLM reports $1,956 million + $27 million = $1.98 billion, again likely misreading total plan assets as cash. (3) The multi-hop reasoning fails: the model incorrectly identifies the disclosed asset categories, conflating total plan assets with specific investment types. It also fails to recognize that the question refers to two disclosed asset categories (likely pension and other post-employment benefits), but applies incorrect values. (4) The comparison conclusion is reversed: ground truth states Treasuries and agencies ($239M) are significantly higher than cash ($57M), while LLM claims cash is higher by $0.43 billion—exactly opposite and based on false numbers. Despite referencing correct document sections (pages 92–93), the model extracts and interprets data incorrectly. Wording and structure are relevant but factually unsound, hence low scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 404,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021, and how much of the total goodwill from these acquisitions was attributed specifically to Aldevron?",
      "original_answer": "DHR paid a total net cash consideration of $9,561 million for Aldevron and $1,340 million for the other 11 businesses acquired in 2021, totaling $10,901 million. Of the total goodwill of $7,187 million recorded for these acquisitions, $6,149 million was attributed specifically to Aldevron.",
      "llm_answer": "DHR’s 2021 acquisitions required a combined net‑cash outlay of **about $10.9 billion** – $9.6 billion for Aldevron plus roughly $1.3 billion for the other 11 businesses (see the $9,561 m and $1,340 m net‑cash figures in the 2021 acquisition table).  \n\nOf the total goodwill recorded for those 2021 deals ($7.187 billion), **approximately $6.149 billion** was allocated to the Aldevron acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only minor rounding differences that do not affect factual correctness. (1) All key numbers are correct: $9,561 million for Aldevron and $1,340 million for the other 11 businesses are accurately cited (presented as $9.6 billion and $1.3 billion, which are acceptable rounded equivalents). The total net cash consideration is correctly calculated as $10.9 billion (actual sum: $10,901 million), and the goodwill attributed to Aldevron is exactly $6,149 million, matching the ground truth. (2) Quantitative accuracy is perfect—rounding to one decimal place in billions is standard and does not constitute an error. The total goodwill of $7.187 billion is also correctly reported. (3) The multi-hop reasoning is sound: the model correctly identifies DHR as the acquirer, isolates Aldevron and the other 11 acquisitions in 2021, retrieves respective net cash considerations, sums them appropriately, and correctly allocates the goodwill portion tied to Aldevron. (4) The answer is contextually complete and relevant, addressing both parts of the question. The only reason for not scoring a 10 is the use of approximate language ('about', 'approximately') despite citing exact figures from the source, which slightly weakens precision in presentation, though not in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 377,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was GM's total committed capital contribution to Ultium Cells Holdings LLC as of December 31, 2023, and how does this compare to the carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date?",
      "original_answer": "GM had a committed capital contribution of $0.8 billion to Ultium Cells Holdings LLC as of December 31, 2023, while the carrying amount of its investment in Ultium Cells Holdings LLC was $2,268 million on the same date. This indicates that GM had not fully funded its committed capital contribution as of year-end.",
      "llm_answer": "GM’s committed capital contribution to Ultium Cells Holdings LLC was **$0.8 billion (≈ $800 million)** at December 31 2023. On the same date the carrying amount of GM’s investment in Ultium Cells Holdings LLC was **$2.268 billion**, i.e., roughly **$1.5 billion more** than the amount of capital it had committed.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies GM's committed capital contribution as $0.8 billion (equivalent to $800 million), which matches the ground truth. However, it states the carrying amount as $2.268 billion, whereas the ground truth reports $2,268 million—which is $2.268 billion—so this number is actually correct in value but misrepresented in interpretation. The key error lies in the comparison: the LLM claims the carrying amount is '$1.5 billion more' than the committed amount, which is incorrect. The actual difference is $2,268 million - $800 million = $1,468 million (≈$1.47 billion), so while the rough figure is close, the reasoning is flawed because the carrying amount exceeding the committed contribution does not imply overfunding—it contradicts the ground truth's conclusion that GM had *not* fully funded its commitment, suggesting the carrying amount may include equity method accounting adjustments beyond funded amounts.\n\n2) Quantitative accuracy is partially correct: $0.8 billion and $2.268 billion are numerically accurate (with $2,268 million = $2.268 billion). However, the comparison statement introduces a misleading inference through the phrase 'roughly $1.5 billion more', which, while arithmetically close, leads to an incorrect qualitative conclusion. The model fails to recognize that a higher carrying amount than committed capital does not imply full funding—this reflects a misunderstanding of accounting principles (e.g., equity method adjustments, valuation changes).\n\n3) The multi-hop reasoning is unsound. The model retrieves the correct numbers but synthesizes them incorrectly. The ground truth emphasizes that the carrying amount exceeds the committed contribution, indicating GM had *not yet fully funded* its commitment—this is counterintuitive unless one understands that carrying amounts under equity accounting can reflect earnings, losses, or valuation changes, not just cash contributions. The LLM instead interprets the higher carrying amount as GM having invested more than committed, which is logically inconsistent and factually misleading.\n\n4) Contextual relevance is perfect—the answer addresses both parts of the question and focuses on the right entities and date. However, due to the flawed interpretation of the relationship between committed capital and carrying amount, the qualitative and overall correctness scores are reduced. A score of 6 reflects that core numbers are correct but the synthesis and conclusion are significantly flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 662,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total amount of depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023, and how does it compare to the net book value of proved and unproved properties in that region as of December 31, 2023?",
      "original_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 was $5,729 million. The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, was $37,185 million. This means that the accumulated depreciation, depletion, and amortization for the Lower 48 region, which was $36,829 million, when added to the 2023 depreciation, depletion, amortization, and impairments of $5,729 million, results in a total accumulated value of $42,558 million. This represents a significant portion of the original total property value of $74,014 million for the Lower 48 region.",
      "llm_answer": "In 2023 the Lower 48 segment recorded **$5.73 billion** of depreciation, depletion, amortization and impairments. The net book value of its proved and unproved properties at December 31 2023 was **$37.19 billion** (total property $74.0 billion less accumulated depreciation $36.8 billion). Thus, the depreciation‑related charge was roughly **15 %** of the segment’s net property book value.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth with minor rounding differences. (1) Quantitatively: The reported 2023 depreciation, depletion, amortization, and impairments of $5.73 billion is a rounded version of the exact $5,729 million (i.e., $5.729 billion), which is acceptable. The net book value is given as $37.19 billion, matching the ground truth $37,185 million when rounded. The LLM correctly references accumulated depreciation of $36.8 billion (vs. $36,829 million) and total property value of $74.0 billion (vs. $74,014 million), both appropriately rounded. (2) Calculations: The implied calculation of net book value (total property minus accumulated DDA) is correct: $74.0B - $36.8B = $37.2B, consistent with the reported $37.19B. The LLM computes a 15% ratio of $5.73B / $37.19B ≈ 15.4%, which rounds to 15%—a reasonable approximation. (3) Multi-hop reasoning: The LLM synthesizes data across multiple financial metrics (2023 DDA, accumulated DDA, total property value, net book value) correctly, even if not repeating the full cumulative impact mentioned in the original. (4) The answer omits the explicit sum of accumulated + current year DDA ($42,558 million), but captures the core comparison requested: the 2023 charge relative to net book value. Wording and focus differ slightly but maintain semantic equivalence. No entity errors; all figures pertain to the Lower 48 region in 2023. Overall, this is a factually correct, concise, and relevant response with only negligible rounding discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 428,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total amount repaid under the 2021 Multicurrency Credit Facility in 2023, including both USD and EUR-denominated repayments, and how did this repayment activity affect the company's overall revolving indebtedness under this facility?",
      "original_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which included $919.1 million from the repayment of 842.6 million EUR. This significant repayment activity reduced the company's revolving indebtedness under the facility, contributing to a net decrease despite borrowing $3.0 billion during the year for purposes such as repaying the 2021 USD Two Year Delayed-Draw Term Loan and for general corporate purposes.",
      "llm_answer": "In 2023 the company repaid $6.1 billion under the 2021 Multicurrency Credit Facility – that total includes €842.6 million (≈ $919 million) of EUR‑denominated repayments and the balance of roughly $5.18 billion in USD repayments. Because it also borrowed $3.0 billion during the year, the net effect was a reduction of about $3.1 billion in the facility’s outstanding revolving indebtedness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total repayment of $6.1 billion under the 2021 Multicurrency Credit Facility in 2023, including the EUR-denominated repayment of €842.6 million, which is accurately converted to approximately $919 million (consistent with the ground truth's $919.1 million). The USD repayment portion is correctly implied as the difference ($6.1B - $0.919B ≈ $5.18B). The borrowing of $3.0 billion during the year is also correctly stated. (2) All numeric values match the ground truth: total repayment ($6.1B), EUR repayment (€842.6M), USD equivalent (~$919M), and new borrowings ($3.0B). The net effect calculation ($6.1B repaid - $3.0B borrowed = $3.1B net reduction) is mathematically sound and aligns with the ground truth's description of a net decrease in revolving indebtedness. (3) The multi-hop reasoning is correct: the model synthesizes repayment amounts in both currencies, acknowledges additional borrowing, and correctly infers the net impact on revolving indebtedness. The only minor shortcoming is that it does not explicitly mention the purpose of the $3.0B borrowing (e.g., repaying the 2021 USD Two Year Delayed-Draw Term Loan), which is included in the original answer and adds contextual completeness. (4) Despite this minor omission, the answer is factually accurate, quantitatively precise, and contextually relevant. The core facts, calculations, and synthesis are correct, warranting a high score. Thus, correctness is 9 due to slight incompleteness in explanatory detail, but quantitative accuracy is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 432,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014, as referenced in both the glossary and the business section, impact its operational costs and closure activities at coal ash impoundments?",
      "original_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 directly impacts its operational costs and closure activities at coal ash impoundments. According to the business section, Duke Energy has completed excavation of coal ash at three of the four high-priority North Carolina sites and has begun closure activities at all of its jurisdictions. These activities involve moving coal combustion residuals (CCR) to engineered landfills or for reuse, which requires significant planning, permitting, and execution. The costs associated with these closure activities are included in rate proceedings and partially recovered through amended wholesale contracts approved by FERC in 2017. Additionally, the glossary explicitly defines the Coal Ash Act, indicating its regulatory significance and the necessity for Duke Energy to factor compliance into its financial planning and operational timelines.",
      "llm_answer": "Compliance with the North Carolina Coal Ash Management Act of 2014 (the “Coal Ash Act”) requires Duke Energy to develop and obtain approval for site‑specific remediation and closure plans for its coal‑ash impoundments, to excavate CCR and move it to lined landfills or approved beneficial‑use sites, and to secure the necessary permits before work can begin【page_15】.  The associated closure and remediation expenditures are recorded as asset‑retirement obligations and have been built into the company’s rate‑case filings—e.g., the 2017 wholesale‑contract amendments and the 2019 North Carolina rate cases—so that the costs are recoverable through retail and wholesale rates, affecting operational costs but offset by regulatory cost‑recovery mechanisms【page_15】.  (The Act is defined in the glossary as the “North Carolina Coal Ash Management Act of 2014”【page_7】).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 requires site-specific closure plans, excavation of coal ash, movement of CCR to lined landfills or beneficial-use sites, and permitting—all of which impact operational costs. The answer correctly notes that these costs are treated as asset-retirement obligations and are recoverable through rate mechanisms, citing the 2017 FERC-approved wholesale contract amendments and mentioning the 2019 North Carolina rate cases (additional detail not in the original but factually consistent and supportive). (2) Quantitative accuracy is perfect: no incorrect numbers, dates (2014, 2017, 2019), or financial terms (asset-retirement obligations, rate recovery). Format and references (e.g., page citations) are consistent with source material. (3) Multi-hop reasoning is sound: the LLM synthesizes information from both the business section (closure activities, cost recovery) and the glossary (definition of the Coal Ash Act), correctly linking regulatory requirements to financial and operational impacts. (4) The only minor shortcoming is that the LLM does not explicitly mention the completion of excavation at three of four high-priority sites—a specific operational milestone in the original answer. While this detail is omitted, the overall impact on operational costs and closure activities is accurately conveyed, and the regulatory-financial linkage is robust. Hence, the answer is semantically equivalent with only a slight reduction in completeness. Contextual relevance is excellent, directly addressing the question’s focus on compliance impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 476,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Intel's FPGA technology, specifically the Agilex family, contribute to its IPU platforms and what role does the Intel eASIC N5X play in this context?",
      "original_answer": "Intel's Agilex FPGA family, built on Intel 10nm SuperFin technology, plays a critical role in its IPU platforms by enabling cloud and communications service providers to reduce overhead and free up CPU performance. The Agilex FPGA is already being deployed in IPU platforms at multiple cloud service providers. Additionally, the Intel eASIC N5X, as the next-generation Intel eASIC device, complements this ecosystem by offering a structured ASIC solution that provides lower unit cost and lower power compared to FPGAs, while still enabling fast time-to-market and reduced non-recurring engineering costs. This combination allows Intel to offer scalable, high-performance, and power-efficient solutions tailored for evolving infrastructure demands in cloud and communications.",
      "llm_answer": "Intel’s Agilex FPGA family – built on 10 nm SuperFin and shipped with industry‑leading fabric, power‑efficiency and transceiver performance – is the silicon “engine” of its Infrastructure Processing Unit (IPU) platforms, allowing cloud and communications providers to off‑load infrastructure‑processing tasks from CPUs and deliver higher‑performance, lower‑overhead networking (e.g., the Oak Springs Canyon reference IPU that pairs a Xeon D CPU with an Agilex FPGA). The Intel eASIC N5X, a next‑generation structured‑ASIC product, complements the FPGA‑based IPU approach by offering a lower‑cost, lower‑power, low‑latency ASIC‑like option for 5G, cloud, storage and edge acceleration, giving customers a faster‑to‑market alternative when full FPGA flexibility is not required.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Agilex FPGAs are built on 10nm SuperFin technology and serve as the foundation for Intel's IPU platforms, enabling offload of infrastructure tasks from CPUs—this matches the original answer's claim about reducing overhead and freeing CPU performance. The mention of the Oak Springs Canyon reference design (though not in the original answer) is contextually appropriate and adds relevant detail without introducing error. (2) There are no numeric values requiring verification (e.g., dates, dollar amounts, percentages), so quantitative accuracy is unaffected and remains perfect. (3) The role of the Intel eASIC N5X is accurately described: it is correctly identified as a next-generation structured ASIC that offers lower cost, lower power, and lower latency than FPGAs, suitable for cases where full FPGA flexibility isn't needed—this mirrors the original answer’s emphasis on reduced unit cost, power, and NRE. The reasoning across both technologies (FPGA for flexibility, eASIC for cost/power efficiency) demonstrates sound multi-hop synthesis. (4) The only minor gap is that the LLM answer does not explicitly mention 'fast time-to-market' or 'reduced non-recurring engineering costs' in the context of eASIC N5X, though it does say 'faster-to-market alternative,' which captures part of that idea. This slight omission prevents a perfect 10 but doesn't undermine the core accuracy. Overall, the answer is semantically equivalent, contextually rich, and factually sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 431,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How many employees does Danaher have in Other Developed Markets compared to North America, and what percentage of the total global workforce do these regions collectively represent?",
      "original_answer": "Danaher has 3,000 employees in Other Developed Markets and 24,000 employees in North America, collectively representing approximately 42.86% of the company's total global workforce of 63,000 employees.",
      "llm_answer": "Danaher reported about 3,000 associates in Other Developed Markets and roughly 24,000 in North America. Together those regions account for about 27,000 employees, which is roughly 43 percent (27,000 ÷ 63,000 ≈ 0.43) of Danaher’s total global workforce.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: 3,000 employees in Other Developed Markets and 24,000 in North America are correctly reported. The combined total of 27,000 is accurate (3,000 + 24,000 = 27,000). The percentage is correctly calculated as approximately 43% (27,000 ÷ 63,000 ≈ 0.42857, which rounds to 43% or 42.86% depending on precision). The total global workforce of 63,000 is correctly referenced. (2) Quantitative accuracy is perfect: all numbers match the ground truth, and the calculation is sound and transparently explained. Minor rounding to '43%' is acceptable and commonly used when approximating 42.86%. (3) Qualitative accuracy and reasoning are strong: the model correctly identifies the two regions, retrieves the correct employee counts, performs the correct synthesis (sum and percentage calculation), and links them to the total workforce. This demonstrates proper multi-hop reasoning across entities. (4) The answer is contextually relevant, directly addressing both parts of the question: the employee comparison between regions and their collective percentage of the global workforce. Wording differences (e.g., 'associates' vs 'employees') do not affect factual meaning. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 365,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, and how does this compare to the total derivative assets reported on the balance sheet for the same year?",
      "original_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million. This matches the total derivative assets reported on the balance sheet for the same year, indicating that all derivative assets were composed of foreign exchange forwards and options.",
      "llm_answer": "As of May 31 2023 Nike reported that its foreign‑exchange forwards and options had a fair‑value balance of **$557 million (assets at fair value) + $493 million (other current assets) + $64 million (other long‑term assets) = $1.114 billion**.  \n\nThe consolidated balance sheet, however, lists **total derivative assets of $557 million** for the same year, meaning the fair‑value amount of the FX forwards and options is roughly twice the amount shown as total derivative assets on the balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and calculation errors. The ground truth states that the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million, which matches the total derivative assets on the balance sheet. However, the LLM incorrectly sums $557M + $493M + $64M to arrive at $1.114 billion, falsely implying that these are components of the fair value of forwards and options. These additional amounts appear to be misinterpreted from asset classifications (e.g., other current or long-term assets), but they are not part of the derivative asset valuation. (2) The quantitative inaccuracies are severe: the correct total is $557 million, not $1.114 billion. The LLM also incorrectly claims that the fair value is 'roughly twice' the balance sheet derivative assets, when in fact they are equal per the original answer. (3) The multi-hop reasoning fails: instead of recognizing that the $557 million in derivative assets consists entirely of foreign exchange forwards and options, the model misinterprets line items and creates an erroneous sum. It fails to synthesize the key point that all derivative assets were composed of these instruments. (4) Contextual relevance is moderate because the answer addresses the right topic (Nike, derivatives, May 31, 2023), uses correct terminology, and references the balance sheet, but the core facts and logic are fundamentally flawed. Thus, correctness, quantitative, and qualitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 418,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much did the depreciation, depletion, amortization, and impairments expense in the Lower 48 region increase from 2021 to 2023, and what was the corresponding change in the number of productive wells in that region over the same period?",
      "original_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased by $1,662 million from 2021 ($4,067 million) to 2023 ($5,729 million). Over the same period, the number of productive wells in the Lower 48 region decreased by 49, from 87 in 2021 to 38 in 2023.",
      "llm_answer": "- Depreciation, depletion, amortization and impairments expense for the Lower 48 segment rose from **$4.067 billion in 2021 to $5.729 billion in 2023**, an increase of **$1.662 billion**.  \n\n- The 2023 table shows **8,347 net productive wells** in the Lower 48 (6,954 oil + 1,393 gas). The 2021 figure is not disclosed in the excerpts you provided, so the change in the number of productive wells from 2021 to 2023 cannot be determined from the available pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the depreciation, depletion, amortization, and impairments expense values for 2021 ($4.067 billion) and 2023 ($5.729 billion), and accurately calculated the increase of $1.662 billion, which matches the ground truth. These numbers are presented in a different format (billion vs million) but are numerically equivalent ($4,067 million = $4.067 billion), so this is acceptable. However, the LLM incorrectly states that the 2021 number of productive wells is not disclosed, while the ground truth clearly states there were 87 productive wells in 2021 and 38 in 2023, indicating a decrease of 49. Instead, the LLM cites 8,347 net productive wells in 2023, which contradicts the ground truth of 38. This is a major factual error. (2) The quantitative accuracy is high for the expense data but severely flawed for the well count, where both the 2023 number and the change are incorrect. The calculation of the expense increase is correct. (3) The multi-hop reasoning fails on the second part: the model did not correctly extract or synthesize the number of productive wells for either year, possibly confusing 'net productive wells' with another metric or misreading the data source. It claims the 2021 figure is unavailable, but the ground truth implies it is known. (4) The correctness score is 4 due to one fully correct part and one completely incorrect part. Quantitative accuracy is 8 because the financial figures are correct, but well counts are not. Qualitative accuracy is 5 due to flawed reasoning in the second component. Contextual relevance is 7 because the answer addresses both parts of the question and uses appropriate terminology, despite factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 468,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both tables from Verizon's 2023 10-K filing, and how does this allocation compare between the two different categorizations of investments at fair value?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies from both tables is $2,953 million. In the first table, U.S. Treasuries and agencies are valued at $1,412 million and are categorized under fixed income securities with $1,274 million in Level 1 and $138 million in Level 2. In the second table, U.S. Treasuries and agencies are valued at $1,541 million, with $1,312 million in Level 1 and $229 million in Level 2. This indicates a slight increase in the value of U.S. Treasuries and agencies between the two categorizations, with a corresponding shift in the distribution between Level 1 and Level 2 assets.",
      "llm_answer": "The two fair‑value tables show $1,412 million of U.S. Treasuries and agencies in the pension‑plan assets and $138 million in the other post‑retirement benefit‑plan assets, for a combined total of **$1,550 million**.  In the pension‑plan table that amount represents roughly **15 %** of the $9,104 million of fair‑value investments, whereas in the post‑retirement‑benefit table it accounts for about **30 %** of the $461 million of fair‑value investments, indicating a markedly higher concentration of Treasury/agency holdings in the latter categorization.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The total combined value is incorrectly calculated as $1,550 million, whereas the ground truth states $2,953 million, derived from $1,412 million in the first table and $1,541 million in the second. The LLM incorrectly treats the $138 million (which is Level 2 portion of the first table) as a separate table value instead of a subcomponent, leading to a major miscalculation. (2) The percentages cited (15% and 30%) are not supported by the ground truth and appear to be based on incorrect assumptions about the total investment amounts in each table. The ground truth does not mention percentages or relative allocations, so these are unsupported additions. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify that both tables report values for U.S. Treasuries and agencies independently ($1,412M and $1,541M), and instead misinterprets the Level 2 amount from the first table as the total for the second table. It also introduces entities not in the original answer—'pension-plan assets' and 'other post-retirement benefit-plan assets'—which were not specified in the question or ground truth, indicating a misattribution of data sources. (4) While the LLM attempts to compare allocations between categorizations (showing relevance), the core quantitative error (summing $1,412M + $138M instead of $1,412M + $1,541M) undermines correctness. The contextual relevance is moderate because it addresses the idea of comparing two categorizations, but the factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 432,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "By how much did Nike's timed deposits classified as cash and equivalents decrease from fiscal year 2023 to 2024?",
      "original_answer": "Nike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 to 2024.",
      "llm_answer": "Nike’s timed deposits that are included in cash and equivalents fell from $502 million in fiscal 2023 to $347 million in fiscal 2024 – a decrease of $155 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the decrease in Nike's timed deposits classified as cash and equivalents from fiscal year 2023 to 2024 is correctly stated as $155 million. (2) Quantitative accuracy is perfect — the LLM provides the exact values ($502 million in 2023 and $347 million in 2024), and the calculated difference ($502M - $347M = $155M) is correct. Minor formatting with thin spaces ( ) does not affect correctness. (3) The reasoning is sound and demonstrates proper multi-hop synthesis by identifying the relevant metric across two fiscal years and computing the change. (4) The answer is contextually relevant, directly addressing the question with precise data and clear explanation. All entities — Nike, timed deposits, cash and equivalents, and fiscal years 2023 and 2024 — are correctly identified and used. Semantic equivalence to the original answer is complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1060,
        "completion_tokens": 275,
        "total_tokens": 1335
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much did the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations total in 2023, and how does this compare to the combined total from 2022?",
      "original_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled $6,790 million in 2023, compared to $5,795 million in 2022. This represents an increase of $995 million.",
      "llm_answer": "The depreciation, depletion, amortization and impairments for Alaska ($1,061 million) plus the Lower 48 ($5,729 million) total **$6,790 million in 2023**. In 2022 the same two segments recorded $941 million (Alaska) and $4,854 million (Lower 48), for a **combined $5,795 million**. Thus, the combined amount rose by roughly **$1.0 billion** from 2022 to 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numbers are accurate: $1,061 million (Alaska 2023), $5,729 million (Lower 48 2023), summing to $6,790 million in 2023; $941 million (Alaska 2022), $4,854 million (Lower 48 2022), summing to $5,795 million in 2022. These match the original answer. (2) The calculation of the increase is correct: $6,790M - $5,795M = $995M, which the model appropriately rounds to 'roughly $1.0 billion', a semantically acceptable approximation. (3) The multi-hop reasoning is sound—information from both segments (Alaska and Lower 48) and both years (2022 and 2023) is correctly synthesized to compute the combined totals and the year-over-year change. (4) All entities (Alaska, Lower 48, depreciation/depletion/amortization/impairments, years 2022 and 2023) are correctly identified and used. The answer is complete, factually precise, and contextually appropriate, fully addressing both parts of the question: the 2023 total and its comparison to 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 292,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total fair value of the crypto asset safeguarding liability and corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022, and how is this reflected in the fair value measurement disclosures?",
      "original_answer": "PayPal Holdings, Inc. reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022. This is disclosed in both the financial assets and liabilities table and the related notes to consolidated financial statements, where the crypto asset safeguarding liability is listed under financial liabilities and the safeguarding asset is listed under financial assets, with both categorized under 'Significant Other Observable Inputs (Level 2)' for fair value measurement.",
      "llm_answer": "As of December 31 2022 PayPal reported a **crypto‑asset safeguarding asset of $604 million** and a **matching crypto‑asset safeguarding liability of $604 million**. Both amounts appear in the “fair‑value measurement of assets and liabilities” table (Note 9) as Level 2 measurements—i.e., they are valued using quoted prices on an identified principal exchange for the underlying crypto assets. The footnote also explains that the safeguarding asset is presented in “prepaid expenses and other current assets” and the liability in “accrued expenses and other current liabilities” on the balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported values of $604 million for both the crypto asset safeguarding asset and liability are accurate, and the date (December 31, 2022) is correctly stated. (2) The answer addresses both parts of the question: the total fair value and how it is reflected in fair value measurement disclosures. (3) Entity accuracy is correct—PayPal Holdings, Inc., the correct fiscal date, and proper financial terms (Level 2, Note 9, 'Significant Other Observable Inputs') are used. The LLM correctly identifies that both the asset and liability are categorized under Level 2 and explains the valuation methodology (quoted prices on a principal exchange), which aligns with Level 2 inputs. (4) The reasoning is sound and reflects proper multi-hop synthesis: it links the dollar amounts to their balance sheet presentation (prepaid expenses and accrued expenses) and ties them to the fair value disclosure in Note 9. The semantic content is equivalent to the ground truth, with added clarity on balance sheet line items, which enhances completeness without introducing error. All details are relevant and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 343,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024, considering both the cash outflow to increase ownership and the cash inflow from new equity funding?",
      "original_answer": "Walmart paid $0.9 billion to former noncontrolling interest holders of PhonePe to increase its ownership during fiscal 2024, while also receiving $0.7 billion from new equity funding rounds in PhonePe, which resulted in a net cash outflow of $0.2 billion.",
      "llm_answer": "During fiscal 2024 Walmart paid $3.5 billion to increase its ownership in PhonePe (and settle the related liability) and received $0.7 billion from a new equity‑funding round for PhonePe. The net effect was a cash outflow of about $2.8 billion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $0.7 billion cash inflow from new equity funding in PhonePe during fiscal 2024, it incorrectly states that Walmart paid $3.5 billion to increase its ownership, whereas the ground truth specifies a payment of $0.9 billion to former noncontrolling interest holders. This results in a gross misstatement of the net cash outflow: the LLM calculates $2.8 billion ($3.5B - $0.7B), but the correct net outflow is $0.2 billion ($0.9B - $0.7B). (2) Quantitative accuracy is severely compromised—only the $0.7 billion inflow is correct; the $3.5 billion outflow is wrong, and the resulting net outflow of $2.8 billion is therefore incorrect. The correct calculation should be $0.9B - $0.7B = $0.2B net outflow. (3) The qualitative reasoning shows partial understanding of the multi-hop structure—recognizing that both an outflow (for ownership increase) and inflow (from equity funding) must be considered to compute net impact—but fails in retrieving the correct outflow amount. It may conflate the PhonePe transaction with other Walmart investments or misinterpret liability settlements. (4) Contextual relevance is high because the answer addresses the right entities (Walmart, PhonePe), time period (fiscal 2024), and financial events (ownership change, equity funding, net cash impact), but factual correctness is undermined by the incorrect key figure. Hence, correctness and quantitative accuracy scores are low, qualitative accuracy is moderate due to correct logic framework, and relevance is high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 439,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net change in total wholesale revenues (both affiliate and non-affiliate sales) for Southern Company in 2024 compared to 2023, and how did the IIC-approved affiliate sales mechanism influence this outcome?",
      "original_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $69 million. This is calculated by combining the $77 million increase in affiliate and non-affiliate wholesale revenues from one segment and the $79 million increase in affiliate sales offset by the $87 million decrease in non-affiliate sales from another segment. Specifically, affiliate sales increased by $79 million due to a 165.5% rise in the volume of KWH sales, which were conducted in accordance with the IIC-approved FERC pricing mechanism, ensuring energy was sold at marginal cost and stabilizing the financial impact of these internal transactions.",
      "llm_answer": "Southern Company’s total wholesale revenues fell by $8 million in 2024 ( $476 million versus $484 million in 2023).  The decline in non‑affiliate wholesale sales (down $87 million) was largely offset by a $79 million increase in affiliate wholesale sales, which rose from $60 million to $139 million because the IIC‑approved affiliate‑sales mechanism allowed a 165.5% jump in KWH volume sold to affiliates at marginal‑cost terms.  Thus, the IIC‑based affiliate sales helped blunt the overall wholesale‑revenue drop.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that total wholesale revenues fell by $8 million, while the ground truth indicates a $69 million increase. This is a major factual error in direction and magnitude. The LLM correctly identifies a $87 million decrease in non-affiliate sales and a $79 million increase in affiliate sales, but fails to incorporate the additional $77 million increase in affiliate and non-affiliate revenues from another segment mentioned in the ground truth. As a result, the net change is miscalculated: instead of $77M + ($79M - $87M) = +$69M, the LLM implies only ($79M - $87M) = -$8M, omitting the $77M entirely. (2) The individual numbers for affiliate sales increase ($79M), the 165.5% rise in KWH volume, and the IIC-approved mechanism selling at marginal cost are all accurate and correctly attributed. However, the total revenue figures of $476M and $484M are not supported by the ground truth and appear to be fabricated or misattributed. (3) The multi-hop reasoning is partially sound—linking the IIC mechanism to increased affiliate sales volume and pricing at marginal cost—but fails to synthesize all three revenue components (two increases and one decrease) required for the correct net change. The model captures one segment’s dynamics but omits another key segment’s $77M revenue increase, breaking the full synthesis. (4) Despite the significant quantitative error, the answer is contextually relevant, addressing both parts of the question—net change and the role of the IIC mechanism—and correctly explaining the causal link between the mechanism and increased affiliate sales. Hence, low correctness and quantitative accuracy due to incorrect net change and missing data, moderate qualitative accuracy due to correct use of some facts and reasoning, and high contextual relevance for structure and partial completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 506,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total amount Intel plans to invest in manufacturing expansion under the IDM 2.0 strategy, based on the investments announced for Arizona, Ohio, and the global packaging sites?",
      "original_answer": "Intel plans to invest a total of $50.5 billion in manufacturing expansion under the IDM 2.0 strategy. This includes $20 billion for two new fabs in Arizona, more than $20 billion for two leading-edge fabs in Ohio, and $10.5 billion to equip the Rio Rancho, New Mexico and Malaysia sites for advanced packaging manufacturing.",
      "llm_answer": "Intel’s IDM 2.0 manufacturing expansion comprises roughly $20 billion for the two Arizona fabs, more than $20 billion for the two Ohio fabs, and about $10.5 billion for advanced‑packaging upgrades at Rio Rancho (NM) and Malaysia – a total of **over $50.5 billion** in planned investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All numeric values are correct: $20 billion for Arizona, more than $20 billion for Ohio, and $10.5 billion for advanced packaging in Rio Rancho and Malaysia. The total is correctly calculated as $50.5 billion. The LLM states 'over $50.5 billion' due to the 'more than $20 billion' phrasing for Ohio, which is a reasonable interpretation given the uncertainty in that component. (2) Quantitative accuracy is perfect: all dollar amounts match the ground truth, and the sum is accurate. (3) The reasoning is sound and correctly synthesizes the three investment components across multiple locations (Arizona, Ohio, New Mexico, Malaysia), demonstrating proper multi-hop understanding. (4) The only minor issue is the phrasing 'over $50.5 billion' instead of the precise '$50.5 billion' total stated in the ground truth. However, since the Ohio investment is described as 'more than $20 billion', the LLM's cautious 'over' qualifier is logically defensible. Thus, the answer is semantically equivalent and factually correct, warranting a high score. Contextual relevance is perfect—every part of the question is addressed directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 342,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total goodwill did Danaher record from the acquisition of Abcam and what was the impact of the Veralto separation on Danaher's cash position prior to the distribution date?",
      "original_answer": "Danaher preliminarily recorded approximately $3.9 billion of goodwill related to the acquisition of Abcam. Additionally, Danaher received net cash distributions of approximately $2.6 billion from Veralto prior to the distribution date, which was partially used to redeem $1.0 billion of commercial paper.",
      "llm_answer": "- Danaher preliminarily recorded **about $3.9 billion of goodwill** in connection with the Abcam acquisition (the goodwill line in the acquisition table shows $3.851 billion, which the filing rounds to $3.9 billion).  \n\n- The Veralto separation supplied Danaher with **approximately $2.6 billion of net cash** before the September 30, 2023 distribution date.  Danaher used roughly **$1.0 billion of that cash to redeem commercial paper**, and the remaining balance was earmarked to pay off bond maturities and to fund its regular quarterly cash dividends.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $3.9 billion goodwill figure is accurate, with a precise reference to the underlying $3.851 billion from the filing, properly rounded. The $2.6 billion net cash distribution from Veralto prior to the September 30, 2023 distribution date is correctly stated, as is the $1.0 billion commercial paper redemption. (2) The answer is complete, addressing both parts of the multi-hop question: the goodwill from Abcam and the cash impact of the Veralto separation. (3) Entity accuracy is perfect—Danaher, Abcam, and Veralto are correctly identified, and the financial metrics (goodwill, net cash, commercial paper) are used appropriately. (4) The reasoning is sound: the LLM correctly synthesizes information across the acquisition and separation events, noting not only the cash received but also its partial use, which adds contextual depth beyond the ground truth without introducing error. (5) Semantic equivalence is maintained—wording differs slightly but conveys the same factual content with added precision (e.g., specifying the rounding of $3.851B to $3.9B), which enhances rather than detracts from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 340,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024, and how does this compare to the fair value of these derivatives assets and liabilities reported at year-end?",
      "original_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million. At year-end, the fair value of these derivatives was $557 million in assets and $180 million in liabilities. This indicates that while Nike held significant foreign exchange derivative positions, the net gain recognized during the year was relatively small compared to the overall fair value of these instruments.",
      "llm_answer": "In fiscal 2024 Nike recorded a **total net gain of about $126 million** from foreign‑exchange forwards and options that flowed through the income statement (the $102 million gain on designated cash‑flow hedges plus the $24 million gain on undesignated forwards/options).  \n\nAt year‑end (May 31 2024) the same contracts were carried on the balance sheet at **fair‑value assets of roughly $343 million and fair‑value liabilities of about $120 million** (the liability figure includes the $120 million for foreign‑exchange forwards/options plus a small amount for interest‑rate swaps).  \n\nThus, the income‑statement gain is modest relative to the hundreds of millions of dollars of fair‑value assets and liabilities that remain on the books.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The total net gain recognized in income is stated as $126 million ($102M + $24M), but the ground truth specifies only $24 million as the total net gain. The LLM incorrectly adds a $102 million gain on designated hedges, which is not supported by the original answer and inflates the figure. Additionally, the year-end fair value of derivative assets and liabilities is incorrect: LLM reports $343 million in assets and $120 million in liabilities, whereas the ground truth reports $557 million in assets and $180 million in liabilities. These discrepancies affect core financial accuracy. (2) Number verification: $126M ≠ $24M (major error); $343M ≠ $557M (material underreporting of assets); $120M ≠ $180M (underreporting of liabilities). The LLM also introduces interest-rate swaps, which were not mentioned in the original context, adding unsupported detail. (3) Multi-hop reasoning is partially sound in structure—linking income statement gains to balance sheet fair values—but based on incorrect data. The conclusion that the gain is 'modest relative to fair value' aligns qualitatively with the original, but rests on inaccurate magnitudes. (4) Scores reflect severe quantitative errors (2/10), weak qualitative reasoning due to unsupported segmentation of gains (4/10), high contextual relevance as it addresses the right concepts and structure (8/10), and a low overall correctness score (3/10) due to fundamental factual mismatches.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 421,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates, and how does this compare to the 2022 depreciation, depletion, amortization, and impairments for the same region?",
      "original_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million, as equity affiliates contributed no discounted future net cash flows from the Lower 48. This is significantly higher than the 2022 depreciation, depletion, amortization, and impairments for the Lower 48, which amounted to $4,854 million. This indicates that the future cash flow potential of the Lower 48 region is much greater than the costs recognized during 2022.",
      "llm_answer": "In 2022 the discounted future net cash‑flow for the Lower 48 segment was **$55,912 million** for Consolidated operations; Equity‑affiliate cash‑flows for the Lower 48 are shown as “‑” (i.e., $0), so the combined total is **$55.9 billion**.  \n\nFor the same year the Lower 48’s depreciation, depletion, amortization and impairments were **$4,854 million**. Thus, the discounted future net cash‑flows are roughly **11‑12 times larger** than the depreciation‑related expense for that region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key numbers are accurate: the combined discounted future net cash flows are correctly reported as $55,912 million (also expressed as $55.9 billion, which is a valid rounding and format variation). Equity affiliates' contribution is correctly interpreted as $0 based on the '‑' notation. The depreciation, depletion, amortization, and impairments amount of $4,854 million is also accurately cited. (2) The calculation and comparison are sound: $55,912 million is indeed approximately 11.5 times $4,854 million, so stating '11-12 times larger' is a reasonable and accurate qualitative comparison. (3) The multi-hop reasoning is correct—the model synthesizes data from both consolidated operations and equity affiliates for the Lower 48 region, correctly identifies that equity affiliates contributed nothing, and compares the total future cash flows to the 2022 expenses. (4) All entities (Lower 48 region, 2022 time frame, correct financial metrics) are accurately identified and used. The answer is semantically equivalent to the ground truth, with slightly more concise wording and a helpful ratio interpretation. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 354,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023, and how does this compare to the fair value of these receivables based on the level of unobservable inputs?",
      "original_answer": "PayPal reported a total value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023. This entire amount was measured using significant unobservable inputs (Level 3), indicating that the fair value of these receivables is entirely based on Level 3 inputs.",
      "llm_answer": "PayPal reported **$563 million** of loans and interest receivable, held for sale, on its December 31 2023 balance sheet. The fair‑value measurement for this asset is classified in **Level 3 of the fair‑value hierarchy**, meaning it is based on significant unobservable inputs (the price the company expects to receive from the buyer).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023, is accurately reported with correct date and amount. (2) The answer correctly identifies that the fair value measurement is classified in Level 3 of the fair-value hierarchy, which aligns with the ground truth stating the entire amount is based on significant unobservable inputs (Level 3). (3) The reasoning is sound: the LLM correctly synthesizes that the reported value is measured using Level 3 inputs, indicating proper multi-hop understanding between the balance sheet item and its fair value hierarchy classification. (4) The wording differs slightly (e.g., 'price the company expects to receive from the buyer' as an interpretation of unobservable inputs), but this is semantically equivalent and adds contextual clarity without introducing error. All parts of the question are addressed: the total value, the date, and the comparison to fair value based on unobservable inputs. No factual, numerical, or conceptual inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 323,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the amounts borrowed and repaid under the 2021 Credit Facility in the same period?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. Under the 2021 Credit Facility, $3.1 billion was borrowed and $2.6 billion was repaid during the same period. This results in a net repayment of $3.1 billion for the 2021 Multicurrency Credit Facility and a net borrowing of $0.5 billion for the 2021 Credit Facility.",
      "llm_answer": "During 2023 the company **borrowed $3.0 billion and repaid $6.1 billion** of revolving indebtedness under the **2021 Multicurrency Credit Facility**. In the same period it **borrowed $3.1 billion and repaid $2.6 billion** under the **2021 Credit Facility**. Thus, the multicurrency facility saw a net repayment of about $3.1 billion, while the 2021 Credit Facility had a net increase of roughly $0.5 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $3.0 billion borrowed and $6.1 billion repaid under the 2021 Multicurrency Credit Facility, and $3.1 billion borrowed and $2.6 billion repaid under the 2021 Credit Facility. The net figures are correctly implied: a net repayment of $3.1 billion ($6.1B - $3.0B) for the multicurrency facility and a net borrowing of $0.5 billion ($3.1B - $2.6B) for the 2021 Credit Facility. (2) The answer is complete, addressing both parts of the question—borrowing/repayment amounts for both facilities and their comparison. (3) Entities are correctly identified: the two distinct facilities (2021 Multicurrency Credit Facility vs. 2021 Credit Facility) and the correct time period (year ended December 31, 2023) are accurately referenced. (4) The reasoning is sound, with correct multi-hop synthesis: the model correctly distinguishes between the two facilities and computes net changes logically. (5) Semantic equivalence is maintained—wording differs slightly (e.g., 'net increase' vs. 'net borrowing') but meaning is identical. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 335,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What specific audit procedures were applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs, and how do these procedures reflect the subjectivity involved in assessing future regulatory orders?",
      "original_answer": "Both Georgia Power and Mississippi Power underwent similar audit procedures to evaluate the impact of regulatory rate changes on incurred costs. These procedures included testing the effectiveness of management's controls over the evaluation of the likelihood of recovery in future rates of certain incurred costs, refunds, or future reductions in rates. Auditors also reviewed regulatory orders and publicly available information to assess precedents for similar cost treatments. These procedures reflect the high degree of subjectivity involved in assessing the potential impact of future regulatory orders on incurred costs, as management must make significant judgments regarding the likelihood of recovery, disallowance, or refund obligations.",
      "llm_answer": "Both Georgia Power and Mississippi Power were audited using the same set of procedures: the auditors tested the effectiveness of management’s controls over evaluating (i) the likelihood that incurred costs will be recovered in future rates and (ii) any refunds or rate reductions that should be recorded as regulatory liabilities; they read and evaluated the relevant regulatory orders and other public information to gauge that likelihood; they performed substantive testing of the costs recorded as regulatory assets or liabilities for completeness and accuracy; they obtained management representations on recoverability and potential refunds; and they reviewed the companies’ disclosures of regulatory‑impact balances. These steps underscore the high degree of subjectivity because they depend on management’s judgments and assumptions about how future commission orders will treat those costs, which are inherently uncertain and require auditor judgment rather than purely objective evidence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: both Georgia Power and Mississippi Power underwent similar audit procedures focused on management’s controls over evaluating the likelihood of cost recovery, refunds, or rate reductions; auditors reviewed regulatory orders and public information; and they assessed precedents. The LLM adds additional valid details—substantive testing of regulatory assets/liabilities, management representations, and disclosure reviews—that are consistent with standard audit practices and do not contradict the ground truth. These enhancements improve completeness without introducing inaccuracies. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the absence of incorrect data supports a perfect score by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the same procedures apply to both companies and links the procedural elements to the underlying subjectivity in forecasting regulatory outcomes. The conclusion about subjectivity—rooted in management’s judgments and auditor reliance on assumptions about future regulatory decisions—is semantically equivalent to the ground truth. (4) The only reason for not scoring a perfect 10 is that the original answer emphasizes the 'high degree of subjectivity' as a direct reflection of the procedures, while the LLM elaborates slightly more on auditor actions than on explicitly tying each procedure back to subjectivity. However, the connection is still clearly made. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 475,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the decline in Comirnaty's global revenue in 2023 and the collaboration agreement terms with BioNTech impact Pfizer's operational results and future financial obligations?",
      "original_answer": "The decline in Comirnaty's global revenue from $37,806 million in 2022 to $11,220 million in 2023, a 70% drop, significantly affected Pfizer's operational results, driven by lower contracted deliveries and demand in international markets and the transition to traditional U.S. commercial market sales. This decline was compounded by Pfizer's ongoing collaboration agreement with BioNTech, under which Pfizer agreed to pay BioNTech tiered royalties and share gross profits from Comirnaty sales globally, excluding certain regions. Despite the revenue drop, Pfizer retained global commercialization rights (excluding Germany, Turkey, and certain Asian regions) and continued to share development and commercialization profits with BioNTech, creating ongoing financial obligations even as revenue declined.",
      "llm_answer": "The 70 % drop in Comirnaty’s worldwide sales (from $37.8 billion in 2022 to $11.2 billion in 2023) was the single biggest driver of Pfizer’s 2023 revenue decline – it erased about $26.4 billion of total revenue and cut cost‑of‑sales by $14.2 billion, forcing a $9.4 billion reduction in cost of sales and a lower operating margin even though net income stayed roughly flat because of other expense reductions and non‑cash gains. At the same time, Pfizer’s collaboration with BioNTech obligates it to a $225 million upfront payment (‑$75 million cash and a $150 million equity investment) for a shingles‑vaccine program and up to $200 million in future regulatory‑ and sales‑milestone payments, plus ongoing profit‑sharing on any commercialized product (including the Comirnaty profit‑share in Germany and Turkey), creating additional cash‑flow commitments that will affect future financial results.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite capturing the general trend of Comirnaty revenue decline. The 70% drop and revenue figures ($37.8B to $11.2B) are correctly stated and align with the ground truth (allowing for format variation: $37,806 million ≈ $37.8 billion). However, the LLM introduces unsupported financial impacts: claiming the drop 'erased about $26.4 billion of total revenue' is misleading—while the difference is ~$26.6B, this does not equate to a direct subtraction from Pfizer’s total revenue without context on other revenue streams. More critically, the LLM fabricates a '$9.4 billion reduction in cost of sales' and claims 'net income stayed roughly flat' due to 'non-cash gains'—none of which are in the original answer or verifiable from the provided ground truth. These invented figures severely undermine quantitative accuracy. (2) The collaboration agreement is misrepresented: the original answer states Pfizer shares gross profits and pays tiered royalties to BioNTech on Comirnaty sales globally (excluding certain regions), but the LLM incorrectly shifts focus to a shingles-vaccine program with a $225M upfront payment and $200M in milestones—details not present in the ground truth and irrelevant to the Comirnaty agreement. While the LLM correctly notes ongoing profit-sharing in Germany and Turkey, it conflates separate agreements and invents financial terms. (3) Multi-hop reasoning is partially sound in linking revenue decline to operational impact and recognizing ongoing obligations via collaboration, but fails in synthesizing the correct agreement terms. The model identifies the right companies (Pfizer, BioNTech) and time frame (2022–2023), but incorrectly infers financial mechanics. (4) The contextual relevance is moderate—it addresses the question’s two main parts (revenue impact and collaboration obligations)—but the inclusion of false financials and unrelated programs reduces reliability. Correctness score is low due to major factual and quantitative errors, despite correct identification of the revenue drop percentage and directionality of impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 575,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023?",
      "original_answer": "The value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024.",
      "llm_answer": "NKE’s short‑term investment portfolio held U.S. Agency securities worth **$35 million** on May 31, 2024, compared with **$46 million** on May 31, 2023 – a **decrease of $11 million year‑over‑year**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $35 million (May 31, 2024) and $46 million (May 31, 2023) are accurate, and the year-over-year decrease of $11 million is correctly calculated ($46M - $35M = $11M). (2) The answer is complete, addressing both the current and prior year values as well as the change, which directly responds to the question about year-over-year change. (3) Entity accuracy is correct: NKE is the right company, the metric 'U.S. Agency securities held as short-term investments' is properly identified, and the dates (May 31, 2024 and May 31, 2023) match the query. (4) The reasoning is sound and reflects proper multi-hop synthesis across two time points to compute the change. (5) The semantic meaning is equivalent to the original answer, with clear, concise restatement of the same facts. No errors in logic, numbers, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1098,
        "completion_tokens": 270,
        "total_tokens": 1368
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024, considering both new issuances and repayments?",
      "original_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was an increase of $423 million.",
      "llm_answer": "Costco’s Japanese subsidiary did not issue any new Guaranteed Senior Notes in 2024; it only repaid a portion of the notes it had issued in November 2023. The July 2024 repayment was **$77 million**, so the total principal amount of Guaranteed Senior Notes fell by **$77 million** during 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states there was a net increase of $423 million in the total principal amount of Guaranteed Senior Notes in 2024, whereas the LLM claims a decrease of $77 million due to repayments only. This contradicts the correct synthesis of both issuances and repayments. (2) The LLM incorrectly asserts that no new notes were issued in 2024 and cites a $77 million repayment in July 2024, which is not supported by the ground truth. The correct net change of +$423 million implies that new issuances exceeded repayments, but the LLM fails to mention any new issuances and misrepresents the net effect. (3) The multi-hop reasoning is flawed: the question requires combining data on both new issuances and repayments across the year, but the LLM only considers repayments and ignores issuances entirely, leading to an incorrect conclusion. (4) The contextual relevance is partially met as it discusses the correct entity (Costco’s Japanese subsidiary) and financial instrument (Guaranteed Senior Notes), but the core quantitative and qualitative inaccuracies severely undermine the answer’s validity. Thus, the correctness and accuracy scores are very low, with only minimal credit for addressing the right topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 364,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments, and how does this compare to the amount of cash, cash equivalents, and marketable securities held by the company in the U.S. as of December 31, 2024?",
      "original_answer": "3M had $0.5 billion in stand-alone letters of credit, bank guarantees, and other similar instruments issued and outstanding as of December 31, 2024. At the same date, the company held $4.2 billion in cash, cash equivalents, and marketable securities in the United States. Therefore, the stand-alone instruments represent approximately 11.9% of the U.S.-held liquidity.",
      "llm_answer": "3M had about **$0.5 billion** in stand‑alone letters of credit, bank guarantees and similar instruments outstanding at December 31 2024.  At the same date the company held roughly **$4.2 billion** in cash, cash equivalents and marketable securities in the United States.  Thus, the letters‑of‑credit and guarantees represent only about one‑tenth (≈12 %) of the U.S. cash‑and‑securities balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key figures: $0.5 billion in stand-alone instruments and $4.2 billion in U.S. cash, cash equivalents, and marketable securities as of December 31, 2024, matching the ground truth exactly. The percentage comparison is stated as 'about one-tenth (≈12%)', which is semantically equivalent to the ground truth's 'approximately 11.9%'. The minor rounding from 11.9% to 12% is acceptable and common in financial communication. (2) All numbers and dates are accurate. The calculation of the ratio (0.5 / 4.2 ≈ 0.119 or 11.9%) is correctly approximated as ~12%, and both values are properly contextualized. (3) The multi-hop reasoning—linking the value of instruments to the U.S. liquidity position and deriving a comparative percentage—is sound and logically presented. The synthesis across two financial metrics from the same time period (December 31, 2024) is correctly executed. (4) The answer is fully relevant, addressing both parts of the question: the total value of instruments and the comparison to U.S. liquidity. The slight simplification of '≈12%' instead of '11.9%' prevents a perfect 10 but does not affect factual correctness. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 355,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What percentage of Meta's worldwide MAUs were estimated to be duplicate accounts in Q4 2023, and how does this compare to the percentage of false accounts during the same period?",
      "original_answer": "In Q4 2023, duplicate accounts were estimated to represent approximately 10% of Meta's worldwide MAUs, while false accounts were estimated at approximately 4% of worldwide MAUs. This means duplicate accounts were more than twice as prevalent as false accounts during the same period.",
      "llm_answer": "In Q4 2023 Meta estimated that duplicate accounts made up roughly **10 % of its worldwide MAUs**, while false accounts accounted for about **4 % of worldwide MAUs**. Thus, duplicate accounts were estimated to be about **6 percentage points higher (more than twice as large)** as the share of false accounts for that quarter.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that in Q4 2023, duplicate accounts represented approximately 10% of Meta's worldwide MAUs and false accounts represented 4%, matching the ground truth exactly. (2) The quantitative values are accurate—10% and 4%—and the comparison stating that duplicate accounts were '6 percentage points higher' and 'more than twice as large' is mathematically correct (10% is 2.5 times 4%, so 'more than twice' is valid). (3) The reasoning is sound and synthesizes the two percentages appropriately to draw a valid comparative conclusion, fulfilling the multi-hop requirement of comparing both metrics and interpreting their relative magnitude. (4) The answer is semantically equivalent to the original, with no factual errors, omissions, or misstatements. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 255,
        "total_tokens": 1415
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How much did Pfizer pay upfront in cash to BioNTech for the shingles mRNA vaccine collaboration, and how does this compare to the upfront payment made to Biohaven for migraine treatment rights outside the U.S.?",
      "original_answer": "Pfizer paid $75 million upfront in cash to BioNTech for the shingles mRNA vaccine collaboration and $150 million upfront to Biohaven for migraine treatment rights outside the U.S., resulting in a $75 million difference in favor of the Biohaven deal.",
      "llm_answer": "Pfizer’s shingles‑vaccine deal with BioNTech included an upfront cash payment of **$75 million** (part of a $225 million total consideration).  \nBy contrast, the migraine‑treatment collaboration with Biohaven required an upfront cash payment of **$150 million** (part of a $500 million total).  \n\nThus, the BioNTech cash up‑front was **half the amount** of the cash up‑front paid to Biohaven.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all key aspects: (1) It accurately states that Pfizer paid $75 million upfront in cash to BioNTech for the shingles mRNA vaccine collaboration, matching the ground truth. (2) It correctly reports the $150 million upfront payment to Biohaven for migraine treatment rights outside the U.S. (3) The comparison—stating the BioNTech upfront was half the Biohaven upfront—is logically sound and mathematically accurate (75 is half of 150), which aligns with the ground truth's conclusion of a $75 million difference in favor of Biohaven. While the ground truth emphasizes the absolute difference ($75 million), the LLM emphasizes the relative ratio (half), but both are semantically equivalent and correct. The inclusion of total deal values ($225M and $500M) adds context not requested but does not detract from accuracy. All entities (Pfizer, BioNTech, Biohaven), financial figures, and comparisons are correct. The reasoning across two separate collaborations is sound and properly synthesized. The only minor shortcoming is that the LLM does not explicitly state the $75 million difference, which was part of the original answer, but the information is inferable. Thus, quantitative accuracy is perfect, qualitative accuracy is excellent with a minor omission, and contextual relevance is full.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 369,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging instruments and non-hedging instruments?",
      "original_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is $115 million. This includes $110 million from derivatives designated as hedging instruments and $5 million from derivatives not designated as hedging instruments.",
      "llm_answer": "The 10‑K shows that, as of May 31 2024, Nike’s foreign‑exchange forward and option liabilities consist of:\n\n* $120 million recorded as “Liabilities at fair value”  \n* $115 million recorded as “Accrued liabilities – term” (both hedging and non‑hedging)  \n* $5 million recorded as “Other long‑term liabilities”\n\nAdding these components gives a total liability of **$240 million** related to foreign‑exchange forwards and options (including both hedging and non‑hedging instruments).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states the total liability is $115 million ($110 million hedging + $5 million non-hedging), but the LLM claims $240 million by summing unrelated line items ($120M + $115M + $5M). These figures do not align with the correct components from the source. The $120 million 'Liabilities at fair value' and $115 million 'Accrued liabilities – term' appear to be misinterpreted or duplicated, leading to a significant overstatement. (2) Completeness: While the question asks for total liabilities from both hedging and non-hedging instruments, the LLM fails to correctly identify the relevant amounts, instead introducing unverified categories not mentioned in the original answer. (3) Entity Accuracy: The company (Nike) and date (May 31, 2024) are contextually acceptable, but the financial instruments and their classifications are misrepresented. (4) Reasoning: The multi-hop synthesis is flawed—the LLM incorrectly aggregates disparate liability line items without verifying they pertain to foreign exchange forwards and options only, and double-counts values. (5) Semantic Equivalence: The final number ($240M) is more than double the correct total ($115M), and the breakdown does not match the ground truth. Even allowing for format flexibility, the numbers and logic are factually wrong. The only partial credit is for addressing the general topic (FX derivatives liabilities) and including both hedging and non-hedging concepts, hence minimal contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 435,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does PayPal's recognition of a crypto asset safeguarding liability connect to its disclosure of risk concentrations, and what does this imply about the company's exposure to credit risk in relation to customer-held crypto assets?",
      "original_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard cryptocurrencies held on behalf of customers, and it discloses that its cash, cash equivalents, customer accounts, and other financial assets are subject to concentration of credit risk. Since crypto assets held for customers are not PayPal's assets but are safeguarded through a liability mechanism, the company's exposure to credit risk arises not from the crypto assets themselves but from the financial institutions where these customer funds are held. PayPal places these funds in high-quality financial institutions but acknowledges that balances may exceed FDIC insurance limits, creating a credit risk concentration that could impact the company if those institutions fail.",
      "llm_answer": "PayPal records a **crypto‑asset safeguarding liability** (with a matching safeguarding asset) to reflect that the cryptocurrencies it holds are *only* custodial obligations to customers, not its own assets (see page 71). In its **concentrations of risk** disclosure, PayPal notes that cash, cash equivalents and customer accounts—including the assets underlying those accounts—are “potentially subject to concentration of credit risk” and are kept with high‑quality financial institutions, although some balances exceed FDIC insurance limits (page 74). Thus, the crypto‑safeguarding liability is treated as part of the broader customer‑account exposure, meaning PayPal’s credit‑risk exposure to customer‑held crypto depends on the creditworthiness of the third‑party custodians that actually hold the crypto; a concentration of such custodial relationships could increase PayPal’s credit‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies PayPal's crypto asset safeguarding liability as a custodial obligation, not an owned asset, and links it to the risk concentration disclosures. All key facts are present: the liability mechanism, the custodial nature of crypto holdings, the concentration of credit risk in financial institutions, and the fact that balances may exceed FDIC insurance limits. (2) There are no numeric values in the question or answer requiring verification, so quantitative accuracy is not applicable in a strict sense, but no numbers are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes the relationship between the safeguarding liability (accounting treatment) and the credit risk exposure (via custodial institutions), which is the core of the question. It accurately infers that PayPal’s credit risk stems from the third-party financial institutions holding the funds, not the crypto assets themselves. (4) The only minor shortcoming is that the LLM answer slightly reframes the exposure as depending on 'the creditworthiness of the third-party custodians that actually hold the crypto,' while the original answer more precisely states that the funds (supporting the liability) are held in high-quality institutions with potential FDIC coverage gaps. The LLM implies a concentration in custodial *relationships*, which is not explicitly stated in the original—this is a small interpretive leap. However, the overall semantic meaning and factual content are substantially equivalent. The answer is fully contextually relevant and addresses all parts of the multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 460,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How many LTIP units were issued net of forfeitures under the 2019 Plan, and what was the impact of these units on potential stock dilution for the year ended December 31, 2024?",
      "original_answer": "689,202 LTIP units were issued net of forfeitures under the 2019 Plan, and these units were considered potentially dilutive securities. However, they did not have a material dilutive effect on the company's stock for the year ended December 31, 2024.",
      "llm_answer": "The 2019 Stock Incentive Plan granted **689,202 LTIP units net of forfeitures**.  For the year ended December 31, 2024, those LTIP units (along with other potentially dilutive securities) **had no material dilutive effect** on the company’s stock.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that 689,202 LTIP units were issued net of forfeitures under the 2019 Plan, matching the original answer exactly. (2) It correctly identifies that these units were considered potentially dilutive but had no material dilutive effect for the year ended December 31, 2024, which aligns with the ground truth. (3) The multi-hop reasoning is sound—linking the number of units issued under the 2019 Plan to their impact on stock dilution in 2024—demonstrating proper synthesis across time and financial concepts. (4) All entities (2019 Plan, LTIP units, December 31, 2024) are correctly identified and contextualized. Minor wording differences (e.g., 'had no material dilutive effect' vs. 'did not have a material dilutive effect') do not affect factual meaning. All scores are 10 due to complete factual accuracy, correct numbers, proper reasoning, and full relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 279,
        "total_tokens": 1411
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products, and how did this compare to the impact in 2022?",
      "original_answer": "The total financial impact on 3M's earnings per diluted share from manufactured PFAS products was a reduction of $0.20 in 2024 and a reduction of $0.90 in 2022, resulting in a total combined impact of $1.10 over the two years.",
      "llm_answer": "In 2024, the manufactured PFAS‑product item added **$0.28 per diluted share** to earnings (see the “Manufactured PFAS products” line in the earnings‑per‑share reconciliation). In 2022 the same item had contributed **$0.90 per diluted share** (shown in the 2022 earnings‑per‑share table). Thus, the PFAS‑related boost to diluted earnings was **$0.62 per share lower in 2024 than it was in 2022**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains major factual and directional errors. (1) Quantitative Accuracy: The ground truth states that PFAS products reduced earnings per diluted share by $0.20 in 2024 and $0.90 in 2022. The LLM incorrectly claims that PFAS added $0.28 per share in 2024 and $0.90 in 2022, reversing the sign (from reduction to addition). This is a critical error in financial interpretation. Additionally, the $0.28 figure for 2024 does not match the correct $0.20 reduction. (2) Completeness: The question asks for the total impact in 2024 and how it compares to 2022. While the LLM attempts both parts, it misrepresents both values and the nature of the impact (positive vs negative). (3) Entity Accuracy: The company (3M), metric (earnings per diluted share), and years (2024, 2022) are correctly identified. (4) Reasoning: The multi-hop comparison between 2024 and 2022 is attempted, but because the underlying numbers and signs are wrong, the conclusion that the 'boost' was $0.62 lower is based on flawed premises. The term 'boost' incorrectly implies a positive contribution, whereas PFAS had a negative financial impact. (5) Semantic Equivalence: The answer fails to convey the same information—portraying PFAS as a financial benefit rather than a cost fundamentally misrepresents the situation. The calculation of a $0.62 difference is mathematically close (using $0.90 - $0.28), but since both numbers are incorrect in value and sign, it lacks validity. Overall, the answer is mostly incorrect due to wrong numbers and a reversed financial impact direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 427,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the volume changes in KWH sales to affiliates and non-affiliates in 2024, governed by the Intercompany Interchange Contract (IIC), impact the overall wholesale revenue performance for the Southern Company system?",
      "original_answer": "The Southern Company system experienced a $87 million (20.5%) decrease in wholesale revenues from non-affiliate sales due to a 30.8% drop in KWH volume after power agreements ended in May 2023. This was partially offset by a $79 million (131.7%) increase in affiliate sales driven by a 165.5% rise in KWH volume, largely due to increased affiliated energy demand. These affiliate sales were conducted under the IIC approved by FERC, showing that while external market conditions reduced non-affiliate revenue, internal energy transfers under the IIC helped mitigate some of the overall revenue decline.",
      "llm_answer": "In 2024 the Southern Company system’s Intercompany Interchange Contract (IIC) saw wholesale KWH sales to affiliates jump 165.5% (to 5.6 billion KWH) and sales to non‑affiliates fall 30.8% (to 6.5 billion KWH). The surge in affiliate volume lifted affiliate wholesale revenue by $79 million (a 131.7% rise to $139 million), while the drop in non‑affiliate volume cut non‑affiliate wholesale revenue by $87 million (a 20.5% decline to $337 million), leaving total wholesale revenue essentially flat – $476 million in 2024 versus $484 million in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 165.5% increase in KWH volume to affiliates and the resulting $79 million (131.7%) revenue increase, as well as the 30.8% drop in non-affiliate KWH volume leading to an $87 million (20.5%) revenue decline, are all factually consistent with the original answer. The mention of the IIC and its FERC approval is implied through context. (2) Quantitatively, the LLM adds specific volume figures (5.6 billion and 6.5 billion KWH) not present in the ground truth, but these are reasonable inferences and do not contradict known data. The total wholesale revenue calculation ($337M + $139M = $476M) is accurate, and the prior year total of $484M correctly reflects a $8M decrease. These calculations are sound and enhance detail without introducing error. (3) The multi-hop reasoning is strong: the model correctly links volume changes to revenue impacts for both affiliate and non-affiliate sales, recognizes the mitigating role of internal transfers under the IIC, and concludes that overall revenue remained nearly flat—consistent with the original answer’s implication of partial offset. (4) The only minor shortcoming is that the original answer emphasizes the cause of non-affiliate decline (end of power agreements in May 2023), which the LLM omits, and the LLM introduces precise volume numbers and total revenue figures that, while plausible, are not confirmed in the ground truth. However, these do not detract from factual correctness. Overall, the answer is semantically equivalent, contextually complete, and quantitatively precise, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 454,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total financial penalty imposed by the Irish Data Protection Commission alongside the corrective orders related to unlawful data transfers, and how might compliance with these orders affect Meta's operational costs in Europe?",
      "original_answer": "The Irish Data Protection Commission imposed a financial penalty of €1.2 billion alongside the corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and cease the processing of EEA Facebook user data in the United States. Compliance with these corrective orders could increase the cost and complexity of delivering Meta's products and services in Europe, as the company may be required to take additional steps to align its data processing operations with Chapter V of the GDPR.",
      "llm_answer": "The Irish Data Protection Commission levied an administrative fine of **€1.2 billion** on Meta Platforms Ireland together with corrective orders to suspend the unlawful EEA‑to‑U.S. data transfers.  Meta warns that meeting those orders – for example, halting the transfers and re‑engineering its processing activities – would **raise the cost and complexity of delivering its products and services in Europe**, thereby increasing its European operating expenses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitative accuracy: The financial penalty of €1.2 billion is correctly reported, matching the original answer exactly. (2) Completeness: The answer addresses both parts of the question — the total financial penalty and the impact on Meta's operational costs in Europe. (3) Entity accuracy: 'Meta Platforms Ireland' and 'EEA-to-U.S. data transfers' are correctly identified, and the reference to halting transfers aligns with the corrective orders. (4) Reasoning: The LLM correctly synthesizes that compliance (e.g., suspending transfers and re-engineering data processing) would increase cost and complexity, directly reflecting the original answer's reasoning about alignment with GDPR Chapter V. The phrasing 'raise the cost and complexity of delivering its products and services in Europe' is a precise restatement of the original. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 281,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does The Home Depot's emphasis on product depth and job lot quantities specifically support its strategy to meet the needs of professional customers (Pros), and what risks are highlighted in the document if this aspect of competitiveness is not effectively maintained?",
      "original_answer": "The Home Depot emphasizes product depth and job lot quantities to meet the complex purchase needs of professional customers (Pros), who require larger volumes and dedicated sales support. If the company fails to maintain these offerings alongside competitive delivery and pickup options, it could negatively impact demand for products and services and reduce profit margins.",
      "llm_answer": "Home Depot’s strategy for Pros hinges on offering a deep, specialized assortment and the ability to sell “job‑lot” quantities – the breadth of SKUs and bulk‑pack options let professional remodelers, contractors and specialty tradespeople source all the parts they need for complex projects in one place, reinforcing the store as a one‑stop, urgent‑purchase destination for the trade market. The filing warns that if Home Depot cannot sustain that product depth, inventory levels or localized assortment (including job‑lot availability), it could lose Pro loyalty, see a drop in demand and market share, and suffer pressure on pricing and profit margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that The Home Depot's product depth and job lot quantities are key to serving Pros, explaining that these features allow professionals to source all necessary parts for complex projects in one place, which aligns with the original answer's emphasis on meeting complex purchase needs. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM synthesizes the strategic rationale (product depth and job lots support Pros) and correctly infers the risk of not maintaining this capability—loss of demand, margin pressure, and reduced competitiveness—consistent with the original answer’s warning about negative impacts on demand and profit margins. The LLM adds slightly more detail (e.g., 'localized assortment', 'market share', 'pricing pressure'), which are reasonable inferences from the context and do not contradict the source. (4) The only minor deviation is that the original answer specifically ties the risk to the combination of product depth, job lots, and competitive delivery/pickup options, while the LLM omits explicit mention of delivery/pickup. This is a small omission but doesn't undermine the overall correctness. Thus, the answer is semantically equivalent and factually sound, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 405,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures, and what might this exclusion indicate about the complexity of valuing these specific investments?",
      "original_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $177 million ($94 million + $83 million). The exclusion of these interests indicates that the valuation of these specific investments is complex and not easily categorized within the standard fair value hierarchy, likely due to the lack of observable market data or the presence of restrictions that limit the company’s ability to readily redeem these investments.",
      "llm_answer": "The two footnotes show that the participating interest in the insurance annuity contract was **$83 million for 2021** and **$94 million for 2020**, for a combined total of **$177 million** that is excluded from the fair‑value‑hierarchy tables.  This exclusion reflects that the interest is classified as a Level 3 asset—its value is derived from a mix of quoted prices, recent transactions and actuarial present‑value calculations—so it requires significant judgment and modeling, making its valuation far more complex than assets that can be measured directly from observable market prices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the two values of the participating interest in insurance annuity contracts as $94 million for 2020 and $83 million for 2021, and accurately calculates the total as $177 million, matching the ground truth. All numeric values and the sum are correct, with acceptable formatting (e.g., $83 million). (2) The quantitative accuracy is perfect: both amounts are correctly extracted from the respective years, and the addition is accurate. (3) The reasoning is largely sound and correctly infers that the exclusion relates to complexity in valuation. However, the LLM states that the interest is 'classified as a Level 3 asset,' which is not explicitly confirmed in the ground truth and goes slightly beyond the provided information—the original answer notes the exclusion from the hierarchy but does not assign a level. This is a minor overinterpretation but does not invalidate the core reasoning. The explanation about lack of observable market data and need for modeling is consistent with the ground truth's implication of complexity. (4) The answer is contextually relevant, fully addressing both parts of the question: the total value and the implication of exclusion. The slight overreach on Level 3 classification prevents a perfect 10, but the answer remains highly accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 374,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does PayPal's use of loss curves in conjunction with macroeconomic forecasts impact its allowance for credit losses on both merchant and consumer receivables, and what specific macroeconomic factors are applied in each category?",
      "original_answer": "PayPal applies loss curves to both merchant and consumer receivables to estimate the allowance for credit losses, incorporating macroeconomic forecasts. For merchant receivables, the loss curves are applied by geography, delinquency, and origination period, and the macroeconomic factors include forecasted trends in unemployment rates and retail e-commerce sales. For consumer revolving credit receivables, the loss curves are also used, and macroeconomic factors such as forecasted trends in household disposable income and retail e-commerce sales are applied. These macroeconomic inputs directly influence the projected loss rates, which are then applied to the principal amounts of receivables to determine the allowance for credit losses, ensuring that economic conditions are factored into the financial estimates.",
      "llm_answer": "PayPal determines its allowance for credit losses by first applying loss‑curve estimates (which project the expected loss‑rate over the life of each loan) and then adjusting those estimates with forward‑looking macro‑economic scenarios. For merchant receivables the loss curves are over‑ridden by forecasts of **unemployment rates** and **retail e‑commerce sales**, while for consumer receivables the revolving‑credit loss curves incorporate forecasts of **household disposable income** and **retail e‑commerce sales** (and, through early‑2023, also **unemployment rates**). These macro‑adjusted loss‑curve results drive the allowance balances for merchant and consumer portfolios respectively.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key factual elements are correct: PayPal uses loss curves adjusted by macroeconomic forecasts for both merchant and consumer receivables; unemployment and retail e-commerce sales are applied to merchant receivables; household disposable income and retail e-commerce sales are used for consumer revolving credit. The mention of unemployment rates being used for consumer receivables 'through early-2023' adds a time-bound nuance not present in the original answer, but does not contradict it—this could reflect a temporary modeling adjustment and is plausible contextually, though not confirmed in the ground truth. (2) There are no numbers, dates, or financial amounts in the question or answers that require verification; all references are qualitative (e.g., 'unemployment rates', 'retail e-commerce sales'), so quantitative accuracy is fully satisfied. (3) The multi-hop reasoning is sound: the model correctly links loss curves with macroeconomic adjustments and distinguishes between merchant and consumer receivables, applying the correct factors to each. (4) The only minor deviation is the addition of a time qualifier ('through early-2023') for unemployment in consumer modeling, which is not in the original answer and slightly exceeds the provided information, but does not make the response factually incorrect. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 422,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does Costco's investment in the development and protection of Kirkland Signature, as well as its reliance on manufacturing and distribution facilities for private-label items, expose the company to risks that could affect both brand loyalty and gross margin performance?",
      "original_answer": "Costco has invested significantly in the development and protection of its private-label brand, Kirkland Signature, which contributes to higher margins and helps differentiate its merchandise offerings. However, the company relies on processing, packaging, and manufacturing facilities to produce these private-label items, and any disruptions in these operations—such as extreme weather, pandemics, or labor issues—could delay production and delivery. If such disruptions occur, Costco risks inconsistent product availability and quality, which could reduce member acceptance of Kirkland Signature products. Since these products represent a growing portion of overall sales and carry higher margins, any loss of member confidence could negatively impact both brand loyalty and gross margin performance.",
      "llm_answer": "Costco’s large‑scale investment in building and protecting the Kirkland Signature brand means that the company’s reputation and profitability are tightly linked to the brand’s perceived quality, price competitiveness and consistent availability; a loss of member confidence in Kirkland products would diminish loyalty and strip away the higher‑margin premium that private‑label items normally generate【page_8】. At the same time, Costco relies on its own depots and manufacturing/packaging facilities to produce and distribute those private‑label goods, so any disruption—such as extreme weather, labor issues, supply‑chain interruptions or other operational failures—could delay or degrade Kirkland product delivery, hurting member satisfaction and eroding gross‑margin performance【page_11】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Costco's investment in Kirkland Signature enhances margins and differentiation; reliance on manufacturing and distribution facilities introduces operational risks such as extreme weather, labor issues, and supply-chain disruptions; these disruptions could affect product availability and quality, leading to reduced member confidence, lower brand loyalty, and negative impacts on gross margin. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly links investment in Kirkland Signature to brand loyalty and margin performance, and connects operational dependencies to potential risks in supply continuity and quality, synthesizing implications across business strategy and operations. (4) Minor difference: the LLM mentions 'Costco’s own depots' which is slightly more specific than the original answer’s general reference to 'processing, packaging, and manufacturing facilities'—this is a reasonable inference but not explicitly confirmed in the ground truth, hence a small deduction in qualitative accuracy. Otherwise, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 379,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total grant date fair value of the performance-based LTIP units across the 2021 and 2022 LTI Programs, and how does this compare to the time-based restricted stock units granted in those same years?",
      "original_answer": "The total grant date fair value of the performance-based LTIP units for the 2021 and 2022 LTI Programs is $39.0 million ($18.4 million in 2021 and $20.6 million in 2022). In comparison, the time-based restricted stock units granted in those years totaled $11.2 million ($4.3 million in 2021 and $6.9 million in 2022). Therefore, the performance-based LTIP units had a significantly higher total grant date fair value than the time-based restricted stock units across both programs.",
      "llm_answer": "The 2021 and 2022 LTI Programs together carry a grant‑date target value of **$12.2 million + $13.7 million = $25.9 million** for the performance‑based LTIP units.  \n\nIn the same years the company granted time‑based restricted‑stock units with a combined grant‑date fair value of **$4.3 million + $6.9 million = $11.2 million**.  \n\nThus, the performance‑based LTIP units represent roughly **$14.7 million more** in grant‑date fair value than the time‑based RSU awards for 2021‑2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the key financial figures for performance-based LTIP units. The ground truth states the total grant date fair value is $39.0 million ($18.4M in 2021 and $20.6M in 2022), but the LLM reports $12.2M + $13.7M = $25.9M, which is incorrect. These numbers do not match the original data, indicating a failure in retrieving or synthesizing the correct values. The time-based RSU values ($4.3M in 2021 and $6.9M in 2022, totaling $11.2M) are correctly reported. (2) Calculations are arithmetically correct (e.g., $12.2M + $13.7M = $25.9M and $4.3M + $6.9M = $11.2M), but the underlying inputs for performance-based units are wrong, invalidating the comparison. The claimed difference of $14.7M is based on incorrect totals and does not reflect the true difference of $27.8M ($39.0M - $11.2M). (3) The multi-hop reasoning is structurally sound—comparing performance-based LTIPs to time-based RSUs across 2021 and 2022—but fails due to incorrect data retrieval for one of the core components. The model identifies the correct years and award types, showing partial understanding of the required synthesis. (4) Despite correct formatting, logical structure, and accurate handling of the RSU data, the severe inaccuracy in the performance-based LTIP values—central to the question—drastically reduces correctness. The answer is contextually relevant and attempts the right comparison, but the quantitative error undermines the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 412,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total fair value of U.S. municipal securities held by 3M as of December 31, 2024, and how are these securities classified in terms of fair value hierarchy due to their valuation methodology?",
      "original_answer": "As of December 31, 2024, 3M holds $16 million in U.S. municipal securities, which are classified as Level 3 in the fair value hierarchy because their valuation references the carrying value of the corresponding finance lease obligation.",
      "llm_answer": "3M reported **$20 million** of U.S. municipal securities at fair value on its December 31, 2024 balance sheet. Because the valuation of these securities is based on the carrying amount of the related finance‑lease obligations rather than observable market prices, they are classified as **Level 3** fair‑value measurements.【page_82】【page_67】",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the fair value of U.S. municipal securities as $20 million, whereas the ground truth is $16 million. This is a significant quantitative error that affects the overall correctness. However, the classification of these securities as Level 3 in the fair value hierarchy is correct. (2) The dollar amount is off by $4 million, which is not a formatting or rounding difference but a factual inaccuracy. All other numerical references (date: December 31, 2024) are correct. (3) The reasoning for Level 3 classification — that valuation is based on the carrying amount of finance-lease obligations rather than observable market prices — is logically sound and matches the ground truth’s explanation, demonstrating correct multi-hop synthesis between valuation methodology and fair value hierarchy rules. (4) While the qualitative reasoning and contextual relevance are strong, the incorrect dollar figure substantially undermines the answer’s factual accuracy, warranting a mid-range score of 5. The answer is partially correct but contains a key numerical error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 315,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What percentage of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts, and how does this estimation process reflect the challenges in identifying such accounts across encrypted platforms like WhatsApp?",
      "original_answer": "Approximately 3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts. This estimation process reflects challenges in identifying such accounts across encrypted platforms like WhatsApp due to limited visibility and reliance on fewer data signals such as phone numbers and device information, which increases the difficulty of accurate detection at scale.",
      "llm_answer": "Meta estimated that **about 3 % of its worldwide Monthly Active People (MAP) in Q4 2023 were “violating” accounts** — accounts it believes are used for bots, spam or other terms‑of‑service breaches【page_31】.  The company notes that this estimate is based on an internal review of a limited sample and heavy judgment, and it is especially hard to gauge because **WhatsApp’s end‑to‑end encryption gives Meta only limited visibility into user activity**, forcing it to rely on indirect signals (e.g., phone numbers, device data) and making the measurement of violating accounts highly uncertain【page_5】【page_31】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) Quantitatively, the percentage of violating accounts is accurately reported as 3%, matching the original answer exactly. The time period (Q4 2023) and metric (Meta's worldwide Monthly Active People, or MAP) are correctly identified. (2) The explanation of the estimation challenges due to WhatsApp's end-to-end encryption is semantically equivalent to the ground truth: both highlight limited visibility and reliance on indirect signals like phone numbers and device information. The LLM adds valuable context by noting the estimation is based on a limited sample and involves 'heavy judgment,' which enhances accuracy without contradicting the original. (3) Multi-hop reasoning is sound—correctly linking Meta’s aggregate MAP data with the difficulty of detecting violations on encrypted platforms like WhatsApp. (4) All entities (Meta, WhatsApp, Q4 2023, violating accounts) are accurate, and the response addresses both sub-questions: the percentage and the reflection on identification challenges. Wording differs slightly but preserves full factual and semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 326,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty (COVID-19 vaccine) programs as of December 31, 2023?",
      "original_answer": "The total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine and the Comirnaty vaccine programs was $375 million.",
      "llm_answer": "Pfizer’s only upfront cash and equity out‑lays to BioNTech were in the shingles‑vaccine collaboration – a $75 million cash payment plus a $150 million equity investment, for a total of **$225 million**. No upfront cash or equity investment was made by Pfizer for the Comirnaty (COVID‑19) program (the agreement notes that BioNTech paid Pfizer its share of prior development costs, but Pfizer did not provide an upfront or equity payment).【page_76】",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative conclusion. The ground truth states that the total upfront payments and equity investments by Pfizer to BioNTech for both the shingles and Comirnaty programs was $375 million. However, the LLM claims the total is $225 million, citing only the shingles collaboration ($75M cash + $150M equity), and explicitly stating that no upfront or equity payment was made for Comirnaty. This contradicts the ground truth, which includes both programs in the $375M total. Therefore, the model fails to correctly synthesize the multi-hop information across both collaborations. While the individual figures for the shingles program ($75M + $150M) may be accurate, the omission of the Comirnaty-related upfront or equity component (which must account for the remaining $150M to reach $375M) indicates a critical gap in reasoning or data sourcing. The model’s claim that 'no upfront cash or equity investment was made... for the Comirnaty program' directly conflicts with the ground truth and undermines the entire answer. Despite correct entity identification (Pfizer, BioNTech, shingles, Comirnaty) and relevance to the question’s context, the core factual output is wrong, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 351,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over the three-year period from 2019 to 2021, and how did it compare to the net loss reported in the Lower 48 region during the same period?",
      "original_answer": "COP's operations in the EMENA region contributed a total net income of $1 million in 2019, $6 million in 2020, and a net loss of $24 million in 2021, resulting in a cumulative net loss of $17 million over the three-year period. In contrast, the Lower 48 region reported a net income of $402 million in 2019, $804 million in 2020, and a net loss of $8 million in 2021, resulting in a total net income of $1,206 million over the same period. Therefore, the EMENA region underperformed significantly compared to the Lower 48 region, with a difference of $1,223 million in total net results.",
      "llm_answer": "Across 2019‑2021, the Europe‑Middle East‑North‑Africa (EMENA) segment posted a net‑income contribution of **about +$17 million** (a $24 million credit in 2021 offset by $6 million and $1 million impairments in 2020 and 2019).  \nIn the same three‑year span, the Lower 48 segment recorded a **net loss of roughly $1.2 billion** (impairment charges of $8 million in 2021, $804 million in 2020 and $402 million in 2019).  \n\nThus, EMENA’s modest positive contribution contrasts sharply with the large cumulative loss generated by the Lower 48 operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and directional errors. It states that EMENA had a 'net-income contribution of about +$17 million', but the ground truth shows a cumulative net loss of $17 million (sum of $1M income in 2019, $6M in 2020, and -$24M in 2021). The LLM incorrectly frames the $24M 2021 loss as a 'credit' and mislabels prior-year profits as 'impairments', reversing the actual financial reality. For Lower 48, the LLM claims a 'net loss of roughly $1.2 billion', but the ground truth shows a net income of $1,206 million. The LLM incorrectly treats the positive earnings in 2019 and 2020 as 'impairment charges', which is factually wrong—those were net income figures, not losses. (2) Calculation verification: EMENA total = $1M + $6M - $24M = -$17M (LLM says +$17M — sign error). Lower 48 total = $402M + $804M - $8M = $1,206M net income (LLM says $1.2B net loss — direction and magnitude wrong). (3) Multi-hop reasoning is fundamentally flawed: the model fails to correctly identify which numbers are income vs. loss, misclassifies financial events, and inverts the comparison. Instead of showing EMENA underperforming Lower 48, it falsely claims EMENA outperformed with a 'modest positive contribution' vs. 'large cumulative loss' in Lower 48—exactly the opposite of the truth. (4) Scores justified: Correctness is low (2/10) due to complete inversion of results and incorrect totals. Quantitative accuracy is poor (2/10) — all totals and signs are wrong. Qualitative accuracy is low (3/10) — entity names and years are correct, but financial logic and synthesis are deeply flawed. Contextual relevance is moderate (6/10) — the answer addresses the right regions and time frame, but with incorrect interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 476,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024, and how does this change contribute to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' over the same period?",
      "original_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is $3,720 (from $172,912 in 2023 to $169,192 in 2024). This contributes to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' from $195,949 in 2023 to $184,729 in 2024, a total decrease of $11,220. The decrease in 'Other noncontrolling redeemable interests' accounts for approximately 33.1% of the total decline in the combined metric.",
      "llm_answer": "The “Other noncontrolling redeemable interests” fell from $172,912 thousand in 2023 to $169,192 thousand in 2024 – a decrease of **$3,720 thousand (≈ $3.7 million)**.  \n\nThe combined line “Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties” dropped from $195,949 thousand to $184,729 thousand, a decline of **$11,220 thousand (≈ $11.2 million)**; thus, the $3.7 million reduction in other noncontrolling redeemable interests accounts for roughly one‑third of the overall $11.2 million decrease, with the balance driven by the lower value of the 7.5% redeemable preferred units.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar decrease in 'Other noncontrolling redeemable interests' is correctly calculated as $3,720 thousand (from $172,912 to $169,192), and the total decrease in the combined metric is accurately stated as $11,220 thousand (from $195,949 to $184,729). The LLM correctly notes that the $3.7 million reduction accounts for approximately one-third of the total $11.2 million decline, which aligns with the ground truth percentage of ~33.1% (3,720 / 11,220 ≈ 0.331). (2) The answer addresses both parts of the question: the specific decrease in the 'Other' component and its contribution to the overall decrease. (3) All entities—financial line items and years—are correctly identified. (4) The multi-hop reasoning is sound: the model correctly synthesizes data across two line items and two years, computes differences, and interprets the relative contribution. Minor wording differences (e.g., 'one-third' vs '33.1%') do not affect factual accuracy. Number formats ($3,720 thousand, ≈$3.7 million) are acceptable variations. The addition of context about the 7.5% redeemable preferred units, while not in the original, is a reasonable inference and does not detract from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 356,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, and how does this compare to the combined fair value of these two asset categories from the prior year?",
      "original_answer": "The total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $55 million ($31 million in foreign corporate debt + $24 million in asset-backed securities). As of December 31, 2023, the combined fair value of these two assets was $0 million, as both categories had no value reported in that year.",
      "llm_answer": "The fair‑value table (Note 18) shows that at December 31 2024 the company held:\n\n* Asset‑backed securities – $24 million  \n* Foreign corporate debt – $31 million  \n\nCombined, the fair value of these two categories was **$55 million**.\n\nIn the prior year (2023) the fair‑value amounts for both asset‑backed securities and foreign corporate debt were reported as “‑” (i.e., $0), so the combined fair value then was **$0**. Thus, the 2024 total represents a $55 million increase over the prior year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the fair values of foreign corporate debt ($31 million) and asset-backed securities ($24 million) as of December 31, 2024, are correctly reported. The sum ($55 million) is accurate. For 2023, the LLM correctly identifies that both categories were reported as '–' (i.e., $0), leading to a combined value of $0, which aligns with the ground truth. (2) Quantitative accuracy is perfect: numbers match exactly, and the $55 million increase is correctly calculated. Format variations (e.g., $55 million vs $55M) are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model synthesizes data across two asset categories and two years, correctly comparing 2024 to 2023. (4) The answer is complete, addressing both parts of the question: the total fair value in 2024 and the comparison to the prior year. Wording differs slightly but conveys identical meaning. All entities (MMM, correct years, correct asset classes) are accurately identified. No errors in reasoning, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 314,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do technical errors and data limitations in Meta's Family metrics estimation process affect the accuracy of its monthly active people (MAP) and average revenue per person (ARPP) metrics, and by what approximate margin could these metrics vary due to such inaccuracies?",
      "original_answer": "Meta acknowledges that its Family metrics, including monthly active people (MAP) and average revenue per person (ARPP), are based on internal data and are inherently subject to statistical variances, uncertainties, and technical errors in their estimation process. The company uses complex algorithms, machine learning models, and user survey data calibrated against signals like IP addresses and device information to estimate the number of unique individuals using its platforms. These models require significant judgment and are affected by data limitations. Meta estimates that the potential error margin for its Family metrics is generally around 3% of its worldwide MAP. Given that Meta reported approximately 3.3 billion worldwide MAP in 2023, this 3% error margin implies that the actual number of unique users could vary by about 99 million. This level of inaccuracy can significantly affect the reliability of ARPP calculations, which depend on MAP for per-user revenue averaging, and could distort business decisions, investor perceptions, and advertising investments.",
      "llm_answer": "Meta says that the algorithms and data signals used to turn account activity into its Family‑metrics (MAP and ARPP) are “subject to algorithm or other technical errors” and to a variety of data‑limitations (e.g., limited signals from encrypted products, inaccurate IP‑ or self‑reported location data, survey error, etc.). Because of those errors and limitations the company cautions that its MAP and ARPP figures are not exact and may be adjusted when inaccuracies are discovered. Meta estimates that the overall error‑margin for its Family metrics “generally will be approximately 3 % of our worldwide MAP,” so the reported MAP – and the ARPP that is calculated from it – could each vary by roughly three percent from the true values.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Meta acknowledges technical errors and data limitations in its Family metrics estimation, including algorithmic inaccuracies, encrypted product signal limitations, IP/location data issues, and survey error. The 3% error margin on worldwide MAP is correctly stated. (2) Quantitatively, the 3% figure is accurate and matches the original answer; while the LLM does not explicitly calculate the 99 million user variance (3% of 3.3 billion), this omission is minor given that the percentage margin—the core quantitative point—is clearly stated and sufficient for the question's scope. (3) The reasoning is sound: the LLM correctly links the estimation inaccuracies to both MAP and ARPP, noting that ARPP depends on MAP for per-user calculations, thus propagating error. It also correctly identifies the implications of potential adjustments. (4) The answer is contextually complete and relevant, addressing both how the errors affect the metrics and the approximate margin of variation. The only minor shortcoming is the lack of the explicit numerical example (99 million), which slightly reduces completeness but does not undermine the correctness of the core response. Overall, the answer demonstrates strong multi-hop understanding and semantic equivalence to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 381,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does The Home Depot's strategic use of BOPIS, as defined in the glossary, contribute to the fulfillment of 50% of U.S. online orders through stores, as stated in the supply chain section?",
      "original_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store), as defined in the glossary, enables customers to place orders online and pick them up in-store, which directly supports the company's supply chain goal of fulfilling 50% of U.S. online orders through stores. This interconnected retail program is part of a broader set of store-based fulfillment options that enhance customer convenience and optimize inventory distribution across the network.",
      "llm_answer": "The Home Depot’s glossary defines **BOPIS** as “Buy Online, Pickup In Store.” By integrating BOPIS (along with BOSS, BODFS and BORIS) into its omnichannel strategy, the company uses its extensive store network as convenient pickup and fulfillment locations, turning stores into a “last‑mile” hub for online sales. This store‑based pickup capability is a key driver of the metric that “approximately 50 % of our U.S. online orders were fulfilled through a store” (Supply‑Chain section).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately defines BOPIS as 'Buy Online, Pickup In Store' per the glossary, and correctly references the 50% fulfillment metric from the supply chain section. The percentage (50%) is reported accurately, satisfying quantitative accuracy. (2) The answer correctly identifies that BOPIS is a key enabler of store-based fulfillment, turning stores into 'last-mile' hubs, which directly supports the 50% fulfillment goal. (3) The reasoning is sound and reflects multi-hop synthesis between the glossary definition and the supply chain section. While the original answer does not mention BOSS, BODFS, or BORIS, their inclusion in the LLM response does not detract from accuracy, as they are plausible extensions of The Home Depot’s omnichannel strategy and do not contradict the ground truth. (4) The semantic meaning matches the original answer: BOPIS contributes to fulfilling 50% of U.S. online orders through stores by leveraging stores for pickup and fulfillment. The only minor deviation is the inclusion of additional acronyms not in the original, but this does not impair correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to slight over-elaboration, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 371,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Morgan Stanley's approach to recognizing compensation expense for Deferred Cash-Based Compensation (DCP) awards differ from its recognition of carried interest compensation, particularly in terms of timing and the nature of the awards?",
      "original_answer": "Morgan Stanley recognizes compensation expense for DCP awards over the vesting period, adjusted for changes in the fair value of referenced investments selected by employees. In contrast, carried interest compensation is recognized immediately for any portion of carried interest (both realized and unrealized) allocated to employees, without being tied to a vesting schedule. This distinction reflects the different nature of the awards: DCP awards are deferred and tied to vesting conditions, while carried interest compensation is directly linked to performance-based allocations that are recognized as they occur.",
      "llm_answer": "Morgan Stanley spreads the cost of its Deferred Cash‑Based Compensation (DCP) awards over the awards’ vesting periods – expense is measured on the notional award value (adjusted for changes in the fair‑value of the employee‑selected investments) and recognized gradually as each vesting portion matures【page_92】.  In contrast, carried‑interest compensation – which represents both realized and unrealized portions of the firm’s performance‑based fee earnings allocated to employees – is recorded as expense in the period it is allocated, without a vesting‑period deferral【page_92】【page_138】.  Thus, DCP expense is deferred and tied to cash‑based, investment‑linked awards, whereas carried‑interest expense is recognized immediately for fee‑based partnership‑type awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that DCP awards are expensed over the vesting period with adjustments for changes in fair value of employee-selected investments, while carried interest compensation is recognized immediately upon allocation, without vesting. These key qualitative distinctions in timing and nature are preserved. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes the differing accounting treatments based on award type and links them to their structural nature (vesting vs. performance-based allocation). The citations (page_92, page_138) suggest proper grounding in source material. (4) The only minor shortcoming is slight imprecision in phrasing—'fee-based partnership-type awards' is less clear than the ground truth's 'performance-based allocations,' and the explanation of carried interest could be slightly more explicit about it being tied to both realized and unrealized gains. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 362,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, based on the information provided?",
      "original_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, as neither entity reported any such interests redeemable at amounts in excess of fair value.",
      "llm_answer": "Both Simon Property Group and its Operating Partnership report the same amount of noncontrolling redeemable interests in properties that are classified as temporary equity. As of December 31 2024, that amount is **$169,192 thousand (approximately $169.2 million).**",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states that the total amount of noncontrolling redeemable interests classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0. The LLM incorrectly reports this amount as $169,192 thousand ($169.2 million), which directly contradicts the ground truth. (2) The quantitative inaccuracy is severe: the reported figure is not just misstated but entirely fabricated relative to the correct value of $0. There is no indication in the ground truth of any redeemable interests being classified as temporary equity. (3) The multi-hop reasoning failed—the LLM either misidentified the entities' disclosures or incorrectly synthesized data across them. The question requires confirming whether both entities report such interests, and the correct conclusion is that neither does. The LLM instead asserts a specific non-zero value shared by both, which is unsupported. (4) Scores are low because the core factual claim (non-zero amount) is wrong. Contextual relevance is slightly above zero because the answer addresses the right entities and metric type, but with completely inaccurate data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 342,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, and how does this compare to the carrying amount of NEE's special use funds on its consolidated balance sheet for the same date?",
      "original_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is $8,922 million ($8,846 million for NEE and $76 million for FPL). This amount represents the fair value of the special use funds, which are primarily composed of equity and available-for-sale debt securities. However, on NEE's consolidated balance sheet, these special use funds are reported at their carrying amount of $2,505 million as of December 31, 2021. The significant difference between the fair value and carrying amount reflects the accounting treatment where certain investments are carried at fair value, while others are reported at amortized cost or adjusted based on regulatory treatment.",
      "llm_answer": "The 2021 estimated fair‑value of the two funds is:\n\n* NEE’s nuclear‑decommissioning fund assets – **≈ $8,846 million**  \n* FPL’s storm‑damage fund assets – **≈ $76 million**  \n\n**Combined fair‑value = $8,846 m + $76 m ≈ $8,922 million (about $8.9 billion).**  \n\nOn NEE’s consolidated balance sheet the “special use funds” line shows a **carrying amount of $906 million** at December 31 2021.  \n\nThus, the combined fair‑value of the nuclear‑decommissioning and storm funds ($8.9 billion) exceeds the carrying amount of NEE’s special‑use funds by roughly **$8.0 billion**.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the fair value of NEE's nuclear decommissioning fund ($8,846 million) and FPL's storm fund ($76 million), and accurately calculates their combined fair value ($8,922 million), which matches the ground truth. This demonstrates correct multi-hop synthesis of the two fund values and accurate quantitative reasoning for that portion. However, the LLM reports the carrying amount of NEE's special use funds as $906 million, which is incorrect — the ground truth states it is $2,505 million. This is a significant factual error in a key part of the answer. As a result, the comparison claiming a $8.0 billion difference between fair value and carrying amount is also wrong (correct difference is ~$6.4 billion). While the structure, terminology, and intent of the answer are sound and contextually appropriate, the incorrect carrying amount undermines the accuracy of the core comparison asked in the question. The model appears to have either misread or misretrieved the carrying amount, leading to major quantitative inaccuracies despite otherwise correct reasoning and entity identification (NEE, FPL, funds, date).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 323,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the significance of APJC as both a geographic segment in which Cisco operates and as a region tied to Cisco's consolidated financial reporting, and how does this dual role influence Cisco's internal performance measurement?",
      "original_answer": "Cisco reports its operations across three geographic segments: the Americas, EMEA, and APJC. APJC is not only a key operating segment where Cisco generates revenue but also a region whose financial results are fully incorporated into Cisco’s consolidated financial statements. This dual role means that performance metrics such as revenue and gross margin from the APJC segment directly feed into Cisco’s overall financial reporting, even though certain expenses like R&D and restructuring charges are not allocated to the segment for internal management review. Therefore, APJC's financial performance influences both strategic decisions and consolidated earnings.",
      "llm_answer": "APJC (Asia‑Pacific, Japan and China) is one of Cisco’s three primary geographic operating segments. The company’s internal management system and its Chief Operating Decision Maker treat APJC as a distinct segment for allocating sales, reporting revenue and gross‑margin performance, and making resource‑allocation decisions (see page 104). Because the same geographic definition is used in the consolidated financial statements (page 65), APJC’s results are presented both as an internal performance‑measurement unit and as a disclosed segment of the company’s overall financial reporting, allowing management to evaluate APJC’s contribution ‑ in revenue and gross margin ‑ independently of corporate‑level costs while still integrating it into the company‑wide financial picture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: APJC is correctly identified as one of Cisco’s three geographic segments (alongside Americas and EMEA, implied by context), and its role in both internal performance measurement and consolidated financial reporting is accurately described. The answer correctly notes that revenue and gross margin are tracked at the segment level and included in consolidated reporting, while corporate-level expenses like R&D and restructuring are not allocated—this matches the original answer’s emphasis on selective metric inclusion. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations or figures; however, the reference to page numbers (104 and 65) appears to reflect source document accuracy and supports fidelity, even if not part of the core truth. (3) The multi-hop reasoning is sound: the model synthesizes APJC’s dual role in internal management and external reporting, connecting operational segmentation with financial consolidation logic. (4) The only minor shortcoming is that the LLM answer does not explicitly name the other two segments (Americas, EMEA), though this is not strictly required to answer the question about APJC’s significance. It also omits a direct mention that this structure influences strategic decisions—though 'resource-allocation decisions' implies this. These omissions are minor and do not detract from the core correctness. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 468,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What percentage of Verizon Business Group's total revenues in 2024 came from Business Markets and Other, and how does this segment specifically incorporate FWA broadband into its offerings?",
      "original_answer": "Business Markets and Other generated $13.1 billion in revenues in 2024, which represented 44% of the Verizon Business Group's total revenues. This segment incorporates FWA broadband as one of its wireless services, offering fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.",
      "llm_answer": "In 2024 the Business Markets and Other segment generated $13.1 billion of the Business group’s $29.5 billion in total revenue – roughly 44 percent of the Business segment’s revenue.  The segment’s product mix explicitly lists “wireless services (including FWA broadband)” among its offerings, meaning it bundles fixed‑wireless‑access broadband together with other wireless, wireline and networking solutions for small‑ and medium‑size business customers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figures are accurate: $13.1 billion for Business Markets and Other and an implied total Verizon Business Group revenue of $29.5 billion (since $13.1B is 44% of ~$29.77B, and $29.5B is a reasonable rounded figure consistent with filings). The percentage (44%) is correctly stated. (2) The answer addresses both parts of the question: it provides the percentage of revenues from Business Markets and Other and explains how FWA broadband is incorporated into the segment’s offerings. (3) Entities are correct—'Business Markets and Other', 'Verizon Business Group', '2024', and 'FWA broadband' are all accurately referenced. (4) The reasoning is sound: the LLM correctly infers that FWA is part of the wireless services bundle and specifies its target market (small- and medium-size businesses), which aligns with the ground truth’s description of services 'tailored for small and medium businesses'. The phrasing 'bundles fixed-wireless-access broadband together with other wireless, wireline and networking solutions' adds contextual clarity without introducing inaccuracies. All information is semantically equivalent to the original answer, with no factual errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 358,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the total fair value of Abbott's interest rate hedge contracts in 2024, and how does this compare to the total notional amount of all foreign currency forward exchange contracts held by Abbott as of the same date?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $50 million (payable position of $51 million offset by a $1 million receivable position). This is significantly smaller than the total notional amount of all foreign currency forward exchange contracts, which was $23.2 billion as of December 31, 2024.",
      "llm_answer": "At December 31 2024 Abbott’s interest‑rate‑hedge contracts had a net fair‑value liability of about **$50 million** (fair‑value assets $1 million vs. fair‑value liabilities $51 million).  \n\nBy contrast, the company held foreign‑currency forward contracts with a **total gross notional amount of roughly $23.2 billion** (about $7 billion of cash‑flow‑hedged contracts plus $16.2 billion of other forward contracts).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net fair value of Abbott's interest rate hedge contracts is accurately reported as $50 million, with a $51 million liability and $1 million asset, which aligns with the ground truth. The total notional amount of foreign currency forward contracts is correctly stated as $23.2 billion. (2) The breakdown of the $23.2 billion into $7 billion (cash-flow-hedged) and $16.2 billion (other) is consistent with the knowledge graph data, even though the original answer only states the total—this additional detail does not contradict but rather enriches the response. (3) The multi-hop reasoning is sound: the model correctly identifies and synthesizes data across two different derivative instruments (interest rate hedges vs. foreign exchange forwards) for the same company (Abbott) and same date (December 31, 2024). (4) All entities—Abbott, 2024, interest rate hedges, foreign currency forwards—are correctly identified and contextualized. The comparison between the $50 million fair value (a net liability) and the $23.2 billion notional amount is logically presented and semantically equivalent to the original answer. Minor wording differences (e.g., 'net fair-value liability' vs. 'total fair value') do not affect factual accuracy, as the net value correctly reflects the economic position. All scores are maximized due to full factual correctness, completeness, and appropriate synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 410,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What does the relationship between proved undeveloped reserves and net acreage in Asia suggest about Equity Companies' development potential in the region, and how does this compare to their consolidated subsidiaries' efficiency in utilizing land for reserves?",
      "original_answer": "Equity Companies in Asia reported 1,503 million barrels of proved undeveloped reserves against 19 thousand net acres. This results in a reserves-to-acre ratio of approximately 79.1 million barrels per thousand acres. In comparison, XOM's consolidated subsidiaries in Asia reported 1,315 million barrels of proved undeveloped reserves against 640 thousand net acres, yielding a reserves-to-acre ratio of approximately 2.05 million barrels per thousand acres. This indicates that Equity Companies are significantly more efficient in terms of reserves per acre in Asia, suggesting a potentially higher development potential in the region.",
      "llm_answer": "The equity‑company portfolio in Asia holds only about 19 thousand net undeveloped acres (page 22) but is backed by roughly 1.5 billion oil‑equivalent barrels of proved undeveloped reserves (page 10), giving a reserve density of roughly 79 million barrels per thousand acres – a very high reserve‑per‑acre ratio that points to strong development potential on relatively little land. In contrast, the consolidated‑subsidiary portfolio controls about 227 thousand net undeveloped acres (page 22) and contains about 1.3 billion barrels of proved undeveloped reserves (page 10), or only about 5‑6 million barrels per thousand acres, indicating a far lower efficiency of land use for reserves.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the high reserve density of Equity Companies in Asia (1.5 billion barrels on 19 thousand acres ≈ 79 million barrels per thousand acres), which aligns with the ground truth (1,503 million barrels, ratio ~79.1 million). However, it significantly misstates the consolidated subsidiaries' net acreage: the LLM claims 227 thousand net acres, while the ground truth is 640 thousand net acres. This leads to an incorrect reserves-to-acre ratio for consolidated subsidiaries: LLM calculates ~5–6 million barrels per thousand acres, whereas the correct value is ~2.05 million (1,315 million / 640 thousand). The LLM also refers to 'XOM's consolidated subsidiaries' as 'the consolidated-subsidiary portfolio' without naming XOM, which may reduce entity clarity. (2) Calculation verification: Equity Companies ratio: 1,503 / 19 = 79.1 — LLM approximates this correctly as ~79 million. Consolidated: 1,315 / 640 = 2.05 — LLM incorrectly uses 227 thousand acres (1,315 / 227 ≈ 5.8), leading to a more than 2x overstatement of efficiency. (3) Multi-hop reasoning: The model correctly compares reserve density between equity companies and consolidated subsidiaries to assess development potential and land-use efficiency. However, due to the incorrect acreage figure, the comparison is quantitatively flawed, undermining the conclusion's accuracy. (4) Correctness score is 6 due to major quantitative error in consolidated subsidiary acreage and resulting ratio, though core reasoning and direction of comparison (Equity Companies more efficient) are correct. Quantitative accuracy is penalized heavily (5/10) for the wrong acreage and miscalculated ratio. Qualitative accuracy is moderate (7/10) — logic and structure are sound, but entity and data precision issues exist. Contextual relevance is high (9/10) — the answer directly addresses the question’s intent and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 517,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the significance of the Parent Company's unconditional guarantee of securities issued by Morgan Stanley Finance LLC, and how does this guarantee relate to the Firm's broader obligations under its amended and restated support agreement in the context of a resolution scenario?",
      "original_answer": "The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary, which ensures that these securities are backed by the full credit of the Parent Company. In the context of a resolution scenario, the Parent Company is also obligated under an amended and restated support agreement to contribute all of its contributable assets to its supported entities and/or the Funding IHC. The Funding IHC, in turn, would be obligated to provide capital and liquidity to its supported entities. These mechanisms are interconnected, as the guarantee of Morgan Stanley Finance LLC's securities represents one of the Parent Company's financial commitments that could be called upon during a resolution event, and the support agreement formalizes the process for distributing capital and liquidity across the organization during such a scenario.",
      "llm_answer": "The Parent Company’s unconditional guarantee means that, if Morgan Stanley Finance LLC were unable to meet the principal or interest on its issued securities, the Parent would be required to pay those obligations in full – it is the only subsidiary that backs those securities.  This guarantee is a concrete example of the Parent’s broader “support” commitment: under the Firm’s amended and restated support agreement, the Parent must contribute all of its contributable assets to its material entities (including the wholly‑owned Funding IHC) in a resolution scenario, and those contributions are secured on a senior basis by the Parent’s assets.  Thus, the Finance‑LLC guarantee is part of the overall framework that obligates the Parent to provide capital and liquidity to its subsidiaries to preserve stability and satisfy the resolution plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Parent Company's unconditional guarantee of Morgan Stanley Finance LLC's securities ensures full backing by the Parent, and this guarantee is linked to the broader support agreement requiring contribution of contributable assets in a resolution scenario. The role of the Funding IHC in receiving assets and providing capital to supported entities is accurately described, though slightly less explicitly than in the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly connects the specific guarantee of Morgan Stanley Finance LLC to the broader support agreement and resolution framework, recognizing that the guarantee is one component of the Parent’s overall obligation to provide capital and liquidity. The synthesis across entities (Parent, Finance LLC, Funding IHC, supported entities) is logically coherent. (4) Minor deduction in qualitative accuracy due to slightly less clarity on the Funding IHC’s obligation to *provide* capital downstream—this is implied but not explicitly stated in the LLM answer. Otherwise, the answer is contextually complete, semantically equivalent, and directly addresses both parts of the multi-hop question: the significance of the guarantee and its relationship to the support agreement in resolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 424,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does the Bipartisan Budget Act of 2015's partnership tax audit rules potentially affect Simon Property Group's (SPG) financial obligations through its joint venture investments, including those managed by third parties such as Klépierre and The Taubman Realty Group, LLC?",
      "original_answer": "The Bipartisan Budget Act of 2015 introduced partnership tax audit rules that assess taxes, interest, or penalties at the partnership level for audit adjustments to income, gain, loss, deduction, or credit items. Simon Property Group (SPG), through its investments in 84 joint venture properties and entities like Klépierre and The Taubman Realty Group, LLC, could be required to bear the economic burden of these taxes, interest, and penalties even though SPG and its subsidiary REITs may not otherwise have been subject to additional corporate-level taxes had they owned the assets directly. This financial exposure arises because SPG applies the equity method of accounting to these joint ventures, and as a direct or indirect partner, SPG may be liable for partnership-level assessments without the ability to opt out of the rules, potentially resulting in material adverse effects on SPG's financial position.",
      "llm_answer": "The 2015 Bipartisan Budget Act requires that any IRS audit adjustment to a partnership’s income, loss, deduction or credit be taxed, with interest and penalties, at the partnership level. Because Simon’s Operating Partnership and its subsidiary partnerships (including the joint‑venture interests that are accounted for under the equity method – e.g., its stakes in Klépierre‑managed and The Taubman Realty Group‑managed ventures) are treated as partnerships, an audit‑related adjustment could generate additional tax, interest and penalty liabilities that Simon, as a direct or indirect partner, would have to pay. Consequently, these partnership‑level obligations could increase Simon’s cash outflows and overall financial obligations on its joint‑venture investments, even though the REIT itself would not otherwise incur corporate‑level tax.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Bipartisan Budget Act of 2015, partnership-level tax assessments, inclusion of interest and penalties, and the application to Simon Property Group’s joint ventures (including those managed by Klépierre and The Taubman Realty Group, LLC) are all correctly identified. (2) Quantitative accuracy is perfect—there are no numerical claims requiring verification (e.g., number of joint ventures), and the absence of incorrect figures supports accuracy. The original answer mentions '84 joint venture properties,' which the LLM omits, but this is a minor completeness issue rather than a quantitative error. (3) The multi-hop reasoning is sound: the LLM correctly links the Act’s rules → partnership-level taxation → SPG’s status as a partner in equity-method joint ventures → potential financial liability despite REIT status. The logic that SPG could face cash outflows due to partnership-level taxes, even without direct corporate taxation, is correctly synthesized. (4) Semantic equivalence is strong—wording differs but meaning aligns closely with the original. The only minor gap is the lack of explicit mention of SPG’s inability to opt out of the rules, which slightly weakens completeness but does not undermine the core accuracy. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 399,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Lockheed Martin's investment impairment in AMMROC in 2020 and restructuring charges in RMS in 2021 collectively impact net earnings and per-share results in those respective years?",
      "original_answer": "Lockheed Martin's noncash impairment charge of $128 million in 2020 on its investment in AMMROC decreased net earnings from continuing operations by $96 million, or $0.34 per share after tax. In 2021, Lockheed recorded a $36 million severance and restructuring charge ($28 million, or $0.10 per share after tax) associated with plans to close and consolidate facilities and reduce the workforce within the RMS business segment. Together, these events reduced net earnings by $96 million in 2020 and $28 million in 2021, with per-share impacts of $0.34 and $0.10, respectively.",
      "llm_answer": "- In 2020, a non‑cash impairment on the AMMROC equity‑method investment was recorded for $128 million (about $96 million after tax), which cut net earnings from continuing operations by roughly $96 million and lowered diluted earnings per share by about **$0.34**.  \n\n- In 2021, Lockheed Martin booked severance and restructuring charges of $36 million in its RMS segment (about $28 million after tax), which reduced net earnings by roughly $28 million and trimmed diluted earnings per share by about **$0.10**.  \n\nTogether, the two items shaved roughly $124 million from net earnings across the two years and reduced EPS by $0.44 in the respective periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $128 million noncash impairment in 2020 related to AMMROC, with accurate after-tax impact of $96 million on net earnings and $0.34 per share. It also correctly reports the 2021 RMS restructuring charge of $36 million pre-tax, $28 million after tax, reducing EPS by $0.10. All numeric values match the ground truth exactly in amount and year. (2) Calculations are accurate: the after-tax amounts are correctly derived and reported, and the total reduction in net earnings across years ($96M + $28M = $124M) and combined EPS impact ($0.34 + $0.10 = $0.44) are mathematically correct. (3) Multi-hop reasoning is sound—information is synthesized across two different years, business segments (AMMROC and RMS), and types of charges (impairment vs. restructuring), correctly attributing each to the right entity and time period. (4) The only minor shortcoming is that the original answer specifies 'net earnings from continuing operations' for the 2020 charge, while the LLM uses the slightly more general 'net earnings'; this is a subtle but acceptable simplification that does not distort meaning. Otherwise, the answer is factually complete, contextually precise, and semantically equivalent to the ground truth. Hence, high scores across all categories with a 9 on correctness due to slight imprecision in financial statement specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 387,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the year-over-year change in the balance of channel partner financing subject to guarantees, and how does this relate to Cisco's overall liquidity and capital resource requirements as stated in the MD&A section?",
      "original_answer": "The balance of channel partner financing subject to guarantees decreased from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, representing a year-over-year decrease of $0.5 billion. Cisco states in its MD&A that it believes its cash and cash equivalents, investments, and cash generated from operations will satisfy its liquidity requirements, including working capital needs, capital expenditures, investment requirements, and commitments such as financing guarantees. This indicates that despite the decrease in guaranteed financing balances, Cisco remains confident in its ability to support such obligations through existing resources.",
      "llm_answer": "The balance of channel‑partner financing that is subject to Cisco’s guarantees fell from **$1.7 billion at July 29 2023 to $1.2 billion at July 27 2024**, a year‑over‑year decline of **$0.5 billion**.  Cisco notes in its MD&A that its cash, cash equivalents, investments, operating cash flow and access to capital markets and credit facilities are expected to meet all liquidity and capital‑resource requirements—including working‑capital needs, debt service, acquisitions and customer financings—over the next 12 months, so the modest reduction in guaranteed financing does not jeopardize its overall liquidity position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the year-over-year change in channel partner financing subject to guarantees, stating a decrease from $1.7 billion to $1.2 billion, amounting to a $0.5 billion decline, which matches the ground truth. The fiscal dates (July 29, 2023, and July 27, 2024) are consistent with Cisco's fiscal year-end timing and do not contradict the original answer's use of 'fiscal 2023' and 'fiscal 2024'. (2) All numeric values and the calculation of the $0.5 billion decrease are accurate. Format variations (e.g., $1.7 billion vs $1.7 billion) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly links the quantitative change in guaranteed financing to Cisco’s broader liquidity position as discussed in the MD&A. It accurately reflects Cisco’s assertion that existing resources (cash, investments, operating cash flow, capital markets access) are sufficient to meet liquidity and capital requirements, including guarantees. The phrase 'modest reduction' is interpretive but reasonable given the context and does not distort the meaning. (4) The answer is fully contextually relevant, addressing both the quantitative change and its implication for liquidity. The only minor deviation from the original answer is the addition of 'access to capital markets and credit facilities' and 'debt service, acquisitions', which are not in the ground truth but are plausible inclusions from Cisco’s MD&A and do not introduce inaccuracies. Overall, the answer is factually correct, well-reasoned, and semantically aligned with the original, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 449,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories in the 2024 10-K filing of VZ, and which category has the higher value?",
      "original_answer": "The difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories is $2,653 million. The first asset category reports 'Investments measured at NAV' at $2,656 million, while the second reports it at $3 million. Therefore, the first category has the higher value.",
      "llm_answer": "The 2024 filing shows that the pension‑plan assets include **$4,432 million** measured at NAV, while the other post‑retirement benefit‑plan assets include only **$5 million** measured at NAV. The difference between the two categories is **$4,427 million**, with the **pension‑plan category having the higher NAV value**【page_94】【page_95】",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in terms of quantitative accuracy. According to the ground truth, the two values for 'Investments measured at NAV' are $2,656 million and $3 million, resulting in a difference of $2,653 million, with the first category having the higher value. However, the LLM reports $4,432 million and $5 million, yielding a difference of $4,427 million, which does not match the ground truth. These numbers appear to be fabricated or extracted from an incorrect source. While the LLM correctly identifies that one category (pension-plan assets) has a much higher value than the other and attempts the correct calculation type (difference), the underlying data is wrong. The entities mentioned (pension-plan vs. other post-retirement benefit-plan assets) may be contextually relevant categories in a 10-K filing, but they are not the correct categories as defined in the ground truth (which refers to two unspecified but distinct asset categories). The reasoning structure is sound—comparing two categories, computing a difference, and identifying the larger one—but the multi-hop synthesis fails because the input data is incorrect. The answer is semantically relevant and addresses the question format properly, hence moderate contextual relevance, but factual correctness is severely lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 366,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does Abbott's production focus on Diabetes Care Devices, as stated in its 2024 10-K filing, relate to the 18.1% revenue increase in its Diabetes Care business, and what accounting policy supports the recognition of this revenue?",
      "original_answer": "Abbott's Diabetes Care business generated $6.805 billion in revenue in 2024, representing an 18.1% increase from the prior year. This growth aligns with Abbott's core business of producing health care products, including Diabetes Care Devices. The revenue from these devices is recognized upon the transfer of control, which occurs upon shipment or delivery, depending on the customer contract terms. This revenue recognition policy ensures that sales from Diabetes Care Devices are recorded in the period when control is transferred to the customer, supporting the reported increase in revenue.",
      "llm_answer": "Abbott’s 2024 10‑K notes that the company is concentrating its manufacturing effort on Diabetes Care devices—particularly its continuous‑glucose‑monitor (CGM) systems—and that this focus drove a strong rise in Diabetes Care sales, which grew 18.1 % year‑over‑year (from $5.8 billion in 2023 to $6.8 billion in 2024). The revenue from those device sales is recorded under the company’s “Revenue Recognition” policy, which requires product‑sale revenue to be recognized when control transfers to the customer, typically at shipment or delivery (see Note 1, Revenue Recognition).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly states the 18.1% year-over-year revenue growth in Abbott's Diabetes Care business and provides approximate revenue figures: $6.8 billion in 2024 (vs. ground truth $6.805 billion) and $5.8 billion in 2023. The $5.8B to $6.8B increase at 18.1% growth is directionally accurate—actual calculation from $5.8B to $6.8B is ~17.2%, but the 18.1% figure matches the ground truth, suggesting the LLM rounded the dollar amounts for simplicity. The slight rounding down of $6.805B to $6.8B is acceptable under format variation. (2) The answer addresses all parts of the question: it links Abbott’s production focus on Diabetes Care Devices (specifically CGMs) to the 18.1% revenue increase and correctly identifies the revenue recognition policy—transfer of control at shipment or delivery—as per Note 1 of the 10-K. (3) Entity accuracy is strong: Abbott, 2024 10-K, Diabetes Care business, and correct accounting policy are all properly identified. (4) Multi-hop reasoning is sound: the model connects production focus → sales growth → revenue recognition policy, synthesizing operational and accounting information. The only minor shortcoming is the omission of the exact $6.805B figure and slightly imprecise backward calculation from 18.1% growth, but not enough to undermine correctness. Overall, the answer is factually solid, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 413,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does The Home Depot's emphasis on project planning tools influence its competitive positioning with Pros, based on the specific customer expectations outlined in both sections of the 2024 10-K filing?",
      "original_answer": "The Home Depot's emphasis on project planning tools directly supports its competitive positioning with Pros by addressing their specific needs for dedicated sales support, product depth, and job-lot quantities for complex purchase needs, as outlined in both sections of the 2024 10-K. This focus enhances the interconnected shopping experience, which is critical for retaining and attracting Pros who require tailored solutions and streamlined purchasing processes.",
      "llm_answer": "Home Depot’s 2024 filing says that professional customers “look for … project‑planning tools” as part of the capabilities they need for complex jobs (Item 1 – Competition, p. 14). By investing in and highlighting those tools, Home Depot directly satisfies a key Pro expectation, differentiating its offering from other retailers and strengthening its competitive position in the Pro market. This focus on project‑planning tools therefore helps the company win and retain Pro business and improves its overall market standing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies that The Home Depot's 2024 10-K (specifically Item 1 – Competition, p. 14) states Pros look for project-planning tools for complex jobs, which is a key customer expectation. The reasoning correctly links the emphasis on these tools to competitive positioning by satisfying Pro needs, helping win and retain business. This matches the original answer’s core claim about addressing Pro needs for complex purchasing. The LLM answer is slightly less detailed than the ground truth in not explicitly mentioning 'dedicated sales support, product depth, and job-lot quantities' or the 'interconnected shopping experience,' but it captures the essential multi-hop logic: Pro expectations → project-planning tools → competitive advantage. No numbers, dates, or entities are incorrect (quantitative accuracy is perfect). Wording differs but meaning is semantically equivalent. Minor deduction in qualitative accuracy due to less comprehensive synthesis of all elements from both sections of the 10-K, but the main reasoning chain is sound and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 322,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024?",
      "original_answer": "The total number of shares available for award under the three plans is 56,689,904. This includes 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer LTIP.",
      "llm_answer": "As of December 31 2024, the company had **56,689,904 shares** available for award – 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non‑Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer Natural Resources Company Amended and Restated 2006 Long‑Term Incentive Plan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: 47,088,821 shares for the 2003 Incentive Program, 238,700 for the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 for the 2006 Long-Term Incentive Plan, which sum to 56,689,904 shares—exactly matching the ground truth total. (2) The quantitative accuracy is perfect; all numbers are correctly reported and the sum is accurate. Minor formatting differences (e.g., 'Long Term' vs. 'Long-Term') are acceptable and do not affect meaning. (3) The reasoning is sound: the model correctly synthesized the share counts across three distinct plans and provided the total, demonstrating proper multi-hop synthesis. (4) The entities (plan names, years) are correctly identified and matched to their respective share counts. The answer is semantically equivalent to the original, with only minor stylistic differences in punctuation and spacing. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 289,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the impact of the reclassification of Customer receivables in 2023 on both interest income and interest expense in the Institutional Securities segment, and which specific financial adjustment amount is explicitly tied to this change?",
      "original_answer": "The reclassification of Customer receivables in 2023 resulted in a $4,432 million decrease to both interest income and interest expense in the Institutional Securities segment. This adjustment had no effect on net interest income but was entirely recorded within the Institutional Securities segment as part of aligning prior-year amounts to the current presentation.",
      "llm_answer": "The 2023 re‑classification of Customer receivables caused a **$4.432 billion reduction in both interest income and interest expense** for the year, with the entire effect recorded in the Institutional Securities segment. The specific adjustment tied to this change is a **$4,432 million decrease** applied to each line item.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the reclassification in 2023 led to a $4,432 million (i.e., $4.432 billion) decrease in both interest income and interest expense within the Institutional Securities segment. The use of 'billion' vs. 'million' is numerically consistent ($4.432 billion = $4,432 million), so format variation is acceptable. (2) Quantitatively, the numbers match exactly when adjusted for unit representation—$4,432 million is correctly stated and explicitly tied to both line items. (3) The reasoning is sound: the answer correctly identifies that the adjustment was entirely within the Institutional Securities segment and implies no net effect on net interest income by showing equal reductions, even if not explicitly stated. (4) The response addresses all parts of the multi-hop question: the impact on interest income and expense, the year (2023), the segment (Institutional Securities), and the specific financial adjustment amount. No critical information is missing, and the synthesis across entities is accurate. Therefore, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 327,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What were the total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined, and what types of contracts are included in the category of net investment hedge derivatives according to the disclosures?",
      "original_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were $208 million ($133 million in 2019 and $75 million in 2021). According to the disclosures, net investment hedge derivatives include cross-currency interest rate swaps and forward contracts.",
      "llm_answer": "The disclosures state that the amounts excluded from hedge‑effectiveness for net‑investment‑hedge derivative contracts were **$75 million for 2021** and **$133 million for 2019**, for a combined total of **$208 million**.  \n\nNet‑investment‑hedge derivatives are defined as **cross‑currency interest‑rate swaps and forward contracts** (used, together with certain non‑U.S.‑dollar debt, to hedge net investments in non‑U.S. operations).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the amounts excluded from hedge effectiveness are accurately reported as $133 million in 2019 and $75 million in 2021, with a correct combined total of $208 million. The calculation (133 + 75 = 208) is accurate. (2) The types of contracts included in net investment hedge derivatives—cross-currency interest rate swaps and forward contracts—are correctly identified and match the original answer. The additional context about their use with non-U.S. dollar debt to hedge non-U.S. operations is consistent with disclosures and adds clarity without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesized data from two different years (2019 and 2021) and linked the financial amounts to the correct derivative contract types based on the same disclosure source. (4) The answer is semantically equivalent to the ground truth, with no factual discrepancies, omissions, or misstatements. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 299,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021, and how does this relate to the maximum aggregate outstanding balance observed during the year ended December 31, 2021?",
      "original_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021 is $9.5 billion. This is calculated as $5.0 billion for the Credit Facility (initial $4.0 billion plus an optional $1.0 billion increase) and $4.5 billion for the Supplemental Facility (initial $3.5 billion increased to $4.5 billion). The maximum aggregate outstanding balance observed during the year ended December 31, 2021, was $2.1 billion, which is significantly lower than the total borrowing capacity, indicating conservative leverage usage.",
      "llm_answer": "After the 2021 amendments, the Credit Facility’s total aggregate size was increased to **$5.0 billion** and the Supplemental Facility’s borrowing capacity could be raised to **$4.5 billion**, giving a combined borrowing capacity of **$9.5 billion**.  During 2021 the highest amount actually drawn under the two facilities was **$2.1 billion**, well below the $9.5 billion total capacity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $5.0 billion for the Credit Facility, $4.5 billion for the Supplemental Facility, resulting in a combined capacity of $9.5 billion, and the maximum aggregate outstanding balance of $2.1 billion during 2021. These values match the original answer exactly, with acceptable formatting (e.g., $5.0 billion). (2) The answer addresses both parts of the multi-part question: it states the total combined borrowing capacity post-amendment and compares it to the maximum outstanding balance observed in 2021. (3) Entity accuracy is correct—Simon Property Group, Credit Facility, Supplemental Facility, and the year 2021 are all properly identified. (4) The reasoning is sound: the LLM correctly synthesizes the amended capacities and draws the implicit conclusion that actual usage ($2.1B) was well below capacity ($9.5B), indicating conservative leverage, even if not explicitly stated. The semantic meaning and factual content are equivalent to the ground truth. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 312,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the increase in risk retirements on Black Hawk and CH-53K helicopter programs in 2021 contribute to the overall increase in RMS' operating profit, and what was the specific dollar amount of this contribution?",
      "original_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs contributed $140 million to the overall increase in RMS' operating profit in 2021. This, along with other factors like higher production volume and lower charges on the CRH program, led to a total $183 million (11%) increase in RMS' operating profit compared to 2020.",
      "llm_answer": "The higher risk‑retirements on the Sikorsky Black Hawk and CH‑53K helicopter programs added roughly **$140 million** to Rotary and Mission Systems’ operating profit in 2021. That gain was the main driver of the segment’s overall operating‑profit increase of $183 million (about an 11% rise) for the year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the $140 million contribution from risk retirements on the Black Hawk and CH-53K programs is correctly stated, matching the original answer exactly. The overall increase in RMS' operating profit of $183 million (11%) is also accurately reported. (2) Quantitative accuracy is perfect: both dollar amounts and the percentage increase are correct, with acceptable formatting variations (e.g., using 'about an 11% rise' vs '11%'). (3) The multi-hop reasoning is sound—the model correctly identifies the specific programs (Black Hawk and CH-53K), links their risk retirements to the profit contribution, and situates this within the broader context of RMS' overall profit increase. (4) The answer is contextually relevant, directly addressing both parts of the question: the contribution amount and its role in the overall profit increase. Minor wording differences (e.g., 'main driver' vs 'along with other factors') do not affect factual correctness, as the original answer also positions the $140M as a major component of the $183M increase.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 327,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas in 2021, and how did this compare to the combined impact in 2019?",
      "original_answer": "The total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas was a loss of $144 million in 2021. In 2019, the combined impact was a gain of $233 million. This represents a difference of $377 million between the two years.",
      "llm_answer": "In 2021 the energy‑related derivatives reduced Southern Company’s natural‑gas results by a total of **$144 million** (a $117 million hit to natural‑gas revenues plus a $27 million hit to cost of natural gas). By contrast, in 2019 the same derivatives produced a **$233 million** net gain (a $223 million boost to revenues and a $10 million increase to cost of gas).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total financial impact in 2021 as a $144 million loss and the 2019 combined impact as a $233 million gain, matching the ground truth. It further breaks down the 2021 loss into $117 million reduction in revenues and $27 million increase in cost of natural gas, and the 2019 gain into $223 million revenue boost and $10 million cost increase. These component figures are not present in the original answer but are consistent with the total impacts and plausible as a detailed breakdown. Since the ground truth does not contradict them and the totals match, this additional detail does not reduce accuracy. (2) All key numbers—$144 million loss in 2021 and $233 million gain in 2019—are factually correct. The comparison between years is implied and accurate, though the LLM does not explicitly calculate the $377 million difference as stated in the original answer. This omission is minor given that the two main figures are provided and the difference can be easily inferred. (3) The multi-hop reasoning is sound: the model correctly synthesizes the impact of derivatives on both revenues and costs for two different years and attributes them to Southern Company (SO). Entity identification (company, years, financial metrics) is accurate. (4) The answer is semantically equivalent to the ground truth, with slightly more granular detail. The only minor shortcoming is the lack of explicit mention of the $377 million year-over-year difference, which slightly affects completeness. However, the core facts, calculations, and synthesis are correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 445,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the change in Cisco's losses from privately held investments between 2023 and 2024, and how did this impact the overall net gains (losses) on investments?",
      "original_answer": "Cisco's losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, resulting in a $29 million improvement. This improvement contributed to the overall net gains (losses) on investments improving from a loss of $177 million in 2023 to a loss of $166 million in 2024, a $11 million positive shift.",
      "llm_answer": "Cisco’s loss on privately‑held investments improved from a $193 million loss in fiscal 2023 to a $164 million loss in fiscal 2024 – a $29 million reduction in the loss.  That helped shrink the company’s overall net loss on investments from $177 million in 2023 to $166 million in 2024, a $11 million improvement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: Cisco's losses from privately held investments were $193 million in 2023 and $164 million in 2024, representing a $29 million improvement, which is correctly calculated (193 - 164 = 29). The overall net gains (losses) on investments improved from a $177 million loss in 2023 to a $166 million loss in 2024, a $11 million positive shift, which is also accurately reflected. (2) Quantitative accuracy is perfect: all dollar amounts and the resulting differences are correct, with acceptable formatting (e.g., $193 million vs $193 million). (3) The multi-hop reasoning is sound—the LLM correctly identifies the change in losses from privately held investments and explains how this contributed to the improvement in overall net investment performance. (4) The answer is semantically equivalent to the original, using slightly different phrasing (e.g., 'reduction in the loss' vs 'improvement') but preserving precise meaning. All entities (Cisco, privately held investments, fiscal years 2023 and 2024, net gains/losses) are correctly identified and contextualized. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 338,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What was the total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024, and how does this compare to the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024?",
      "original_answer": "VZ made a total principal repayment of $4.5 billion in 2024 in connection with anticipated redemptions of ABS Notes. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, was $8.0 billion and $5.0 billion, respectively. Therefore, the total outstanding balance across both facilities was $13.0 billion, which is significantly higher than the $4.5 billion in principal repayments made during the year.",
      "llm_answer": "In 2024 Verizon repaid **about $4.5 billion** of principal in connection with anticipated redemptions of its asset‑backed securities.  At the same date the two asset‑backed loan facilities held **approximately $13.0 billion** of outstanding balances (the 2021 facility at $8.0 billion plus the 2022 facility at $5.0 billion).  Thus, the 2024 repayment represents roughly one‑third of the combined outstanding balance of the two ABS financing facilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the principal repayment of $4.5 billion in 2024 is accurately reported. The outstanding balances of the 2021 and 2022 ABS Financing Facilities are correctly stated as $8.0 billion and $5.0 billion, respectively, and their sum ($13.0 billion) is accurate. (2) The comparison between the $4.5 billion repayment and the $13.0 billion total outstanding balance is correctly framed, with the LLM noting that the repayment represents roughly one-third of the combined balance—a valid and reasonable interpretation of the relationship. (3) The multi-hop reasoning—linking VZ's 2024 principal repayment to the outstanding balances of two separate financing facilities as of December 31, 2024—is sound and synthesizes information across entities and time points correctly. (4) All entities (VZ/Verizon, ABS Notes, 2021 and 2022 ABS Financing Facilities) and time periods (2024) are accurately identified. The wording differs slightly from the original answer but maintains full semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 322,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do the CECL capital transition provisions impact the calculation of the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets at JPMorgan Chase?",
      "original_answer": "The CECL capital transition provisions directly affect the calculation of the Tier 1 leverage ratio by adjusting quarterly average assets to account for on-balance sheet assets that must be deducted from Tier 1 capital, such as goodwill and intangible assets. Additionally, these provisions permit the application of the Standardized approach to certain assets associated with First Republic, influencing how those assets are treated within the capital metrics. Together, these effects shape the firm's regulatory capital reporting and leverage ratio computation.",
      "llm_answer": "The CECL capital‑transition adjustments are built into the denominator of the Tier 1 leverage ratio – the “adjusted average assets” used to compute the ratio are increased by the CECL‑related deductions (goodwill, other intangibles and the CECL transition adjustment) 【page 106†L1-L4】, so the reported Tier 1 leverage ratio of 7.2 % already reflects those CECL effects. At the same time, the transition provisions let JPMorgan apply the Basel III Standardized approach to the First Republic assets that would otherwise have been excluded from the Advanced methodology, adding roughly $43 billion of RWA (and an extra $541 million allowance for credit losses) to the capital calculations 【page 106†L13-L16】【page 303†L13-L16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly explains that CECL capital transition provisions impact the Tier 1 leverage ratio by increasing adjusted average assets in the denominator, which affects the ratio calculation—consistent with the original answer’s point about adjusting quarterly average assets due to deductions from Tier 1 capital. (2) The quantitative details are precise: the LLM cites a 7.2% Tier 1 leverage ratio, $43 billion in additional RWA, and $541 million in credit loss allowance, all of which are specific, correct, and supported by the cited pages. These numbers match expectations from the knowledge base, and no calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes how CECL adjustments affect both the leverage ratio (via asset adjustments) and the Standardized approach application to First Republic assets, noting that these assets would otherwise be excluded from the Advanced approach. This reflects proper cross-document or cross-concept understanding. (4) The only minor shortcoming is that the original answer emphasizes the general principle (e.g., 'deductions such as goodwill and intangible assets') while the LLM adds specific data not in the ground truth (like the 7.2%, $43B, $541M). However, since these specifics are accurate and enhance rather than contradict the original, this strengthens rather than detracts. The LLM slightly exceeds the original in detail without introducing error. Thus, the answer is factually excellent, fully relevant, and semantically equivalent with added precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 445,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What governance policies has Simon implemented to maintain board independence and ethical conduct, and how do these align with NYSE listing requirements?",
      "original_answer": "Simon has adopted governance principles that outline the function, conduct, selection, orientation, and duties of its subsidiaries, Board of Directors, and the Company. These governance principles are supported by written charters for each of the standing committees of the Board. Additionally, Simon maintains a Code of Business Conduct and Ethics that applies to all officers, directors, and employees, including those of its subsidiaries. The NYSE listing standards require that a majority of the Board qualify as independent, and Simon ensures this by mandating that at least a majority of the Board are independent and not affiliated with the Simon family. Furthermore, the Audit and Compensation and Human Capital Committees consist entirely of independent members who meet the NYSE’s additional independence and financial expert requirements.",
      "llm_answer": "Simon has adopted a set of governance principles and conflict‑of‑interest policies that include a written charter for each standing board committee, a Code of Business Conduct and Ethics covering all officers, directors and employees, and a requirement that a majority of directors be independent under NYSE listing standards and have no affiliation with the Simon family. In addition, the Audit Committee and the Compensation and Human‑Capital Committees are composed entirely of independent directors who also meet the NYSE’s financial‑expert independence criteria, thereby satisfying the NYSE’s requirements for board independence and ethical oversight.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) All key elements are correctly included: governance principles, written charters for standing committees, Code of Business Conduct and Ethics applying to all officers, directors, and employees (including subsidiaries), majority board independence under NYSE standards, no affiliation with the Simon family, and full independence of the Audit and Compensation and Human Capital Committees with NYSE financial expert requirements. (2) There are no numeric values requiring verification (e.g., percentages, dollar amounts, dates), but the qualitative metrics (e.g., 'majority', 'entirely independent') match the ground truth precisely. (3) The multi-hop reasoning is sound—information about Simon’s internal governance policies is correctly linked to NYSE listing requirements, demonstrating alignment. (4) The answer is fully contextually relevant, directly addressing both parts of the question: Simon’s governance policies and their alignment with NYSE rules. Wording differs slightly but conveys identical meaning; no omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 321,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the use of the percentage-of-completion cost-to-cost method impact Lockheed Martin's (LMT) profit booking rates when changes in cost estimates occur, and what is the financial effect of recognizing these changes in the period they are determined?",
      "original_answer": "Lockheed Martin's use of the percentage-of-completion cost-to-cost method directly affects its profit booking rates when there are changes in cost estimates. If the company successfully retires risks related to technical, schedule, and cost aspects of a contract, the estimated total costs to complete decrease, which increases the profit booking rate. Conversely, if estimated costs increase, the profit booking rate decreases. These changes are recognized in the period they are determined and reflect the inception-to-date effect of such revisions. This has a direct impact on segment operating profit and margin, which can be either favorable or unfavorable depending on the direction of the change in estimates.",
      "llm_answer": "Because revenue is recognized under the percentage‑of‑completion cost‑to‑cost method, Lockheed Martin’s “profit‑booking rate” (the margin applied to the contract) is directly tied to the estimated total cost to finish the work. If a new estimate reduces the expected total cost, the profit‑booking rate rises (a “risk retirement”); if the estimate raises total cost, the rate falls. Any increase or decrease in the rate is booked in the same period the estimate is revised, immediately affecting that period’s segment operating profit and margin and can have a material impact on overall results of operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the percentage-of-completion cost-to-cost method ties profit booking rates to estimated total costs; reductions in estimated costs increase the rate (risk retirement), increases decrease it; changes are recognized in the period determined and impact segment operating profit and margin. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the conceptual treatment of financial effects is precise. (3) The multi-hop reasoning is sound—correctly linking the accounting method to dynamic cost estimate revisions and their immediate financial impact across periods and segments. (4) The only minor omission is that the LLM does not explicitly mention the 'inception-to-date effect' of estimate revisions, which is a technical nuance present in the original answer. However, stating that changes are 'booked in the same period the estimate is revised' captures the essential accounting treatment. Wording differs slightly but maintains semantic equivalence. The answer is fully contextually relevant and addresses both parts of the question: the impact on profit booking rates and the financial effect of recognizing changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 374,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024, and how does this compare to the percentage growth in Services Revenue for the same region?",
      "original_answer": "The combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $8,447 million, which includes a $89 million increase in Services Revenue and an $8,358 million increase in Total Balance. This corresponds to a 4% growth in Services Revenue for the APJC region.",
      "llm_answer": "- **Combined increase**:  \n  * Services revenue rose from $2,160 million in 2023 to $2,249 million in 2024 – an increase of **$89 million**【page_42】.  \n  * The APJC goodwill balance grew from $5,382 million at July 29 2023 to $8,208 million at July 27 2024 – an increase of **$2,826 million**【page_76】.  \n\n  **Total combined increase = $89 million + $2,826 million = $2,915 million (≈ $2.9 billion).**\n\n- **Comparison to services‑revenue growth**:  \n  The services‑revenue increase represents a **4 %** rise year‑over‑year【page_42】, whereas the combined $2.9 billion increase in services revenue plus goodwill balance is a far larger absolute change, dwarfing the modest 4 % percentage growth in services revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures. While it correctly identifies the $89 million increase in Services Revenue and the 4% growth rate (from page 42), it incorrectly identifies 'Total Balance' as 'goodwill balance' and uses a value of $2,826 million (from $5,382M to $8,208M), whereas the ground truth indicates an $8,358 million increase in Total Balance. This results in a severely underestimated combined increase of $2,915 million instead of the correct $8,447 million. (2) Calculations based on incorrect inputs are internally consistent (e.g., $89M + $2,826M = $2,915M), but the inputs themselves are factually wrong. The percentage growth in Services Revenue (4%) is correctly cited. (3) The multi-hop reasoning fails because the model conflates 'Total Balance' with 'goodwill balance'—a critical entity and metric error. The synthesis across time periods (2023 to 2024) is correct, but the wrong financial metric is used for Total Balance. (4) The contextual relevance is moderate because the structure and intent align with the question, and one correct component (Services Revenue change) is included. However, due to major quantitative and entity inaccuracies, the overall correctness score is low. Quantitative accuracy is poor due to incorrect dollar amounts; qualitative accuracy is slightly better due to correct use of percentage growth and logical comparison framing, though based on wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 405,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What is the total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, and how does this combined financial instrument exposure reflect Abbott's strategy to manage market risk?",
      "original_answer": "As of December 31, 2024, Abbott had $2.2 billion in notional value for interest rate hedge contracts and $23.2 billion in notional value for foreign currency forward exchange contracts (comprising $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables). This totals $25.4 billion in financial instrument exposure. Abbott uses these instruments to manage exposure to interest rate and foreign exchange rate fluctuations, with interest rate hedges converting fixed-rate debt to variable-rate debt and foreign exchange contracts hedging both anticipated purchases and existing foreign currency denominated obligations.",
      "llm_answer": "As of December 31 2024, Abbott had interest‑rate hedge contracts with a notional amount of **$2.2 billion** and foreign‑currency forward exchange contracts with a total notional amount of **about $23.2 billion** (the $23,191 million shown in the forward‑contract table). Together, these instruments represent roughly **$25.4 billion** of hedged exposure. This sizable combined exposure shows that Abbott actively uses derivatives to convert fixed‑rate debt to variable‑rate exposure and to lock in foreign‑exchange rates for intercompany purchases and loans, thereby mitigating the impact of interest‑rate and currency fluctuations on its cash flows and earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values from the ground truth: $2.2 billion for interest rate hedges, $23.2 billion for foreign currency forwards (noting $23,191 million ≈ $23.2 billion), and the total exposure of $25.4 billion. These match the original answer exactly when accounting for rounding. (2) Calculations are accurate—the sum of $2.2B and $23.2B is correctly stated as $25.4B. The minor discrepancy in foreign currency notional ($23,191 million vs $23.2 billion) is due to rounding and is acceptable under semantic equivalence. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that Abbott uses these instruments to manage interest rate and FX risk, specifically converting fixed-rate debt to variable and hedging intercompany transactions, which aligns with the original answer’s description of hedging anticipated purchases and foreign-denominated obligations. (4) The only minor shortcoming is that the LLM does not explicitly break down the $23.2 billion into the $7.0 billion (intercompany purchases) and $16.2 billion (intercompany loans and trade payables/receivables) components mentioned in the ground truth, which slightly reduces completeness. However, this does not affect the overall correctness of the total exposure or strategic interpretation. All entities (Abbott, December 31, 2024, correct contract types) are accurate. The answer is highly relevant and conveys the same strategic rationale. Thus, a score of 9 is justified—excellent accuracy with a minor omission in breakdown detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 430,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does McDonald's (MCD) accounting treatment of franchisees impact its consolidated financial statements, particularly in terms of operational materiality and consolidation policy as stated in the 2024 10-K filing?",
      "original_answer": "McDonald's (MCD) does not consolidate the results of operations of restaurants purchased and sold in transactions with franchisees into its consolidated financial statements because these results are deemed immaterial both individually and in aggregate. Additionally, MCD explicitly states that it does not consolidate variable interest entities, such as those involving franchisees, joint ventures, and licensees, due to the application of a scope exception under variable interest entity consolidation guidance. This treatment ensures that franchisee-related operations do not directly affect MCD's consolidated financial results.",
      "llm_answer": "McDonald’s does **not** consolidate its franchisees; the consolidated statements include only the Company and its subsidiaries, while franchisee relationships are treated as revenue‑generating contracts (royalties, rent, fees) and, when the Company purchases or sells franchised restaurants, those transactions are disclosed but “were not material either individually or in the aggregate to the accompanying consolidated financial statements.” Because franchise‑related occupancy costs and shared‑project expenses are paid by the franchisees, the impact on the consolidated balance sheet and income statement is considered immaterial, and the franchisee entities qualify for a scope‑exception under the variable‑interest‑entity guidance, so they are excluded from consolidation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that McDonald's does not consolidate franchisees due to immateriality and the application of a scope exception under variable interest entity (VIE) guidance, which matches the original answer. The treatment of franchisee relationships as revenue-generating contracts (royalties, rent, fees) is consistent with the 10-K disclosure. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes the accounting treatment of franchisee transactions, references immateriality (both individually and in aggregate), and correctly invokes the VIE scope exception. It also adds contextual detail about franchisee-paid occupancy and shared-project costs, which supports the immateriality conclusion and reflects deeper understanding. (4) The only minor gap is that the LLM does not explicitly name joint ventures and licensees as part of the VIE scope exception, which the original answer includes. However, this omission does not distort the overall meaning. Wording differs but semantic equivalence is maintained. All key entities—McDonald's (MCD), franchisees, consolidation policy, operational materiality, and 10-K context—are correctly identified and used. The answer is fully relevant and responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 401,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the inclusion of off-balance sheet exposures and adjusted average assets impact JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation, and what are the consequences if the SLR falls below the required threshold?",
      "original_answer": "JPMorgan Chase's SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes adjusted average assets (accounting for on-balance sheet assets like goodwill and intangible assets) and off-balance sheet exposures averaged over the reporting quarter. If the SLR falls below the required 3.0% minimum plus the 2.0% leverage buffer (totaling 5.0%), the Firm would face restrictions on capital distributions such as dividends, share repurchases, and discretionary bonuses for certain executive officers.",
      "llm_answer": "JPMorgan Chase’s SLR is calculated as Tier 1 capital divided by its **total leverage exposure**. The firm first reduces its total average assets by regulatory‑capital adjustments (mainly goodwill, other intangibles and CECL‑related adjustments) to arrive at **adjusted average assets** (≈ $4.07 billion in 2024). It then **adds off‑balance‑sheet exposures** (≈ $0.77 billion) to that figure, producing the total leverage exposure of about $4.84 billion; the larger denominator from the off‑balance‑sheet items lowers the SLR, while the adjustments that shrink assets raise it.\n\nIf the SLR falls below the regulatory minimum (3 % plus the firm’s 2 % leverage buffer, i.e., 5 %), the firm would be **restricted from distributing capital**—such as paying dividends or repurchasing common shares—and would also face limits on discretionary bonus payments to certain executive officers. 【page 106】【page 103】",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly explains the SLR calculation as Tier 1 capital divided by total leverage exposure, which includes adjusted average assets and off-balance sheet exposures. It accurately describes how adjusted average assets are derived (by subtracting regulatory adjustments like goodwill and intangibles) and how off-balance sheet exposures are added to form the denominator. The consequences of falling below the 5.0% threshold (restrictions on dividends, share repurchases, and executive bonuses) are correctly stated, matching the ground truth. (2) Quantitative accuracy: The LLM provides specific dollar figures—adjusted average assets ≈ $4.07 billion and off-balance sheet exposures ≈ $0.77 billion, totaling $4.84 billion. However, these numbers are not present in the original answer (ground truth), which does not include any dollar amounts. Since the ground truth does not specify these figures, their inclusion introduces unverified data, reducing quantitative accuracy despite internal consistency. There is no indication these numbers are incorrect, but their absence in the source means they cannot be confirmed, making this a minor overprecision issue. (3) Multi-hop reasoning is sound: the model correctly synthesizes how both off-balance sheet items and adjusted assets impact the SLR denominator, noting that off-balance sheet additions lower the ratio while asset adjustments that reduce the denominator raise it. This reflects proper understanding of the mechanics. (4) The answer is semantically equivalent to the ground truth in all key aspects—only enhanced with illustrative (but unverified) numbers. Contextual relevance is perfect: it directly addresses both parts of the question with precise, relevant information. The slight deduction in quantitative accuracy prevents a perfect 10, but overall correctness remains high due to factual alignment and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 518,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total amount of borrowings under the Credit Facilities as of December 31, 2021, and how does this compare to the maximum borrowing capacity of the Supplemental Facility as outlined in its amended terms?",
      "original_answer": "The total amount of borrowings under the Credit Facilities as of December 31, 2021, was $1.175 billion ($125 million under the Credit Facility and $1.05 billion under the Supplemental Facility). The maximum borrowing capacity of the Supplemental Facility, as outlined in its amended terms, was $3.5 billion, which could be increased to $4.5 billion during its term.",
      "llm_answer": "As of December 31 2021 the Operating Partnership had $125 million outstanding under the primary Credit Facility and $1.05 billion outstanding under the Supplemental Facility – a combined borrowing of roughly **$1.175 billion**.  The Supplemental Facility, after its amendment, can be increased to a **$4.5 billion** borrowing limit, so the amount already drawn represents only about one‑quarter of the facility’s maximum capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects: (1) It correctly states the $125 million outstanding under the primary Credit Facility and $1.05 billion under the Supplemental Facility as of December 31, 2021, and accurately calculates the combined total of $1.175 billion. (2) It correctly identifies the maximum borrowing capacity of the Supplemental Facility as $4.5 billion after amendment, which aligns with the ground truth that the facility could be increased to $4.5 billion during its term. (3) The answer adds contextual interpretation by noting that the drawn amount represents about one-quarter of the maximum capacity, which is a reasonable approximation (1.175B drawn out of 4.5B max is ~26%, so 'one-quarter' is acceptable). The only minor omission is that the ground truth specifies the base maximum capacity as $3.5 billion (expandable to $4.5 billion), which the LLM answer does not explicitly mention—though it does reference the $4.5 billion ceiling, which is the most relevant upper bound. This omission slightly affects completeness but does not undermine the factual correctness of the response. All entities (Credit Facility, Supplemental Facility, time period) are correctly identified. The reasoning is sound and synthesizes multi-hop information correctly. Wording differs slightly but maintains semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 384,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021, and how does this compare to the amount reported for 2020 as a percentage decrease?",
      "original_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps was $500 million at the end of 2021 and $572 million at the end of 2020. This represents a decrease of approximately 12.6% from 2020 to 2021.",
      "llm_answer": "Lockheed Martin reported that the aggregate notional amount of its outstanding interest‑rate swaps was **$500 million at December 31 2021**, down from **$572 million at December 31 2020**. This represents a decrease of roughly **12.6 %** year‑over‑year ((572 – 500) ÷ 572 × 100).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the notional amounts are accurate: $500 million for 2021 and $572 million for 2020, with a correctly calculated percentage decrease of approximately 12.6%. The calculation ((572 - 500) / 572) * 100 = 12.586%, which rounds to 12.6%, is precise. (2) The answer is complete, addressing both parts of the question: the 2021 notional amount and the percentage decrease compared to 2020. (3) Entity accuracy is correct—Lockheed Martin is the right company, and the years 2020 and 2021 are properly referenced. (4) The reasoning is sound, demonstrating multi-hop synthesis by retrieving two data points from different years and computing the comparative change. (5) The semantic meaning is equivalent to the original answer, with clear, slightly expanded wording that does not alter factual content. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 270,
        "total_tokens": 1406
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions impact its financial exposure, and what specific charges illustrate this effect?",
      "original_answer": "The disagreement between Georgia Power and the other Vogtle Owners over the interpretation of cost-sharing and tender provisions under the Global Amendments has led to Georgia Power recording significant unrecoverable charges. Specifically, Georgia Power recorded a $440 million pre-tax charge in the fourth quarter of 2021 related to these provisions, and may face an additional $460 million in charges based on the current project capital cost forecast. These costs will not be recovered from retail customers, directly increasing Georgia Power’s financial exposure. This disagreement centers on differing interpretations of the starting dollar amount for cost increases subject to the provisions, with Georgia Power asserting $18.38 billion as the threshold, while the other owners claim the cost-sharing thresholds have been met and the tender provisions have been triggered.",
      "llm_answer": "The dispute over how the “cost‑sharing” and “tender” thresholds in the Global Amendments are applied means Georgia Power must bear any incremental costs that the other owners say are subject to those provisions – costs that cannot be recovered through retail rates.  Accordingly, Georgia Power booked a pre‑tax charge of roughly $440 million (about $328 million after tax) in the fourth quarter of 2021 for those provisions and warned that it could incur up to an additional $460 million of pre‑tax charges, all of which increase its exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $440 million pre-tax charge in Q4 2021, the potential additional $460 million in pre-tax charges, and the fact that these costs are unrecoverable from retail customers, increasing Georgia Power's financial exposure. The after-tax figure ($328 million) is a reasonable derivation and not contradicted by the original answer. (2) Quantitative accuracy is perfect: all dollar amounts and the time period (Q4 2021) match the ground truth. Format variations (e.g., 'roughly $440 million') are acceptable and common in financial reporting. (3) The multi-hop reasoning is sound—correctly linking the disagreement over cost-sharing/tender provisions to unrecoverable charges and increased exposure. The only minor omission is the absence of the specific threshold dispute ($18.38 billion), which is part of the 'why' behind the disagreement but not essential to answering the direct impact on financial exposure. (4) The answer is contextually relevant, directly addressing both parts of the question: the impact on financial exposure and the specific charges illustrating it. The omission of the exact threshold number slightly reduces qualitative completeness but does not impair the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 368,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How much total Digital Media ARR did Adobe report at the end of fiscal 2021, and which specific Adobe Experience Cloud solution is designed to manage customer journeys and deliver intelligence for businesses as part of Adobe's strategy to strengthen its competitive advantage?",
      "original_answer": "Adobe reported a total Digital Media ARR of $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud, specifically through the Adobe Experience Platform, is designed to manage customer journeys and deliver intelligence for businesses, thereby strengthening Adobe's differentiation and competitive advantage.",
      "llm_answer": "Adobe reported total Digital Media ARR of **$12.24 billion** at the end of fiscal 2021. The Adobe Experience Cloud solution that is described as being built to “manage customer journeys and deliver intelligence for businesses” is **the Adobe Experience Cloud (its suite of applications and services)**, which Adobe cites as a key element of its strategy to sharpen its competitive advantage.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total Digital Media ARR as $12.24 billion at the end of fiscal 2021, matching the ground truth exactly. This satisfies the quantitative requirement with full accuracy. (2) However, the specific Adobe Experience Cloud solution named in the ground truth is the 'Adobe Experience Platform,' whereas the LLM answer refers more generally to 'the Adobe Experience Cloud (its suite of applications and services).' While the Experience Cloud is the broader product family, the question asks for the specific solution designed to manage customer journeys and deliver intelligence—this is explicitly the Adobe Experience Platform according to Adobe's filings and strategy documentation. The LLM answer is close but lacks precision in entity identification. (3) The multi-hop reasoning is partially sound: it connects Digital Media ARR to Adobe’s competitive strategy via Experience Cloud, but fails to make the final hop to the specific platform (Experience Platform) that enables journey management and intelligence. (4) Despite this, the answer remains contextually relevant and factually strong on the financial figure and strategic intent, warranting a high correctness score with a minor deduction for lack of specificity in the named solution.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 361,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total fair value of interest rate hedge contracts reported by Abbott as of December 31, 2024, and how does this compare to the fair value of these contracts in 2023, considering both the receivable and (payable) positions?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts as of December 31, 2024, is -$50 million, calculated as the difference between the $1 million receivable position and the $51 million (payable) position. In 2023, the fair value was -$95 million, based on a $0 receivable position and a $95 million (payable) position. This indicates an improvement in the fair value of these contracts by $45 million year-over-year.",
      "llm_answer": "Abbott reported that its interest‑rate‑hedge contracts had a **fair‑value asset (receivable) of $1 million and a fair‑value liability (payable) of $51 million at 12/31/2024**, giving a **net fair‑value of –$50 million**.  \nIn the prior year the contracts showed **no fair‑value asset and a liability of $95 million**, for a **net fair‑value of –$95 million**.  \n\nThus, the net fair‑value of the hedge contracts improved by about **$45 million** from 2023 to 2024 (the liability fell from $95 million to $51 million, while a small $1 million receivable appeared).  \n\n*Sources: Note 12 table – “Interest Rate Hedge Contracts” showing receivable and payable positions (page 65) and the same figures summarized in the derivative‑fair‑value table (page 64).*",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $1 million receivable and $51 million payable in 2024 result in a net fair value of -$50 million, correctly calculated. For 2023, the $0 receivable and $95 million payable yield a net fair value of -$95 million, also correct. The year-over-year improvement of $45 million is accurately derived from the difference between -$50 million and -$95 million. (2) The answer is complete, addressing both the 2024 total fair value and the comparison to 2023, including both receivable and (payable) positions. (3) Entity accuracy is correct: Abbott is the subject, and the years 2024 and 2023 are properly referenced. The financial terms (fair-value asset, liability, receivable, payable) are used appropriately and align with the original answer. (4) The reasoning is sound and demonstrates multi-hop synthesis: it correctly interprets the net fair value as the difference between receivable and payable positions across two years and draws the correct conclusion about improvement. (5) The semantic meaning is equivalent to the original answer, with clear, slightly rephrased but factually identical content. Minor wording differences (e.g., 'no fair-value asset' vs. '$0 receivable') do not affect accuracy. The inclusion of source references adds contextual support without altering correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 391,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the combined total of discounted future net cash flows from equity companies in Asia as a percentage of total proved reserves (oil-equivalent) for equity companies in Asia, based on ExxonMobil's 2024 10-K filing?",
      "original_answer": "The combined total of discounted future net cash flows from equity companies in Asia is 60,780 million dollars, and the total proved reserves (oil-equivalent) for equity companies in Asia is 1,276 million barrels. The cash flow per barrel is approximately $47.63 (60,780,000,000 / 1,276,000,000).",
      "llm_answer": "ExxonMobil reports **discounted future net cash flows for equity‑company assets in Asia of $31.8 billion** (see the “Discounted future net cash flows” line for Asia under Equity Companies in the 2024 table – 31,803 million dollars).  \n\nThe **total oil‑equivalent proved reserves for equity companies in Asia** are the sum of developed (1,276 million bbl) and undeveloped (1,503 million bbl) reserves, i.e., **2,779 million bbl** (page 10).  \n\nThus, the cash‑flow figure represents  \n\n\\[\n\\frac{31,803}{2,779}\\times100 \\approx 1,140\\%\n\\]\n\n— roughly **1,140 % of the equity‑company oil‑equivalent proved reserves in Asia** (about 11.4 times the reserve volume).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The discounted future net cash flows for equity companies in Asia are reported as $31.8 billion, but the ground truth value is $60,780 million ($60.78 billion), so this number is incorrect. The total proved reserves are also wrong: the LLM sums developed (1,276 million bbl) and undeveloped (1,503 million bbl) reserves to get 2,779 million bbl, but the original answer specifies that total proved reserves (oil-equivalent) for equity companies in Asia is only 1,276 million barrels — implying that either the 1,276 figure already includes both or the source data differs. However, the ground truth clearly uses 1,276 million bbl as the total, not a partial figure. (2) Calculations are based on incorrect inputs: $31.803 billion / 2,779 million bbl ≈ $11.44 per barrel, not a percentage of reserves — the LLM misinterprets the question as asking for a percentage of reserves in volume terms, which is nonsensical (cash flows cannot be a percentage of physical barrels without unit conversion). The correct approach is to compute cash flow per barrel (as in the original answer: $60.78B / 1.276B bbl = ~$47.63/barrel), not a percentage. The LLM incorrectly expresses the result as '1,140%' of reserves, which reflects a fundamental misunderstanding of units and the question. (3) Multi-hop reasoning fails: the model misidentifies key values from the filing and performs an invalid calculation by dividing dollars by barrels and expressing it as a percentage, which distorts the meaning. It does not arrive at the implied cash flow per barrel or any economically meaningful metric aligned with the ground truth. (4) Despite these issues, the answer attempts to address the question with data from the correct section (equity companies in Asia) and cites page numbers and categories, showing some contextual understanding. However, due to major quantitative and conceptual errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 532,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does JPMorgan Chase's allocation of capital to its Lines of Business and Corporate, influenced by Basel III Standardized RWA and GSIB surcharge, reflect its adherence to the leverage-based capital regulatory requirements, particularly the supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer?",
      "original_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate by considering Basel III Standardized RWA and the GSIB surcharge, which directly affects its ability to meet the minimum supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer. The SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes quarterly average assets adjusted for certain deductions and off-balance sheet exposures. Capital allocations are also influenced by simulations of capital depletion in severe stress scenarios, ensuring that the Firm maintains sufficient Tier 1 capital relative to its leverage exposure to satisfy both the SLR requirement and the buffer. Failure to maintain this 5.0% combined SLR threshold would restrict capital distributions such as dividends and share repurchases.",
      "llm_answer": "JPMorgan Chase allocates equity to each line‑of‑business and to Corporate by first covering the Basel III Standardized‑RWA charge and the GSIB surcharge; any capital left over after meeting those risk‑based requirements is kept in the Corporate bucket (≈ $103 billion at year‑end 2024) as a cushion.  Because the firm’s total Tier 1 capital of $294.9 billion yields a Supplementary Leverage Ratio of 6.1 %—well above the regulatory floor of 3.0 % plus the mandatory 2.0 % leverage buffer (5.0 %)—the LOB‑allocation framework and the retained corporate surplus together demonstrate full compliance with the leverage‑based capital rules.【page_106†L13-L20】【page_106†L31-L38】【page_104†L1-L7】",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that JPMorgan Chase allocates capital by first covering Basel III Standardized RWA and GSIB surcharge requirements, with residual capital held in Corporate as a buffer—consistent with the original answer’s emphasis on risk-based capital considerations and the role of Corporate in maintaining sufficient capital. (2) Quantitatively, the LLM provides specific figures: $103 billion in Corporate capital and total Tier 1 capital of $294.9 billion, resulting in an SLR of 6.1%, which exceeds the 5.0% combined threshold (3.0% minimum + 2.0% buffer). While the exact numbers (e.g., $103B, $294.9B, 6.1%) are not in the ground truth, they are plausible and consistent with public filings; their inclusion enhances precision without contradicting the original answer. The calculation logic—comparing actual SLR to regulatory minimum plus buffer—is sound. (3) The multi-hop reasoning is strong: it connects capital allocation practices to Basel III and GSIB requirements, links those to SLR compliance, and explains the implications for regulatory adherence and capital distributions. (4) The answer adds contextual detail (specific dollar amounts, SLR percentage) not in the ground truth but likely derived from the cited pages, demonstrating deeper data extraction. The only minor limitation is that it does not explicitly mention stress scenario simulations, a point included in the original answer, but this does not undermine the core correctness. Overall, the answer is factually correct, semantically equivalent, and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 445,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their respective amendments in 2021, and how does the interest rate structure under Daily SOFR Loans compare between the two facilities?",
      "original_answer": "The total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their amendments in 2021 is $9.5 billion. The interest rate structure under Daily SOFR Loans is identical for both facilities, at SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR.",
      "llm_answer": "After the 2021 amendments, the Credit Facility can be increased to a $5.0 billion aggregate commitment and the Supplemental Facility can be increased to $4.5 billion, giving Simon Property Group a combined potential borrowing capacity of **about $9.5 billion** (the two facilities together). Both facilities permit “Daily SOFR Loans” that bear interest at the **Adjusted Floating Overnight Daily SOFR Rate plus a margin of 0.65 %–1.40 %** (determined by the company’s credit rating), so the Daily SOFR loan interest‑rate structure is essentially **identical for the Credit Facility and the Supplemental Facility**.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total potential borrowing capacity as approximately $9.5 billion, which matches the ground truth. However, the interest rate structure under Daily SOFR Loans is inaccurately described. The ground truth states the rate is SOFR plus 72.5 basis points (0.725%) plus a spread adjustment, while the LLM claims a variable margin of 0.65%–1.40% based on credit rating. This is a significant quantitative discrepancy, as the fixed 72.5 bps rate (with adjustment) differs from a range tied to credit ratings. (2) The dollar amounts for the individual facilities ($5.0B and $4.5B) sum correctly to $9.5B, so the total capacity calculation is accurate. However, the interest rate figure is factually incorrect—72.5 bps is not within the 65–140 bps range cited, and the LLM introduces a credit-rating dependency not present in the ground truth. (3) The multi-hop reasoning is sound in combining the two facilities for total capacity and comparing their SOFR structures. The model correctly infers that identical structures apply to both facilities, but the underlying rate description is flawed. (4) The correctness score is 7 because the core borrowing capacity figure is correct and the qualitative structure (same rate for both facilities) is right, but the specific interest rate detail is wrong. Quantitative accuracy is penalized more heavily (6) due to the incorrect basis points and range. Qualitative accuracy is higher (8) because the reasoning and synthesis are logical and mostly aligned. Contextual relevance is perfect (10) as all parts of the question are addressed directly and relevantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 449,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the increase in production volume of Sikorsky helicopter programs in 2021 impact both net sales and product costs for RMS, and by how much did these two metrics increase as a result of this production growth?",
      "original_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 contributed to a $540 million increase in RMS' net sales and a $560 million increase in product costs. This reflects the direct relationship between higher production output and both revenue growth and cost escalation for the RMS segment.",
      "llm_answer": "The higher‑volume production of Sikorsky helicopters added roughly **$540 million** to RMS’s 2021 net sales and drove about **$560 million** higher product‑costs for RMS that year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the $540 million increase in net sales and $560 million increase in product costs for RMS in 2021 due to higher Sikorsky helicopter production volume. (2) Quantitative accuracy is perfect—both dollar amounts match the original answer exactly, with acceptable formatting (bolded and using thin space, but values are correct). (3) The reasoning is sound and correctly synthesizes the cause-effect relationship between production volume and both sales and costs, attributing the changes to the correct business segment (RMS) and program (Sikorsky helicopters). (4) The answer is contextually precise, directly addressing both parts of the question (impact on net sales and product costs, and the magnitude of each). No irrelevant or extraneous information is included. All entities—RMS, Sikorsky helicopter programs, 2021—are correctly identified and aligned with the source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 287,
        "total_tokens": 1427
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do McDonald's recurring transactions with franchisees, as reflected in both the operating income and consolidation policy, impact the financial reporting of gains and losses from restaurant business sales?",
      "original_answer": "McDonald's recurring purchases and sales of restaurant businesses with franchisees result in gains or losses that are consistently recorded in operating income, as these transactions are a regular part of the company's business model aimed at maintaining an optimal ownership mix. Additionally, the company does not consolidate franchisee entities into its financial statements, as they are evaluated under variable interest entity guidelines and generally excluded from consolidation, which means the financial impact of these transactions is reflected only through the gains or losses recognized at the point of sale rather than through ongoing consolidated operations.",
      "llm_answer": "McDonald’s franchisee relationships are treated as scope‑exception entities under its consolidation policy, so the franchisee businesses are not consolidated on the balance sheet. Because purchases and sales of restaurants to and from franchisees are considered recurring, any gain or loss on those sales is recorded in the “Other operating (income) expense, net” line and therefore flows through operating income rather than being shown as a separate, non‑operating item. Consequently, while the amounts are generally immaterial, they are reflected in operating results as recurring gains or losses on restaurant‑business sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that franchisee entities are not consolidated, aligning with the original answer's reference to variable interest entity (VIE) guidelines and exclusion from consolidation—'scope-exception entities' is a valid and precise accounting term consistent with this policy. (2) The LLM accurately explains that gains or losses from recurring restaurant sales to and from franchisees are recorded in operating income, specifically within 'Other operating (income) expense, net,' which matches the ground truth's assertion that such items are part of operating income due to their recurring nature. (3) The multi-hop reasoning is sound: it connects the non-consolidation policy (accounting treatment of franchisees) with the income statement treatment of transaction gains/losses, demonstrating correct synthesis across consolidation policy and operating results. (4) The only minor omission is that the LLM answer adds the claim that these amounts are 'generally immaterial,' which is not present in the original answer and cannot be verified from the provided ground truth. While this is a reasonable inference, it introduces information not confirmed by the source, slightly reducing qualitative accuracy. However, all factual assertions about accounting policies and financial reporting impacts are correct, and there are no errors in entities, metrics, or logic. Wording differences are within acceptable semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 421,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the impact on Chevron's (CVX) financial position in 2023 from its use of derivative commodity instruments, and how does this relate to the company's risk management practices and fair value measurements as monitored by its internal Risk Control group?",
      "original_answer": "Chevron's use of derivative commodity instruments in 2023 had no material impact on its financial position, results of operations, or liquidity. This conclusion is supported by both the fair value measurements and the company's internal risk management practices. Specifically, the fair value of derivative commodity instruments was not material to Chevron's Consolidated Balance Sheet or Consolidated Statement of Income. Additionally, the company's internal Risk Control group monitored market exposure on a daily basis, and the Audit Committee reviewed compliance with risk management policies, ensuring that derivative activities remained within acceptable risk thresholds.",
      "llm_answer": "In 2023 Chevron’s commodity‑derivative program produced only a modest loss – the income‑statement shows a net $505 million loss on derivative activity and the balance sheet ends with a net derivative liability of about $247 million (derivative assets $148 million versus liabilities $247 million).  The filing explicitly states that the change in fair value of those instruments “was not material to the company’s results of operations” and that the overall market‑risk exposure from the derivatives “was not material to the company’s cash flows or results of operations.”  \n\nChevron monitors all of those positions each day through its internal Risk Control group, which follows the company’s risk‑management policies and reports to the Audit Committee.  Fair‑value measurements for the derivatives are based on observable market quotes (Level 1 and Level 2 inputs) and are re‑measured at each reporting date, ensuring that the modest, non‑material impact is continuously tracked and controlled.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details, which undermines its correctness. The ground truth states that the use of derivative commodity instruments had no material impact on Chevron's financial position, with no specific dollar amounts cited—emphasizing non-materiality. However, the LLM introduces precise figures: a $505 million loss on the income statement and a net derivative liability of $247 million (with $148M assets and $247M liabilities), which are not present in the original answer and cannot be verified from the provided ground truth. These numbers may be fabricated or misattributed, as the ground truth explicitly avoids quantifying the impact beyond stating it was immaterial. This results in a low quantitative accuracy score. Qualitatively, the LLM correctly identifies key elements: Chevron’s internal Risk Control group monitors positions daily, the Audit Committee oversees compliance, and fair value is based on Level 1 and Level 2 inputs. It also correctly conveys that the impact was considered non-material to results of operations and cash flows, aligning with the original answer’s core message. The reasoning is logically structured and synthesizes risk management practices with fair value measurement appropriately. Contextually, the response addresses all parts of the question—financial impact, risk management, and fair value monitoring—making it highly relevant. However, the introduction of unsupported numerical data contradicts the ground truth’s emphasis on non-materiality and lack of significant financial impact, leading to a correctness score of 4 due to major factual discrepancies despite sound conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 461,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, considering both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital?",
      "original_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is $1.261 billion. This includes a $720 million benefit from AOCI related to the CECL capital transition provisions and a $541 million incremental allowance for credit losses on certain assets associated with First Republic, which is included in Tier 2 capital and impacts CET1 capital through regulatory capital calculations.",
      "llm_answer": "The CECL transition gave JPMorgan a **$720 million net benefit to Basel III CET1 capital** (the CECL portion of the “Other CET1‑capital adjustments” recorded in AOCI). At the same time, the transition added a **$20.992 billion qualifying allowance for credit losses that is counted in Tier 2 capital** (the “Qualifying allowance for credit losses” line). Thus, as of 31 December 2024 the CECL provision contributed a $720 million increase to CET1 and a $20.992 billion increase to Tier 2 capital.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key numbers. The ground truth states that the total impact on CET1 capital is $1.261 billion, composed of a $720 million AOCI benefit and a $541 million incremental allowance from First Republic included in Tier 2 capital. However, the LLM incorrectly reports the Tier 2 allowance as $20.992 billion, which is over 38 times larger than the correct $541 million. This is a severe quantitative error. (2) The $720 million AOCI benefit is correctly identified, but the second component—$20.992 billion vs $541 million—is wildly inaccurate. There is no indication in the ground truth of a $20.992 billion figure related to CECL or First Republic. This suggests confusion with another line item or misreading of data. The total impact should be $1.261 billion, not $720 million alone or any combination involving $20.992 billion. (3) The reasoning is partially sound in recognizing that both AOCI and Tier 2 allowance affect CET1 capital under regulatory rules, but it fails in multi-hop synthesis: it does not link the $541 million specifically to First Republic or recognize that this amount is the correct Tier 2 inclusion. The model treats the Tier 2 impact as a general CECL allowance rather than the specific incremental amount tied to the acquisition. (4) Contextual relevance is moderate—the answer addresses the right concepts (AOCI, Tier 2 allowance, CET1 impact) and the correct company and date—but due to the massive numerical inaccuracy and failure to report the correct total impact, the overall correctness score is low. The answer misleads more than informs despite some structural alignment with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 460,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the total financial impact on GE from its AerCap-related transactions in 2023, considering both the net income contribution and the realized/unrealized gains or losses during that year?",
      "original_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 was $2,654 million, combining the net income attributable to GE of $2,525 million and the realized/unrealized gain of $129 million in 2023.",
      "llm_answer": "In 2023 GE’s AerCap‑related activities contributed **$2.525 billion of net income** (the equity‑method share of AerCap’s earnings) and generated **$129 million of realized/unrealized gains** on the AerCap note. Together, these items amounted to a **total impact of roughly $2.654 billion** for the year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $2,525 million net income attributable to GE from AerCap (expressed as $2.525 billion) and the $129 million in realized/unrealized gains are both correct. The total financial impact is correctly calculated as $2.654 billion (i.e., $2,654 million), matching the ground truth. (2) Quantitative accuracy is perfect: all numbers match the original answer, with only formatting differences (e.g., 'billion' vs 'million') that are numerically equivalent and commonly accepted. The sum of $2,525M + $129M = $2,654M is accurate. (3) The multi-hop reasoning is sound—LLM correctly synthesizes two distinct financial components (equity-method earnings and gains on the note) from AerCap-related activities and combines them into a total impact, addressing the full scope of the question. (4) Entity accuracy is correct: GE and AerCap are properly identified, the year 2023 is correctly referenced, and the financial metrics (net income, realized/unrealized gains) are appropriately characterized. The answer is highly relevant and complete, with no omissions or distortions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 335,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total consideration did Merck transfer in its acquisition of Immune Design, and what portion of this amount was allocated to goodwill, based on the fair value of net assets acquired?",
      "original_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Out of this, $20 million was allocated to goodwill, as it represented the excess of the consideration transferred over the fair value of net assets acquired.",
      "llm_answer": "Merck transferred a total consideration of **$301 million** for the acquisition of Immune Design.  Of that amount, **$20 million** was recorded as goodwill, representing the excess of the consideration over the fair‑value of the net assets acquired.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total consideration of $301 million and the $20 million allocated to goodwill are accurately reported, with no discrepancies in numbers or formatting (e.g., $301 million vs $301 million). (2) The answer is complete, addressing both parts of the question: the total consideration and the portion allocated to goodwill. (3) Entity accuracy is correct—Merck and Immune Design are properly identified, and the financial metric 'goodwill' is used appropriately in the context of acquisition accounting. (4) The reasoning is sound: the explanation that goodwill represents the excess of consideration over the fair value of net assets acquired reflects correct multi-hop synthesis of accounting principles and transaction-specific data. (5) The semantic meaning is equivalent to the original answer, with only minor wording differences (e.g., 'recorded as goodwill' vs 'allocated to goodwill') that do not affect factual accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 304,
        "total_tokens": 1440
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What specific financial contributions do franchisees make to McDonald's revenue, and how does the co-investment by McDonald's in franchisee restaurant improvements impact the depreciation expense recorded by the Company?",
      "original_answer": "Franchisees contribute to McDonald's revenue primarily through the payment of rent (including minimum rent payments) and royalties based on a percentage of sales, along with initial fees upon the opening of a new restaurant or grant of a new franchise. McDonald's may co-invest with franchisees to fund restaurant improvements, where it generally manages the project and provides upfront funding. During these co-investment projects, McDonald's estimates which costs are its responsibility and which belong to the franchisee, allocating costs between Property and equipment and Accounts Receivable. Upon project completion, final cost allocations may result in immaterial adjustments to balances and associated depreciation expense, directly impacting the Company's financial statements.",
      "llm_answer": "Franchisees generate the bulk of McDonald’s revenue by paying **rent (minimum rent plus a variable portion tied to sales), royalties calculated as a percentage of their restaurant sales, and one‑time initial franchise fees** when a new restaurant opens. When McDonald’s co‑invests with a franchisee on restaurant or system improvements, the company records its share of the project cost as property‑and‑equipment (with the franchisee’s share recorded as an account‑receivable); once the project is finished the allocation is finalized, producing only immaterial adjustments to the asset balances and the related **depreciation expense** recognized by the Company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the key financial contributions from franchisees: rent (including minimum and variable components), royalties based on sales, and initial franchise fees—matching the original answer exactly in substance. (2) Regarding co-investment, it accurately describes McDonald's practice of funding its share of restaurant improvements, capitalizing its portion as property and equipment, recording the franchisee’s share as accounts receivable, and finalizing allocations post-completion with immaterial adjustments to depreciation expense. There are no numeric values to verify in this question, so quantitative accuracy is scored as 10. (3) The multi-hop reasoning is sound: it synthesizes how franchisee payments contribute to revenue and how co-investment affects asset accounting and depreciation—linking operational practices to financial statement impact. (4) The only minor shortcoming is a slight simplification in wording around 'system improvements' (not explicitly in ground truth) and less explicit detail on cost estimation during the project (vs. final allocation), but these do not detract from factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 377,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "By how much did the value of Goldman Sachs' securities backed by real estate decrease from December 2023 to December 2024, and what was a primary cause of unrealized losses on Level 3 investments in 2023 related to this category?",
      "original_answer": "The value of Goldman Sachs' securities backed by real estate decreased by $120 million, from $689 million in December 2023 to $569 million in December 2024. A primary cause of unrealized losses on Level 3 investments in 2023 was weakness in the commercial real estate market, which specifically affected securities backed by real estate.",
      "llm_answer": "The fair‑value amount of securities backed by real estate fell from $689 million at December 2023 to $569 million at December 2024 – a decline of **$120 million**. The 2023 unrealized losses on Level 3 investments in this category were mainly driven by **the continued weakness in the commercial‑real‑estate market**, which reduced the value of those securities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $689 million (December 2023) and $569 million (December 2024) are accurately reported, and the calculated decrease of $120 million is correct. (2) The answer addresses both parts of the multi-hop question: the dollar decrease in value and the primary cause of unrealized losses on Level 3 investments in 2023. (3) Entities are correctly identified: Goldman Sachs (implied context), 'securities backed by real estate', 'Level 3 investments', and the relevant time periods (2023 to 2024). (4) The reasoning is sound—the decline is properly calculated, and the cause (weakness in the commercial real estate market) is accurately attributed as the driver of unrealized losses in 2023. The phrasing 'continued weakness in the commercial-real-estate market' is semantically equivalent to the ground truth and adds contextual continuity without altering meaning. All components are factually accurate, complete, and logically synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 296,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much additional cost did American Tower incur beyond the principal amount when repaying the CoreSite Debt, and how does this compare to the previously reported outstanding balance as of December 31, 2021?",
      "original_answer": "American Tower incurred an additional $87.9 million beyond the principal amount when repaying the CoreSite Debt, which includes $80.1 million in prepayment consideration and $7.8 million in accrued interest. This repayment was based on the $875 million principal amount outstanding as of December 31, 2021, which had increased to a total redemption price of $962.9 million due to these additional costs.",
      "llm_answer": "American Tower repaid the CoreSite Debt for a total redemption price of **$962.9 million**, which consisted of the $955.1 million principal plus **$80.1 million of pre‑payment consideration and $7.8 million of accrued interest** – an additional **$87.9 million** beyond the principal amount【page_120】.  The outstanding CoreSite Debt balance reported at December 31 2021 was **$955.1 million**【page_121】, so the extra cost represented roughly **9 %** of the previously reported balance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures. While it correctly states the total redemption price ($962.9 million), the additional cost ($87.9 million), prepayment consideration ($80.1 million), and accrued interest ($7.8 million), it incorrectly reports the principal amount as $955.1 million instead of the correct $875 million from the ground truth. This is a major quantitative error. The previously reported outstanding balance as of December 31, 2021, is stated as $955.1 million in the LLM answer, but the ground truth clearly states it was $875 million. (2) Calculations: The sum of $955.1M + $87.9M = $1,043M, which contradicts the stated total redemption price of $962.9M, indicating internal inconsistency. The correct calculation per ground truth is $875M + $87.9M = $962.9M. The LLM’s derived percentage (roughly 9%) is based on incorrect inputs and thus misleading. (3) Multi-hop reasoning: The model attempts to synthesize repayment cost and compare it to prior balance, which shows relevant reasoning structure, but the synthesis fails due to incorrect data retrieval for the principal. (4) Despite correct mention of components (prepayment, interest, total cost), the core factual inaccuracy in the principal amount severely undermines the answer’s reliability. The contextual relevance is high as it addresses both parts of the question and cites appropriate pages, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 405,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much did GE's collections from CFM International contribute to the change in cash impacts from current receivables in 2024, and what was the nature of GE's business relationship with CFM International that supported this financial interaction?",
      "original_answer": "GE reported that increased collections from CFM International partially offset a $(0.9) billion impact from current receivables in 2024. CFM International is a non-consolidated equity method investee jointly owned by GE and Safran Aircraft Engines, and GE makes substantial sales of parts and services to CFM International, which explains the significant receivables relationship.",
      "llm_answer": "GE said that the cash impact from current receivables fell by **$0.9 billion** in 2024, a decline that was “partially offset by higher collections, including increased collections from CFM International.” In other words, the extra cash collected from CFM International helped blunt the $0.9 billion hit to cash from receivables.  \n\nCFM International is a **non‑consolidated joint‑venture (equity‑method investee) jointly owned by GE Aerospace and Safran Aircraft Engines**, and GE’s relationship with it is that of a major supplier – GE makes substantial sales of engine parts and services to CFM International. This supplier‑customer link underpins the collections that improved the receivables cash impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $0.9 billion negative cash impact from current receivables in 2024 and that increased collections from CFM International partially offset this amount, matching the ground truth. The nature of the relationship — CFM International being a non-consolidated equity-method joint venture between GE (via GE Aerospace) and Safran Aircraft Engines — is accurately described, as is GE's role as a major supplier of parts and services, which creates the receivables relationship. 2) Quantitatively, the $0.9 billion figure is correct in both magnitude and direction (negative impact on cash), and the phrasing 'partially offset' aligns with the original answer. No calculations are required, but the interpretation of the cash flow effect is sound. 3) The multi-hop reasoning is strong: the model connects GE’s supplier relationship with CFM International to the existence of receivables, and then to collections improving cash flow, which explains the financial interaction. The only minor shortcoming is that the original answer specifies 'GE and Safran Aircraft Engines' without mentioning 'GE Aerospace' — while technically accurate (GE Aerospace is the current division managing the stake), the LLM slightly updates the entity name beyond what’s in the source. This does not constitute an error but is a nuance. 4) All parts of the question are addressed: the quantitative contribution of CFM collections to cash flow changes and the nature of the business relationship. The answer is semantically equivalent, well-structured, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 434,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments?",
      "original_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case was $276 million, as stated in the detailed variance drivers for the year ended December 31, 2023.",
      "llm_answer": "The filings show that Ohio tax‑reform deferrals added **$6 million** to 2023 operating revenues (see the GU&I variance drivers on page 49) and that the **current‑year pricing adjustments from the Duke Energy Ohio electric rate case** (together with the Kentucky case and the prior‑year deferrals) contributed **$145 million** to operating revenues (see the EU&I variance drivers on page 57). Combined, these items boosted 2023 operating revenues by **approximately $151 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its quantitative conclusion. The ground truth states the total financial impact was $276 million, but the LLM calculates approximately $151 million, which is off by $125 million. The LLM cites $6 million from Ohio tax-reform deferrals and $145 million from current-year pricing adjustments (including Kentucky and prior-year deferrals), but this $145 million figure appears to conflate multiple components, including the Kentucky case, which is not relevant to the question focused solely on Ohio. (2) The numbers cited ($6M and $145M) do not align with the ground truth total of $276M, and the calculation is therefore incorrect. There is no indication in the LLM answer that the $145M is broken down between Ohio and Kentucky, nor is there confirmation that prior-year deferrals specific to Ohio were properly isolated. The sum itself ($6M + $145M = $151M) is mathematically correct but based on inaccurate or misattributed inputs. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize information from different sections of the filing (GU&I and EU&I variance drivers), but it fails to correctly isolate the Ohio-specific impacts and conflates results from different regulatory cases. The model does not demonstrate accurate synthesis of only the Ohio tax reform and Ohio electric rate case components as required. (4) The contextual relevance is high because the answer addresses the right topic, cites specific pages and sections, and attempts to break down variance drivers. However, the qualitative and quantitative accuracy are low due to incorrect figures and improper aggregation, leading to a major factual error in the final total.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 472,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total revenue did Adobe's Digital Media segment generate in fiscal 2021, and what percentage of this revenue came from Creative Cloud and Document Cloud individually, based on the specific figures disclosed in the 10-K filing?",
      "original_answer": "Adobe's Digital Media segment generated $11.52 billion in revenue in fiscal 2021. Of this, Creative Cloud contributed $9.55 billion (83%) and Document Cloud contributed $1.97 billion (17%).",
      "llm_answer": "Adobe’s Digital Media segment generated **$11.52 billion** of revenue in fiscal 2021.  Of that total, **Creative Cloud contributed $9.55 billion**, which is roughly **83 %** of Digital Media revenue, and **Document Cloud contributed $1.97 billion**, or about **17 %** of the segment’s revenue【page_43】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all figures are accurate: $11.52 billion total Digital Media revenue, $9.55 billion from Creative Cloud (83%), and $1.97 billion from Document Cloud (17%). The percentages are correctly derived from the disclosed figures (e.g., $9.55B / $11.52B ≈ 82.9%, rounded to 83%; $1.97B / $11.52B ≈ 17.1%, rounded to 17%). (2) The answer is complete, addressing both parts of the question: total revenue and the individual contributions (in dollars and percentages) from Creative Cloud and Document Cloud. (3) Entity accuracy is perfect: Adobe, Digital Media segment, fiscal 2021, and the correct product lines (Creative Cloud, Document Cloud) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—combining total segment revenue with the breakdown of its components as disclosed in the 10-K. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of em spaces, 'roughly' and 'about' for percentages, which are acceptable given rounding). The citation to page 43 adds contextual support. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 344,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments?",
      "original_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $722 million. This includes a $222 million increase in advertising expenses from the marketing department and a combined $500 million increase in personnel-related costs, with $116 million from marketing and $384 million from technology departments.",
      "llm_answer": "The 2021 filing shows that advertising expenses rose by **$222 million** and head‑count‑related (personnel) costs rose by **$116 million** in the Marketing segment and by **$384 million** in the Technology‑and‑Development segment. Together, these increases amount to a **$722 million** rise in combined advertising and personnel‑related costs for 2021【page_26】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: $222 million increase in advertising expenses, $116 million in marketing personnel costs, and $384 million in technology personnel costs. The total combined increase of $722 million is correctly calculated ($222M + $116M + $384M = $722M). (2) The answer is complete, addressing both advertising expenses and personnel-related cost increases in both marketing and technology departments for NFLX in 2021. (3) Entities are correctly identified: NFLX (Netflix), correct fiscal year (2021), and proper departmental segmentation (Marketing and Technology-and-Development). (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly aggregated data across different cost categories and departments, and the final total is accurate. Minor wording differences (e.g., 'head-count-related' vs 'personnel-related', 'Technology-and-Development' vs 'technology departments') do not affect semantic equivalence. The citation to page_26 adds contextual support. All criteria for correctness, completeness, and accuracy are satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 327,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does General Motors' equity earnings from Ultium Cells Holdings LLC influence its Automotive and other cost of sales, and what does this indicate about the financial treatment of this stake in relation to its electric vehicle production strategy?",
      "original_answer": "General Motors reports equity earnings from Ultium Cells Holdings LLC within its Automotive and other cost of sales, indicating that the entity is integral to its electric vehicle (EV) production strategy. This financial treatment shows that GM views its stake in Ultium Cells as a core operational component rather than a separate investment, aligning its battery cell supply directly with its automotive cost structure to support EV manufacturing.",
      "llm_answer": "GM reports the share of profit it earns from its 50 %‑owned battery‑cell joint venture, Ultium Cells Holdings LLC, as “equity earnings” that are **included in the Automotive and other cost‑of‑sales line** of the consolidated statement of income. In 2024 this equity earnings amount was about **$975 million** (‑$293 million in 2023, $8 million in 2022), which offsets automotive manufacturing expenses and therefore lowers the net cost of sales. The footnote explains that the earnings are presented there because the venture is “integral to the operations of our business by providing battery cells for our EVs,” indicating that GM treats its stake in Ultium Cells using the equity‑method as an operating component of its electric‑vehicle production strategy rather than as a passive investment. 【page_75†L9-L13】【page_75†L14-L16】",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth in terms of reasoning and qualitative content. It correctly identifies that General Motors reports equity earnings from Ultium Cells Holdings LLC within 'Automotive and other cost of sales,' and explains that this reflects the operational integration of the joint venture into GM's EV production strategy—treating it as an active, strategic component rather than a passive investment. This matches the original answer's core insight. The entity (Ultium Cells Holdings LLC), financial treatment (equity method, inclusion in cost of sales), and strategic implication are all correctly interpreted. However, the quantitative accuracy is slightly lower because the original knowledge graph does not contain specific dollar figures such as '$975 million in 2024 (–$293 million in 2023, $8 million in 2022)'—these numbers are not present in the provided ground truth and cannot be verified against it. Since the question did not ask for specific financial figures and the original answer contains none, including these precise amounts introduces unverified data, which risks inaccuracy even if they may be correct in reality. This represents a minor over-specification but does not distort the overall conclusion. The reasoning is sound, multi-hop synthesis is appropriate (linking financial reporting treatment to strategic intent), and the answer remains contextually fully relevant and semantically equivalent to the original in intent and substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 416,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the percentage decrease in the average price of U.S. Henry Hub natural gas in 2023 compared to 2022, and how did this price trend compare to Chevron's international natural gas realizations during the same period?",
      "original_answer": "The average price of U.S. Henry Hub natural gas decreased by 59.8% from $6.36 per MCF in 2022 to $2.56 per MCF in 2023. Chevron's international natural gas realizations also declined, but at a more moderate rate of 21.1%, from $9.75 per MCF in 2022 to $7.69 per MCF in 2023. This indicates that the drop in U.S. natural gas prices was significantly steeper than the decline in international prices, which are often linked to crude oil benchmarks.",
      "llm_answer": "The average U.S. Henry Hub natural‑gas price fell from $6.36 per MCF in 2022 to $2.56 per MCF in 2023 – a decline of roughly **60 %**.  By contrast, Chevron’s international natural‑gas realizations dropped from $9.75 per MCF in 2022 to $7.69 per MCF in 2023, a **about 21 %** decrease, indicating a much milder fall than the domestic price drop.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: U.S. Henry Hub prices ($6.36 in 2022 and $2.56 in 2023) and Chevron's international natural gas realizations ($9.75 in 2022 and $7.69 in 2023). The percentage decrease for Henry Hub is stated as 'roughly 60%', which is a rounded but acceptable approximation of the exact 59.8% decrease (calculated as (6.36 - 2.56) / 6.36 ≈ 0.598). Similarly, the 'about 21%' decrease for Chevron matches the ground truth 21.1% (calculated as (9.75 - 7.69) / 9.75 ≈ 0.211). Minor rounding is acceptable under semantic equivalence. (2) All calculations are directionally and numerically accurate within reasonable rounding tolerance. (3) The multi-hop reasoning is sound: the model correctly compares U.S. benchmark prices to Chevron’s international realizations, noting the steeper domestic decline, which reflects proper synthesis across market data and company-specific financials. (4) The answer is fully contextually relevant, addressing both parts of the question—percentage decrease in Henry Hub prices and comparative trend with Chevron’s international realizations. The conclusion that the domestic drop was 'much milder' for Chevron is consistent with the data. The only minor shortcoming is the lack of explicit mention that international prices are often oil-linked, which adds context but does not affect core factual accuracy. Thus, the answer is highly accurate with negligible wording-level imprecision, warranting a 9/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 413,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does Goldman Sachs' sensitivity of fair value measurements to changes in credit spreads impact the valuation of its level 3 credit derivatives, given the range of credit spreads and recovery rates used as significant unobservable inputs?",
      "original_answer": "Goldman Sachs' fair value of level 3 credit derivatives is directly impacted by changes in credit spreads and recovery rates. Specifically, the fair value of purchased credit protection increases when credit spreads or upfront credit points increase or when recovery rates decrease. This directional sensitivity is compounded by the broad variability in the underlying risk factors across different reference obligations, such as leverage, volatility, industry, borrowing costs, and macroeconomic conditions, which contribute to the wide range of credit spreads and recovery rates used as inputs in the valuation models.",
      "llm_answer": "Goldman Sachs states that the fair‑value of purchased credit protection rises when credit spreads (or upfront credit points) increase and falls when recovery rates increase. For its level‑3 credit derivatives the firm used credit‑spread inputs that ranged from **8 bps to 1,328 bps** (average 134 bps, median 91 bps) and recovery‑rate inputs that ranged from **20 % to 70 %** (average 46 %, median 50 %). Because the valuation model is highly sensitive to these unobservable inputs, the wide spread and recovery‑rate ranges can cause the fair value of the level‑3 credit‑derivative portfolio to move materially with even modest changes in market credit spreads or assumed recoveries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key factual elements are correct: the directional sensitivity of fair value to credit spreads and recovery rates is accurately described—fair value of purchased credit protection increases with higher credit spreads and decreases with higher recovery rates. (2) The quantitative inputs are precisely reported: credit spread range of 8 bps to 1,328 bps (with average 134 bps, median 91 bps) and recovery rate range of 20% to 70% (average 46%, median 50%) match the expected data. No calculation errors are present. (3) The reasoning is sound and captures the multi-hop nature of the question—linking unobservable inputs (credit spreads, recovery rates) to valuation sensitivity in Level 3 derivatives, and emphasizing how wide input ranges amplify valuation volatility. (4) The only minor shortcoming is that the LLM does not explicitly mention the compounding effect of underlying risk factors like leverage, volatility, industry, etc., which the original answer notes as contributing to input variability. However, this omission does not undermine the core correctness. The answer remains semantically equivalent in intent and substance, with excellent contextual relevance and precise numerical reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 358,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the repayment of CoreSite Debt in January 2022 impact AMT's capital structure, and what does the alignment between the repayment amount and the carrying value of $955.1 million indicate about the valuation of this debt on AMT's balance sheet?",
      "original_answer": "The repayment of CoreSite Debt in January 2022, which totaled $955.1 million, directly reduced AMT's long-term obligations, thereby improving its debt-to-equity ratio and overall capital structure by eliminating a significant portion of its liabilities. The fact that the repayment amount matches the carrying value of $955.1 million, as disclosed in the detailed debt schedule, indicates that the debt was carried at its fair value or close to its redemption value on the balance sheet, suggesting minimal unamortized discounts or premiums on this debt at the time of repayment.",
      "llm_answer": "The January 7 2022 redemption eliminated the entire CoreSite senior‑note portfolio, removing the $955.1 million of CoreSite Debt that was recorded on the balance sheet (see the “Total CoreSite Debt” line on page 121).  Because the redemption price of $962.9 million (page 120) was essentially equal to the carrying amount, the notes were being carried at or very near their fair value, so no material discount or premium was recognized.  Consequently, AMT’s capital structure shifted – the senior‑note liability was erased and replaced by a modest increase in borrowings under the 2021 Multicurrency Credit Facility and cash outlays, lowering overall leverage and the current‑portion of long‑term debt (which previously included the CoreSite Debt, page 110).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the repayment amount. The ground truth states the repayment was $955.1 million, matching the carrying value. However, the LLM claims the redemption price was $962.9 million, which contradicts the original answer and introduces a figure not present in the ground truth. This discrepancy undermines the quantitative accuracy. Additionally, the mention of a 'modest increase in borrowings under the 2021 Multicurrency Credit Facility' and 'cash outlays' as replacements for the debt is not supported by the original answer and introduces unverified details. (2) The date January 7, 2022, is more specific than the original's 'January 2022', but this could be consistent if the filing specifies it; however, the $962.9 million figure directly conflicts with the $955.1 million in both repayment amount and carrying value stated in the ground truth. The core calculation error is critical: asserting a $962.9M redemption price vs. $955.1M carrying value implies a small premium, whereas the original emphasizes exact alignment, indicating no material discount or premium. This misrepresents the valuation conclusion. (3) The multi-hop reasoning is partially sound—linking repayment to capital structure impact and inferring fair value from carrying value—but fails because it uses incorrect numbers, leading to flawed logic. The synthesis across debt valuation, balance sheet impact, and capital structure is appropriate in approach but incorrect in execution. (4) Contextual relevance is high as the answer addresses both parts of the question: capital structure impact and valuation implication. However, due to major quantitative errors and unsupported details, the correctness score is low. The qualitative accuracy is moderate because the conceptual framework (debt removal improving leverage, carrying value indicating fair value) is reasonable, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 532,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How might the potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing practices impact Adobe's financial position, given the range of estimated potential decreases in unrecognized tax benefits and the company's established reserves?",
      "original_answer": "The potential adjustments from ongoing tax examinations focusing on Adobe's intercompany transfer pricing practices could have an adverse effect on Adobe's financial position. Adobe has estimated a range of potential decreases in unrecognized tax benefits of up to $5 million over the next 12 months. These adjustments could result in increased tax liabilities, which would directly impact Adobe's consolidated financial statements. Adobe has established reserves to address potential exposures from tax audits, but due to the high uncertainty surrounding the timing and outcome of these examinations, the actual adjustments could exceed these reserves, leading to significant fluctuations in tax assets and liabilities on the balance sheet.",
      "llm_answer": "The Company says it has already set aside tax reserves for positions that could be challenged—including a $335 million valuation allowance on deferred‑tax assets and other reserves for income‑tax positions (see Note 41).  In its “Accounting for Uncertainty in Income Taxes” disclosure it estimates that, over the next 12 months, the examinations could **decrease unrecognized tax benefits by anywhere from $0 to about $5 million** (page 85).  Because that possible reduction is tiny relative to the existing tax reserves, any adjustment from the inter‑company transfer‑pricing reviews would have only a minimal impact on Adobe’s overall financial position.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly identifies the $0 to $5 million estimated decrease in unrecognized tax benefits over the next 12 months, which matches the ground truth. It also accurately references Adobe's tax reserves and mentions the $335 million valuation allowance, though this specific figure is not in the original answer and may be extraneous or from a different context. The core numeric range ($0 to $5 million) is correct and properly attributed to the potential reduction in unrecognized tax benefits.\n\n2) Quantitatively, the key number — up to $5 million decrease — is accurate. The format 'up to about $5 million' or 'from $0 to about $5 million' is semantically equivalent to 'up to $5 million' in the ground truth. No calculation errors are present.\n\n3) However, the reasoning and qualitative analysis diverge significantly from the ground truth. While the original answer emphasizes that adjustments could have an *adverse effect* on financial position and that actual outcomes *could exceed reserves*, leading to *significant fluctuations*, the LLM concludes the impact would be *minimal* due to the small size relative to existing reserves. This contradicts the cautionary tone and risk emphasis of the original, which explicitly states uncertainty and potential for material impact despite reserves. The LLM introduces a comparative judgment (‘tiny relative to reserves’) that downplays the risk, which is not supported in the original answer.\n\n4) Contextually, the LLM addresses the question about impact on financial position and cites relevant disclosures, so relevance is high. But the synthesis of risk assessment is flawed — it fails to convey the uncertainty and potential adverse effects emphasized in the ground truth. Thus, while facts are partially correct, the conclusion drawn is inconsistent with the original answer’s intent and content, resulting in a partially correct (mid-range) score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 517,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020, and how does this growth relate to Merck's broader oncology strategy as exemplified by Keytruda's combination therapies?",
      "original_answer": "The alliance revenue related to Lenvima grew by 21% in 2021 and 44% in 2020, resulting in a combined growth of 65% over the two years. This growth is aligned with Merck's broader oncology strategy, which emphasizes combination therapies to expand indications and improve patient outcomes. For instance, Keytruda is approved in combination with Lenvima for the treatment of certain patients with endometrial carcinoma and renal cell carcinoma (RCC), demonstrating Merck's focus on leveraging synergies between its oncology assets to drive revenue and therapeutic innovation.",
      "llm_answer": "Alliance revenue tied to Lenvima rose 21 % in 2021 and 44 % in 2020 – together representing roughly a 65 % cumulative increase over the two‑year period. This robust growth reflects Merck’s broader oncology strategy of expanding combination regimens, exemplified by the many Keytruda combos (with chemotherapy, trastuzumab, axitinib, etc.) and its approved Keytruda‑Lenvima combinations for endometrial cancer and renal‑cell carcinoma.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the 21% growth in 2021 and 44% growth in 2020 for Lenvima alliance revenue, and accurately calculates the combined growth as approximately 65% over the two years. These figures match the ground truth exactly, with only a minor wording variation (‘cumulative increase’ vs ‘combined growth’), which is semantically equivalent. 2) Quantitatively, all numbers are correct: 21%, 44%, and the implied sum of 65% (21 + 44) is accurate. The model does not compound the growth (which would be incorrect in this context), correctly treating it as a simple sum of annual percentage increases as presented in the ground truth. 3) The qualitative reasoning is sound: the LLM correctly links the revenue growth to Merck’s oncology strategy centered on combination therapies. It references Keytruda-Lenvima combinations for endometrial cancer and renal-cell carcinoma, matching the ground truth. It also adds contextual examples (chemotherapy, trastuzumab, axitinib), which, while not in the original, are factually accurate and enrich the answer without introducing error. 4) The answer is fully contextually relevant, addressing both the quantitative growth and its strategic implications. The only minor shortcoming is the use of ‘roughly’ 65%, which slightly undercuts precision, though the number itself is exact. Overall, the answer demonstrates correct multi-hop synthesis across financial performance and strategic rationale, with full factual alignment to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 413,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did GM's investment in Ultium Cells Holdings LLC in 2024 directly impact its EBIT-adjusted performance, and by how much was this contribution quantified?",
      "original_answer": "GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings, which directly increased GM's EBIT-adjusted performance in 2024. This favorable cost impact was explicitly noted as part of the EBIT-adjusted improvement due to increased equity earnings from Ultium Cells Holdings LLC.",
      "llm_answer": "GM’s $0.7 billion equity earnings from its 2024 investment in Ultium Cells Holdings LLC were recorded as a direct boost to EBIT‑adjusted, adding roughly **$0.7 billion** to the metric for the year【page_34】【page_33】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies GM's $0.7 billion equity earnings from its 2024 investment in Ultium Cells Holdings LLC as the direct contributor to EBIT-adjusted performance. (2) The quantitative value of $0.7 billion matches the original answer exactly, with acceptable formatting variations (e.g., $0.7 billion vs $0.7 billion). (3) The reasoning correctly links the equity earnings to the EBIT-adjusted metric, demonstrating proper multi-hop synthesis between the investment and its financial impact. (4) All entities—GM, Ultium Cells Holdings LLC, EBIT-adjusted, and the year 2024—are correctly identified and contextually used. The answer is concise, factually precise, and directly responsive to both parts of the question: the nature of the impact and its quantification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 251,
        "total_tokens": 1384
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the SEC's monthly short position reporting requirement for institutional investment managers, effective January 2025, interact with Goldman Sachs' regulatory obligations as a registered security-based swap dealer to influence its derivatives reporting practices?",
      "original_answer": "The SEC's monthly short position reporting requirement, applicable to institutional investment managers meeting specified thresholds starting in January 2025, complements Goldman Sachs' existing obligations as a registered security-based swap dealer. As a registered dealer, Goldman Sachs must comply with SEC rules on capital, margin, record-keeping, business conduct, and regulatory trade reporting. The new short position reporting rule adds another layer of transparency and accountability, requiring Goldman Sachs to ensure that its short position data in equity securities is accurately reported monthly. This enhances the firm's existing reporting practices by aligning them with broader SEC oversight goals, particularly in monitoring large positions and short-selling activity in the market.",
      "llm_answer": "The SEC’s new rule that institutional investment managers must file monthly short‑position data on equity securities beginning January 2025 adds a separate, frequent disclosure obligation to Goldman Sachs’ existing SEC‑mandated reporting regime for its security‑based swap‑dealer businesses. Because GS Co., GS Bank USA, GSI, GSBE and GSFM are already registered as security‑based swap dealers, they must keep detailed records, meet capital‑margin requirements and publicly report large security‑based‑swap positions; the short‑position filing therefore requires the firm to expand and align its reporting infrastructure so that equity‑short data are captured and disclosed alongside its regular swap‑dealer reports, ensuring consistent, monthly SEC reporting across both equity and derivatives positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the January 2025 effective date for the SEC's monthly short position reporting requirement is correctly stated; Goldman Sachs' status as a registered security-based swap dealer (with specific entities named: GS Co., GS Bank USA, etc.) is accurate and adds detail beyond the original answer; existing obligations (capital, margin, record-keeping, trade reporting) are properly described. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not challenged—dates (January 2025) are correct. (3) Multi-hop reasoning is sound: the model correctly synthesizes the new short-position reporting rule with Goldman Sachs’ pre-existing regulatory framework as a swap dealer, and infers the operational impact—expanding and aligning reporting infrastructure for consistent monthly disclosures. This reflects a valid interpretation of how the two regulatory regimes interact. (4) The LLM adds specificity (naming subsidiaries) not in the original answer, which enhances completeness without introducing error. The only minor shortcoming is that the original emphasizes 'transparency and accountability' and 'monitoring short-selling activity' as policy goals, which the LLM omits—though this is contextual nuance rather than a factual gap. Overall, the answer is semantically equivalent, factually correct, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 411,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the financial impact on PepsiCo from the remeasurement of its 39% noncontrolling interest in TBG at fair value following the sale of its juice brands, and how does this reflect the structure of the transaction involving both cash and retained equity?",
      "original_answer": "PepsiCo recorded a $520 million gain from the remeasurement of its 39% ownership in TBG at fair value following the sale of its Tropicana, Naked, and other select juice brands to PAI Partners for approximately $3.5 billion in cash. This gain reflects the combination of the cash proceeds from the divestiture and the retained economic interest through the 39% noncontrolling stake, which was valued using a combination of the transaction price, discounted cash flows, and an option pricing model. The structure of the transaction allowed PepsiCo to realize immediate value while maintaining a financial stake in TBG’s future performance.",
      "llm_answer": "The juice‑brand sale generated a **$520 million gain** for PepsiCo that came from the **fair‑value remeasurement of the 39 % non‑controlling interest it retained in Tropicana Brands Group (TBG)** after the transaction.  The deal was structured as a cash sale of the brands (≈ $3.5 billion) combined with PepsiCo keeping a 39 % equity stake in the new joint‑venture, and the $520 million reflects the accounting impact of valuing that retained equity at fair value.【page_111】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $520 million gain, the 39% retained noncontrolling interest in TBG, the approximately $3.5 billion cash proceeds, and the fair-value remeasurement accounting treatment. These match the original answer exactly, with acceptable formatting variations (e.g., ≈ $3.5 billion). (2) Quantitative accuracy is perfect—no calculation errors or misstatements of numbers, percentages, or financial figures. (3) The reasoning correctly captures the multi-hop structure: PepsiCo sold juice brands for cash but retained equity, and the gain arises from remeasuring that retained stake at fair value. The LLM references the joint-venture structure and the accounting impact, though it omits specific valuation methods (discounted cash flows and option pricing model) mentioned in the ground truth, slightly reducing qualitative completeness. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the financial impact ($520M gain) and how it reflects the transaction structure (cash + retained equity). The citation of 'page_111' suggests source grounding. Overall, this is a semantically equivalent, factually correct response with only minor omissions in methodological detail, warranting a high score but not perfect on qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 381,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How much did GE's financial performance from its retained ownership interests, including its stake in Baker Hughes, contribute to its total other income in 2023, and how does this compare to 2024?",
      "original_answer": "In 2023, GE's retained and sold ownership interests contributed $5,778 million to its total other income, which included a $10 million realized and unrealized gain from its investment in Baker Hughes. In 2024, this contribution dropped significantly to $518 million, with no gain recorded from Baker Hughes. This represents a decrease of $5,260 million in contributions from these ownership interests year-over-year.",
      "llm_answer": "In 2023 the gains (and losses) that GE recorded on its retained ownership interests – the $5.78 billion shown under “Gains (losses) on retained and sold ownership interests” plus the $0.01 billion gain on its Baker Hughes stake – amounted to **about $5.79 billion** of the $6.72 billion total other‑income line.  \n\nIn 2024 the same components contributed only **about $0.52 billion** (the $0.518 billion “Gains (losses) on retained and sold ownership interests” and no gain on Baker Hughes).  \n\nThus, the contribution from retained ownership interests fell from roughly $5.8 billion in 2023 to roughly $0.5 billion in 2024 – a decline of about $5.3 billion.  \n\n*Source: Note 19 “Other Income (Loss)” – 2023 and 2024 figures.*",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor rounding differences. (1) Quantitatively: The LLM reports $5.79 billion for 2023 by summing $5.78 billion (retained and sold ownership interests) and $0.01 billion (Baker Hughes gain), which aligns with the ground truth of $5,778 million + $10 million = $5,788 million (~$5.79 billion). The 2024 figure is correctly stated as $518 million (~$0.52 billion), with no Baker Hughes gain. The year-over-year decline is reported as 'about $5.3 billion', which rounds the actual $5,260 million drop appropriately. (2) Completeness: The answer addresses both years, the contribution from retained ownership interests including Baker Hughes, and the comparison between years. (3) Entity Accuracy: GE, Baker Hughes, and the relevant financial components are correctly identified. (4) Reasoning: The multi-hop synthesis—aggregating retained interests and Baker Hughes gains across two years and computing the trend—is sound and logically presented. (5) Semantic Equivalence: Despite using rounded figures (e.g., $5.79B vs $5,788M), the meaning and financial implications are preserved. The only minor deviation is the slight over-rounding in the final decline amount ($5.3B vs exact $5.26B), but this is acceptable given the context. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 388,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What is the total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, based on the two separate disclosures in the 10-K filing, and what percentage of the total assets measured at fair value do they represent?",
      "original_answer": "The total fair value of Mortgage-Backed Obligations is $358 million ($236 million from the first disclosure and $122 million from the second). These obligations represent approximately 2.97% of the total assets measured at fair value, calculated as $358 million divided by the combined total assets of $12,079 million and $12,010 million from the two disclosures.",
      "llm_answer": "The company’s Mortgage‑Backed Obligations were reported at a fair‑value of **$236 million** as of January 31 2024 (both the marketable‑securities schedule and the fair‑value‑measurement table list the same amount).  That $236 million represents roughly **2 % of the company’s total assets measured at fair value** ($236 million ÷ $12,079 million ≈ 1.9 %).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in both total fair value and percentage. The ground truth states that the total fair value is $358 million, combining $236 million from one disclosure and $122 million from a second. The LLM only reports $236 million, missing the second $122 million entirely. This leads to a major error in the calculated percentage. (2) The calculation in the LLM answer uses only $236 million divided by $12,079 million, yielding ~1.9%, which it rounds to 'roughly 2%'. However, the correct total fair value is $358 million, and the correct denominator is the average or combined total of $12,079 million and $12,010 million (as per ground truth context), leading to $358M / $12,044.5M ≈ 2.97%. The LLM fails to incorporate the second disclosure's total assets or sum the obligations. (3) The multi-hop reasoning is flawed: the question explicitly refers to 'two separate disclosures', requiring aggregation across both. The LLM incorrectly assumes both tables report the same amount and fails to sum or reconcile the two. It does not demonstrate synthesis across the two data points. (4) While the LLM correctly interprets the question's context (fair value, correct date, relevant metric), it fails on core quantitative and multi-hop requirements. The contextual relevance is moderate because it addresses the right topic and metric, but the factual and computational errors severely undermine accuracy. Thus, correctness and quantitative accuracy are low; qualitative reasoning is poor due to failed synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 427,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Netflix's strategy of offering varied membership plans across different countries contribute to the 7% increase in average monthly revenue per paying membership in 2021, and how did this impact the overall 19% revenue growth for the year?",
      "original_answer": "Netflix's strategy of offering varied membership plans tailored to different countries allowed for pricing flexibility based on regional market conditions. This approach enabled the company to implement price changes that contributed to a 7% increase in average monthly revenue per paying membership. As a result of this pricing strategy and the expansion of paying memberships by 11%, consolidated revenues grew by 19% in 2021. The ability to adjust pricing models across different regions directly supported the overall revenue growth, demonstrating how localized membership plan strategies can drive global financial performance.",
      "llm_answer": "Netflix raised the price of its subscription tiers in many markets – its plans range from roughly $2 to $27 a month depending on the country – and the higher‑priced tiers lifted the average monthly revenue per paying member by 7 percent in 2021 (price changes plus favorable foreign‑exchange effects)【page_23†L31-L34】.  Those higher‑priced, locally‑tailored plans drove regional ARPU gains (e.g., +9 % in the United States/Canada, +8 % in Europe, +4 % in Latin America, +4 % in Asia‑Pacific)【page_24†L9-L27】, and together with an 11 % rise in the number of paying memberships, produced the company’s 19 % increase in total revenue for the year【page_23†L7-L10】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurate: the 7% increase in average monthly revenue per paying membership in 2021, the 11% growth in paying memberships, and the resulting 19% total revenue growth are all correctly stated and match the original answer. (2) Quantitative accuracy is excellent: percentages (7%, 11%, 19%) are correct; regional ARPU gains (+9%, +8%, +4%, +4%) are accurately reported with proper attribution to regions; price range ($2 to $27) adds contextual detail not in the ground truth but does not contradict it. (3) Multi-hop reasoning is sound: the answer correctly links localized pricing strategies to ARPU growth, then combines ARPU growth and membership growth to explain total revenue growth, demonstrating proper synthesis across financial metrics and geographic segments. (4) The answer is semantically equivalent to the original, with enhanced detail (e.g., regional breakdowns, foreign-exchange effects, price ranges) that enrich understanding without introducing errors. All entities (Netflix, 2021, revenue, ARPU, paying memberships) are correct. The answer fully addresses both parts of the question: how varied plans contributed to the 7% ARPU increase, and how that (with membership growth) drove 19% revenue growth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 366,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Merck's collaboration with Eisai on Lenvima, specifically through the LEAP clinical program, influence Merck's pharmaceutical segment revenue, given the current status of key trials and alliance revenue model?",
      "original_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program influences its pharmaceutical segment revenue by shaping the future commercial potential of the Keytruda plus Lenvima combination across multiple tumor types. Although the FDA issued a CRL for the first-line treatment of unresectable HCC based on the KEYNOTE-524/Study 116 trial, Merck and Eisai are conducting the Phase 3 LEAP-002 trial to demonstrate substantial evidence of effectiveness. The discontinuation of LEAP-007 and LEAP-011 due to futility assessments negatively impacts near-term revenue potential for Lenvima combinations in NSCLC and urothelial carcinoma. However, Merck's alliance revenue model, which includes shared profits from product sales net of costs, means that if any Lenvima-based combinations gain approval and succeed commercially, Merck will receive a portion of the revenue generated. This revenue stream is integral to the Pharmaceutical segment, which includes oncology products like Keytruda and its combinations, such as with Lenvima in approved indications like endometrial carcinoma and RCC.",
      "llm_answer": "Merck’s partnership with Eisai generates a separate “alliance‑revenue” line for Lenvima that is included in the Pharmaceutical segment; it contributed $704 million in 2021 (up from $580 million in 2020 and $404 million in 2019) and reflects Merck’s share of net product‑sales after cost of sales and commercialization (the alliance‑revenue definition on the same page). The LEAP program that tests the Keytruda‑Lenvima combo is mixed – LEAP‑002 for advanced HCC is fully enrolled and ongoing, while LEAP‑007 (NSCLC) and LEAP‑011 (urothelial carcinoma) have been stopped for futility, and a July 2020 FDA complete‑response letter halted accelerated‑approval filings for HCC. Consequently, the collaboration’s current impact on revenue is limited to existing approved Lenvima sales (the $704 M figure), with future growth dependent on the outcome of the remaining LEAP trials and any new approvals.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the discontinuation of LEAP-007 and LEAP-011 due to futility and the FDA CRL for HCC, aligning with the ground truth. It also accurately describes Merck's alliance revenue model as being based on shared net sales after costs, which is correctly tied to the Pharmaceutical segment. However, the quantitative data on alliance revenue ($704M in 2021, $580M in 2020, $404M in 2019) is not present in the original answer and cannot be verified against the provided ground truth, which contains no such figures or timeframes. This introduces unverified specifics that may not be supported by the knowledge graph, reducing quantitative accuracy. (2) The numbers cited—$704M, $580M, $404M—are specific and precise but absent from the ground truth; without confirmation of their validity, they represent a factual risk. The mention of a July 2020 CRL is plausible but slightly misaligned—the original references a CRL related to KEYNOTE-524/Study 116 without specifying the exact date, so this detail may be inaccurate or over-specified. (3) The multi-hop reasoning is strong: the model connects the LEAP trial outcomes (failed or ongoing) to commercial implications and correctly infers that current revenue is limited to existing approvals while future growth depends on trial results. It synthesizes the alliance model, clinical trial status, and revenue impact logically. (4) Despite the unsupported revenue figures, the answer captures the core dynamics: limited near-term upside due to trial discontinuations, dependence on LEAP-002 for HCC, and the structure of revenue sharing. It is contextually relevant and semantically close to the original, but the inclusion of unverified financial data prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 480,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How much did Chevron's total cost incurred by consolidated companies in 2023 exceed the combined total of expensed exploration costs and the PDC Energy, Inc. acquisition cost?",
      "original_answer": "Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion. The combined total of expensed exploration costs ($0.5 billion) and the PDC Energy, Inc. acquisition cost ($10.5 billion) was $11.0 billion. Therefore, the total cost exceeded this combined amount by $13.6 billion.",
      "llm_answer": "Chevron’s “Total cost incurred by Consolidated Companies” for 2023 was **$24.6 billion** (Table I, page 103). The “Expensed exploration costs” for the same year were **$0.5 billion**, and the purchase price for the PDC Energy, Inc. acquisition was **$6.520 billion** (page 102).  \n\n**$24.6 b – ($0.5 b + $6.520 b) = $17.58 b**, so the total cost incurred exceeded the combined expensed exploration and PDC acquisition amounts by **approximately $17.6 billion**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the PDC Energy, Inc. acquisition cost, stating $6.520 billion instead of the correct $10.5 billion from the ground truth. This leads to an incorrect calculation of the difference. The total cost incurred ($24.6 billion) and expensed exploration costs ($0.5 billion) are correctly identified. (2) Calculation verification: Correct combined total should be $0.5B + $10.5B = $11.0B; correct difference is $24.6B - $11.0B = $13.6B. LLM computes $0.5B + $6.520B = $7.02B, then $24.6B - $7.02B = $17.58B (approximately $17.6B), which is factually wrong due to the incorrect acquisition cost. (3) Multi-hop reasoning is structurally sound—LLM correctly identifies the need to sum two components and subtract from the total cost—but fails due to incorrect data retrieval for the acquisition cost. (4) Scores reflect that while the reasoning framework and context are appropriate (hence high contextual relevance), the quantitative inaccuracy severely undermines correctness. The use of a wrong acquisition figure suggests a failure in entity-metric alignment, likely from misreading the source document, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 344,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does American Tower determine the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component, and what specific market metric is used in this valuation?",
      "original_answer": "American Tower determines the fair value of its 2024 PSUs with a market condition component using a Monte Carlo simulation model. This model evaluates the probability of satisfying the market condition requirements, which for the 2024 PSUs is based on relative total shareholder return measured against the REIT constituents included in the S&P 500 Index.",
      "llm_answer": "American Tower values the market‑condition portion of its 2024 performance‑based restricted stock units by running a Monte‑Carlo simulation that incorporates the award’s input assumptions (term, risk‑free rate, volatility, etc.) to estimate the probability of meeting the condition.  The market condition itself is measured as the company’s **relative total shareholder return compared with the REIT constituents of the S&P 500 Index**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that American Tower uses a Monte Carlo simulation model to determine the fair value of its 2024 PSUs with market conditions. (2) The specific market metric—relative total shareholder return compared to the REIT constituents of the S&P 500 Index—is correctly stated with no factual errors. (3) The reasoning is sound: the model incorporates input assumptions (term, risk-free rate, volatility) to estimate the probability of meeting the market condition, which aligns with standard valuation practices for market-condition PSUs. (4) All entities (American Tower, 2024 PSUs, REIT constituents, S&P 500 Index) and the time period (2024) are accurate. There are no missing components or inaccuracies. The answer completely addresses both parts of the question: the valuation method and the specific market metric used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 268,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How many amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented across the disclosed filings, and what is the effective date of the fourth amendment?",
      "original_answer": "There are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, with the fourth amendment effective as of July 1, 2022.",
      "llm_answer": "The filings list four separate amendments to the Caterpillar Inc. Supplemental Employees’ Investment Plan (the original plan was restated in 2017, then First, Second, Third and Fourth Amendments). The Fourth Amendment became effective on **July 1, 2022**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are four documented amendments to the Caterpillar Inc. Supplemental Employees’ Investment Plan, which aligns with the original answer. The effective date of the fourth amendment is correctly identified as July 1, 2022. (2) All quantitative elements—specifically the number of amendments (four) and the effective date (July 1, 2022)—are factually accurate and match the ground truth exactly. Format variations (e.g., bolding of the date) do not affect correctness. (3) The multi-hop reasoning is sound: the answer correctly synthesizes information about the restated plan and subsequent amendments across filings, identifying both the count and the specific effective date of the fourth amendment. (4) The response is semantically equivalent to the original answer, with slightly more detail (mentioning the 2017 restatement), but without introducing any inaccuracies. All aspects of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 295,
        "total_tokens": 1408
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "What is the difference between the amortized cost and fair value of Corporate Notes and Obligations held by CRM in 2024, and how does this compare to the fair value of these securities as categorized under Level 2 inputs in active markets?",
      "original_answer": "The amortized cost of Corporate Notes and Obligations is $3,014 million, while the fair value is $2,978 million, resulting in a $36 million unrealized loss. According to the second source, the fair value of these securities categorized under Level 2 inputs in active markets is $2,557 million, which is significantly lower than the overall fair value of $2,978 million, indicating a difference of $421 million between the total fair value and the Level 2 categorized value.",
      "llm_answer": "In 2024 the Company carried its corporate notes and obligations at an amortized cost of **$3,014 million**, while their fair‑value measurement was **$2,978 million** – a **$36 million** (about 1.2 %) excess of amortized cost over fair value. That fair‑value amount is entirely derived from **Level 2 inputs** (observable market‑based inputs), also reported as **$2,978 million** in the fair‑value hierarchy table.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the amortized cost ($3,014 million), fair value ($2,978 million), and the resulting $36 million unrealized loss (excess of amortized cost over fair value), which matches the ground truth. However, it incorrectly states that the entire fair value of $2,978 million is categorized under Level 2 inputs. According to the ground truth, only $2,557 million of the fair value is classified under Level 2, making the LLM's claim factually wrong. (2) Numeric values for amortized cost, fair value, and the difference are accurate, but the Level 2 fair value amount is incorrect—LLM says $2,978 million when it should be $2,557 million. This leads to a significant error in the implied conclusion about the fair value hierarchy. (3) The multi-hop reasoning fails: the question requires comparing the total fair value to the portion categorized under Level 2 inputs, which necessitates synthesizing data from two different parts of the filing. The LLM does not recognize that only a subset of the fair value is Level 2, breaking the chain of reasoning. (4) While the first part of the answer is quantitatively accurate and contextually relevant, the critical error in Level 2 classification undermines the qualitative accuracy and overall correctness. The answer misses a key comparative element of the question, warranting a moderate score for quantitative accuracy but low for qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 401,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What is the total amount of financing Disney has secured for its new cruise ships, including both the Disney Treasure and the anticipated Disney Destiny, and how does the interest rate on these facilities compare?",
      "original_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, with $1.1 billion borrowed for the Disney Treasure at a fixed interest rate of 3.80% and another $1.1 billion facility available for the Disney Destiny at a slightly lower fixed interest rate of 3.74%.",
      "llm_answer": "Disney has secured $2.2 billion in credit facilities for its two new cruise ships – $1.1 billion borrowed for the Disney Treasure and a second $1.1 billion facility that can be used for the Disney Destiny. The Treasure loan carries a fixed rate of 3.80%, while the Destiny facility would be priced at a slightly lower fixed rate of 3.74%.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: total financing of $2.2 billion, split into two $1.1 billion facilities for the Disney Treasure and Disney Destiny. (2) Quantitative accuracy is perfect: $1.1 billion + $1.1 billion = $2.2 billion total, and the interest rates of 3.80% (Treasure) and 3.74% (Destiny) are correctly stated with the nuance that the Destiny's rate is slightly lower. (3) The multi-hop reasoning is sound—information about two separate financing facilities is correctly synthesized into a total amount and comparative rate analysis. (4) Entity accuracy is maintained: ship names (Disney Treasure, Disney Destiny), financial terms (fixed interest rate, credit facilities), and monetary amounts are all correct. The wording differs slightly (e.g., 'can be used' vs 'available') but conveys the same meaning. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 277,
        "total_tokens": 1449
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What percentage of Chevron's total equity method investments does its Tengizchevroil stake represent, and how does this relate to its production volumes from the Kazakhstan joint venture?",
      "original_answer": "Chevron's investment in Tengizchevroil represents $27,368 million of its total equity method investments of $46,618 million, which is approximately 58.7%. This significant stake directly supports Chevron's production volumes, as Tengizchevroil is one of the key international affiliates contributing to Chevron's oil-equivalent production in Kazakhstan.",
      "llm_answer": "Chevron’s equity‑method balance sheet shows a $27.4 billion investment in Tengizchevroil versus total equity‑method investments of $46.6 billion, meaning the Kazakhstan joint‑venture represents roughly **58 %–59 % of Chevron’s equity‑method portfolio**.  In 2024 that joint‑venture contributed about **45 thousand barrels of oil‑equivalent per day** (≈26 k bbl of crude oil and 113 MMcf/d of gas) to Chevron’s worldwide production.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses both parts of the multi-hop question. (1) Quantitatively: The $27.4 billion figure for Tengizchevroil is a rounded version of the ground truth $27,368 million, and $46.6 billion matches $46,618 million when rounded. The calculated percentage of 58%–59% is correct (27,368 / 46,618 ≈ 58.7%), so minor rounding is acceptable. However, the LLM introduces a specific production volume figure of '45 thousand barrels of oil-equivalent per day' and breaks it into crude and gas components, which were not present in the original answer. While this data may be factually accurate, it goes beyond the ground truth without verification, slightly reducing quantitative precision. (2) Completeness: The LLM correctly identifies the percentage of equity method investments and links Tengizchevroil to Chevron's production, satisfying both sub-questions. (3) Entity accuracy: 'Tengizchevroil', 'Chevron', and 'Kazakhstan joint venture' are correctly identified. The year '2024' is introduced without being in the original; this is a minor issue as the original does not specify a year. (4) Reasoning: The multi-hop synthesis—linking investment size to production relevance—is sound and logically presented. (5) Semantic equivalence: The core message aligns with the ground truth: a ~58.7% stake in a major equity-method investment that significantly contributes to production. The added production details enhance context but are not corroborated by the original, preventing a perfect score. Overall, the answer is factually strong, well-reasoned, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 435,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does a change in credit spreads or upfront credit points impact the fair value measurement of Goldman Sachs' level 3 credit derivatives, and what valuation techniques are used to determine this fair value?",
      "original_answer": "An increase in credit spreads or upfront credit points leads to an increase in the fair value measurement of purchased credit protection for Goldman Sachs' level 3 derivatives. These derivatives are valued using a combination of option pricing, correlation, and discounted cash flow models.",
      "llm_answer": "A rise in credit spreads or in the upfront credit‑points input pushes the fair‑value of Goldman Sachs’ Level 3 credit‑derivative positions higher (the fair value of purchased credit protection increases when those inputs increase, and falls when they decline)【page_154】.  The firm values its credit derivatives with a mix of **option‑pricing models, correlation inputs and discounted‑cash‑flow models** (often used together)【page_154】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately states that an increase in credit spreads or upfront credit points increases the fair value of purchased credit protection for Goldman Sachs' Level 3 credit derivatives, which matches the ground truth. The directional impact (increase/decrease) is correctly described. (2) There are no numerical values requiring calculation in this question, but the qualitative financial inputs (credit spreads, upfront credit points) are correctly interpreted in terms of their effect on fair value. (3) The valuation techniques—option pricing models, correlation inputs, and discounted cash flow models—are accurately listed and correctly described as being used together, reflecting the multi-hop synthesis required from the source material. (4) All entities (Goldman Sachs, Level 3 credit derivatives, fair value measurement) are correctly identified and contextually applied. The answer is highly relevant, complete, and factually precise, warranting top scores across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 306,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does the potential failure to meet the Minimum DSCR impact AMT's ability to fund the construction of communications sites globally as outlined in their 2024 10-K filing?",
      "original_answer": "If AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) of 1.15x, an amortization period will commence, during which all excess cash flow and any amounts in the Cash Trap Reserve Account will be applied to pay down the principal of the Series 2015-2 Notes or the Loan. This would prevent AMT from receiving distributions needed to fund capital expenditures, including the construction of 1,950 to 2,550 communications sites globally. As a result, AMT may be unable to proceed with its planned tower construction, which could hinder its growth and expansion initiatives.",
      "llm_answer": "If the Minimum DSCR (1.15 ×) falls below the required level, the securitization agreements trigger an “amortization period.” During that period all excess cash flow – and any cash held in the cash‑trap reserve – must be applied each month to repay principal on the 2015‑2 Notes or the related loan, rather than being distributed to AMT. Consequently, the cash that would otherwise be used for capital expenditures is reduced, limiting AMT’s ability to fund its planned construction of roughly 1,950‑2,550 communications sites worldwide.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the Minimum DSCR is accurately stated as 1.15x, the consequence of falling below it (amortization period), the redirection of excess cash flow and cash-trap reserve funds to debt repayment, and the impact on AMT's ability to fund capital expenditures for constructing 1,950–2,550 communications sites globally. (2) Quantitative accuracy is perfect: the range '1,950–2,550' matches the original, and the DSCR threshold of 1.15x is correctly cited. Number formatting (e.g., '1,950‑2,550') is acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—linking the DSCR breach to the amortization trigger, then to restricted cash distributions, and finally to impaired capital funding for construction. The only minor omission is that the original specifies AMT would be *prevented* from receiving distributions, while the LLM says 'reduced,' which slightly understates the severity. However, the overall implication—that funding capacity is significantly constrained—is preserved. (4) Contextual relevance is excellent, directly addressing how the DSCR failure impacts global site construction as asked. The answer is concise and focused. The qualitative score is 9 due to this slight softening of the impact wording, but factual and logical alignment remains strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 388,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Caterpillar's use of historical claim rates in determining its product warranty liability influence the critical audit matter identified by PricewaterhouseCoopers LLP, and what is the resulting financial estimate of this liability as of December 31, 2024?",
      "original_answer": "Caterpillar determines its product warranty liability by applying historical claim rate experience to the current field population and dealer inventory, which involves significant judgment by management. This method was identified as a critical audit matter by PricewaterhouseCoopers LLP due to the high degree of auditor judgment, subjectivity, and effort required to evaluate the reasonableness of management's assumptions. As of December 31, 2024, the resulting financial estimate of the product warranty liability was $1,700 million.",
      "llm_answer": "Caterpillar determines its product‑warranty liability by applying historical claim‑rate experience to the current field population and dealer inventory; because this reliance on historical rates requires substantial management judgment and extensive auditor evaluation of those assumptions, PwC flagged the warranty estimate as a critical audit matter. The resulting liability that management recorded for the product warranty as of December 31, 2024 was **$1.7 billion**【page_59†L9-L15】【page_115†L13-L20】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: Caterpillar uses historical claim rates applied to current field population and dealer inventory to determine warranty liability, which involves significant management judgment; this subjectivity led PricewaterhouseCoopers LLP (PwC) to identify it as a critical audit matter due to the high degree of auditor effort and evaluation required. (2) The financial estimate of $1.7 billion as of December 31, 2024, matches the ground truth of $1,700 million—these are numerically equivalent, with acceptable format variation (billion vs. million). (3) The multi-hop reasoning is sound: the answer correctly links Caterpillar’s accounting method → management judgment → auditor scrutiny → critical audit matter designation → resulting financial estimate. (4) Entities (Caterpillar, PwC, product warranty liability, December 31, 2024) and financial metric are all correctly identified. The inclusion of citation markers (e.g., page references) further supports contextual accuracy and sourcing. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 328,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference between Disney's stated interest rate on Asia Theme Parks borrowings and the effective interest rate on its senior unsecured notes reflect the company's relative cost of capital across these debt categories?",
      "original_answer": "The stated interest rate on Asia Theme Parks borrowings is 7.93%, while the effective interest rate on Disney's senior unsecured notes is 4.71%. This indicates that the Asia Theme Parks debt carries a significantly higher cost of capital compared to the senior unsecured notes. The difference of 3.22 percentage points highlights the premium Disney pays for this specific borrowing, potentially due to factors such as risk profile, collateralization, or market conditions at the time of issuance.",
      "llm_answer": "Disney’s Asia Theme Parks borrowings carry a weighted‑average **stated coupon of 7.93 %**, whereas its senior unsecured U.S.‑dollar notes have an **effective interest rate of about 4.71 %** (the rate after accounting for swaps, issuance costs and premiums). The roughly 3.2‑percentage‑point spread shows that Disney’s capital is materially more expensive for the Asia‑park debt than for its senior unsecured notes, reflecting the higher risk‑ or currency‑related cost of that borrowing category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the stated interest rate on Asia Theme Parks borrowings as 7.93% and the effective interest rate on Disney's senior unsecured notes as 4.71%, matching the ground truth exactly. The calculated difference of approximately 3.2 percentage points is accurate (7.93 - 4.71 = 3.22), and the answer appropriately rounds it to 'roughly 3.2-percentage-point spread', which is semantically acceptable. 2) All numeric values are correct and properly contextualized. The use of 'about 4.71%' is consistent with the ground truth, and the term 'weighted-average stated coupon' adds precision without deviating from the original. 3) The reasoning correctly infers that the higher rate on Asia Theme Parks debt reflects a higher cost of capital, linking it to risk or currency factors—this aligns with the ground truth's implication of a risk premium. The answer goes slightly beyond the original by mentioning currency-related costs, which is a reasonable and plausible extension given the context, though not explicitly stated in the ground truth. 4) The answer fully addresses the question about relative cost of capital across debt categories and synthesizes the two interest rates correctly to draw a valid comparison. The only minor shortcoming is not explicitly stating the exact 3.22 percentage point difference, opting for 'roughly 3.2', which is acceptable for rounding but slightly less precise. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 415,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was Chevron's capitalized cost associated with the PDC acquisition in 2023, and in which U.S. basin was this acquisition primarily responsible for contributing 2.2 TCF of purchases in 2023?",
      "original_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, and this acquisition was primarily responsible for contributing 2.2 TCF of purchases in the DJ Basin in 2023.",
      "llm_answer": "Chevron capitalized about **$10.5 billion (≈ $10,487 million)** of costs for the PDC acquisition in 2023, and that acquisition was **primarily responsible for the 2.2 TCF of purchases in the U.S. DJ (Denver‑Julesburg) basin**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the capitalized cost is accurately reported as $10,487 million, with an acceptable rounded format of $10.5 billion; this matches the original answer exactly in substance. (2) The basin is correctly identified as the DJ Basin, also accurately expanded as the Denver-Julesburg (DJ) basin, which aligns with the ground truth. (3) The multi-hop reasoning is sound: the model correctly links Chevron’s 2023 PDC acquisition to both the financial figure and its operational impact (2.2 TCF of purchases) in the correct U.S. basin. (4) All entities—Chevron, PDC acquisition, 2023 timeframe, 2.2 TCF, and DJ Basin—are accurately identified and synthesized. No factual, numerical, or contextual errors are present; minor wording differences do not affect meaning. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 260,
        "total_tokens": 1378
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and how does this retrospective application reflect the impact of the guidance on MetLife's consolidated financial reporting?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of comprehensive income as a result of the adoption of the new LDTI accounting guidance. This retrospective application demonstrates that the LDTI guidance had a material effect on MetLife's financial reporting, specifically requiring restatement of prior period financial statements to align with the new accounting standards for long-duration insurance contracts.",
      "llm_answer": "MetLife applied the new LDTI guidance retrospectively to all of its primary consolidated statements – the statement of comprehensive income (page 164), the balance sheet (page 162), the statement of operations/income statement (page 163), the statement of equity (page 165) and the statement of cash flows (page 166). The adjustments altered the previously reported numbers (for example, net income rose by roughly $2.7 billion, assets fell about $3.5 billion, equity increased by $2.8 billion and cash‑flow from operations was reduced by $160 million), demonstrating that the new LDTI accounting principles materially reshaped MetLife’s consolidated financial results.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies that affect the correctness score. (1) The original answer states that MetLife retrospectively adjusted the consolidated statement of operations and consolidated statements of comprehensive income. However, the LLM claims that *all* primary consolidated statements were adjusted — including the balance sheet, statement of cash flows, and statement of equity — which goes beyond the ground truth and is not supported by the provided information. This overstatement reduces qualitative and quantitative accuracy. (2) The LLM introduces specific numerical adjustments (e.g., net income up $2.7B, assets down $3.5B, equity up $2.8B, cash flow down $160M), but these figures are not present in the original answer and cannot be verified against the ground truth. Since the original answer does not include any numbers, the inclusion of precise dollar amounts in the LLM response suggests fabrication or hallucination, severely impacting quantitative accuracy. (3) While the LLM correctly identifies the retrospective application of LDTI and its material impact on financial reporting — aligning with the core reasoning in the original answer — it fails to restrict its claims to the specific statements mentioned (operations and comprehensive income). The multi-hop reasoning is sound in intent but flawed in execution due to overgeneralization. (4) Contextual relevance is high because the response addresses the retrospective application of LDTI and its material effect on consolidated reporting, which is central to the question. However, the addition of unsupported details and financial figures undermines factual reliability. Overall, the answer captures the general implication of material impact but misses precision in entity and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 495,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How many amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing, and what is the effective date of the most recent amendment?",
      "original_answer": "Two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing. The most recent amendment is the Second Amendment, which became effective on January 1, 2022.",
      "llm_answer": "The filing lists two amendments to the Solar Turbines Inc. Managerial Retirement Objective Plan – a First Amendment (dated December 10, 2014) and a Second Amendment. The most recent amendment, the Second Amendment, became effective on **January 1, 2022**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that there are two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan documented in the Caterpillar Inc. 2024 10-K filing. (2) The most recent amendment is correctly identified as the Second Amendment with an effective date of January 1, 2022, which aligns with the original answer. The mention of the First Amendment's date (December 10, 2014) is additional but accurate context not required by the question and does not detract from correctness. (3) The multi-hop reasoning is sound—information about plan amendments and their effective dates was correctly synthesized from the 10-K filing. (4) All entities (Solar Turbines Inc., Managerial Retirement Objective Plan, Caterpillar Inc. 2024 10-K) are correctly identified. Semantic equivalence is maintained, and formatting variations (e.g., spacing) do not affect meaning. All scores are maximized due to complete factual accuracy, correct synthesis, and full responsiveness to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 302,
        "total_tokens": 1441
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total financial impact of the North Carolina Rate Case Order on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress, and how was this reflected in the consolidated statements of operations?",
      "original_answer": "The North Carolina Rate Case Order resulted in a total financial impact of $68 million on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress. Specifically, $35 million was recorded by Duke Energy Carolinas and $33 million by Duke Energy Progress under Impairment of Assets and Other Charges, as stated in the consolidated statements of operations.",
      "llm_answer": "The North Carolina rate‑case order reduced the “Impairment of assets and other charges” line‑item by **$13 million at Duke Energy Carolinas** (see page 52) and by **$22 million at Duke Energy Progress** (see page 53), for a **total impact of $35 million**. In the consolidated statements of operations this $35 million reduction appears as a lower “Impairment of assets and other charges” expense, which trims total operating expenses and therefore lifts consolidated operating income.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that the North Carolina Rate Case Order resulted in a total financial impact of $68 million — $35 million from Duke Energy Carolinas and $33 million from Duke Energy Progress — recorded as Impairment of Assets and Other Charges. However, the LLM claims a total impact of $35 million, with $13 million from Carolinas and $22 million from Progress, which is inconsistent with the ground truth on all counts. These numbers are not only wrong individually but also sum incorrectly: $13M + $22M = $35M, which contradicts the correct total of $68M. (2) Quantitative accuracy is severely lacking: all dollar amounts are incorrect, and the direction of impact (whether it's an increase or decrease) may also be misrepresented, as the ground truth indicates charges were recorded (i.e., expenses added), while the LLM describes a 'reduction' in expenses, implying a benefit, which contradicts the nature of an impairment charge. (3) The qualitative reasoning is partially sound in structure — the model attempts to synthesize impacts across both subsidiaries and link them to the consolidated statements of operations — but the logic is based on false premises. It correctly identifies where the information might appear (consolidated statements of operations) and understands that impairment charges affect operating expenses and operating income, but it mischaracterizes the nature of the impact (reduction vs. increase in charges). (4) Contextual relevance is moderate: the answer addresses the right entities (Duke Energy Carolinas and Progress), the correct financial line item (Impairment of Assets and Other Charges), and the correct document location (consolidated statements of operations), but due to fundamental factual and numerical errors, the overall correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 512,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What is the financial impact on Starbucks from the 12% of total net revenues generated by licensed stores, considering the structure of payments received from licensees including margins on products, royalties, and license fees?",
      "original_answer": "Starbucks receives a combination of product margins, royalties, and license fees from its licensed stores, which accounted for 12% of total net revenues in fiscal 2024. This revenue contribution is derived from the sale of branded products, supplies, and equipment to licensees, along with ongoing royalty payments based on retail sales. Despite lower per-store revenues compared to company-operated stores, the licensed model benefits Starbucks by shifting operating costs and capital investments to the licensees, thereby improving overall operating margins.",
      "llm_answer": "Licensed stores generate ≈ 12 % of Starbucks’ total net revenues (Fiscal 2024) 【page_11】.  Under the licensed‑store model Starbucks does not bear the operating or capital costs; instead it receives a margin on the branded products and supplies it sells to the licensee, a royalty on the licensee’s retail sales, and a fixed license fee 【page_11】.  Consequently, although licensed stores have a lower gross margin than company‑operated stores, the combination of product margins, royalties and fees yields a modest but profitable contribution that offsets the lower revenue share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that licensed stores accounted for approximately 12% of Starbucks' total net revenues in fiscal 2024, matching the ground truth. It accurately describes the structure of payments: margins on branded products and supplies, royalties on retail sales, and fixed license fees. The conclusion that this model shifts operating and capital costs away from Starbucks and provides a profitable contribution is consistent with the original answer.\n\n2) Quantitatively, the 12% figure is correct and properly attributed to fiscal 2024. No calculations are required beyond this percentage, and all financial structures are described without numerical error.\n\n3) The reasoning is sound and reflects multi-hop synthesis: the model connects the revenue contribution (12%) with the payment structure (product margins, royalties, fees), links this to cost-shifting benefits, and evaluates profitability despite lower per-store revenue. The only minor omission is that the original answer explicitly notes the benefit of improved overall operating margins due to cost and capital shifting—this concept is implied but not stated as clearly in the LLM answer.\n\n4) The LLM answer is semantically equivalent to the ground truth in content and intent. Wording differs slightly (e.g., 'modest but profitable contribution' vs. 'improving overall operating margins'), but the core financial impact is accurately conveyed. Contextual relevance is perfect—the response directly addresses the financial impact and payment structure as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 425,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "Given that Target's owned and exclusive brands account for approximately one-third of its sales and carry higher margins than national brands, what financial risk does Target face if it fails to successfully develop, source, and market these brands, particularly considering the longer lead times and increased responsible sourcing risks involved?",
      "original_answer": "If Target fails to successfully develop, source, and market its owned and exclusive brands—which represent approximately one-third of its overall sales and generally carry higher margins—its results of operations could be significantly adversely affected. This risk is amplified by the fact that owned brand products involve greater responsible sourcing risk due to the selection of vendors and longer lead times between order placement and product delivery. These longer lead times require earlier ownership of products in the supply chain and longer-term forecasting of consumer demand, which increases exposure to supply chain disruptions and the risk of misjudging rapidly changing consumer preferences. Since these brands contribute meaningfully to revenue and profitability, any failure in this area could directly impact financial performance.",
      "llm_answer": "If Target cannot develop, source and market its owned‑and‑exclusive brands—products that make up roughly one‑third of sales and earn higher margins—it risks a material hit to its results of operations and overall financial condition.  The longer lead times and greater responsible‑sourcing exposure for these brands amplify supply‑chain disruption risk and can erode margins, lower sales and increase costs, thereby depressing profitability【page_11】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core risks outlined in the ground truth. (1) Quantitatively, it correctly states that owned and exclusive brands make up 'roughly one-third of sales,' matching the original answer's 'approximately one-third of its overall sales'—minor wording variation but semantically equivalent. No other numerical values are involved. (2) The LLM captures the higher margins, longer lead times, and responsible sourcing risks, linking them to supply chain disruptions, margin erosion, lower sales, and increased costs. It correctly identifies the financial impact on results of operations and profitability. (3) The multi-hop reasoning is sound: it connects the strategic importance of owned brands (sales and margin contribution) with operational risks (lead times, sourcing) and financial outcomes. The only minor omission is not explicitly mentioning 'longer-term forecasting of consumer demand' and 'misjudging rapidly changing preferences,' which are part of the risk from longer lead times in the original. However, the reference to supply chain disruption and profitability impact implies these elements. (4) All entities (Target, owned and exclusive brands) and financial concepts (margins, sales, operations) are accurate. The answer is fully relevant and well-synthesized. A score of 9 is justified due to this slight reduction in detail on demand forecasting, but overall the answer is factually correct and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 404,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many amendments to the Caterpillar Inc. Deferred Employees' Investment Plan were incorporated into the 2024 10-K filing by reference from prior SEC filings, and which specific SEC filings contained the most recent two amendments?",
      "original_answer": "There were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K filing. The most recent two amendments were: the Third Amendment, effective January 1, 2022, which was incorporated by reference from Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021; and the Fourth Amendment, effective as of July 1, 2022, which was incorporated by reference from Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "llm_answer": "The 2024 Form 10‑K incorporates **five** amendments to the Caterpillar Inc. Deferred Employees’ Investment Plan (the 2017 amendment‑and‑restatement plus four subsequent amendments).  \n\nThe two most recent amendments are:  \n\n* **Fourth Amendment** (effective July 1 2022) – incorporated by reference to the **Company’s Quarterly Report on Form 10‑Q for the quarter ended September 30 2022**.  \n* **Third Amendment** (effective January 1 2022) – incorporated by reference to the **Company’s Annual Report on Form 10‑K for the year ended December 31 2021**.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a critical quantitative error: it states that five amendments were incorporated, while the ground truth specifies four amendments (the 2017 version is the restated plan, not counted as an amendment in this context). The question asks specifically for the number of amendments incorporated by reference, and the correct count is four. However, the LLM correctly identifies the two most recent amendments—the Third and Fourth—and their effective dates (January 1, 2022, and July 1, 2022), which matches the ground truth. It also correctly identifies the source filings: the Third Amendment from the 2021 10-K (Exhibit 10.28) and the Fourth Amendment from the Q3 2022 10-Q (Exhibit 10.6), though the exhibit numbers are omitted in the LLM response. The reasoning and synthesis across filings are sound, and the answer addresses both parts of the multi-hop question. The wording order (listing Fourth before Third) does not affect accuracy as long as both are clearly labeled. The core factual error in the total number of amendments prevents a higher score, but the key details about the most recent two amendments are accurate. Hence, quantitative accuracy is penalized, but qualitative reasoning and contextual relevance remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 355,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many shares remain available for future grant or issuance under the 2013 Equity Incentive Plan, and what types of equity awards were outstanding related to this plan according to the 2024 10-K filing?",
      "original_answer": "73 shares remain available for future grant or issuance under the 2013 Equity Incentive Plan. The types of equity awards outstanding related to this plan include options outstanding and restricted stock awards and units and performance-based stock units outstanding.",
      "llm_answer": "The filing shows that **73 million shares are still reserved for future grant or issuance under the 2013 Equity Incentive Plan**. At the same time, the plan had **approximately 8 million stock options outstanding and about 26 million restricted‑stock awards (including RSUs and performance‑based stock units) outstanding**.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative claims. The ground truth states that 73 shares (not million) remain available for future grant under the 2013 Equity Incentive Plan. The LLM incorrectly reports this as 73 million shares, which is off by a factor of one million. Additionally, the ground truth does not provide specific numbers for outstanding awards (e.g., 8 million options or 26 million restricted stock awards), so these figures are fabricated or hallucinated. (2) Number verification: The only correct number is the 73 shares available, but the magnitude is wrong (73 vs 73 million). No calculations were required, but the introduction of unsupported figures (8 million, 26 million) severely undermines accuracy. (3) Multi-hop reasoning: The question asks for two pieces of information—shares available and types of awards outstanding. The LLM identifies the correct plan and attempts to address both parts, but fails on both counts—wrong quantity and invents numerical breakdowns not present in the original. The types of awards (options, restricted stock, RSUs, performance-based units) are generally consistent with the ground truth, but the LLM bundles them with false quantities. (4) Justification: The correctness score is low (2) due to major factual and quantitative errors. Quantitative accuracy is 1 because the numbers are almost entirely incorrect or hallucinated. Qualitative accuracy is 3 because while the types of awards are semantically aligned, they are presented with false precision. Contextual relevance is 6 because the answer addresses the right plan and topic but distorts the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 451,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What percentage of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, given that most of these revenues come from product sales and royalties through this partnership?",
      "original_answer": "The majority of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, as stated in the document. While an exact percentage is not provided, the document specifies that 'most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.' This indicates that the percentage is greater than 50% but the exact figure is not disclosed.",
      "llm_answer": "Starbucks says that “most” of its Channel Development revenues come from product sales and royalty revenues earned through the Global Coffee Alliance with Nestlé. In other words, more than 50 percent of the fiscal‑2024 Channel Development revenue ($1.77 billion) is derived from that partnership.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the key qualitative point from the ground truth: that 'most' (i.e., more than 50%) of Starbucks' Channel Development revenues in fiscal 2024 come from the Global Coffee Alliance with Nestlé, based on product sales and royalties. This aligns with the original answer's interpretation that the percentage exceeds 50%, even though an exact figure is not disclosed. However, the LLM introduces a specific dollar amount—'$1.77 billion'—for Channel Development revenue, which is not present in the original answer or supported by the provided context. This number may be factually accurate but cannot be verified from the ground truth statement and thus introduces unverified quantitative detail. While 'most' implies over 50%, the addition of a precise revenue figure without confirmation reduces quantitative accuracy. The reasoning is otherwise sound, correctly interpreting 'most' as >50%, and the entities (Starbucks, Nestlé, Global Coffee Alliance, fiscal 2024, Channel Development) are accurate. The answer is contextually relevant and semantically close to the original, but the unsupported revenue number prevents a top score in correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 337,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and which specific effects are illustrated in tables presented as of December 31 according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of cash flows as a result of the adoption of the new LDTI accounting guidance. These adjustments are illustrated in tables presented as of December 31 in the 2023 10-K filing.",
      "llm_answer": "MetLife applied the new LDTI guidance retrospectively to all of its primary financial statements – the consolidated balance sheet, statement of operations (income statement), statement of comprehensive income, statement of cash flows and statement of equity.  For each statement a “as‑previously reported,” “adoption adjustment” and “post‑adoption” column is shown in tables that present the effects of the LDTI adoption as of December 31 (2022, with 2021 comparatives).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in entity identification and completeness. The ground truth states that MetLife retrospectively adjusted only the consolidated statement of operations and consolidated statements of cash flows due to the LDTI adoption. However, the LLM answer incorrectly expands this to include the consolidated balance sheet, statement of comprehensive income, and statement of equity, which are not mentioned in the original answer. This overstatement reflects a failure in qualitative accuracy and entity precision. While the mention of 'tables presented as of December 31' aligns with the original (and the comparative use of 2022 and 2021 data is plausible contextually), the original answer does not specify which years' tables are shown, so that detail is an unsupported addition. The LLM also misrepresents the scope of the adjustment by implying all primary financial statements were adjusted, when only two were explicitly adjusted according to the ground truth. Quantitative accuracy is acceptable because no explicit numbers are incorrect—just extra, unverified details added. Contextual relevance is high because the response stays on topic and addresses the LDTI adoption effects. However, the core factual error in identifying the affected financial statements reduces correctness significantly. Multi-hop reasoning is flawed because the model failed to precisely extract and synthesize only what was stated, instead inferring broader impacts without evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 419,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the value of equity method investment contracts compare to total asset derivatives in 2022, and what does this indicate about their relative significance in MDLZ's derivative portfolio?",
      "original_answer": "In 2022, the value of equity method investment contracts was $3 million, while the total value of asset derivatives was $393 million. This indicates that equity method investment contracts represented less than 1% of the total asset derivatives portfolio, highlighting their minimal relative significance in MDLZ's overall derivative holdings.",
      "llm_answer": "In 2022 the equity‑method investment contracts were recorded at a **$3 million liability** (the table shows no asset amount). By contrast, the **total asset‑side derivative exposure was $393 million**. Thus, equity‑method investment contracts represented only about 0.8 % of the overall asset‑derivative balance, indicating they were a very minor component of Mondelez’s derivative portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $3 million for equity method investment contracts and $393 million for total asset derivatives. The calculated percentage (0.8%) is accurate (3/393 ≈ 0.00763 or 0.763%, which rounds to 0.8%), and the year 2022 is correctly referenced. (2) The answer addresses both parts of the question: it compares the values and interprets the relative significance. The slight discrepancy is the characterization of the $3 million as a 'liability'—while technically precise based on the table (if no asset was recorded), the original answer treats it neutrally as a 'value.' However, this does not contradict the ground truth, which focuses on magnitude rather than balance sheet classification. (3) Entity accuracy is strong: MDLZ (Mondelez) is correctly identified, and the financial metrics are properly interpreted. (4) The reasoning is sound: the model correctly computes the relative size and concludes minimal significance, equivalent to 'less than 1%' in the original answer. The phrase 'very minor component' is semantically equivalent to 'minimal relative significance.' Overall, the answer is factually correct, complete, and well-reasoned, warranting a high score with only minor nuance in presentation preventing a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 373,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the freezing of U.S. pension benefits as of December 31, 2019, specifically impact the actuarial assumptions used by CAT in its postemployment benefit plan accounting?",
      "original_answer": "The freezing of U.S. pension benefits as of December 31, 2019, directly affected the actuarial assumptions used by CAT, particularly resulting in the discontinuation of the 'expected rate of compensation increase' assumption, as this was no longer applicable under the new frozen benefit structure.",
      "llm_answer": "The 2019 freeze of all U.S. pension benefits means Caterpillar no longer applies a “rate of compensation increase” when measuring its U.S. pension obligations. In the actuarial‑assumption tables (page 46) the compensation‑increase line for U.S. pension benefits is shown as “‑ %” for 2022‑2024, and the footnote states that because the benefits were frozen, the expected compensation‑increase assumption is no longer applicable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies that the freezing of U.S. pension benefits as of December 31, 2019, led Caterpillar (CAT) to discontinue using the 'expected rate of compensation increase' assumption in its actuarial calculations. The answer provides additional contextual support by referencing the actuarial assumption tables (page 46) and noting the '‑%' entry for 2022–2024, which correctly reflects the discontinuation. The date (2019 freeze) and the specific assumption impacted are both accurate. The only minor limitation is that the original answer emphasizes the *direct effect* on actuarial assumptions more explicitly, while the LLM answer includes extraneous detail about reporting periods (2022–2024), which, while correct, slightly shifts focus. However, all core facts, entities (CAT, U.S. pension benefits, actuarial assumptions), and reasoning are sound and semantically equivalent. No calculation errors; numbers and dates match or are consistent with the ground truth. Multi-hop reasoning is correctly applied: linking the benefit freeze to the removal of a specific actuarial assumption.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 330,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as reflected in its hardware revenue structure, impact its ability to manage supply chain disruptions and maintain profitability in its hardware business?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which constitute a significant portion of its hardware revenues, makes the company more vulnerable to supply chain disruptions because these systems are complex and rely on timely delivery of components from third-party suppliers. According to the 10-K filing, supply chain shortages have increased production costs and led to higher inventory purchases to secure manufacturing capacity, which in turn has increased inventory excess and obsolescence risk and negatively impacted operating cash flows. This dynamic directly affects Oracle's ability to maintain profitability in its hardware business, as it cannot always pass these increased costs on to customers, and delays in manufacturing can lead to lost sales and delayed revenue recognition.",
      "llm_answer": "Oracle’s hardware strategy now concentrates on the higher‑margin Oracle Engineered Systems and other “strategic” appliances while de‑emphasizing lower‑margin commodity servers and storage.  This focus helps preserve profitability even as overall hardware revenues have been falling, because the engineered‑systems line contributes a larger share of the hardware profit pool.  However, the business still relies on a limited set of third‑party component suppliers, so the same supply‑chain shortages and manufacturing delays that Oracle cites (COVID‑19‑related component constraints, single‑source parts, logistics disruptions) can raise production costs and threaten those margins, requiring the company to hold extra inventory and absorb cost increases to keep the engineered‑systems segment profitable. 【page_23】",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately captures Oracle's strategic focus on higher-margin Oracle Engineered Systems and the associated risks from supply chain disruptions. The answer correctly identifies that Oracle relies on third-party suppliers, faces component shortages (including due to COVID-19), and must hold extra inventory, which increases costs and affects profitability. These points are consistent with the original answer. (2) There are no specific numbers, dates, or financial figures mentioned in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the model connects Oracle's product strategy (engineered systems) to supply chain dependencies, cost pressures, inventory risks, and margin protection. However, the LLM answer omits explicit mention of the impact on operating cash flows and the risk of inventory obsolescence, which are key elements in the ground truth and important for full completeness. It also does not state that Oracle cannot always pass cost increases to customers, a critical nuance affecting profitability. (4) Despite these omissions, the answer remains contextually relevant and semantically close to the original, with accurate entity identification (Oracle, Engineered Systems, third-party suppliers) and correct qualitative logic. The score is reduced slightly for missing key details that affect completeness, but the core reasoning and factual accuracy are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 430,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area, and how does this total compare in percentage growth to the overall Pulmonary Hypertension category's 2023 growth rate?",
      "original_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT is $3,555 million ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI). This represents a 10.6% growth for OPSUMIT and a 19.7% growth for UPTRAVI, which are both higher than the overall Pulmonary Hypertension category's 11.6% growth rate in 2023.",
      "llm_answer": "In 2023 the worldwide sales of the two Pulmonary Hypertension drugs were:\n\n- **OPSUMIT:** $1,973 million  \n- **UPTRAVI:** $1,582 million  \n\n**Combined 2023 revenue:** **$3,555 million** (≈ $3.6 billion).\n\nCompared with their 2022 totals ($1,783 m + $1,322 m = $3,105 m), the pair grew about **14.5 %** year‑over‑year, which is roughly **3 percentage points higher** than the overall Pulmonary Hypertension category’s growth rate of **11.6 %** in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the individual 2023 sales figures for OPSUMIT ($1,973 million) and UPTRAVI ($1,582 million), and their combined revenue ($3,555 million), which matches the ground truth. However, it introduces a significant error in calculating the year-over-year growth rate for the combined sales. The LLM computes a 14.5% growth rate based on 2022 totals ($1,783M + $1,322M = $3,105M), but this calculation is not supported by the ground truth, which does not provide or imply these 2022 figures. Instead, the ground truth specifies individual growth rates: 10.6% for OPSUMIT and 19.7% for UPTRAVI. The LLM incorrectly aggregates these into a single 14.5% combined growth rate, which is not a valid synthesis of the provided data. (2) The overall Pulmonary Hypertension category growth rate of 11.6% is correctly cited. However, the comparison is flawed: the ground truth states that *both* drugs individually grew faster than the category (10.6% > 11.6%? No — this is actually incorrect in the ground truth; 10.6% < 11.6%, so OPSUMIT did *not* outperform the category). This reveals a potential error in the ground truth logic. However, the LLM’s claim that the *combined* growth (14.5%) exceeds the category (11.6%) by 3 percentage points is based on an incorrect aggregate growth calculation. (3) The multi-hop reasoning is partially sound — the model identifies the correct drugs, correct revenues, and correct category growth rate — but fails in accurately comparing growth because it fabricates a combined growth rate not derivable from the given data. It also does not report the individual growth rates as stated in the ground truth. (4) Scores reflect that core revenue numbers are accurate (quantitative accuracy = 6), but reasoning and synthesis are flawed due to incorrect growth calculation and misrepresentation of comparative performance. Contextual relevance is full as all entities and metrics are on-topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 527,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "By how much did the full-year contribution from legacy PDC Energy assets increase U.S. upstream earnings for CVX in 2024, and what was the corresponding impact on net oil-equivalent production?",
      "original_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX by $2.2 billion in 2024, and it contributed to a 19% increase in net oil-equivalent production, or 250,000 barrels per day.",
      "llm_answer": "The full‑year contribution from the legacy PDC Energy assets helped lift U.S. upstream earnings by about **$3.5 billion in 2024**, and it was reflected in a **rise of roughly 250,000 barrels of oil‑equivalent per day (about a 19 % increase) in net production**.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the impact on net oil-equivalent production as 250,000 barrels per day and a 19% increase, which matches the ground truth. However, it incorrectly states the increase in U.S. upstream earnings as $3.5 billion instead of the correct $2.2 billion. This is a significant quantitative error affecting the core of the question. (2) Number verification: The production figures (250,000 bbl/d and 19%) are accurate; however, the earnings figure is off by $1.3 billion. No calculation is required beyond reporting, but the reported value is factually wrong. (3) Multi-hop reasoning: The model correctly synthesizes the impact across earnings and production metrics and attributes them to the correct entity (legacy PDC Energy assets) and time frame (2024). It also links the assets to CVX’s U.S. upstream segment appropriately. (4) The contextual relevance is high because the answer addresses both parts of the question and uses appropriate terminology. The qualitative accuracy is moderate because the reasoning structure is sound, but the key financial figure is incorrect, which reduces overall correctness. The correctness score is 5 due to partial accuracy—half the key data points are correct, but the error in earnings is material.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 359,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific financial statements were adjusted as a result of MetLife's retrospective application of the new LDTI accounting guidance, and what does this imply about the scope of the guidance's impact on the company's financial reporting?",
      "original_answer": "MetLife adjusted both its previously reported consolidated statements of equity and consolidated statements of comprehensive income as a result of the retrospective application of the new LDTI accounting guidance. This implies that the guidance had a broad impact on the company's financial reporting, affecting not only comprehensive income but also the presentation of equity, which reflects the materiality and foundational nature of the changes required under the new accounting rules.",
      "llm_answer": "MetLife restated its **consolidated statements of comprehensive income (including other‑comprehensive‑income), the statement of operations, the balance sheet, the statement of equity and the statement of cash flows** to reflect the retrospective application of the new LDTI guidance. This breadth of restatements indicates that the LDTI changes affect virtually every major component of the company’s financial reporting—not just a single line item—by altering the measurement of policy‑holder benefits, discount‑rate remeasurements and related items across income, assets, liabilities, equity and cash‑flow presentation.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in spirit but factually inaccurate in key aspects. (1) The original answer states that MetLife adjusted only the 'consolidated statements of equity' and 'consolidated statements of comprehensive income' due to the retrospective application of LDTI guidance. However, the LLM answer claims restatements to five financial statements: comprehensive income, statement of operations, balance sheet, statement of equity, and statement of cash flows—going significantly beyond the ground truth. There is no mention in the original answer of restatements to the balance sheet, statement of operations, or statement of cash flows, which makes these additions incorrect. (2) No numeric values, dates, or percentages are present in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: while the LLM correctly infers broad impact from multiple restatements, it fabricates the scope. The implication about broad impact is reasonable and aligns with the original answer’s interpretation, but it is based on incorrect premises. The original answer derives the 'broad impact' conclusion from just two adjusted statements, emphasizing materiality and foundational changes, not quantity. (4) Contextual relevance is high because the LLM addresses both parts of the question—identifying adjusted statements and interpreting the implications—and uses appropriate financial terminology. However, the overstatement of restated statements undermines factual correctness. The core error is entity/reporting accuracy: the LLM invents financial statements that were not mentioned in the ground truth, leading to a significant drop in qualitative and overall correctness scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 483,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What was the total fair value of equity method investment contracts as disclosed in the derivatives fair value table as of December 31, 2022, and how does this compare to the total fair value of net investment hedge contracts in the same period?",
      "original_answer": "The total fair value of equity method investment contracts as of December 31, 2022, was $(3) million, while the total fair value of net investment hedge contracts was $24 million. Therefore, the equity method investment contracts had a significantly smaller fair value compared to net investment hedge contracts during the same period.",
      "llm_answer": "The derivatives‑fair‑value table shows that, as of December 31 2022, the equity‑method investment contracts had a disclosed fair value of **$3 million (liability side only)**.  \n\nIn the same table, net‑investment‑hedge contracts were shown with a fair‑value asset of **$265 million** and a liability of **$241 million**, for a combined fair‑value total of **$506 million**.  \n\nThus, the net‑investment‑hedge contracts were roughly **$503 million larger** than the equity‑method investment contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, the fair value of equity method investment contracts was $(3) million (a liability of $3 million), which the LLM partially captures but misrepresents as '$3 million (liability side only)' without acknowledging the negative sign, which is critical in financial reporting. More critically, the LLM states that net investment hedge contracts had a combined fair value of $506 million ($265M asset - $241M liability), but this is incorrect: the ground truth reports the total fair value as $24 million. The LLM appears to have misread or miscalculated the net value, instead summing absolute values or misunderstanding net presentation. (2) The quantitative inaccuracies are severe: the correct comparison is $3M liability vs $24M asset, yielding a difference of about $27M, not $503M. The LLM’s calculation is off by orders of magnitude. (3) The reasoning is flawed in the multi-hop synthesis: the model fails to correctly extract and net the derivative positions for net investment hedges, suggesting a misunderstanding of how fair values are reported (net asset/liability vs gross). It also fails to properly interpret negative values, undermining the comparison. (4) While the LLM addresses the right table and general concepts (equity method investments, net investment hedges, fair value), the severe numerical and calculation errors drastically reduce correctness. Contextual relevance is moderate as it attempts the right analysis, but factual accuracy is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 430,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the change in Universal Beijing Resort's net assets from December 31, 2023, to December 31, 2024, and how does this reflect the financial activity reported in Comcast's consolidated balance sheets?",
      "original_answer": "The net assets of Universal Beijing Resort decreased by $0.5 billion, from $0.6 billion on December 31, 2023 ($7.8B assets - $7.2B liabilities), to $0.3 billion on December 31, 2024 ($7.3B assets - $7.0B liabilities). This reflects a reduction in both assets and liabilities, indicating potential ongoing operational or investment adjustments during the year.",
      "llm_answer": "Universal Beijing Resort’s net assets fell from about $0.6 billion at year‑end 2023 (assets $7.8 billion – liabilities $7.2 billion) to roughly $0.3 billion at year‑end 2024 (assets $7.3 billion – liabilities $7.0 billion), a decline of approximately $0.3 billion. This drop is reflected in Comcast’s consolidated balance sheets, where the resort’s lower asset total and modest liability reduction are incorporated into the overall assets‑liabilities composition of the company.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a critical error in the calculated change in net assets: it states a decline of approximately $0.3 billion, whereas the ground truth correctly reports a $0.5 billion decrease (from $0.6B to $0.3B is a $0.3B drop, but the original answer computes the change as $0.5B, which contradicts its own numbers—this suggests the ground truth may have an internal inconsistency). However, the LLM uses the correct starting and ending net asset values ($0.6B and $0.3B), so the actual change should be $0.3B, meaning the LLM's calculation is numerically correct based on the provided figures, but the ground truth claims a $0.5B change from the same inputs, which is mathematically incorrect. This creates ambiguity in scoring. Assuming the ground truth intended to say the change was $0.3B, then the LLM is correct; however, as written, the ground truth asserts a $0.5B change from $0.6B to $0.3B, which is wrong. Given that the LLM correctly computes $0.6B → $0.3B = $0.3B decrease, it is quantitatively accurate, but the evaluation must align with the ground truth. Since the ground truth states '$0.5 billion' change despite supporting numbers indicating $0.3B, and the LLM contradicts this by stating $0.3B, the LLM is marked down for disagreeing with the (flawed) ground truth. (2) All other numbers—assets and liabilities for both years—are accurately reported: $7.8B/$7.2B in 2023 and $7.3B/$7.0B in 2024. Net assets are correctly derived as $0.6B and $0.3B. (3) The multi-hop reasoning is sound: the LLM identifies Universal Beijing Resort’s balance sheet items within Comcast’s consolidated statements, correctly infers net assets, and links the change to Comcast’s reporting. (4) The qualitative reasoning and contextual relevance are strong—the answer explains the trend and ties it to Comcast’s consolidated financials appropriately. However, due to the discrepancy in the reported change amount (LLM says $0.3B, ground truth says $0.5B despite math suggesting $0.3B), the quantitative accuracy is penalized because the evaluation must favor the provided ground truth even if potentially flawed. Final scores reflect partial correctness: quantitative accuracy reduced due to mismatch with stated change in ground truth, but strong performance in reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 610,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29, 2024, and how does the 2021 Revolving Credit Agreement explicitly support the commercial paper program in terms of borrowing capacity and usage?",
      "original_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is $103.6 million, consisting of a ¥5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a ¥10.0 billion ($69.1 million) facility maturing on March 27, 2025. The 2021 Revolving Credit Agreement supports the commercial paper program by requiring that all outstanding amounts under the program be backstopped by available commitments under the 2021 credit facility. The commercial paper program allows Starbucks to issue unsecured notes up to $3.0 billion, with proceeds used for working capital needs, capital expenditures, business expansion, cash dividends, and share repurchases.",
      "llm_answer": "As of September 29 2024 Starbucks had two Japanese‑yen credit facilities – ¥5 billion (≈ $34.5 million) and ¥10 billion (≈ $69.1 million) – for a combined USD value of about **$103.6 million**.  \n\nThe 2021 unsecured five‑year revolving credit facility (up to $3 billion, with an optional $1 billion increase) is expressly designated to back‑stop the commercial‑paper program: the company may issue unsecured commercial‑paper notes up to a $3 billion aggregate limit, and any amounts outstanding must be supported by available commitments under the 2021 revolving credit facility, which can be drawn for working‑capital, capital‑expenditure and other corporate purposes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the two yen-denominated facilities are accurately reported: ¥5.0 billion = $34.5 million and ¥10.0 billion = $69.1 million, summing to $103.6 million total, which is correctly stated. The date (September 29, 2024) is properly referenced. (2) The explanation of the 2021 Revolving Credit Agreement's role in backstopping the commercial paper program is accurate: it correctly states that outstanding commercial paper must be supported by available commitments under the $3 billion revolving facility. The $3 billion aggregate limit for commercial paper issuance is correctly noted. (3) Multi-hop reasoning is sound—information is synthesized across currency conversion, facility terms, and interlinked credit structures. (4) All entities (Starbucks, 2021 Revolving Credit Agreement, commercial paper program) and their functional relationships are correctly identified. Wording differs slightly but maintains full semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 308,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as part of its hardware business, impact both its infrastructure technologies revenue and its exposure to supply chain risks?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which are part of its hardware business, contributes to its infrastructure technologies revenue by offering integrated, high-performance solutions such as the Oracle Exadata Database Machine. These systems are designed to improve performance, availability, and scalability for Oracle Database workloads, which supports Oracle's broader infrastructure technologies offerings. Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022, indicating the importance of these technologies to Oracle's financial performance. However, this strategic emphasis also increases Oracle's exposure to supply chain risks. As noted in the second chunk, Oracle depends on suppliers for critical technologies and components, some of which are sourced from single vendors. The company experienced manufacturing and fulfillment delays during fiscal 2022 due to supply chain disruptions, particularly those caused by the COVID-19 pandemic. These delays led to increased inventory purchases, which in turn raised inventory excess and obsolescence risk and negatively impacted operating cash flows. Thus, while Oracle Engineered Systems are a key part of Oracle's infrastructure technologies and contribute to revenue, they also expose the company to material risks related to supply chain constraints and logistics delays.",
      "llm_answer": "Oracle’s hardware strategy now concentrates on its higher‑margin Oracle Engineered Systems product line, which is counted as part of its “infrastructure technologies” sold through the hardware business and therefore lifts revenue from that segment. At the same time, because Engineered Systems rely on a limited set of specialized components that are sourced from a few third‑party manufacturers, the company’s focus on these systems increases its exposure to supply‑chain disruptions, component shortages and manufacturing‑logistics delays.【page_23】【page_23】",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in its core claims and aligns well with the ground truth, but lacks some completeness in addressing all aspects of the question, particularly the quantitative financial context and specific impacts on operating cash flows and inventory risks. (1) Quantitatively, there are no numbers, percentages, or dates in the LLM answer, so no inaccuracies—however, it omits the key statistic from the original answer that infrastructure cloud services and license support revenues represented 58% of total cloud services and license support revenues in fiscal 2022. This omission reduces completeness. (2) The LLM correctly identifies that Oracle Engineered Systems contribute to infrastructure technologies revenue and increase supply chain risk due to reliance on specialized components and third-party manufacturers. It also correctly links this to supply chain disruptions, shortages, and logistics delays. (3) The multi-hop reasoning is sound: it connects Oracle's strategic focus on Engineered Systems → reliance on limited suppliers → increased supply chain risk. However, it misses the deeper synthesis that such disruptions led to increased inventory purchases, higher obsolescence risk, and negative impacts on operating cash flows during fiscal 2022, which are critical consequences mentioned in the ground truth. (4) Entity accuracy is strong: Oracle, Engineered Systems, infrastructure technologies, and supply chain risks are all correctly identified. Wording differs but meaning is semantically aligned. The answer is highly relevant and well-structured, but partial omissions in financial impact and specific risk outcomes prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 458,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What was the change in Universal Beijing Resort's debt from 2023 to 2024, and how did this affect the total 'Debt Not Guaranteed' category?",
      "original_answer": "The Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion. This contributed to the overall 'Debt Not Guaranteed' category decreasing from $5.0 billion in 2023 to $4.8 billion in 2024, alongside a decrease in 'Other' debt from $1.5 billion to $1.4 billion.",
      "llm_answer": "Universal Beijing Resort’s debt fell from $3.5 billion in 2023 to $3.4 billion in 2024 – a decrease of $0.1 billion. That decline was part of a broader drop in the “Debt Not Guaranteed” category, which fell from $5.0 billion to $4.8 billion, a total reduction of $0.2 billion.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the decrease in Universal Beijing Resort's debt from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion, which matches the ground truth. It also accurately reports the change in the 'Debt Not Guaranteed' category from $5.0 billion to $4.8 billion, a $0.2 billion decrease. However, the LLM answer omits the additional detail from the original answer explaining that the broader drop in 'Debt Not Guaranteed' was due not only to the Universal Beijing Resort's debt reduction but also a decrease in 'Other' debt from $1.5 billion to $1.4 billion. While the quantitative facts and core reasoning are correct, this missing context slightly weakens the completeness of the multi-hop synthesis. The entity names, years, and financial metrics are accurate, and the reasoning is logically sound, though less detailed than the ground truth. The answer remains semantically close and highly relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 277,
        "total_tokens": 1425
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Honeywell's use of the cost-to-cost input method for long-term contracts influence the complexity of its audit procedures, particularly in relation to the estimation of contract costs and the recognition of revenue over time?",
      "original_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts significantly increases the complexity of its audit procedures because it requires extensive auditor judgment to evaluate the reasonableness and consistency of management's estimates of total contract costs and progress toward completion. Given that contract costs can span several years and are influenced by factors such as inflationary trends, technical and schedule risk, subcontractor performance, and labor agreements, auditors must perform detailed procedures to test controls, validate assumptions, and profile contracts with longer durations or significant gross margin changes. This complexity is further heightened by the fact that revenue recognition under this method depends on the proportion of costs incurred to date relative to total estimated costs, which can lead to material adjustments if estimates change over time.",
      "llm_answer": "Honeywell measures progress on long‑term contracts with the cost‑to‑cost input method, which means revenue is recognized in proportion to the costs incurred to date versus the total estimated cost at completion. Because the total cost estimate must be forecast for contracts that can span many years and involve many judgmental inputs (inflation trends, technical and schedule risks, subcontractor performance, labor agreements, etc.), the auditors must devote extensive procedures to evaluate those cost estimates and the related revenue recognition. Accordingly, Deloitte tested the effectiveness of internal controls over the cost‑estimation process, reviewed management’s assumptions, performed analytical and detailed contract testing, and profiled high‑margin or loss‑prone contracts to ensure the cost‑to‑cost calculations and the resulting revenue recognitions were appropriate and free of bias.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Honeywell uses the cost-to-cost input method, which requires estimating total contract costs over long durations involving judgmental inputs like inflation, technical risk, subcontractor performance, and labor agreements. Auditors must perform extensive procedures to evaluate these estimates and revenue recognition. The LLM correctly identifies Deloitte (Honeywell’s auditor) testing internal controls, reviewing assumptions, performing analytical and detailed testing, and profiling high-risk contracts. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly links the use of the cost-to-cost method to the need for forward-looking cost estimates, which introduces estimation uncertainty, thereby increasing audit complexity. It appropriately infers that auditors respond with specific procedures to mitigate risk of misstatement. (4) The only minor shortcoming is that the LLM answer adds a specific auditor name (Deloitte) and slightly more procedural detail (e.g., 'high-margin or loss-prone contracts') not explicitly stated in the original ground truth. However, this does not contradict the original and is plausibly consistent with standard audit practice. The core explanation about increased audit complexity due to judgmental cost estimates and the need for detailed auditor scrutiny is fully aligned. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight over-specificity, but remains factually sound and contextually perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 473,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "In NEE's 2023 financial results, what was the difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains included in net income and FPL's $300 million of gains included in net income, and how does this reflect the different treatment of derivative transactions between the two business units as disclosed in the 10-K filing?",
      "original_answer": "The difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains and FPL's $300 million of gains included in net income was $1,429 million. This significant difference reflects the distinct treatment of derivative transactions between the two business units. According to the 10-K filing, NEER's non-qualifying hedge activity was a primary driver of its improved results in 2023 compared to 2022, with approximately $1,729 million of gains included in NEER's net income. In contrast, FPL's derivative transactions are largely deferred as regulatory assets or liabilities until contract settlement, with only $300 million of gains passed through to net income in 2023. This reflects FPL's regulatory framework where most changes in fair value of energy derivatives are deferred rather than immediately impacting earnings, unlike NEER's market-oriented operations where non-qualifying hedges directly affect net income volatility.",
      "llm_answer": "The 2023 filing shows NEER recorded about **$1,729 million** of non‑qualifying hedge gains in net income versus roughly **$300 million** of gains for FPL – a magnitude gap of **approximately $1.43 billion**. This gap reflects the differing accounting treatment: NEER’s non‑qualifying hedge positions are marked‑to‑market and recognized directly in earnings, while FPL’s derivative gains are largely deferred as regulatory assets or liabilities and only flow through earnings via the fuel‑clause on settlement, resulting in a much smaller amount reported in net income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: NEER's $1,729 million and FPL's $300 million gains are accurately reported, and the difference is correctly calculated as $1.43 billion (equivalent to $1,429 million in the ground truth). The minor rounding from $1,429 million to $1.43 billion is acceptable and common in financial reporting. (2) Quantitative accuracy is perfect: both input figures match the ground truth, and the difference is mathematically correct ($1,729M - $300M = $1,429M ≈ $1.43B). Number formats are appropriately varied but semantically equivalent. (3) The reasoning correctly captures the multi-hop synthesis: it distinguishes NEER’s market-based accounting (mark-to-market gains directly in earnings) from FPL’s regulated model (deferral of most derivative gains as regulatory assets/liabilities, with limited pass-through via fuel clause). This aligns with the 10-K disclosure about differing treatment impacting net income volatility. (4) The answer is contextually complete and relevant, addressing both the quantitative difference and the accounting rationale. The only minor shortcoming is that it does not explicitly state that NEER’s hedges were a 'primary driver' of improved results year-over-year as noted in the original answer, slightly reducing qualitative completeness. However, the core reasoning and factual content are sound, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 392,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Comcast's ownership stake in Universal Beijing Resort influence the assets and liabilities reported in its consolidated balance sheets as of December 31, 2024, and what proportion of the total debt financing does Comcast's maximum risk of financial loss represent?",
      "original_answer": "Comcast owns a 30% interest in Universal Beijing Resort, which it consolidates due to its determination that Universal Beijing Resort is a VIE and Comcast has the power to direct its major activities. As of December 31, 2024, Universal Beijing Resort had $7.3 billion in assets and $7.0 billion in liabilities, which are fully included in Comcast’s consolidated balance sheet. Universal Beijing Resort had $3.4 billion in debt outstanding, and Comcast’s maximum risk of financial loss is limited to its 30% equity interest, which equates to 30% of the total debt, or $1.02 billion.",
      "llm_answer": "Comcast’s 30 % ownership of Universal Beijing Resort means that the resort’s $7.3 billion of assets and $7.0 billion of liabilities are consolidated into Comcast’s balance sheet as of December 31 2024 (Note 7).  Because Comcast’s exposure is limited to its 30 % equity interest, its maximum risk of loss equals roughly 30 % of the resort’s $3.4 billion of debt – about $1.0 billion – which is only about 1 % of Comcast’s total debt financing of $99.1 billion (current $4.9 billion + non‑current $94.2 billion).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Comcast's 30% ownership stake and that Universal Beijing Resort's $7.3 billion in assets and $7.0 billion in liabilities are consolidated into Comcast’s balance sheet as of December 31, 2024, which matches the ground truth. However, it introduces a fact not present in the original answer: that Comcast’s maximum risk of loss ($1.0 billion) represents about 1% of Comcast’s total debt financing of $99.1 billion (current $4.9 billion + non-current $94.2 billion). This total debt figure and the 1% comparison are not in the ground truth and appear to be fabricated or inferred from external data not provided in the context. (2) The calculation of 30% of $3.4 billion debt = $1.02 billion is correctly approximated as $1.0 billion, which is acceptable within rounding. However, the ground truth explicitly states that Comcast’s maximum risk of financial loss is 30% of the total debt, or $1.02 billion — the LLM alters the interpretation by comparing it to Comcast’s overall debt, which changes the focus of the answer. (3) The multi-hop reasoning is partially sound: the model correctly links ownership → consolidation → inclusion of assets/liabilities → limited risk to equity stake. But it fails to stop at the correct conclusion and instead adds an unsupported comparative analysis (1% of total debt), indicating a deviation from the required synthesis. (4) The correctness score is 6 due to significant but not fundamental errors: core facts (ownership, consolidation, asset/liability amounts, debt amount, and risk as 30%) are correct, but the addition of unverified total Comcast debt and the 1% contextualization introduces major inaccuracies not present in the ground truth. Quantitative accuracy is 5 because while most numbers are correct, the introduction of $99.1 billion in total debt (not in the original) undermines numerical fidelity. Qualitative accuracy is 7 because reasoning is logical but overreaches with unsupported synthesis. Contextual relevance is 9 — the answer is highly relevant and addresses the question’s structure well, just with extraneous and incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 575,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the cumulative goodwill impairment charges recognized for OpenTable in 2020 compare to its 2021 revenue contribution to Booking Holdings' advertising and other segment?",
      "original_answer": "In 2020, Booking Holdings recognized cumulative goodwill impairment charges of $1,062 million ($489 million in Q1 and $573 million in Q3) related to OpenTable. In 2021, OpenTable contributed to the 'advertising and other' revenue category, which totaled $1.1 billion for the full year. This means the impairment charges over the course of 2020 were nearly equivalent to the entire annual revenue contribution from OpenTable's restaurant reservation and related services in 2021.",
      "llm_answer": "In 2020 Booking Holdings recorded two goodwill‑impairment charges for the OpenTable (and KAYAK) reporting unit—a $489 million charge in the March‑31 interim test and a $573 million charge in the September‑30 annual test—totaling roughly **$1.06 billion**.  By contrast, OpenTable’s share of the 2021 “advertising and other” revenue stream was only a modest portion of the company’s $11 billion total revenue (well under a billion dollars), so the 2020 goodwill‑impairment amount **far exceeded** OpenTable’s 2021 contribution to the advertising‑and‑other segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the two goodwill impairment charges in 2020—$489 million in Q1 and $573 million in Q3—summing to $1.062 billion (rounded to $1.06 billion), which matches the ground truth. This part is quantitatively accurate. However, the LLM incorrectly states that OpenTable’s 2021 contribution to the 'advertising and other' segment was 'well under a billion dollars' and a 'modest portion' of total revenue. The ground truth states that the entire 'advertising and other' segment revenue was $1.1 billion in 2021, and OpenTable contributed to this category. The LLM misrepresents this by implying OpenTable’s share was much smaller, when in fact the original answer suggests the impairment was nearly equivalent to OpenTable’s full revenue contribution. (2) The calculation of the $1.06 billion total is correct. However, the comparison to 2021 revenue is flawed: the LLM uses Booking Holdings’ total revenue of $11 billion (which is accurate) but incorrectly infers OpenTable’s segment contribution was 'well under a billion,' which contradicts the ground truth that the entire 'advertising and other' segment was $1.1 billion and primarily driven by OpenTable. (3) The multi-hop reasoning fails: the model should have compared the $1.062 billion impairment to the $1.1 billion segment revenue as a direct comparison, concluding they are nearly equivalent. Instead, it downplays OpenTable’s contribution and incorrectly concludes the impairment 'far exceeded' the revenue, which is not supported by the data. (4) The correctness score is 4 due to major errors in interpretation and synthesis despite correct input numbers. Quantitative accuracy is 5 because key numbers are correct but the comparison is misrepresented. Qualitative accuracy is 4 due to flawed reasoning and incorrect inference. Contextual relevance is 7 because the answer addresses the right entities and timeframes but draws an incorrect conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 526,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does ExxonMobil incorporate greenhouse gas emission costs into its Corporate Plan when assessing the recoverability of asset groups, and what specific future emission-reduction goal is factored into these assessments?",
      "original_answer": "ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in the future cash flow assessments used to determine the recoverability of asset groups. These costs are considered even for jurisdictions without current greenhouse gas pricing policies. Specifically, the Corporation factors in costs related to its 2030 greenhouse gas emission-reduction plans, including the goal of achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin.",
      "llm_answer": "ExxonMobil builds estimated greenhouse‑gas (GHG) emission costs—including any applicable carbon‑price assumptions—directly into the cash‑flow assumptions that underlie the Corporate Plan, and those cash‑flow projections are used to test whether the undiscounted cash flows of an asset group exceed its carrying amount. When it does so, the plan also incorporates the projected costs needed to meet its 2030 emission‑reduction target – net‑zero Scope 1 and 2 GHG emissions from its unconventional operated assets in the Permian Basin.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes how ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in cash-flow assumptions used to assess asset group recoverability, even in jurisdictions without current carbon pricing—this matches the original answer. (2) The specific future emission-reduction goal—achieving net-zero Scope 1 and 2 GHG emissions from unconventional operated assets in the Permian Basin by 2030—is correctly identified with accurate entity, metric, and time period. (3) The multi-hop reasoning is sound: the model correctly links emission cost assumptions to asset recoverability testing and ties them to a specific corporate target. (4) All factual elements (entities: ExxonMobil, Permian Basin; metrics: Scope 1 and 2 emissions; time frame: 2030; financial concept: undiscounted cash flows for recoverability) are accurately represented. Minor wording differences (e.g., 'carbon-price assumptions' vs 'estimated greenhouse gas emission costs') do not affect factual accuracy and enhance clarity. No omissions or errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 329,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in after December 31, 2023, and how does this affect its capital conservation buffer requirements for the period from October 1, 2023 through September 30, 2024?",
      "original_answer": "As of December 31, 2023, $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in. This amount will be phased in equally at $600 million per year on January 1, 2024 and 2025. Capital One's capital conservation buffer requirements for CET1, Tier 1, and total capital are 2.5% under the Federal Reserve's regulations, which are separate from the stress capital buffer framework. The stress capital buffer requirement for the period from October 1, 2023 through September 30, 2024, is 4.8%, and Capital One currently exceeds the minimum capital requirements and conservation buffers, maintaining a 'well-capitalized' status.",
      "llm_answer": "Capital One added back a total of $2.4 billion of regulatory capital under the CECL Transition Rule and, as disclosed, had phased‑in 50 % of that amount by December 31, 2023. The balance that still must be phased in after that date is **$1.2 billion** (to be added at $600 million per year in 2024 and 2025). For the supervisory period October 1, 2023 through September 30, 2024, the company’s capital‑conservation‑buffer requirements—including the CECL addition—are **9.3 % of CET1, 10.8 % of Tier 1, and 12.8 % of total capital**.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that $1.2 billion of Capital One's $2.4 billion CECL capital addition remains to be phased in after December 31, 2023, and accurately states the $600 million per year phasing in 2024 and 2025—this part is factually correct and matches the ground truth. However, the answer introduces a critical error in the capital conservation buffer requirements: it claims the requirements are 9.3% for CET1, 10.8% for Tier 1, and 12.8% for total capital, which conflates the stress capital buffer (4.8%) with the standard capital conservation buffer (2.5%). The original answer clarifies that the 2.5% conservation buffer is separate from the 4.8% stress capital buffer, and does not provide composite totals. The LLM incorrectly synthesizes these into higher percentage requirements, which are not supported by the ground truth. This is a major factual and conceptual error in regulatory capital treatment. While the answer addresses both parts of the question (amount remaining and buffer impact), the second part is significantly flawed. The entities (Capital One, CECL, dates) and timeline are correct, and the phasing schedule is accurate. The reasoning fails in the multi-hop synthesis between CECL phase-in and buffer requirements, incorrectly aggregating buffers rather than distinguishing them. Quantitative accuracy is partially correct (dollar amounts right, percentages wrong), hence a moderate score. Contextually, the answer is relevant and structured well, but the erroneous buffer percentages undermine the correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 425,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What was the total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023, and how did this reduction compare to the change in their Euro notes over the same period?",
      "original_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million ($11,275 million to $9,562 million). During the same period, Euro notes increased by $250 million ($7,666 million to $7,916 million). Therefore, the reduction in U.S. dollar notes and term loans was significantly larger than the increase in Euro notes.",
      "llm_answer": "Mondelez’s U.S. dollar‑denominated notes and term loans fell from **$11,275 million at year‑end 2022 to $9,562 million at year‑end 2023**, a decline of **$1,713 million**.  In contrast, its Euro‑denominated notes rose slightly, from **$7,666 million to $7,916 million**, an **increase of about $250 million** over the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: U.S. dollar notes and term loans decreased from $11,275 million to $9,562 million, resulting in a $1,713 million decrease, which is correctly calculated. Euro notes increased from $7,666 million to $7,916 million, a $250 million increase, also accurately reported. (2) The answer addresses both parts of the multi-part question: the total decrease in U.S. dollar instruments and the comparison with the change in Euro notes. (3) Entities are correct—MDLZ (Mondelez) is properly identified, and the financial instruments (U.S. dollar notes and term loans, Euro notes) and time period (2022 to 2023) are accurate. (4) The reasoning is sound: the LLM correctly synthesizes data across years and currencies, and the implicit comparison (a large reduction in U.S. dollar debt vs. a modest increase in Euro debt) aligns with the ground truth's conclusion that the reduction was significantly larger. Wording differs slightly but maintains semantic equivalence. No errors in calculation, logic, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 316,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What is the maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement, and how does this payment relate to Honeywell's net spending on environmental matters?",
      "original_answer": "The maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell is $140 million, which represents 90% of Honeywell's annual net spending on environmental matters at certain defined sites.",
      "llm_answer": "The indemnification agreement limits the Resideo subsidiary’s payment to Honeywell to **a maximum of $140 million per year** (the amount is 90 % of Honeywell’s net environmental‑matter spending, but never exceeds $140 million)【page 97】.  \n\nHoneywell’s own net cash outlays for environmental matters run in the same range – for example, the company recorded **environmental‑liability payments of about $196 million in 2023 (and $211 million in 2022)**【page 97】 – so the $140 million cap is lower than, and therefore only partially offsets, Honeywell’s annual environmental spending.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the maximum annual payment of $140 million, which matches the ground truth. It also correctly states that this amount is related to 90% of Honeywell's net spending on environmental matters, aligning with the original answer. However, the LLM adds specific figures for Honeywell's environmental payments in 2023 ($196 million) and 2022 ($211 million), which, while possibly accurate from the cited page 97, were not part of the original answer and introduce extraneous detail not required by the question. More critically, the original answer states that the $140 million *represents* 90% of Honeywell’s net spending, implying that 90% of the spending equals $140 million (i.e., total spending would be ~$155.6 million). The LLM instead frames $140 million as a cap that is 90% of spending but never exceeded, which subtly misrepresents the relationship — it suggests 90% could be less than $140M and capped there, whereas the original implies $140M is exactly 90% of defined spending. (2) Quantitative accuracy is high: $140M is correct; the additional $196M and $211M figures are plausible but not in the ground truth, so they don’t count against accuracy but add unnecessary detail. The core calculation (90%) is mentioned but not verified or explained. (3) Multi-hop reasoning is partially sound — the model connects Resideo’s obligation to Honeywell’s environmental spending, but the causal or definitional relationship between the 90% and the cap is reversed or unclear. The original answer presents $140M as the result of taking 90% of spending; the LLM presents it as a cap that may not reflect the full 90%. (4) Contextual relevance is excellent — the answer directly addresses the question and provides supporting context. However, due to the misrepresentation of the financial relationship between the 90% and the $140M cap, the answer is not fully factually aligned with the ground truth, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 535,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impact NEE's total financial position for FPL and NEER segments between December 31, 2022, and December 31, 2023?",
      "original_answer": "The total financial position for FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3 million in 2022 to $2 million in 2023, a $1 million drop. For NEER, the amount tied to these clauses fell from $148 million in 2022 to $114 million in 2023, a decrease of $34 million. Combined, the reduction in FPL and NEER segments led to a total $35 million decline in NEE's obligations tied to these clauses over the period.",
      "llm_answer": "The non‑qualifying hedge portfolio swung from a **$3.689 billion fair‑value loss at 12/31/2022 to a $2.178 billion gain at 12/31/2023**, delivering an overall improvement of roughly **$5.9 billion** for NEE’s regulated (FPL) and non‑regulated (NEER) businesses【page_52】.  \n\nIn contrast, the **FPL cost‑recovery‑clause hedges fell from a $212 million gain in 2022 to only a $5 million gain in 2023**, cutting that contribution by about **$207 million** – roughly **$1 million less for the FPL segment and $34 million less for the NEER segment**【page_53】.  \n\nThus, the sharp reversal in non‑qualifying hedges boosted the total financial position of both segments, while the modest decline in cost‑recovery‑clause hedges slightly reduced the net benefit, especially for NEER.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, FPL's Non-Qualifying Hedges and Hedges in Cost Recovery Clauses decreased from $3M to $2M (a $1M drop), and NEER's from $148M to $114M (a $34M drop), totaling a $35M decline. However, the LLM claims a swing from a $3.689 billion loss to a $2.178 billion gain — a $5.9 billion improvement — which is not supported by the ground truth and misrepresents both magnitude and direction. The LLM also states that FPL cost-recovery-clause hedges fell from a $212M gain to $5M gain, which contradicts the original answer that does not mention gains or losses in that form, nor does it reference such large figures. The $1M less for FPL and $34M less for NEER appear to align roughly with the ground truth's segment-level declines, but they are framed as reductions in 'contribution' or 'gain', not obligations, reversing the financial interpretation. (2) Calculations are entirely incorrect: the claimed $5.9 billion improvement and $207 million cut are unsupported. The ground truth reports a total $35 million decline in obligations, not a multi-billion-dollar gain. Number formats are consistent but values are wildly off. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the actual changes in obligations over time; instead, it introduces fair-value gains/losses not mentioned in the original answer and misattributes them to the wrong categories. It conflates 'non-qualifying hedges' with 'cost-recovery-clause hedges' in a way that distorts the financial impact. (4) The contextual relevance is moderate because the answer addresses the right segments (FPL and NEER) and the two hedge types, but the substance is factually wrong. Due to severe quantitative and qualitative errors, the correctness score is low despite partial entity and structural alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 508,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the change in Universal Beijing Resort's net assets from 2023 to 2024, and how does this compare to the change in its debt obligations over the same period?",
      "original_answer": "Universal Beijing Resort's net assets decreased by $0.7 billion from 2023 to 2024, while its debt obligations decreased by $0.1 billion over the same period. In 2023, Universal Beijing Resort had $7.8 billion in assets and $7.2 billion in liabilities, resulting in net assets of $0.6 billion. In 2024, it had $7.3 billion in assets and $7.0 billion in liabilities, resulting in net assets of -$0.3 billion. This represents a decrease in net assets of $0.9 billion. However, liabilities (debt) decreased from $7.2 billion to $7.0 billion, a $0.2 billion reduction, indicating that while the resort reduced its debt slightly, its overall financial position weakened.",
      "llm_answer": "Universal Beijing Resort’s net assets fell from $0.6 billion at year‑end 2023 (assets $7.8 bn – liabilities $7.2 bn) to $0.3 billion at year‑end 2024 (assets $7.3 bn – liabilities $7.0 bn), a decline of roughly $0.3 billion. During the same period its debt fell from $3.5 billion to $3.4 billion, a reduction of about $0.1 billion. Thus the resort’s net‑asset drop was about three times larger than the decrease in its debt obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures and calculations. While it correctly states the 2023 net assets ($0.6 billion) and liabilities ($7.2 billion), it incorrectly reports 2024 net assets as $0.3 billion instead of -$0.3 billion, leading to a wrong change in net assets of -$0.3 billion instead of the correct -$0.9 billion. The ground truth shows net assets decreased from $0.6B to -$0.3B, a $0.9B decline, not $0.3B. Additionally, the LLM claims debt obligations decreased from $3.5B to $3.4B, but the original answer states total liabilities (debt obligations) decreased from $7.2B to $7.0B — a $0.2B reduction. The LLM invents new debt figures not present in the ground truth. (2) Calculations are flawed: the net asset change is miscalculated due to incorrect starting and ending values; the comparison that 'net-asset drop was about three times larger' is based on false numbers. (3) Multi-hop reasoning is partially sound in structure — the model attempts to compute net assets from assets and liabilities and compare changes — but fails due to incorrect data inputs and misrepresentation of liabilities as 'debt' with fabricated values. (4) Despite correct mention of Universal Beijing Resort and the 2023–2024 timeframe, and an attempt to synthesize assets and liabilities into net assets, the severe numerical inaccuracies — especially in the core metrics of net asset change and debt — severely undermine the answer’s validity. Contextual relevance is high as the response addresses the right entities and question structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 436,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What specific new patient population became eligible for treatment with EDURANT (rilpivirine) according to JNJ's 2023 10-K filing, and which regulatory regions were targeted for filing as indicated in the same report?",
      "original_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) was targeted for treatment of pediatric patients aged 2-12 years with HIV. The filing was specifically targeted at the US and EU regulatory regions.",
      "llm_answer": "The filing notes that EDURANT (rilpivirine) was newly approved for **pediatric patients aged 2 to 12 years with HIV**. The company indicated that it is pursuing **filings in both the United States and the European Union** for this indication【page_33】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies the new patient population as 'pediatric patients aged 2 to 12 years with HIV', matching the original answer exactly. (2) It correctly states that filings were targeted for the United States and the European Union, which aligns with the 'US and EU regulatory regions' in the ground truth. (3) The reasoning is sound and demonstrates proper synthesis from JNJ's 2023 10-K filing, correctly interpreting both the expanded indication and the regulatory strategy. (4) All entities (EDURANT/rilpivirine, JNJ, pediatric population, US, EU) are accurate, and the answer addresses both parts of the multi-hop question completely. Minor wording differences (e.g., 'pursuing filings' vs 'targeted for filing') do not affect factual accuracy. The citation to page 33 adds contextual support. No errors in facts, numbers, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 269,
        "total_tokens": 1401
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How do Booking.com's merchant-based transaction model and regulatory investigations in Switzerland and the EU collectively impact Booking Holdings' operating margins and business strategy as reported in 2022?",
      "original_answer": "Booking.com's increasing use of a merchant-based transaction model leads to higher expenses related to personnel, payment processing, and chargebacks, which negatively affects operating margins despite incremental revenues such as credit card rebates. Additionally, regulatory investigations, such as the ongoing Swiss Price Surveillance Office investigation into Booking.com's commission rates, could force Booking.com to reduce commissions in Switzerland, further compressing margins. In the EU, the proposed Digital Markets Act could classify Booking.com as a 'gatekeeper,' imposing additional restrictions on data usage, service bundling, and parity clauses, which could reduce competitive flexibility and increase compliance costs. Together, these financial pressures and regulatory uncertainties constrain both short-term profitability and long-term strategic initiatives like the Connected Trip platform.",
      "llm_answer": "Booking.com’s move to process an increasing share of reservations on a merchant‑basis means it now bears payment‑processing fees, charge‑back and fraud‑detection costs and additional compliance work (e.g., PSD2), which “negatively impacts our operating margins despite increases in incremental revenues” (p. 50‑36).  At the same time, the ongoing Swiss commission investigation and EU competition and Digital‑Markets‑Act probes expose the company to possible fines, required commission cuts and extra regulatory‑compliance expenses, further pressuring margins and forcing Booking Holdings to lean on its “Connected Trip” strategy and other diversification investments while accepting near‑term margin headwinds (p. 34‑33‑35).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Booking.com's shift to a merchant-based model increases costs (payment processing, chargebacks, fraud, compliance like PSD2), which negatively impacts operating margins despite incremental revenues—this aligns with the original answer. Regulatory pressures from Switzerland (commission investigation) and the EU (Digital Markets Act) are correctly identified as sources of margin pressure and strategic constraint. The mention of 'Connected Trip' as a strategic focus amid margin headwinds matches the original. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense—but the absence of incorrect numbers and correct referencing of qualitative financial impacts earns full marks. (3) Multi-hop reasoning is sound: the model synthesizes financial model impacts (merchant vs. agency) with regulatory risks across jurisdictions (Switzerland and EU) and connects them to both margin impacts and strategic responses. The only minor shortcoming is that the LLM answer does not explicitly mention the EU's potential restrictions on 'data usage, service bundling, and parity clauses' or the 'gatekeeper' designation, which are key elements in the original. While it refers to 'extra regulatory-compliance expenses,' it omits specific mechanisms of the DMA’s impact. (4) Contextual relevance is excellent—the answer directly addresses how both the transaction model and regulatory environment affect margins and strategy in 2022, citing appropriate page references and maintaining focus throughout. The omission of specific DMA provisions prevents a perfect 10, but overall the answer is factually correct, well-reasoned, and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 500,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the maximum total duration of a petroleum retention license in Papua New Guinea, considering both the initial term and possible extensions, and how does this regulatory framework potentially influence ExxonMobil's long-term LNG development strategy in the region as outlined in its 2022 10-K filing?",
      "original_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, which includes an initial 5-year term and up to two extensions at the Minister's discretion. This regulatory framework influences ExxonMobil's long-term LNG development strategy by allowing the Corporation to maintain rights over gas resources that are not currently commercially viable but may become so within that 15-year window. This aligns with ExxonMobil's strategy of selectively developing attractive natural gas resources and pursuing long-term LNG projects such as the one in Papua New Guinea.",
      "llm_answer": "In Papua New Guinea a petroleum‑retention licence is issued for an initial five‑year term and can be extended twice, with extensions limited to a combined ten years, giving a **maximum total duration of 15 years** (5 years + 10 years of extensions)【page_34】.  \n\nBecause ExxonMobil’s 2022 10‑K highlights PNG as one of its key LNG development targets【page_59】, the ability to hold gas rights for up to 15 years lets the company secure and retain undeveloped gas resources while they become commercially viable, providing the regulatory certainty needed for long‑term LNG investment planning and reducing the risk of losing access to the resource base during the multi‑year development cycle.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the maximum total duration of 15 years is accurately stated, with correct breakdown of the initial 5-year term and up to 10 years in extensions (two extensions at the Minister's discretion, totaling 15 years), which aligns with the original answer. (2) The answer is complete, addressing both the regulatory duration and its influence on ExxonMobil's long-term LNG strategy. (3) Entity accuracy is correct: Papua New Guinea, petroleum retention license, ExxonMobil, and reference to the 2022 10-K (via page citations) are all accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the 15-year license framework to ExxonMobil’s strategic need for long-term resource retention, regulatory certainty, and commercial viability planning, which is consistent with the company’s stated LNG development goals in PNG as outlined in its 10-K. The semantic meaning and factual content are equivalent to the ground truth, with only minor rephrasing for clarity. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 313,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the year-over-year change in Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets, and how does this shift compare to the change in their Hedge funds/limited partnerships investments?",
      "original_answer": "Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets decreased by $46 million year-over-year (from $83 million in 2022 to $37 million in 2023). Meanwhile, their investment in Hedge funds/limited partnerships remained relatively stable, increasing slightly by $4 million (from $14 million in 2022 to $18 million in 2023). This indicates a significant reallocation away from Level 2 pooled funds while maintaining a consistent position in alternative investments like hedge funds.",
      "llm_answer": "Coca‑Cola’s Level 2 holdings of **Mutual, pooled and commingled funds** rose from **$202 million in 2022 to $257 million in 2023**, a **$55 million increase** year‑over‑year.  \n\nBy contrast, its **Hedge‑funds/limited‑partnerships** investments (recorded in the “Other” category) grew from **$936 million in 2022 to $1,057 million in 2023**, an **increase of $121 million**, more than double the rise seen in the Level 2 mutual‑fund holdings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of factual content and quantitative accuracy. (1) The numbers provided are completely wrong: the original answer states that Coca-Cola's investment in Mutual, pooled and commingled funds under Level 2 assets decreased from $83 million in 2022 to $37 million in 2023 (a $46 million decrease), whereas the LLM claims an increase from $202 million to $257 million ($55 million increase). This is a major factual error. (2) For Hedge funds/limited partnerships, the original answer reports a small increase from $14 million to $18 million ($4 million rise), but the LLM claims an increase from $936 million to $1,057 million ($121 million rise), which is over 30 times larger than the correct figure. (3) The multi-hop reasoning is fundamentally flawed: the question asks for a comparison between changes in two specific investment categories, but the LLM uses fabricated data for both, leading to an incorrect conclusion about reallocation trends. Instead of showing a shift away from Level 2 pooled funds with stable hedge fund exposure, the LLM suggests strong growth in both categories, contradicting the ground truth. (4) While the structure of the response is relevant and addresses the right types of comparisons (year-over-year changes and relative shifts), the complete inaccuracy of the underlying data renders the answer misleading. The entities (Coca-Cola, investment categories) and time frame (2022–2023) are correctly identified, but all financial figures and resulting calculations are incorrect, leading to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 436,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What was the total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023, considering both the reduction in net income at gas distribution operations and the additional earnings adjustment mentioned in the financial statements?",
      "original_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a $53 million reduction, combining the $29 million decrease in net income at gas distribution operations and the additional $24 million earnings adjustment.",
      "llm_answer": "The regulatory disallowances at Nicor Gas cut Southern Company Gas’s earnings by roughly **$53 million in 2023** – a $29 million decline in net income at the gas‑distribution operations plus an additional $24 million earnings hit recorded as a separate adjustment in the financial statements.【page_86】【page_86】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $53 million total impact, composed of a $29 million reduction in net income at gas distribution operations and an additional $24 million earnings adjustment. The sum ($29M + $24M = $53M) is correct. (2) The answer is complete, addressing both components of the financial impact as required by the question. (3) Entities are correctly identified: Nicor Gas, Southern Company Gas, and the year 2023. (4) The reasoning is sound and reflects proper multi-hop synthesis—combining two distinct financial impacts from the same regulatory disallowance into a total effect on net income. (5) The semantic meaning is equivalent to the original answer, with clear, concise wording and appropriate emphasis on key figures. The inclusion of citation markers (【page_86】) further supports contextual grounding in the source material. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 285,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "Which businesses, in addition to WarnerMedia, were classified as discontinued operations by AT&T as part of its strategic shift, and what was the significance of this classification in relation to AT&T's broader restructuring efforts?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification was significant because it reflected AT&T’s comprehensive restructuring plan that involved divesting multiple business units, even those that did not individually meet the materiality threshold for discontinued operations. The combined divestiture of these businesses was treated as a single strategic shift, enabling AT&T to focus on its core communications segment while exiting non-core or underperforming businesses.",
      "llm_answer": "AT&T said that, besides WarnerMedia, the discontinued‑operations group also includes Vrio, Xandr and Playdemic (Lines 23‑24).  By moving these businesses into discontinued‑operations accounting, AT&T isolates the financial results of the media‑entertainment divestitures from its core communications business, signaling that the spin‑offs are a key element of its broader restructuring and strategic‑shift plan to focus on its remaining telecom operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all businesses classified as discontinued operations in addition to WarnerMedia: Vrio, Xandr, and Playdemic, matching the ground truth. There are no numeric values, dates, or financial figures in the question or answer that require quantitative verification, so quantitative accuracy is scored as 10 by default. The answer addresses both parts of the question: it lists the correct entities and explains the significance of the discontinued operations classification—namely, that it isolates financial results to highlight AT&T’s strategic shift toward its core telecom business. The reasoning is sound and reflects the multi-hop synthesis required: connecting the accounting treatment (discontinued operations) to AT&T’s broader restructuring strategy. The only minor shortcoming is that the LLM does not explicitly mention that these divestitures were treated as a single strategic shift despite some units not meeting materiality thresholds individually—a nuanced but important point in the original answer. However, the core meaning regarding strategic focus and restructuring is preserved. Wording differs but maintains semantic equivalence. Contextual relevance is strong, directly addressing the question with accurate, focused information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 357,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What was the change in the fair value of Medtronic's auction rate securities from April 30, 2021, to April 29, 2022, and how did this impact the total available-for-sale debt securities' fair value over the same period?",
      "original_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. However, the total available-for-sale debt securities' fair value decreased from $7,257 million to $6,893 million, a decline of $364 million. This indicates that while auction rate securities held stable, other components of available-for-sale debt securities experienced significant unrealized losses, contributing to the overall decline in fair value.",
      "llm_answer": "The fair value of Medtronic’s auction‑rate securities was $33 million at both April 30 2021 and April 29 2022, so the change was **$0**.  Over the same period the fair value of the company’s total available‑for‑sale debt securities fell from $7,257 million to $6,893 million, a **decrease of $364 million**, with the unchanged auction‑rate securities having no impact on that overall decline.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value of auction rate securities is correctly stated as $33 million on both dates, resulting in a $0 change; the total available-for-sale debt securities decreased from $7,257 million to $6,893 million, a difference of $364 million, which is correctly calculated. (2) The answer is complete, addressing both parts of the question: the change in auction rate securities and the impact on total available-for-sale debt securities. (3) Entities are accurate—Medtronic, correct dates (April 30, 2021, and April 29, 2022), and correct financial instruments (auction rate securities and available-for-sale debt securities). (4) The reasoning is sound: the LLM correctly infers that since auction rate securities did not change, they had no impact on the overall decline, which aligns with the multi-hop logic required. The semantic meaning is equivalent to the original answer, with clear, concise rewording that preserves all factual content. No errors in calculation, logic, or factual representation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 319,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did the goodwill impairment charges related to OpenTable and KAYAK in 2020 affect the adjusted carrying value of goodwill by September 30, 2020, and what was the cumulative impact of these charges?",
      "original_answer": "The goodwill impairment charge of $489 million recognized in March 2020 and the additional charge of $573 million recognized in September 2020 cumulatively reduced the carrying value of goodwill for the OpenTable and KAYAK reporting unit from its initial value to $1.0 billion by September 30, 2020. This represents a total impairment of $1,062 million over the two periods.",
      "llm_answer": "The interim goodwill‑impairment test on March 31 2020 recorded a $489 million charge for the OpenTable‑KAYAK reporting unit, leaving an adjusted goodwill balance of $1.5 billion.  The subsequent annual test on September 30 2020 added a $573 million charge, bringing the adjusted carrying value of goodwill for OpenTable and KAYAK down to $1.0 billion.  Taken together, the two 2020 impairments represent a cumulative reduction of roughly $1.06 billion in goodwill.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the two goodwill impairment charges ($489 million in March 2020 and $573 million in September 2020) and the resulting adjusted carrying value of $1.0 billion by September 30, 2020. The cumulative impact is accurately calculated as $1.062 billion, which the LLM rounds to 'roughly $1.06 billion'—an acceptable approximation. (2) All numeric values match the ground truth: $489M and $573M charges are correct, their sum ($489M + $573M = $1,062M) is accurate, and the final carrying value of $1.0 billion aligns with the original answer. The dates (March 31 and September 30, 2020) are consistent with the interim and annual testing periods mentioned in the context. (3) The multi-hop reasoning is sound: the model correctly synthesizes the two impairment events, tracks the reduction in carrying value across time, and computes the total impact. It correctly treats OpenTable and KAYAK as a combined reporting unit. (4) The only minor shortcoming is the use of 'roughly $1.06 billion' instead of the precise $1,062 million, which slightly reduces qualitative precision but does not affect factual correctness. All entities, metrics, and timeframes are accurate. The answer fully addresses both parts of the question: the effect on adjusted carrying value and the cumulative impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 371,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Nicor Gas's regulatory disallowances affect Southern Company Gas's 2023 financial performance across both net income and revenue?",
      "original_answer": "Nicor Gas's regulatory disallowances contributed to a $29 million decrease in net income at gas distribution operations for Southern Company Gas in 2023. Additionally, these disallowances reduced revenues, as noted in the report of revenue declines due to lower volumes sold and the regulatory disallowances at Nicor Gas. Therefore, the disallowances had a dual negative financial impact by reducing both net income and revenue.",
      "llm_answer": "Regulatory disallowances at Nicor Gas created an $88 million pre‑tax charge (recorded as “estimated loss on regulatory disallowance”) that helped reduce Southern Company Gas’s 2023 net income by about $29 million – the amount the company said offset part of its net‑income increase 【page_85†L1-L4】.  The same disallowances also shaved off operating revenue, contributing to the $1.26 billion (≈21 %) decline in 2023 operating revenues versus 2022 【page_83†L19-L23】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $29 million decrease in net income is explicitly stated in both the original and LLM answers, and the LLM adds contextual detail about an $88 million pre-tax charge, which is consistent with the knowledge graph's broader context (though not in the original answer, it does not contradict it). The LLM correctly notes the 21% (≈$1.26 billion) decline in operating revenues, which supports the original answer’s claim of revenue reduction due to disallowances and lower volumes. These figures are accurately presented with proper context and sourcing from specific pages. (2) The answer is complete, addressing both net income and revenue impacts as required by the question. (3) Entity accuracy is strong: Nicor Gas, Southern Company Gas, and the year 2023 are correctly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis: it connects Nicor’s regulatory disallowances to a pre-tax charge, links that to net income impact, and separately ties the disallowances to revenue declines, aligning with the dual impact described in the ground truth. The only minor limitation is that the original answer attributes revenue declines to both lower volumes and disallowances, while the LLM implies the disallowances were a primary contributor to the full revenue drop, which could slightly overstate their role. However, the LLM does not deny other factors and uses 'contributing to,' which is reasonable. Overall, the answer is factually correct, well-supported, and semantically equivalent to the ground truth with excellent use of evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 456,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How many Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP as of August 31, 2022, and what percentage of the total shares authorized does this represent?",
      "original_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, representing 17.99% of the total 90,000,000 shares authorized.",
      "llm_answer": "The 2010 Employee Share Purchase Plan authorizes up to **90 million** Class A ordinary shares. By August 31 2022 the company had issued **73,808,772** of those shares, leaving **16,191,228 shares** still available for issuance. This residual amount equals roughly **18 %** of the total 90 million authorized Class A shares (16,191,228 ÷ 90,000,000 ≈ 0.18).【page_92】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 16,191,228 shares remaining and 90,000,000 total authorized shares are correctly stated. The LLM correctly infers the issued shares (73,808,772) by subtracting remaining from authorized, which aligns with the data. (2) The percentage is reported as 'roughly 18%' (16,191,228 ÷ 90,000,000 ≈ 0.1799, or 17.99%), which rounds appropriately to 18% and matches the ground truth of 17.99% when precision is considered. Minor rounding in communication is acceptable and does not affect correctness. (3) The entities are accurate: 'Accenture plc', 'Class A ordinary shares', '2010 ESPP', and the date 'August 31, 2022' are all correctly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis: the model correctly combines total authorized shares, calculates issued shares, derives remaining shares, and computes the percentage—all required for the question. (5) The answer is semantically equivalent to the original, with clear, accurate rewording and proper contextual citation (page_92). All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 329,
        "total_tokens": 1479
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, as outlined in its 2023 10-K, influence its 2024 expense trends and longer-term operational efficiency goals?",
      "original_answer": "AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment will pressure 2024 expense trends due to the spending required to support growth and efficiency initiatives, including the deployment of Open RAN and associated accelerated depreciation. However, the software benefits of 5G wireless technology, enabled by Open RAN, are expected to result in a more efficient use of capital and lower network-related expenses in the coming years. This aligns with AT&T's longer-term operational efficiency goals by fostering lower network costs and improved operational efficiencies through a more robust ecosystem of network infrastructure providers and suppliers.",
      "llm_answer": "AT&T’s December 2023 agreement with Ericsson to roll out commercial‑scale Open RAN is reflected in its 2024 outlook as a near‑term cost driver: the company says the spending needed to deploy Open RAN (and the related accelerated depreciation of new equipment) will “pressure expense trends in 2024.” However, the filing also notes that the software‑based, open‑architecture network is expected to deliver “lower network‑related expenses” and a more efficient use of capital in the years ahead, supporting AT&T’s longer‑term goal of reducing operating costs and improving overall network efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment is correctly identified as occurring in December 2023 (consistent with the 2023 10-K), and its impact on 2024 expense trends is accurately described as a cost pressure due to deployment spending and accelerated depreciation. The longer-term benefits—lower network-related expenses, more efficient capital use, and improved operational efficiency—are all correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2023 agreement, 2024 impact) are correct. (3) Multi-hop reasoning is sound: the model correctly links the Ericsson collaboration (entity and event) to near-term financial impact (expense pressure) and long-term operational goals (efficiency, cost reduction), synthesizing cause and effect across time horizons. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'software-based, open-architecture network' vs. 'software benefits of 5G wireless technology'), but the meaning is consistent. The only minor gap is that the LLM answer does not explicitly mention the 'robust ecosystem of network infrastructure providers' aspect of Open RAN’s strategic benefit, which is included in the original answer and supports long-term efficiency. This omission is minor and does not detract from the core accuracy, hence the 9/10 on qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 435,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, and how did this compare to the discounted future net cash flows from this region in the same year?",
      "original_answer": "The total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, were 2,635 million barrels. This corresponds to a discounted future net cash flow of $28,710 million from Canada/Other Americas in 2021. The reserves represent a significant portion of XOM's future cash flow projections from the region.",
      "llm_answer": "The pages you provided (128‑132) contain cost, capital‑ized‑cost and results‑of‑operations tables, but they do **not** include a reserve‑quantity table or a discounted‑future‑cash‑flow valuation for the Canada/Other Americas region. Consequently, the total proved‑developed bitumen reserves for ExxonMobil’s consolidated subsidiaries as of December 31 2021, and the corresponding discounted future net cash‑flow amount for that region, are not disclosed in the excerpts you shared.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect in the context of the evaluation. The question is based on a ground truth derived from a knowledge graph of actual SEC 10-K filing data, not on the limited pages provided to the model. The LLM incorrectly concludes that the information is not available in the provided excerpts, which is a response appropriate only if the task were to extract information from those specific pages. However, the evaluation is about whether the LLM can provide the correct factual answer from its training data, not whether the data appears in a particular document excerpt. The ground truth states that the proved developed bitumen reserves were 2,635 million barrels and the discounted future net cash flows were $28,710 million — both specific, verifiable facts that should have been retrievable. The LLM failed to provide any correct numbers, entities, or synthesis, resulting in a correctness score of 0. It also demonstrates a fundamental misunderstanding of the task, likely due to over-reliance on the document snippets rather than recalling factual knowledge. Thus, all accuracy and relevance scores are minimal.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 321,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the adoption of ASU No. 2022-02 impact Capital One's allowance for credit losses and loan modification reporting practices as of December 31, 2023?",
      "original_answer": "The adoption of ASU No. 2022-02 led to a $2.1 billion increase in Capital One's allowance for credit losses, bringing the total to $15.3 billion as of December 31, 2023. Additionally, the standard eliminated the classification of loan modifications as Troubled Debt Restructurings (TDRs), replacing them with a new framework for reporting modified loans, which affects how loan modifications are disclosed and managed under the new accounting guidance.",
      "llm_answer": "The adoption of ASU 2022‑02 lowered Capital One’s allowance for credit losses by about **$63 million** (the “cumulative effects of accounting standards adoption” line in the allowance‑for‑credit‑losses table for 2023). It also eliminated the old “troubled‑debt‑restructuring” (TDR) accounting rule; after Jan 1 2023 any concession‑type modification is reported as a **Financial‑Difficulty Modification (FDM)**—principal forgiveness, interest‑rate cuts, payment delays or term extensions—rather than as a TDR, with the new FDM disclosures appearing in Note 3.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains major factual errors, particularly in the quantitative claim: it states that ASU 2022-02 lowered Capital One’s allowance for credit losses by $63 million, which directly contradicts the ground truth stating a $2.1 billion increase. This is a critical error in direction (increase vs decrease) and magnitude ($63M vs $2.1B). The final allowance amount of $15.3 billion in the original answer is also omitted in the LLM response. (2) The date reference is partially correct—ASU 2022-02 was effective January 1, 2023—but the LLM incorrectly implies the $63 million adjustment is from this standard, when the source of that figure (if real) does not align with the known impact of ASU 2022-02. The $63 million figure does not appear in the ground truth and contradicts it. (3) On qualitative aspects, the LLM correctly identifies that ASU 2022-02 eliminated TDR accounting and introduced a new framework for loan modifications. The mention of Financial-Difficulty Modifications (FDMs) and examples (principal forgiveness, interest rate cuts, etc.) shows some understanding of the new disclosure framework, though 'FDM' is not a standard term widely recognized in GAAP—this may be a misinterpretation or oversimplification. The reference to Note 3 is plausible but unverifiable without the filing. (4) Contextual relevance is moderate: the answer addresses both parts of the question (impact on allowance and loan modification reporting), but the severe quantitative inaccuracy undermines the correctness. Multi-hop reasoning fails because the model misattributes a financial figure to ASU 2022-02 that contradicts the verified outcome. Overall, while the directional change in accounting treatment is acknowledged, the core financial impact is entirely incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 491,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland impact GE's liquidity position as reported in its 2023 10-K filing?",
      "original_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could negatively impact GE's liquidity position. GE reported total cash, cash equivalents, and restricted cash of $17.0 billion at December 31, 2023. However, $14.2 billion of this amount was held outside the U.S., with $1.7 billion in countries with currency control restrictions. If additional contingent liabilities from Bank BPH become payable, GE may face challenges in accessing sufficient liquidity without incurring substantial costs or repatriation taxes. This could constrain its ability to meet business needs and financial obligations, especially under stressed conditions.",
      "llm_answer": "The filing notes that the Bank BPH mortgage‑portfolio litigation in Poland could generate additional contingent liabilities that may have to be recorded (or that loss estimates could rise) and ultimately be paid. Management warns that such future liabilities “could materially and adversely affect GE’s business, financial position, cash flows or capacity to provide financing,” meaning they could erode the company’s liquidity cushion and strain its ability to meet short‑term cash‑flow needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the risk posed by Bank BPH's litigation in Poland to GE's liquidity and cites management's warning about material adverse effects on cash flows and financial position. However, it fails to include any of the specific quantitative data from the 2023 10-K filing that are central to the ground truth, such as GE's total cash, cash equivalents, and restricted cash of $17.0 billion, the $14.2 billion held outside the U.S., or the $1.7 billion in countries with currency controls. These omissions significantly reduce quantitative accuracy. (2) There are no numbers in the LLM answer to verify against the ground truth, indicating a complete absence of quantitative support despite the original answer being heavily data-driven. This results in a low quantitative accuracy score. (3) The multi-hop reasoning is partially sound: the model connects Bank BPH litigation to contingent liabilities and then to potential impacts on GE’s liquidity, which aligns with the logic in the ground truth. It also accurately reflects the qualitative risk disclosure language used in SEC filings (e.g., 'materially and adversely affect'). However, it does not synthesize the geographic cash distribution constraints, which is a critical second hop in the reasoning chain required to fully answer the question. (4) Contextual relevance is high because the response directly addresses the question’s focus on litigation impact on liquidity. The qualitative accuracy is moderate because while the entities (Bank BPH, Poland, GE), the nature of the risk, and the source (management disclosure) are correct, the lack of key financial data and full multi-hop synthesis limits completeness and precision. The correctness score reflects partial accuracy—core risk is identified, but critical supporting facts from the 10-K are missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 503,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How many total shares were both issued upon exercise of outstanding options and still available for future issuance under the Amended and Restated 2010 Share Incentive Plan as disclosed in the 2022 10-K filing?",
      "original_answer": "The Amended and Restated 2010 Share Incentive Plan had 14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares still available for future issuance, totaling 42,212,084 shares.",
      "llm_answer": "The 2022 Form 10‑K shows that, for the Amended and Restated 2010 Share Incentive Plan, Accenture had **14,830,623** shares that would be issued upon exercise of outstanding options and **27,381,461** shares still available for future issuance. Together, these represent **42,212,084 shares** under the plan【page_49】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: 14,830,623 shares issued upon exercise of outstanding options, 27,381,461 shares available for future issuance, and a total of 42,212,084 shares under the plan. The calculations are correct (14,830,623 + 27,381,461 = 42,212,084). (2) The answer is complete, addressing both components of the question: shares issued upon exercise and shares available for future issuance, as well as their sum. (3) Entity accuracy is correct: the plan name 'Amended and Restated 2010 Share Incentive Plan' is properly identified, and the context from the 2022 10-K filing is correctly referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis—combining two distinct data points from the same plan and computing their total. (5) Semantic equivalence is maintained; the LLM conveys the same information as the original answer with slight rewording but no loss or distortion of meaning. The citation of page 49 adds contextual support. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 310,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total amount of the 2025 Term Loan that AT&T paid off in 2023, and on what date was this loan terminated according to the disclosures?",
      "original_answer": "AT&T paid off the $2,500 million 2025 Term Loan in full and terminated it on March 30, 2023.",
      "llm_answer": "AT&T repaid the entire **$2,500 million** 2025 Term Loan in 2023, and the loan was **terminated on March 30, 2023**【page_71†L31-L38】【page_71†L45-L48】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the amount of the loan ($2,500 million) and the termination date (March 30, 2023) are correctly stated. Minor formatting differences (e.g., use of thin spaces, bolding) do not affect meaning. (2) Quantitative accuracy is perfect—both the dollar amount and date match the original answer exactly in substance. (3) The reasoning is sound; the model correctly synthesized the information from the disclosed filing, identifying both the repayment amount and termination date from the relevant sections (page 71, lines 31–38 and 45–48). (4) The answer is contextually relevant and directly addresses both parts of the multi-hop question: the total amount paid off and the termination date. Semantic equivalence is maintained despite slight rewording (e.g., 'repaid the entire' vs 'paid off in full'). No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1060,
        "completion_tokens": 267,
        "total_tokens": 1328
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023, and how much of the 2023 investment was categorized under Level 2 valuation inputs?",
      "original_answer": "KO's investment in mutual, pooled and commingled funds decreased by $47 million from 2022 to 2023. In 2023, $37 million of the $39 million investment was categorized under Level 2 valuation inputs.",
      "llm_answer": "KO’s investment in mutual, pooled and commingled funds grew from $767 million in 2022 to $778 million in 2023 – an increase of **$11 million**. Of the 2023 balance, **$257 million** was measured using **Level 2** fair‑value inputs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively: The ground truth states that KO's investment decreased by $47 million from 2022 to 2023, but the LLM claims an increase of $11 million. Additionally, the LLM reports the 2023 investment measured under Level 2 as $257 million, whereas the correct amount is $37 million of a $39 million total. These numbers are drastically different and factually wrong. (2) Calculations: The LLM's implied starting value of $767 million in 2022 and ending value of $778 million in 2023 contradicts the ground truth (which implies a drop from $86 million in 2022 to $39 million in 2023, though exact prior value isn't given, the $47M decrease is definitive). The Level 2 percentage is also nonsensical given the claimed total. (3) Multi-hop reasoning: The question requires comparing two years' investments and identifying the portion under Level 2 in 2023. The LLM fails both steps completely, indicating a failure to retrieve or synthesize the correct data. (4) Entity and context: While the company (KO) and financial concepts (mutual/pooled funds, Level 2 inputs) are correctly identified, the answer fabricates large-scale numbers and trends. The contextual relevance is low due to incorrect figures, though the structure of the response matches the question's intent. Overall, this represents a significant factual and quantitative failure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 384,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, and how much net cash did GE pay to AerCap related to continuing involvement with the company during the same period?",
      "original_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million. Additionally, GE paid $203 million in net cash to AerCap related to continuing involvement activities.",
      "llm_answer": "The 2023 pre‑tax charge tied to the ongoing borrower litigation was **$1,189 million**, and GE paid **$203 million of net cash to AerCap** for its continuing involvement during the year ended December 31, 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, both key figures are accurate: the pre-tax charge of $1,189 million and the net cash payment of $203 million to AerCap are correctly reported, with acceptable formatting (e.g., 'million' vs 'M'). (2) The answer is complete, addressing both parts of the multi-part question: the pre-tax litigation charge and the net cash paid to AerCap for continuing involvement, both for the correct period (year ended December 31, 2023). (3) Entity accuracy is correct—GE and AerCap are properly identified, and the financial metrics (pre-tax charge, net cash payment) are accurately attributed. (4) The reasoning, while not explicitly shown, is reflected in the correct synthesis of multi-hop information from different parts of the filing(s), correctly associating GE’s litigation charge and its cash flow activity with AerCap. (5) The semantic meaning is equivalent to the original answer, with clear, concise restatement using bold formatting for emphasis, which does not affect factual accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 319,
        "total_tokens": 1448
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Accenture's investment in research and development and its focus on delivering 360° value contribute to its competitive positioning in the global IT services market, especially when compared to its competitors' offerings?",
      "original_answer": "Accenture invested $1.1 billion in research and development during fiscal 2022, which supports its ability to innovate and deliver advanced solutions. This investment underpins its strategy of delivering 360° value—defined as providing financial business cases, inclusion and diversity progress, employee reskilling, and sustainability support to clients. This differentiates Accenture in a competitive market where competitors include multinational IT providers, offshore firms, consultancies, and in-house corporate departments. Accenture claims no other firm offers the same breadth of services at scale, and its 360° value approach, backed by R&D and global ecosystem partnerships, enables it to deliver outcomes across strategy, execution, and transformation, giving it a unique competitive edge.",
      "llm_answer": "Accenture’s $1.1 billion R&D spend in fiscal 2022 (page 5) produced more than 8,300 patents and a portfolio of proprietary platforms, labs, research and venture units that let the firm “continuously invest in advanced tools, methods and platforms” and rapidly incubate emerging‑technology solutions (page 13).  By pairing that deep‑technology capability with its “360° value” model—delivering the client’s financial business case while also advancing inclusion, reskilling, sustainability and experience goals (page 14)—Accenture can offer a full‑scale, end‑to‑end service set that few rivals can match, positioning it as a trusted, differentiated partner in the highly competitive global IT‑services market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.1 billion R&D investment in fiscal 2022 is correctly stated, matching the original answer. While the ground truth does not mention '8,300 patents' or specific page numbers, these details are not contradicted and may reflect additional data from the source document; their inclusion does not reduce accuracy. (2) The core elements—Accenture’s R&D investment enabling innovation and the 360° value model encompassing financial, inclusion, reskilling, and sustainability outcomes—are accurately represented. (3) The reasoning correctly synthesizes the link between R&D, proprietary capabilities, and differentiated service offerings, supporting Accenture’s competitive positioning. It appropriately contrasts Accenture with competitors by implication of unmatched breadth, though it doesn’t explicitly name competitor types (e.g., offshore firms, consultancies), a minor omission. (4) The answer is fully contextually relevant, directly addressing how R&D and 360° value enhance competitive positioning. Wording differs but semantic meaning matches. One point deducted from qualitative accuracy for not explicitly referencing the claim that no other firm offers the same breadth at scale, which is a key differentiator in the original. Otherwise, the answer is factually sound, well-reasoned, and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 388,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What specific entities, in addition to WarnerMedia, were classified as discontinued operations by AT&T in 2023, and how does this classification affect the presentation of their financial results?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations in 2023. This classification means that the financial results of these entities are excluded from ongoing operations and are instead reported separately as discontinued operations, including for periods prior to the consummation of the WarnerMedia/Discovery transaction.",
      "llm_answer": "AT&T said that, in addition to WarnerMedia, the discontinued‑operations group also includes **Vrio, Xandr and Playdemic Ltd.** These businesses are reported separately from the company’s continuing operations – their revenues, expenses and net loss are shown in a distinct “discontinued operations” section of the income statement and summarized in Note 24, with the results excluded from the continuing‑operations totals and presented on a stand‑alone basis for the current and prior periods.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Entity accuracy: The LLM correctly identifies Vrio, Xandr, and Playdemic (including 'Playdemic Ltd.' which is a valid variation of the entity name) as the additional entities classified as discontinued operations alongside WarnerMedia in 2023. (2) Quantitative accuracy: There are no numerical values or calculations in this question, so this criterion is not applicable, but the answer contains no incorrect numbers. (3) Multi-hop reasoning: The answer correctly synthesizes the classification of multiple entities as discontinued operations and explains the financial reporting impact—specifically, that their results are separated from continuing operations, reported in a distinct section of the income statement, and adjusted in prior periods. It also references Note 24, which aligns with typical SEC filing disclosures, adding contextual fidelity. (4) Semantic equivalence: The LLM conveys the same meaning as the original answer, with added detail (e.g., mention of Note 24) that enhances clarity without introducing error. The explanation of financial presentation—exclusion from continuing operations and standalone reporting for current and prior periods—precisely matches the ground truth. All parts of the question are addressed completely and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 374,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, and how does this loss distribute across the maturity periods according to the 2022 10-K filing?",
      "original_answer": "The total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, is $3 million. This loss is entirely associated with securities having maturity periods of more than 12 months, as no unrealized loss is reported for securities with maturity periods of less than 12 months.",
      "llm_answer": "The 2022 10‑K shows that Medtronic’s auction‑rate securities carried an unrealized loss of **$3 million** as of April 29, 2022. All of that loss is recorded in the “**more than 12‑month**” maturity bucket; there is **no unrealized loss** reported for auction‑rate securities that mature in **less than 12 months**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $3 million unrealized loss is accurately reported, along with the correct date (April 29, 2022), and the distribution across maturity periods is precisely stated: all loss is in the 'more than 12-month' bucket, with no loss in the 'less than 12-month' category. (2) The answer is complete, addressing both parts of the question: total unrealized loss and its distribution by maturity. (3) Entity accuracy is correct—Medtronic (MDT), Auction Rate Securities, and the 2022 10-K are properly identified. (4) The reasoning is sound and reflects proper synthesis from the filing, correctly interpreting the maturity period segmentation. (5) The semantic meaning is equivalent to the original answer, with clear, concise rewording that preserves all factual content. No errors in calculation, logic, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 265,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How many shares of Class B-2 common stock were issued during the Class B-1 common stock exchange offer in May 2024, and what percentage of the total shares issued in that exchange consisted of Class B-2 common stock?",
      "original_answer": "In May 2024, 120 million shares of Class B-2 common stock were issued during the exchange offer for Class B-1 common stock. A total of 168 million shares were issued in that exchange (120 million Class B-2 and 48 million Class C). Therefore, Class B-2 shares accounted for approximately 71.4% of the total shares issued.",
      "llm_answer": "The May 2024 exchange offer resulted in the issuance of **about 120 million shares of Class B‑2 common stock**.  \nThose 120 million shares were part of a total of **≈ 168 million shares issued** (120 million B‑2 + 48 million Class C), so Class B‑2 shares made up **roughly 71 % of the shares issued** in the exchange offer【page_40】【page_89】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it correctly states that 120 million shares of Class B-2 common stock were issued, which aligns with the original answer. It also accurately reports the total shares issued as approximately 168 million (120 million B-2 + 48 million Class C), and calculates the percentage as roughly 71%, which is a valid rounding of the precise 71.4%. Minor formatting differences (e.g., '≈' vs 'approximately', '71 %' vs '71.4%') do not affect factual accuracy. (2) The answer addresses both parts of the question: the number of Class B-2 shares issued and their percentage of the total. (3) All entities—Class B-2, Class C, the May 2024 exchange offer—are correctly identified and contextually accurate. (4) The reasoning is sound: the model correctly synthesizes the composition of the total share issuance and derives the correct proportion, demonstrating proper multi-hop logic by combining share counts to compute a percentage. The cited sources (page_40, page_89) further support the answer's grounding in evidence. Overall, the answer is factually precise, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 338,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023, and how does this reflect in the change in the number of Wind Turbines sold during the same period?",
      "original_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 (11.7 GW) to 2023 (8.5 GW) is 3.2 GW. During the same period, the number of Wind Turbines sold decreased from 3,590 units in 2021 to 2,225 units in 2023, a reduction of 1,365 units. This indicates a decline in both the volume of turbines sold and the overall capacity of wind energy systems delivered by GE.",
      "llm_answer": "GE’s wind‑turbine sales fell by 3.2 gigawatts between 2021 (11.7 GW) and 2023 (8.5 GW). During the same period the number of turbines sold dropped by 1,365 units, from 3,590 in 2021 to 2,225 in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the decrease in capacity from 11.7 GW in 2021 to 8.5 GW in 2023 is correctly calculated as a 3.2 GW reduction. The number of turbines sold decreased from 3,590 to 2,225, a difference of 1,365 units, which is correctly reported. (2) The answer addresses both parts of the multi-part question: the change in GW capacity and the change in number of turbines sold. (3) Entities are accurate—GE is the correct company, and the years 2021 and 2023 are correctly referenced with appropriate metrics. (4) The reasoning is sound and reflects proper synthesis across time points and metrics, even though the explanation is concise. The LLM omits the interpretive sentence about the decline indicating reduced volume and capacity delivery, but it still conveys all key facts required by the question. The omission does not detract from factual correctness or completeness of the core data. Therefore, all scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 294,
        "total_tokens": 1451
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "What was the total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, and how does this reflect in the company's cash flow classification?",
      "original_answer": "AT&T paid a total of $26,477 million for C-Band licenses, including $23,406 million in auction deposits and payments, $3,067 million in incentive and relocation costs ($955 million for Phase I, $2,112 million for Phase II, and $1,100 million in compensable relocation costs over several years, of which $650 million was paid in 2021, $98 million in 2022, and $109 million in 2023). These payments are classified under 'Acquisitions, net of cash acquired' on AT&T's consolidated statements of cash flows.",
      "llm_answer": "AT&T’s total cash outlay for the C‑Band spectrum through 2023 was $23.406 billion for the licenses themselves plus $3.067 billion in incentive payments and $0.857 billion in relocation costs, amounting to roughly **$27.3 billion** in total. All of these cash payments – the deposit, the purchase price, the capitalized interest and the incentive/relocation amounts – are reported in the cash‑flow statement under **“Acquisitions, net of cash acquired,”** i.e., as an investing‑activity outflow.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly identifies the $23.406 billion in auction payments and $3.067 billion in incentive and relocation costs, it adds an additional $0.857 billion in relocation costs, which is incorrect. According to the ground truth, the $3.067 billion already includes all incentive and relocation costs: $955 million (Phase I), $2,112 million (Phase II), and $1,100 million in compensable relocation costs (with specific payments of $650M in 2021, $98M in 2022, $109M in 2023). The LLM incorrectly separates relocation costs from the $3.067 billion, leading to double-counting. The total amount is stated as $27.3 billion, but the correct total is $26,477 million ($26.477 billion). (2) The calculation is flawed: $23.406B + $3.067B = $26.473B (approx $26.477B with rounding), not $27.3B. The $0.857B relocation figure does not match the ground truth breakdown. (3) The qualitative reasoning is partially sound: the answer correctly identifies that all payments are classified under 'Acquisitions, net of cash acquired' in the cash flow statement, which aligns with the ground truth. It also correctly frames the payments as investing outflows. (4) Contextual relevance is high—the answer addresses both parts of the question (total cost and cash flow classification), but the numerical error in total cost significantly undermines correctness. The multi-hop synthesis is attempted but flawed due to misaggregation of cost components.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 417,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Medtronic's decision to discontinue the HVAD System impact its financial performance in fiscal year 2022, and what other product lines were highlighted as growth drivers in the same period?",
      "original_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 removed a product that had generated $141 million in net sales during fiscal year 2021. This discontinuation likely contributed to the company's focus on other growth drivers in fiscal year 2022, such as the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and transcatheter mitral and tricuspid therapy products led by the Intrepid system. Despite the loss of HVAD revenue, Medical Surgical's net sales increased to $9.1 billion in fiscal year 2022, up 5% compared to the prior year, driven by recovery in global procedure volumes and strong performance in Surgical Innovations, partially offset by supply chain disruptions.",
      "llm_answer": "The June 2021 decision to stop distribution of the Medtronic HVAD system eliminated its sales in FY 2022, producing a “decline of Medtronic HVAD System net sales” that partially offset the overall 6 % increase in Cardiovascular net sales for the year.  Growth in FY 2022 was instead driven by a range of other products, most notably the continued adoption of the CoreValve Evolut transcatheter aortic‑valve platform (including Evolut PRO), strong sales of Extra‑Corporeal Life Support (ECLS) devices, the Micra transcatheter pacing system (and its Azure/​S SureScan extensions), the Cobalt and Crome ICD/CRT‑D portfolio, the Claria MRI CRT‑D and LINQ II cardiac monitor, Arctic Front cryo‑ablation, and peripheral‑vascular offerings such as the VenaSeal closure system and the Abre venous self‑expanding stent.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that the HVAD discontinuation caused a decline that 'partially offset' a 6% increase in Cardiovascular net sales, but the ground truth reports a 5% increase in Medical Surgical (not Cardiovascular) net sales to $9.1 billion. The LLM incorrectly attributes the growth to the Cardiovascular segment and cites a 6% increase, which does not match the 5% figure in the original answer. Additionally, the original answer notes that HVAD generated $141 million in FY2021, but the LLM does not mention this figure, omitting a key quantitative impact of the discontinuation. (2) The LLM introduces product lines not mentioned in the ground truth as growth drivers—such as CoreValve Evolut, Micra, Cobalt, Crome, Claria, LINQ II, Arctic Front, VenaSeal, and Abre stent—while missing the specific growth drivers highlighted in the original answer: Symplicity Spyral, Pulse Field Ablation, Aurora Extravascular ICD, and Intrepid transcatheter mitral/tricuspid therapy. This represents a major deviation in entity accuracy. (3) The multi-hop reasoning is flawed: while the LLM correctly links the HVAD discontinuation to a negative impact on sales, it misattributes the business segment and growth rate, and fails to connect the strategic shift to the correct alternative product lines. The synthesis across time (FY2021 discontinuation affecting FY2022 performance) is logically sound, but the financial and product-level details are incorrect. (4) The contextual relevance is moderate—the answer addresses the general theme of HVAD's impact and identifies other products as growth drivers—but the specific facts, numbers, and product lines are largely mismatched, reducing overall correctness. The answer fabricates detailed product-level data not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 501,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How much total cash did Walmart pay to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024, and what was the impact on Walmart's ownership percentage in Flipkart?",
      "original_answer": "Walmart paid $3.5 billion to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024. This increased Walmart's ownership in Flipkart from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024.",
      "llm_answer": "Walmart spent $3.5 billion in fiscal 2024 to buy out additional Flipkart non‑controlling‑interest shareholders and to settle the liability to former PhonePe non‑controlling‑interest holders.  That cash outlay lifted Walmart’s stake in Flipkart from roughly 75 % at the start of the year to about 85 % – an increase of roughly 10 percentage points.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Walmart paid $3.5 billion during fiscal 2024 for two purposes—acquiring additional shares from Flipkart noncontrolling interest holders and settling the liability to former PhonePe noncontrolling interest holders. (2) The quantitative accuracy is perfect: the dollar amount ($3.5 billion) matches exactly, and the ownership change—from approximately 75% to approximately 85%—is correctly stated, with an implied 10 percentage point increase, consistent with the original. Minor wording differences (e.g., 'start of the year' vs 'as of January 31, 2023') are acceptable as they refer to the same fiscal year-end dates in Walmart's reporting calendar. (3) The multi-hop reasoning is sound: the answer synthesizes information about two separate transactions (Flipkart share acquisition and PhonePe liability settlement) into a single cash outlay and correctly links this to the change in ownership percentage in Flipkart. (4) Entities are accurate: Walmart, Flipkart, PhonePe, noncontrolling interest holders, fiscal 2024—all correctly identified and contextually used. The answer is complete, factually precise, and logically coherent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 351,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Microsoft's treatment of unearned revenue from volume licensing programs, including the timing of invoicing and revenue recognition, impact the presentation and auditability of its financial statements, given the complexity in determining standalone selling prices (SSP) and the auditor's focus on revenue recognition?",
      "original_answer": "Microsoft recognizes unearned revenue from volume licensing programs, which include Software Assurance (SA) and cloud services, by invoicing annually at the beginning of each contract period and recognizing revenue ratably over the coverage period. This creates contract balances such as receivables or unearned revenue, depending on the timing mismatch between invoicing and revenue recognition. Due to the complexity in determining standalone selling prices (SSP) for on-premises licenses sold with SA or software updates, Microsoft must use judgment and estimates based on customer size and geographic region, which affects the allocation of discounts and the pattern of revenue recognition. This complexity was a critical audit matter for Microsoft’s independent auditors, who focused on the application of revenue recognition principles, especially around transfer of control and variable consideration. Therefore, the structure and accounting treatment of volume licensing programs directly influence both the presentation of financial statements and the nature of the audit procedures performed.",
      "llm_answer": "Microsoft records the cash it receives for multi‑year volume‑licensing agreements (including Enterprise Agreements with Software Assurance) as a liability called “unearned revenue” and invoices the customer at the start of each coverage year, even though the related revenue is recognized ratably over the contract period. Because many of the performance obligations are not sold separately, management must estimate a standalone‑selling price for each obligation using market data, customer size, geography and other inputs, and then allocate the contract price; this judgment‑intensive SSP determination is disclosed as a significant estimate (Note 1) and drives the timing of the receivable‑vs‑unearned‑revenue split. The auditors therefore treated revenue recognition for these programs as a critical audit matter, performing extensive testing of the SSP estimates, contract‑term allocations and the controls over the invoicing‑recognition timing to ensure that the liability presentation and the ratably recognized revenue are reliable and free of material misstatement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key elements are correctly addressed: Microsoft invoices annually at the beginning of each contract period, recognizes revenue ratably, records unearned revenue as a liability, and faces complexity in determining standalone selling prices (SSP) due to bundled offerings like Software Assurance. The use of judgment based on customer size, geography, and market data for SSP estimation is accurately described. (2) There are no numeric values in the original or LLM answer requiring verification, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the answer correctly links the invoicing timing, revenue recognition pattern, estimation challenges, and their impact on financial statement presentation and audit focus. It correctly identifies that these factors lead to critical audit matters, with auditors testing SSP estimates, allocations, and controls—directly aligning with the original answer. (4) The LLM response uses slightly different phrasing (e.g., 'judgment-intensive SSP determination' vs 'use judgment and estimates') but preserves all technical and conceptual meaning. It even adds a specific reference to 'Note 1' for disclosures, which enhances detail without introducing error. The contextual relevance is perfect, addressing all aspects of the question including auditability, presentation, and complexity. Therefore, all scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1589,
        "completion_tokens": 410,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What were the total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, and why were no profit sharing contributions included in this total?",
      "original_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $343 million ($126 million in 2022, $110 million in 2021, and $107 million in 2020). No profit sharing contributions were included in this total because the company did not make any discretionary profit sharing contributions for the fiscal years 2022, 2021, or 2020, as stated in the plan terms.",
      "llm_answer": "Nike’s qualified 401(k) Savings and Profit Sharing Plan received total company contributions of **$126 million for 2022, $110 million for 2021 and $107 million for 2020 – a combined $343 million** over the three fiscal years ended May 31, 2022. The plan also permits discretionary profit‑sharing contributions, but **no profit‑sharing contributions were made in any of those years**, so the total reflects only the mandatory savings‑plan matches.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all company contributions: $126 million in 2022, $110 million in 2021, and $107 million in 2020, with a correctly calculated total of $343 million, matching the ground truth exactly. (2) All numeric values are accurate and properly summed; format variations (e.g., $343 million vs $343M) are acceptable and semantically equivalent. (3) The reasoning is sound: the LLM correctly explains that no profit-sharing contributions were included because none were made in any of the three fiscal years, aligning with the plan terms cited in the original answer. It correctly distinguishes between mandatory savings-plan matches and discretionary profit-sharing contributions, demonstrating accurate multi-hop synthesis across time periods and plan provisions. (4) The answer is fully complete, addressing both parts of the question—total contributions and the reason for absence of profit-sharing—using correct entities (Nike, 401(k) Savings and Profit Sharing Plan, correct fiscal years). Wording differs slightly but preserves full semantic equivalence. All evaluation dimensions are satisfied at the highest level, justifying perfect scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 336,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024, and how does this compare to the change in natural gas reserves in Africa over the same period?",
      "original_answer": "Chevron's consolidated natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet from 312 (2023) to 296 (2024). In contrast, natural gas reserves in Africa increased by 297 billion cubic feet from 172 (2023) to 468 (2024). Therefore, while reserves declined slightly in the Asia Pacific/Middle East, they significantly increased in Africa.",
      "llm_answer": "From the 2024 10‑K table of proved natural‑gas reserves:\n\n* **Asia Pacific/Middle East** – total (developed + undeveloped) reserves fell from **312 billion cubic feet (BCF) at 12/31/2023** to **296 BCF at 12/31/2024**, a **decline of 16 BCF**.\n\n* **Africa** – total reserves rose from **172 BCF at 12/31/2023** to **468 BCF at 12/31/2024**, a **increase of 296 BCF**.\n\nSo, while the Asia Pacific/Middle East region saw a modest 16 BCF drop, the African region experienced a much larger 296 BCF gain over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all parts of the question. (1) The numbers for Chevron's natural gas reserves in the Asia Pacific/Middle East region are correct: 312 BCF in 2023 and 296 BCF in 2024, resulting in a decrease of 16 BCF, which matches the ground truth. (2) For Africa, the LLM correctly reports reserves increasing from 172 BCF to 468 BCF. However, it calculates the change as 296 BCF, while the ground truth states 297 BCF. The correct difference is 468 - 172 = 296 BCF, so the LLM's calculation is actually accurate; the ground truth appears to have a minor error (likely a typo: 297 instead of 296). Thus, the LLM answer is mathematically correct. (3) The multi-hop reasoning—comparing changes across regions and synthesizing data from two different regions and years—is sound and clearly explained. (4) All entities (Chevron, Asia Pacific/Middle East, Africa, years 2023–2024) are correctly identified. The wording differs slightly but maintains semantic equivalence. The only reason for not giving a perfect 10 is the discrepancy with the ground truth's stated 297 BCF increase in Africa, but since the LLM's calculation (296 BCF) is numerically correct, this reflects an issue with the ground truth, not the model. Therefore, the LLM answer should be considered fully correct in practice.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 367,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How much total cash did Walmart receive from equity funding related to PhonePe during fiscal 2024, and how did this compare to the amount paid to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year?",
      "original_answer": "Walmart received $0.7 billion from equity funding related to PhonePe during fiscal 2024 and paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year. Therefore, Walmart spent $2.8 billion more than it received in net cash related to PhonePe equity transactions during fiscal 2024.",
      "llm_answer": "Walmart received **about $0.7 billion** in cash from new equity‑funding rounds for its majority‑owned PhonePe subsidiary in fiscal 2024. In the same year it **paid roughly $3.5 billion** to purchase shares from former non‑controlling interest holders of PhonePe (and related Flipkart interests), so the cash received was only about one‑fifth of the amount it spent to acquire those shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Walmart received $0.7 billion from equity funding and paid $3.5 billion to acquire shares from noncontrolling interest holders in fiscal 2024, matching the ground truth exactly in numerical terms. The use of 'about' and 'roughly' is acceptable as it reflects standard reporting conventions and does not distort the precision of the figures, which are accurate. (2) All numeric values are correct: $0.7 billion received and $3.5 billion paid. While the original answer includes the derived net cash difference of $2.8 billion (i.e., $3.5B - $0.7B), the LLM answer conveys the same comparative insight by stating that the amount received was 'only about one-fifth' of the amount spent — which is mathematically accurate (0.7 / 3.5 = 0.2). This demonstrates correct implicit reasoning. (3) The multi-hop reasoning is sound: the model synthesizes two distinct cash flows related to PhonePe equity transactions — inflows from funding and outflows from share acquisitions — and correctly compares them. The mention of 'related Flipkart interests' adds contextual detail that may be present in source documents but is not in the ground truth; however, it does not contradict or mislead, so it doesn't reduce accuracy. (4) The answer is semantically equivalent to the original, with only minor phrasing differences. The only reason for not scoring a perfect 10 is the absence of the explicit $2.8 billion net outflow statement, though the comparison is effectively communicated. Thus, correctness is very high but not fully complete in explicit detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 439,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving the SEC Administrative Order and related legal matters, and how long will the compliance monitor oversee RTX's obligations under these agreements?",
      "original_answer": "RTX recorded a total pre-tax charge of $918 million in 2024 related to the SEC Administrative Order and other legal resolutions. The compliance monitor will oversee RTX's obligations for a period ending three years from the date on which the monitor is engaged.",
      "llm_answer": "RTX recorded a total pre‑tax charge of **$918 million** in 2024 to settle the SEC Administrative Order and the related DOJ and trade‑compliance matters.  An independent compliance monitor must be retained to oversee RTX’s obligations under the DPAs and the SEC order for **a period of three years from the date the monitor is engaged**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the pre-tax charge of $918 million in 2024 is accurately reported, with acceptable formatting (bold and thin space). The oversight period of 'three years from the date the monitor is engaged' exactly matches the original answer's 'three years from the date on which the monitor is engaged'—semantically equivalent. (2) The answer is complete, addressing both parts of the multi-part question: the financial impact and the duration of compliance monitoring. (3) Entity accuracy is correct: RTX is the subject, the SEC Administrative Order and related legal matters (including DOJ and trade-compliance) are properly referenced. (4) The reasoning is sound and reflects multi-hop synthesis—tying the financial charge to specific regulatory actions and correctly linking the compliance monitor’s role across the DPAs and SEC order. No factual, numerical, or logical errors are present. All criteria are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 293,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What was the total Microsoft Cloud revenue in fiscal year 2023, and which specific cloud-based offerings, including Dynamics 365, contributed to this revenue?",
      "original_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was $111.6 billion. This revenue was generated from offerings such as Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties.",
      "llm_answer": "Microsoft’s “Microsoft Cloud” revenue was **$111.6 billion for fiscal year 2023**. That figure aggregates the cloud‑based portions of several businesses – Azure and other cloud services, Office 365 Commercial (the Office‑365 component of Microsoft 365), the commercial portion of LinkedIn, Dynamics 365 (including its ERP, CRM, Power Apps and Power Automate offerings), and other commercial cloud properties.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figure of $111.6 billion for fiscal year 2023 is accurate and correctly formatted. (2) The answer completely addresses both parts of the question: it provides the total Microsoft Cloud revenue and lists all contributing cloud-based offerings, including Dynamics 365. The listed components—Azure and other cloud services, Office 365 Commercial, commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties—exactly align with the ground truth. (3) The reasoning is sound and reflects proper multi-hop synthesis, as it aggregates revenue contributions from multiple services under the Microsoft Cloud umbrella. (4) The LLM adds minor clarifying details (e.g., mentioning ERP, CRM, Power Apps, and Power Automate under Dynamics 365), which are semantically consistent and enhance accuracy without introducing errors. All entities, time periods, and financial metrics are correct. Therefore, the answer achieves perfect scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 306,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Universal Beijing Resort's $3.5 billion debt position as of December 31, 2023, reflect both its direct financing arrangements and its position within Comcast's consolidated debt structure?",
      "original_answer": "Universal Beijing Resort's $3.5 billion debt position reflects both its direct financing arrangements and its consolidated position within Comcast's debt structure. As stated in the evidence, Universal Beijing Resort secured its financing through a debt facility with a maximum borrowing limit of ¥29.7 billion RMB (approximately $4.2 billion), funded by a syndicate of Chinese financial institutions and secured by the resort's assets and investor equity interests. As of December 31, 2023, the resort had $3.5 billion of debt outstanding under this arrangement, including $3.1 billion in term loans. Despite this secured debt structure, Comcast consolidates Universal Beijing Resort as a Variable Interest Entity (VIE) due to its governance structure and its ability to direct major economic activities. However, Comcast explicitly states that there are no liquidity arrangements, guarantees, or financial commitments between itself and the resort, meaning Comcast's risk exposure is limited to its 30% equity interest. In the consolidated debt disclosures, Universal Beijing Resort's $3.5 billion debt is categorized under 'Debt Not Guaranteed,' appearing separately from Comcast's other major debt segments like NBCUniversal and Comcast Cable, which are subject to cross-guarantees.",
      "llm_answer": "Universal Beijing Resort carries $3.5 billion of debt on Comcast’s balance sheet, but that debt is **not covered by any Comcast guarantee** – it is listed under “Debt Not Guaranteed” in the debt‑guarantee table (​$3.5 bn for UBR in 2023)​【page_56】. The liability stems from a **direct financing arrangement** in which a syndicate of Chinese banks provided a term loan (about $3.1 bn of principal, secured by the resort’s assets and the investors’ equity interests, with a maximum borrowing limit of ¥29.7 bn ≈ $4.2 bn)**​【page_86】. Although the debt is included in Comcast’s consolidated total debt of $97.1 bn, it sits outside the cross‑guarantee and one‑way guarantee structures, reflecting that Comcast’s exposure is limited to its 30 % equity stake while the resort’s own assets back the borrowing​【page_87】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Universal Beijing Resort's $3.5 billion debt as of December 31, 2023, is accurately stated; the $3.1 billion in term loans and the $4.2 billion maximum borrowing limit (converted from ¥29.7 billion RMB) are correctly reported. The debt is properly characterized as being under 'Debt Not Guaranteed' in Comcast’s consolidated structure. (2) Quantitative accuracy is perfect: all dollar amounts, percentages (30% equity stake), and conversions (¥29.7 billion ≈ $4.2 billion) match the original answer. No calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across financing arrangements, consolidation accounting (VIE), and Comcast’s debt disclosures. It correctly notes that while the debt is consolidated, there are no guarantees, and Comcast’s exposure is limited to equity—though it does not explicitly mention the term 'Variable Interest Entity (VIE)', which is a minor omission. (4) The answer is contextually relevant and directly addresses both parts of the question: the direct financing and the position within Comcast’s debt structure. The only reason for not scoring a 10 is the lack of explicit mention of VIE, which is a key technical reason for consolidation and thus a small gap in qualitative completeness. However, the functional implications (no guarantees, limited exposure) are correctly conveyed, preserving semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 412,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What was the change in Nike's investment in commercial paper and bonds from May 31, 2021, to May 31, 2022, and how did this shift affect the composition of their short-term investments?",
      "original_answer": "Nike's investment in commercial paper and bonds decreased from $748 million on May 31, 2021, to $660 million on May 31, 2022, representing a decline of $88 million. This reduction was part of a broader reallocation in their short-term investments, where total Level 2 short-term investments dropped from $695 million to $630 million, indicating a strategic shift toward more liquid or alternative short-term instruments such as U.S. Treasury securities and money market funds.",
      "llm_answer": "Nike’s short‑term investment in commercial paper and bonds fell from **$691 million at May 31 2021 to $623 million at May 31 2022**, a decline of **$68 million**. Because total short‑term investments rose from $3.587 billion to $4.423 billion over the same period, the commercial‑paper‑and‑bonds component became a **smaller proportion of the overall short‑term investment portfolio**, even though the absolute dollar amount fell.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Nike's investment in commercial paper and bonds was $748 million on May 31, 2021, and $660 million on May 31, 2022, a decline of $88 million. The LLM incorrectly reports these figures as $691 million and $623 million, respectively, with a decline of $68 million—both values and the difference are wrong. Additionally, the LLM claims total short-term investments increased from $3.587 billion to $4.423 billion, which is not supported by the original answer and introduces data not present in the ground truth. (2) The calculation of the decline is incorrect due to wrong base numbers. The correct decline is $88 million ($748M - $660M), not $68 million. The LLM’s calculation based on its incorrect inputs is internally consistent but factually wrong. (3) The reasoning about the composition shift is partially logical—reduction in a component while total portfolio grows would reduce proportion—but this narrative contradicts the ground truth, which states that total Level 2 short-term investments *decreased* from $695 million to $630 million, indicating a broader reduction, not growth. Thus, the multi-hop synthesis fails: the LLM misrepresents both the specific asset class and the overall portfolio trend. (4) The contextual relevance is moderate because the answer addresses the question's structure (change in investment and effect on composition), but the qualitative reasoning is undermined by incorrect data. The entity (Nike) and time periods (May 31, 2021–2022) are correct, but financial metrics are inaccurate. Due to major quantitative errors and flawed synthesis, the correctness score is low despite some structural alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 479,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the introduction of Class B-2 common stock impact the diluted earnings per share calculation for fiscal 2023, given that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer?",
      "original_answer": "The introduction of Class B-2 common stock affects the diluted earnings per share calculation by increasing the weighted-average number of as-converted Class A common stock outstanding. Since Class B-2 shares were not outstanding prior to the Class B-1 exchange offer, their assumed conversion into Class A stock in the diluted EPS calculation contributes to the as-converted equity structure, thereby potentially lowering the diluted earnings per share compared to the basic earnings per share, which does not include these conversions.",
      "llm_answer": "The 2023 diluted‑EPS computation is unchanged by the new Class B‑2 shares because, as the filing notes, **no Class B‑2 shares existed before the Class B‑1 exchange offer**. Consequently the diluted‑EPS table shows a dash (“‑”) for Class B‑2 in 2023 and the weighted‑average diluted share count for that class is zero, so the B‑2 stock does not enter the diluted EPS numerator or denominator for fiscal 2023【page_59†L31-L38】【page_91†L31-L38】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its conclusion, directly contradicting the ground truth. The original answer states that the introduction of Class B-2 common stock *does* impact diluted EPS by increasing the as-converted weighted-average share count, thereby potentially lowering diluted EPS. In contrast, the LLM claims the diluted EPS computation is 'unchanged' and that Class B-2 shares do not enter the denominator because none were outstanding and the weighted-average is zero. This misinterprets the accounting treatment: even if shares are issued during or after an exchange offer, their potential dilutive effect must be considered in the as-converted structure for diluted EPS if they are dilutive and part of the conversion framework. The LLM incorrectly relies on the absence of shares prior to the exchange offer to conclude no impact, failing the multi-hop reasoning required. While the citation references (page_59, page_91) may correctly point to disclosures about the exchange offer and share classes, the interpretation is flawed. There are no numerical values to verify (so quantitative accuracy is not severely penalized), but the qualitative reasoning is unsound. The answer is contextually relevant—addressing the right topic and metric—but arrives at the opposite of the correct conclusion, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 376,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) specifically impact the Raytheon segment's financial reporting compared to Collins and Pratt & Whitney?",
      "original_answer": "The Raytheon segment recognizes pension and PRB expenses under U.S. government Cost Accounting Standards (CAS), which differ in cost recognition patterns compared to Financial Accounting Standards (FAS) used by Collins and Pratt & Whitney. While the ultimate liability for pension and PRB costs under FAS and CAS is similar, the Raytheon segment adjusts its financial reporting to reflect CAS-based expenses, impacting its operating profit. Over time, Raytheon expects to recover these pension and PRB liabilities through the pricing of its products and services to the U.S. government, which is not a factor for Collins and Pratt & Whitney.",
      "llm_answer": "The 10‑K notes that the pension and PRB (post‑retirement benefit) expense for the Raytheon segment is accounted for under U.S. government Cost Accounting Standards (CAS), while Collins Aerospace and Pratt & Whitney record the same costs under U.S. GAAP (FAS). Because CAS spreads the expense differently—recognizing it later and then recovering it through pricing of U.S. government contracts—the company reports a “FAS/CAS operating adjustment” that adds roughly $833 million to Raytheon’s 2024 operating profit; Collins and Pratt & Whitney have no such adjustment and therefore show their pension/PRB costs on a straight‑line FAS basis.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key distinction in pension cost recognition between Raytheon (under CAS) and Collins & Pratt & Whitney (under FAS/GAAP), and explains the financial reporting impact via the FAS/CAS operating adjustment. It accurately captures the core reasoning: CAS delays expense recognition and allows recovery through U.S. government contract pricing, which is not applicable to the other segments. However, the $833 million figure for the 2024 operating profit adjustment is not present in the original answer (ground truth), making it a hallucinated or unsupported quantitative claim. The original answer mentions no specific dollar amount or year for the adjustment, so this number cannot be verified and reduces quantitative accuracy. While the qualitative explanation of differing cost recognition patterns and recovery mechanisms is sound and aligns with the ground truth, the addition of a precise figure without support undermines factual correctness. The entities (Raytheon, Collins, Pratt & Whitney), accounting standards (CAS vs FAS), and multi-hop synthesis across segments and accounting frameworks are correctly identified and logically compared. The answer is highly relevant and addresses the comparative financial reporting impact as required by the question, but the unsupported number prevents a higher score on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 385,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How many separate Supplemental Indentures related to the 1.850% Notes due 2020 are documented across the provided excerpts, and which trustees were involved in these agreements?",
      "original_answer": "There are two Supplemental Indentures related to the 1.850% Notes due 2020 documented across the provided excerpts. The first was part of the Ninth Supplemental Indenture dated February 12, 2015, with U.S. Bank National Association as Trustee. The second was part of the Twelfth Supplemental Indenture dated February 6, 2017, with The Bank of New York Mellon Trust Company, N.A. as Trustee.",
      "llm_answer": "Two separate Supplemental Indentures covering the 1.850 % Notes due 2020 are listed. The Ninth Supplemental Indenture (Exhibit 4.12) names **U.S. Bank National Association** as trustee, and the Twelfth Supplemental Indenture (Exhibit 4.15) names **The Bank of New York Mellon Trust Company, N.A.** as trustee.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that there are two Supplemental Indentures related to the 1.850% Notes due 2020, matching the original answer. (2) The quantitative and entity details are precise: the Ninth Supplemental Indenture is correctly dated (implied by context, though date not repeated in LLM answer, but exhibit reference and trustee match), with U.S. Bank National Association as Trustee; the Twelfth Supplemental Indenture is correctly attributed to The Bank of New York Mellon Trust Company, N.A. as Trustee. While the LLM omits the exact dates (February 12, 2015, and February 6, 2017), the exhibit numbers (4.12 and 4.15) and indenture numbers provide sufficient identifying context, and the core entities and count are correct. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across documents to identify two separate agreements and their respective trustees. (4) The answer is contextually relevant, complete in addressing both parts of the question (count and trustees), and conveys the same factual content as the original answer, with only minor wording differences. No factual or calculation errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 345,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the net gain (or loss) recognized in income from foreign exchange forwards and options in fiscal year 2022, and how did this compare to the fair value of foreign exchange forwards and options assets as of May 31, 2021?",
      "original_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 was $40 million. As of May 31, 2021, the fair value of foreign exchange forwards and options assets was $92 million. This indicates that while Nike held a significant fair value in these instruments at the end of fiscal 2021, the net impact on income in the following year was a relatively smaller gain of $40 million.",
      "llm_answer": "In fiscal 2022 the Company recorded a **$40 million net gain** from foreign‑exchange forwards and options in the “Other (income) expense, net” line of the Consolidated Statements of Income. By contrast, the fair‑value of those foreign‑exchange forward and option assets on the balance sheet was **$92 million** as of May 31 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net gain of $40 million in fiscal year 2022 and the fair value of $92 million as of May 31, 2021 are accurately reported, with correct fiscal year and date references. Minor formatting differences (e.g., spacing in '$40 million') do not affect accuracy. (2) The answer addresses both parts of the multi-part question: the net gain in income for fiscal 2022 and the fair value of assets as of May 31, 2021. (3) Entities are correct—the Company refers to Nike (implied by context in the knowledge graph), and the financial instruments (foreign exchange forwards and options) and metrics (net gain, fair value) are properly identified. (4) The reasoning is sound: the LLM correctly separates the income statement impact (net gain in 2022) from the balance sheet fair value (as of 2021), demonstrating appropriate multi-hop synthesis across time periods and financial statements. The semantic meaning is equivalent to the original answer, with slightly more technical detail (mentioning 'Other (income) expense, net' and 'Consolidated Statements of Income'), which enhances accuracy without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 338,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does AIG's use of loss development methods in U.S. Personal Insurance and U.S. Property differ in terms of reserving approach and what impact did prior year developments have on each segment during 2021?",
      "original_answer": "In U.S. Personal Insurance, AIG uses loss development methods in combination with frequency/severity methods, particularly for domestic personal auto, where claim counts emerge quickly, allowing for immediate analysis of loss trends. In 2021, this segment experienced $412 million of favorable prior year development, mainly due to favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years. In contrast, for U.S. Property, AIG uses loss development methods along with IBNR factor methods, especially for short-tail classes, and relies on expected loss ratio methods for the latest accident year. The U.S. Property segment does not have a specific 2021 prior year development figure mentioned in the provided text, but the reserving methodology reflects a need to adjust for loss trends including inflation. The difference in methodology reflects the distinct claim emergence patterns and severity profiles between the two segments.",
      "llm_answer": "AIG reserves U.S. Property by applying a **mix of frequency‑/severity, loss‑development and IBNR‑factor techniques** – the IBNR factor is added for the low‑frequency, high‑severity exposures, and loss‑development factors are weighted together with the other methods for short‑tail property classes.  \n\nFor U.S. Personal Insurance the company **relies mainly on frequency‑/severity and loss‑development methods** (especially for personal auto, where claim counts emerge quickly) and uses those methods, together with IBNR where appropriate, to set reserves for the personal‑lines portfolio.  \n\nIn 2021, prior‑year development produced a **$412 million favorable adjustment** to U.S. Personal Insurance (net of reinsurance and before ADC cessions). No material prior‑year development impact was disclosed for U.S. Property in 2021, indicating that the segment’s reserves were not materially affected by prior‑year emergence that year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $412 million favorable prior year development for U.S. Personal Insurance in 2021 is correctly reported, matching the original answer exactly. The statement that no material prior year development was disclosed for U.S. Property is consistent with the ground truth, which explicitly states that no specific 2021 figure was mentioned. (2) The reserving methodologies are accurately described: for U.S. Personal Insurance, the use of loss development and frequency/severity methods—especially for personal auto with quick claim emergence—is correctly noted. For U.S. Property, the combination of loss development, IBNR factor methods, and reliance on expected loss ratios for short-tail classes is well captured, though the LLM slightly rephrases 'expected loss ratio methods for the latest accident year' as part of a broader mix without highlighting it as distinctly as the original. (3) Multi-hop reasoning is sound: the model correctly synthesizes methodology differences and links them to segment-specific characteristics (e.g., low-frequency, high-severity for property), and correctly infers that lack of disclosure implies no material impact. (4) Minor qualitative difference: the original emphasizes inflation adjustments in U.S. Property reserving, which the LLM omits, but this is a contextual nuance rather than a factual error. Overall, the answer is factually correct, complete, and semantically equivalent with only slight variation in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 426,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does Walmart's majority stake in Flipkart, acquired in 2018, expose Walmart to potential financial risks based on ongoing regulatory proceedings initiated by India's Directorate of Enforcement, and how does this relate to Walmart's broader international investment strategy as described in its 2023 10-K filing?",
      "original_answer": "Walmart's majority stake in Flipkart, acquired in 2018, exposes it to potential financial risks due to ongoing regulatory proceedings initiated by India's Directorate of Enforcement. These proceedings investigate alleged violations of India's Foreign Direct Investment (FDI) rules by Flipkart and its subsidiaries during 2009–2015, prior to Walmart's acquisition. If the regulatory authority determines that violations occurred, it could impose monetary penalties. Walmart is unable to predict the final outcome or scope of the proceedings, and while it does not currently believe the matter will have a material adverse effect, it cannot provide assurance. This situation highlights the risks inherent in Walmart's broader international investment strategy, which includes expanding through acquisitions such as Flipkart to strengthen its global retail ecosystem and omni-channel capabilities.",
      "llm_answer": "Walmart’s 2018 purchase of a majority stake in Flipkart has become a source of contingent risk because India’s Directorate of Enforcement issued a show‑cause notice that could, if the proceedings advance, impose monetary or non‑monetary penalties on Flipkart (and indirectly on Walmart) and could affect the proceeds Walmart may receive from the 2018 share‑sale — the company says it cannot predict the outcome and cannot assure that the matter will not have a material adverse effect on its financial results【page_32】. This exposure is a direct consequence of Walmart’s broader international investment strategy, which the 2023 10‑K describes as “expanding our e‑commerce and digital presence through acquisitions with our majority stakes in Flipkart and PhonePe in India” as part of its global omni‑channel growth plan 【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Walmart acquired a majority stake in Flipkart in 2018; India's Directorate of Enforcement initiated proceedings over alleged FDI rule violations prior to Walmart's acquisition; potential penalties (monetary or otherwise) could affect Walmart; Walmart cannot predict the outcome or assure no material adverse effect. These points are all supported by the original answer and the cited 10-K pages. (2) Quantitative accuracy is perfect: no incorrect numbers, dates (2018 acquisition, 2023 10-K), or financial terms. The reference to 'show-cause notice' is consistent with regulatory proceedings and adds detail not contradicted by the ground truth. (3) Multi-hop reasoning is sound: the LLM correctly links the Flipkart regulatory risk to Walmart’s broader international strategy of acquiring e-commerce platforms like Flipkart and PhonePe to advance its global omni-channel presence, as described on page 6 of the 10-K. (4) The only minor shortcoming is that the LLM slightly overstates the risk by saying 'could affect the proceeds Walmart may receive from the 2018 share-sale' — the original answer does not mention proceeds from the 2018 transaction, focusing instead on potential penalties and material adverse effects more broadly. This introduces a narrow financial claim not present in the ground truth, but it does not materially distort the overall risk. Otherwise, semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 425,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the total dollar value of Class A ordinary shares issued in the 2023 fiscal year, and how did this issuance impact the total Accenture plc shareholders' equity by August 31, 2024?",
      "original_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was $7,970. This issuance, along with other changes, contributed to an increase in total Accenture plc shareholders' equity from $25,692,839 (as of August 31, 2023) to $28,288,646 (as of August 31, 2024), an increase of $2,595,807.",
      "llm_answer": "In fiscal 2023 Accenture issued Class A ordinary shares worth **about $8.9 million** (recorded as a $8,883 thousand increase in the “Issuances of Class A shares for employee share programs” line of the equity statement).  By the end of the next fiscal year, that issuance – together with other equity‑affecting items – helped lift **total Accenture plc shareholders’ equity to $28.3 billion** on August 31 2024, an increase of roughly **$2.6 billion** versus the $25.7 billion reported a year earlier.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The total dollar value of Class A ordinary shares issued in fiscal 2023 is reported as $8,883 thousand (~$8.9 million), but the ground truth is $7,970 (approximately $7.97 thousand, not million). This is a critical error—$8.9 million vs. $7,970 is off by three orders of magnitude. The LLM likely misread 'thousands' as 'millions' or confused the unit. (2) The total shareholders’ equity figures are approximately correct in magnitude: LLM reports $28.3 billion (actual: $28,288,646), $25.7 billion (actual: $25,692,839), and an increase of ~$2.6 billion (actual: $2,595,807). These are rounded but semantically acceptable. However, the linkage of the share issuance to the equity increase is oversimplified and implies the $8.9 million issuance caused a $2.6 billion increase, which misrepresents the causal relationship—the issuance was only one of several contributing factors. (3) The multi-hop reasoning is partially sound: the model correctly identifies that share issuance affects equity and that total equity increased over the period. However, it fails to accurately isolate the specific issuance value and misrepresents its scale and impact. (4) Entity accuracy and contextual relevance are strong—the company (Accenture plc), fiscal years (2023 to 2024), and financial concepts (shareholders’ equity, Class A shares) are correctly identified and relevant. The answer structure addresses both parts of the question. Due to the severe numerical error in the key figure (share issuance value), the correctness and quantitative accuracy scores are low despite reasonable approximations elsewhere.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 459,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does AIG's use of loss development methods for excess casualty lines, particularly those with attachment points above $10 million, influence its reserving methodology for U.S. Property and aerospace exposures, and what role do expected loss ratios play in both analyses?",
      "original_answer": "AIG uses a layered approach in its excess casualty reserving, where losses capped at $10 million are analyzed using traditional loss development and expected loss ratio methods, and this estimate is then used to derive the expected loss estimate for losses above $10 million, reflecting the expected relationships between the layers. In U.S. Property and aerospace exposures, AIG also employs a combination of loss development methods and expected loss ratio methods, especially for aviation claims where severity drives reserving. Expected loss ratios are critical in both cases, particularly for recent accident years where reported loss data is insufficient, and projections are adjusted for inflation, rate changes, and market conditions. This shows that AIG relies heavily on expected loss ratios to bridge early uncertainty across both excess casualty and aviation lines, while layer-specific development patterns guide the ultimate loss estimation process.",
      "llm_answer": "AIG treats its high‑attachment‑point excess‑casualty business by first applying traditional loss‑development techniques to the portion of losses that stays below the $10 million limit and then uses the resulting development pattern and the expected relationship between layers to project the ultimate loss for the “above‑$10 million” layer.  The same blend of development‑based estimates and top‑down expected‑loss‑ratio calculations is used for U.S. Property (short‑tail classes) and for aerospace (U.S. Special Risk) exposures, where loss‑development methods are combined with expected‑loss‑ratio methods to set reserves, especially for the most recent accident years where credibility is low.  In both cases, expected loss ratios serve as a supplemental, forward‑looking driver—adjusted for rate changes, trends, inflation and market conditions—to refine the ultimate reserve when the loss‑development data alone is insufficient.【page_263】【page_273】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) All key elements are correctly addressed: AIG's layered reserving approach for excess casualty lines with attachment points above $10 million, the use of loss development methods below $10 million, and the derivation of estimates above $10 million using expected relationships between layers. It correctly extends this methodology to U.S. Property and aerospace exposures, noting the combination of loss development and expected loss ratio methods. (2) There are no numeric inaccuracies—dollar amounts ($10 million) are correctly stated and consistently used; no calculations are required beyond correct conceptual application of methods. (3) Multi-hop reasoning is sound: the answer synthesizes AIG’s reserving logic across different lines (excess casualty, property, aerospace), correctly identifying the role of expected loss ratios in early accident years and when data credibility is low. (4) The LLM accurately reflects that expected loss ratios are adjusted for inflation, rate changes, and market conditions, and are used as a forward-looking supplement where loss development data is immature. Wording differs slightly but meaning is preserved, and citations to page_263 and page_273 support contextual grounding. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 381,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What was the total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022, and how does this compare to the remaining share purchase authorization as of August 31, 2024?",
      "original_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was $4,111,266. As of August 31, 2024, the remaining share purchase authorization was $2,694,281. This indicates that a significant portion of the available authorization had already been utilized prior to 2024.",
      "llm_answer": "During fiscal 2022 Accenture repurchased Class A ordinary shares for **$4.1 million** (the “Purchases of Class A shares” line shows a cash outflow of $4,111,266). As of August 31 2024, the company had **$2.7 million** of share‑purchase authority still available. Thus, the 2022 repurchase amount exceeded the remaining authorization by roughly $1.4 million.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the dollar value of shares repurchased during the period ending August 31, 2022, as $4,111,266, accurately reflecting the ground truth, and rounds it appropriately to $4.1 million. It also correctly reports the remaining share purchase authorization as of August 31, 2024, as $2.7 million (rounded from $2,694,281), which is acceptable in format. However, the critical error lies in the comparison: the LLM states that the 2022 repurchase amount ($4.1M) exceeded the remaining authorization in 2024 ($2.7M) by $1.4M, which misrepresents the timeline and logic. The repurchase occurred in 2022, while the remaining authorization is reported in 2024—meaning the authorization balance in 2024 is the result of repurchases made *after* 2022, possibly including later repurchases or new authorizations. Thus, comparing a 2022 outflow to a 2024 remaining balance as if they are directly comparable is flawed reasoning. (2) Numeric values are correctly extracted and rounded appropriately: $4,111,266 → $4.1M and $2,694,281 → $2.7M are acceptable. However, the calculation of a $1.4M excess is factually incorrect because it assumes the 2024 remaining balance should be greater than the 2022 repurchase, which is not logically valid. (3) The multi-hop reasoning fails: the model should have noted that the 2022 repurchase was part of prior usage of the authorization, and the 2024 remaining balance reflects subsequent activity, not a constraint at the time of the 2022 repurchase. The conclusion that the repurchase 'exceeded' the later remaining balance is illogical. (4) Scores reflect mostly correct data extraction but a significant error in interpretation and temporal reasoning, which undermines the correctness despite accurate numbers. Contextual relevance is high as all parts of the question are addressed with relevant data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 507,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How do changes in META's advertising policies to comply with regulatory developments in Europe impact both user engagement and advertising revenue, particularly in relation to the shift from 'legitimate interests' to 'consent' for behavioral advertising?",
      "original_answer": "META's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe has led to the introduction of a 'subscription for no ads' alternative and an option for users to see less personalized ads, which are less relevant and effective than premium ad offerings. This change has reduced META's ability to effectively target and measure ads, which has adversely affected advertising revenue. Additionally, the implementation of these advertising policies has contributed to reduced user engagement, particularly in features like Feed and Stories that monetize at higher rates, further impacting revenue. These policy changes were made to comply with European regulations, but they have had a material adverse effect on both user engagement and advertising revenue.",
      "llm_answer": "Meta’s move to replace the “legitimate‑interests” legal basis with a “consent” model for behavioral advertising in the EU (and to offer a “no‑ads” subscription and a “less‑personalized‑ads” option) limits the data signals it can use for targeting 【page_20】. Because the ads become less relevant, user‑experience and time‑spend can fall and marketers receive lower ROI, which the company says has already “adversely affected … our advertising business” and will continue to pressure ad‑revenue growth 【page_62】【page_18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. It correctly identifies Meta's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe, the introduction of the 'no-ads' subscription and 'less-personalized-ads' options, and the resulting limitations on data signals for ad targeting. It accurately states that less relevant ads lead to reduced user experience and time spent, which impacts user engagement—particularly in high-monetization features like Feed and Stories (implied through 'time-spend'). The adverse effect on advertising revenue and future revenue growth is explicitly mentioned, aligning with the original answer. The reasoning is sound and reflects multi-hop synthesis: regulatory change → policy adjustment → reduced targeting capability → lower ad effectiveness → reduced user engagement and ad revenue. All entities (Meta, EU, behavioral advertising, consent model) are correct. There are no numeric inaccuracies (no specific numbers in the original, so quantitative accuracy is not compromised). The only minor omission is not explicitly naming 'Feed and Stories' as the affected engagement features, though 'time-spend' broadly captures the idea. This does not detract significantly from the overall correctness. Citations to page numbers (e.g., page 20, 62, 18) suggest grounding in source material. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 435,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does the redemption policy of Accenture plc Class X ordinary shares directly affect the total number of shares outstanding and what specific mechanism ensures this relationship remains aligned with the number of Accenture Canada Holdings Inc. exchangeable shares?",
      "original_answer": "The redemption policy of Accenture plc Class X ordinary shares ensures that the number of Class X ordinary shares outstanding never exceeds the number of Accenture Canada Holdings Inc. exchangeable shares. This is achieved through a mechanism where Accenture plc redeems Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares on a one-for-one basis, maintaining alignment between the two share classes.",
      "llm_answer": "The redemption provision states that Accenture plc may redeem any Class X ordinary share at par, but it will only do so when Accenture Canada Holdings Inc. exchangeable shares are redeemed or exchanged, and it will never redeem enough Class X shares to leave a holder with fewer Class X shares than the exchangeable shares that holder still owns. Because of this, the total number of Class X shares outstanding is kept at or below the total number of Accenture Canada Holdings Inc. exchangeable shares outstanding, with the redemption‑or‑exchange trigger acting as the mechanism that aligns the two share counts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. It accurately describes the redemption policy of Accenture plc Class X ordinary shares and how it ensures the number of Class X shares outstanding does not exceed the number of Accenture Canada Holdings Inc. exchangeable shares. The mechanism—the one-for-one redemption or exchange trigger—is correctly identified, even if not explicitly labeled as 'one-for-one' in wording; the concept is clearly implied by stating redemptions only occur when exchangeable shares are redeemed or exchanged, and that Class X shares will not fall below the holder's remaining exchangeable shares. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced (9) because the answer frames the policy more from a holder-level perspective ('a holder') rather than the overall corporate-level alignment emphasized in the ground truth, though this does not make it incorrect. Contextual relevance is perfect—directly addresses both parts of the question: effect on shares outstanding and the aligning mechanism. Semantic equivalence is strong, with only minor differences in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 342,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What was the change in net milestone capitalization for Jardiance between 2020 and 2021, and how does this trend reflect the amortization practices described in the filing?",
      "original_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a $20.1 million decline. This decrease reflects the amortization of capitalized milestones over time, as described in the filing. These milestone payments were capitalized as intangible assets and are being amortized to cost of sales through their respective terms under the collaboration, based on factors such as the latest of the launch date, patent expiration, or supplementary protection certificates. The reduction from 2020 to 2021 illustrates the ongoing amortization of this intangible asset over its useful life.",
      "llm_answer": "The net milestone balance for Jardiance fell from $156.2 million at the end of 2020 to $136.1 million at the end of 2021 – a decline of about $20.1 million. The filing explains that milestone payments for Jardiance are capitalized as intangible assets and then amortized to cost of sales over the collaboration term; thus the lower 2021 balance reflects the amortization of a portion of the previously capitalized milestones.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the net milestone capitalization decreased from $156.2 million in 2020 to $136.1 million in 2021, a $20.1 million decline. These numbers match the ground truth exactly, and the calculation (156.2 - 136.1 = 20.1) is accurate. (2) Quantitative accuracy is perfect—values, years, and the computed difference are all correct, with acceptable formatting (e.g., 'about $20.1 million' is semantically equivalent to $20.1 million). (3) The reasoning correctly links the decrease to amortization of capitalized milestones, citing the appropriate accounting practice (amortization to cost of sales over the collaboration term). While the LLM omits some detail about the factors determining the amortization period (e.g., patent expiration, supplementary protection certificates), it captures the core logic and multi-hop synthesis: capitalized milestones → amortized over time → resulting balance decrease reflects this amortization. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the numerical change and its relation to amortization practices. The only minor shortcoming is the slightly less detailed explanation of amortization drivers, which prevents a perfect 10 in qualitative accuracy. Overall, the answer is factually correct, well-reasoned, and complete for practical purposes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 386,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does the use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differ in terms of claim frequency and severity characteristics, and what impact does this have on the reserving process for each region?",
      "original_answer": "The IBNR factor methods are used in both U.S. Property and UK/Europe Property insurance lines, but the reserving process reflects differences in claim frequency and severity. In the UK/Europe Property segment, IBNR factor methods are applied due to low frequency/high severity losses, where IBNR factors are applied to earned premium to estimate ultimate expected losses based on prior accident quarters adjusted for current cost levels and historical emergence patterns. In the U.S. Property segment, similar IBNR factor methods are used, but the reserving process also accounts for a shift toward non-admitted coverages that have altered the customer profile to be less severe in the aggregate. This difference in severity and customer base influences how IBNR factors are continually reevaluated and applied in each region to ensure reserve adequacy.",
      "llm_answer": "Both regions apply IBNR‑factor techniques only to loss‑streams that are **low‑frequency/high‑severity**. In the U.S. Property book the overall portfolio has become “less severe” because a growing share of business is non‑admitted, so claim counts are relatively higher and the IBNR factor is used mainly for the few low‑frequency, high‑severity segments, with reserves built from a mix of frequency‑severity, loss‑development and IBNR inputs. In the UK/Europe Property book the exposures are more traditionally low‑frequency and high‑severity (commercial, industrial and catastrophe‑prone risks), so the IBNR factor carries greater weight in the reserving mix, while loss‑development and expected‑loss‑ratio methods are used to fine‑tune the reserve for the latest accident years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that IBNR factor methods are used in both U.S. Property and UK/Europe Property lines, specifically for low-frequency/high-severity claims, which matches the original answer. It accurately contrasts the U.S. segment's shift toward non-admitted coverages leading to a less severe aggregate profile, while the UK/Europe segment maintains traditional low-frequency/high-severity characteristics. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in claim severity and frequency between regions and links them to how IBNR methods are applied within the reserving process. The mention that U.S. reserves use a 'mix' of methods while UK/Europe gives greater weight to IBNR factors reflects the nuanced difference in methodology emphasis, which is consistent with the original answer’s point about continual reevaluation based on regional characteristics. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the adjustment of IBNR factors for 'prior accident quarters adjusted for current cost levels and historical emergence patterns' in UK/Europe, which is a detail present in the ground truth. However, this omission does not distort the overall correctness. Semantic equivalence is maintained, and the answer is fully contextually relevant. Thus, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 462,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the combined global market share of Procter & Gamble's Grooming segment for blades and razors, and how does this compare to their global market share in male electric shavers?",
      "original_answer": "Procter & Gamble holds more than 60% global market share in blades and razors and over 25% global market share in male electric shavers, resulting in a difference of more than 35 percentage points.",
      "llm_answer": "Procter & Gamble’s Grooming segment commands **more than 60 % of the global blades‑and‑razors market**, while its share of the **male electric‑shaver market is just over 25 %**. Thus, its razor‑blade share is roughly double the share it holds in male electric shavers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Procter & Gamble's market shares: 'more than 60%' in blades and razors and 'just over 25%' in male electric shavers, which matches the ground truth of 'more than 60%' and 'over 25%'. These values are quantitatively accurate. 2) While the original answer emphasizes the *difference* of more than 35 percentage points, the LLM instead states that the razor-blade share is 'roughly double' the electric shaver share. This is a reasonable qualitative comparison (60% is about 2.4x 25%), though it omits the explicit percentage-point difference highlighted in the ground truth. 3) The reasoning is sound and reflects correct multi-hop synthesis: the model correctly distinguishes between two product categories within P&G’s Grooming segment and compares their global market positions. 4) The answer is contextually relevant and addresses both parts of the question—market shares in both categories. The only minor shortcoming is the slightly different framing of the comparison (ratio vs. absolute difference), but the core facts and intent are preserved. Hence, high scores across all dimensions with a 9 on correctness due to the omission of the precise comparative metric (35-percentage-point gap).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 345,
        "total_tokens": 1470
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did General Dynamics invest in Aerospace segment product development in 2023, and what mechanism do they use with suppliers to offset a portion of these costs?",
      "original_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. They use cost-sharing arrangements with suppliers to offset a portion of these financial costs, where supplier contributions are explicitly for reimbursement of development costs and are recorded as a reduction of R&D expenses.",
      "llm_answer": "General Dynamics recorded $510 million of company‑sponsored research and development expenses—including Aerospace product‑development costs – in 2023.  To offset part of those costs, the Aerospace segment uses cost‑sharing arrangements with selected suppliers, whereby the suppliers make milestone‑based reimbursements that are recorded as a reduction of R&D expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $510 million investment in Aerospace segment product development in 2023, matching the ground truth exactly. The mechanism—cost-sharing arrangements with suppliers—is also accurately described, including the key detail that supplier contributions are recorded as a reduction of R&D expenses. (2) Quantitatively, the dollar amount ($510 million) and year (2023) are correct with no calculation errors. Format variation (using 'company-sponsored research and development expenses' to encompass Aerospace product development) is acceptable and semantically aligned. (3) The multi-hop reasoning is sound: the model correctly links General Dynamics, the Aerospace segment, 2023 R&D investment, and the supplier cost-sharing mechanism. The only minor gap is that the LLM answer frames the $510 million as 'company-sponsored R&D expenses' that include Aerospace costs, whereas the ground truth specifies the full $510 million was for the Aerospace segment. This could imply a slight overgeneralization, though in context it is likely referring to the same figure. (4) Despite this nuance, the answer is factually accurate, complete, and contextually appropriate, warranting a high score. The core facts, numbers, and mechanisms are all correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 363,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did Accenture spend on Class A Ordinary Share purchases during fiscal 2024, and how did this affect the total value of treasury shares held by the company?",
      "original_answer": "Accenture spent $4,111,266 on Class A Ordinary Share purchases during fiscal 2024, which increased the total value of treasury shares held by the company by the same amount.",
      "llm_answer": "Accenture spent **$4.5 billion** on purchases of Class A ordinary shares in fiscal 2024 (13.9 million shares for a total cash outlay of **$4,509,392**). These purchases were recorded as a reduction of treasury‑share assets, increasing the total value of treasury shares held by the company by the same amount – roughly **$4.5 billion** of treasury‑share value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the key financial figure. The ground truth states Accenture spent $4,111,266 on Class A Ordinary Share purchases in fiscal 2024, but the LLM claims $4,509,392 (approximately $4.5 billion), which is over 1,000% higher. This major discrepancy invalidates the quantitative core of the answer. (2) The number of shares (13.9 million) and the total cash outlay ($4.5 billion) do not align with the ground truth and appear to be fabricated or misattributed. The calculation of treasury share value increase is logically sound in concept—share repurchases do increase treasury stock value—but the amount is incorrect. (3) The reasoning structure is correct: repurchases increase the value of treasury shares, which is a valid accounting treatment. However, the multi-hop synthesis fails because the input data is wrong. There is no evidence the model correctly retrieved or processed the actual filing data. (4) While the answer addresses both parts of the question (amount spent and effect on treasury shares) and uses appropriate financial terminology, the massive numerical error severely undermines factual correctness. Contextual relevance is high because the response is well-structured and on-topic, but accuracy is critically compromised. Thus, correctness and quantitative accuracy scores are low; qualitative reasoning is partially sound but based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 399,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023, to December 31, 2024, and how does this relate to META's depreciation policy for assets placed in service?",
      "original_answer": "The value of META's Servers and Network Assets increased by $21.559 billion year-over-year, from $46.838 billion on December 31, 2023, to $68.397 billion on December 31, 2024. According to META's depreciation policy, assets placed in service are depreciated over their estimated useful life, while assets still in construction in progress (CIP) are not depreciated until they are placed in service. This significant increase in asset value suggests that a large amount of previously unplaced CIP assets were placed into service during 2024 and are now being depreciated prospectively over their revised estimated useful lives.",
      "llm_answer": "META’s “Servers and network assets” grew from $46.8 billion at 12/31/2023 to $68.4 billion at 12/31/2024 – a year‑over‑year increase of about **$21.6 billion**. These assets are depreciated on a straight‑line basis over their estimated useful life of four to five years (extended to 5.5 years beginning 2025) once they are placed in service, so the additional $21.6 billion will be expensed over that period rather than being capitalized indefinitely.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the year-over-year increase in META's Servers and Network Assets as approximately $21.6 billion, which rounds accurately from the ground truth $21.559 billion. The starting ($46.8B) and ending ($68.4B) values also correctly round the ground truth figures of $46.838B and $68.397B. These are acceptable rounding variations and do not affect factual accuracy. (2) The calculation of the increase is accurate: $68.4B - $46.8B = $21.6B, matching the expected difference. All numeric values, dates, and time periods are correct within standard rounding conventions. (3) The LLM correctly explains META's depreciation policy — that assets are depreciated once placed in service over an estimated useful life of 4–5 years (with a note about the extension to 5.5 years in 2025). While the original answer emphasizes that CIP assets are not depreciated until placed in service and links the large increase to the transition of CIP assets into service, the LLM answer captures the core of this logic by stating the new assets 'will be expensed over that period,' implying they are now in service and being depreciated. However, it omits explicit mention of construction-in-progress (CIP) assets and the shift from CIP to service, which is a minor gap in qualitative completeness. (4) Despite this omission, the reasoning is sound and contextually relevant, correctly linking the asset increase to future depreciation. The answer addresses both parts of the question: the dollar increase and its relation to depreciation policy. The slight lack of detail on CIP does not undermine the overall correctness but prevents a perfect qualitative score. All entities (META, Servers and Network Assets, correct years) are accurate. Semantic equivalence is maintained with minor wording differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 496,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How many drug indications for which Eli Lilly received FDA Breakthrough Therapy designation in 2022 are currently in the submitted status versus discontinued development, and what are the specific compounds and therapeutic areas associated with each status?",
      "original_answer": "Eli Lilly had two drug indications with FDA Breakthrough Therapy designation in 2022 that were in the submitted status: Empagliflozin (Jardiance®) for heart failure with preserved ejection fraction and Baricitinib (Olumiant®) for alopecia areata. No indications with FDA Breakthrough Therapy designation were in the discontinued status in 2022.",
      "llm_answer": "Eli Lilly had **three** 2022 indications that carried an FDA Breakthrough Therapy designation and are still listed as **Submitted** (or “submission initiated”) – none have been discontinued.\n\n| Compound (indication) | Therapeutic area | Current status |\n|-----------------------|------------------|----------------|\n| **Empagliflozin (Jardiance)** – heart‑failure with preserved ejection fraction | Cardiovascular/heart‑failure (diabetes‑derived) | Submitted (U.S. & Europe 2021; Japan Jan 2022)【page_39】 |\n| **Baricitinib (Olumiant)** – alopecia areata | Dermatology/auto‑immune skin disease | Submitted (U.S., Europe, Japan 2021)【page_39】 |\n| **Donanemab** – early Alzheimer’s disease | Neurology/Alzheimer’s disease | Submission initiated (rolling U.S. submission started 2021)【page_38】 |\n\n**Result:** Submitted = 3 indications; Discontinued = 0.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error in the quantitative claim: it states that Eli Lilly had *three* drug indications with FDA Breakthrough Therapy designation in 2022 that were in the submitted status, while the ground truth confirms only *two*. The LLM incorrectly includes Donanemab for early Alzheimer’s disease as a 2022 Breakthrough Therapy designation in submitted status, but the original answer and knowledge graph confirm no such designation for that indication in 2022. While Donanemab may have had a rolling submission initiated, the Breakthrough Therapy designation itself was not received in 2022 according to the ground truth, making its inclusion incorrect. The two correct entries—Empagliflozin for heart failure with preserved ejection fraction and Baricitinib for alopecia areata—are accurately described in terms of compound, indication, therapeutic area, and status. The claim that none were discontinued aligns with the ground truth. Thus, the answer is semantically accurate for two out of three listed indications and correctly identifies the discontinued count, but the core numerical answer (3 vs. 2) is wrong, which significantly impacts correctness. The reasoning shows multi-hop synthesis (linking designation, year, status, compound, and therapeutic area), but the inclusion of Donanemab reflects either a misattribution of the designation year or incorrect linkage of status. Contextual relevance is high as all information provided is pertinent and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 419,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does AIG's reliance on loss development methods differ between U.S. Other Casualty lines and U.S. Property lines, and what specific reserving adjustments were made in 2021 for U.S. Personal Insurance due to prior year catastrophe recoveries?",
      "original_answer": "AIG uses a combination of loss development methods, frequency/severity, and expected loss ratio methods for U.S. Other Casualty lines, particularly for long-tail general liability or products liability lines, while giving more weight to expected loss ratio methods for recent accident years due to the long-tail nature and less credible reported losses. In contrast, for U.S. Property lines, which are short-tail, AIG primarily uses frequency/severity methods, loss development methods, and IBNR factor methods, with IBNR factors applied to earned premiums for low frequency/high severity losses. In 2021, AIG recognized $412 million of favorable prior year development in U.S. Personal Insurance due to subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "llm_answer": "AIG treats the two segments differently. For U.S. Other Casualty it “generally uses a combination of loss‑development methods, frequency‑severity and expected‑loss‑ratio methods,” giving **significant weight to loss‑development for lines with enough volume (and only limited weight for smaller or volatile subsets) and relying on expected‑loss‑ratio for the most recent accident years**. For U.S. Property, the company “uses frequency/severity, loss‑development and IBNR‑factor methods alone or in combination,” applying loss‑development together with **IBNR‑factor techniques (especially for low‑frequency/high‑severity, short‑tail classes)** rather than relying on it as the primary driver.\n\nIn 2021, AIG recorded a **$412 million favorable prior‑year development adjustment to U.S. Personal Insurance reserves**, reflecting the net effect of favorable emergence and sub‑rogation recoveries from the 2017‑ and 2018‑catastrophe years (before ADC cessions and external reinsurance).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AIG uses a combination of loss development, frequency/severity, and expected loss ratio methods for U.S. Other Casualty lines, with greater reliance on expected loss ratio for recent accident years due to long-tail characteristics—this is accurately reflected in the LLM's statement about 'limited weight' for volatile subsets and reliance on expected loss ratio for recent years. For U.S. Property lines, the use of frequency/severity, loss development, and IBNR factor methods is correctly described, with proper emphasis on IBNR factors for low-frequency/high-severity, short-tail classes. (2) The quantitative figure of $412 million in favorable prior year development for U.S. Personal Insurance in 2021 is exactly correct, and the cause—subrogation recoveries from 2017 and 2018 catastrophes—is accurately stated, including the clarification that it is pre-ADC cessions and external reinsurance, which adds contextual precision. (3) Multi-hop reasoning is sound: the answer correctly differentiates reserving methodologies across two distinct lines of business (Casualty vs. Property) and links a specific financial adjustment in 2021 to prior-year catastrophe recoveries, synthesizing information across time and business segments. (4) Wording differs slightly but meaning is preserved; for example, 'giving significant weight to loss-development for lines with enough volume' aligns with the ground truth's implication about credibility of data, and 'IBNR factors applied to earned premiums' is consistent with 'IBNR-factor techniques applied to low frequency/high severity classes.' No factual, numerical, or conceptual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 478,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What proportion of Procter & Gamble's fiscal year 2024 net sales was contributed by the Baby, Feminine & Family Care segment, and approximately what portion of that can be attributed to the Charmin brand given its North American toilet paper market position?",
      "original_answer": "The Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's net sales in fiscal year 2024. Within this segment, Charmin holds approximately 25% North American market share in toilet paper, which is a key component of the family care business that is predominantly concentrated in North America.",
      "llm_answer": "The Baby, Feminine & Family Care segment generated **about 24 % of Procter & Gamble’s FY 2024 net sales** (≈ $20 billion of the $84 billion total).  \n\nBecause the segment’s family‑care business is driven mainly by the North‑American Bounty and Charmin brands—and Charmin holds **over 25 % of the U.S. toilet‑paper market**—Charmin can be estimated to contribute roughly **one‑quarter of the segment’s sales**, or **around 6 % of total net sales** (≈ $5 billion).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly states that the Baby, Feminine & Family Care segment contributed 24% of P&G's FY2024 net sales, matching the original answer. It estimates the segment's sales at ~$20 billion out of $84 billion total, which is mathematically sound (24% of $84B = $20.16B). It also correctly notes Charmin's over 25% U.S. toilet paper market share, consistent with the 'approximately 25%' in the ground truth. The inference that Charmin contributes roughly one-quarter of the segment’s sales (~$5B or 6% of total net sales) is a reasonable extrapolation based on market position and regional concentration. (2) Calculations are accurate: 25% of 24% equals 6%, and 25% of $20B is $5B. (3) The multi-hop reasoning is sound—linking Charmin’s market share in North America to its likely contribution within the Family Care business, which is itself a component of the larger segment. The mention of Bounty as a co-driver adds context not in the original but does not detract from accuracy. (4) While the original answer stops short of quantifying Charmin’s exact sales contribution, the LLM makes a logical estimate based on available data. The slight leap to '6% of total net sales' is not explicitly confirmed in the ground truth but is a defensible approximation. No factual errors; minor deduction due to the inferred specificity beyond what the original asserts directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 401,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "Given General Dynamics' $510 million R&D investment in 2023, how does the Combat Systems segment leverage this spending to support the development and modernization of platforms like the M1E3 Abrams tank, and what financial or strategic outcomes are tied to this investment?",
      "original_answer": "General Dynamics' Combat Systems segment leverages its $510 million R&D investment in 2023 to modernize existing platforms and develop next-generation capabilities, such as the M1E3 Abrams main battle tank. This investment supports the development of advanced systems architecture, improved communications, power generation, fuel efficiency, optics, and armor for the Abrams fleet. The M1E3 Abrams program is an engineering change that incorporates significant capability improvements to counter future threats, including quicker technology upgrades, reduced sustainment footprint, and increased tactical mobility. These R&D-driven enhancements aim to maintain General Dynamics' market-leading position in land combat systems and ensure long-term value creation through innovation, affordability, and speed-to-market. The financial outcome of this investment is reflected in the company’s ability to secure long-term contracts, support modernization programs, and drive sustained revenue from both U.S. and international defense customers.",
      "llm_answer": "The $510 million of company‑wide research‑and‑development expense reported for 2023 (​​【page_60】​​) is funneled into the Combat Systems segment’s work on next‑generation tank upgrades.  Combat Systems uses that spend to field the SEPv3 upgrade for the existing M1A2 Abrams and to engineer the new M1E3 Abrams, which adds modern communications, power‑generation, fuel‑efficiency, optics, armor and a reduced sustain‑ment footprint that “enhance efficacy through reduced sustainment footprint and increased tactical mobility” (​​【page_10】​​).  By delivering these upgrades on‑schedule and on‑budget, the segment sustains its market‑leading position in land combat vehicles, drives higher‑value contracts and supports strong operating cash flow ($4.7 billion in 2023) and a fair‑value‑to‑carrying‑value assessment that shows no impairment (​​【page_62】​​).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $510 million R&D investment in 2023 is accurately cited, and the $4.7 billion operating cash flow in 2023 is a valid supporting financial outcome, even though not in the original answer—it does not contradict it and adds context from the source (page 62). Format variations like '$510 million' vs '$510M' are acceptable. (2) The answer correctly identifies the Combat Systems segment as the beneficiary of R&D spending and links it to both the SEPv3 upgrade and the M1E3 Abrams development. Key technical improvements—modern communications, power generation, fuel efficiency, optics, armor, and reduced sustainment footprint—are all accurately listed and tied to enhanced tactical mobility, matching the original answer's substance. (3) Multi-hop reasoning is sound: the model connects company-wide R&D spending to segment-level activity (Combat Systems), specifies platform outcomes (M1E3), and infers strategic and financial impacts (market leadership, higher-value contracts, strong cash flow). (4) The only minor gap is that the original answer emphasizes 'long-term contracts' and 'international customers' as financial outcomes, which the LLM mentions only implicitly via 'higher-value contracts.' While the LLM adds a specific cash flow figure not in the original, this is a valid contextual enhancement, not an error. Overall, the answer is factually correct, well-sourced with page references, and semantically equivalent to the ground truth with only slight omission of international customer emphasis. Hence, a 9/10 on correctness and qualitative accuracy, full marks on quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 472,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs?",
      "original_answer": "The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 was $609.1 million. This includes $605 million from purchases under the publicly announced open-market share purchase program and $4.1 million from purchases unrelated to publicly announced programs.",
      "llm_answer": "Accenture repurchased **about $605 million** of Class A ordinary shares under its publicly announced open‑market share‑purchase program, and it also bought **72,255 shares in transactions unrelated to that program**.  Using the quarter’s average price of $303 per share, those unrelated purchases represent roughly **$23 million**.  Together, the total cash outlay for Class A share purchases in fiscal 2024 was therefore **approximately $628 million**【page_39】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key dollar amounts. The ground truth states that Accenture spent $609.1 million total: $605 million under the program and $4.1 million outside it. The LLM incorrectly calculates the unrelated purchases as $23 million (72,255 shares × $303/share), which contradicts the ground truth of $4.1 million. This results in a total of $628 million instead of $609.1 million. These are major quantitative errors. (2) Number verification: The $605 million figure for program-related purchases is correct and matches the ground truth. However, the 72,255 shares and $303 average price per share, while possibly present in the document, lead to an incorrect inference—either the share count or price is misapplied, or the calculation does not reflect actual cash outlay. The correct unrelated purchase value is $4.1 million, not $23 million. The sum ($605M + $23M = $628M) is therefore wrong. (3) Multi-hop reasoning: The model attempts the correct synthesis—combining program and non-program purchases—but fails due to incorrect valuation of the latter. It uses a plausible method (average price × shares) but arrives at a figure inconsistent with the ground truth, suggesting either misreading of data or flawed application. (4) Scores justified: Correctness is low (3/10) due to major dollar amount errors despite partial data accuracy. Quantitative accuracy is poor (2/10) because total and component figures are significantly off. Qualitative accuracy is moderate (4/10) as the model identifies the right categories and sources but misexecutes the logic. Contextual relevance is high (8/10) because the response addresses the right question structure and cites appropriate context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 475,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does AT&T's 2021 payment to Crown Castle under their sublease arrangement compare to the initial cash proceeds received from Crown Castle in the 2013 tower transaction?",
      "original_answer": "AT&T made $253 in payments to Crown Castle in 2021 under the sublease arrangement, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction were $4,827. This indicates that the 2021 payment represents a small fraction of the original transaction value.",
      "llm_answer": "AT&T paid Crown Castle **$253 million** in 2021 under the sub‑lease arrangement. In the original 2013 tower deal, Crown Castle paid AT&T **$4.827 billion** in cash for the towers. Thus, the 2021 payment is only a small fraction—about 5 %—of the cash proceeds received in 2013.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $253 million payment by AT&T to Crown Castle in 2021 and the $4.827 billion initial cash proceeds from the 2013 tower transaction. These figures match the ground truth exactly in value and context, with acceptable formatting variations ($253 million = $253, $4.827 billion = $4,827 in millions). (2) The calculation of the 2021 payment as approximately 5% of the 2013 proceeds is accurate: (253 / 4827) ≈ 0.0524 or ~5.24%, which rounds to about 5%—a reasonable approximation. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two different time points (2013 and 2021) and two different financial directions (inflow in 2013, outflow in 2021), correctly interpreting the sublease payment as a cost to AT&T and the 2013 amount as proceeds received. (4) The only minor shortcoming is that the original answer does not include the percentage comparison (~5%), which the LLM added. While this is an inference and not strictly incorrect, it introduces a detail not in the ground truth without qualification. However, since the calculation is correct and supports the same conclusion (that the 2021 payment is a small fraction), this does not detract significantly from accuracy. All entities (AT&T, Crown Castle, 2013 transaction, 2021 sublease payments) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 382,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does General Motors' valuation methodology for Stellantis warrants and their sensitivity to equity price risk inform the potential financial impact of a 10% adverse change in Stellantis stock price on GM's equity investments in 2021?",
      "original_answer": "General Motors estimates the fair value of its Stellantis warrants using the Black-Scholes formula, which incorporates inputs such as the Stellantis stock price and estimated dividend yield. At the end of 2021, GM's investment in Stellantis warrants had a fair value of $1.5 billion. GM also assessed that a 10% adverse change in quoted security prices for Stellantis would have had an insignificant effect on its financial statements. This suggests that even though the valuation methodology is sensitive to stock price changes, the overall financial impact of a 10% adverse movement in Stellantis stock would not have been material to GM’s equity investments in 2021.",
      "llm_answer": "General Motors values its Stellantis warrants with a Black‑Scholes option‑pricing model, using the Stellantis share price (and dividend yield) as a key input. In its 2021 market‑risk disclosure the company notes that a 10 % adverse move in Stellantis’s quoted stock price would have had an “insignificant” effect on the fair‑value of those warrants (and the broader $1.5 billion of equity‑price‑risk exposures). Thus, even a 10 % drop in Stellantis’s share price would be expected to produce only a negligible impact on GM’s equity‑investment earnings in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GM uses the Black-Scholes model to value Stellantis warrants, a 10% adverse change in Stellantis stock price would have an 'insignificant' effect, and the fair value of GM's investment in Stellantis warrants was $1.5 billion at the end of 2021. The wording differs slightly—'broader $1.5 billion of equity-price-risk exposures'—but this does not misrepresent the original, as the $1.5 billion refers specifically to the warrants. (2) Quantitative accuracy is perfect: the 10% adverse change, $1.5 billion value, and 2021 time frame are all correctly stated with no calculation errors. (3) Multi-hop reasoning is sound: the model correctly links valuation methodology (Black-Scholes) to sensitivity analysis and concludes that despite theoretical sensitivity, the financial impact is negligible—this reflects proper synthesis of risk disclosure and valuation inputs. (4) The only minor issue is slight imprecision in implying the $1.5 billion includes other equity exposures, whereas the original specifies it is the value of the warrants themselves. However, this does not materially distort the conclusion. Overall, the answer is factually correct, contextually appropriate, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 362,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What percentage of P&G's total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category, specifically through the Always Discreet brand?",
      "original_answer": "The adult incontinence sub-category, represented by the Always Discreet brand, contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment. This is derived from the stated 20% global market share of the overall Baby, Feminine & Family Care segment, where Always Discreet holds a 15% market share within its specific sub-category of adult incontinence.",
      "llm_answer": "P&G’s adult‑incontinence business—represented by the Always Discreet brand—accounts for roughly **15 % of the company’s global market share in the Baby, Feminine & Family Care segment**. This share is cited in the MD&A discussion of the segment’s sub‑categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that the Always Discreet brand accounts for approximately 15% of P&G's total global market share in the Baby, Feminine & Family Care segment, which matches the ground truth. The percentage is accurate and directly responsive to the question. The source reference to MD&A is plausible though not specified in the original answer, but this does not detract from factual correctness. The answer omits the explanatory detail about how the 15% is contextualized within the adult incontinence sub-category (i.e., that Always Discreet holds a 15% share within adult incontinence, which itself is a part of the larger segment), but the core claim—15% contribution to the total segment share—is preserved and factually aligned. There are no calculation errors or entity misidentifications. The reasoning is sound in outcome, though the multi-hop logic (linking brand → sub-category → segment share) is not explicitly articulated. Overall, the answer is semantically equivalent and factually correct with only minor completeness limitations in explanation depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 307,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What was the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024, based on the total cash outlay and the number of shares acquired through both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans?",
      "original_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was approximately $299.48.",
      "llm_answer": "During the fourth quarter of fiscal 2024 Accenture paid an average of **$303.05 per Class A ordinary share**. This figure reflects the total cash outlay divided by the total shares acquired—including the 2,000,308 shares bought under the publicly announced open‑market purchase program and the 72,255 shares purchased in transactions unrelated to those plans. (Source: “Purchases of Accenture plc Class A Ordinary Shares” table, page 39.)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states an average price of $303.05 per share, which is incorrect compared to the ground truth of $299.48. This discrepancy affects the core factual accuracy. While the LLM correctly identifies that the average price should be derived from total cash outlay divided by total shares acquired, and references both the publicly announced program and unrelated transactions, the final number is wrong. (2) The quantitative accuracy is low because the key figure—the average price—is off by over $3.50 per share, which is significant in financial terms. Even if the source table (page 39) were accurate, the model’s calculation or data extraction must have been flawed. The share counts (2,000,308 and 72,255) may be correct, but without the corresponding cash amounts, we cannot verify whether the model computed the weighted average correctly. However, the result does not match the ground truth, indicating a calculation or data retrieval error. (3) The qualitative accuracy is moderate: the model understands the multi-hop nature of the question—aggregating shares and cash across two types of purchase programs—and applies the correct logic (total cash / total shares). It also correctly identifies the fiscal period and security type (Class A ordinary shares). However, the failure to produce the correct numerical result undermines the reasoning. (4) Contextual relevance is high, as the answer directly addresses the question, cites the correct table and page, and includes all relevant components of the calculation. The structure and intent are sound, but the factual output is incorrect. The model appears to have accessed or interpreted the source data incorrectly, leading to an inaccurate final figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 473,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the difference in net milestones capitalized for Jardiance between 2020 and 2021, and how does this compare to the collaboration revenue reported for Jardiance in 2021?",
      "original_answer": "The net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This $136.1 million in 2021 net milestones capitalized for Jardiance was part of the broader collaboration and other revenue, which totaled $175.0 million for the year ended December 31, 2021.",
      "llm_answer": "The net milestones capitalized for Jardiance fell from $156.2 million in 2020 to $136.1 million in 2021 – a decrease of $20.1 million. In 2021, Lilly reported $1,490.8 million of collaboration and other revenue for the Jardiance product family, so the change in capitalized milestones represents only about 1.3 % of that year’s Jardiance collaboration revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the net milestones capitalized for Jardiance in 2020 ($156.2 million) and 2021 ($136.1 million), and accurately calculates the decrease of $20.1 million, which matches the ground truth. This part of the answer is factually correct and demonstrates proper multi-hop reasoning across years. However, the LLM introduces a major factual error in stating that Lilly reported $1,490.8 million in collaboration and other revenue for Jardiance in 2021. The ground truth states that the total collaboration and other revenue for Jardiance in 2021 was $175.0 million, not $1,490.8 million. This significant overstatement leads to an incorrect comparison, claiming that the $136.1 million in capitalized milestones represents only 1.3% of collaboration revenue, when in fact it represents approximately 77.8% ($136.1M / $175.0M). The entity (Jardiance, Lilly) and time period (2021) are correct, and the structure of the response addresses both parts of the question, but the core financial data for the second part is wrong. The reasoning framework is sound, but based on incorrect data. The answer is contextually relevant and well-structured, but the magnitude of the numerical error in the collaboration revenue figure severely undermines the factual correctness, especially for a financial analysis question where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 377,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How much in gains did GM record from its Stellantis warrants in 2021, and what ongoing business relationship with Stellantis affects GM's post-sale operations?",
      "original_answer": "General Motors recorded $316 million in gains from its Stellantis warrants in 2021. Additionally, GM continues to have an operational relationship with Stellantis, involving the purchase and supply of certain vehicles, parts, and engineering services following the sale of the Opel/Vauxhall Business.",
      "llm_answer": "GM recorded net gains of **$316 million** from its Stellantis (formerly PSA) warrants in 2021. After selling the Opel/Vauxhall business, GM still purchases from and supplies Stellantis with certain vehicles, parts and engineering services for a defined period following the sale.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $316 million gain from Stellantis warrants in 2021 is accurately reported, with acceptable formatting (bold and thin space). (2) The ongoing business relationship—purchasing and supplying vehicles, parts, and engineering services post-Opel/Vauxhall sale—is correctly described, capturing the multi-hop synthesis between the warrant gains and the continued operational ties. (3) Entity accuracy is sound: 'Stellantis (formerly PSA)' correctly identifies the company, and the reference to the Opel/Vauxhall sale aligns with the knowledge graph. (4) The reasoning is logically sound, connecting GM's financial gain from warrants to the broader operational context after divesting Opel/Vauxhall. (5) Semantic equivalence is maintained despite slightly different phrasing (e.g., 'for a defined period' vs 'following the sale'). All parts of the question are addressed accurately and completely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 284,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the pre-tax loss recognized by AIG from the deconsolidation of AIG Financial Products Corp. (AIGFP), and how does this reflect the financial impact of AIGFP's Chapter 11 reorganization on AIG's consolidated financial statements?",
      "original_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) as a result of its Chapter 11 reorganization filing on December 14, 2022. This loss was reported in the line item 'Net gain (loss) on divestitures and other' in AIG’s consolidated financial statements. Despite the deconsolidation of AIGFP and the reclassification of its $37.6 billion loan receivable to a third-party asset with a full allowance for credit losses, AIG stated that the reorganization would not have a material impact on its consolidated balance sheets or respective businesses. Therefore, while the $114 million loss reflects a direct financial consequence of the reorganization, AIG assessed that the broader financial position of the company remained largely unaffected.",
      "llm_answer": "AIG recorded a **pre‑tax loss of $114 million** when AIG Financial Products Corp. (AIGFP) was deconsolidated – the loss is shown in the “Net gain (loss) on divestitures and other” line of the income statement. This one‑time loss reduced AIG’s pre‑tax earnings from continuing operations and contributed to the overall loss reported under discontinued operations, illustrating that the Chapter 11 reorganization of AIGFP produced a material expense on the consolidated income statement even though it had no material effect on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the pre-tax loss of $114 million from the deconsolidation of AIGFP, which matches the ground truth. The loss is accurately attributed to the 'Net gain (loss) on divestitures and other' line item in the income statement. The date of the Chapter 11 filing (December 14, 2022) is missing in the LLM answer, which is a minor omission but does not affect the core financial impact assessment. (2) All numeric values are correct: $114 million is accurately reported, and there are no calculations required beyond correct attribution. Format is consistent and acceptable. (3) The reasoning is sound: the LLM correctly links the deconsolidation to a one-time loss impacting the income statement, and notes the distinction between income statement impact and balance sheet immateriality, aligning with AIG’s stated position. It correctly characterizes the loss as affecting pre-tax earnings and being reported in discontinued operations context, though it slightly overemphasizes 'discontinued operations' without explicit confirmation from the original answer. (4) The answer is contextually relevant, directly addressing both parts of the question: the amount of the loss and its financial impact on consolidated statements. The core message — that the loss is a direct income statement hit but does not materially affect the overall financial position — is preserved. Only minor lack of mention of the $37.6 billion loan receivable and full allowance for credit losses prevents a perfect score, but these are secondary to the main query. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 459,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What is the total net value of Acquired Franchise Rights in 2024, and how does this compare to the reported gross value of the same asset category in the prior year?",
      "original_answer": "The total net value of Acquired Franchise Rights in 2024 is $598 million. This net value is derived from the gross value of $821 million in 2024 after subtracting accumulated amortization of $223 million. In 2023, the gross value of Acquired Franchise Rights was $840 million. Therefore, the gross value of Acquired Franchise Rights decreased by $19 million from 2023 to 2024.",
      "llm_answer": "The 2024 net carrying amount of **Acquired Franchise Rights** is **$598 million** (the “Net” column in the intangible‑asset table). In the prior year, the **gross** amount for the same category was **$840 million**. Thus, the 2024 net value is about **$242 million lower** than the 2023 gross amount.【page_83】",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2024 net value of Acquired Franchise Rights as $598 million and the 2023 gross value as $840 million, both of which match the ground truth. However, it incorrectly states that the 2024 net value is $242 million lower than the 2023 gross value. The correct comparison is between 2024 net ($598M) and 2023 gross ($840M), which yields a difference of $242 million — this calculation is numerically correct, but the question asks how the 2024 net value compares to the prior year's gross value, not whether it decreased from that point. The ground truth emphasizes that the gross value itself decreased by $19 million from 2023 to 2024 (from $840M to $821M), which the LLM omits entirely. (2) The numbers cited — $598M net in 2024 and $840M gross in 2023 — are accurate. The $242M difference is mathematically correct (840 - 598 = 242), so no quantitative error in subtraction, but the model fails to report the actual trend in gross value over time, which is central to the second part of the question. (3) The reasoning is partially sound: it retrieves the correct values from different years and categories (net vs. gross) but fails the multi-hop synthesis by not incorporating the 2024 gross value ($821M) and the $19M year-over-year decrease in gross value, which is a key element of the original answer. (4) The contextual relevance is high because the answer addresses the core comparison asked. However, due to the omission of the gross value trend and amortization context, the completeness and qualitative accuracy are reduced. The correctness score is 7 because the key facts are present but an important dimension of the multi-hop comparison is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 466,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial commitment made by AT&T for the C-Band licenses, including both the auction payment and the estimated future costs for spectrum clearing and relocation, as disclosed in the 10-K filing?",
      "original_answer": "AT&T's total financial commitment for the C-Band licenses was $26,478, which includes $23,406 for the auction payment, $2,112 for future spectrum clearing costs, and $1,000 for compensable relocation costs.",
      "llm_answer": "AT&T said it paid **$23.4 billion** for the C‑Band auction licenses and, in addition, expects to incur roughly **$2.1 billion** of Phase‑II clearing incentives plus about **$1.0 billion** of compensable relocation costs. Together, the total financial commitment for the C‑Band spectrum is therefore about **$26.5 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor formatting differences. (1) All key financial figures are correct: $23.4 billion (auction payment) matches $23,406 million, $2.1 billion (clearing costs) aligns with $2,112 million (rounding), and $1.0 billion (relocation) matches exactly. The total commitment of $26.5 billion is a rounded version of $26,478 million, which is reasonable given the context. (2) Calculations are sound: 23,406 + 2,112 + 1,000 = 26,518 million (~$26.5 billion), so the total is correctly rounded. (3) Multi-hop reasoning is accurate—the model correctly synthesized auction payment, clearing incentives, and relocation costs into a total financial commitment, as required. (4) Entities (AT&T, C-Band licenses, spectrum clearing, relocation costs) are correctly identified and contextualized. The only minor deviation is the use of rounded figures (e.g., $2.1B vs $2.112B), but this does not affect factual correctness. Wording differs but semantic meaning is equivalent. All aspects of the question are addressed thoroughly and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 316,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the change in net milestones capitalized for Jardiance between 2020 and 2021, and how does this reflect in the financial performance of Lilly's diabetes product portfolio?",
      "original_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a decline of $20.1 million. This reduction indicates a lower recognition of milestone-related revenue or a deferral of payments tied to Jardiance's performance metrics during this period. As Jardiance is a key diabetes product in Lilly's portfolio, this decline could signal a slowdown in the product's developmental or commercial milestone achievements, potentially affecting the overall financial performance of Lilly’s diabetes segment.",
      "llm_answer": "The net milestones that were capitalized for Jardiance fell from $156.2 million at year‑end 2020 to $136.1 million at year‑end 2021 – a decrease of about $20.1 million. At the same time, Lilly’s reported net product revenue for the Jardiance family rose sharply, from $1,153.8 million in 2020 to $1,490.8 million in 2021, showing that the diabetes portfolio’s sales performance improved even as the amount of capitalized milestones declined.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the net milestones capitalized for Jardiance in 2020 ($156.2 million) and 2021 ($136.1 million), and accurately calculates the $20.1 million decrease. These numbers match the ground truth exactly, and the format variations (e.g., 'about $20.1 million') are acceptable. (2) The additional revenue data—Jardiance product revenue increasing from $1,153.8 million in 2020 to $1,490.8 million in 2021—is factually accurate and relevant, though not included in the original answer. However, this introduces new information not present in the ground truth without citation, which affects qualitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly identifies the decline in capitalized milestones and contrasts it with rising sales, suggesting that financial performance in terms of revenue improved despite lower capitalization. This adds useful context, but it diverges from the original answer’s focus on milestone deferrals potentially signaling slower developmental progress. The LLM downplays the cautionary interpretation of declining milestones by emphasizing revenue growth, which shifts the qualitative inference. (4) While all quantitative facts are correct (hence a 10 in quantitative accuracy), the qualitative analysis differs in emphasis and omits the original interpretation about milestone achievement slowdown affecting the diabetes portfolio’s financial outlook. The answer remains contextually relevant and adds value, but does not fully align with the ground truth’s reasoning, justifying a 7 in qualitative accuracy and a 7 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 447,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants?",
      "original_answer": "General Motors recognized a total financial benefit of $1.0 billion in 2021 from its relationship with Stellantis, which included $0.8 billion in non-service pension income and $0.2 billion in gains related to Stellantis N.V. warrants.",
      "llm_answer": "In 2021, General Motors recognized a total of **about $1.0 billion** from its Stellantis relationship – $0.8 billion of non‑service pension income plus $0.2 billion of gains on Stellantis warrants.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the total financial benefit of $1.0 billion in 2021 from Stellantis, broken down into $0.8 billion in non-service pension income and $0.2 billion in gains from Stellantis warrants. (2) Quantitatively, all numbers match exactly—$0.8B + $0.2B = $1.0B—and the year 2021 is correctly identified. Format variations (e.g., 'about $1.0 billion' vs. '$1.0 billion') are acceptable and common in financial reporting. (3) The multi-hop reasoning is sound: the model correctly synthesized two distinct financial components (pension income and warrant gains) tied to GM's relationship with Stellantis, as required by the question. (4) Entities—General Motors, Stellantis, non-service pension income, warrants—are all accurately referenced. The answer is concise, relevant, and complete, addressing all parts of the question with precise, factually correct information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 282,
        "total_tokens": 1398
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the impact of changes in Corebridge's stock price on AIG's financial statements for the period following the initial equity method investment, and how does this reflect AIG's ownership interest?",
      "original_answer": "The changes in Corebridge's stock price directly impacted AIG's financial statements by affecting the value of AIG's ownership interest in Corebridge and resulting in a gain on the sale of Corebridge shares. This is explicitly stated in the Consolidated Statements of Income under the fair value option, where the impact of changes in Corebridge's stock price is recognized. Additionally, AIG's equity method income from Corebridge, which includes changes in the stock price since the initial investment, contributes to AIG's overall financial position.",
      "llm_answer": "After Corebridge was de‑consolidated, AIG elected the fair‑value option and records its remaining Corebridge stake as an equity‑method investment measured at Corebridge’s market price.  The change in that share price produced a **$601 million equity‑method income (loss) for the June 10‑December 31 2024 period** that is included in Net Investment Income, and the same price movement appears in the reconciliation of Net Investment Income as a **$29 million “change in the fair value of equity securities, AIG’s investment in Corebridge and gain on sale of shares.”** These amounts reflect AIG’s continued **22.7 % ownership interest** in Corebridge, with price‑related gains or losses recognized directly in earnings. (See pages 108, 109, 107 and 122 of the 2024 Form 10‑K.)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that changes in Corebridge's stock price impact AIG's financial statements through fair value recognition under the equity method and inclusion in Net Investment Income, which matches the original answer's emphasis on fair value option and income recognition. (2) The quantitative details are mostly correct: the $601 million equity-method income (loss) for the June 10–December 31, 2024 period and the $29 million 'change in fair value...' line item are specific and match disclosures expected in the 10-K (pages cited: 108, 109, 107, 122). While the original answer does not include these exact figures, they are consistent with the type of detailed financial impact described and do not contradict the ground truth. The 22.7% ownership interest is accurately stated and reflects AIG’s continued stake. (3) The reasoning is sound: the LLM correctly synthesizes the accounting treatment (fair-value option post de-consolidation), links stock price changes to income recognition, and ties it to ownership interest—demonstrating proper multi-hop logic across accounting policy, financial impact, and ownership. (4) Minor deduction in quantitative accuracy due to the introduction of specific dollar amounts ($601M, $29M) not present in the ground truth; while plausible and likely correct based on context, they cannot be fully verified against the provided original answer. However, since the original answer lacks such detail and the LLM’s figures are internally consistent and contextually appropriate, this does not constitute an error but introduces slight uncertainty. Overall, the answer is factually robust, complete, and semantically equivalent to the ground truth with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 484,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total net value of Other Identifiable Intangibles for PEP in 2024, and by how much did this value decrease from 2023 to 2024 according to the amortization data provided?",
      "original_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144. This value decreased by $30 from 2023 ($174) to 2024 ($144) due to amortization.",
      "llm_answer": "The 2024 net carrying amount of **Other Identifiable Intangibles** is **$144 million**. This is **$30 million lower** than the 2023 net amount of $174 million (2023 $174 M – 2024 $144 M = $30 M).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net value of Other Identifiable Intangibles for PEP in 2024 is correctly stated as $144 million (equivalent to $144 in the ground truth, with 'million' implied in context), and the 2023 value is accurately given as $174 million. The decrease of $30 million is correctly calculated (174 - 144 = 30). (2) The answer addresses both parts of the question: the 2024 net value and the year-over-year decrease due to amortization. (3) Entities are accurate—PEP is correctly identified, the metric 'Other Identifiable Intangibles' is properly named, and the years 2023 and 2024 are correctly referenced. (4) The reasoning is sound: the LLM correctly infers the decrease from amortization by computing the difference between the two years' net carrying amounts, which aligns with the multi-hop logic required. (5) Despite minor formatting differences (explicit 'million' vs. implied), the semantic meaning and financial data are equivalent. All criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1097,
        "completion_tokens": 303,
        "total_tokens": 1400
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total revenue generated from nuclear-powered submarines in 2023, and how does this compare to the revenue from surface ships, given the strategic importance of submarine programs like the Columbia-class and Virginia-class?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment generated $8,631 million in revenue from nuclear-powered submarines, compared to $2,698 million from surface ships. This results in a ratio of approximately 3.2:1 in favor of nuclear-powered submarine revenue over surface ship revenue. This significant revenue disparity reflects the strategic importance and high demand for submarine programs like the Columbia-class and Virginia-class, which are central to the U.S. Navy's long-term defense strategy and have received top acquisition priority and substantial investment.",
      "llm_answer": "In 2023 the Marine Systems segment recorded **$8.631 billion** of revenue from nuclear‑powered submarines, while revenue from surface‑ship programs was **$2.698 billion**【page_64】【page_9】. Thus, submarine revenue was about **$5.9 billion higher**—roughly three times the amount earned from surface ships—reflecting the outsized strategic importance of the Columbia‑class and Virginia‑class submarine programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the revenue from nuclear-powered submarines ($8.631 billion) and surface ships ($2.698 billion) in 2023, matching the ground truth exactly in both values and units (with acceptable format variation: $8,631 million = $8.631 billion). The difference of $5.933 billion is rounded to $5.9 billion, which is reasonable and common in reporting. The statement that submarine revenue is 'roughly three times' that of surface ships aligns with the ground truth ratio of approximately 3.2:1—while not exact, 'roughly three times' is a defensible approximation in qualitative terms.\n\n2) Quantitative accuracy is perfect: both revenue figures are correct, and the $5.9 billion difference is a properly rounded version of the actual $5.933 billion difference. The ratio of ~3.2:1 is slightly understated as 'roughly three times,' but this does not constitute a factual error given the use of approximate language.\n\n3) The multi-hop reasoning is sound: the model correctly attributes the revenue figures to General Dynamics' Marine Systems segment (implied by citation of page_64 and page_9, which in context refer to the correct segment), links the higher submarine revenue to the strategic importance of the Columbia-class and Virginia-class programs, and draws a logical conclusion about their priority in U.S. Navy acquisition strategy.\n\n4) The answer is contextually relevant and addresses both parts of the question: total submarine revenue in 2023, comparison to surface ship revenue, and the strategic rationale. The only minor shortcoming is the slight simplification of the 3.2:1 ratio to 'roughly three times,' which slightly reduces qualitative precision but does not impair correctness. Hence, a score of 9/10 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 505,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What was the change in the fair value of GM's investment in Stellantis warrants between December 31, 2020, and December 31, 2021, and how does this compare to the change in the fair value of marketable debt securities over the same period?",
      "original_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion (from $1.2 billion in 2020 to $1.5 billion in 2021). The fair value of marketable debt securities decreased by $0.4 billion (from $9.0 billion in 2020 to $8.6 billion in 2021). Therefore, the increase in equity investment was $0.3 billion, while the decrease in debt securities was $0.4 billion, showing contrasting trends in the valuation of these two asset classes.",
      "llm_answer": "The fair‑value of GM’s Stellantis‑warrant investment rose from about **$1.2 billion at 12/31/2020 to $1.5 billion at 12/31/2021**, a **$0.3 billion increase**. In contrast, the fair‑value of its marketable debt securities fell from roughly **$9.0 billion to $8.6 billion**, a **$0.4 billion decline** over the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the Stellantis warrants increased from $1.2 billion to $1.5 billion, resulting in a $0.3 billion increase, and marketable debt securities decreased from $9.0 billion to $8.6 billion, a $0.4 billion decline—both figures match the original answer exactly. (2) The answer is complete, addressing both parts of the question: the change in fair value for Stellantis warrants and the change for marketable debt securities, including correct time periods (December 31, 2020, to December 31, 2021). (3) Entity accuracy is perfect: GM, Stellantis warrants, and marketable debt securities are correctly identified, with no confusion between asset types or companies. (4) The reasoning is sound and demonstrates proper multi-hop synthesis—comparing two distinct financial instruments across the same time period and correctly inferring contrasting trends (increase vs. decrease). The LLM conveys the same semantic meaning as the original answer, with only minor formatting differences (e.g., use of 'about' and 'roughly') that do not affect factual precision. All criteria for correctness, accuracy, and relevance are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 348,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the net decrease in the value of Acquired Franchise Rights for PEP from 2023 to 2024, and how does this reflect in the company's amortization expense over the same period?",
      "original_answer": "The net value of Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, resulting in a $28 decrease. This decrease is partially attributable to the amortization expense of $74 in 2024, which contributes to the reduction in net value of the franchise rights.",
      "llm_answer": "The balance of Acquired Franchise Rights fell from **$1,891 million in 2023 to $1,858 million in 2024**, a net decline of **$33 million**.  Over the same period the company’s amortization expense slipped slightly, from **$75 million in 2023 to $74 million in 2024** (a $1 million reduction).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, a $28 decrease. However, the LLM reports values of $1,891 million and $1,858 million, resulting in a $33 million decrease—both values and the difference are incorrect. The amortization expense in the ground truth is $74 million in 2024, which matches the LLM's figure, but the LLM incorrectly adds that it was $75 million in 2023, implying a decrease in amortization, which is not supported by the original answer. (2) The calculation of the net decrease is wrong: $1,891M - $1,858M = $33M (correct arithmetic but wrong inputs). The actual decrease should be $626 - $598 = $28. The amortization expense is partially responsible for the decline, but the LLM introduces unsupported comparative data (change from $75M to $74M) not present in the original. (3) The multi-hop reasoning is flawed: the model fails to correctly retrieve the values for Acquired Franchise Rights and incorrectly infers a year-over-year change in amortization expense without evidence. It also does not explain the relationship between amortization and the decrease in net value as required. (4) The contextual relevance is moderate because the answer addresses the right metric and time frame and mentions amortization, but the incorrect numbers and unsupported claims severely undermine factual correctness. Quantitative accuracy is very low due to wrong core figures. Qualitative accuracy is low due to incorrect reasoning and synthesis. Correctness score is low because the key financial data is entirely mismatched despite partial structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 467,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "By how much did the increase in service costs related to F-35 sustainment contracts at Aeronautics affect the overall service costs increase in 2023, and how does this compare to the corresponding increase in service sales for the same business unit and reason?",
      "original_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics was approximately $570 million, which accounted for the majority of the overall $775 million (8%) increase in service costs in 2023. This corresponds to an increase in service sales of approximately $600 million at Aeronautics due to higher volume on F-35 sustainment contracts. Therefore, the cost increase was $30 million less than the sales increase, indicating a potential improvement in margin or profitability on these contracts.",
      "llm_answer": "The rise in service costs tied to higher‑volume F‑35 sustainment work at Aeronautics added roughly **$570 million** to the total service‑cost increase of $775 million in 2023.  By contrast, the same F‑35 sustainment activity drove about **$600 million** of the overall $788 million increase in Aeronautics’ service sales, a slightly larger uplift than the cost increase.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $570 million increase in service costs related to F-35 sustainment at Aeronautics and correctly states it contributed to the overall $775 million increase in service costs, aligning with the ground truth. However, the LLM incorrectly states the overall increase in service sales as $788 million, whereas the original answer does not specify a total service sales increase—only that F-35 sustainment drove a $600 million increase in service sales. This introduces a fact not present in the ground truth and slightly misrepresents the context. (2) The key numbers—$570 million in cost increase and $600 million in sales increase—are accurate and correctly compared. The calculation that the sales increase exceeds the cost increase by $30 million is implied in both answers, though the LLM omits explicitly stating this difference or its implication for margins. (3) The multi-hop reasoning is sound: the model correctly links F-35 sustainment to cost and sales increases within Aeronautics in 2023 and synthesizes the financial impact across related concepts. However, the addition of the $788 million total sales increase, not found in the original, suggests potential hallucination or data misattribution, reducing quantitative accuracy. (4) Despite this, the core of the answer is factually correct, addresses both parts of the question (cost impact and comparison to sales), and maintains strong qualitative and contextual alignment. The omission of the margin implication slightly reduces completeness, but the essential facts and logic are preserved, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 450,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How much total share repurchase authority did Accenture plc have as of September 25, 2024, and how does this reflect the company's financial strategy regarding Class A Ordinary Shares?",
      "original_answer": "As of September 25, 2024, Accenture plc had a total outstanding share repurchase authority of $6,694 million. This reflects the company's ongoing financial strategy to actively manage its equity structure by repurchasing Class A Ordinary Shares, as demonstrated by the additional $4,000 million in authority approved by the Board of Directors, bringing the total from $2,694 million to $6,694 million. This strategy includes both open-market purchases and other share purchase programs.",
      "llm_answer": "As of September 25 2024 Accenture’s Board approved an additional $4 billion of repurchase authority, bringing the company’s **total outstanding share‑repurchase authority to $6.694 billion**【page_39†L31-L38】. This sizable authority, layered on top of its long‑standing open‑market buy‑back program, underscores Accenture’s strategy of using cash to return value to shareholders and to support the market price of its Class A ordinary shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the total outstanding share repurchase authority as $6.694 billion (equivalent to $6,694 million), matching the ground truth. It also accurately notes the $4 billion ($4,000 million) additional authority approved by the Board, which brought the total from $2,694 million to $6,694 million. The date (September 25, 2024) is correctly implied as the reference point. 2) Quantitatively, all numbers are accurate and correctly formatted: $6.694 billion = $6,694 million, and $4 billion = $4,000 million. The calculation (2,694 + 4,000 = 6,694) is correct and properly reflected. 3) The reasoning is sound: the LLM correctly infers that the increase in authority reflects an ongoing financial strategy involving share repurchases of Class A Ordinary Shares, including open-market purchases. It connects the approval of additional authority to shareholder value return and price support, which aligns with the original answer’s intent. 4) The only minor shortcoming is that the LLM does not explicitly mention 'Class A Ordinary Shares' in the context of the repurchase programs beyond naming them, whereas the original emphasizes the strategy is specifically for managing equity structure via repurchasing those shares. However, the reference to 'Class A ordinary shares' and buy-back programs provides sufficient context. Overall, the answer is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 394,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "Given Netflix's expansion into live programming and the fixed nature of its content costs, how might a failure to meet membership growth expectations directly impact its financial flexibility and profitability?",
      "original_answer": "Netflix's expansion into live programming introduces additional fixed content costs, which are largely non-adjustable regardless of membership growth rates. If Netflix fails to meet membership growth expectations, it may not be able to proportionally increase per-member revenue or adjust expenditures, thereby negatively impacting margins, liquidity, and overall profitability.",
      "llm_answer": "Because Netflix’s content spend—including new live‑programming— is largely fixed, a shortfall in the number of members means those costs cannot be reduced to match lower revenue. If membership growth falls short, per‑member revenue and pricing adjustments may be insufficient to cover the fixed content outlays, compressing margins, draining cash and limiting the company’s liquidity and financial flexibility, which in turn hurts profitability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually and semantically equivalent to the original (ground truth) answer. (1) All key elements are correctly addressed: Netflix's fixed content costs, expansion into live programming, failure to meet membership growth expectations, inability to adjust costs, and the resulting impact on margins, liquidity, financial flexibility, and profitability. (2) There are no numeric values in the question or answers that require verification—both responses are qualitative and consistent in their descriptions of financial dynamics. (3) The multi-hop reasoning is sound: the model correctly synthesizes the cause-effect chain—fixed costs + lower-than-expected membership growth → revenue shortfall → inability to cover fixed outlays → margin compression → reduced cash and liquidity → impaired financial flexibility and profitability. (4) The wording differs slightly but preserves full meaning; for example, 'draining cash and limiting liquidity' aligns with 'negatively impacting liquidity' in the original. No omissions or inaccuracies. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 309,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What is the total carrying value of the 5.15% 2041 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged according to the debt exchange table?",
      "original_answer": "The total carrying value of the 5.15% 2041 Notes was $729 million, which represents approximately 2.19% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $245 million in principal amount of these notes was exchanged.",
      "llm_answer": "The 5.15 % 2041 Notes carried $729 million on the balance sheet, which is roughly **2.2 % of AMGN’s total debt carrying value of $33,309 million** (2021‑end figures used for the 2022 filing).  \n\nAccording to the debt‑exchange table, **$245 million of principal on the 5.15 % 2041 Notes was exchanged**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key facts: the carrying value of the 5.15% 2041 Notes is $729 million, the total debt carrying value is $33,309 million, and $245 million in principal was exchanged. The percentage is reported as approximately 2.2%, which is a rounded but accurate representation of 2.19% (729 / 33,309 ≈ 0.02189), so this is semantically equivalent. (2) All numeric values match the ground truth exactly: $729 million, $33,309 million, and $245 million. The calculation for the percentage is correct when rounded to one decimal place. (3) The multi-hop reasoning is sound—information about carrying values and debt exchange is synthesized correctly across the relevant financial statements and tables. The only minor issue is the parenthetical note stating '2021-end figures used for the 2022 filing', which is potentially confusing but not factually incorrect if the 2022 filing uses prior-year-end data; however, this detail is not in the ground truth and introduces slight ambiguity without contradicting facts. (4) Scores reflect near-perfect factual accuracy, with full quantitative correctness and only a negligible impact on qualitative reasoning due to the extra clarification about reporting timing, which does not detract from the answer's validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 362,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does McDonald's acquisition and subsequent sale of franchised restaurants impact its financial reporting of goodwill, specifically when sold within 24 months versus beyond 24 months from acquisition?",
      "original_answer": "When McDonald's acquires franchised restaurants, it records goodwill as the excess cost over the net tangible and identifiable intangible assets. If a Company-operated restaurant is sold within 24 months of acquisition, the goodwill associated with the acquisition is written off in its entirety. However, if a Company-operated restaurant is sold beyond 24 months from acquisition, the amount of goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This distinction directly affects how goodwill impacts financial reporting depending on the time of sale.",
      "llm_answer": "McDonald’s treats the goodwill created when it buys a franchised (company‑operated) restaurant differently depending on how quickly the restaurant is later sold. If the restaurant is sold **within 24 months of the acquisition**, the entire goodwill recorded for that purchase is **written off in full**. If the restaurant is sold **after more than 24 months**, the goodwill removal is **partial** – the write‑off is calculated on a proportional basis using the fair‑value of the sold business relative to the reporting unit’s total goodwill (i.e., only the portion of goodwill attributable to the portion of the business sold is removed【page_45】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correct: McDonald's records goodwill upon acquisition of franchised (company-operated) restaurants, and the treatment upon sale depends on whether it occurs within or beyond 24 months. The answer correctly states that goodwill is written off in full if sold within 24 months and partially (based on relative fair value) if sold after 24 months. (2) There are no numeric values requiring calculation, but the 24-month threshold is accurately cited and consistently applied. Format variations are not an issue here. (3) The multi-hop reasoning is sound—synthesizing acquisition accounting, goodwill recognition, and differential disposal treatment based on time—is correctly captured. The reference to 'relative fair value of the business sold compared to the reporting unit' is accurately rephrased as 'proportional basis using the fair-value of the sold business relative to the reporting unit’s total goodwill,' preserving technical correctness. (4) The answer is fully relevant, directly addressing the impact on financial reporting of goodwill under both scenarios. Minor wording differences (e.g., 'partial' vs. 'based on relative fair value') do not affect meaning. The citation of [page_45] suggests source grounding. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 386,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was AIG's equity method income from Corebridge after the deconsolidation date in 2024, and how was this income calculated based on the post-deconsolidation period?",
      "original_answer": "AIG's equity method income from Corebridge after the deconsolidation date (June 9, 2024) was calculated as the sum of dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024. This income reflects AIG's retained 48.4% ownership stake and the financial performance of Corebridge during the post-deconsolidation period.",
      "llm_answer": "AIG reported **$601 million of equity‑method income from Corebridge for the post‑deconsolidation period (June 10 – December 31 2024).**  \n\nThe amount is the **sum of the dividends AIG received from Corebridge and the change in Corebridge’s stock price (fair‑value adjustment) after the June 9, 2024 deconsolidation date.**",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the conceptual basis for equity-method income—dividends received and changes in Corebridge’s stock price (fair-value adjustment)—which aligns with the ground truth description of how the income was calculated. It also correctly references the deconsolidation date (June 9, 2024) and the post-deconsolidation period (June 10 to December 31, 2024), showing accurate entity and time-period identification. However, the LLM introduces a specific dollar amount—$601 million—that is not present in the original answer (ground truth). The ground truth does not provide any numerical value for the equity-method income, only the method of calculation. This makes the quantitative claim unsupported and factually inaccurate in the context of the provided knowledge. While the reasoning framework is sound and contextually relevant, the inclusion of a fabricated figure significantly undermines factual correctness. There is no indication in the ground truth that the income was calculated using fair-value adjustments under equity method accounting (which typically applies to marketable securities, not equity method investments), so this may reflect a technical mischaracterization. Overall, the qualitative reasoning and structure are mostly correct, but the unsupported number leads to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 372,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "Given that McDonald's heavily franchised business model relies on franchisee contributions to revenue and considers franchisees as a critical component of its business, by what percentage do franchisees contribute to McDonald's global workforce, and how does the company's recruitment initiative for diverse franchisees aim to influence this demographic composition?",
      "original_answer": "Franchisees contribute to over 93% of McDonald's global workforce, as over two million individuals work in franchised restaurants compared to over 150,000 company employees. McDonald's recruitment initiative for diverse franchisees aims to influence this demographic composition by reducing upfront equity requirements for eligible candidates and providing ongoing learning and development, specifically targeting underrepresented groups in both the U.S. and International Operated Markets to increase diversity among franchisees.",
      "llm_answer": "Franchise‑owned restaurants employ roughly 2 million people versus about 150,000 company‑direct employees, meaning franchisees account for **about 93 % of McDonald’s total global workforce**. The company’s new recruitment program is designed to **grow the share of franchisees from under‑represented backgrounds** by cutting upfront equity requirements and pairing candidates with ongoing learning and development support, thereby diversifying the franchisee demographic.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) Quantitatively, the figures of 2 million employees in franchised restaurants and 150,000 company employees are correctly stated, and the derived percentage of approximately 93% is accurate (2,000,000 / (2,000,000 + 150,000) ≈ 93%). Minor phrasing differences (e.g., 'about 93%' vs 'over 93%') are acceptable as they convey the same approximate value. (2) The answer fully addresses both parts of the question: the percentage of the global workforce contributed by franchisees and the impact of McDonald's recruitment initiative on demographic composition. (3) Entity accuracy is correct—McDonald's is the subject, and the reference to franchisees and company employees is precise. (4) The reasoning is sound: the LLM correctly infers workforce distribution from employment figures and accurately describes the recruitment initiative’s goal of increasing diversity among underrepresented groups through reduced equity requirements and learning support. The synthesis across workforce data and corporate initiatives reflects proper multi-hop reasoning. All components align with the original answer in meaning and factual content.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 341,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume in 2023 collectively impact the operating profit of RMS, and how does this compare to the contribution from Sikorsky programs to the backlog increase?",
      "original_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together caused a significant decrease in RMS' operating profit for Sikorsky helicopter programs in 2023. This decrease was partially offset by higher operating profit from IWSS programs, including a favorable adjustment of $65 million and increased volume on the Aegis program, resulting in an overall $41 million decrease in RMS' operating profit compared to 2022. Despite this profit decline, Sikorsky programs contributed to an increase in backlog during 2023 due to higher orders, indicating future revenue potential.",
      "llm_answer": "The $100 million unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together caused RMS’s operating profit to fall by **$41 million (about 2 %) in 2023**. At the same time, **the backlog grew because of higher orders on Sikorsky programs**, so the Sikorsky line that hurt profit also drove the year‑over‑year backlog increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core facts from the ground truth. (1) Quantitatively, it correctly states the $100 million unfavorable adjustment and the resulting $41 million decrease in RMS operating profit, which aligns with the ground truth (the $41M decrease is the net effect after partial offset from other programs). The 2% decline is a reasonable inference if derived from total operating profit, though not explicitly stated in the original answer—this is a minor addition but not incorrect. (2) The answer correctly identifies that Sikorsky programs contributed to backlog growth due to higher orders, which matches the original answer’s claim about backlog increase despite profit decline. (3) Multi-hop reasoning is sound: it connects the negative impact on profit from two factors (Canadian Maritime Helicopter adjustment and lower Black Hawk volume) to the net profit decrease, and contrasts this with the positive backlog trend from the same business segment. (4) The only minor shortcoming is the lack of explicit mention of the offsetting factors (e.g., $65M favorable adjustment in IWSS, Aegis program volume), which are part of the full causal chain in the original answer. However, the LLM correctly reports the net outcome ($41M decrease), so the omission affects completeness slightly but not correctness. Overall, the answer is factually correct, contextually relevant, and semantically equivalent in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 400,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What was the total value of Broadcom's acquisition of VMware, and how does this acquisition align with Broadcom's strategic focus on infrastructure software solutions?",
      "original_answer": "Broadcom acquired VMware for a total value of $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by enhancing its capabilities in multi-cloud services and enabling digital innovation with enterprise control, as stated in the overview of Broadcom's business segments and strategic priorities.",
      "llm_answer": "Broadcom completed the VMware transaction on Nov. 22, 2023 in a cash‑and‑stock deal that provided VMware shareholders with roughly $30.8 billion in cash plus 544 million Broadcom shares, giving the transaction a total fair‑value consideration of about $53.4 billion.  The company says it acquired VMware “to enhance our infrastructure software capabilities,” and the deal fits Broadcom’s stated strategy of driving growth through strategic acquisitions that expand its infrastructure‑software portfolio and deepen its multi‑cloud, private‑cloud and security offerings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. The ground truth states the total acquisition value was $84,186 million ($84.186 billion), composed of $30,788 million in cash and $53,398 million in stock. However, the LLM incorrectly reports the total fair-value consideration as $53.4 billion, conflating the stock component with the total value. It also states 544 million shares without linking them to the correct valuation, and misrepresents the total value by nearly $30 billion. The closing date (Nov. 22, 2023) is accurate and correctly cited. (2) Calculation verification: $30.8 billion (cash) + $53.4 billion (stock) would equal ~$84.2 billion, but the LLM incorrectly labels only the stock portion ($53.4 billion) as the 'total fair-value consideration', indicating a fundamental error in synthesis. The LLM appears to have reversed or misattributed the components. (3) Multi-hop reasoning is partially sound: the answer correctly identifies that the acquisition aligns with Broadcom’s strategic focus on infrastructure software, citing multi-cloud, private-cloud, and security offerings, which is consistent with the ground truth’s mention of multi-cloud services and enterprise control. The qualitative rationale is relevant and reflects accurate strategic context. (4) Despite correct strategic reasoning and contextual relevance, the severe quantitative error in the total deal value—reporting $53.4 billion instead of $84.2 billion—drags down correctness and quantitative accuracy significantly. This is a critical factual failure in a financial multi-hop question where precise valuation is central to the query.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 459,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the introduction of the $6.99 ad-supported tier relate to Netflix's reported 18% year-over-year increase in global paid memberships, considering the company's stated strategy of balancing average revenue per user (ARPU) with broader market penetration?",
      "original_answer": "The introduction of the $6.99 ad-supported tier contributed to Netflix's 18% year-over-year increase in global paid memberships by making the service more accessible to price-sensitive consumers, aligning with the company's strategy to prioritize broader market penetration even at the expense of lower ARPU. This pricing decision reflects Netflix's explicit acknowledgment in its filings of the tradeoff between subscriber growth and per-user revenue, as the lower price point likely accelerated membership expansion while moderating average revenue per user growth.",
      "llm_answer": "The $6.99‑a‑month ad‑supported tier is being used as a low‑price entry point that expands Netflix’s reach, and that expansion is reflected in the 18 % year‑over‑year rise in global paid memberships (paid memberships grew from 80.1 million at the end of 2023 to 89.6 million at the end of 2024, and net paid additions rose sharply).  By adding price‑sensitive viewers, the tier boosts total subscriber count while the modest price is intended to limit any erosion of average revenue per user, allowing Netflix to balance higher market penetration with a relatively stable ARPU.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The reported membership numbers (80.1 million in 2023 to 89.6 million in 2024) imply a growth of about 11.9%, not 18%, contradicting the stated 18% year-over-year increase. Additionally, these specific figures (80.1M, 89.6M) are not present in the ground truth and appear fabricated, undermining factual reliability. (2) The $6.99 ad-supported tier is correctly identified and its strategic role in expanding reach to price-sensitive users is accurately described, aligning with the company's penetration strategy. However, the claim that the tier 'limits erosion of ARPU' contradicts the ground truth, which acknowledges a tradeoff where lower ARPU is accepted in exchange for higher subscriber growth. The LLM incorrectly frames the tier as protecting ARPU, when in fact it likely reduces it. (3) The multi-hop reasoning is partially sound—linking the pricing tier to membership growth and strategic balance between ARPU and penetration—but flawed in its conclusion about ARPU impact. The synthesis misses the explicit tradeoff emphasized in the original answer. (4) Despite strong contextual relevance and mostly correct qualitative framing, the incorrect numbers and misleading ARPU interpretation significantly reduce correctness. The answer gets core concepts right but fails on key facts and logical precision, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 394,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised restaurants, and how does this workforce contribute to the company's stated purpose and mission?",
      "original_answer": "The total number of individuals working in McDonald's restaurants globally is over 2,150,000, which includes over 150,000 Company employees and over two million individuals working in franchised restaurants. This extensive workforce contributes to the company's purpose of feeding and fostering communities and its mission to make delicious feel-good moments easy for everyone by delivering consistent, high-quality service across the global restaurant network.",
      "llm_answer": "McDonald’s reports that, at year‑end 2023, its own employees numbered **more than 150,000** worldwide and **over 2 million people work in its franchised restaurants**, giving a combined workforce of **roughly 2.15 million individuals** across the system. This global team is described as “critical to the Company’s success, enabling it to drive long‑term value creation and further its purpose to feed and foster communities and its mission to make delicious feel‑good moments easy for everyone.” Their collective effort brings the brand’s core values to life in every restaurant and underpins the company’s purpose‑driven strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 'more than 150,000' Company employees and 'over 2 million' in franchised restaurants align exactly with the original answer, and the sum of roughly 2.15 million is correctly stated (150,000 + 2,000,000 = 2,150,000). Minor phrasing differences like 'roughly 2.15 million' vs 'over 2,150,000' are semantically equivalent. (2) The answer is complete, addressing both the total workforce and how it contributes to McDonald's purpose and mission. (3) Entity accuracy is correct: McDonald’s is the subject, and the metrics (employee counts, purpose, mission) are properly attributed. (4) The reasoning is sound and reflects multi-hop synthesis: combining Company and franchisee employee counts and linking the workforce to corporate purpose and mission as stated in the filings. (5) Semantic equivalence is strong—the LLM uses slightly different phrasing (e.g., 'critical to the Company’s success', 'brings the brand’s core values to life') but accurately reflects the original meaning. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 324,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total fair value of the VMware acquisition by Broadcom, and how does this acquisition enhance Broadcom's infrastructure software capabilities?",
      "original_answer": "The total fair value of the VMware acquisition by Broadcom was $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition enhances Broadcom's infrastructure software capabilities by adding VMware's multi-cloud services, which enable digital innovation with enterprise control, thereby strengthening Broadcom’s portfolio of infrastructure and security software solutions.",
      "llm_answer": "Broadcom completed the VMware acquisition for a total fair‑value consideration of **about $53.4 billion** (approximately $53,398 million) 【page 38】【page 58】.  Adding VMware’s multi‑cloud, virtualization and private‑cloud software (including VMware Cloud Foundation) broadens Broadcom’s infrastructure‑software portfolio, giving it deeper capabilities in hybrid‑cloud, license‑portability and enterprise‑cloud management and thereby strengthening its overall infrastructure‑software offering.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains a significant error in the total fair value of the VMware acquisition. It states the total fair value is approximately $53.4 billion ($53,398 million), which corresponds only to the Broadcom common stock portion of the deal. However, the ground truth specifies the total fair value as $84,186 million, which includes both $30,788 million in cash and $53,398 million in stock. The LLM incorrectly presents the stock component as the total consideration, missing the cash portion entirely. This is a critical quantitative error.\n\n2) Quantitatively, the $53,398 million figure is accurate as the stock component, and the formatting variation ($53.4 billion vs $53,398 million) is acceptable. However, the omission of the $30,788 million cash component results in a total value that is off by over $30 billion. This severely undermines the factual accuracy of the answer.\n\n3) Qualitatively, the reasoning about how the acquisition enhances Broadcom’s infrastructure software capabilities is sound and semantically equivalent to the ground truth. The LLM correctly identifies VMware’s multi-cloud, virtualization, and private-cloud software (e.g., VMware Cloud Foundation) as key additions that broaden Broadcom’s portfolio and strengthen its hybrid-cloud, license-portability, and enterprise-cloud management capabilities. This aligns well with the ground truth’s mention of multi-cloud services enabling digital innovation with enterprise control.\n\n4) Contextually, the answer is highly relevant and addresses both parts of the question. The enhancement to infrastructure software capabilities is explained clearly and accurately. However, due to the major error in the total fair value, the answer fails on a core factual element despite strong performance on the qualitative aspect. The citation of page numbers adds credibility but does not compensate for the incorrect total value.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 514,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Netflix's pricing strategy for its membership plans, as outlined in the 2024 10-K, potentially conflict with its need to retain existing members amid rising macroeconomic pressures also mentioned in the filing?",
      "original_answer": "Netflix's pricing strategy, which includes a range of membership plans priced between $1 and $32 per month as of December 31, 2024, could conflict with its ability to retain existing members if price increases or plan adjustments are not favorably received. The 2024 10-K highlights that adverse macroeconomic conditions, such as inflation, may impact consumers' willingness or ability to continue paying for the service. If Netflix adjusts pricing or modifies membership plans in a way that is not perceived as valuable by members, it could lead to increased cancellations and negatively affect revenue and results of operations, especially since content costs are largely fixed and may not be adjusted in line with reduced growth.",
      "llm_answer": "Netflix’s 10‑K says it regularly adjusts the price of its membership plans – in 2024 the paid plans ranged from roughly $1 to $32 a month and “price increases” helped lift streaming revenue (see page 22). At the same time, the filing warns that “adverse macro‑economic conditions, including inflation… may also adversely impact our ability to attract and retain members” and that pricing changes “may not be well‑received by consumers” (see page 6). Thus, while higher prices boost average revenue per paying member, they also risk increasing churn among cost‑conscious subscribers facing tighter household budgets, creating a tension between revenue‑growth pricing and member‑retention goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $1 to $32 monthly price range for Netflix membership plans as of December 31, 2024, is accurately reported, with acceptable phrasing like 'roughly $1 to $32'. No calculations were required, and the figures match the original answer. (2) The answer addresses all parts of the question: it identifies Netflix's pricing strategy, cites the relevant price range, links price increases to revenue growth, and connects macroeconomic pressures (e.g., inflation) to potential member churn. (3) Entity accuracy is strong: 'Netflix', '2024 10-K', and key concepts like 'streaming revenue', 'churn', and 'macroeconomic conditions' are correctly used. (4) The reasoning is sound and reflects multi-hop synthesis: it connects pricing actions (increases boosting revenue) with risks (consumer sensitivity during inflation), highlighting the tension between revenue goals and retention—exactly as in the ground truth. The only minor shortcoming is that the LLM does not explicitly mention the fixed nature of content costs, which the original answer notes as a factor that limits Netflix’s ability to adjust expenses if membership growth slows. This omission slightly weakens the completeness of the risk explanation but does not undermine the core correctness. Overall, the answer is semantically equivalent, well-reasoned, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 400,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does McDonald's financial exposure from franchisee performance impact its goodwill accounting when acquiring and subsequently selling restaurants, based on the risks described in the franchise business model and the goodwill valuation methodology?",
      "original_answer": "McDonald's financial exposure from franchisee performance impacts its goodwill accounting significantly when acquiring and selling restaurants. According to the franchise business model, McDonald's relies heavily on franchisee sales growth to drive its revenues, as franchisees contribute through rent and royalties. If franchisee sales trends worsen, it could lead to financial distress for franchisees, increasing the likelihood of restaurant closures or sales. When McDonald's acquires restaurants from franchisees, it assigns goodwill based on expected profitability and cash flows using a discounted cash flow methodology. However, if a restaurant is sold within 24 months of acquisition, the associated goodwill is written off entirely. If sold after 24 months, goodwill is written off based on the relative fair value of the business sold. Therefore, poor franchisee performance that leads to acquisition and early resale directly affects McDonald's goodwill balances and may result in material write-offs.",
      "llm_answer": "McDonald’s goodwill on restaurant acquisitions is calculated with a discounted‑cash‑flow model that relies on the expected profitability of the acquired unit — profits that are driven largely by franchisee sales and cash‑flow performance (the franchise‑business‑model risk described on page 30). Because franchisee performance can materially alter those cash‑flow forecasts, any deterioration can trigger goodwill impairment or, if the restaurant is sold, a full write‑off when sold within 24 months or a proportional write‑off based on the fair‑value of the sold business relative to the reporting unit when sold after 24 months (page 45). Thus, franchisee‑related financial risk directly influences both the initial goodwill amount and the amount that must be written off on subsequent disposals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: McDonald's uses a discounted cash flow model to assign goodwill based on expected profitability tied to franchisee performance; deterioration in franchisee sales impacts cash flow forecasts and thus goodwill; restaurants sold within 24 months trigger a full goodwill write-off, while those sold after 24 months result in a proportional write-off based on fair value. These points align exactly with the original answer. (2) Quantitative accuracy is perfect: the 24-month threshold and the two-tier write-off rule (full vs. proportional) are correctly stated with no numerical or temporal errors. Format variations (e.g., '24 months' vs. 'within 24 months') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly links franchisee performance → cash flow expectations → goodwill valuation → disposal timing → write-off treatment, synthesizing across business model risks and accounting policy. (4) Minor deduction in qualitative accuracy due to reference to 'page 30' and 'page 45'—these page numbers are not in the ground truth and may be hallucinated, though they don’t affect factual correctness. Otherwise, the reasoning, entity identification (McDonald's, franchisee performance, goodwill), and synthesis are excellent. Contextual relevance is full—directly addresses the question’s focus on financial exposure, acquisition, and goodwill accounting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 412,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How do Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities and contribute to its anticipated growth through 2026?",
      "original_answer": "Lockheed Martin's hypersonics programs are a key part of its Space segment's strategic priorities, as they are explicitly mentioned among major programs such as those with the U.S. Army and U.S. Navy to design, develop, and build hypersonic strike weapons. These programs align with the Space segment's focus on advanced strike capabilities and are expected to enter early production phases through 2026. This anticipated production transition directly supports Lockheed Martin's strategic growth objective, as outlined in its 2023 10-K filing, which highlights hypersonics as one of four key growth areas in the near-to-mid-term alongside current programs of record, classified programs, and new awards.",
      "llm_answer": "Lockheed Martin’s hypersonics work is explicitly tied to the Space segment’s focus on “strategic, advanced‑strike and defensive systems” and on integrating space‑based situational‑awareness data with kinetic weapons — the Space segment lists hypersonic‑strike programs with the Army and Navy as a core activity (see page 5).  The company’s corporate growth plan identifies hypersonics as one of four near‑ to‑mid‑term growth pillars, and it expects many of those hypersonic projects to move into early‑production phases through 2026 (see page 3).  By feeding advanced‑strike capability into its space‑systems portfolio, the hypersonics programs directly support Space’s strategic priorities and are a key driver of the anticipated revenue expansion up to 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key facts are correct: Lockheed Martin's hypersonics programs are properly linked to the Space segment's strategic priorities, specifically advanced strike capabilities and integration with space-based situational awareness. The mention of U.S. Army and Navy programs is consistent with the original answer. (2) Quantitative accuracy is perfect: the LLM correctly states that hypersonics programs are expected to enter early production through 2026, matching the time frame in the ground truth. There are no numerical errors. (3) Multi-hop reasoning is sound: the LLM synthesizes information across the Space segment’s strategic focus and the corporate growth plan, correctly identifying hypersonics as one of four near-to-mid-term growth pillars, as stated in the 2023 10-K. (4) Semantic equivalence is strong—though the LLM adds slight elaboration (e.g., 'integrating space-based situational-awareness data with kinetic weapons'), this is contextually supported and does not distort meaning. The only minor shortcoming is that the original answer explicitly names the 2023 10-K filing, while the LLM refers to 'page 3' and 'page 5' without specifying the document, which slightly reduces qualitative precision. However, this does not affect factual correctness. Overall, the answer is complete, factually accurate, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 396,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflect its projected financial contribution, and what specific technique was used to estimate its economic benefit over time?",
      "original_answer": "Broadcom used the multi-period excess earnings method under the income approach to value the developed technology related to VMware Cloud Foundation. This method estimates the present value of projected cash flows generated by the technology, subtracting charges that represent the contribution of other assets to those cash flows. The economic useful life of the technology was determined based on the technology cycle and forecasted cash flows, directly linking its expected financial contribution over time to its valuation.",
      "llm_answer": "Broadcom valued the VMware Cloud Foundation‑related developed technology at $24.2 billion (amortized over an 8‑year useful life) by estimating the **present value of the cash flows the technology is expected to generate**, net of the portion attributable to other assets.  The economic benefit was calculated with the **multi‑period excess‑earnings method** under the income approach, which projects cash flows over the technology‑cycle and discounts them to reflect the anticipated contribution.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the valuation technique as the 'multi-period excess-earnings method' under the income approach, which matches the original answer. (2) The method is accurately described as estimating the present value of expected cash flows, net of contributions from other assets—this aligns with the 'subtracting charges that represent the contribution of other assets' in the ground truth. (3) The economic benefit over time is correctly tied to projected cash flows over the technology cycle, and the concept of useful life is mentioned (8 years), which corresponds to the 'economic useful life... based on the technology cycle and forecasted cash flows' in the original. (4) While the $24.2 billion value and 8-year amortization are not in the ground truth provided, these are plausible details that may come from the actual 10-K filing and do not contradict the knowledge graph answer; their inclusion enhances completeness without introducing error. (5) The multi-hop reasoning is sound: the model links the valuation method to its financial contribution over time, correctly synthesizing methodology, cash flow projection, and useful life. (6) Minor deduction in quantitative accuracy because the original answer does not specify the dollar amount or exact useful life, so including them—while likely correct—introduces unverified specifics. However, since the question asks about methodology and economic benefit estimation, and those are correctly explained, the core correctness remains high. Overall, the answer is semantically equivalent, contextually relevant, and factually sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 461,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the launch of Sky Glass influence Comcast's Corporate and Other segment expenses in 2021 and what strategic expectation did the company have regarding costs for 2022?",
      "original_answer": "The launch of Sky Glass contributed to increased costs in the Corporate and Other segment in 2021, as noted by the mention of 'costs related to Sky Glass and XClass TV' partially offsetting prior-year cost savings. The company expected to incur further increased costs in 2022 related to the continued rollout of Sky Glass and XClass TV, indicating a strategic anticipation of ongoing investment in these new product launches.",
      "llm_answer": "The Sky Glass launch added new hardware‑related costs to the Corporate & Other segment in 2021, offsetting part of the overall expense decline that year (expenses fell because prior‑year COVID‑related severance charges were largely completed, but were partially offset by Sky Glass and XClass TV costs).  Comcast said it expects those launch‑related costs to rise again in 2022 as Sky Glass (and XClass TV) continue to be rolled out.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that the launch of Sky Glass contributed to increased costs in the Corporate and Other segment in 2021, noting that these costs partially offset prior-year savings from reduced severance expenses (post-COVID), which matches the original answer's context. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—no calculations are required, and all time references (2021, 2022) are correct. (3) The multi-hop reasoning is sound: the LLM connects Sky Glass and XClass TV to rising segment costs in 2021 and correctly projects that these costs will increase in 2022 due to continued rollout, reflecting strategic investment expectations. (4) The only minor shortcoming is a slight lack of explicit mention that this reflects a 'strategic expectation' of ongoing investment—though the phrase 'expects those launch-related costs to rise again' implies it. Wording differs slightly but maintains semantic equivalence. All entities (Comcast, Sky Glass, XClass TV, Corporate & Other segment, 2021, 2022) are accurate. The answer is fully relevant and addresses both parts of the question: 2021 impact and 2022 outlook.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 363,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's (MCD) valuation methodology for acquiring restaurants from franchisees impact the treatment of goodwill when those restaurants are sold within or beyond 24 months of acquisition, and what is the financial implication of this policy on goodwill write-offs?",
      "original_answer": "McDonald's uses a discounted cash flow methodology (Level 3 inputs) to determine the fair value of restaurants acquired from franchisees. If a restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off. If sold beyond 24 months, only a portion of the goodwill is written off, based on the relative fair value of the business sold compared to the reporting unit. This policy directly affects the magnitude and timing of goodwill write-offs, potentially increasing write-off amounts for recently acquired restaurants.",
      "llm_answer": "McDonald’s values restaurants bought from franchisees with a discounted‑cash‑flow (Level 3) model, which creates goodwill on the reporting unit that is expected to benefit from the acquisition’s synergies. If a company‑operated restaurant is sold **within 24 months** of purchase, the entire goodwill attached to that restaurant is written off; if the sale occurs **after 24 months**, only a proportional amount of goodwill is removed, based on the fair‑value of the sold business relative to the whole reporting unit. Consequently, the policy can generate a full, one‑time goodwill write‑off for early sales (while later sales trigger only partial write‑offs), and historically this has resulted in modest goodwill impairments – the company reported only $14.5 million of accumulated goodwill impairment as of December 31 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key elements of the original answer. It correctly identifies McDonald's use of discounted cash flow (Level 3 inputs) for valuing acquired restaurants, the 24-month threshold for goodwill treatment, and the distinction between full goodwill write-off within 24 months versus proportional write-off after 24 months based on relative fair value. The reasoning and multi-hop synthesis across valuation methodology, timing of sale, and financial impact on goodwill are sound and semantically equivalent to the ground truth. The only deviation is the inclusion of an additional detail — $14.5 million of accumulated goodwill impairment as of December 31, 2023 — which is not present in the original answer. While this figure may be factually correct, it was not part of the ground truth and introduces quantitative information that cannot be verified against the provided knowledge graph. This does not make the answer incorrect but adds unverified precision, slightly reducing quantitative accuracy. However, since the core financial logic and policy implications are accurately conveyed, and the extra detail does not contradict the original, the overall correctness remains high. No entity errors; all terms (goodwill, reporting unit, fair value, Level 3) are used appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 368,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, compound the financial vulnerability caused by the $1.8 billion portfolio defaults linked to the impact of the COVID-19 pandemic on airline revenues and cash flows?",
      "original_answer": "The concentration risk in Boeing's customer financing portfolio, especially in 717 and 747-8 aircraft, increases the financial exposure because a significant portion of the portfolio is tied to fewer customers and specific aircraft types. If these customers face financial difficulties or defaults, Boeing could suffer significant losses. This risk is compounded by the impact of the COVID-19 pandemic, which has already caused a dramatic decline in commercial air traffic, reducing airline revenues and cash flows. As a result, some airlines may not be able to make timely payments, increasing the likelihood of defaults within the $1.8 billion customer financing portfolio. This dual exposure heightens Boeing's risk of material adverse effects on its financial position, results of operations, and cash flows.",
      "llm_answer": "Boeing’s 2021 customer‑financing portfolio – $1.8 billion – has already been stressed by COVID‑19‑driven airline revenue and cash‑flow shortfalls that could trigger defaults (Item 1A, page 11). Because a large share of that portfolio is concentrated in a few customers and in specific aircraft types, especially the 717 and 747‑8 models, any default by those customers would not only add to the $1.8 billion loss but also leave Boeing with aircraft that are harder to redeploy or re‑lease, magnifying the hit to its cash flows and overall financial condition (Item 1A, page 23).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.8 billion portfolio amount is correct, and the reference to customer financing defaults linked to the pandemic is consistent with the original. No calculations are required, and all figures match. (2) The LLM correctly identifies the concentration risk in Boeing's portfolio, specifically naming the 717 and 747-8 aircraft types and linking them to heightened financial vulnerability. (3) The reasoning is sound: it explains that concentration in few customers and less marketable aircraft types compounds default risk, especially during the pandemic-induced downturn, and correctly infers that such defaults would lead to larger cash flow and financial condition impacts due to difficulty in redeploying these aircraft. This reflects proper multi-hop synthesis between portfolio concentration, aircraft type, customer risk, and pandemic effects. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'material adverse effects on financial position, results of operations, and cash flows' in the same breadth as the original, though it does reference impacts on 'cash flows and overall financial condition,' capturing most of the idea. Wording differences are acceptable under semantic equivalence. All entities (Boeing, 717, 747-8, $1.8 billion, customer financing portfolio, pandemic impact) are correct and contextually well-used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 402,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the launch of Sky Glass in the fourth quarter of 2021 impact the financial performance of CMCSA's Corporate and Other segment in 2021, and what specific cost and revenue effects were tied to this product introduction?",
      "original_answer": "The launch of Sky Glass in the fourth quarter of 2021 contributed to increased revenue in the Corporate and Other segment in 2021 due to sales of the new televisions. However, it also led to higher expenses tied to the product's introduction, partially offsetting the financial benefit. This dual impact reflects both the revenue generation from hardware sales and the cost investment required for launching a new product line.",
      "llm_answer": "The fourth‑quarter 2021 introduction of Sky Glass added a new hardware‑sales line to the Corporate & Other segment. Revenue in that segment jumped to **$461 million in 2021 from $248 million in 2020 (an 86 % increase)**, “primarily due to … sales of Sky Glass televisions”【page_62】. At the same time, the segment’s operating costs fell **10.5 % to $1,819 million**, the decline being “partially offset by costs related to Sky Glass and XClass TV” (the launch‑related hardware costs)【page_62】.  Thus, Sky Glass generated a sizable revenue boost while also adding launch‑related expenses, though the latter were more than offset by prior‑year severance and other cost‑saving measures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite addressing the right question. The ground truth states that Sky Glass led to increased revenue and higher expenses in the Corporate and Other segment, but does not provide specific dollar amounts or percentages. The LLM answer fabricates precise figures: a revenue increase from $248M to $461M (86%) and operating costs falling 10.5% to $1,819M. These numbers are not present in the original answer and cannot be verified from the provided context. Additionally, the claim that operating costs 'fell' contradicts the ground truth, which states that expenses increased due to Sky Glass launch costs. The LLM incorrectly claims that launch-related expenses were 'more than offset by prior-year severance and cost-saving measures,' which is not supported by the original answer. (2) Quantitative accuracy is low because all cited numbers ($461M, $248M, 86%, $1,819M, 10.5%) are either hallucinated or mischaracterized. Even if such figures existed in a source document, they are not part of the ground truth provided, and the direction of cost change (decrease vs increase) is factually wrong. (3) Qualitatively, the model correctly identifies that Sky Glass contributed to revenue and added launch-related costs, which aligns with the multi-hop reasoning required. However, it fails to accurately synthesize the net impact, incorrectly framing cost reductions rather than increases. The mention of 'XClass TV' introduces an entity not referenced in the ground truth, adding noise. (4) Contextual relevance is high because the answer focuses on the correct segment (Corporate and Other), the correct product (Sky Glass), and the correct year (2021), and attempts to explain both revenue and cost effects as asked. However, the inclusion of unsupported specifics undermines correctness. Overall, while the directional impact (revenue up, costs up) is partially correct, the specific financial claims and contradictory cost trend make the answer significantly misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 550,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, and how much unrealized loss does this category represent compared to its total debt securities portfolio?",
      "original_answer": "CVS held commercial mortgage-backed securities with a fair value of $675 million as of December 31, 2023, which represented $100 million in unrealized losses. This unrealized loss accounts for approximately 12% of the total unrealized losses across all debt securities, which stood at $836 million.",
      "llm_answer": "- **Fair‑value of commercial mortgage‑backed securities (CMBS) (Dec 31 2023):** **$975 million**【page_147】  \n- **Unrealized loss on CMBS:** **$100 million** (gross unrealized loss)【page_147】  \n\nCompared with the whole debt‑securities portfolio, the CMBS loss represents roughly **12 % of the total unrealized loss** ($100 m of $836 m) and about **4.5 % of the total debt‑securities fair value** ($975 m of $21,713 m)【page_147】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the unrealized loss on commercial mortgage-backed securities (CMBS) as $100 million and accurately states that this represents approximately 12% of the total unrealized losses ($100M of $836M), which matches the ground truth. However, it reports the fair value of CMBS as $975 million, which is incorrect — the ground truth from the knowledge graph specifies $675 million. This is a significant quantitative error affecting the primary metric requested in the question. (2) The calculation of 12% is correct and matches the original answer, but the additional calculation of 4.5% of total debt securities fair value, while mathematically plausible ($975M / $21,713M ≈ 4.5%), introduces data not requested in the question and is based on an incorrect CMBS fair value. The total debt securities fair value and this percentage were not part of the original answer and may reflect over-interpretation. (3) The multi-hop reasoning is partially sound — the model correctly links CMBS unrealized loss to total debt securities unrealized loss and computes the correct proportion. However, the foundational error in the CMBS fair value undermines the accuracy of the synthesis. (4) The contextual relevance is high as the answer addresses both parts of the question and provides relevant comparisons. Qualitative reasoning is mostly sound, but the quantitative inaccuracy in a key figure (fair value) reduces overall correctness. The model appears to have sourced from a plausible document (page 147), but the data does not align with the verified ground truth, leading to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 449,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the growth in third-party seller unit sales contribute to Amazon's overall sales increase in 2023, and what international risk related to third-party sellers could potentially impact Amazon's international expansion strategy?",
      "original_answer": "The growth in third-party seller unit sales was a key contributor to Amazon's 12% overall sales increase in 2023, particularly in both North America and International segments. However, Amazon faces international risks such as regulatory restrictions in countries like India, where foreign ownership rules limit control over online retail platforms, potentially complicating Amazon's expansion and reliance on third-party sellers in such markets.",
      "llm_answer": "Amazon said that the 12 % rise in total net sales for 2023 was driven largely by “increased unit sales, primarily by third‑party sellers” in both its North‑America and International segments (page 24). That surge in third‑party seller volume was a key component of the overall sales increase. A related international risk is that China‑based (and other foreign) third‑party sellers—who generate a large share of Amazon’s marketplace and advertising revenue—are exposed to regulatory, trade‑restriction and data‑protection laws that could lead to fines, licensing losses or forced shutdowns, potentially curbing Amazon’s ability to expand abroad (page 8).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the 12% overall sales increase in 2023 and accurately attributes it to increased unit sales by third-party sellers in both North America and International segments, aligning with the ground truth. The quantitative data (12% sales growth) is correct and matches the original answer. 2) All numbers and percentages are accurate—specifically, the 12% sales increase is correctly cited, and no calculations are required beyond that. Format and referencing (e.g., page numbers) are consistent with source-based reporting. 3) The multi-hop reasoning is partially sound: the LLM correctly links third-party seller growth to Amazon’s overall sales increase. However, the international risk differs from the ground truth. While the original answer cites regulatory restrictions in *India* related to foreign ownership limiting control over platforms, the LLM cites risks from *China-based* sellers facing trade and data laws. This is a significant deviation in entity and risk specificity. Although foreign regulatory risks are a valid concern, the shift from India’s foreign ownership rules (a structural market access issue) to China-based sellers’ compliance risks changes the nature of the threat to Amazon’s expansion strategy. 4) The answer is contextually relevant and well-structured, citing specific pages and linking cause and effect appropriately. Due to the factual accuracy of the sales growth contribution (core of first part) but the substitution of a different country and risk type in the second part (India → China, ownership rules → trade/data compliance), the qualitative accuracy is reduced. Correctness score is 7 because the key financial claim is accurate, but the international risk component—while plausible—is not factually aligned with the ground truth from the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 495,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors at Wells Fargo in 2023?",
      "original_answer": "The difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors is 1,712,810 shares.",
      "llm_answer": "In 2023, the Deferred Compensation Plan had **1,853,363** shares remaining available for future issuance, while the Non‑Qualified Deferred Compensation Plan for Independent Contractors had **140,553** such shares. The Deferred Compensation Plan therefore had **1,712,810 more shares** available than the Independent‑Contractor plan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the Deferred Compensation Plan had 1,853,363 shares and the Non-Qualified Deferred Compensation Plan for Independent Contractors had 140,553 shares remaining in 2023. (2) The difference is correctly calculated: 1,853,363 - 140,553 = 1,712,810 shares, which exactly matches the ground truth. (3) The multi-hop reasoning is sound — the model correctly identified two distinct plans, retrieved the correct share counts for each, and computed the difference. (4) Entities (plan names, year 2023, Wells Fargo context implied) are accurately referenced. The answer is semantically equivalent to the original, with clear, precise, and relevant information directly addressing the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 233,
        "total_tokens": 1390
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What specific categories of products are included in PMI's reduced-risk product line, and how do heated tobacco units contribute to this classification based on the company's 2022 10-K filing?",
      "original_answer": "PMI's reduced-risk product line includes heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. Heated tobacco units are a core component of this category, as explicitly stated in both sections of the 10-K filing, which specifically name them as part of the reduced-risk offerings.",
      "llm_answer": "PMI’s “reduced‑risk products” (RRPs) are defined as the sale of **heated‑tobacco units, heat‑not‑burn devices and their accessories, plus other nicotine‑containing products such as e‑vapor and oral‑nicotine products**【page_33】. Heated‑tobacco units (HTUs) – the consumable sticks that include the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, TEREA and the KT&G‑licensed Fiit and Miix brands – are explicitly listed as a component of the RRP portfolio and therefore drive a portion of the reduced‑risk product revenue and shipment volume【page_34】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately identifies all product categories included in PMI's reduced-risk product line: heated tobacco units, heat-not-burn devices and accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, shipment numbers), so quantitative accuracy is not compromised. (3) The reasoning is sound and reflects multi-hop synthesis from the 2022 10-K filing, correctly citing page 33 for the definition and page 34 for the specific inclusion of heated tobacco units (HTUs) as a core component. The mention of specific brand names (e.g., HEETS, Marlboro HeatSticks, Fiit, Miix) adds contextual detail that is consistent with the filing and enhances accuracy without introducing error. (4) The answer fully addresses both parts of the question: the composition of the reduced-risk product line and the role of heated tobacco units within it. Semantic equivalence is maintained and exceeded with precise sourcing and elaboration. All entities (PMI, RRPs, HTUs) are correctly identified and contextualized. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 346,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What percentage of NVDA's revenue came from DirectCustomerA in fiscal year 2025, and how does this compare to the previous year for which data is available?",
      "original_answer": "In fiscal year 2025, DirectCustomerA accounted for 12% of NVDA's revenue. For the previous year with available data (fiscal year 2024), DirectCustomerA's contribution was not disclosed (marked as '*'). Therefore, a direct numerical comparison cannot be made, but we observe that DirectCustomerA became a named top customer in 2025 after not being reported in 2024.",
      "llm_answer": "DirectCustomer A contributed **12 % of NVIDIA’s total revenue in fiscal 2025**. In the prior year (fiscal 2024) the customer’s share was **below the 10 % reporting threshold**, meaning it represented **less than 10 % of total revenue**.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that DirectCustomerA contributed 12% of NVDA's revenue in fiscal year 2025, which matches the ground truth. However, it incorrectly states that in fiscal year 2024, the customer's share was 'below the 10% reporting threshold' and 'less than 10%'. The original answer clarifies that DirectCustomerA's contribution in 2024 was not disclosed and marked as '*', meaning the information is unavailable—not that it was below 10%. The SEC reporting threshold rule (where customers contributing less than 10% may not be disclosed) is contextually plausible, but the LLM overinterprets the absence of disclosure as definitive evidence of sub-threshold status, which is not supported by the data provided. This constitutes a significant factual overreach. While the model addresses both parts of the question (2025 percentage and comparison to prior year), the reasoning is flawed in the multi-hop inference from non-disclosure to quantitative conclusion. The entity names and years are correct, and the 2025 figure is accurate, but the unsupported inference undermines the qualitative and quantitative accuracy. Hence, partial credit is given for correct 2025 data but major deduction for incorrect interpretation of 2024 status.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 350,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How many distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively, in Wells Fargo's 2023 10-K filing?",
      "original_answer": "There are two distinct versions of the Restricted Share Rights Award Agreement: one for grants on or after January 24, 2023, which was incorporated by reference, and another for grants on or after January 23, 2024, which was filed herewith.",
      "llm_answer": "The 2023 Form 10‑K lists a single Restricted Share Rights Award Agreement for each grant date:\n\n* **Grants on or after January 24, 2023** – one version, incorporated by reference to Exhibit 10(a) of the 2022 Form 10‑K.  \n* **Grants on or after January 23, 2024** – one version, filed with the 2023 Form 10‑K (“filed herewith”).  \n\nSo, there is **one distinct version for each of the two grant dates**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies two distinct versions of the Restricted Share Rights Award Agreement, one for each specified grant date, matching the original answer. (2) The dates (January 24, 2023, and January 23, 2024) are correct, and the filing status—'incorporated by reference' for the first and 'filed herewith' for the second—is accurately reported. The reference to Exhibit 10(a) of the 2022 Form 10-K adds precision without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about two separate agreements tied to different grant dates and their respective filing methods within the 2023 10-K. (4) All entities (Wells Fargo, 2023 10-K, grant dates, filing statuses) are correctly identified and contextualized. The answer is complete, factually accurate, and conveys the same information as the original with added clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 280,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the continued uncertainty in FAA approval timelines for the 787 Program in 2022 impact Boeing's cost of sales and margin forecasting, given the reach-forward loss and contractual termination risks described in the critical audit matter?",
      "original_answer": "The continued uncertainty in the FAA approval timeline to resume 787 deliveries significantly increased estimation uncertainty in Boeing's revenue forecasts, particularly for aircraft nearing contractual termination rights. This uncertainty led to potential additional customer considerations and could result in lower margins or further material reach-forward losses. This is reflected in the 2021 cost of sales, which saw a $4,574 million decrease compared to 2020, partly due to the reach-forward loss on the 787 program, highlighting the financial impact of delayed deliveries and increased risk in forecasting.",
      "llm_answer": "The 2022‑year audit notes that because the FAA’s approval date for restarting 787 deliveries remained uncertain, Boeing had to record a “reach‑forward loss” on the 787 program. That loss was reflected in the cost‑of‑sales calculation, offsetting some of the $4.6 billion reduction in cost of sales for 2021 and keeping the cost‑of‑sales ratio higher than it would have been without the loss. Consequently, management’s margin forecasts for the 787 had to incorporate the risk that additional delivery‑delay penalties or contractual termination rights could generate further reach‑forward losses and lower overall margins. (See Cost of Sales table – page 34; 787 Program critical‑audit‑matter description – page 136.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $4.6 billion reduction in cost of sales for 2021 is correctly stated (matches $4,574 million in original answer, rounded appropriately). The reference to the reach-forward loss being reflected in cost of sales is factually correct and consistent with the 2021 financials. (2) The answer correctly identifies the cause (FAA approval uncertainty in 2022) and effect (impact on cost of sales and margin forecasting), even though the financial impact is reflected in 2021 results—this is accurate because the reach-forward loss was recorded prior to 2022 due to ongoing delays. (3) The multi-hop reasoning is sound: it connects FAA timeline uncertainty → estimation uncertainty in revenue → risk of customer penalties/contract terminations → potential for additional reach-forward losses → impact on margins and cost of sales. (4) The only minor shortcoming is that the original answer emphasizes the *forecasting* challenge due to aircraft nearing contractual termination rights, which the LLM mentions but could have integrated more explicitly. However, the core financial impact, entities (Boeing, 787 program), years (2021 cost of sales), and logic are all correct. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing all parts of the question with appropriate sourcing cues.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 393,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the role of third-party sellers contribute to Amazon's North America and International sales growth in 2023, and what was the net effect of foreign exchange rate changes on these sales increases?",
      "original_answer": "Third-party sellers were a key driver of unit sales growth in both North America and International segments in 2023. In North America, sales increased by 12%, primarily due to increased unit sales by third-party sellers, advertising sales, and subscription services. Similarly, International sales increased by 11%, also largely driven by increased unit sales by third-party sellers. Foreign exchange rate changes had a mixed impact: they reduced North America net sales by $71 million but increased International net sales by $88 million, resulting in a net positive impact of $17 million on total sales growth.",
      "llm_answer": "In 2023 Amazon said that the bulk of the 12 % rise in North‑America net sales and the 11 % rise in International net sales came from “increased unit sales, primarily by third‑party sellers” (along with advertising and subscription revenue)【page_24】.  Foreign‑exchange movements, however, offset those gains differently: they trimmed North‑America sales by about **$71 million**, while they added roughly **$88 million** to International sales, producing a net foreign‑exchange benefit of roughly **$17 million** to the combined growth【page_24】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 12% growth in North America, 11% in International, $71 million reduction in North America due to FX, $88 million increase in International, and the net positive impact of $17 million ($88M - $71M) are all correctly reported. Minor formatting differences (e.g., 'about $71 million' vs exact value) are acceptable and do not affect factual accuracy. (2) The answer is complete, addressing both parts of the question: the role of third-party sellers in driving sales growth in both regions and the net effect of foreign exchange rate changes. (3) Entities are correct—Amazon, North America and International segments, 2023 time frame, and financial metrics like net sales and FX impact are properly identified. (4) Multi-hop reasoning is sound: the model correctly synthesizes that third-party seller unit growth contributed significantly to sales increases in both regions and accurately combines the opposing FX effects to compute the net $17 million benefit. (5) Semantic equivalence is strong—the wording differs slightly (e.g., 'bulk of the rise' vs 'primarily due to') but conveys the same meaning and factual content as the original. No errors in logic, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 363,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given Wells Fargo's obligations under the USA PATRIOT Act, how might deficiencies in its anti-money laundering program constrain its ability to pursue future bank acquisitions, and which regulatory body would assess these deficiencies during the approval process?",
      "original_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue future bank acquisitions because the Federal Reserve Board (FRB), along with other federal banking regulators, is required to evaluate the effectiveness of a financial institution's AML compliance program when determining whether to approve a proposed bank acquisition. If the FRB finds that Wells Fargo's AML program is ineffective or non-compliant, it may deny the acquisition proposal, citing risks to financial integrity and national security under the provisions of the USA PATRIOT Act.",
      "llm_answer": "Deficiencies in Wells Fargo’s anti‑money‑laundering (AML) program could cause federal banking regulators to view the bank as insufficiently able to combat illicit financing, which the USA PATRIOT Act requires them to evaluate when deciding whether to approve a bank purchase. If the AML program is judged weak, the regulator can deny the transaction or impose remedial conditions, effectively limiting Wells Fargo’s ability to complete future acquisitions. The regulator that reviews these AML‑related deficiencies in an acquisition filing is the **Federal Reserve Board (the Fed)**, the primary federal banking regulator for the company.【page_6】【page_4】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) It correctly identifies that deficiencies in Wells Fargo's AML program could constrain its ability to pursue bank acquisitions due to regulatory scrutiny under the USA PATRIOT Act. (2) It accurately names the Federal Reserve Board (the Fed) as the regulatory body responsible for assessing AML deficiencies during the acquisition approval process, aligning with the original answer. (3) The reasoning is sound: weak AML controls may lead to denial or conditional approval of acquisitions, which reflects the multi-hop logic connecting AML compliance, regulatory authority, and acquisition constraints. (4) While the LLM answer does not explicitly mention 'national security' or 'financial integrity' as cited risks in the original, it captures the essential regulatory consequence—denial or conditional approval—making the omission minor. There are no numerical values, so quantitative accuracy is not applicable but assumed perfect. The answer is semantically equivalent, with only slight differences in phrasing. Thus, the correctness score is 9 due to minor contextual omissions, but all key facts and logic are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 342,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What was the percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020, and which product category does heated tobacco units fall under in PMI's financial reporting?",
      "original_answer": "The total international industry cigarette and heated tobacco unit volume increased by 2.4% in 2021 compared to 2020. Heated tobacco units fall under the 'reduced-risk products' category in PMI's financial reporting.",
      "llm_answer": "PMI said that estimated international industry cigarette + heated‑tobacco unit volume rose **2.4 %** in 2021 versus 2020. In its financial reporting, heated‑tobacco units are classified under the **Reduced‑Risk Products** category.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The percentage increase in PMI's total international industry cigarette and heated tobacco unit volume from 2020 to 2021 is accurately reported as 2.4%, which aligns with the original answer. (2) The classification of heated tobacco units under 'Reduced-Risk Products' in PMI's financial reporting is correctly identified, with capitalization and terminology matching standard usage. (3) The question involves a multi-hop synthesis: identifying the correct volume change metric across years and linking heated tobacco units to the appropriate product category in financial reporting—both are correctly executed. (4) All entities (PMI, 2020–2021 time frame, international industry volume) are accurate, and the reasoning is sound. Minor formatting differences (e.g., use of em dashes, bolding) do not affect meaning. The answer is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 272,
        "total_tokens": 1405
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given the $1.8 billion customer financing portfolio and the 24.2% default rate applied to CCC-rated receivables, by how much could Boeing's potential losses increase if the ongoing impacts of the COVID-19 pandemic cause all CCC-rated receivables within this portfolio to default?",
      "original_answer": "Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables within the $1.8 billion customer financing portfolio were to default, based on the 24.2% default rate applied to CCC-rated receivables.",
      "llm_answer": "If every CCC‑rated receivable in the $1.8 billion customer‑financing portfolio were to default, Boeing would incur a loss equal to the full CCC exposure of roughly **$445 million**.  Because the company currently applies a 24.2 % default rate (≈ $108 million) to that exposure, the additional loss that could materialize would be about **$337 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core calculation and misinterprets the question. The ground truth states that Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables defaulted, which is simply 24.2% of $1.8 billion (0.242 × 1,800 = 435.6). However, the LLM incorrectly calculates a 'full CCC exposure' of $445 million (which is close but not exact), then assumes Boeing already reserves $108 million (24.2% of $445M ≈ $108M), and concludes the 'additional' loss would be $337 million. This reasoning is flawed because the question does not ask for incremental losses beyond existing reserves—it asks for the total potential loss increase if all CCC-rated receivables defaulted, which is the full $435.6 million. (2) Quantitative accuracy is low: the correct value is $435.6 million; the LLM reports $337 million as the additional loss, which is not supported by the data. The $445 million exposure figure is also slightly off (24.2% of $1.8B = $435.6M). (3) The multi-hop reasoning fails: the model incorrectly introduces the concept of existing provisions or expected losses as a baseline, which is not part of the question. The question is a straightforward counterfactual: if the default rate went to 100% instead of 24.2%, what would the loss be? But the LLM interprets it as an incremental loss beyond expected losses, which changes the meaning. (4) Contextual relevance is high—the answer addresses Boeing, the customer financing portfolio, CCC-rated receivables, and the pandemic context. However, due to fundamental errors in calculation and reasoning, the correctness and quantitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 458,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What percentage of NVDA's revenue came from DirectCustomerC in the fiscal year ending January 26, 2025, and how does this compare to the previous year's data for the same customer?",
      "original_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for 11% of NVDA's revenue. This is unchanged from the prior year, as DirectCustomerC also represented 11% of NVDA's revenue in the fiscal year ending January 28, 2024.",
      "llm_answer": "In fiscal 2025 (year ended January 26, 2025), sales to DirectCustomer C accounted for **about 11 % of NVIDIA’s total revenue**. In the prior year (fiscal 2024), DirectCustomer C contributed **less than 10 % of total revenue** (the filing marks it with “*”, indicating it was under the 10 % threshold).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key claim about the prior year percentage. The ground truth states that DirectCustomerC accounted for 11% of NVDA's revenue in both fiscal years ending January 26, 2025, and January 28, 2024. However, the LLM incorrectly claims that in fiscal 2024, the customer contributed 'less than 10%', citing a footnote marker '*'. This contradicts the ground truth and represents a major factual error. (2) The current year percentage (11%) is correct, as is the fiscal year-end date (January 26, 2025). However, the prior year percentage is wrong—11% vs. the claimed 'less than 10%'. This error affects a core part of the question, which asks for a comparison between two years. (3) The multi-hop reasoning fails because the model did not correctly synthesize the data across both fiscal years. It appears to misinterpret a disclosure convention (use of '*') as indicating sub-10%, but according to the ground truth, the percentage was still 11% in the prior year. There is no indication in the original answer of a change or threshold issue. (4) While the answer is relevant and addresses the right entities (NVDA, DirectCustomerC, correct fiscal years), the critical quantitative error in the prior year figure severely undermines the correctness and qualitative accuracy. The contextual relevance is high because the structure and focus are appropriate, but the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 400,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What is the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, and how does this compare to the unrealized losses associated with these securities according to the investment maturity breakdown?",
      "original_answer": "CVS Health Corporation held a total fair value of $675 million in Commercial Mortgage-Backed Securities (CMBS) as of December 31, 2023. The unrealized losses associated with these CMBS were $100 million, representing a significant portion (approximately 14.8%) of the total unrealized losses across all investment categories.",
      "llm_answer": "CVS Health held Commercial Mortgage‑Backed Securities (CMBS) with a **fair value of $975 million** at December 31 2023 (see the debt‑securities table on page 147).  \n\nAccording to the investment‑maturity breakdown, those CMBS carried **unrealized losses of $100 million** (see the “Commercial mortgage‑backed securities” line in the maturity‑breakdown table on page 150).  \n\nThus, the unrealized loss represents roughly **10 % of the CMBS fair‑value portfolio**.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the fair value of CMBS: it reports $975 million, whereas the ground truth is $675 million. This is a significant factual discrepancy that undermines the quantitative accuracy. The unrealized losses of $100 million are correctly reported and match the ground truth. However, due to the incorrect fair value, the derived percentage (10%) is inaccurate; the correct percentage is approximately 14.8% ($100M / $675M), which the LLM fails to compute correctly. (2) Number verification: Fair value is wrong ($975M vs $675M), unrealized loss is correct ($100M), and resulting percentage is incorrect (10% vs 14.8%). Calculations based on correct inputs were not performed accurately. (3) Multi-hop reasoning: The model correctly identifies the need to combine fair value and unrealized loss data from what appears to be separate tables (debt securities and maturity breakdown), showing appropriate synthesis structure. However, because one of the source values is incorrect, the final comparison is flawed. (4) Despite the reasoning framework being sound and contextually relevant, the major numerical error in fair value severely impacts correctness and quantitative accuracy. The answer is partially complete and well-structured but factually compromised on a key metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 370,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the treatment of changes in estimated fair value of Unit-linked securities differ between net investment income and net derivative gains (losses) based on the disclosed components of MetLife's financial statements?",
      "original_answer": "Changes in the estimated fair value of Unit-linked securities are included in net investment income, while lapses associated with net embedded derivatives, which may arise from these securities, are included in net derivative gains (losses). This distinction reflects different accounting treatments for valuation changes versus derivative-related outcomes.",
      "llm_answer": "MetLife records the change in the estimated fair value of its **Unit‑linked (and FVO) securities** as part of **net investment income**. The roll‑forward footnote for Level‑3 assets states that “changes in estimated fair value of Unit‑linked and FVO securities are included in net investment income” (see page 252, footnote (1)).  \n\nBy contrast, **net derivative gains (losses)** capture the fair‑value changes of embedded derivatives (e.g., funds‑withheld liabilities and other embedded derivatives) and do **not** include the Unit‑linked securities; those are reported separately in net investment income. Thus, Unit‑linked fair‑value movements affect net investment income, while net derivative gains (losses) reflect only derivative‑related fair‑value changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that changes in the estimated fair value of Unit-linked securities are included in net investment income, citing the correct disclosure (page 252, footnote (1)) and using semantically equivalent language. It correctly contrasts this with net derivative gains (losses), which capture fair-value changes of embedded derivatives (e.g., funds-withheld liabilities), not the Unit-linked securities themselves. The distinction between valuation changes (in net investment income) and derivative-related outcomes (in net derivative gains/losses) is logically and accurately conveyed. There are no numerical inaccuracies—though no specific numbers (e.g., dollar amounts) are mentioned, the qualitative financial reporting treatment is correctly described. The answer is complete, addressing both components of the question: where fair value changes are reported and how derivative gains differ. The only minor limitation is that it does not explicitly mention 'lapses associated with net embedded derivatives' as part of net derivative gains (losses), which is included in the ground truth and adds a small nuance about the source of derivative activity. However, the reference to embedded derivatives and their accounting in net derivative gains (losses) captures the essential point. Thus, the answer is highly accurate, contextually relevant, and demonstrates sound multi-hop reasoning by synthesizing accounting treatments across different financial statement components.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 427,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How much financial loss did Boeing record on the 787 Program in the fourth quarter of 2021, and how does the uncertainty around FAA approval for resuming deliveries potentially affect future revenue estimates for the program, based on the accounting methodology described?",
      "original_answer": "Boeing recorded a $3.5 billion loss on the 787 Program in the fourth quarter of 2021. The uncertainty around FAA approval for resuming deliveries affects future revenue estimates because Boeing uses program accounting, which requires estimating the revenue expected upon delivery of each aircraft. The timing of FAA approval is a key factor in determining which aircraft will reach contractual termination rights, and changes in the expected delivery resumption date could lead to additional customer considerations, lower margins, or further material reach-forward losses.",
      "llm_answer": "Boeing recorded a **$3.5 billion loss on the 787 program in the fourth quarter of 2021**. Because the program’s accounting relies on estimating the revenue that will be earned when each aircraft is delivered, the **uncertainty over when the FAA will approve the resumption of 787 deliveries creates significant judgment about delivery timing, customer compensation and possible contract terminations**; any further delay or additional re‑work could lower the forecasted revenue and trigger additional reach‑forward losses in future periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3.5 billion loss Boeing recorded on the 787 program in Q4 2021, matching the ground truth exactly in both amount and time period. All numeric and entity details (Boeing, 787 program, Q4 2021, $3.5 billion) are accurate. (2) Quantitative accuracy is perfect—no calculations were required beyond correct reporting of the loss figure, which is precisely stated. Format variations (e.g., $3.5 billion vs $3.5B) are acceptable and not an issue here. (3) The reasoning around program accounting and the impact of FAA approval delays is sound and semantically equivalent to the ground truth. The LLM correctly explains that uncertainty affects delivery timing, which in turn influences revenue estimation under program accounting, potentially leading to customer compensation, contract terminations, and additional reach-forward losses. It captures the core cause-effect relationship, though it does not explicitly mention 'contractual termination rights' or 'changes in expected delivery resumption date' as directly as the original, slightly reducing completeness in nuanced terminology. (4) Contextual relevance is excellent—the response directly addresses both parts of the multi-hop question: the historical financial loss and the forward-looking accounting implications. The synthesis across time (past loss and future estimates) and domains (financial reporting and regulatory approval) is appropriate and accurate. Minor deduction in qualitative accuracy due to slightly less precise articulation of contractual mechanics, but overall meaning and substance are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 444,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What percentage of revenue did NVDA derive from DirectCustomerA in the fiscal year ending January 26, 2025, and how does this compare to the availability of data for the same customer in the prior fiscal year?",
      "original_answer": "NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. The data for DirectCustomerA in the prior fiscal year (January 28, 2024) is marked as unavailable (denoted by '*'), indicating no disclosed percentage for that year.",
      "llm_answer": "In fiscal year 2025 (year ended January 26, 2025), NVIDIA reported that DirectCustomer A accounted for **12 % of total revenue**. For the prior fiscal year (ended January 28, 2024), the company did not disclose a specific percentage for DirectCustomer A—its share was marked with an asterisk (“*”), indicating it was **below the 10 % reporting threshold** and therefore not separately reported.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that NVDA derived 12% of revenue from DirectCustomerA in the fiscal year ending January 26, 2025, matching the ground truth. It also accurately notes that the prior year (ended January 28, 2024) data is marked with an asterisk (*), indicating unavailability. (2) All numeric values—12%, the fiscal year-end dates (January 26, 2025, and January 28, 2024)—are correct. The interpretation of '*' as denoting non-disclosure is factually sound. (3) The LLM adds a reasonable explanation that the asterisk indicates the customer was below the 10% reporting threshold, which is consistent with SEC disclosure practices and provides helpful context not explicitly in the ground truth. While this detail is an inference, it is a correct and common interpretation, enhancing rather than distorting accuracy. (4) The answer fully addresses both parts of the question: the percentage in FY2025 and the status of prior-year data. The reasoning is sound, and the synthesis across fiscal years is accurate. The slight deduction in qualitative accuracy is because the ground truth does not explicitly state the 10% threshold reasoning, though it is valid. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 354,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What was the total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses related to the collaboration?",
      "original_answer": "The total financial impact on Amgen from its relationship with BeiGene in 2023 was $4.374 billion, combining the fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million).",
      "llm_answer": "In 2023 Amgen’s BeiGene relationship generated a combined impact of roughly **$4.47 billion** – the $4.2 billion fair‑value of Amgen’s equity stake in BeiGene plus the collaboration‑related amounts of $109 million in net cost recoveries, $125 million in product‑sale revenue and $40 million in profit‑and‑loss‑share expenses.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all components of the financial impact: fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million). However, the total sum is incorrect. The correct total is $4.2B + $109M + $125M + $40M = $4.474B, which rounds to $4.474 billion, not $4.47 billion as stated. The original answer states $4.374 billion, which appears to be a discrepancy in the ground truth itself—based on the provided numbers, the correct sum should be $4.474 billion. This suggests a possible error in the ground truth. Assuming the ground truth is authoritative, the LLM’s total of $4.47 billion (likely rounded from $4.474B) contradicts the stated $4.374B, creating confusion. (2) Individual numbers are accurate and match the ground truth exactly. The calculation error lies in the final sum: $4.2B + $0.109B + $0.125B + $0.040B = $4.474B, not $4.374B. Therefore, either the ground truth has an arithmetic error, or the LLM misread one of the inputs. Since the LLM reports $4.47B (consistent with $4.474B rounded), but the ground truth says $4.374B, there is a $100M discrepancy. This is a significant quantitative error. (3) The multi-hop reasoning is sound—the model correctly identifies the equity investment and collaboration components and aggregates them. It synthesizes the four elements appropriately. (4) Despite strong qualitative reasoning and contextual relevance, the quantitative inaccuracy in the final total—especially given the conflict with the ground truth—reduces the correctness score. The LLM may actually be arithmetically correct, but since the task is to match the ground truth (which states $4.374B), the deviation cannot be overlooked. Thus, the correctness score is 7 due to the unresolved total discrepancy, quantitative accuracy is 6 due to the significant sum error, qualitative accuracy is 8 for correct component identification and logic, and contextual relevance is 10 as all parts are addressed directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 554,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does MetLife's use of different forecast periods for commercial/agricultural versus residential mortgage loans affect the duration over which estimated lifetime loss rates are applied before reverting to historical loss experience?",
      "original_answer": "MetLife applies estimated lifetime loss rates over a two-year forecast period for commercial and agricultural mortgage loans before reverting to historical loss experience, whereas for residential mortgage loans, the forecast period is two years but reverts to industry historical loss experience over a one-year period. This means the duration before reverting to historical data is longer for commercial and agricultural loans (two-year forecast + two-year reversion = 4 years total) compared to residential loans (two-year forecast + one-year reversion = 3 years total).",
      "llm_answer": "MetLife applies estimated lifetime loss rates to commercial and agricultural mortgage loans for a **two‑year economic‑forecast horizon** (a one‑year horizon for a small subset of loans). After that period the loan‑segment’s loss rates are “phased‑in” to the company’s historical loss experience on a **straight‑line basis over two years**.  \n\nFor residential mortgage loans the forecast horizon is also **two years**, but once that period ends the rates are reverted to historical loss experience **on a straight‑line basis over one year**.  \n\nThus, the post‑forecast transition period is longer for commercial/agricultural loans (two years) than for residential loans (one year).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key numbers are correct: two-year forecast period for both commercial/agricultural and residential loans, with a two-year reversion period for the former and one-year for the latter. The mention of a one-year horizon for a small subset of commercial/agricultural loans is an additional detail not in the original answer but does not contradict it and may reflect nuance in the source data. (2) Calculations implied by the total duration (4 years vs 3 years) are accurate, though the LLM does not explicitly state the total durations (e.g., '4 years total'), which slightly reduces completeness. (3) The multi-hop reasoning is sound—correctly distinguishing between forecast period and reversion period across loan types and synthesizing the impact on duration before reverting to historical data. (4) The answer is contextually relevant and directly addresses how differing reversion periods affect the overall duration. The only minor omission is the lack of explicit total duration (4 vs 3 years), which slightly affects completeness but not factual correctness. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 365,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does Costco's self-insurance funding for employee health care benefits, as estimated through actuarial assumptions, potentially impact its financial condition in the context of unpredictable cost fluctuations and labor-related risks?",
      "original_answer": "Costco's self-insurance funding for employee health care benefits relies on historical claims experience, demographic factors, severity factors, and other actuarial assumptions. These liabilities are not discounted and are subject to significant unpredictability due to inflation rates, regulatory or legal changes, and unforeseen developments in claims. Since actual claims and costs could differ significantly from recorded liabilities, this could lead to unexpected financial burdens. Given that Costco also faces challenges in controlling labor and benefit costs—impacted by factors like healthcare costs and regulatory changes—these financial pressures could adversely affect its business, financial condition, and results of operations.",
      "llm_answer": "Costco funds employee health‑care, workers’‑comp and other benefit claims primarily through self‑insurance, recording a liability that is estimated using historical claims data, demographic and severity factors and other actuarial assumptions (see page 30). Because these estimates are not discounted and the actual costs can swing sharply with inflation, regulatory or legal changes, or other unforeseen claim developments, a rise in health‑care or labor‑related expenses could increase the self‑insurance liability and drain cash flows, thereby putting pressure on Costco’s overall financial condition (as noted on page 13).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that Costco uses self-insurance for employee health care and other benefits (including workers’ comp), with liabilities estimated using historical claims, demographic factors, severity factors, and actuarial assumptions—consistent with the original. It accurately notes these liabilities are not discounted and subject to volatility from inflation, regulatory or legal changes, and unforeseen claims developments. The answer correctly links potential increases in healthcare or labor-related costs to increased liabilities and financial pressure, aligning with the original’s concern about adverse impacts on financial condition and operations. The only minor difference is the inclusion of workers’ comp (which is accurate but not emphasized in the original), and a reference to page numbers (30 and 13), which are not in the ground truth but suggest proper sourcing. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), reasoning is sound across multiple hops (self-insurance → estimation method → uncertainty sources → financial impact), and the response fully addresses the question’s focus on financial condition and risk. Thus, the answer earns a 9/10 for correctness due to slight expansion beyond the original scope, but remains highly accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 394,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How much did 3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 total, and what was the impact of the reconsolidation of the Aearo Entities on 3M's balance sheet as of December 31, 2023?",
      "original_answer": "3M recorded a pre-tax charge of $4.2 billion related to the CAE Settlement and $437 million in restructuring charges in 2023, totaling $4.637 billion in charges. The reconsolidation of the Aearo Entities resulted in the removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability for former intercompany amounts, impacting the consolidated balance sheet as of December 31, 2023.",
      "llm_answer": "- In 2023 3M recorded a pre‑tax charge of **$4.2 billion** for the CAE Settlement (Q3) and **$437 million** of restructuring pre‑tax charges, for a combined total of **about $4.64 billion**.\n\n- When the former de‑consolidated Aearo Entities were reconsolidated in Q2 2023, the balance‑sheet items that had appeared on the 2022 comparative disappeared. Specifically, the company no longer shows the **$0.7 billion equity‑and‑other‑investments asset** and the **approximately $0.6 billion net inter‑company liability** (grossly $0.9 billion in other liabilities and $0.3 billion in other assets) that were recorded when the entities were de‑consolidated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key numbers are correct: $4.2 billion for the CAE Settlement, $437 million in restructuring charges, totaling $4.637 billion (LLM rounds to $4.64 billion, which is acceptable). The $0.7 billion asset in equity and other investments and the $0.6 billion net intercompany liability are correctly reported. (2) Quantitative accuracy is perfect—minor rounding of the total ($4.637B → $4.64B) does not affect correctness. (3) The multi-hop reasoning is sound: the answer correctly links the CAE and restructuring charges as separate pre-tax items and synthesizes their total, and it accurately explains the balance sheet impact of reconsolidating the Aearo Entities by referencing the removal of specific balance sheet items. (4) The only minor shortcoming is that the LLM does not explicitly state that the reconsolidation impacted the balance sheet *as of December 31, 2023*, though the context implies it. This slight omission prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is complete, factually correct, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 324,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does Google's integration of Gemini 2.0 into its Vertex AI platform expand the capabilities available to developers on Google Cloud Platform?",
      "original_answer": "Google's integration of Gemini 2.0 into its Vertex AI platform provides developers with advanced tools to train, tune, augment, test, and deploy applications using Gemini, Imagen, Veo, and other generative AI models. This significantly enhances the development environment on Google Cloud Platform, allowing developers to build more sophisticated and multimodal applications.",
      "llm_answer": "By embedding Gemini 2.0—the company’s most capable, multimodal generative‑AI model—into Vertex AI, Google lets Cloud developers not only train, fine‑tune, augment, test and deploy their own applications with Gemini, but also tap pre‑packaged AI agents that can write, document, test and operate software and help cybersecurity teams. The platform also bundles complementary services such as vector‑search, grounding and model distillation, dramatically widening the range of generative‑AI functions developers can build on Google Cloud Platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the integration of Gemini 2.0 into Vertex AI and accurately describes the expanded capabilities for developers on Google Cloud Platform. The core functionalities—train, fine-tune, augment, test, and deploy applications using Gemini—are all present and match the original answer. The LLM adds specific details not in the original, such as 'pre-packaged AI agents' and 'vector-search, grounding and model distillation,' which are contextually appropriate and consistent with Google's known AI offerings, though not explicitly mentioned in the ground truth. These additions enhance completeness without introducing inaccuracies. There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects correct multi-hop synthesis: connecting Gemini 2.0, Vertex AI, and developer capabilities on Google Cloud. The only reason for not scoring a perfect 10 is that the original answer emphasizes multimodal applications using 'Imagen, Veo, and other generative AI models,' which the LLM omits—this is a minor but notable omission in completeness. However, the mention of 'multimodal generative-AI model' partially compensates. Overall, the answer is factually correct, semantically equivalent, and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 388,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the inclusion of FVO securities in the yield calculation for fixed maturity securities impact the reported investment income and sensitivity to fair value changes for MetLife in 2024, given the valuation techniques applied to FVO securities under Level 3 classifications?",
      "original_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities contributed $205 million in investment income for 2024, directly affecting yield performance metrics. Since FVO securities are classified under Level 3 and are subject to valuation techniques involving significant unobservable inputs (such as nonperformance risk spreads and long-term equity volatilities), changes in these inputs can materially alter the estimated fair value of these securities. This dual treatment—using FVO securities in both yield calculations and fair value measurements—means that fluctuations in market assumptions not only affect income volatility but also the sensitivity of the fair value of FVO securities, amplifying financial statement variability.",
      "llm_answer": "MetLife’s 2024 yield table notes that the “fixed‑maturity securities” line includes its FVO (fixed‑value‑obligation) securities, so the $205 million of investment income (loss) recorded for those securities is counted in the $13.1 billion of fixed‑maturity‑securities earnings and the FVO carrying balances are used in the average‑quarterly asset base that generates the 4.44 % yield. Because FVO securities are classified in Level 3, they are valued with matrix, consensus and offered‑quote pricing that rely on significant unobservable inputs; the same sensitivity ranges shown for other Level 3 assets (e.g., changes in offered quotes or default rates) therefore apply, making the reported investment income and the calculated yield more responsive to shifts in those inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $205 million investment income contribution from FVO securities in 2024, aligning with the ground truth. It accurately references the classification of FVO securities under Level 3 and their inclusion in yield calculations and average asset bases, which impacts the reported 4.44% yield. The mention of $13.1 billion in fixed-maturity-securities earnings is consistent with contextually derived figures from MetLife’s financials, though not explicitly stated in the original answer—this is a reasonable inference and does not contradict the ground truth. (2) All numeric values—$205 million, 4.44%, Level 3 classification—are factually correct and properly contextualized. Format variations (e.g., $205 million vs $205 million) are acceptable and semantically equivalent. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly links FVO inclusion in yield calculations to investment income, ties Level 3 classification to valuation techniques involving unobservable inputs, and explains how this affects income volatility and yield sensitivity. It accurately extends the sensitivity ranges (e.g., offered quotes, default rates) to FVO securities, consistent with Level 3 treatment. The only minor gap is that it does not explicitly name the specific unobservable inputs mentioned in the original answer (e.g., nonperformance risk spreads, long-term equity volatilities), instead referring more generally to 'offered quotes or default rates.' This slightly reduces qualitative precision but does not invalidate the reasoning. (4) The answer is highly contextually relevant, directly addressing how FVO inclusion affects both investment income and sensitivity to fair value changes. It synthesizes valuation techniques, financial impact, and yield implications coherently. The omission of specific input types is minor given the overall accuracy and completeness. Thus, the answer earns a 9/10 for correctness—excellent but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 546,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was the total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023, and how did these events relate to the Combat Arms Earplugs litigation?",
      "original_answer": "The total pre-tax financial impact on 3M from both the deconsolidation and reconsolidation of the Aearo Entities was $1.2 billion. This includes a $1.0 billion funding commitment plus $0.2 billion for projected case expenses related to the Combat Arms Earplugs litigation, which led to a pre-tax charge in 2022. The reconsolidation in 2023 had an immaterial income statement impact, but the overall litigation and settlement process directly triggered both events.",
      "llm_answer": "The 2022 de‑consolidation of the Aearo Entities was recorded in the third quarter of 2022, but 3M disclosed that the resulting charge “was not material to 3M.” When the entities were re‑consolidated in the second quarter of 2023, the company again said the income‑statement effect was “immaterial.” Thus, the combined pre‑tax financial impact of the de‑consolidation and the later reconsolidation was essentially negligible. Both moves were tied to the Combat‑Arms Earplugs litigation – the Aearo bankruptcy was used to stay the ear‑plug claims, and the reconsolidation followed the bankruptcy’s dismissal and set the stage for the 2023 CAE Settlement that ultimately resolved the ear‑plug lawsuits.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. The ground truth states the total pre-tax financial impact was $1.2 billion, comprising a $1.0 billion funding commitment and $0.2 billion for projected case expenses. The LLM incorrectly claims the impact was 'essentially negligible' and 'not material,' directly contradicting the $1.2 billion charge explicitly stated in the original answer. This is a major factual error. (2) The dates mentioned (Q3 2022 deconsolidation, Q2 2023 reconsolidation) are plausible and contextually consistent, but the financial figures are completely inaccurate. The LLM fails to report any dollar amounts and instead asserts immateriality, which contradicts the $1.2 billion charge. (3) The reasoning around the connection to the Combat Arms Earplugs litigation is partially correct — the deconsolidation was used to stay claims via Aearo's bankruptcy, and reconsolidation followed dismissal, leading to the 2023 settlement. This shows some correct multi-hop understanding of the litigation's role. However, the failure to recognize that the $1.2 billion charge was a direct result of these actions undermines the reasoning. (4) The contextual relevance is high because the answer addresses the right entities, timeline, and litigation context. However, the quantitative accuracy is extremely low due to the complete omission and contradiction of the key financial figure. The qualitative accuracy is modest because the narrative logic about the litigation linkage is sound, but the financial cause-and-effect is misrepresented. The correctness score is low because the answer fails on the primary factual requirement: the total pre-tax impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 467,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the integration of Adobe Firefly into Creative Cloud and Document Cloud contribute to Adobe's strategy of increasing recurring revenue and expanding its customer base, as evidenced by specific product offerings and AI-driven capabilities in fiscal 2023?",
      "original_answer": "Adobe Firefly, introduced in September 2023, is integrated into Creative Cloud apps such as Photoshop and Express, providing generative AI capabilities that enhance user engagement and attract new customers, including novice creators and communicators. This integration supports Adobe's strategy to increase recurring revenue by offering new features that justify subscription renewals and attract cost-sensitive users through targeted packages like Adobe Express and Substance 3D Collection. Additionally, Firefly's generative AI features are part of Adobe's broader AI-driven tools (e.g., Adobe Sensei), which improve Document Cloud's functionality, such as making PDFs more intelligent and responsive. These innovations help Adobe expand its customer base and drive long-term revenue growth through increased product value and user retention.",
      "llm_answer": "Adobe folded its generative‑AI engine, Firefly, into the core of both Creative Cloud and Document Cloud so that AI‑driven features—such as Firefly‑powered “generative fill,” text‑to‑image and text‑effects in Photoshop, Illustrator, Premiere Pro and the web‑based Express app, plus AI‑enhanced review, editing and “Liquid Mode” tools in Acrobat—are delivered as part of the subscription‑based cloud services【page_5†L13-L22】【page_37†L9-L15】.  By bundling these capabilities with existing apps, Adobe increases the functional value of each subscription, uses “Generative Credits” to boost usage and retention, and attracts first‑time creators and non‑professional users, which in fiscal 2023 helped lift Creative Cloud ARR to $12.37 billion and grow total Digital Media ARR 14 % to $15.17 billion while expanding the customer base through new‑user acquisition and upsell to higher‑value plans【page_38†L1-L8】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Adobe Firefly was integrated into Creative Cloud (Photoshop, Illustrator, Express) and Document Cloud (Acrobat), delivering generative AI features like 'generative fill', text-to-image, and Liquid Mode. These are subscription-based offerings that enhance product value, support recurring revenue, and attract new users, including non-professionals—directly supporting Adobe's strategy. (2) Quantitative accuracy is excellent: The LLM correctly cites Creative Cloud ARR of $12.37 billion and total Digital Media ARR growth of 14% to $15.17 billion in fiscal 2023. These figures match the ground truth context and are critical evidence of revenue impact. (3) Reasoning is sound: The model correctly synthesizes multi-hop information—linking Firefly’s integration → enhanced subscription value → increased user retention and acquisition → growth in ARR. It also identifies Generative Credits as a mechanism to drive engagement, which is consistent with Adobe’s monetization strategy. (4) The only minor shortcoming is that the LLM does not explicitly mention Adobe Sensei or Substance 3D Collection, which are part of the original answer and contribute to the broader AI and product strategy. However, the core strategic contribution—using AI to increase recurring revenue and expand the customer base—is thoroughly and accurately conveyed. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect, directly addressing all parts of the question with precise evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 440,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What is the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, and how does this value compare to the total fair value of all available-for-sale investments?",
      "original_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, is $4,335 million ($1,676 million + $2,659 million). This amount represents the full value of all available-for-sale investments, which also totals $4,335 million.",
      "llm_answer": "As of December 31 2022, Amgen’s fair‑value holdings were:\n\n* **U.S. Treasury bills:** $1,676 million  \n* **Money‑market mutual funds:** $2,659 million  \n\nTogether they total **$4,335 million**, which is exactly the same as the reported **total fair value of all available‑for‑sale investments** ($4,335 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All numeric values are accurate: $1,676 million for U.S. Treasury bills and $2,659 million for money market mutual funds, with their sum correctly calculated as $4,335 million. (2) The total fair value of these two investment types is correctly identified as equal to the total fair value of all available-for-sale investments, which is also $4,335 million—this matches the original answer exactly. (3) The multi-hop reasoning is sound: the model correctly synthesized that the sum of the two components equals the total available-for-sale investments, implying no other investment types exist in that category for Amgen as of that date. (4) All entities—Amgen, December 31, 2022, U.S. Treasury bills, money market mutual funds, and available-for-sale investments—are correctly identified and contextualized. Wording differs slightly but maintains full semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 283,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How do the valuation techniques for Unit-linked securities described in the MetLife 2024 10-K affect the sensitivity of fair value measurements to changes in long-term equity volatility and nonperformance risk spreads?",
      "original_answer": "The valuation techniques for Unit-linked securities at MetLife involve using long-term equity volatility and nonperformance risk spreads as significant unobservable inputs. According to the 10-K filing, long-term equity volatility affects the estimated fair value of these securities, especially when observable equity volatilities are not available beyond a certain period. Additionally, nonperformance risk spreads, which vary by duration and currency, are applied to discount cash flows for purposes of valuing market risk benefits (MRBs). As a result, changes in either of these inputs directly influence the fair value of Unit-linked securities, making them sensitive to shifts in long-term market expectations and credit risk assessments.",
      "llm_answer": "The fair‑value of the unit‑linked securities is derived with option‑pricing (e.g., Black‑Scholes) and present‑value methods that depend on unobservable inputs such as long‑term equity volatility and non‑performance risk spreads【page_248】. Because the same Level‑3 techniques are applied to unit‑linked and FVO securities, the sensitivity table shows that a higher assumed long‑term equity volatility pushes the estimated fair value **up** (weighted‑average impact ≈ +18 % in 2024) while a higher non‑performance risk spread pushes the estimated fair value **down** (weighted‑average impact ≈ ‑0.6 % in 2024)【page_249】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a detailed, factually correct response that aligns well with the ground truth. (1) It correctly identifies that long-term equity volatility and nonperformance risk spreads are key unobservable inputs in the valuation of Unit-linked securities, consistent with the original answer. The directional impacts—positive sensitivity to equity volatility and negative sensitivity to nonperformance risk spreads—are accurately described. (2) The quantitative details are precise: the +18% upward impact on fair value from higher long-term equity volatility and the -0.6% downward impact from higher nonperformance risk spreads match the sensitivity data reported in the MetLife 2024 10-K (pages 248–249). These numbers are correctly attributed and formatted. (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects valuation techniques (option pricing and present value) to Level 3 inputs, explains how these inputs affect fair value, and references the sensitivity analysis from the filing. The mention of Black-Scholes and application across unit-linked and FVO securities adds contextual depth not in the ground truth but is consistent with the source. (4) The only minor shortcoming is that the original answer emphasizes the structural role of these inputs in the absence of observable markets and their use in valuing market risk benefits (MRBs), which the LLM answer omits. While the directional and numerical impacts are well-covered, this slight lack of contextual elaboration on MRBs and discounting cash flows prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually excellent, directly responsive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 467,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does Adobe's introduction of Generative Credits in Adobe Firefly, as part of its Creative Cloud offering, support its broader strategy to increase customer engagement and subscription revenue across both creative professionals and non-creative stakeholders?",
      "original_answer": "Adobe introduced Generative Credits as part of Adobe Firefly within its Creative Cloud offering, allowing users to generate AI-based content after reaching a usage limit. These credits enhance the value of existing subscriptions and encourage continued engagement by offering a paid upsell option. This aligns with Adobe’s strategy to use product-led growth, infusing AI into creative apps like Photoshop and Illustrator to make workflows more efficient and accessible. By integrating Firefly’s generative AI capabilities into widely used tools and offering tiered access (free and premium), Adobe expands its customer base beyond traditional creative professionals to include communicators, marketers, and other stakeholders involved in content creation and approval. This drives higher engagement, conversion, and retention, directly supporting Adobe’s goal of increasing recurring subscription revenue and deepening customer relationships.",
      "llm_answer": "Adobe built “Generative Credits” into the Firefly web app and the paid Creative Cloud plans as a token‑based allowance that lets any subscriber instantly generate images, text effects or design templates with AI prompts.  By bundling these credits with Creative Cloud subscriptions, Adobe adds measurable, usage‑driven value to its existing plans, encourages more frequent product interaction and upsell opportunities, and extends the appeal of Creative Cloud beyond traditional designers to marketers, communicators and other non‑creative stakeholders who need AI‑generated content—thereby driving higher engagement, retention and recurring subscription revenue. 【page_5†L19-L24】【page_10†L1-L5】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. It correctly identifies Generative Credits as a token-based system within Adobe Firefly, tied to Creative Cloud subscriptions, and explains their role in driving engagement and upsell opportunities. The answer accurately captures Adobe's strategy to expand beyond creative professionals to marketers and communicators by lowering barriers to content creation via AI, thus increasing subscription revenue and retention. All entities (Adobe, Firefly, Creative Cloud), product mechanics (token-based credits, AI generation), and strategic goals (engagement, revenue, expansion to non-creative users) are correctly represented. There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10. The only minor gap is that the LLM answer does not explicitly mention the 'free and premium tiered access' model or the integration of Firefly into specific apps like Photoshop and Illustrator, which are part of the multi-hop reasoning in the original. However, the omission does not undermine the overall correctness. Semantic equivalence is strong, and the response is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 346,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does the integration of Gemini 2.0 across Google's billion-user products and Vertex AI platform contribute to Google Cloud's ability to generate revenue from AI-optimized infrastructure and developer services?",
      "original_answer": "Gemini 2.0 powers AI features across all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—enhancing user experiences and increasing engagement. This widespread integration supports Google's broader ecosystem, which in turn drives demand for Google Cloud's AI-optimized infrastructure and Vertex AI platform. Google Cloud offers Gemini through Vertex AI, enabling developers to train, tune, and deploy applications using advanced generative AI models. This provides scalable AI solutions for enterprises and developers, which directly contributes to Google Cloud's revenue through consumption-based fees and subscriptions for infrastructure and platform services.",
      "llm_answer": "Integrating Gemini 2.0 into all seven of Google’s two‑billion‑user products (Android, Chrome, Gmail, Maps, Play Store, Search and YouTube) demonstrates the model’s capabilities at massive scale and creates a built‑in demand for the same AI‑power‑on‑Google‑Cloud infrastructure. That demand is captured through Google Cloud’s AI‑optimized infrastructure (e.g., TPUs and scalable compute) and its Vertex AI developer platform, which lets customers train, tune and deploy Gemini‑based applications, generating consumption‑based fees and subscription revenue for the cloud business【page_6†L9-L15】【page_8†L1-L7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 'seven' Google products and 'two-billion-user' scale are accurately stated, matching the original answer. There are no calculations, so numerical precision is fully maintained. (2) The LLM correctly identifies the key products (Android, Chrome, Gmail, Maps, Play Store, Search, YouTube) and links Gemini 2.0's integration to demand for Google Cloud’s AI infrastructure and Vertex AI platform. (3) The reasoning is sound: it traces the multi-hop logic from consumer product integration → demonstration of scale → increased demand for cloud infrastructure → revenue via consumption and subscriptions. The only minor shortcoming is that the LLM does not explicitly mention developers using Vertex AI to build enterprise applications, slightly reducing completeness in describing the developer services revenue stream. (4) Despite this, the core mechanisms of revenue generation (consumption-based fees, subscriptions) are correctly identified, and the contextual relevance is excellent. Semantic equivalence is strong, with only slight variation in emphasis. No factual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 338,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How do changes in prepayment and default rates impact MetLife's income recognition on FVO securities, and what unobservable inputs further influence the valuation of these securities?",
      "original_answer": "Changes in prepayment and default rates directly impact MetLife's income recognition on FVO securities, as income on these securities is dependent on such factors. Additionally, unobservable inputs such as long-term equity volatilities and nonperformance risk spreads are used in the valuation of FVO securities, which affect their fair value and, consequently, the financial statement presentation.",
      "llm_answer": "MetLife explains that the income it records on Fixed‑Value‑Obligation (FVO) securities is driven by the cash‑flow assumptions in the fair‑value model; higher pre‑payment speeds or higher default rates reduce the expected cash‑flows from the securities and therefore lower the amount of income recognized, while lower pre‑payments or defaults increase the recognized income.  The fair‑value of these Level‑3 FVO securities is further affected by a range of significant unobservable inputs—including offered or quoted price quotes, swap‑yield curves used for discounting, assumptions about loss‑severity, mortality, lapse, utilization and withdrawal rates, long‑term equity volatility and non‑performance risk spreads—which together shape the valuation of the securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly explains that changes in prepayment and default rates affect income recognition on FVO securities by altering expected cash flows, which directly impacts income under the fair value model—this matches the original answer's assertion that income is dependent on these factors. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the question or the original answer, so quantitative accuracy is not applicable; however, the absence of incorrect numbers supports a perfect score. (3) The LLM correctly identifies unobservable inputs influencing FVO valuation, including long-term equity volatility and non-performance risk spreads—both explicitly mentioned in the ground truth. It goes further by listing additional unobservable inputs (e.g., loss severity, mortality, lapse rates), which are consistent with Level 3 fair value disclosures in MetLife’s 10-Ks and do not contradict the original answer. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects prepayment/default dynamics to cash flow assumptions, links those to income recognition, and integrates unobservable inputs into the fair value framework. The only minor point reducing qualitative accuracy slightly is the expansion beyond the specific inputs named in the ground truth, which, while accurate, introduces elements not confirmed in the source. However, this does not detract from correctness. Overall, the answer is semantically equivalent, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 434,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does Costco's investment in Kirkland Signature products influence its gross margin performance, considering the brand's role in member loyalty and the risks associated with its production and availability?",
      "original_answer": "Costco's investment in Kirkland Signature products positively influences its gross margin performance because these private-label items generally carry higher margins than national brand products and represent a growing portion of overall sales. However, this margin benefit is contingent on maintaining consistent product quality, competitive pricing, and availability. If the Kirkland Signature brand experiences a loss of member acceptance or confidence, or if there are disruptions in production and delivery, Costco's sales and gross margin results could be adversely affected due to reduced member loyalty and potential out-of-stock situations.",
      "llm_answer": "Costco’s heavy investment in its private‑label Kirkland Signature line is a key driver of gross‑margin strength because Kirkland items “generally earn higher margins” than national brands and, by offering high quality at lower prices, they deepen member loyalty and increase sales penetration ( p. 7 & p. 10 ). At the same time, the company warns that “maintaining consistent product quality, competitive pricing, and availability” of Kirkland goods is essential—any loss of member confidence or supply‑chain disruption could reduce sales and depress gross‑margin results ( p. 10 ).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies that Kirkland Signature products contribute positively to gross margin due to higher margins compared to national brands, which aligns with the ground truth. It also accurately notes the role of these products in enhancing member loyalty and sales penetration. (2) There are no numeric values (e.g., percentages, dollar amounts, years) in either the original or LLM answer, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM synthesizes the financial benefit (higher margins) with strategic risks (quality, availability, member confidence), correctly linking private-label performance to both profitability and operational risks. (4) The LLM cites specific page references (p. 7, p. 10), suggesting proper grounding in source material, and captures all key elements: margin advantage, member loyalty, dependency on quality/availability, and potential adverse impacts from disruptions or loss of confidence. Wording differs slightly but meaning is preserved with high fidelity. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 332,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the change in the fair value of 'Other short-term interest-bearing securities' from December 31, 2022, to December 31, 2023, and how does this shift reflect in the total available-for-sale investments for those respective years?",
      "original_answer": "The fair value of 'Other short-term interest-bearing securities' increased from $0 on December 31, 2022, to $138 million on December 31, 2023. This increase contributed to a rise in total available-for-sale investments from $4,335 million in 2022 to $10,404 million in 2023, reflecting a significant growth of $6,069 million in the company's short-term investment portfolio.",
      "llm_answer": "The fair‑value of “Other short‑term interest‑bearing securities” rose from **$0 million in 2022 (no balance reported) to $138 million in 2023**, an increase of **$138 million**.  That addition is reflected in the overall available‑for‑sale portfolio, whose fair‑value total grew from **$4,335 million at year‑end 2022 to $10,404 million at year‑end 2023**, a net increase of about **$6.07 billion**, of which the $138 million gain in other short‑term securities is a component.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value of 'Other short-term interest-bearing securities' correctly increases from $0 million in 2022 to $138 million in 2023. The total available-for-sale investments are accurately reported as $4,335 million in 2022 and $10,404 million in 2023, with an implied increase of $6,069 million, which the model correctly rounds to $6.07 billion (equivalent to $6,070 million, acceptable rounding). (2) The answer addresses both parts of the multi-part question: the change in the specific security class and its reflection in the total available-for-sale investments. (3) Entity accuracy is correct—time periods (December 31, 2022, and December 31, 2023) and financial terms ('fair value', 'available-for-sale investments') are properly used. (4) The reasoning is sound and demonstrates correct multi-hop synthesis: it links the $138 million increase in a subcategory to the overall portfolio growth, acknowledging it as a component of the larger change. (5) Semantic equivalence is maintained—though wording differs slightly (e.g., 'no balance reported', 'about $6.07 billion'), the factual content and meaning align perfectly with the original answer. No errors in logic, calculation, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 369,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, influence the quantitative valuation of PMI’s investment in RBH as of December 31, 2024, and what was the resulting impairment charge recorded in the consolidated statement of earnings?",
      "original_answer": "Developments in the Proposed Plan, including RBH's objection filed on January 24, 2025, narrowed the range of possible outcomes regarding the allocation of the CAD 32.5 billion aggregate global settlement amount among RBH, ITL, and JTIM. This narrowing of outcomes served as an indicator that PMI's investment in RBH may be impaired. As a result, PMI performed a quantitative valuation of its investment in RBH as of December 31, 2024, using a discounted cash flow analysis that incorporated significant assumptions such as discount rate, sales volumes, and operating margins for the combustible tobacco business in Canada, as well as estimates regarding the allocation of the settlement amount and its tax deductibility. This valuation concluded that the fair value of PMI’s investment in RBH was $714 million, significantly lower than its carrying value, leading to a non-cash impairment charge of $2,316 million recorded in the consolidated statement of earnings for the year ended December 31, 2024.",
      "llm_answer": "The filing of RBH’s objection to the Proposed Plan on January 24 2025, together with other parties’ positions that narrowed the possible allocation of the CAD 32.5 billion settlement, signaled that PMI’s 49 % equity investment in RBH might be impaired.  PMI therefore performed a quantitative discounted‑cash‑flow valuation of the investment as of December 31 2024, concluding that its fair value was only $714 million—well below its carrying amount—so it recorded a non‑cash impairment charge of **$2.316 billion** in the consolidated statement of earnings for the year ended December 31 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: RBH's objection on January 24, 2025, the CAD 32.5 billion settlement amount, the narrowing of possible outcomes leading to impairment indicators, PMI's quantitative valuation as of December 31, 2024, the use of discounted cash flow analysis (implied in 'quantitative discounted-cash-flow valuation'), the fair value of $714 million, and the non-cash impairment charge of $2.316 billion (equivalent to $2,316 million). (2) Quantitative accuracy is perfect: $2.316 billion = $2,316 million (format variation accepted), and the date December 31, 2024, is correctly used as the valuation date. The impairment charge is correctly tied to the difference between carrying value and fair value. (3) Multi-hop reasoning is sound: the answer correctly links RBH’s objection to increased uncertainty resolution, which triggered an impairment assessment, leading to a valuation and resulting charge—this reflects proper synthesis across events, entities (PMI, RBH), and financial reporting. (4) The answer addresses all parts of the question: the influence of developments on valuation and the resulting impairment charge. While slightly more concise than the original, it retains all critical information without omissions that affect meaning. Entities (PMI, RBH), dates, and financial terms are accurate. Thus, all scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 396,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "Given the increase in advertising revenues from Google Network properties and the expectation that TAC paid to Google Network partners will increase as revenues grow, how much would the absolute dollar amount of TAC paid to Google Network partners increase if advertising revenues from Google Network properties grew by $10 billion in 2023 compared to 2022, assuming the TAC rate remained constant at 22% as indicated in the filing?",
      "original_answer": "$2.2 billion",
      "llm_answer": "If advertising revenues from Google Network properties rise by $10 billion and the TAC rate stays at 22 %, the additional TAC paid to Google Network partners would be:\n\n\\(10 \\text{billion} \\times 22\\% = 2.2 \\text{billion dollars}\\).\n\nSo the absolute dollar amount of TAC paid would increase by roughly **$2.2 billion**.【page_30】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The quantitative calculation is accurate: $10 billion increase in revenue multiplied by a constant TAC rate of 22% yields $2.2 billion, which matches the original answer exactly. Minor formatting differences (e.g., '2.2 billion' vs '$2.2 billion') do not affect correctness. (2) The answer addresses all parts of the question: it identifies the revenue increase, applies the correct TAC rate from the filing, and computes the resulting increase in TAC payments. (3) Entity accuracy is correct—refers to Google Network properties, TAC paid to Google Network partners, and the 22% rate as stated in the filing. (4) The reasoning is sound and demonstrates proper multi-hop synthesis: it connects the expected revenue growth with the contractual obligation to pay TAC at a fixed rate, assuming constancy as specified. The inclusion of a citation placeholder [page_30] suggests grounding in the source document. Overall, the answer is factually accurate, complete, and logically coherent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 299,
        "total_tokens": 1455
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023, to December 31, 2024, and how does this compare to the change in fair value over the same period?",
      "original_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by $14,155 million from $61,449 million in 2023 to $75,604 million in 2024. The fair value increased by $10,714 million from $59,851 million in 2023 to $70,565 million in 2024. This indicates that the carrying value increased more significantly than the fair value over the same period.",
      "llm_answer": "UnitedHealth’s long‑term debt and other financing obligations rose from **$61.449 billion** at 12/31/2023 to **$75.604 billion** at 12/31/2024 – an increase of **≈ $14.2 billion**.  The same obligations’ fair value grew from **$59.851 billion** to **$70.565 billion**, a rise of **≈ $10.7 billion**.  Thus, the carrying amount grew about **$3.5 billion** more than the fair‑value increase over the year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the carrying value increased from $61,449 million to $75,604 million, a difference of $14,155 million (~$14.2 billion), and the fair value increased from $59,851 million to $70,565 million, a difference of $10,714 million (~$10.7 billion). The LLM correctly rounds these figures appropriately (e.g., $14.2 billion ≈ $14,155 million). (2) Calculations are accurate: $75,604 - $61,449 = $14,155 million; $70,565 - $59,851 = $10,714 million. The difference in growth ($14.2B - $10.7B ≈ $3.5B) is correctly inferred. (3) Multi-hop reasoning is sound: the model synthesizes data across two time points and two valuation methods (carrying value vs. fair value), correctly comparing their changes. (4) Entities are accurate: UnitedHealth Group, long-term debt and other financing obligations, correct years (2023 to 2024), and proper financial terms. (5) The answer fully addresses both parts of the question: the change in carrying value, the change in fair value, and their comparison. Wording differs slightly but meaning is preserved. No factual, numerical, or logical errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 338,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in merchant transaction costs in 2022, and how does this relate to the overall growth in merchant revenues compared to agency revenues?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs in 2022. This significant rise in transaction costs indicates strong growth in merchant activity, which aligns with the observation that merchant revenues increased more than agency revenues during the same period. The growth in merchant revenues was driven by the expansion of these services, reflecting stronger demand and operational scale in the merchant model compared to the agency model.",
      "llm_answer": "The expansion of merchant‑accommodation reservation services added roughly **$573 million** to Booking.com’s merchant transaction costs in 2022.  That same expansion helped merchant revenues jump **about 94.6 %** (to $7.2 billion) versus a **35.1 %** rise in agency revenues (to $9.0 billion), indicating that merchant‑side growth was far stronger than the agency side.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $573 million increase in merchant transaction costs due to the expansion of merchant accommodation services at Booking.com in 2022, which matches the ground truth. However, it introduces two specific percentage figures—94.6% growth in merchant revenues (to $7.2 billion) and 35.1% growth in agency revenues (to $9.0 billion)—that are not present in the original answer and cannot be verified from the provided ground truth. These numbers appear to be hallucinated or sourced from external data not in the knowledge graph. (2) While the $573 million figure is accurate, the additional quantitative claims about revenue growth rates and absolute revenue values lack support in the original answer, significantly undermining quantitative accuracy. The original answer only states that merchant revenues increased more than agency revenues, without specific percentages or final revenue amounts. (3) The reasoning is partially sound: the LLM correctly infers stronger merchant-side growth and links rising transaction costs to increased merchant activity. It attempts multi-hop synthesis by connecting cost increases to revenue trends, which aligns with the original logic. However, the unsupported numerical precision weakens the reasoning chain. (4) Contextual relevance is high because the answer addresses both parts of the question—contribution to transaction costs and comparison of merchant vs. agency revenue growth—though with overreach in specificity. The qualitative accuracy is moderate because entity identification (Booking.com, merchant vs. agency models) and conceptual understanding are correct, but the addition of unverified metrics reduces reliability. Overall, the answer gets the key fact right but adds incorrect quantitative details, leading to a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 499,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the significance of AMD introducing Zynq UltraScale+ RFSoCs in the context of its FPGA and Adaptive SoC product lines, and how does this introduction align with AMD's broader strategy to serve markets requiring high-performance RF data conversion capabilities?",
      "original_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs is significant because it expands the company's FPGA and Adaptive SoC portfolio to target specialized markets such as wireless communications, radar, and cable access, which demand high-performance RF data converters. This aligns with AMD's broader strategy to offer adaptable platforms that combine hardware acceleration with domain-specific customization, enabling faster time-to-market for customers. By integrating RF data converters directly into the SoC architecture, AMD enhances its value proposition for embedded systems requiring real-time control, sensor fusion, and analytics, thereby strengthening its position in high-growth sectors like aerospace, defense, and communication infrastructure.",
      "llm_answer": "AMD’s introduction of the Zynq UltraScale+ RFSoC adds a new tier to its Adaptive SoC family that combines the programmable fabric of its FPGAs with on‑chip, high‑performance RF data‑converter blocks (ADCs/DACs) 【page_11】. By positioning the RFSoC alongside its traditional Zynq‑7000, UltraScale+ MPSoC and Versal devices 【page_12】, AMD extends the FPGA/Adaptive SoC portfolio into markets such as wireless communications, radar and cable‑access that demand integrated, high‑speed RF conversion, thereby reinforcing its broader strategy to supply differentiated, end‑to‑end solutions for high‑performance RF‑centric applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Zynq UltraScale+ RFSoCs integrate high-performance RF data converters (ADCs/DACs) into the Adaptive SoC architecture, targeting markets like wireless communications, radar, and cable access. The positioning alongside Zynq-7000, UltraScale+ MPSoC, and Versal is correctly noted, aligning with AMD's strategy to deliver differentiated, high-performance solutions. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the product's technical integration (RF converters + SoC) with strategic market expansion and portfolio alignment. It accurately reflects AMD’s intent to serve RF-centric applications through adaptable platforms. (4) The only minor shortcoming is that the LLM answer omits explicit mention of 'aerospace, defense, and communication infrastructure' as high-growth sectors and does not reference 'real-time control, sensor fusion, and analytics'—details present in the original that add contextual depth. However, these omissions do not detract from the core correctness. The answer remains semantically equivalent in intent and substance, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 391,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total carrying value of UnitedHealth Group's debt securities - held-to-maturity for both 2023 and 2024 combined, and how does this compare to the total fair value of those securities in those years?",
      "original_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is $1,115 million ($603 million in 2023 + $512 million in 2024). The total fair value for the same periods is $1,104 million ($596 million in 2023 + $508 million in 2024), resulting in a $11 million unrealized loss when comparing combined carrying value to combined fair value.",
      "llm_answer": "UnitedHealth Group reported held‑to‑maturity debt securities with a **carrying value of $512 million in 2024 and $603 million in 2023**, for a **combined carrying amount of $1.115 billion**.  \nThe **fair value of those securities was $508 million in 2024 and $596 million in 2023**, totaling **$1.104 billion**.  \n\nThus, the combined carrying value exceeds the combined fair value by roughly **$11 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: carrying values of $603 million (2023) and $512 million (2024) sum to $1,115 million ($1.115 billion), and fair values of $596 million (2023) and $508 million (2024) sum to $1,104 million ($1.104 billion). The difference of $11 million is correctly calculated. (2) The answer addresses both parts of the question: total carrying value for 2023 and 2024 combined, and comparison to total fair value. (3) Entities are correct—UnitedHealth Group, held-to-maturity debt securities, and the years 2023 and 2024 are properly identified. (4) The multi-hop reasoning—aggregating values across two years and comparing carrying value to fair value to determine unrealized loss—is sound and clearly explained. (5) Semantic equivalence is maintained: formatting variations like $1.115 billion vs $1,115 million are acceptable and convey the same meaning. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 291,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in sales and other expenses in 2022, and how does this relate to the growth in merchant gross bookings?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs, which is a key component of the overall increase in sales and other expenses in 2022. This growth in merchant transaction costs was driven by the expansion of merchant accommodation reservation services, which also directly supported the greater increase in merchant gross bookings compared to agency gross bookings during the same period.",
      "llm_answer": "The expansion of merchant‑accommodation reservation services added roughly **$573 million** of merchant‑transaction costs to “sales and other expenses” in 2022 (see the discussion of the $573 million increase on page 52). That expense increase occurred alongside a **108.4 % jump in merchant gross bookings**, which rose from $25.8 billion in 2021 to $53.9 billion in 2022 – an increase of about **$28 billion** (page 50).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $573 million increase in merchant transaction costs is accurately cited, and the merchant gross bookings increase from $25.8 billion in 2021 to $53.9 billion in 2022 is correctly calculated as a ~$28 billion increase and a 108.4% growth rate. These figures match the expected data and are properly contextualized within the 2022 fiscal year. (2) The answer addresses both parts of the question: it identifies the $573 million contribution to sales and other expenses via merchant transaction costs and links this to the growth in merchant gross bookings. (3) Entity accuracy is strong—Booking.com, merchant accommodation services, merchant gross bookings, and the correct time frame (2022) are all properly referenced. (4) The reasoning is sound and reflects multi-hop synthesis: it connects the expansion of services to increased costs and ties that cost increase to the surge in gross bookings, which is consistent with the ground truth’s implication of a causal relationship. The only minor shortcoming is that the original answer emphasizes that the merchant gross bookings grew more than agency bookings, which the LLM omits. While not critical, this comparative context slightly enriches the qualitative explanation. Overall, the answer is factually excellent, well-supported, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 395,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total value of the crypto asset safeguarding asset and corresponding liability reported by PayPal as of December 31, 2023, and how does this reflect the company's involvement in crypto-related financial activities?",
      "original_answer": "PayPal reported a crypto asset safeguarding asset of $1,241 million and a corresponding crypto asset safeguarding liability of $1,241 million as of December 31, 2023. This indicates that PayPal holds crypto assets on behalf of its customers and records an equal liability to reflect its obligation to safeguard these assets, showing its active participation in crypto-related financial services.",
      "llm_answer": "As of December 31 2023 PayPal reported a **crypto‑asset safeguarding asset of $1.241 billion** and an equal **crypto‑asset safeguarding liability of $1.241 billion** (​page 92). Together they represent roughly **$2.48 billion** of balance‑sheet items, showing that PayPal is actively custodial‑holding crypto assets for its users and records a matching liability – a clear indication of the company’s involvement in crypto‑related financial activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly reports the crypto-asset safeguarding asset and liability as $1.241 billion each, matching the ground truth of $1,241 million (equivalent values, different units). The date (December 31, 2023) and entity (PayPal) are accurate. The mention of page 92 adds sourcing but does not affect accuracy. 2) Quantitatively, all numbers are correct: $1.241 billion = $1,241 million, and the sum of $2.48 billion (i.e., $1.241B + $1.241B) is accurately calculated. No errors in figures or conversions. 3) The reasoning is sound: the model correctly interprets that equal asset and liability reflect custodial activity and ties this to PayPal's involvement in crypto services. It synthesizes the balance sheet impact and implications appropriately, though it adds 'custodial-holding' which is slightly more specific than the original but still accurate. 4) The answer is semantically equivalent and fully addresses both parts of the question: total value (via individual components and implied total) and interpretation of PayPal's crypto involvement. The only minor deviation is the phrasing 'together they represent roughly $2.48 billion of balance-sheet items,' which is technically correct but not part of the original answer; however, this addition does not introduce error. Thus, high scores across all categories with a 9 in correctness due to slight rephrasing and extra detail not in the original, but no factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 397,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do the aircraft impairment charges recorded by FedEx in 2023 and 2024 reflect the company's Network 2.0 optimization strategy, and what is the cumulative financial impact of these charges on the DRIVE transformation program through 2024?",
      "original_answer": "The aircraft impairment charges of $70 million in 2023 and $157 million in 2024 reflect FedEx's strategic decision to modernize its fleet and align air network capacity with current and anticipated shipment volumes, as part of the broader Network 2.0 optimization initiative. These charges resulted from the permanent retirement of older aircraft models, including Boeing MD-11F, Boeing 757-200, and Airbus A300-600 aircraft, to support more efficient operations under the DRIVE program. The DRIVE program also includes $582 million in business optimization costs incurred in 2024 alone, bringing the total cumulative optimization-related costs (including impairment charges) to $839 million through 2024, demonstrating the significant financial investment FedEx is making to implement Network 2.0 and improve long-term profitability.",
      "llm_answer": "The $70 million non‑cash aircraft impairment recorded in 2023 and the $157 million impairment recorded in 2024 were taken to permanently retire older Boeing MD‑11F, 757‑200 and Airbus A300‑600 aircraft and their engines so that FedEx Express can modernize its fleet, improve its global network and better match capacity to current and anticipated shipment volumes – a core element of the Network 2.0 optimization effort described in the DRIVE transformation plan【page_55】. Together, these two charges represent a cumulative $227 million of non‑cash impairment expense that is included in the DRIVE‑related operating costs through 2024【page_56】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the aircraft impairment charges of $70 million in 2023 and $157 million in 2024, and accurately links them to the retirement of specific aircraft models (Boeing MD-11F, 757-200, Airbus A300-600) as part of the Network 2.0 optimization under the DRIVE program. The cumulative impairment charge of $227 million ($70M + $157M) is correctly calculated and reported. However, the LLM omits the $582 million in business optimization costs incurred in 2024, which are part of the DRIVE program and critical to computing the total cumulative financial impact of $839 million through 2024. This omission significantly affects completeness and overall correctness. (2) Quantitative accuracy is high: all individual figures ($70M, $157M, and their sum) are correct, and the years are accurate. The only missing number is the $582M in 2024 business optimization costs, which prevents full quantitative completeness. (3) The reasoning is sound in connecting aircraft retirements to Network 2.0 and DRIVE, and the multi-hop synthesis between impairment charges and strategic fleet modernization is well-executed. However, the failure to incorporate the additional $582M in costs shows incomplete synthesis across all components of the DRIVE program, weakening the qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing the relationship between impairment charges and strategic goals, and citing specific document pages. The main shortcoming is the incomplete financial picture, which limits the depth of the response despite correct reasoning and partial data accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 447,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, and how much did the gross unrealized losses on these obligations increase from December 31, 2023, to December 31, 2024?",
      "original_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is $3,627 million. The gross unrealized losses on these obligations increased by $40 million, from $234 million in 2023 to $274 million in 2024.",
      "llm_answer": "- The combined fair‑value of UnitedHealth’s U.S. government and agency obligations (available‑for‑sale $4.327 billion plus held‑to‑maturity $0.442 billion) was **about $4.77 billion** as of December 31 2024.  \n\n- Gross unrealized losses on these obligations rose from **$240 million** at year‑end 2023 to **$276 million** at year‑end 2024 – an increase of **approximately $36 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The total fair value is reported as $4.77 billion, whereas the ground truth is $3,627 million ($3.627 billion), a difference of over $1.1 billion. This major discrepancy suggests incorrect sourcing or miscalculation. Additionally, the LLM reports gross unrealized losses increasing from $240 million in 2023 to $276 million in 2024 (an increase of $36 million), while the ground truth states they increased from $234 million to $274 million—an increase of $40 million. Both the starting/ending values and the calculated difference are incorrect. (2) Calculations: The LLM’s implied sum of $4.327B + $0.442B = $4.769B is mathematically correct, but the components do not align with ground truth data, making the result factually wrong. The increase in unrealized losses ($276M - $240M = $36M) is correctly computed based on its own numbers, but the inputs are inaccurate. (3) Multi-hop reasoning: The model attempts to synthesize across categories (available-for-sale and held-to-maturity) and years, which shows correct qualitative intent, but the underlying data is incorrect, leading to flawed conclusions. It correctly identifies UNH and the relevant time frame (December 31, 2023 and 2024), showing proper entity and temporal alignment. (4) Scores justified: Correctness is low (3/10) due to major numerical errors in both parts of the answer. Quantitative accuracy is poor (3/10) because all core financial figures are incorrect. Qualitative accuracy is moderate (4/10) as the structure and reasoning approach are sound, but based on wrong data. Contextual relevance is high (8/10) because the answer addresses the right entities, metrics, and time periods, just with incorrect values.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 483,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the 54% merchant basis transaction mix in 2023 and the associated increase in merchant-related expenses impact Booking.com's operating margins compared to 2022, and what were the key cost components contributing to this effect?",
      "original_answer": "The increase in merchant basis transaction mix from 44% in 2022 to 54% in 2023 led to higher merchant-related expenses, which negatively impacted Booking.com's operating margins despite associated incremental revenues. Key cost components included personnel expenses, payment processing fees, and chargebacks (including those related to fraud), all of which are recorded in 'Personnel' expenses and 'Sales and other expenses' in the Consolidated Statements of Operations. This shift toward a greater proportion of business conducted on a merchant basis resulted in additional costs that outweighed the benefits of increased revenues such as payment card rebates, thereby compressing operating margins.",
      "llm_answer": "The share of Booking.com’s gross‑bookings that were processed on a merchant basis rose from 44 % in 2022 to 54 % in 2023.  Because a merchant‑basis transaction requires Booking.com to front‑end payment‑processing, handle charge‑backs and fraud, and support the extra back‑office work, the company recorded higher “personnel” costs and higher “sales and other expenses” that are specifically tied to those merchant‑related activities.  Those incremental merchant‑related expenses outweighed the incremental merchant‑revenues, so operating margins were lower in 2023 than they were in 2022.  The primary cost drivers of the margin pressure were personnel expenses for the additional payment‑operations staff, payment‑processing fees, and charge‑back/fraud‑related costs that are booked under “personnel” and “sales and other expenses.”",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the merchant basis transaction mix increased from 44% in 2022 to 54% in 2023, which led to higher expenses that negatively impacted operating margins. (2) Quantitative accuracy is perfect: percentages (44%, 54%) match exactly, and no calculations are required beyond these reported figures. (3) The multi-hop reasoning is sound—LLM correctly links the shift in business mix to increased operational costs (personnel, payment processing, chargebacks/fraud), identifies the relevant expense categories in the financial statements ('Personnel' and 'Sales and other expenses'), and explains that these incremental costs outweighed the associated revenue benefits, leading to margin compression. (4) The answer fully addresses all parts of the question: impact on operating margins, comparison between 2022 and 2023, and key cost components. Wording differs slightly but conveys identical meaning. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 296,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' and the subsequent change in fair value measurement methodology impact PayPal's financial statements in 2024, particularly in terms of asset valuation and income recognition?",
      "original_answer": "The reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' led to a change in valuation methodology from an unobservable price-based model to one using observable inputs such as executed prices for comparable loans sold to the global investment firm. This reclassification caused these assets to be classified within Level 2 in the fair value hierarchy starting in Q1 2024, improving transparency and reliability of valuation. Additionally, any previously recorded allowance for credit losses was reversed, decreasing transaction and credit losses in 2023. In 2024, valuation changes and charge-offs for these held-for-sale loans were recorded in 'restructuring and other' on the consolidated statements of income (loss), directly impacting income recognition.",
      "llm_answer": "When PayPal re‑classified the eligible consumer‑installment portfolio to **Loans and interest receivable, held for sale**, it derecognised the related allowance for credit losses, eliminating the associated transaction‑and‑credit‑loss expense that had been recorded in prior periods.  Beginning in 2024 the company also changed the fair‑value measurement of those held‑for‑sale loans from a price‑based, unobservable‑input model (Level 3) to an observable‑input model using recent transaction prices (Level 2), which reduced the reported balance to about **$541 million** (down from $563 million in 2023) and caused any valuation adjustments to be booked in the “restructuring and other” line of the income statement, thereby impacting earnings for 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core financial impact of PayPal's reclassification and change in fair value methodology accurately and addresses both asset valuation and income recognition as required. It correctly identifies the shift from Level 3 (unobservable inputs) to Level 2 (observable inputs) in the fair value hierarchy, which improves transparency—this aligns with the ground truth. It also correctly states that the allowance for credit losses was derecognized, reducing prior-period expenses, and that valuation changes are now recorded in 'restructuring and other' on the income statement, affecting 2024 earnings.\n\nHowever, there are quantitative inaccuracies: the LLM claims the reclassified loan balance decreased from $563 million in 2023 to $541 million in 2024. This specific numerical comparison is not present in the ground truth, and no dollar amounts were provided in the original answer. Introducing these figures—while possibly derived from external data—cannot be verified against the provided ground truth and thus constitutes a factual overreach. The ground truth does not mention any specific balance amounts or a reduction due to the revaluation, so including them reduces quantitative accuracy.\n\nQualitatively, the reasoning is strong: the multi-hop synthesis of reclassification, valuation methodology change, hierarchy re-leveling, derecognition of allowances, and income statement impact is correct and logically presented. The use of 'restructuring and other' as the income statement line item matches the ground truth. Contextual relevance is perfect—the response directly addresses the question’s focus on asset valuation and income recognition impacts in 2024. Minor deduction in correctness due to unsupported numbers, but overall a high-quality, semantically aligned answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 490,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total combined borrowing capacity in USD from both the newly established €1.5 billion credit facility and the existing short-term credit arrangements as of December 31, 2024, and how does this compare to the borrowing capacity from short-term credit arrangements as of December 31, 2023?",
      "original_answer": "The total combined borrowing capacity as of December 31, 2024, from the newly established €1.5 billion (approximately $1.6 billion) credit facility and the existing short-term credit arrangements of $2.1 billion was $3.7 billion. This represents a decrease compared to the $2.7 billion in short-term credit arrangements available as of December 31, 2023.",
      "llm_answer": "At December 31 2024 PMI could draw the full €1.5 billion senior unsecured revolving facility – roughly **$1.6 billion** – plus its existing short‑term credit arrangements of about **$2.1 billion**, giving a total borrowing capacity of **approximately $3.7 billion**.  By contrast, the short‑term credit arrangements alone were **about $2.7 billion** at December 31 2023, so the 2024 combined capacity is roughly **$1.0 billion higher** than the 2023 short‑term capacity.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the €1.5 billion credit facility and converts it to approximately $1.6 billion, and correctly states the existing short-term credit arrangements as $2.1 billion in 2024, leading to a total combined capacity of $3.7 billion. These figures match the ground truth. However, the LLM incorrectly states that the 2024 combined capacity ($3.7 billion) is $1.0 billion higher than the 2023 short-term capacity ($2.7 billion), which is factually wrong—the correct comparison is that $3.7 billion is actually $1.0 billion *higher*, but the ground truth states this represents a *decrease*, implying the LLM has misinterpreted the direction of the change. This is a critical error in reasoning and factual accuracy. (2) Numeric values are accurate: €1.5B ≈ $1.6B, $2.1B (2024 short-term), $2.7B (2023 short-term), sum $3.7B—all correct. The calculation of the difference ($3.7B - $2.7B = $1.0B) is mathematically correct, but the conclusion drawn (‘higher’) contradicts the ground truth which states the total capacity is a decrease, suggesting either a data conflict or misinterpretation. Given the ground truth explicitly says ‘this represents a decrease’, the LLM’s assertion of an increase cannot be correct. (3) Multi-hop reasoning is partially sound—information is synthesized across two time points and two credit sources—but the final comparative analysis is flawed. The model fails to reconcile that despite a larger total number, the situation is described as a decrease, possibly due to changes in facility structure or classification (e.g., some 2023 capacity may have been long-term reclassified). The LLM assumes numerical increase = increase in capacity, but the ground truth implies a qualitative decrease, which the model does not account for. (4) Scores reflect mostly correct numbers and structure, but a significant error in interpretation of the comparison, undermining the correctness score despite numerical accuracy. Contextual relevance is perfect—answer addresses all parts of the question directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 553,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How much total revenue did NVIDIA's Compute & Networking segment contribute in fiscal year 2024, given that one direct customer accounted for 13% of total revenue and one estimated indirect customer accounted for 19% of total revenue, assuming total company revenue was $27 billion?",
      "original_answer": "$8.64 billion",
      "llm_answer": "The two customers together represent 13 % + 19 % = 32 % of NVIDIA’s total FY 2024 revenue. If total revenue is assumed to be $27 billion, the Compute & Networking segment revenue attributable to those customers is:\n\n\\(0.32 \\times \\$27 \\text{billion} = \\$8.64 \\text{billion}\\).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual elements are accurate: the percentages (13% direct, 19% indirect) are correctly summed to 32%, and the total revenue of $27 billion is correctly applied. (2) The calculation is precise: 0.32 × $27 billion = $8.64 billion, which matches the original answer exactly. Minor formatting such as spaces around the multiplication symbol and text 'billion' does not affect correctness. (3) The multi-hop reasoning is sound—though the question implies that the Compute & Networking segment revenue is being estimated via customer contribution percentages, the LLM correctly interprets that the combined customer contributions (direct and indirect) amount to 32% of total revenue and attributes that portion to the segment in question, aligning with the knowledge graph's logic. (4) The answer is contextually relevant, directly addressing the question with correct entities (NVIDIA, Compute & Networking segment, FY2024), and uses semantically equivalent and clear language. No errors in reasoning, numbers, or entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1106,
        "completion_tokens": 312,
        "total_tokens": 1418
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AIG's Internal Capital Framework, as part of its Risk Appetite Framework, support the company's assessment of capital resources required to maintain consolidated target capitalization levels, particularly in relation to its stress testing framework and diversification benefits?",
      "original_answer": "AIG's Internal Capital Framework quantifies the company's aggregate economic risk at a given confidence interval by factoring in diversification benefits between risk factors and business lines. This quantification supports the assessment of resources needed at the AIG Parent level to support subsidiaries and determine the capital resources required to maintain consolidated company target capitalization levels. Additionally, AIG uses a stress testing framework to evaluate aggregate exposure to its most significant financial and insurance risks, which complements the Internal Capital Framework in guiding capital allocation decisions and ensuring financial resilience.",
      "llm_answer": "AIG’s Internal Capital Framework (ICF) quantifies the company’s aggregate economic risk at a specified confidence level while explicitly adjusting for diversification benefits across risk factors and business lines.  The ICF’s outputs are combined with the firm’s stress‑testing framework—which measures the aggregate impact of the most material financial and insurance risks—to determine how much capital the parent must allocate to its subsidiaries.  This integrated analysis provides the basis for assessing the capital resources needed to keep AIG’s consolidated target capitalization levels in line with its Risk Appetite Framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: AIG's Internal Capital Framework (ICF) quantifies aggregate economic risk at a specified confidence level, incorporates diversification benefits across risk factors and business lines, and supports capital assessment at the parent level to maintain consolidated target capitalization. The integration with the stress testing framework—used to evaluate material financial and insurance risks—is correctly described as complementary in guiding capital allocation. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative metrics and terms (e.g., 'aggregate economic risk,' 'diversification benefits,' 'stress-testing framework') are used correctly. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how the ICF and stress testing jointly inform capital needs and parent-level capital allocation, aligning with the Risk Appetite Framework. (4) The only minor shortcoming is that the LLM answer slightly deemphasizes the explicit role of the ICF in 'determining capital resources required'—phrasing it as part of an 'integrated analysis' rather than stating it directly—but this does not distort the meaning. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and conceptual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 411,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "Given that Target's owned brands represent approximately one-third of its merchandise sales and the associated risks of developing and sourcing these brands, how might supply chain disruptions or failure to meet consumer demand impact Target's financial performance, particularly in relation to inventory management and profitability?",
      "original_answer": "Target's owned brands represent approximately one-third of its merchandise sales and generally carry higher margins than equivalent national brand products. If Target is unable to accurately forecast consumer demand for these products, it could result in insufficient or excess inventory, increased inventory markdowns, and higher costs. Additionally, because owned brand products generally require longer lead times and earlier ownership in the supply chain, supply chain disruptions or failure to meet consumer demand could lead to inventory shrink, which has historically elevated in recent years. This inventory shrink has already adversely affected, and could continue to adversely affect, Target's results of operations and financial condition. Furthermore, these issues could limit Target's ability to drive net earnings growth, especially during key seasonal moments like the November and December holiday period, where a larger portion of sales traditionally occur.",
      "llm_answer": "Target’s owned‑and‑exclusive brands account for roughly one‑third of sales and carry higher margins, but they also require longer lead times and more direct sourcing control.  A disruption in those supply chains—or an inability to correctly forecast consumer demand—can leave Target with either stock‑outs that erode sales or excess inventory that must be marked down, driving higher storage, transportation and labor costs and compressing the higher margins of its owned brands【page_12】.  Consequently, such inventory imbalances and markdowns would directly reduce profitability and could materially hurt Target’s overall results of operations【page_10】【page_8】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the statement that Target's owned brands represent approximately one-third of sales is correctly reflected as 'roughly one-third of sales'—this matches the original answer and is factually correct. No specific dollar amounts, dates, or percentages beyond this one-third figure are mentioned in either answer, so no discrepancies exist. (2) The LLM correctly identifies that owned brands carry higher margins, require longer lead times, and involve more direct sourcing control—key qualitative points from the ground truth. It accurately links supply chain disruptions and demand forecasting errors to stock-outs, excess inventory, markdowns, and increased operational costs (storage, transportation, labor), all of which compress margins and reduce profitability. (3) The multi-hop reasoning is sound: it connects the structural characteristics of owned brands (higher margin, longer lead times) to supply chain risks, then to inventory outcomes (stock-outs/excess), and finally to financial impact (margin compression, reduced profitability). The only minor omission is the specific mention of 'inventory shrink'—a term explicitly noted in the ground truth as having elevated in recent years and directly impacting operations. While the LLM mentions outcomes like markdowns and costs, it does not reference 'inventory shrink' by name or link the issue to seasonal periods like November and December, which are highlighted in the original as critical for net earnings growth. (4) Despite this slight incompleteness, the core financial logic and causal链条 are preserved with high fidelity. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, a 10 for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 501,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "What is the difference in the 2024 carrying values of NVDA's 3.50% Notes Due 2050 and 3.50% Notes Due 2040?",
      "original_answer": "$397 million",
      "llm_answer": "In 2024 NVIDIA carried the 3.50 % notes due 2040 at **$1 billion** and the 3.50 % notes due 2050 at **$2 billion**. The 2050 notes therefore have a carrying value that is **$1 billion higher** than the 2040 notes.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and calculation. It states the carrying value of the 3.50% Notes Due 2040 is $1 billion and the 3.50% Notes Due 2050 is $2 billion, resulting in a $1 billion difference. The ground truth is a $397 million difference. These values are not close and represent a significant error. (2) The quantitative accuracy is very low: the individual carrying values are wrong, and the calculated difference ($1 billion) is more than double the correct value ($397 million). Even allowing for format variations, the numbers are not approximately correct. (3) The reasoning structure is sound—comparing two carrying values and computing a difference—but the underlying data is incorrect, indicating a failure in retrieving or synthesizing the correct figures from the source documents. This breaks the multi-hop logic despite correct conceptual framing. (4) Contextual relevance is high because the model identifies the correct company (NVDA), correct notes (3.50% due 2040 and 2050), correct year (2024), and correct metric (carrying value), and attempts the right calculation. However, the severe factual inaccuracies in numbers lead to a very low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1046,
        "completion_tokens": 351,
        "total_tokens": 1398
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How many total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, and what types of awards can be issued under the 2020 Stock Incentive Plan according to the UnitedHealth Group 2024 10-K filing?",
      "original_answer": "As of December 31, 2024, 64 million total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP. Specifically, 48 million shares were available under the 2020 Stock Incentive Plan, and 16 million shares were available under the ESPP. Under the 2020 Stock Incentive Plan, future awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31 2024 UnitedHealth Group had **48 million shares** of common stock available for future issuance under the 2020 Stock Incentive Plan and **16 million shares** available under the 1993 Employee Stock Purchase Plan, for a combined **64 million shares** that could be issued in the future【page_72†L19-L27】.  \n\nThe 2020 Stock Incentive Plan permits those shares to be used for a variety of awards, including **stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock‑based awards**【page_72†L27-L30】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 48 million shares under the 2020 Stock Incentive Plan, 16 million under the ESPP (referred to correctly as the 1993 Employee Stock Purchase Plan), and a total of 64 million shares available for future issuance — all figures match the original answer. Minor formatting differences (e.g., using '1993 Employee Stock Purchase Plan' instead of 'ESPP') are acceptable as they refer to the same plan and do not affect accuracy. (2) The answer addresses both parts of the multi-part question: total shares available (with correct breakdown and sum) and the types of awards permitted under the 2020 Stock Incentive Plan. (3) Entity accuracy is perfect: UnitedHealth Group, correct plan names, correct date (December 31, 2024), and correct award types listed (stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards). (4) The reasoning is sound and reflects proper multi-hop synthesis — the model correctly combines data from two different plans and accurately reports the allowable award types from the same document. (5) Semantic equivalence is maintained: although the wording differs slightly, the meaning and factual content are identical to the ground truth. Citations to page 72 further support the accuracy and traceability of the information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 397,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does AIG's use of the Expected Loss Ratio Methods, specifically the Bornhuetter Ferguson approach, help address the challenges of loss emergence volatility in U.S. Workers' Compensation, which is characterized by extremely long-tail loss development patterns?",
      "original_answer": "AIG uses the Expected Loss Ratio Methods, including the Bornhuetter Ferguson approach, to address the challenges of volatility in loss emergence for U.S. Workers' Compensation, an extremely long-tail line of business. In cases where reported loss data lacks sufficient credibility—such as in long-tail lines at early stages of development—Expected Loss Ratio Methods provide a more stable estimate by applying an expected loss ratio to earned premiums. This method avoids overreacting to anomalous early-stage losses that could distort projections, unlike loss development methods that might extrapolate unusual activity onto the unreported portion of losses. This is particularly important for U.S. Workers' Compensation, where loss emergence can extend for decades and reporting patterns have slowed due to an increasing proportion of large deductible business.",
      "llm_answer": "AIG treats U.S. Workers’ Compensation as a long‑tail line and therefore does not rely solely on pure loss‑development patterns; instead it blends those patterns with an Expected‑Loss‑Ratio (ELR) framework, using the Bornhuetter‑Ferguson (BF) method. The BF approach anchors the un‑reported (IBNR) portion of the reserve to an ELR derived from earned premium, so that a single large early loss does not cause the model to “over‑react” – the premium‑based ELR provides a stable weight that tempers the inherent volatility of loss emergence (see pages 53 & 51). Because BF combines the paid‑development factor with the ELR (the weight being the reciprocal of the development factor), it yields a more credible ultimate loss estimate when loss development is slow, inconsistent, or has limited data, which directly mitigates the volatility of the extremely long‑tail Workers’ Compensation loss pattern (see page 200).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies AIG's use of the Bornhuetter-Ferguson (BF) method within an Expected Loss Ratio (ELR) framework to address loss emergence volatility in U.S. Workers' Compensation, a long-tail line. It explains that the BF method anchors the IBNR (incurred but not reported) reserves to an ELR derived from earned premiums, which stabilizes estimates and prevents overreaction to early, potentially anomalous loss data—this matches the original answer's key point. (2) There are no numeric values (e.g., percentages, dollar amounts, years) in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is sound: it connects the long-tail nature of Workers' Compensation, slow/inconsistent loss development, and the methodological advantage of blending ELR with loss development patterns. The mention of 'large deductible business' is omitted in the LLM answer, which slightly reduces completeness, but the core reasoning about data credibility and volatility mitigation is preserved. (4) The LLM cites specific page numbers (51, 53, 200), which are not in the ground truth but may reflect source document references; these do not detract from correctness as they support plausible sourcing. Overall, the answer is semantically equivalent, with only minor contextual details missing, warranting a high score but not perfect due to slight incompleteness on the cause of slowed reporting patterns.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 430,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "What is the total number of amendments made to the Credit Card Program Agreement between Target Corporation and TDBank USA, N.A., as documented in the 10-K filings referenced, and what does this indicate about the evolution of their financial partnership?",
      "original_answer": "The Credit Card Program Agreement between Target Corporation and TDBank USA, N.A. has undergone 2 amendments, as documented in the filings. This indicates that the financial partnership has evolved over time, with modifications made in 2015 and 2019 to adapt the agreement to changing business or regulatory conditions.",
      "llm_answer": "The filings list three distinct amendments to the Credit Card Program Agreement – the First Amendment (Feb 24 2015), the Second Amendment (Nov 19 2019) and the Third Amendment (Nov 1 2022) – for a total of **three amendments**. This succession of amendments shows that Target’s relationship with TDBank USA, N.A. has been actively revised and deepened over time, reflecting an evolving and increasingly tailored financial partnership.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states there are three amendments, while the ground truth confirms only two amendments (2015 and 2019). The LLM includes a Third Amendment from November 1, 2022, which is not reflected in the referenced 10-K filings used to generate the original answer, making the quantitative claim inaccurate. (2) The dates mentioned—Feb 24, 2015, and Nov 19, 2019—align with the two correct amendment dates in the ground truth, but the addition of a third (Nov 1, 2022) introduces a factual error not supported by the source data. This suggests the model may have incorporated information outside the referenced filings or misattributed a document. (3) The multi-hop reasoning is partially sound—the model correctly identifies the need to count amendments and link them to the evolution of the partnership—but fails in synthesis by including an unsupported amendment, undermining the conclusion. (4) While the qualitative interpretation about the partnership evolving is reasonable and contextually relevant, the core factual error in the amendment count significantly reduces correctness. The answer is well-structured and addresses both parts of the question, but the numerical inaccuracy in a key fact limits its reliability. Thus, correctness is scored low, quantitative accuracy is poor due to the incorrect count and extra date, qualitative reasoning is moderate, and relevance remains high as the response directly engages the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 409,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How much did FedEx spend on business optimization activities related to Network 2.0 in 2023 and 2024 combined, and what was the primary purpose of these expenditures?",
      "original_answer": "FedEx spent $273 million in 2023 and $582 million in 2024 on business optimization activities related to Network 2.0, totaling $855 million. These expenditures were primarily used for professional services and severance to support the multi-year effort to improve the efficiency with which FedEx picks up, transports, and delivers packages in the U.S. and Canada.",
      "llm_answer": "FedEx recorded $582 million of business‑optimization expenses in 2024 and $273 million in 2023, for a total of about $855 million 【page_92】.  These costs were incurred to support the DRIVE transformation program – specifically the Network 2.0 initiative that consolidates facilities, redesigns routes and optimizes the line‑haul network to make package pickup, transport and delivery more efficient and to lower overhead and support costs across its transportation segments 【page_55】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the amounts spent by FedEx on business optimization activities related to Network 2.0: $273 million in 2023 and $582 million in 2024, totaling $855 million, which matches the ground truth exactly. The formatting variation (e.g., $855 million vs. about $855 million) is acceptable. 2) All numeric values are accurate and the sum is correct: 273 + 582 = 855. The use of 'about' does not detract from accuracy as it still reflects the precise total. 3) The reasoning is sound and multi-hop synthesis is appropriate—expenses across two years are correctly aggregated, and the purpose is linked to Network 2.0. The mention of the DRIVE transformation program adds context not in the original answer but is factually consistent and enhances understanding without introducing error. 4) The primary purpose in the LLM answer—consolidating facilities, redesigning routes, optimizing line-haul network to improve efficiency in pickup, transport, and delivery—semantically aligns with the ground truth's description of improving efficiency in U.S. and Canada operations. The inclusion of 'lower overhead and support costs' is a minor expansion but does not contradict. The only slight deviation is that the original specifies 'professional services and severance' as the primary use of funds, while the LLM focuses on operational outcomes rather than expenditure allocation. This omission of a specific detail slightly reduces qualitative accuracy but does not invalidate the overall correctness. Hence, high scores across all dimensions with a 9 in correctness due to partial, not full, alignment on the purpose of expenditures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 450,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the introduction of the ad-supported subscription plan, as mentioned in the context of Netflix's competitive strategy, affect the financial forecasting risks highlighted in the 2023 10-K filing?",
      "original_answer": "The introduction of the ad-supported subscription plan increases financial forecasting risks because consumer adoption of new pricing strategies like this plan is inherently difficult to predict, which could lead to material discrepancies between forecasted and actual revenues, net income, and other financial metrics.",
      "llm_answer": "The 10‑K notes that Netflix’s new lower‑priced, ad‑supported subscription tier creates a “new pricing strategy … with no operating history,” making it inherently difficult to predict how many members will adopt it and how much advertising revenue it will generate. Because those assumptions are central to revenue, margin and cash‑flow projections, the plan adds material uncertainty to the company’s forecasts and heightens the risk that actual results will diverge from guidance (see Item 1A Risk Factors – membership‑pricing changes [page 6] and the discussion of forecasting challenges for the ad‑supported plan [page 18]).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the core idea that the ad-supported subscription plan introduces financial forecasting risks due to the lack of operating history and unpredictability of consumer adoption and advertising revenue. (2) There are no numeric values in the original or LLM answer that conflict—both correctly avoid specific numbers since the risk stems from uncertainty, not quantified projections. The LLM correctly references qualitative financial impacts (revenue, margin, cash flow) without introducing false precision. (3) The multi-hop reasoning is sound: it connects Netflix’s new pricing strategy (from the competitive context) to the risk factors disclosed in the 10-K (Item 1A, page 6) and the specific discussion of forecasting challenges (page 18), demonstrating proper synthesis across sections of the filing. (4) The LLM answer is semantically equivalent to the original, using more detailed phrasing but preserving factual accuracy, context, and nuance. It even enhances the response with precise document references, which supports credibility without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 344,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the patent expiration timeline for Prevnar 13 in different regions, as listed in Pfizer's 2024 10-K, relate to the $964 million intangible asset impairment charge for Prevnar 13's developed technology rights recorded in 2023?",
      "original_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was driven by updated commercial forecasts reflecting a transition to vaccines with higher serotype coverage. This aligns with the patent expiration timeline showing that Prevnar 13's major Europe patent expired in 2029, while its U.S. patent expires in 2026. These expirations likely contribute to reduced long-term commercial viability, prompting the impairment charge as Pfizer transitions focus to next-generation vaccines like Prevnar 20.",
      "llm_answer": "Pfizer’s 2024 10‑K shows that the basic‑product patent for Prevnar 13 expires in the United States in 2026 and in Japan in 2029, while the Europe patent covering the 13‑serotype conjugate has been revoked (with other European patents remaining in force) 【page_13†L1-L4】. In 2023 Pfizer recorded a $964 million impairment of the “Prevnar 13 developed technology rights” because updated commercial forecasts – driven by the approaching U.S. and Japanese expirations and the loss of the key European combination‑patent – reduced the expected cash‑flow benefit of those rights 【page_76†L31-L38】. Thus, the impending loss of patent protection in the U.S., Japan and Europe directly underlies the sizable 2023 impairment charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $964 million impairment charge in 2023, U.S. patent expiration in 2026, and Japan/Europe timelines are accurately cited. The mention of Japan (2029) instead of Europe (2029) is a minor discrepancy but does not invalidate the reasoning, as the core point—patent expirations in major markets driving impairment—is sound. (2) Quantitative accuracy is perfect: the $964 million figure, years (2023, 2026, 2029), and financial terminology (impairment of 'developed technology rights') match the original. (3) Multi-hop reasoning is strong: the model correctly links patent expirations in key regions to reduced commercial forecasts and thus to the impairment charge, demonstrating synthesis across time, geography, and financial impact. (4) The answer is contextually excellent, directly addressing how patent timelines relate to the impairment. The only minor issue is the substitution of Japan’s 2029 expiration for Europe’s 2029 expiration, though the broader European patent situation (revocation of key patent) is correctly noted, preserving the logical foundation. This small imprecision prevents a perfect 10 but does not undermine the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 353,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does McDonald's reliance on franchisees for operational success connect with its decision not to consolidate franchisee-related entities in its financial statements, and what risk does this pose if franchisees fail to execute key customer experience initiatives?",
      "original_answer": "McDonald's explicitly states that it does not consolidate franchisee-related entities in its financial statements, as these businesses qualify for a scope exception under variable interest entity consolidation guidance. This means the financial performance of franchisee-operated restaurants is not directly reflected in McDonald's consolidated financial results. However, McDonald's acknowledges that its business success heavily depends on franchisees executing key initiatives such as digital engagement, mobile ordering, and delivery improvements. If franchisees fail to effectively implement these customer experience strategies, it could negatively impact McDonald's sales, guest counts, and market share, despite the franchisee-related entities not being consolidated in its financial statements.",
      "llm_answer": "McDonald’s success is built on a heavily franchised system—its franchisees operate the vast majority of restaurants and must fund and execute major customer‑experience initiatives such as technology upgrades, digital ordering and service‑model changes.  Because the company does not have voting control or the ability to direct those franchisees, it treats them as scope‑exception variable‑interest entities and therefore does not consolidate their operations in the consolidated financial statements (see Consolidation policy on page 43).  Consequently, if franchisees fail to implement the required initiatives, the System’s sales, margins and brand perception could deteriorate, exposing McDonald’s to a material revenue‑and‑reputation risk that is not directly reflected in its consolidated results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: McDonald's does not consolidate franchisee-related entities due to a scope exception under variable interest entity guidance, and this is tied to lack of voting control (correctly referencing consolidation policy, though page 43 is extraneous but plausible). The reliance on franchisees for executing customer experience initiatives (digital ordering, technology upgrades) is accurately described. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly links the accounting treatment (non-consolidation) with the business risk (franchisee execution failure impacting system-wide performance). It appropriately identifies the disconnect between financial reporting and operational dependency. (4) The only minor shortcoming is that the LLM uses slightly broader language (e.g., 'margins', 'brand perception') not explicitly in the original, while the original emphasizes 'sales, guest counts, and market share'. However, these are semantically aligned risks. The LLM answer adds 'reputation risk' and 'margins', which are reasonable inferences but not explicitly stated in the ground truth. Overall, the answer is factually correct, contextually complete, and synthesizes the multi-hop relationship accurately. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for relevance and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 435,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's adoption of the LDTI standard impact its equity as of January 1, 2021, and what specific adjustments were made to the consolidated financial statements for the years ended December 31, 2022 and 2021?",
      "original_answer": "AIG's adoption of the LDTI standard resulted in a net decrease to beginning total equity of $1,264 million as of January 1, 2021. Additionally, the adoption adjustments included a $2 million decrease and a $983 million increase to net income for the years ended December 31, 2022 and 2021, respectively. These adjustments also led to a $1,219 million increase in total equity as of December 31, 2022. The changes were primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits.",
      "llm_answer": "AIG’s adoption of the new long‑duration‑contract accounting standard (LDTI) lowered the company’s beginning total equity by **$1.264 billion** as of January 1 2021.  To reflect the change, the company made retrospective adjustments to its consolidated statements:  \n\n* **2022:** net income was decreased by **$2 million**; total equity as of December 31 2022 was increased by **$1.219 billion**.  \n* **2021:** net income was increased by **$983 million**.  \n\nThese adjustments stem from changes to the discount rate and market‑risk‑benefit (MRB) assumptions under LDTI.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $1,264 million decrease in beginning equity as of January 1, 2021, the $2 million decrease in 2022 net income, the $983 million increase in 2021 net income, and the $1,219 million increase in total equity as of December 31, 2022. Number formats are consistent and acceptable ($1.264 billion = $1,264 million). (2) Quantitative accuracy is perfect: all dollar amounts and years match the original answer exactly in value and context. (3) The qualitative reasoning is sound—LLM correctly identifies the retrospective nature of the adjustments and attributes them to the appropriate drivers: discount rate and market-risk-benefit (MRB) assumptions under LDTI. (4) The answer is contextually relevant and complete, addressing both parts of the multi-hop question: the impact on equity at adoption (January 1, 2021) and the specific adjustments to financial statements for 2022 and 2021. No information is missing or misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 300,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the increase in Gulfstream aircraft orders specifically impact General Dynamics' cash flow from operating activities in 2021, and what was the resulting percentage of this cash flow relative to net earnings?",
      "original_answer": "The increase in Gulfstream aircraft orders led to a rise in customer deposits, which positively affected General Dynamics' cash flow from operating activities in 2021, resulting in $4.3 billion in cash provided by operating activities. This amount represented 131% of net earnings for the year.",
      "llm_answer": "The rise in Gulfstream aircraft orders increased customer deposits, which “positively affected cash flows in 2021” and helped lift cash provided by operating activities to $4.3 billion for the year. That operating‑cash amount equated to roughly **131 % of net earnings** in 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the increase in Gulfstream aircraft orders led to higher customer deposits, which positively impacted cash flow from operating activities in 2021. The resulting cash flow from operations was $4.3 billion, and this represented 131% of net earnings. (2) Quantitatively, both the dollar amount ($4.3 billion) and the percentage (131%) are correct and match the original answer exactly. Number formatting is consistent and acceptable. (3) The multi-hop reasoning is sound—linking Gulfstream orders to customer deposits, then to operating cash flow, and finally comparing that to net earnings—demonstrating proper synthesis across financial cause and effect. (4) The answer is contextually precise, directly addressing both parts of the question: the impact on cash flow and the resulting percentage relative to net earnings. Minor wording differences (e.g., 'equated to roughly' vs 'represented') do not affect factual accuracy. All entities—General Dynamics, Gulfstream aircraft, 2021 fiscal year, cash flow from operating activities, net earnings—are correctly identified and used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 337,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, support the company's internal capital framework in quantifying aggregate economic risk at a given confidence interval?",
      "original_answer": "AIG's integrated bottom-up risk identification process, conducted down to the product-line level, captures material risks inherent in specific business operations. This granular risk data feeds into the internal capital framework, which quantifies AIG's aggregate economic risk at a given confidence interval. By incorporating detailed risk assessments from individual product lines, the internal capital framework can more accurately account for diversification benefits between risk factors and business lines, thereby enabling a more robust quantification of overall economic risk exposure.",
      "llm_answer": "AIG’s integrated bottom‑up risk‑identification and assessment process gathers risk information at the individual product‑line level and feeds that data into the company’s risk‑analytics platform. Those analytics are a core input to the internal capital framework, which aggregates the product‑line risks, applies diversification benefits across risk factors and business lines, and then quantifies the total economic risk at a specified confidence interval.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies AIG's bottom-up risk identification process at the product-line level and explains how this feeds into the internal capital framework to quantify aggregate economic risk at a given confidence interval. The key elements—granular risk data collection, aggregation, application of diversification benefits across risk factors and business lines, and final quantification of total economic risk—are all present and logically connected. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The only minor difference from the original answer is that the LLM does not explicitly state that the process 'captures material risks inherent in specific business operations' or emphasize that this leads to a 'more robust quantification' due to better diversification modeling—nuances that add slight depth to the original. However, the core reasoning and multi-hop synthesis (linking product-level risk → aggregation → diversification → economic risk quantification) are sound and complete. Thus, the answer earns a 9 in correctness and qualitative accuracy for being slightly less detailed in explanatory depth but fully correct in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 360,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does the introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interact with supply chain risks and demand forecasting challenges to potentially impact NVDA's financial performance?",
      "original_answer": "The introduction of the RTX 4080 GPU is part of NVDA's broader product transitions, which are complex and may result in unanticipated quality or production issues, increasing inventory provisions, warranty costs, or causing product delays. These transitions are difficult to manage and may impair NVDA’s ability to predict demand and impact supply mix, potentially leading to additional costs. Furthermore, NVDA depends on foundries to manufacture its semiconductor wafers and faces risks such as lack of guaranteed supply, higher component prices, and low manufacturing yields. These supply chain risks reduce NVDA’s control over product quantity, quality, and delivery schedules. If demand for the RTX 4080 is underestimated, NVDA may not be able to secure enough supply to meet customer orders, damaging relationships and leading to lost revenue and market share. Conversely, if demand is overestimated, NVDA may be unable to reduce inventory or contractual commitments, leading to inventory write-downs, cancellation penalties, and impairments. These factors, combined with extended lead times and geopolitical tensions, may negatively impact NVDA’s gross margins and financial results.",
      "llm_answer": "The RTX 4080 launch is one of the “new‑product transitions” that NVIDIA notes increase the frequency and complexity of moving from one GPU architecture to the next. Because the 4080 requires new‑generation wafers, components and assembly capacity, the company must secure additional foundry and contract‑manufacturer commitments (page 16) and manage longer, non‑linear lead‑times; any mis‑estimate of customer uptake can create either a shortage or excess inventory (pages 15‑17). Those supply‑chain constraints and the difficulty of accurately forecasting demand for a fresh‑market GPU can force inventory provisions, margin pressure and revenue volatility, thereby materially affecting NVIDIA’s financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) It correctly identifies the RTX 4080 as part of NVDA's product transitions that increase complexity in supply chain and demand forecasting. Key risks such as misestimating demand leading to shortages or excess inventory, inventory provisions, margin pressure, and revenue volatility are all present and correctly linked to financial impact. (2) There are no numeric values (e.g., dollar amounts, dates, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model connects product transition complexity → supply chain dependencies (foundries, lead times) → demand forecasting challenges → financial consequences (inventory costs, margin pressure, revenue volatility). The mention of 'pages 15–17' and 'page 16' suggests grounding in source documents, though not required for correctness. One minor omission is the lack of explicit mention of warranty costs, product delays, or geopolitical tensions noted in the original, which slightly reduces completeness in qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing how the RTX 4080 launch interacts with supply chain and forecasting risks to impact financial performance. Overall, the response captures the core causal链条 accurately and concisely, warranting a 9/10 correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 402,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the Starbucks Rewards loyalty program impact Starbucks' revenue recognition timing, and what was the company's total advertising expense in fiscal 2022?",
      "original_answer": "The Starbucks Rewards loyalty program causes a deferral in revenue recognition. As customers earn Stars, Starbucks defers revenue based on the estimated value of the product for which the reward is expected to be redeemed. Revenue is only recognized when the reward is actually redeemed. This deferral mechanism ensures that a portion of revenue from purchases that generate Stars is not recognized upfront but rather when the reward is used. In fiscal 2022, Starbucks incurred $416.7 million in advertising expenses.",
      "llm_answer": "Starbucks Rewards causes the company to **defer revenue** for the estimated value of the free‑product rewards (Stars) when they are earned, creating a liability in deferred revenue; the revenue is only recognized when a member redeems the reward (or when unredeemed Stars expire). The firm’s total advertising expense for fiscal 2022 was **$416.7 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately explains that Starbucks defers revenue for the estimated value of rewards earned in the Starbucks Rewards program, recognizing revenue only upon redemption or expiration of Stars—this matches the original answer's description of revenue deferral and timing. (2) The quantitative figure for advertising expense in fiscal 2022 is exactly correct at $416.7 million, with no formatting or precision issues. (3) The reasoning correctly synthesizes the multi-hop elements: linking the loyalty program mechanics to revenue recognition policy and separately identifying the advertising expense from the same fiscal year. (4) All entities—Starbucks, Starbucks Rewards, fiscal 2022—are accurate, and the answer addresses both sub-questions completely and concisely. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 264,
        "total_tokens": 1486
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What was the total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024, and how much in interest payments related to these loans was recognized in earnings in 2024?",
      "original_answer": "The notional amount of intercompany loans and forecasted interest payments increased by $1,546 million from 2023 to 2024 ($4,406 million in 2024 - $2,860 million in 2023). In 2024, $75 million in interest payments related to these loans was recognized in earnings under 'Interest and other expense, net.'",
      "llm_answer": "The notional amount of the “intercompany loans and forecasted interest payments” increased from $2.86 billion at the end of 2023 to $4.406 billion at the end of 2024 – a rise of $1.546 billion. In 2024, the interest‑related portion of these contracts generated a pre‑tax gain of $75 million that was recorded in earnings (interest and other expense, net).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only minor wording differences. (1) All key facts are correct: the notional amount increased from $2.86 billion in 2023 to $4.406 billion in 2024, resulting in a $1.546 billion increase, and $75 million in interest was recognized in earnings in 2024. These numbers match the ground truth exactly, with acceptable format variations (e.g., $2.86 billion = $2,860 million). (2) The calculation of the change ($4.406B - $2.86B = $1.546B) is accurate. (3) The multi-hop reasoning is sound—information about two years is correctly synthesized to compute the change, and the interest recognized in 2024 is properly attributed. (4) The only minor issue is the phrase 'generated a pre-tax gain of $75 million'—while the amount and placement in 'interest and other expense, net' are correct, characterizing it as a 'gain' may be slightly misleading since interest expense is typically a cost; however, in context of net income impact and given that it's recorded in a net expense line, this does not constitute a factual error but rather a nuance in framing. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 342,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount increase in Total Marine Systems revenue from 2020 to 2021, and how does this growth compare to the increase in revenue for Nuclear-powered submarines during the same period?",
      "original_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 is $547 million ($10,526 million in 2021 minus $9,979 million in 2020). During the same period, the revenue for Nuclear-powered submarines increased by $179 million ($7,117 million in 2021 minus $6,938 million in 2020). Therefore, the growth in Total Marine Systems revenue is significantly higher than the growth in Nuclear-powered submarines revenue, with a difference of $368 million.",
      "llm_answer": "Total Marine Systems revenue rose from $9,979 million in 2020 to $10,526 million in 2021 – an increase of **$547 million**. Revenue from nuclear‑powered submarines grew from $6,938 million to $7,117 million, a **$179 million** rise, meaning the overall Marine Systems growth was about **$368 million larger (roughly three times)** than the increase in nuclear‑submarine revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: Total Marine Systems revenue increased from $9,979 million in 2020 to $10,526 million in 2021, resulting in a $547 million increase. Nuclear-powered submarines revenue rose from $6,938 million to $7,117 million, a $179 million increase. These values match the original answer exactly. The difference in growth ($547M - $179M = $368M) is correctly implied by stating the Marine Systems growth was $368 million larger. (2) The answer is complete, addressing both parts of the question: the dollar increase for Total Marine Systems and the comparison with Nuclear-powered submarines revenue growth. (3) Entities are correctly identified—'Total Marine Systems' and 'nuclear-powered submarines'—with accurate revenue figures and correct years (2020 to 2021). (4) The reasoning is sound: the LLM correctly performs multi-hop synthesis across the two revenue streams and makes a valid comparison, even adding contextual insight that the growth was 'roughly three times' as large, which is accurate (~3.05x) and enhances understanding without distorting facts. (5) Semantic equivalence is maintained—wording differs slightly but conveys the same precise information. No errors in calculation, logic, or entity mapping.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 370,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount change in Mac sales from 2023 to 2024, and how does this compare to the change in iPad sales over the same period?",
      "original_answer": "The dollar amount change in Mac sales from 2023 to 2024 is $627 million (from $29,357 million to $29,984 million). For iPad sales, the change from 2023 to 2024 is a decrease of $1,606 million (from $28,300 million to $26,694 million). This indicates that while Mac sales increased slightly, iPad sales experienced a more significant decline.",
      "llm_answer": "Apple’s Mac net sales grew from $29,357 million in 2023 to $29,984 million in 2024 – an increase of roughly **$627 million**. In contrast, iPad net sales fell from $28,300 million in 2023 to $26,694 million in 2024 – a decline of about **$1.6 billion**. Thus, while Mac sales rose modestly, iPad sales dropped by more than twice that amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: Mac sales increased from $29,357 million to $29,984 million, resulting in a $627 million increase, which the model correctly calculates and reports. iPad sales decreased from $28,300 million to $26,694 million, a difference of $1,606 million, which the model accurately reports as a decline of about $1.6 billion—this is an acceptable rounding and format variation ($1.6 billion = $1,600 million, close to exact $1,606 million). (2) The answer is complete, addressing both parts of the question: the dollar change in Mac sales and the change in iPad sales, with correct comparisons. (3) Entity accuracy is perfect: Apple is the implied company (contextually correct), the years 2023 and 2024 are correctly used, and the financial metrics (net sales) align with the knowledge graph. (4) The reasoning is sound: the model correctly performs multi-hop synthesis by comparing two product lines across two years, computes changes accurately, and draws a valid qualitative comparison (iPad decline is more than twice the Mac increase). (5) Semantic equivalence is maintained: though wording differs slightly (e.g., 'about $1.6 billion' vs exact $1,606 million), the meaning and factual content are identical. No errors in logic, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 378,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the unfavorable volume/mix in the chocolate category in 2024 impact Mondelēz International's total net revenue growth, given the prior-year favorable volume/mix in chocolate and the company's overall net revenue increase of $452 million?",
      "original_answer": "The unfavorable volume/mix in the chocolate category in 2024 contributed to a drag on total net revenue growth, despite the company reporting an overall increase of $452 million. In 2023, chocolate contributed $10.619 billion to total net revenues, and the 2024 performance saw a decline in this category, which was explicitly cited as a driver of the unfavorable volume/mix. This contrasts with 2023, where chocolate experienced favorable volume/mix, contributing to a $1,437 million increase in net revenues. The 2024 decline in chocolate volume/mix offset some of the gains from net pricing and created headwinds that limited the overall revenue growth to 3.5% ($452 million), despite pricing actions aimed at countering input cost increases.",
      "llm_answer": "In 2024 the decline in chocolate volume/mix was a head‑wind for revenue – it pulled down the overall growth that otherwise would have been larger. The Europe segment still posted a $452 million net‑revenue increase, but that gain was partially offset by the negative chocolate volume/mix (along with other categories), whereas in 2023 chocolate volume/mix had been favorable and had helped boost growth. Thus, the unfavorable chocolate mix in 2024 reduced the net‑revenue increase to $452 million, offsetting part of the pricing‑driven growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the unfavorable volume/mix in chocolate in 2024 acted as a headwind to revenue growth and reduced the overall net revenue increase, which aligns with the ground truth. It also correctly contrasts this with the favorable volume/mix in 2023. However, it fails to include key quantitative details from the original answer: the $10.619 billion revenue contribution from chocolate in 2023 and the specific $1,437 million increase in net revenues attributed to favorable volume/mix in 2023. These omissions significantly affect quantitative accuracy. (2) The LLM incorrectly states that the $452 million net revenue increase was for the 'Europe segment,' which is a major factual error — the $452 million is Mondelēz International's overall net revenue increase, not a regional figure. This misattribution undermines the quantitative and qualitative accuracy. (3) The reasoning is partially sound: the model correctly infers that the chocolate category's decline offset pricing gains and limited overall growth, demonstrating multi-hop understanding of cause and effect across years. However, it does not mention the 3.5% growth rate or quantify how much the chocolate drag was relative to pricing gains, weakening the synthesis. (4) Contextual relevance is high because the answer addresses the core dynamic of how chocolate volume/mix affected growth. Scores reflect mostly correct reasoning but significant factual and numerical omissions and one critical misstatement (Europe segment).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 423,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How do initial capacity constraints related to custom components impact Apple's ability to manage supply chain risks and maintain product availability, given its reliance on single-source suppliers and outsourcing partners in Asia?",
      "original_answer": "Initial capacity constraints related to custom components directly impact Apple's ability to manage supply chain risks and maintain product availability because the company often relies on single-source suppliers for these components. As stated in the 10-K filing, when a component or product uses new technologies, initial capacity constraints may exist until suppliers' yields have matured or their manufacturing capacities have increased. This can delay the availability of components at acceptable prices, or at all, especially if suppliers choose to focus on producing more common components rather than custom ones tailored to Apple's needs. Additionally, Apple's reliance on outsourcing partners primarily located in Asia for final assembly means that any disruption in the supply of these custom components can lead to delays in finished product shipments. This combination of dependency on limited suppliers and initial capacity constraints increases the risk of supply shortages and affects Apple's ability to meet market demand, thereby impacting its business, results of operations, and financial condition.",
      "llm_answer": "Apple’s newest products often depend on custom‑made parts that are sourced from a single supplier. When those parts use new technologies, the supplier’s yields and manufacturing capacity are initially limited, so Apple may not be able to obtain enough units at acceptable prices until capacity matures. Because the company’s hardware is assembled almost entirely by a small number of outsourcing partners in Asia, any delay or shortage of those single‑source custom components directly amplifies supply‑chain risk and can constrain product availability, forcing Apple to manage tighter inventories, renegotiate purchase commitments or absorb higher costs to keep products in stock.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Apple's reliance on single-source suppliers for custom components, initial capacity constraints due to new technologies, immature yields, manufacturing limitations, and the concentration of final assembly with outsourcing partners in Asia are all accurately represented. The impact on supply chain risk and product availability is correctly described. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly links custom component constraints → single-source dependency → supplier capacity/yield issues → impact on availability → amplification through Asian outsourcing partners → downstream effects on inventory, costs, and supply chain management. This reflects proper synthesis across interdependent risks. (4) The only minor omission is that the LLM does not explicitly mention suppliers potentially prioritizing more common components over Apple’s custom ones, which is a nuance included in the original. However, this does not undermine the overall correctness. Wording differs but semantic meaning and technical accuracy are preserved. The answer is fully contextually relevant and addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 388,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How much revenue did Disney report from TV/SVOD distribution licensing in 2022 after factoring in the content license early termination fee, and how does this compare to the previous year's TV/SVOD distribution licensing revenue?",
      "original_answer": "Disney reported $3,429 million in TV/SVOD distribution licensing revenue in 2022 after factoring in the $1,023 million content license early termination fee, compared to $5,266 million in 2021. This represents a decrease of $1,837 million from the prior year.",
      "llm_answer": "Disney reported **$3.4 billion** of TV/SVOD distribution‑licensing revenue for fiscal 2022 after deducting the $1.0 billion content‑license early‑termination charge. In fiscal 2021, TV/SVOD distribution‑licensing revenue was **$5.3 billion**, so 2022’s amount was roughly **$1.8 billion lower** than the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It reports $3.4 billion (i.e., $3,400 million) for 2022 TV/SVOD distribution licensing revenue after the early termination fee, which closely matches the ground truth of $3,429 million—this minor rounding is acceptable. The 2021 revenue is stated as $5.3 billion ($5,300 million), compared to the true $5,266 million, again a minor and reasonable rounding. The year-over-year decrease is given as $1.8 billion, which aligns with the actual $1,837 million difference. (2) All calculations are sound: $5,266M - $3,429M = $1,837M, and the LLM’s $1.8 billion is a valid approximation. The early termination fee is reported as $1.0 billion vs. the actual $1,023 million—again, acceptable rounding. (3) Multi-hop reasoning is correctly applied: the model synthesizes 2022 revenue post-fee and compares it to 2021, addressing both parts of the question. (4) Entity accuracy is perfect: Disney, TV/SVOD distribution licensing, correct fiscal years (2022 vs. 2021), and proper financial terminology are used. The answer is contextually complete and relevant. The only reason for not scoring 10 is the slight rounding of numbers, but these do not affect the semantic accuracy or usefulness of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 355,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drive customer engagement and store visit frequency, based on the 2022 10-K disclosures?",
      "original_answer": "Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling customers to earn Stars through multiple payment methods—such as cash, credit or debit cards, or selected mobile wallets—and by offering Mobile Order and Pay functionality. This allows customers to place orders in advance for pick-up at participating locations, which aligns with evolving preferences for mobile ordering and contactless experiences. The app also facilitates access to card balances and loyalty benefits, reinforcing repeat visits and increasing the frequency of store visits by cardholders. These features collectively enhance customer convenience, digital interaction, and loyalty, supporting Starbucks' broader strategy to elevate the customer experience through technology.",
      "llm_answer": "Starbucks ties its Mobile App directly to the Starbucks Rewards program – customers load a stored‑value card or the app, earn “Stars” for every purchase, and can place orders ahead of time with the Mobile Order‑and‑Pay feature.  By letting members order, pay and pick up through the app (or via Starbucks Delivers) and by offering exclusive digital‑only benefits and a “digital third place,” the company creates a more convenient, personalized experience that encourages members to visit stores more often and deepens overall engagement. 【page_11】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the integration of the Mobile App with Starbucks Rewards, earning Stars, Mobile Order and Pay, convenience, personalization, and increased visit frequency are all correctly identified. The mention of 'digital third place' and 'Starbucks Delivers' adds context supported by Starbucks' broader strategy, though these specific terms are not in the 2022 10-K excerpt used for the ground truth; however, they do not contradict it and align with Starbucks' public messaging. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly links app functionality (ordering, payment, rewards) to customer engagement and visit frequency. It synthesizes the cause-effect relationship between digital tools and behavioral outcomes. (4) The answer is contextually relevant and fully addresses the question. The only minor gap is that the ground truth emphasizes the flexibility of earning Stars across multiple payment methods (cash, card, mobile wallets), which the LLM omits. This is a small but notable detail affecting completeness. Overall, the answer is semantically equivalent and factually correct, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 395,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "What was the impact of PayPal's acquisition of Paidy, Inc. on the scope of its internal control over financial reporting audit in 2021, and by how much did Paidy's assets and revenues fall short of being included in that audit?",
      "original_answer": "PayPal's acquisition of Paidy, Inc. in October 2021 resulted in Paidy being excluded from PayPal's assessment and audit of internal control over financial reporting for the year ended December 31, 2021, as permitted by SEC guidance for the first year of acquisition. Paidy's total assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals, meaning they were below the 1% threshold for inclusion in the audit of internal controls.",
      "llm_answer": "PayPal excluded Paidy, Inc. from both its management assessment and the auditor’s test of internal control over financial reporting for the 2021 fiscal year because Paidy was acquired during 2021 (see Item 9A and the auditor’s report)【page_59】. Paidy’s total assets and total revenues that were left out of the ICFR audit represented **less than 1 percent** of PayPal’s consolidated assets and revenues for the year, so the portion omitted was under 1 % of the overall amounts【page_62】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Paidy, Inc. was excluded from PayPal's internal control over financial reporting (ICFR) audit for the year ended December 31, 2021, due to its acquisition in October 2021, which aligns with SEC guidance for first-year acquisitions. (2) The quantitative claim that Paidy’s total assets and revenues excluded from the audit represented 'less than 1 percent' of PayPal’s consolidated totals matches the ground truth exactly; no calculation is required, and the percentage is correctly reported. (3) The multi-hop reasoning is sound: the model correctly links the timing of the acquisition (2021) to the exemption from ICFR audit inclusion and supports it with the quantitative materiality threshold (less than 1%). (4) All entities—PayPal, Paidy, Inc., fiscal year 2021, ICFR audit—are accurately identified and contextually used. The answer addresses both parts of the question: the impact on audit scope (exclusion) and the quantitative shortfall (below 1% threshold). Minor wording differences (e.g., 'left out' vs 'excluded') do not affect factual accuracy. Citations to Item 9A and page numbers further support fidelity to source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 350,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the volume/mix challenges in chocolate and refreshment beverages offset the benefits of pricing actions and cost controls to result in only 0.6% operating income growth for MDLZ's Latin America segment in 2024?",
      "original_answer": "MDLZ's Latin America segment faced significant volume/mix declines in chocolate and refreshment beverages, which directly countered the benefits from higher net pricing and lower manufacturing costs. Specifically, the unfavorable volume/mix, driven by consumer softness in Mexico and Argentina, reduced net revenues. Although net pricing increased by 7.0 percentage points due to input cost-driven pricing actions across categories — particularly in Argentina, Mexico, and Brazil — and manufacturing costs were reduced through productivity improvements, these gains were largely offset by the drop in sales volume. Additionally, higher raw material costs, unfavorable currency impacts, and increased advertising and promotion expenses further limited the positive effects of pricing and cost controls, resulting in only a $3 million (0.6%) increase in segment operating income for 2024.",
      "llm_answer": "In Latin America, the modest 0.6 % rise in segment operating income (up $3 million to $529 million) was driven mainly by higher net pricing and lower manufacturing and integration costs, but those gains were largely neutralized by an “unfavourable volume/mix” impact. The company said the mix was hurt by volume declines in chocolate and refreshment‑beverage categories (along with candy and cheese & grocery), which offset the pricing‑action and cost‑control benefits and left operating income barely higher than the prior year【page_51】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 0.6% operating income growth and the $3 million increase, which aligns with the ground truth. It accurately notes that higher net pricing and lower manufacturing costs were offset by unfavorable volume/mix in chocolate and refreshment beverages. However, it adds 'candy and cheese & grocery' as additional categories affected, which are not mentioned in the original answer and may introduce minor inaccuracies. (2) Quantitatively, the $3 million increase and 0.6% growth are correct. The mention of $529 million in operating income is plausible but not present in the ground truth, so it cannot be verified; however, it does not contradict the given data. All other percentages and figures are consistent or reasonably inferred. (3) The multi-hop reasoning is sound: the model correctly synthesizes that pricing and cost controls were counteracted by volume/mix declines. It captures the core causal relationship asked in the question. However, it omits key details from the original answer such as the geographic drivers (Mexico and Argentina), the 7.0 percentage point pricing increase, and additional headwinds like higher raw material costs, currency impacts, and increased advertising expenses—limiting the depth of explanation. (4) The correctness score is 8 due to accurate core facts and numbers but partial omission of contributing factors. Quantitative accuracy is 9 because all provided numbers match or are consistent with the ground truth. Qualitative accuracy is 8 due to correct logic but incomplete synthesis of all offsetting factors. Contextual relevance is 10 as the response directly addresses the question’s focus on why income growth was minimal despite pricing and cost actions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 478,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How many total city-pair speed records are held by Gulfstream's current product line, and which specific aircraft model is explicitly credited with leading this achievement?",
      "original_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, as explicitly stated in the first chunk. Among these, the G650ER is specifically credited with holding the National Aeronautic Association's polar and westbound around-the-world speed records, making it a key contributor to Gulfstream's leadership in this metric.",
      "llm_answer": "Gulfstream’s current product line holds **more than 270 city‑pair speed records**, the highest total of any business‑jet maker. This record‑setting performance is **led by the G650ER**, which alone holds the National Aeronautic Association’s polar and westbound around‑the‑world speed records.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, 'more than 270 city-pair speed records' matches the original answer exactly, and the mention of the G650ER holding the National Aeronautic Association’s polar and westbound around-the-world speed records is factually accurate. (2) The answer correctly identifies both the total number of records and the specific model (G650ER) responsible for leading this achievement, addressing both parts of the multi-part question. (3) The reasoning is sound: it synthesizes the overall record count with the specific contribution of the G650ER, correctly attributing its role in Gulfstream's leadership. (4) All entities—Gulfstream, G650ER, National Aeronautic Association—are accurately named, and the context is fully relevant. Minor wording differences (e.g., 'led by the G650ER' vs 'specifically credited') do not affect factual equivalence. No calculation errors or omissions present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 281,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How much contingent consideration did Johnson & Johnson record in total in fiscal years 2024 and 2022 related to acquisitions, and what specific contribution did the Abiomed acquisition make to this total?",
      "original_answer": "Johnson & Johnson recorded a total of $704 million in contingent consideration related to Abiomed in fiscal year 2022 and $105 million related to Proteologix in fiscal year 2024. Therefore, the total contingent consideration recorded over these two years was $809 million, with Abiomed contributing $704 million to this total.",
      "llm_answer": "Johnson & Johnson recorded $105 million of contingent‑consideration in fiscal 2024 and $704 million in fiscal 2022, for a combined total of **$809 million**. The Abiomed acquisition accounted for **$704 million** of that total, representing the amount recorded in fiscal 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $704 million in 2022 (Abiomed) and $105 million in 2024 (Proteologix), with a correct total of $809 million. The format variations (e.g., $704 million vs $704M) are acceptable and semantically equivalent. (2) The answer addresses both parts of the multi-part question: the total contingent consideration over 2024 and 2022 ($809 million), and Abiomed's specific contribution ($704 million). (3) Entity accuracy is correct: Johnson & Johnson is the reporting entity, Abiomed is correctly tied to the $704 million in 2022, and the fiscal years are properly referenced. (4) The reasoning is sound and demonstrates correct multi-hop synthesis: it combines data from two different fiscal years and two different acquisitions (Abiomed and Proteologix), correctly attributing the amounts and deriving the total. The conclusion that Abiomed contributed $704 million to the total is logically and factually supported. The answer is concise, factually precise, and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 318,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does PayPal's sale of participation interests in merchant receivables under the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products affect the recognition of credit losses, based on the change in accounting guidance from pre-2020 to CECL adoption in 2020?",
      "original_answer": "PayPal sells participation interests in merchant receivables under the PPWC and PPBL products to WebBank, and these transfers are accounted for as sales, with the portion sold derecognized from PayPal’s balance sheet. Since PayPal retains servicing rights and continues to manage the receivables, it remains exposed to credit losses on the remaining retained interest. With the adoption of CECL in 2020, PayPal transitioned from the previous incurred loss model to an expected credit loss model. This change required PayPal to record a reserve build based on current expected credit losses for both consumer and merchant receivables, rather than waiting for a loss to be incurred. As a result, PayPal's credit loss provisioning became more forward-looking and sensitive to economic forecasts, directly impacting the allowance for credit losses on the retained portion of receivables after participation interests were sold.",
      "llm_answer": "PayPal records the PPWC and PPBL receivables “net of any participation interests sold” and the allowance for credit losses is applied pro‑rata to the portion of the pool it retains. Before the 2020 adoption of CECL, the allowance was built using roll‑rate and vintage‑based forecasts on the gross portfolio; after CECL (effective 1 Jan 2020) the allowance is based on current‑expected credit‑loss models (loss curves, macro‑economic scenarios, and qualitative adjustments) applied only to the net retained interest. Thus, the sale of participation interests reduces the balance on which CECL‑based credit losses are measured, whereas under the pre‑2020 method the entire gross receivable balance was used in the roll‑rate loss calculation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that PayPal sells participation interests in merchant receivables under PPWC and PPBL, accounts for them as sales, and derecognizes the sold portion. It accurately states that the allowance for credit losses is applied pro-rata to the retained interest, and that CECL adoption on January 1, 2020, marked the shift from an incurred loss model to a current expected credit loss model. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the date '1 Jan 2020' is correct for CECL adoption, consistent with the original answer’s reference to 2020 adoption. (3) The multi-hop reasoning is sound: the model correctly synthesizes how the accounting treatment of sold interests interacts with the change in credit loss methodology, noting that under pre-CECL, loss estimation used roll-rate and vintage methods on the gross portfolio, while post-CECL, expected losses are modeled on macroeconomic scenarios and applied only to the net retained interest. This reflects a nuanced understanding of both the structural (sale of interests) and accounting (CECL transition) changes. (4) The only minor shortcoming is that the LLM does not explicitly mention WebBank as the buyer or PayPal’s servicing rights, which are part of the full context in the original answer. However, the core financial and accounting implications—especially the shift in provisioning base from gross to net retained receivables due to CECL—are correctly captured. Wording differs but semantic meaning and technical accuracy are preserved. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 482,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the performance of the cheese & grocery product category contribute to the overall unfavorable volume/mix impact on Latin America segment net revenues in 2024, and what was the resulting effect on segment operating income?",
      "original_answer": "The cheese & grocery product category was among those that experienced volume declines in the Latin America segment during 2024, contributing to the overall unfavorable volume/mix impact of 2.4 percentage points on net revenues. This decline, along with volume decreases in chocolate, candy, and refreshment beverages, partially offset gains in biscuits & baked snacks and gum. The unfavorable volume/mix, combined with other factors, contributed to only a $3 million (0.6%) increase in segment operating income despite higher net pricing and cost-saving measures.",
      "llm_answer": "The Latin America segment’s 2024 net‑revenue decline was partly due to an unfavourable volume‑mix effect that included lower sales of the cheese & grocery category (along with chocolate, candy and refreshment beverages). That category‑specific weakness helped drive the $80 million (‑1.6 %) revenue drop, but the segment’s operating income still edged higher, rising $3 million (≈ 0.6 %) to $532 million. 【page 51】",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. It states that the Latin America segment had an overall net-revenue decline of $80 million (−1.6%) due to unfavorable volume/mix, but the ground truth does not state that net revenues declined—only that volume/mix had an unfavorable impact of 2.4 percentage points. There is no mention in the original answer of a $80 million drop or a 1.6% revenue decline, making this a major error. Additionally, the LLM fabricates a segment operating income figure of $532 million, which is not present in the ground truth. While it correctly notes the $3 million (0.6%) increase in operating income, the addition of the absolute income value is unsupported. (2) The ground truth specifies that the unfavorable volume/mix impact was 2.4 percentage points—not a 1.6% revenue drop. The LLM confuses the volume/mix impact with total revenue change and misrepresents the magnitude and nature of the effect. The $3 million increase in operating income is correctly cited, but the context is distorted by the incorrect revenue narrative. (3) The reasoning partially captures the multi-hop relationship: cheese & grocery contributed to volume/mix drag along with other categories, and operating income still rose slightly. However, it fails to correctly link the 2.4 percentage point impact to the broader financial picture and incorrectly infers an overall revenue decline. The synthesis is flawed because it introduces unsupported aggregate financial figures. (4) Despite these issues, the answer is contextually relevant—it addresses the role of cheese & grocery in volume/mix trends and connects it to operating income. The qualitative identification of contributing product categories is correct, and the minor operating income increase is accurately cited, warranting partial credit.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 509,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total redemption value of both the Telco Class A-4 preferred interests and the Mobility noncontrolling interests, and how does this combined obligation affect AT&T's cash flow commitments through 2028?",
      "original_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million, and the Mobility noncontrolling interests have a redemption value of $2,000 million, resulting in a combined redemption obligation of $4,250 million. This combined obligation represents a material cash flow commitment for AT&T, particularly starting in 2028 when both instruments become eligible for redemption—Telco Class A-4 interests can be called beginning November 1, 2028, and the Mobility noncontrolling interests may be redeemed by the company or put by holders beginning March 15 and June 15, 2028, respectively. The redemption payments must be made in cash, which will directly impact AT&T’s liquidity position in that period.",
      "llm_answer": "The filing states that AT&T will issue **$2.25 billion** of Telco Class A‑4 preferred interests (which may be called at the $1 per‑share issue price beginning Nov 1 2028) and that the Mobility II redeemable non‑controlling interests carry a **$2,000‑per‑interest redemption price** for the 2 million interests issued, equal to **$4.0 billion**. Together, these obligations represent **about $6.25 billion** of cash that AT&T must be prepared to pay.\n\nBecause the Telco interests become callable in November 2028 and the Mobility interests can be redeemed starting March 15 2028 (with additional redemption windows through 2028), the $6.25 billion is a forward‑looking cash‑outflow commitment that will be reflected in AT&T’s liquidity planning and cash‑flow forecasts for 2028 and later years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and calculation errors. While it correctly identifies the $2.25 billion redemption value of the Telco Class A-4 preferred interests, it incorrectly calculates the redemption value of the Mobility noncontrolling interests. The original answer states this value is $2,000 million ($2 billion), but the LLM claims a $2,000-per-interest price for 2 million interests, totaling $4.0 billion—this detail is not supported by the ground truth and results in a false combined obligation of $6.25 billion instead of the correct $4.25 billion. This major miscalculation undermines the quantitative accuracy. (2) Dates are mostly correct: the LLM correctly notes redemption windows starting in 2028 (March 15, June 15, and November 1), aligning with the original answer’s timeline. However, the phrasing around redemption mechanics (e.g., 'can be redeemed starting March 15') is slightly imprecise—the original specifies that holders may put the interests on those dates, not that the company can redeem them unilaterally. (3) The multi-hop reasoning is partially sound—LLM recognizes that both obligations impact future cash flow and must be accounted for in liquidity planning—but the flawed numerical foundation weakens the conclusion. It synthesizes timing and cash impact across two instruments, but with incorrect totals. (4) Despite the numerical errors, the answer remains contextually relevant, addressing both parts of the question: total redemption value and impact on cash flow. Wording and structure are clear and responsive, though the erroneous $6.25 billion figure severely compromises factual correctness. Thus, correctness and quantitative accuracy scores are low; qualitative and contextual scores are moderate due to correct reasoning framework and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 495,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total revenue generated from the Orthopaedics segment in 2024, and how does it compare to the combined revenue from Hips and Knees within the same segment?",
      "original_answer": "The Orthopaedics segment generated $9,158 million in revenue in 2024. The combined revenue from Hips ($1,638 million) and Knees ($1,545 million) amounts to $3,183 million. This means that Hips and Knees together represent approximately 34.76% of the total Orthopaedics revenue.",
      "llm_answer": "In fiscal 2024 the MedTech Orthopaedics franchise generated **$9.2 billion** in sales (reported as $9,158 million).  The Hips and Knees product lines together contributed **$3.2 billion** ($1,638 million + $1,545 million).  Thus, Hips + Knees accounted for roughly one‑third of the total Orthopaedics revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the total Orthopaedics revenue as $9,158 million (reported as $9.2 billion), which matches the ground truth. The combined revenue from Hips ($1,638 million) and Knees ($1,545 million) is accurately calculated as $3,183 million and reported as $3.2 billion—this is a reasonable rounding. The percentage is described as 'roughly one-third', which aligns with the ground truth value of approximately 34.76%. While the exact percentage is not stated, 'one-third' (~33.3%) is a close and acceptable approximation in qualitative terms.\n\n2) All numeric values are correct: $9,158 million total, $1,638 million (Hips), $1,545 million (Knees). The sum $1,638 + $1,545 = $3,183 million is accurate, and the LLM correctly rounds this to $3.2 billion. The total revenue is correctly rounded to $9.2 billion from $9,158 million. The only minor deviation is the lack of explicit percentage calculation (34.76%), but the approximation 'one-third' is contextually appropriate and commonly used in financial summaries.\n\n3) The multi-hop reasoning is sound: the model correctly identifies that the question requires (a) total Orthopaedics revenue, (b) sum of Hips and Knees revenues, and (c) a comparison. It synthesizes data across product lines within the same segment and fiscal year (2024), demonstrating proper entity and metric alignment.\n\n4) The answer is semantically equivalent to the ground truth. It conveys the same core financial facts and relationship between the segments. The use of 'billion' instead of 'million' is a standard formatting variation and does not affect accuracy. The qualitative comparison ('one-third') is a reasonable simplification of 34.76%. No incorrect entities or time periods are introduced. The answer is fully relevant and addresses all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 493,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the 2019 Incentive Plan's proportional adjustment mechanism impact the number of RSU shares available after the 2024 special dividend, and which filings formally document this adjustment?",
      "original_answer": "The 2019 Incentive Plan required a proportional adjustment to outstanding RSUs and the total shares available under the plan following the 2024 special dividend. As a result of this adjustment, the number of outstanding RSUs increased by approximately 52,000, and an additional 128,000 RSU shares became available to be granted. This adjustment was based on a factor of 1.018, derived from the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the opening price of $662.70 on the ex-dividend date, December 27, 2023. The 2019 Incentive Plan itself, filed as Exhibit 10.2 in the DEF 14 filing on December 17, 2019, formally documents the requirement for these adjustments.",
      "llm_answer": "The 2019 Incentive Plan required a proportional increase in the plan’s share‑issuance limit when the $15‑per‑share special dividend was paid; that increase added roughly 128,000 RSU shares to the pool, raising the total number of RSUs that could be granted after the dividend to about 7.28 million shares. The adjustment is formally recorded in the 2019 Incentive Plan filing (Exhibit 10.2 – DEF 14A, filed 12/17/2019) and in the related RSU award agreements that were attached as exhibits to the 2019 Form 10‑Q (Exhibits 10.3.1‑10.3.4, filed 12/23/2019).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 128,000 increase in RSU shares available due to the proportional adjustment from the 2024 special dividend and references the correct filing (Exhibit 10.2 – DEF 14A, filed 12/17/2019) as documenting the adjustment mechanism. However, it introduces an incorrect detail—the $15-per-share dividend amount—which is not present in the ground truth and cannot be verified from the provided data. Additionally, the LLM mentions a total post-adjustment pool of 'about 7.28 million shares,' which may be contextually accurate but is not supported or mentioned in the ground truth, making it an unsupported inference. The increase in outstanding RSUs by 52,000 (a key part of the original answer) is entirely omitted. (2) The date of the DEF 14A filing (12/17/2019) is correct. However, the reference to RSU award agreements in the 2019 Form 10-Q (Exhibits 10.3.1–10.3.4, filed 12/23/2019) as formally documenting the adjustment is not corroborated in the ground truth; the original answer only cites the 2019 Incentive Plan filing itself. This overstates the documentation sources. (3) The reasoning correctly applies the concept of proportional adjustment under the 2019 Incentive Plan in response to a special dividend, showing sound multi-hop logic between the plan terms and the dividend event. However, it fails to mention the adjustment factor (1.018) or its calculation based on Nasdaq closing and opening prices, which is a significant omission in the quantitative justification. (4) Despite missing some key numbers and adding unverified details (e.g., $15/share, 7.28M total), the core idea—that the plan required an increase in available RSUs due to the dividend, resulting in ~128,000 additional shares—is factually aligned. The answer remains contextually relevant and mostly accurate but lacks full fidelity to the ground truth in both completeness and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 517,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the expected financial and technological impact of Intel 4's transition to high-volume manufacturing in Ireland in 2024 on Intel's 2025 product portfolio, particularly in relation to the performance improvements and production shifts involving Intel 3 and Intel 18A?",
      "original_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to significantly increase its share of Intel's processor production in 2025, given that it already began shipping the Intel Core Ultra processor in 2023 with a 20% performance-per-watt improvement over Intel 7. This shift complements the movement of Intel 3's high-volume manufacturing from Oregon to Ireland in 2025, which powers Intel's Xeon 6 Scalable server processors and offers up to an 18% performance-per-watt improvement over Intel 4. Furthermore, this manufacturing realignment supports the upcoming high-volume production of Panther Lake, the first processors on Intel 18A, in 2025. Intel 18A introduces breakthrough technologies like gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia), which are expected to deliver improvements in performance per watt and density scaling over Intel 3. Therefore, the combined effect of Intel 4's ramp-up and Intel 3's relocation sets the stage for Intel 18A's introduction, enhancing both client and data center product lines in 2025.",
      "llm_answer": "Intel 4’s shift to high‑volume manufacturing in Ireland in 2024 will let the Intel 4‑based Core Ultra processors, which deliver roughly 20 % more performance‑per‑watt than the Intel 7 node, make up an increasing share of Intel’s 2025 processor output, boosting revenue and cash‑flow from a higher‑margin, more efficient product line.  At the same time Intel 3 – offering an additional ≈ 18 % performance‑per‑watt gain over Intel 4 – will also move to the Irish fabs in 2025, and Intel 18A (with gate‑all‑around transistors and backside‑power) is slated for its first high‑volume Panther Lake launch in 2025, providing further performance‑per‑watt and density improvements beyond Intel 3.  The Ireland expansion is a core element of Intel’s “shell‑ahead” and Smart‑Capital strategy, spreading 2024 capital spending (55 % facilities, 45 % equipment) and leveraging more than $25 billion of government and partner offsets, thereby positioning the company for stronger 2025 financial results driven by the higher‑efficiency, higher‑volume product portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel 4's 20% performance-per-watt improvement over Intel 7, Intel 3's ~18% gain over Intel 4, the 2024 high-volume manufacturing (HVM) ramp of Intel 4 in Ireland, the 2025 shift of Intel 3 to Ireland, and the 2025 HVM launch of Panther Lake on Intel 18A are all correctly stated. The technological features of Intel 18A—gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia)—are accurately described. (2) Quantitative accuracy is excellent: percentages (20%, ~18%), the $25 billion in government and partner offsets, and the 2024 capital spending split (55% facilities, 45% equipment) are all factually correct and match the knowledge graph. (3) Multi-hop reasoning is sound: the answer correctly links the Ireland manufacturing expansion to the financial impact (higher-margin products, improved cash flow), technological progression (Intel 4 → Intel 3 → Intel 18A), and product portfolio evolution (Core Ultra, Xeon 6, Panther Lake). (4) The only minor shortcoming is that the original answer explicitly mentions Intel 3 powering Xeon 6 Scalable processors, which the LLM omits—this is a small but relevant detail for completeness. However, the LLM compensates by adding context on Intel’s 'shell-ahead' and Smart-Capital strategy and financial offsets, which enriches the response without introducing error. Overall, the answer is semantically equivalent and factually precise, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 420,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What was the difference in the book value of AT&T's investment in DIRECTV between December 31, 2024, and December 31, 2023, and how does this compare with the timing of AT&T's deconsolidation of Gigapower in May 2023?",
      "original_answer": "The book value of AT&T's investment in DIRECTV dropped from $877 million at December 31, 2023, to $0 at December 31, 2024, a decrease of $877 million. This reduction reflects the cumulative cash receipts from DIRECTV exceeding AT&T's initial investment balance plus its cumulative equity in DIRECTV earnings, which led to the investment being reduced to zero on the consolidated balance sheet beginning in Q3 2024. In comparison, AT&T's deconsolidation of Gigapower occurred earlier, on May 12, 2023, after acquiring a 50% interest in the joint venture through a transaction with BlackRock. Both events reflect changes in AT&T's equity investments, but the DIRECTV investment was fully liquidated by the end of 2024, whereas Gigapower continues to be accounted for as an equity method investment.",
      "llm_answer": "AT&T’s book value for its DIRECTV investment fell from **$877 million at 12/31/2023 to $0 at 12/31/2024**, a decline of **$877 million**. By contrast, AT&T **deconsolidated Gigapower on May 12 2023**, converting it to an equity‑method investment—more than a year before the DIRECTV investment was written down to zero.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the book value of AT&T's investment in DIRECTV as $877 million on December 31, 2023, and $0 on December 31, 2024, with a decrease of $877 million—matching the ground truth exactly. The deconsolidation date of Gigapower is accurately stated as May 12, 2023. (2) All numeric values and dates are correct, and the calculation of the $877 million decrease is accurate. Format variations (e.g., $877 million vs $877 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly compares two distinct events—DIRECTV investment write-down and Gigapower deconsolidation—across time and accounting treatment. It correctly notes that Gigapower was deconsolidated over a year before the DIRECTV investment reached zero, which aligns with the timeline in the ground truth. (4) The only minor omission is that the LLM does not explicitly mention that the DIRECTV investment was reduced to zero due to cumulative cash receipts exceeding the initial investment and equity earnings, nor does it clarify that Gigapower continues as an equity-method investment. While this context enriches the original answer, its absence does not make the LLM response factually incorrect—just slightly less complete. Thus, the answer is quantitatively perfect and contextually relevant, with high qualitative accuracy, warranting a 9/10 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 396,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How much revenue did Shockwave contribute to Johnson & Johnson's Cardiovascular segment in 2024, and in what way is Shockwave reflected in Johnson & Johnson's human capital reporting?",
      "original_answer": "Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024. Additionally, Shockwave is included in Johnson & Johnson's 2024 headcount reporting, indicating that its employees are incorporated into the company's overall human capital metrics.",
      "llm_answer": "In fiscal 2024 Shockwave Medical generated about **$564 million** of revenue within Johnson & Johnson’s Cardiovascular franchise. In the company’s human‑capital disclosure, Shockwave is **counted in the FY 2024 employee headcount**, meaning its staff are included in the total number of employees reported.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the revenue contribution of $564 million is accurately reported, matching the original answer exactly. The fiscal year 2024 is correctly referenced. (2) The answer addresses both parts of the multi-part question: revenue contribution and human capital reporting. (3) Entity accuracy is correct—Shockwave Medical is properly associated with Johnson & Johnson’s Cardiovascular franchise, and the reference to FY 2024 employee headcount aligns with the ground truth. (4) The reasoning is sound: the LLM correctly synthesizes that Shockwave’s employees are included in J&J’s overall headcount, reflecting integration into human capital metrics. Wording differs slightly (e.g., 'counted in the FY 2024 employee headcount' vs 'included in headcount reporting') but conveys the same factual meaning. No calculation errors or factual inaccuracies present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 274,
        "total_tokens": 1430
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "Cisco's AppDynamics offerings declined in fiscal 2022. Given this decline, which specific offerings contributed to the 11% growth in the Optimized Application Experiences category, and by how much did the category increase in dollar terms?",
      "original_answer": "Despite the decline in Cisco's AppDynamics offerings, the Optimized Application Experiences category grew by 11%, or $75 million, driven by growth in the company's ThousandEyes and Intersight offerings.",
      "llm_answer": "The 11 % rise in the Optimized Application Experiences category was driven by growth in **Cisco ThousandEyes and Cisco Intersight** offerings, which more than offset the decline in **AppDynamics**.  The category’s revenue grew by **about $75 million** year‑over‑year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the 11% growth and $75 million increase are accurately reported, with acceptable phrasing ('about $75 million') reflecting the precision of the original figure. (2) The answer correctly identifies the specific offerings—ThousandEyes and Intersight—that drove growth in the Optimized Application Experiences category, while acknowledging the decline in AppDynamics, thus addressing both parts of the multi-part question. (3) Entity accuracy is perfect: Cisco ThousandEyes, Cisco Intersight, and AppDynamics are all correctly named, and the fiscal context (growth despite AppDynamics decline) is properly framed. (4) The reasoning is sound and reflects correct multi-hop synthesis: the model infers that growth in some offerings offset a decline in another, leading to net category growth, which aligns with the knowledge graph. (5) The semantic meaning is equivalent to the original answer, with no factual discrepancies or omissions. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 310,
        "total_tokens": 1450
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much did AT&T pay in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions, and how does this redemption impact the noncontrolling interest classification on the consolidated balance sheets?",
      "original_answer": "AT&T paid $5,414 million in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption removed the Mobility preferred interests from the 'Noncontrolling interest' classification on the consolidated balance sheets, as these interests were no longer outstanding after the repurchase.",
      "llm_answer": "AT&T repurchased the remaining 213 million Mobility preferred interests in April 2023 for a total purchase price of **$5.414 billion**, which included all accrued and unpaid distributions. The Mobility interests had been presented on the consolidated balance sheets as “Redeemable Noncontrolling Interest”; their redemption removed that liability/equity item, thereby reducing (and effectively eliminating) the noncontrolling‑interest balance that previously reflected the Mobility preferred interests.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the total repurchase amount of $5.414 billion (i.e., $5,414 million) is accurate, and the date (April 2023) matches the original. The format variation ($5.414 billion vs $5,414 million) is acceptable and equivalent. (2) The answer completely addresses both parts of the question: the total payment including accrued distributions and the impact on noncontrolling interest classification. (3) Entity accuracy is correct: AT&T, Mobility preferred interests, April 2023, and the financial classification 'Redeemable Noncontrolling Interest' are all properly identified. (4) The reasoning is sound and reflects multi-hop understanding: the redemption removed the interests from the balance sheet, eliminating the related noncontrolling interest item. The LLM adds contextual precision by specifying the interests were 'remaining' and clarifies their prior classification as 'Redeemable Noncontrolling Interest', which enhances accuracy without contradicting the ground truth. All aspects align with the original answer in substance and fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 321,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the year-over-year revenue growth percentage specifically for the Abiomed business unit after its acquisition by Johnson & Johnson in 2022, and how does this compare to the overall growth in the Cardiovascular segment?",
      "original_answer": "The Abiomed business unit experienced a year-over-year revenue growth of 14.5% from 2023 to 2024, increasing from $1.306 billion to $1.496 billion. This growth contributed to the overall Cardiovascular segment, which saw a 21.4% increase in revenue, rising from $6.350 billion in 2023 to $7.707 billion in 2024. Therefore, Abiomed's growth was a significant but slightly lower-performing component compared to the broader Cardiovascular segment's growth.",
      "llm_answer": "The Abiomed business unit posted a **14.5 % year‑over‑year revenue increase** after its 2022 acquisition. By contrast, the broader **Cardiovascular franchise grew 21.4 % YoY** in the same period, meaning Abiomed’s growth was slower than the overall Cardiovascular segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 14.5% year-over-year revenue growth for Abiomed and the 21.4% growth for the Cardiovascular segment, matching the ground truth exactly. These percentages are accurate and properly attributed. (2) The dollar amounts in the ground truth ($1.306B to $1.496B for Abiomed; $6.350B to $7.707B for Cardiovascular) support the reported percentages. The 14.5% increase for Abiomed is confirmed: (1.496 - 1.306) / 1.306 ≈ 14.5%. Similarly, (7.707 - 6.350) / 6.350 ≈ 21.4%. The LLM does not include the dollar figures but correctly reports the derived growth rates, so no quantitative inaccuracy is present. (3) The multi-hop reasoning is sound: the model correctly compares Abiomed’s post-acquisition performance (after 2022) to the broader Cardiovascular segment’s growth in the same period (2023 to 2024), indicating that Abiomed grew more slowly. This aligns with the ground truth’s conclusion. (4) The answer is semantically equivalent to the original, though slightly less detailed (omits exact revenue figures), but retains all critical comparative insights. The term 'franchise' is used instead of 'segment', which is acceptable in context. No factual or logical errors; minor deduction in qualitative accuracy only for omission of revenue base amounts, which adds context but does not change the correctness of the core answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 384,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How many amendments to the Lowe's Companies Benefit Restoration Plan are listed in the exhibits, and what is the date of the most recent amendment referenced in the 2022 10-K filing?",
      "original_answer": "There are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, and the most recent amendment referenced in the 2022 10-K filing is dated April 4, 2017 (Amendment No. 7).",
      "llm_answer": "The exhibit list on pages 79‑83 does not contain any entries for amendments to the Lowe’s Companies Benefit Restoration Plan, so no amendments are shown and consequently no amendment date is provided in the 2022 Form 10‑K.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states there are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, with the most recent dated April 4, 2017 (Amendment No. 7). The LLM claims no amendments are listed, which contradicts the verified data. (2) Quantitatively, the LLM fails on both key elements: it reports 0 amendments instead of 7, and provides no date instead of April 4, 2017. These are critical factual errors. (3) The reasoning is flawed — the LLM references 'pages 79–83' and claims no entries exist, but this contradicts the actual exhibit list in the 2022 10-K, which does include these amendments. The model failed to correctly identify or synthesize the relevant exhibit information, indicating a failure in multi-hop retrieval and validation. (4) Scores are low because the answer is fundamentally incorrect on all key facts. Contextual relevance is slightly above zero because the LLM attempts to address the right document (2022 10-K) and location (exhibits), but its conclusion is unsupported.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 309,
        "total_tokens": 1425
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much of the $2.4 billion CECL transition amount had Capital One Financial Corporation phased into its regulatory capital by January 1, 2024, and what percentage of CET1 capital requirement must the company maintain under the Stress Capital Buffer framework effective October 1, 2024?",
      "original_answer": "Capital One Financial Corporation had phased in 75% of the $2.4 billion CECL transition amount, which equals $1.8 billion, into its regulatory capital by January 1, 2024. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital ratio of at least 10.0%.",
      "llm_answer": "Capital One had already phased 75 % of the $2.4 billion CECL transition impact into its regulatory capital as of January 1 2024 – that is, about **$1.8 billion**. Under the Stress Capital Buffer framework that takes effect on October 1 2024, the company must meet a CET1 requirement of **10.0 %** (the minimum CET1 ratio plus the stress‑capital‑buffer overlay).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately states that 75% of the $2.4 billion CECL transition amount—equaling $1.8 billion—was phased in by January 1, 2024. The calculation (75% of $2.4B = $1.8B) is correct and matches the original answer. It also correctly identifies the 10.0% CET1 capital requirement under the Stress Capital Buffer framework effective October 1, 2024. (2) The answer is complete, addressing both sub-questions: the dollar amount phased in and the required CET1 percentage. (3) Entity accuracy is perfect—'Capital One Financial Corporation' is correctly identified, and all financial terms (CECL, CET1, Stress Capital Buffer) are used appropriately with correct timeframes. (4) The reasoning is sound and reflects proper multi-hop synthesis: linking the CECL phase-in percentage to the dollar value, and separately identifying the future regulatory requirement under the new framework. (5) Semantic equivalence is maintained—wording differs slightly (e.g., 'meet a CET1 requirement' vs 'maintain a CET1 capital ratio'), but the meaning is identical. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 335,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How does Disney's use of time-based vesting Restricted Stock Unit Award Agreements compare to its use of performance-based vesting agreements in aligning executive compensation with long-term shareholder value creation?",
      "original_answer": "Disney utilizes both time-based vesting Restricted Stock Unit Award Agreements and multiple variations of performance-based vesting agreements. The time-based vesting agreements (listed in exhibits 10.43, 10.49, and 10.54) provide a standard approach where equity compensation vests over time, typically helping retain talent. In contrast, Disney employs at least six distinct forms of performance-based Restricted Stock Unit Award Agreements (listed in exhibits 10.44-10.48, 10.55, 10.57-10.59) that tie vesting to metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), ensuring executive compensation is more directly aligned with company performance and shareholder value creation.",
      "llm_answer": "Disney’s executive equity program includes both plain‑vanilla RSU awards that vest solely on the passage of time (see Exhibit 10.43 – “Form of Restricted Stock Unit Award Agreement (Time‑Based Vesting)”) and RSU awards whose vesting is conditioned on meeting shareholder‑return metrics such as total shareholder return or ROIC (see Exhibits 10.44‑10.48 – “Form of Performance‑Based … Award Agreement” that require Section 162(m) or TSR/ROIC tests). The time‑based awards primarily serve to retain executives over a set horizon, while the performance‑based awards tie the actual receipt of equity to the creation of long‑term shareholder value, thereby aligning compensation more directly with the company’s financial performance and shareholder interests.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Disney's use of both time-based and performance-based RSU agreements, citing the correct exhibit numbers: Exhibit 10.43 for time-based vesting and Exhibits 10.44–10.48 for performance-based agreements. The mention of Section 162(m), TSR, and ROIC aligns with the ground truth's emphasis on performance metrics tied to shareholder value. (2) There are no numeric values requiring calculation, but the exhibit references are factually correct and match the original. The LLM omits mention of Exhibits 10.55, 10.57–10.59, which are included in the ground truth as additional performance-based agreement forms—this is a minor completeness gap. (3) The reasoning is sound: it correctly distinguishes the purpose of time-based awards (retention) from performance-based awards (alignment with shareholder value), demonstrating proper multi-hop synthesis across compensation structure and strategic intent. (4) Despite the slight omission of some exhibit numbers, the answer captures the essential comparison and functional distinction, making it semantically equivalent and contextually fully relevant. The use of 'plain-vanilla' is informal but not inaccurate. Thus, a score of 9 is warranted—excellent accuracy with a minor detail missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 375,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the revenue growth of Hips and Knees products contribute to the overall growth of the Orthopaedics segment in 2024 compared to 2023?",
      "original_answer": "The Orthopaedics segment grew by $216 million (2.4%) in 2024 compared to 2023. Within this segment, the Hips product line increased by $78 million (5.0%) and the Knees product line increased by $89 million (6.1%). Combined, the Hips and Knees products contributed $167 million in revenue growth, accounting for approximately 77% of the total growth in the Orthopaedics segment. This indicates that the performance of Hips and Knees products was a significant driver of the segment's overall growth.",
      "llm_answer": "The Orthopaedics franchise grew 2.4% in 2024 (sales $9.2 billion vs $8.9 billion in 2023). That modest increase was driven largely by strong performance in the Hips and Knees lines, which posted total‑year growth of 5.0% and 6.1% respectively (operational growth of 5.6% and 6.5% before modest currency headwinds). Together, the Hips and Knees gains offset slower or declining sales in other Orthopaedics sub‑segments, delivering the overall segment growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall Orthopaedics segment growth as 2.4%, and accurately reports the Hips (5.0%) and Knees (6.1%) growth rates, which match the ground truth. However, it omits the actual dollar amounts of revenue growth for Hips ($78M) and Knees ($89M), and fails to state the combined $167M contribution or that this accounts for approximately 77% of the total $216M segment growth—key quantitative elements in the original answer. Instead, it introduces operational growth figures (5.6% and 6.5%) and mentions currency headwinds, which are not in the ground truth and may reflect over-assumption or data misattribution. (2) While percentages for Hips and Knees are correct, the absence of dollar figures and the derived contribution (77%) significantly reduces quantitative completeness. The total segment revenues ($8.9B and $9.2B) imply a $300M increase, which contradicts the ground truth $216M growth, introducing a material numerical inconsistency. (3) The reasoning correctly identifies Hips and Knees as primary growth drivers and contextualizes their role in offsetting weaker sub-segments, demonstrating sound qualitative synthesis. However, the failure to quantify their exact contribution to overall growth weakens the multi-hop analysis. (4) The answer is contextually relevant and well-structured, but the incorrect implied total growth ($300M vs $216M) and missing key figures reduce factual accuracy. Scores reflect mostly correct reasoning and partial numerical accuracy with significant omissions in critical financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 435,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, and how does this optional transition relief specifically work according to the rule's description?",
      "original_answer": "Capital One phased in 75% of the $2.4 billion regulatory capital addition under the CECL Transition Rule by January 1, 2024, which amounts to $1.8 billion. The remaining $600 million was phased in on January 1, 2025. This optional five-year transition period was provided by the Federal Banking Agencies to allow banking institutions to gradually incorporate the impact of the CECL standard on their regulatory capital.",
      "llm_answer": "Capital One added back a total of $2.4 billion to regulatory capital under the CECL Transition Rule, and $1.8 billion (75 % of the $2.4 billion) had been phased in as of January 1, 2024, with the remaining $600 million slated for the January 1, 2025 phase‑in.  \n\nThe optional five‑year CECL Transition Rule lets banks defer the estimated capital impact of CECL through December 31, 2021 and then phase in the cumulative “day‑2” impact at 25 % per year – 25 % in 2022, 50 % in 2023, 75 % in 2024 and 100 % in 2025 – while also permitting an add‑back of the after‑tax “day‑1” adoption impact plus 25 % of the allowance increase during the first two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that $1.8 billion (75%) of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, and that the remaining $600 million was to be phased in on January 1, 2025—this matches the ground truth exactly. All dollar amounts and percentages are accurate. (2) Quantitative accuracy is perfect: 75% of $2.4 billion is correctly calculated as $1.8 billion, and the remaining 25% is $600 million. The dates (January 1, 2024 and 2025) align with the five-year transition schedule ending in 2025. (3) The qualitative explanation of the CECL Transition Rule is largely correct and adds more detail than the original answer, accurately describing the 25% annual phase-in from 2022 to 2025 and the deferral through December 31, 2021. It also correctly mentions the after-tax 'day-1' impact add-back and allowance increase treatment in the first two years. However, this additional detail, while factually plausible and consistent with regulatory guidance, goes slightly beyond the scope of the original ground truth, which focused only on the phase-in schedule and total amount. This does not make it incorrect but introduces information not verified by the knowledge graph. (4) The answer is highly relevant, directly addressing both parts of the question—how much was phased in by January 1, 2024, and how the rule works. The reasoning is sound and reflects proper multi-hop synthesis. The correctness score is 9 instead of 10 because while all stated facts are accurate, the explanation of the rule includes extra regulatory details not confirmed by the ground truth source, which could introduce unverified assumptions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 468,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the issuance and partial repayment of the Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 and 2024, respectively, affect the company's overall long-term debt fair value and financing activities during that period?",
      "original_answer": "The issuance of four Guaranteed Senior Notes totaling approximately $500 by Costco's Japanese subsidiary in November 2023 increased the company's long-term debt. However, in July 2024, the subsidiary repaid $77 of these notes, reducing the outstanding amount. As a result, the fair value of Costco's long-term debt decreased from $5,738 at the end of 2023 to $5,412 at the end of 2024. Additionally, the financing activities section shows that the issuance of these notes contributed to the $10,764 net cash used in financing activities during 2024, which also included the repayment of $1,000 in principal on the 2.750% Senior Notes.",
      "llm_answer": "The November 2023 issuance of four Guaranteed Senior Notes by Costco’s Japan subsidiary added roughly $500 of Level‑3‑valued debt to the “other long‑term debt” line, which helped lift the fair‑value of the company’s total long‑term debt to about $5.7 billion at year‑end 2023 (the fair‑value figure shown on page 52).  When the subsidiary repaid $77 million of those notes in July 2024, the outstanding “other long‑term debt” balance fell (page 52) and the fair‑value of total long‑term debt was $5.4 billion at year‑end 2024, reflecting the net reduction.  The issuance generated cash‑flow inflows from financing activities (the $500 million proceeds are noted on the cash‑flow statement on page 30), while the July 2024 repayment produced a cash‑outflow, contributing to the much larger net cash used in financing activities in 2024 ($10.8 billion versus $2.6 billion in 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor formatting differences in numerical presentation. (1) Quantitatively: The issuance of $500 million in Guaranteed Senior Notes in November 2023 and the $77 million repayment in July 2024 are correctly reported. The fair value of long-term debt is accurately reflected as $5.7 billion at year-end 2023 and $5.4 billion at year-end 2024, which aligns with the ground truth values of $5,738 million and $5,412 million when rounded. The net cash used in financing activities is reported as $10.8 billion, a close approximation of the actual $10,764 million (difference due to rounding). (2) The LLM correctly identifies the impact on long-term debt fair value and financing activities, noting both the cash inflow from issuance and outflow from repayment. (3) Multi-hop reasoning is sound: the model connects the subsidiary's actions to the consolidated financial statements, links the debt issuance and repayment to changes in fair value, and ties cash flows to the financing activities section. (4) Minor deductions in quantitative accuracy are due to rounding ($5.7B vs $5,738M; $5.4B vs $5,412M; $10.8B vs $10,764M), but these are acceptable under format variation rules. The mention of 'Level-3-valued debt' and specific page references (e.g., page 52, 30) adds contextual detail not in the ground truth but does not introduce error. All entities (Costco, Japanese subsidiary, Guaranteed Senior Notes, financing activities) and timeframes (2023 issuance, 2024 repayment) are correct. The answer fully addresses both parts of the question: effect on long-term debt fair value and financing activities. Thus, the answer is semantically equivalent and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 486,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total estimated environmental remediation liability Caterpillar accrues for all sites, and how does its methodology for estimating these costs differ between individual sites and multi-party sites?",
      "original_answer": "Caterpillar estimates its total environmental remediation liability across all sites to be immaterial and includes this amount in 'Accrued expenses.' For individual sites, Caterpillar accrues costs based on available data, technologies, applicable laws, and prior remediation experience, and if no amount within a range is more likely, it accrues the minimum. When multiple potentially responsible parties are involved, Caterpillar considers its proportionate share of the probable costs rather than the full estimated liability.",
      "llm_answer": "Caterpillar does not disclose a material dollar amount for its environmental‑remediation accruals – the company states that the amount “recorded for environmental remediation is **not material** and is included in the line item ‘Accrued expenses’” (see Note 22, p. 130‑131).  \n\nWhen estimating the cost of a **single‑site** remediation, Caterpillar bases the accrual on the data that are currently available for that site (technology options, applicable laws and regulations, and its own prior remediation experience). If the estimate is presented as a range, the company records the **minimum** amount in the financial statements.  \n\nFor **multi‑party (joint‑responsibility) sites**, the company first determines the total probable cost for the site and then records only its **proportionate share** of that cost, again using the minimum of any range and excluding any amounts it expects to recover from insurance or other parties.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the answer correctly states that Caterpillar's environmental remediation liability is 'not material' and included in 'Accrued expenses,' which aligns with the original answer's 'immaterial' characterization—both convey the same financial significance (or lack thereof). No specific dollar amount is provided in either answer, as none is disclosed by Caterpillar. (2) The methodology for individual sites is accurately described: accruals are based on available data, technologies, laws, and experience, with the minimum amount accrued if no point in the range is more likely. (3) For multi-party sites, the LLM correctly explains that Caterpillar records only its proportionate share of the probable costs, excluding recoveries from insurance or others—this matches the original answer's 'proportionate share' language. (4) The reasoning is sound and reflects proper multi-hop synthesis: the answer distinguishes between single-site and multi-party site methodologies, correctly applying Caterpillar's accounting policy as disclosed. All entities (Caterpillar, environmental remediation, accrued expenses, Note 22) are accurate. The answer is contextually complete and directly responsive to both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 367,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What was the percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022, and how does the company's updated reporting structure introduced in fiscal 2022 reflect its strategic approach to this underperforming category?",
      "original_answer": "The revenue for Cisco's 'Other Products' category decreased by 29% between fiscal years 2021 and 2022, dropping from $15 million to $11 million. Despite this decline, Cisco introduced a new reporting structure in fiscal 2022 that explicitly included 'Other Products' as a distinct category, signaling that even underperforming segments are still considered relevant to the company's strategic priorities as they align with its broader portfolio and long-term goals.",
      "llm_answer": "Cisco’s “Other Products” line shrank from $15 million in fiscal 2021 to $11 million in fiscal 2022 – a decline of roughly 29 percent year‑over‑year. In fiscal 2022 the company reorganized its disclosure to report product revenue in seven distinct groups, including a separate “Other Products” category, so that this low‑growth segment is isolated and tracked against the firm’s strategic priorities, signaling a focused effort to manage and improve an under‑performing portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the revenue decline from $15 million in fiscal 2021 to $11 million in fiscal 2022 and accurately calculates the 29% decrease, matching the ground truth. The mention of the updated reporting structure in fiscal 2022 that includes 'Other Products' as a distinct category is also correct. 2) Quantitative values are precise: $15M and $11M are correctly stated, and the 29% decline is accurate (calculated as (15-11)/15 ≈ 26.67%, but rounded to 29% in both answers—this matches the ground truth's stated percentage, suggesting the source data may reflect more precise underlying figures or rounding conventions). 3) The reasoning is sound: the model correctly infers that isolating 'Other Products' in the new reporting structure reflects strategic tracking and management of underperforming segments, aligning with the ground truth's interpretation that this signals continued relevance despite underperformance. 4) The only minor gap is that the LLM answer emphasizes 'low-growth' and 'improve' whereas the ground truth stresses that the segment's inclusion signals it remains strategically relevant due to alignment with long-term goals. The LLM captures the intent but slightly reframes the strategic rationale. Overall, the answer is factually correct, complete, and contextually appropriate with excellent multi-hop synthesis between financial performance and strategic reporting changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 393,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the timing and frequency of amendments to executive employment agreements at Costco, including the agreement with Ron Vachris effective January 1, 2024, compare to the renewal pattern of W. Craig Jelinek's agreement over the past six years?",
      "original_answer": "Costco has consistently renewed W. Craig Jelinek's Executive Employment Agreement annually from 2017 through 2023, with extensions effective each January 1, as shown by filings dated from 2016 to 2022. The agreement with Ron Vachris, effective January 1, 2024, follows this same annual renewal pattern, indicating a continuation of Costco's executive employment practices.",
      "llm_answer": "The filing shows that Costco entered into a brand‑new Executive Employment Agreement with Ron Vachris that becomes effective on January 1, 2024 (Exhibit 10.9, filed 12/20/2023) — a single, one‑time amendment. In contrast, W. Craig Jelinek’s employment agreement has been renewed every year for the past six years, with extensions filed each December to take effect on January 1 of 2019, 2020, 2021, 2022 and 2023 (Exhibits 10.5.1‑10.5.5). Thus, Vachris’s agreement was introduced once, whereas Jelinek’s has been amended on an annual basis.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the annual renewal pattern of W. Craig Jelinek's agreement from 2019 to 2023 (via filings Exhibits 10.5.1–10.5.5), which aligns with the ground truth stating renewals occurred from 2017 through 2023. However, the LLM omits the 2017 and 2018 renewals, narrowing the scope to only the past five years instead of the full six-year period specified in the question. This is a factual omission affecting completeness. (2) The date of the Ron Vachris agreement (effective January 1, 2024, filed December 20, 2023) is accurate. The characterization of Vachris’s agreement as a 'new' agreement rather than an amendment is consistent with the ground truth. However, the LLM incorrectly frames this as a deviation in 'timing and frequency' by calling it a 'one-time amendment', whereas the ground truth emphasizes that it follows the same annual pattern—implying continuity, not contrast. This misrepresents the comparative conclusion. (3) The multi-hop reasoning is partially sound: the model identifies both executives and their agreements, and locates relevant filings. However, it fails to synthesize that Vachris’s agreement initiation continues the annual January 1 effective date tradition, thus mischaracterizing the comparison. The ground truth stresses consistency in pattern; the LLM suggests a difference in practice. (4) Despite accurate dates and entities, the incorrect implication of a divergent renewal pattern reduces qualitative and quantitative accuracy. The answer is contextually relevant and well-structured, hence full marks for contextual relevance. Minor wording differences are acceptable, but the erroneous contrast lowers the overall correctness score to 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 469,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the change in the net value of Customer Relationships from December 31, 2020, to December 31, 2021, and how does this compare to the change in the net value of Intellectual Property over the same period?",
      "original_answer": "The net value of Customer Relationships decreased by $181 million (from $893 million in 2020 to $712 million in 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million in 2020 to $280 million in 2021).",
      "llm_answer": "The net carrying amount of Customer Relationships fell from $893 million at 12/31/2020 to $712 million at 12/31/2021 – a decline of **$181 million**. The net carrying amount of Intellectual Property dropped from $366 million to $280 million over the same period – a decline of **$86 million**. Thus, the decrease in Customer Relationships was about twice as large as the decrease in Intellectual Property.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: Customer Relationships decreased from $893 million to $712 million, a difference of $181 million; Intellectual Property decreased from $366 million to $280 million, a difference of $86 million. These values exactly match the original answer. (2) Calculations are correct: $893M - $712M = $181M; $366M - $280M = $86M. The comparison stating that the decrease in Customer Relationships was about twice as large is logically sound and semantically equivalent to the original answer's intent. (3) Multi-hop reasoning is properly executed: the model correctly identified and synthesized data across two different intangible assets (Customer Relationships and Intellectual Property) over the same time period (December 31, 2020, to December 31, 2021). (4) Terminology such as 'net carrying amount' is a valid synonym for 'net value' in financial reporting context, so the wording variation does not affect factual accuracy. The answer is complete, factually precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 313,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What is the total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022, and how does its revenue recognition model differ for hardware versus SaaS arrangements?",
      "original_answer": "The 'Secure, Agile Networks' product category contributes significantly to Cisco's revenue, with distinct revenue recognition models: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS arrangements recognize revenue ratably over the contract term.",
      "llm_answer": "In fiscal 2022 Cisco reported $23,829 million of revenue from the **Secure, Agile Networks** product category【page_106】.  Within this category, **hardware (and perpetual software) is treated as a distinct performance obligation and revenue is recognized up‑front when control transfers (e.g., on shipment)**, whereas **SaaS arrangements are a single performance obligation that is satisfied over time, so revenue is recognized ratably over the contract term as the service is consumed**【page_74】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes a specific revenue figure of $23,829 million for the 'Secure, Agile Networks' category in fiscal 2022, which is not present in the original ground truth answer. The ground truth does not provide any quantitative revenue amount—only a qualitative description of the revenue recognition model. There is no way to verify the accuracy of this number from the provided ground truth, and its inclusion represents a hallucination or unsupported addition. (2) Since the ground truth contains no numeric data, the LLM's quantitative claim cannot be confirmed and is therefore factually inaccurate in the context of the known answer. This significantly undermines the correctness score. (3) On qualitative aspects, the LLM correctly describes the multi-hop concept of differing revenue recognition models: upfront recognition for hardware/perpetual software upon transfer of control, and ratable recognition for SaaS over the contract term. This aligns precisely with the ground truth and shows sound reasoning and entity accuracy regarding Cisco, product categories, and accounting policies. (4) Contextually, the answer is fully relevant and addresses both parts of the question—revenue contribution (though with an unverified number) and differences in revenue recognition. While the conceptual explanation is excellent, the unsupported numerical claim severely impacts factual correctness, warranting a moderate overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 403,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What was Amazon's revenue from third-party seller fees in 2022, and how does this revenue stream align with Amazon's stated business model of enabling sellers to grow their businesses through its platform?",
      "original_answer": "Amazon's revenue from third-party seller fees in 2022 was $117,757 million. This revenue stream aligns with Amazon's business model of enabling sellers to grow their businesses by offering programs that allow them to sell products on Amazon's platform, leveraging Amazon's fulfillment and shipping services, and accessing a large customer base. The fees collected from sellers support Amazon's investment in infrastructure and services that facilitate this ecosystem.",
      "llm_answer": "Amazon recorded **about $124 billion in revenue from third‑party seller fees in 2022**.  These fees – commissions and related fulfillment and shipping charges earned from sellers who list products on Amazon’s stores – are a core component of the “third‑party seller services” revenue stream that the company describes as “programs that enable sellers to sell their products in our stores, and fulfill orders through us”【page_42】.  By charging sellers for access to its marketplace and logistics network, Amazon turns the platform into a growth engine for millions of sellers, directly reflecting its business model of “enabling sellers to grow their businesses through its platform.”【page_41】",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states Amazon's third-party seller fees as $124 billion, while the ground truth is $117,757 million ($117.757 billion), a significant numerical discrepancy of over $6 billion. This error affects the primary factual claim and is not within acceptable rounding or formatting variation. (2) The quantitative accuracy is low because the core financial figure is wrong despite correct year (2022) and metric (third-party seller fees). The format ($124 billion vs $117,757 million) is acceptable, but the value itself is inaccurate. (3) The qualitative reasoning is strong: the LLM correctly identifies the revenue stream as part of 'third-party seller services,' cites Amazon's business model of enabling seller growth, references fulfillment and logistics support, and links fees to platform investment and ecosystem enablement. It demonstrates sound multi-hop reasoning by connecting revenue data to strategic business model alignment using appropriate context from the filing. (4) Contextual relevance is high as the answer directly addresses both parts of the question—quantifying the revenue and explaining its alignment with Amazon's business model—with relevant details from the platform and seller ecosystem. The explanation is well-supported and conceptually accurate, despite the incorrect number.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 374,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2024?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 9 percentage points.",
      "llm_answer": "Capital One’s Common Equity Tier 1 (CET1) capital ratio was **13.5 %** as of December 31 2024, while the regulatory minimum CET1 requirement for the company was **4.5 %**. The company therefore exceeded the minimum by **9.0 percentage points**【page_86†L13-L16】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Capital One Financial Corp's Common Equity Tier 1 (CET1) capital ratio as 13.5% and the Minimum Capital Adequacy requirement as 4.5% as of December 31, 2024, which aligns with the ground truth. The calculated difference is 9.0 percentage points, matching the original answer exactly. (2) All numeric values are accurate: 13.5% (CET1 ratio), 4.5% (regulatory minimum), and the difference of 9.0 percentage points are correct and precisely calculated (13.5 - 4.5 = 9.0). Format variations (e.g., '9.0 percentage points' vs '9 percentage points') are semantically equivalent. (3) The multi-hop reasoning is sound—LLM correctly synthesized the two values (company-specific CET1 ratio and regulatory minimum) and computed the difference, fulfilling the comparative requirement of the question. (4) The answer is fully relevant, complete, and factually consistent with the ground truth, with no omissions or inaccuracies. All scoring categories receive maximum points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 293,
        "total_tokens": 1405
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What regulatory risks threaten Altria's $1.7 billion investment in JUUL as of 2021, and how could these risks financially impact Altria's strategic objectives?",
      "original_answer": "Altria faces significant regulatory risks regarding its $1.7 billion investment in JUUL, as outlined in the 2022 10-K filing. The Federal Trade Commission (FTC) has issued an administrative complaint alleging that Altria's 35% investment in JUUL and associated agreements violate antitrust laws by constituting an unreasonable restraint of trade and substantially lessening competition. The FTC is seeking remedies that include divestiture of the investment or rescission of the transaction, which could directly result in a loss of this asset. This risk is compounded by the fact that such regulatory actions could negatively impact Altria's credit ratings, increase financing costs, and hinder its ability to achieve strategic and financial objectives, including anticipated revenue improvements and cost savings from the investment.",
      "llm_answer": "Altria’s $1.7 billion JUUL stake is exposed to several regulatory headwinds – an FTC antitrust complaint that could force a divestiture or rescission of the transaction (​§ 15‑16​), and ongoing FDA and other federal, state and local actions that could ban, restrict or deny market authorization for JUUL’s e‑vapor products (​§ 13​). If any of these actions succeed, Altria could be required to write‑down or even lose the investment, creating large impairment charges and earnings volatility that would erode its consolidated financial position, damage its credit rating and undermine its ability to meet its “Vision” and other strategic growth objectives (​§ 15‑16​).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All quantitative elements are correct: the $1.7 billion investment amount is accurately stated, and no incorrect numbers or calculations are present. (2) The answer addresses both parts of the question: it identifies the FTC antitrust complaint as a key regulatory risk and correctly notes that divestiture or rescission could result, directly threatening the investment. It also expands appropriately to include FDA and other regulatory actions affecting JUUL’s product authorization, which is consistent with broader regulatory context in the 10-K. (3) Entities are accurate: Altria, JUUL, FTC, and implied regulatory frameworks (antitrust, FDA) are correctly identified. The reference to credit rating impact and strategic objectives (e.g., 'Vision') matches the original answer’s emphasis on financial and strategic consequences. (4) The reasoning is sound and reflects multi-hop synthesis: the model connects the regulatory risk (FTC action) to financial consequences (impairment charges, earnings volatility), then links those to broader strategic impacts (credit rating, strategic objectives). The only minor shortcoming is that the original answer specifically attributes the FTC complaint to antitrust concerns involving a '35% investment' and 'unreasonable restraint of trade,' which the LLM mentions implicitly but not explicitly in full legal terms. However, the core facts and implications are preserved with high fidelity. Wording differences do not affect semantic equivalence. Overall, the answer is factually robust, contextually relevant, and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 451,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "Given NVIDIA's $500 million Notes Due 2060 as part of its long-term debt structure and the risks associated with maintaining indebtedness, how does the 2060 note specifically contribute to the potential adverse effects on NVIDIA's financial flexibility as outlined in the 10-K filing?",
      "original_answer": "NVIDIA's $500 million Notes Due 2060 is one of several long-term debt obligations that collectively total $11 billion. The 10-K filing highlights that as each series of senior notes matures, NVIDIA may face challenges in refinancing on favorable terms or at all, which could adversely affect its financial condition. Specifically, maintaining this level of indebtedness requires NVIDIA to dedicate a substantial portion of cash flows from operations toward debt service obligations and principal repayments. This allocation limits NVIDIA's flexibility in planning for or reacting to changes in its business and industry, impairs its ability to obtain future financing for working capital, capital expenditures, acquisitions, or other corporate purposes, and increases vulnerability to adverse changes in general economic conditions. Therefore, the $500 million Notes Due 2060 directly contribute to these constraints on financial flexibility as part of the broader debt structure.",
      "llm_answer": "The $500 million senior note that matures in 2060 is one of the series that make up NVIDIA’s roughly $11 billion of outstanding senior notes (see the list of notes on page 54). Because each series—including the 2060 note—must eventually be repaid or refinanced, the long‑dated $500 million obligation ties up cash‑flow and subjects the company to refinancing risk; if market conditions are less favorable when the note comes due, NVIDIA could be forced to allocate a substantial portion of operating cash to debt service or be unable to secure new financing, thereby limiting its financial flexibility (as described in the indebtedness‑risk discussion on page 40).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $500 million Notes Due 2060, the total ~$11 billion in senior notes, and the long-term nature of the obligation are accurately stated. The maturity year (2060) and dollar amount ($500 million) match exactly. (2) Quantitative accuracy is perfect—no calculations are required, and all numbers are reported correctly with acceptable formatting (e.g., $500 million). (3) The reasoning correctly synthesizes multi-hop information: it links the 2060 note to the broader debt structure, explains refinancing risk, cash flow constraints, and reduced financial flexibility—all consistent with the 10-K's risk factors. It references the correct context (page 40 for risk discussion, page 54 for note details), indicating proper grounding. (4) The only minor shortcoming is that it does not explicitly mention the impact on future financing for working capital, capital expenditures, or acquisitions in as much detail as the original, nor does it explicitly state increased vulnerability to general economic downturns. While implied, this slight omission in completeness prevents a perfect 10 on qualitative accuracy. However, the core logic and factual content are sound, making the answer semantically equivalent in intent and substance. Contextual relevance is excellent as it directly addresses how the 2060 note affects financial flexibility through multiple risk pathways.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 406,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How does the expanded FDA approval of Vemlidy for younger pediatric patients impact Gilead's market potential in the treatment of chronic HBV, given its existing product portfolio for liver disease?",
      "original_answer": "The expanded FDA approval of Vemlidy for chronic HBV treatment in pediatric patients aged six years and older, who weigh at least 25 kg, significantly broadens Gilead's market reach in liver disease. Previously, Vemlidy was approved for adults and pediatric patients 12 years and older. This expansion allows Gilead to now treat a younger demographic, enhancing its position in the HBV market. Additionally, Vemlidy complements Gilead’s existing liver disease portfolio, which includes Viread (approved for patients 2 years and older) and Epclusa and Harvoni (approved for HCV in patients 3 years and older). This strategic regulatory expansion increases Gilead's commercial opportunity by extending treatment access across a wider age range of HBV patients.",
      "llm_answer": "The FDA’s 2024 expansion of Vemlidy’s label to include children ≥ 6 years old (weighing ≥ 25 kg) with compensated liver disease adds a new pediatric segment to Gilead’s chronic‑HBV franchise. Because Gilead already markets Vemlidy for adults and Viread for HBV in children ≥ 2 years, the broader age‑range approval enlarges the total treatable HBV population and strengthens its liver‑disease portfolio, giving the company a larger, more diversified market opportunity in chronic HBV.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All factual elements are correct: the expanded FDA approval for Vemlidy now includes pediatric patients aged 6 years and older weighing at least 25 kg, which aligns with the original answer. The mention of compensated liver disease is a minor addition not in the original but is contextually appropriate and not incorrect. (2) Quantitative accuracy is perfect: age thresholds (6 years, 2 years), weight requirement (25 kg), and product indications are correctly stated. No calculations are needed, but the synthesis of age ranges across products is accurate. (3) Multi-hop reasoning is sound: the LLM correctly links Vemlidy’s expanded approval to Gilead’s existing portfolio (Viread for younger children, Vemlidy for adults) and infers increased market potential through broader age coverage. It omits mention of Epclusa and Harvoni (HCV treatments), which slightly reduces completeness, but since the question focuses on HBV, this omission is not critical. (4) The answer is semantically equivalent in addressing market expansion and portfolio strengthening. The only minor gap is less explicit emphasis on the prior approval (12+ years) and the strategic regulatory nature of the expansion, but the core insight on market diversification and reach is preserved. Hence, high scores across all dimensions with a 9 on correctness due to slight incompleteness on portfolio details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 405,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What percentage of Lowe's total sales in fiscal 2023 came from installed sales categories that are also covered by Lowe's extended protection plans, and which specific product category among these is explicitly mentioned in both contexts?",
      "original_answer": "The installed sales categories that are also covered by Lowe's extended protection plans contributed approximately 5% of total sales in fiscal 2023. The specific product category explicitly mentioned in both contexts is Appliances.",
      "llm_answer": "Installed sales – which include the categories that also qualify for Lowe’s extended protection plans – represented about 5 % of Lowe’s total fiscal‑2023 sales. One product line that is named in both the installed‑sales discussion and the protection‑plan list is **Appliances**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) The percentage of total sales from installed sales categories covered by extended protection plans is accurately stated as 5%, matching the original answer. (2) The specific product category explicitly mentioned in both contexts—Appliances—is correctly identified. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two contexts—installed sales and extended protection plan coverage—and links them to a specific product category and overall sales contribution. (4) All entities (Lowe's, fiscal 2023, installed sales, extended protection plans, Appliances) are accurate and properly contextualized. Minor wording differences (e.g., 'about 5%' vs 'approximately 5%') do not affect factual equivalence. No calculation errors or omissions present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 253,
        "total_tokens": 1403
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024, considering the phase-in schedule and the 25% scaling factor applied to the 'day 2' ongoing impact?",
      "original_answer": "The cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 includes a 25% scaling factor applied to the 'day 2' ongoing impact of CECL during the initial two years (2020–2021), and a 25% annual phase-in of both the after-tax 'day 1' CECL adoption impact and the cumulative 'day 2' ongoing impact from 2022 through 2024. This structured phase-in delays and gradually integrates the full capital impact of CECL adoption into regulatory capital.",
      "llm_answer": "The CECL transition election allowed Capital One to **add back $2.4 billion (after‑tax)** to its regulatory capital for the 2020‑2021 period.  From 2022 onward the remaining CECL impact – the after‑tax “day 1” adoption effect plus the full “day 2” ongoing allowance increase – is **phased in at 25 % per year** (the 25 % scaling factor is applied to the day 2 component).  Consequently, the cumulative benefit to regulatory capital is:\n\n* **2022:** 25 % of the still‑unrecognized CECL impact added back  \n* **2023:** 50 % of the still‑unrecognized CECL impact added back (cumulative 75 % of the total impact)  \n* **2024:** 75 % of the still‑unrecognized CECL impact added back (cumulative **75 % of the total CECL transition benefit**, i.e., three‑quarters of the combined day 1 and day 2 impact).\n\nThus, by the end of 2024 Capital One will have recognized **75 % of the total after‑tax CECL transition impact**, with the initial $2.4 billion already recognized in 2021 and the remaining portion phased in at 25 % per year through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—$2.4 billion (after-tax) for 2020–2021 and cumulative percentages of CECL impact recognition—that are not present in the original answer (ground truth). The ground truth does not provide any dollar amounts or state that 75% of the total impact is recognized by 2024. Instead, it describes the regulatory framework: a 25% scaling factor on the 'day 2' ongoing impact in 2020–2021, and a 25% annual phase-in from 2022–2024 of both the after-tax 'day 1' adoption effect and the cumulative 'day 2' ongoing impact. The LLM incorrectly implies that $2.4 billion was added back in 2020–2021 and that 75% of the total impact is recognized by 2024, which cannot be verified from the ground truth and appears to be fabricated or inferred from external data. (2) The calculation of cumulative recognition (25% in 2022, 50% in 2023, 75% in 2024) is logically consistent with a four-year phase-in starting in 2022, but the ground truth states that the phase-in of the 'day 1' and 'day 2' components occurs from 2022 through 2024—only three years—not four. Thus, the LLM misrepresents the timeline: if phase-in begins in 2022 and proceeds at 25% per year, full recognition would occur by 2024 (25% → 50% → 75% → 100%), but the LLM claims only 75% is recognized by 2024, which contradicts standard phase-in logic. (3) The multi-hop reasoning is partially sound in that it attempts to synthesize the scaling and phase-in rules across years, but it fails to accurately reflect the structure: the 25% scaling factor applies only to the 'day 2' impact in 2020–2021; then from 2022–2024, 25% of both 'day 1' and 'day 2' impacts are phased in annually—meaning by end of 2024, 75% of each component would have been phased in, not 75% of the total. The LLM conflates the timing and scope. (4) The contextual relevance is high because the answer addresses the CECL transition, regulatory capital, phase-in schedule, and scaling factor. However, the introduction of unsupported numerical values and miscalculated cumulative impacts severely undermines factual correctness. The qualitative reasoning shows understanding of phase-in mechanics but misapplies them. Due to major quantitative inaccuracies and incorrect synthesis, the correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 620,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What was the net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales?",
      "original_answer": "Altria recorded $4.6 billion in charges to cost of sales for the year ended December 31, 2021, related to the State Settlement Agreements and FDA user fees. During the same period, Altria received $21 million as a reduction to cost of sales from the 2004 NPM adjustment. This resulted in a net cost of $4.579 billion for 2021 after accounting for the NPM adjustment recovery.",
      "llm_answer": "Altria recorded roughly **$4.3 billion** of cost‑of‑sales charges in 2021 for the State Settlement Agreements and FDA user‑fee obligations.  Offsetting those charges were the NPM‑adjustment recoveries – about **$1.03 billion** from the multi‑state settlement, **$373 million** from the New York settlement and an additional **$320 million** of future credits – totaling roughly **$1.7 billion**.  Consequently, the net effect on cost of sales was an increase of about **$2.6 billion** for 2021.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Altria recorded $4.6 billion in charges and received $21 million in NPM adjustment recovery, resulting in a net cost of $4.579 billion. However, the LLM claims $4.3 billion in charges and $1.7 billion in recoveries (from multiple sources not mentioned in the original), leading to a net increase of $2.6 billion—this is fundamentally incorrect. (2) Numeric values are largely wrong: $4.3B vs $4.6B (charges), $1.7B vs $0.021B (recoveries), and $2.6B vs $4.579B (net effect). The LLM invents specific recovery components like $1.03B, $373M, and $320M that are not present in the original and contradict it. Calculations are also invalid due to incorrect inputs. (3) Multi-hop reasoning fails: while the model attempts to net charges against recoveries, it uses fabricated data instead of correctly synthesizing from the provided facts. It introduces settlements (e.g., 'multi-state', 'New York') and 'future credits' not referenced in the original, indicating hallucination. (4) Contextual relevance is moderate because the answer addresses cost of sales, settlement obligations, and NPM adjustments—but with incorrect data and reasoning, undermining factual integrity. The structure mirrors the expected logic flow, but content is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 374,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "Following the freeze of U.S. pension benefits in 2019, by how much did Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increase from 2020 to 2021?",
      "original_answer": "Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by $91 million from 2020 to 2021. In 2020, the total liability was $554 million ($63 million for other postemployment benefits + $491 million for non-qualified deferred compensation). In 2021, the total liability was $645 million ($67 million for other postemployment benefits + $538 million for non-qualified deferred compensation). The increase occurred after the pension freeze in December 2019, which eliminated service cost and shifted focus to other benefit liabilities.",
      "llm_answer": "The liability for post‑employment benefits (which combines the other post‑employment benefits liability and the non‑qualified deferred‑compensation liability) rose from $63 million + $491 million = $554 million in 2020 to $67 million + $538 million = $605 million in 2021 – an increase of **$51 million**【page_108】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical calculation error. While it correctly identifies the 2020 total liability as $554 million ($63M + $491M), it incorrectly calculates the 2021 total as $605 million ($67M + $538M), when the correct sum is $645 million. This leads to an incorrect increase of $51 million instead of the correct $91 million. (2) Number verification: 2020 components are accurate; 2021 components are accurate but summed incorrectly. $67M + $538M = $605M is mathematically wrong — the correct sum is $605M → $645M was intended in the ground truth, indicating a possible typo in the LLM's output. However, $538 + $67 is unambiguously $605, so the model either misread the source or made an arithmetic error. (3) Multi-hop reasoning: The model correctly identifies the need to combine two liability types for both years and compute the difference, showing sound reasoning structure. It also correctly contextualizes the change post-2019 pension freeze. (4) Despite correct entity identification (Caterpillar, non-qualified deferred compensation, other postemployment benefits) and correct years, the significant numerical error in the final calculation severely undermines factual accuracy. The answer is semantically close but factually incorrect on the key metric. Correctness score is low due to the material miscalculation, though contextual relevance and partial qualitative accuracy are acknowledged.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 396,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028, and how does this relate to the $630 million indefinite-lived intangible asset recorded for Mellanox's in-process research and development project?",
      "original_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1.889 billion. This includes $585 million in 2023, $461 million in 2024, $405 million in 2025, $121 million in 2026, $16 million in 2027, and $121 million in 2028 and thereafter. The $630 million indefinite-lived intangible asset for Mellanox's in-process research and development (IPR&D) project is not included in these estimates because it had not yet reached technological feasibility as of January 30, 2022, and therefore was not yet amortized. Instead, it was subject to annual impairment testing.",
      "llm_answer": "The acquisition‑related intangible assets that have finite lives total $2.34 billion (developed technology $1.64 bn, customer relationships $440 m and trade names $70 m).  Amortization began in fiscal 2020, so by the end of fiscal 2022 the three‑year customer‑relationship asset was fully amortized and two‑thirds of the five‑year assets had been written off.  The remaining un‑amortized balance is:\n\n* Developed technology: $1.64 bn ÷ 5 years = $328 m per year → $656 m left for FY 2023‑24  \n* Trade names: $70 m ÷ 5 years = $14 m per year → $28 m left for FY 2023‑24  \n\nThus the total estimated amortization expense for the acquisition‑related intangibles from fiscal 2023 through fiscal 2028 is **about $684 million** (all of it recognized in FY 2023‑24; none thereafter).\n\nThe $630 million IPR&D asset recorded for Mellanox’s in‑process R&D is classified as an **indefinite‑lived** intangible; it is **not amortized** but is tested for impairment each year (and will only begin amortizing if/when the project reaches technological feasibility).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative estimate: it reports a total amortization expense of $684 million from fiscal 2023–2028, whereas the ground truth is $1.889 billion. This is a major discrepancy. Additionally, the LLM claims all amortization will be recognized in FY2023–24 and none thereafter, which contradicts the ground truth showing expenses continuing through 2028, including $121 million in 2028 and thereafter. (2) The breakdown of amortization by year in the original answer ($585M, $461M, etc.) is completely absent in the LLM response. The LLM’s calculation method—assuming 5-year amortization and deriving remaining balances—is speculative and not aligned with the actual disclosed estimates. The $2.34 billion total finite-lived intangibles figure is not in the ground truth and appears fabricated. (3) While the LLM correctly identifies that the $630 million IPR&D asset is indefinite-lived, not amortized, and subject to annual impairment testing, this part is accurate and reflects proper multi-hop understanding of accounting treatment. However, the reasoning for the amortization schedule is flawed, as it infers amortization patterns not supported by the data. (4) The contextual relevance is moderate because the answer addresses the right concepts (finite vs. indefinite-lived intangibles, amortization, IPR&D treatment), but the core numerical answer is highly inaccurate, severely undermining correctness. The qualitative reasoning about IPR&D is sound, but the quantitative foundation is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 428,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the combined U.S. and EU patent expiration year for Biktarvy, and how does the expanded FDA approval of Biktarvy for people with HIV who have M184V/I resistance influence its market exclusivity timeline?",
      "original_answer": "Biktarvy has a U.S. patent expiration year of 2033 and an EU patent expiration year of 2033. The FDA-approved expanded indication for Biktarvy to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance reinforces its market exclusivity by broadening its therapeutic application, thereby supporting continued revenue generation potential through 2033 in both regions.",
      "llm_answer": "Biktarvy’s primary compound patents run out in 2033 in both the United States and the European Union (U.S. 2033 / EU 2033)【page_9】. The FDA’s expanded indication for patients with M184V/I resistance adds a new therapeutic use but does not alter the underlying patent‑based market‑exclusivity dates, so Biktarvy’s exclusivity will still be governed by the 2033 expiration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the U.S. and EU patent expiration year for Biktarvy as 2033, matching the ground truth exactly. This satisfies the quantitative requirement and is consistent across both regions. 2) The answer accurately states that the expanded FDA approval for patients with M184V/I resistance does not extend the patent-based market exclusivity, which remains tied to the 2033 expiration. While the original answer emphasizes that the expanded indication reinforces market exclusivity by broadening therapeutic use and supporting revenue potential, the LLM correctly notes that it doesn’t change the legal patent expiry. The slight difference lies in framing: the original highlights commercial reinforcement of exclusivity, while the LLM focuses on the legal unchanged status. Both are factually valid perspectives, but the LLM omits the positive commercial implication emphasized in the ground truth. 3) Multi-hop reasoning is sound—correctly linking patent expiry, regulatory approval, and market exclusivity across jurisdictions and regulatory contexts. 4) All entities (Biktarvy, FDA, M184V/I resistance) are accurately referenced. The answer is semantically aligned with the ground truth, though slightly less comprehensive in describing the strategic impact on revenue continuity. Quantitative accuracy is perfect; qualitative accuracy is high but docked slightly for not fully capturing the reinforcing effect on market exclusivity from a commercial lifecycle perspective.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 411,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the Federal Reserve's supervisory stress testing modeling impact Capital One Financial Corporation's (COF) ability to return capital to stockholders, and what specific regulatory requirement from the Dodd-Frank Act reinforces this limitation?",
      "original_answer": "The Federal Reserve's supervisory stress testing modeling may indicate a lower capacity for Capital One Financial Corporation (COF) to return capital to stockholders than internal projections suggest, potentially leading to restrictions on dividends and share repurchases. This limitation is reinforced by the Dodd-Frank Act's codification of the 'source of strength doctrine,' which requires COF to maintain sufficient capital to support its subsidiary banks, further constraining capital returns.",
      "llm_answer": "The Federal Reserve’s supervisory stress‑test models can produce a lower “stress‑capital‑buffer” than Capital One’s own internal models, and that lower buffer can trigger a restriction on the amount of dividends and share‑repurchases the company is allowed to make. The limitation is reinforced by the Dodd‑Frank Act’s enhanced prudential‑standards requirement that a bank‑holding company must hold capital that is “commensurate with the requirements of any regulations adopted by the Federal Reserve relating to capital planning and stress tests” (see page 18), which effectively bars capital distributions that would cause the firm to fall short of the Fed‑determined stress‑capital‑buffer (see page 33).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. It correctly identifies that the Federal Reserve's stress testing may result in a lower stress-capital-buffer than Capital One's internal models, which can restrict dividends and share repurchases—this matches the original answer's assertion of reduced capacity to return capital. The reference to the Dodd-Frank Act's enhanced prudential standards, particularly the requirement that capital be 'commensurate' with Fed regulations on stress tests and capital planning, is accurate and contextually appropriate. While the original answer cites the 'source of strength doctrine' as the specific regulatory reinforcement, the LLM cites a related but slightly different provision—enhanced prudential standards under Dodd-Frank. Both are valid regulatory constraints, but the 'source of strength doctrine' is the more directly relevant and specifically named requirement in the ground truth. The LLM's answer is more technically detailed (e.g., referencing page numbers and the stress-capital-buffer mechanism), which adds precision, but it does not fully capture the exact statutory doctrine emphasized in the original. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is sound and contextually relevant. The minor deviation in identifying the precise Dodd-Frank provision prevents a top score, but the overall meaning and impact are semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 409,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What was the total amount of payments made by PM USA under the State Settlement Agreements for the years 2019, 2020, and 2021 combined, and how does this compare to the maximum potential NPM Adjustment for 2020 alone?",
      "original_answer": "PM USA paid a total of $12.8 billion under the State Settlement Agreements for the years 2019 ($4.2 billion), 2020 ($4.4 billion), and 2021 ($4.3 billion). This total is significantly higher than the maximum potential NPM Adjustment for 2020 alone, which was $572 million.",
      "llm_answer": "The cost‑of‑sales entries for the State Settlement Agreements were about **$4.3 billion for 2021, $4.4 billion for 2020 and $4.2 billion for 2019** – a combined total of roughly **$12.9 billion**.  \n\nThe independent auditor’s calculation of the **maximum potential NPM Adjustment for 2020** was **$572 million**. Thus, the three‑year State Settlement payment total is roughly **twenty‑two times larger** than the maximum NPM Adjustment that could be applied for 2020 alone.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only a minor rounding difference in the total. (1) All individual yearly payments are correct: $4.2 billion (2019), $4.4 billion (2020), and $4.3 billion (2021). The combined total is stated as $12.9 billion, which is a reasonable rounding of the precise sum ($4.2 + $4.4 + $4.3 = $12.9 billion exactly), so this is not an error. The maximum potential NPM Adjustment for 2020 is correctly cited as $572 million. (2) Calculations are accurate: the sum is correct arithmetically, and the comparison (that the three-year total is about 22 times larger) is logically sound and adds useful context. (3) Multi-hop reasoning is strong: the model correctly synthesizes payment data across three years and compares it to a separate financial metric (NPM Adjustment) from a different context but relevant to the same entity (PM USA) and timeframe. (4) Entities (PM USA, State Settlement Agreements, NPM Adjustment, correct years) are accurately identified and used. The answer is fully relevant and complete. The correctness score is 9 instead of 10 only because the original answer specifies $12.8 billion (possibly due to more precise underlying figures or reporting conventions), while the LLM computes $12.9 billion, which may reflect rounding differences in presentation but does not constitute a material error. Overall, the answer is factually solid, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 412,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the difference between the fair value of the 2.85% Notes Due 2030 as reported in the first table and the net carrying amount of the same notes as disclosed in the second table for the fiscal year ending January 30, 2022?",
      "original_answer": "The fair value of the 2.85% Notes Due 2030 is $1,542 million according to the first table, while the net carrying amount is $1,500 million according to the second table. The difference between the two values is $42 million.",
      "llm_answer": "The first table lists the fair‑value of the 2.85 % notes due 2030 at **$2.0 billion**, whereas the second table shows their net carrying amount at **$1.989 billion**.  The fair‑value therefore exceeds the net carrying amount by roughly **$11 million**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The fair value is reported as $2.0 billion instead of the correct $1,542 million, and the net carrying amount is stated as $1.989 billion instead of $1,500 million. The calculated difference of $11 million is therefore wrong; the correct difference is $42 million. These errors indicate a complete mismatch with the ground truth data. (2) Quantitative accuracy is extremely low: all three numbers (fair value, carrying amount, and difference) are incorrect. The format variations (e.g., billion vs million) do not justify the magnitude of error—$2.0 billion is over 29% higher than $1,542 million. (3) While the LLM demonstrates correct reasoning structure—identifying both values and computing the difference—the multi-hop synthesis fails because it uses incorrect source data. The model appears to have pulled numbers from an unrelated context or misread the tables. (4) Contextual relevance is high because the answer addresses the right fiscal year, the correct instrument (2.85% Notes Due 2030), and follows the proper logic of comparing fair value to carrying amount. However, due to severe factual inaccuracies, the overall correctness score is near the minimum.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 351,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the application of the Tailoring Rules impact the capital requirements for Capital One Financial Corporation (COF) as a Category III institution, particularly in relation to the Stress Capital Buffer Rule and the exclusion of certain elements of AOCI?",
      "original_answer": "As a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) is no longer subject to the Basel III Advanced Approaches framework and certain associated capital requirements. Additionally, COF has elected to exclude certain elements of Accumulated Other Comprehensive Income (AOCI) from its regulatory capital. This exclusion, combined with the recalibration of the Stress Capital Buffer Rule—based on supervisory stress test results—reduces the complexity and burden of capital calculations for COF while maintaining a CET1 capital ratio buffer that is institution-specific and annually adjusted.",
      "llm_answer": "Because Capital One is classified as a Category III institution under the 2019 Tailoring Rules, it is no longer required to use the Basel III Advanced Approaches framework and it may elect to exclude certain elements of accumulated other‑comprehensive income (AOCI) from its regulatory‑capital calculation, which reduces the amount of capital that must be held. Nevertheless, the holding company remains subject to the Stress Capital Buffer Rule; the Federal Reserve determines a firm‑specific stress‑buffer (5.6 % for 2020‑21 and 2.5 % for 2021‑22) that is added to the statutory minimum ratios, so the total CET1, Tier 1 and total‑capital requirements become, for example, 10.1 %/11.6 %/13.6 % (2020‑21) and 7.0 %/8.5 %/10.5 % (2021‑22). Thus, the Tailoring Rules lower the baseline capital base by permitting the AOCI exclusion, while the Stress Capital Buffer Rule raises the effective minimum ratios that Capital One must maintain.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that as a Category III institution under the Tailoring Rules, Capital One is no longer subject to the Basel III Advanced Approaches and may exclude certain AOCI elements from regulatory capital, which aligns with the ground truth. It also correctly notes the application of the Stress Capital Buffer (SCB) Rule and that it results in firm-specific, annually adjusted capital requirements. However, the LLM introduces specific numerical values for the SCB (5.6% for 2020-21 and 2.5% for 2021-22) and derived total capital ratios (e.g., 10.1%/11.6%/13.6%), which are not present in the original answer and cannot be verified from the provided ground truth. These numbers may be factually accurate in reality, but since they are absent from the original answer (our source of truth), their inclusion constitutes a quantitative overreach. (2) The quantitative accuracy is reduced because the original answer does not specify any percentages or years for the SCB; it only states that the buffer is 'institution-specific and annually adjusted.' Thus, while the structure of the SCB is described correctly, the precise figures introduced by the LLM are unsupported in this context. (3) The multi-hop reasoning is sound: the model correctly synthesizes the impact of the Tailoring Rules (removal from advanced approaches, AOCI exclusion) with the ongoing applicability of the SCB, and infers that the AOCI exclusion reduces baseline capital while the SCB increases required ratios. This logical structure matches the intent of the original answer. (4) The answer is contextually relevant and captures the core qualitative dynamics. The correctness score is 7 because the key facts and relationships are correct, but the addition of unsupported specific percentages lowers confidence in factual fidelity, even if the directionality is right.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 509,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the total change in fair value of Altria's JUUL investment from 2020 to 2021, and how was this change reflected in Altria's consolidated financial statements?",
      "original_answer": "The fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021. This amount was included in 'investments in equity securities' on Altria's consolidated balance sheets at December 31, 2021, and was accounted for under the fair value option following the Share Conversion in the fourth quarter of 2020. Changes in the fair value of the JUUL investment, calculated quarterly using level 3 fair value measurements, were included in 'income (losses) from equity investments' in Altria's consolidated statements of earnings (losses).",
      "llm_answer": "Altria’s JUUL stake fell about $100 million in fair‑value during 2020 and then recovered that amount in 2021, so the net change in fair value from the end of 2020 to the end of 2021 was an increase of roughly $100 million.  The change was reflected in the consolidated statements of earnings under “(income) losses from equity investments”: a $(100) million loss was recorded for 2020, and no loss (i.e., a $100 million gain) was recorded for 2021.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Altria's JUUL investment changed in fair value from 2020 to 2021. The ground truth states that the fair value remained unchanged at $1,705 million during this period. The LLM incorrectly claims a $100 million decline in 2020 and a $100 million recovery in 2021, resulting in a net increase of $100 million, which contradicts the ground truth of no change. (2) The quantitative inaccuracies are significant: the claimed $100 million loss in 2020 and $100 million gain in 2021 are not supported by the data. The actual fair value was stable, so no such gains or losses were recorded in 2021. The ground truth confirms that changes in fair value are recorded in 'income (losses) from equity investments', but the magnitude and direction of the reported changes are wrong. (3) The reasoning is flawed in terms of multi-hop synthesis: while the LLM correctly identifies the financial statement line item ('income (losses) from equity investments') where changes would be reflected, it fabricates the amounts and movements. It fails to recognize that after the Share Conversion in Q4 2020, the fair value was fixed at $1,705 million and remained there through 2021. (4) The contextual relevance is moderate because the answer addresses the correct company (Altria), investment (JUUL), and financial statement impact mechanism, but the core factual claim about the change in fair value is incorrect, severely undermining the answer's validity. Thus, the correctness and quantitative accuracy scores are low, with slightly higher qualitative and contextual scores due to correct identification of accounting treatment and terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 462,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What percentage of Union Pacific's total locomotives are leased rather than owned, and how does this compare to the total number of switching locomotives in their fleet?",
      "original_answer": "Union Pacific leases 1,037 out of 7,154 total locomotives, which represents approximately 14.5% of their fleet. This number is significantly higher than the 132 switching locomotives in their fleet.",
      "llm_answer": "Union Pacific reported a total locomotive fleet of 7,154 units, of which 1,037 were leased. The leased units represent roughly 14.5 percent of the total locomotive base (1,037 ÷ 7,154 ≈ 0.145). Within that fleet, the company operates 132 switching locomotives, all of which are owned.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 1,037 leased locomotives out of 7,154 total units, resulting in 14.5% (1,037 ÷ 7,154 ≈ 0.145), and 132 switching locomotives—all correctly reported. The calculation is precise and properly contextualized. (2) The answer is complete, addressing both parts of the question: the percentage of leased locomotives and how that compares to the number of switching locomotives. (3) Entity accuracy is correct—Union Pacific is the subject, and all metrics (total fleet, leased units, switching locomotives) are correctly identified. (4) The reasoning is sound: it correctly notes that the number of leased locomotives (1,037) is significantly higher than the number of switching locomotives (132), even though the latter are all owned. The multi-hop synthesis—comparing leased units to a subset of the fleet (switching locomotives)—is logically and factually handled. (5) The semantic meaning is equivalent to the original answer, with slightly more detail (e.g., specifying that switching locomotives are owned), which enhances clarity without introducing error. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 342,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the change in fair value of the 2.20% Notes Due 2021 from January 31, 2021, to January 30, 2022, and how does this reflect in both the fair value disclosures and the debt-specific maturity and interest rate table?",
      "original_answer": "The fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, as shown in the fair value disclosures. This aligns with the debt-specific maturity and interest rate table, which indicates that the notes had an effective interest rate of 2.38% and a remaining term of 0 years by January 30, 2022, meaning the notes had matured and were no longer outstanding.",
      "llm_answer": "The 2.20 % Notes Due 2021 were carried at the same fair value on both balance‑sheet dates – $1.0 billion on January 31 2021 and $1.0 billion on January 30 2022 – so the change in fair value was **$0**.  \n\nThis $0 change appears in the fair‑value disclosure where the line for the 2.20 % Notes shows $1.0 billion for each date, and the same amount is shown in the debt‑specific “Maturity and Interest‑Rate” table, which lists the notes with a 2.20 % coupon, a 2021 maturity and an unchanged outstanding balance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. The ground truth states that the fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 on January 30, 2022, indicating the notes matured and were no longer outstanding. However, the LLM claims the fair value remained constant at $1.0 billion on both dates, resulting in a $0 change—this contradicts the ground truth. (2) The numbers are incorrect: $1.0 billion vs. $1,011 million (though close, directionally misleading), and $0 change vs. a $1,011 million decrease. More critically, the LLM fails to recognize the notes matured, hence their fair value should be $0 in 2022. (3) The multi-hop reasoning is flawed: the model fails to connect the maturity date (2021) with the implication that by January 30, 2022, the notes are no longer outstanding, which should be reflected in both the fair value disclosures and the debt table. Instead, it incorrectly assumes the balance remains unchanged. (4) The contextual relevance is low but not zero because the answer addresses the correct financial instrument and tables, but with wrong data and logic. Thus, correctness and accuracy scores are very low due to major factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 360,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks impact the calculation of Capital One's supplementary leverage ratio, and what specific regulatory framework influenced this adjustment?",
      "original_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio, as permitted under an interim final rule issued by the Federal Reserve, increased Capital One's supplementary leverage ratio. This adjustment was made under the Basel III Standardized Approach framework, which governs the company's capital ratios and regulatory requirements.",
      "llm_answer": "The temporary exclusion removed U.S. Treasury securities and deposits held at the Federal Reserve Banks from the “total leverage exposure” denominator of the supplementary leverage ratio, so Tier 1 capital was divided by a smaller amount and the ratio was correspondingly higher. This treatment was authorized by the Federal Reserve’s interim‑final rule issued in April 2020 (the COVID‑19‑related interim final rule that allowed BHCs to exclude those items from the supplementary leverage‑ratio calculation).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly explains that the exclusion of U.S. Treasury securities and Fed deposits reduced the denominator (total leverage exposure), thereby increasing the supplementary leverage ratio—this matches the original answer's explanation. (2) The LLM correctly identifies the regulatory source as the Federal Reserve’s interim final rule, and adds a specific date (April 2020) and context (COVID-19-related), which is factually correct and consistent with the regulatory framework, even though the original answer does not include the date. This additional detail does not contradict but enhances accuracy. (3) The LLM omits explicit mention of 'Basel III Standardized Approach'—the specific regulatory framework named in the ground truth—which is a minor gap in completeness. However, referencing the Federal Reserve’s rule implies the Basel III context, as the supplementary leverage ratio is a Basel III construct. (4) All entities (Federal Reserve, Tier 1 capital, supplementary leverage ratio) are correctly identified. The reasoning is sound and reflects proper multi-hop synthesis between regulatory policy and its financial impact. The answer is semantically equivalent and contextually fully relevant. The minor omission of 'Basel III Standardized Approach' prevents a perfect 10, but the answer is otherwise factually and quantitatively precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 399,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023, and how were these assets valued?",
      "original_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million. These assets, which include Federal Government Securities valued at $1,508 million and Bonds and Debentures valued at $1,696 million, were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "llm_answer": "Union Pacific reported **$3,209 million** of pension‑plan assets classified as Level 2 (measured with “significant other observable inputs”) for 2023. These Level 2 assets—including federal government securities, corporate and municipal bonds, and certain preferred‑stock holdings—are valued using a **bid‑evaluation process that incorporates bid data from independent pricing sources** (i.e., observable market inputs rather than quoted prices).【page_58】【page_57】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the total value of Union Pacific's Level 2 pension plan assets in 2023 as $3,209 million, matching the ground truth exactly. The valuation method—'bid-evaluation process with bid data from independent pricing sources'—is accurately reported, aligning with the ground truth's description. 2) Quantitative accuracy is perfect: the dollar amount ($3,209 million) is correct, and no calculations are required beyond what is stated. While the original answer breaks down the components (Federal Government Securities: $1,508M; Bonds and Debentures: $1,696M), the LLM answer does not include these specific sub-allocations, which are part of the ground truth but not explicitly asked for in the question. Since the question only asks for total value and valuation method, this omission does not detract significantly from correctness. 3) The reasoning is sound and reflects proper synthesis: the LLM correctly attributes the data to Union Pacific, the correct year (2023), and the correct classification (Level 2 investments). It also correctly explains that Level 2 uses significant other observable inputs and ties the bid-evaluation process to observable market inputs, which is consistent with accounting standards and the source. 4) Contextual relevance is high—the answer directly addresses both parts of the question (total value and valuation method) and adds minor contextual clarification about asset types (federal government securities, corporate/municipal bonds, preferred stock), which is consistent with and expands upon the ground truth without introducing inaccuracies. The only minor shortcoming is the lack of explicit mention of the two component values that sum to $3,209M, but since the total is correct and the breakdown wasn't explicitly requested, this does not warrant a major deduction. Overall, the answer is factually correct, well-supported, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 523,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What specific automotive applications of NVIDIA Omniverse are mentioned in the 10-K filing, and how does its integration with the DRIVE platform support NVIDIA's end-to-end AI computing strategy?",
      "original_answer": "The 10-K filing specifically mentions that NVIDIA Omniverse Avatar software is used for real-time conversational AI capability in automotive applications, particularly as part of the DRIVE Chauffeur and DRIVE Concierge systems. This integration with the DRIVE platform supports NVIDIA's end-to-end AI computing strategy by combining Omniverse's real-time 3D simulation and collaboration capabilities with DRIVE's autonomous driving and in-vehicle experience solutions. This strategic integration allows NVIDIA to provide a comprehensive, software-defined approach to automotive computing—from training deep neural networks using GPUs to deploying AI-driven cockpit experiences and autonomous driving features, enabling continuous innovation through over-the-air updates.",
      "llm_answer": "The filing lists two automotive‑focused uses of Omniverse: (1) virtual car showrooms that let manufacturers display vehicles in a photorealistic, interactive 3‑D environment, and (2) the Omniverse Avatar component that is bundled with DRIVE Concierge to provide real‑time conversational AI inside the vehicle. By embedding Omniverse‑based services in the DRIVE software stack, NVIDIA extends its unified AI computing flow—training deep‑neural networks on its GPUs in the data‑center, then deploying those models on the DRIVE AGX/Hyperion hardware for perception, planning and in‑car experiences—thereby delivering a complete end‑to‑end AI solution from cloud training to on‑board inference.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the use of Omniverse Avatar for real-time conversational AI in DRIVE Concierge, which aligns with the ground truth. However, it introduces 'virtual car showrooms' as a specific automotive application mentioned in the 10-K, which is not present in the original answer and not supported by the ground truth from the knowledge graph. This is an addition not found in the source, reducing factual accuracy. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are involved. (3) The multi-hop reasoning is mostly sound: the LLM correctly links Omniverse integration with DRIVE to NVIDIA’s end-to-end AI strategy, describing the flow from cloud training to on-board inference. However, it omits mention of DRIVE Chauffeur (only mentions Concierge), which is a key component in the ground truth and part of the full end-to-end strategy. This omission affects completeness and qualitative accuracy. (4) Contextual relevance is high—the answer stays on topic, explains the integration meaningfully, and connects it to NVIDIA’s broader AI computing vision. The incorrect addition of 'virtual car showrooms' and omission of 'DRIVE Chauffeur' prevent a higher correctness score, but core facts about Avatar and end-to-end strategy are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 387,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023, and how did this compare to the percentage change in Converse's operating income over the same period?",
      "original_answer": "Converse's contribution to NIKE, Inc.'s total revenues increased by 3.4% from 2022 to 2023, while its operating income decreased by 30.0% over the same period.",
      "llm_answer": "Converse’s share of NIKE, Inc.’s total revenue fell from ≈5.02 % in 2022 ( $2,346 m ÷ $46,710 m) to ≈4.74 % in 2023 ( $2,427 m ÷ $51,217 m), a decline of roughly **5.6 %**. In contrast, Converse’s operating income (EBIT) rose from $669 m in 2022 to $676 m in 2023, an increase of about **1.0 %**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) The percentage change in Converse's contribution to NIKE's total revenues is incorrectly calculated: the original answer states a 3.4% increase in Converse's contribution to total revenues from 2022 to 2023, whereas the LLM claims a 5.6% decline in share, based on flawed reasoning. The LLM computes Converse's revenue share (which is not the same as percentage change in contribution) and misinterprets it as a negative change, when the ground truth indicates a positive 3.4% change in Converse's actual revenue contribution. (2) For operating income, the original answer reports a 30.0% decrease, but the LLM incorrectly states a 1.0% increase from $669M to $676M. This contradicts the ground truth and shows a failure in data retrieval or calculation. (3) The multi-hop reasoning is unsound: the LLM attempts to compute revenue shares as percentages of total NIKE revenue rather than assessing the year-over-year growth in Converse's revenue contribution, which is the actual intent of the question. It also fails to compute the correct percentage change in operating income. (4) Despite addressing the right entities (Converse, NIKE, revenues, operating income, 2022–2023), the answer is factually wrong on all key metrics. The contextual relevance is low because the model misunderstands what 'contribution to total revenues' means—it should reflect the growth rate of Converse's own revenue within Nike’s portfolio, not its shrinking share due to faster growth in other segments. Thus, all scores are very low, with correctness at 1 due to complete factual inversion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 452,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the changes to the TDR accounting guidance impact the classification of trial modifications in both the residential real estate and credit card loan portfolios for the year ended December 31, 2023?",
      "original_answer": "The changes to the TDR accounting guidance eliminated the 'reasonably expected' and 'concession' assessment criteria, which resulted in trial modifications being classified as TDRs but not FDMs in both the residential real estate and credit card loan portfolios. For residential real estate, this meant $69 million of loans under trial modification were considered TDRs but not FDMs. Similarly, for credit card loans, $27 million of loans under trial modification were classified as TDRs but not FDMs.",
      "llm_answer": "The new TDR accounting guidance removed the “reasonably‑expected” and concession‑assessment criteria, so loans that were only in a trial‑modification stage could no longer be counted as full loan modifications (FDMs). As a result, the $69 million of residential‑real‑estate loans under trial modification were re‑classified as TDRs, and the $27 million of credit‑card loans under trial modification were likewise re‑classified as TDRs for the year ended December 31 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the removal of the 'reasonably expected' and 'concession' criteria is accurately described, and the reclassification of trial modifications as TDRs but not FDMs is correctly stated for both residential real estate and credit card portfolios. (2) Quantitative accuracy is perfect: the $69 million for residential real estate and $27 million for credit card loans under trial modification are correctly reported with proper context and time period (year ended December 31, 2023). Format variations (e.g., spacing in $69 million) are acceptable. (3) The multi-hop reasoning is sound—LLM correctly links the change in accounting guidance to its impact on classification across two loan types. The only minor shortcoming is that the answer does not explicitly state that these loans were classified as TDRs *but not FDMs*, though this is strongly implied by saying they 'could no longer be counted as FDMs' and were 'reclassified as TDRs'. This omission slightly affects qualitative precision but does not change the factual outcome. (4) The answer is fully contextually relevant, directly addressing the impact of the guidance change on both portfolios. Overall, this is a strong response with only a slight reduction in qualitative accuracy due to incomplete phrasing of the classification outcome.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 391,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How many total retention shares and retention units were outstanding under Union Pacific's stock incentive plans as of December 31, 2023, and how does this compare to the number of restricted shares outstanding under the Directors Plan on the same date?",
      "original_answer": "As of December 31, 2023, Union Pacific had 954,405 retention shares and 366,046 retention units outstanding under its stock incentive plans, totaling 1,320,451. This compares to 16,000 restricted shares outstanding under the Directors Plan on the same date.",
      "llm_answer": "Union Pacific had **about 1.32 million retention awards** (≈ 954,405 retention shares + 366,046 retention units) outstanding under its stock‑incentive plans at December 31 2023【page_75】.  \nBy contrast, the Directors Plan had **only 16,000 restricted shares** outstanding on the same date【page_51】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values are accurate: 954,405 retention shares and 366,046 retention units are correctly stated, and their sum (1,320,451) is accurately represented as 'about 1.32 million'—a reasonable rounding. The 16,000 restricted shares under the Directors Plan are also exactly correct. (2) Calculations are sound: the addition of retention shares and units is correct, and the comparison between the total retention awards and the Directors Plan shares is properly framed. (3) Multi-hop reasoning is valid: the model correctly synthesizes data from two different plans (stock incentive plans vs. Directors Plan) for the same company (Union Pacific) on the same date (December 31, 2023), fulfilling the multi-hop requirement. (4) Entities are correctly identified—Union Pacific, retention shares/units, restricted shares, and the respective plans. (5) Contextual relevance is high, with direct answers to both parts of the question and citation of supporting pages. Minor formatting (e.g., 'about' or '≈') does not affect factual accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 328,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided to the JV?",
      "original_answer": "AMD's total investment in the ATMP JV as of December 28, 2024, was $249 million. This includes the carrying value of its equity investment, which was $149 million, and a secured term loan of $100 million provided to the JV.",
      "llm_answer": "As of December 28 2024 AMD’s stake in the ATMP joint venture consisted of:\n\n* **Equity‑method investment:** about **$149 million** (recorded as “Investments: equity method” on the balance sheet).  \n* **Secured term loan to the JV:** **$100 million** (the one‑year loan entered into on October 9 2024 and recorded as a receivable from related parties).\n\n**Total AMD investment in the ATMP JV = $149 million + $100 million = approximately $249 million.**",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All key facts are accurately reported: the equity investment carrying value of $149 million and the $100 million secured term loan are correctly identified and match the original answer. The total investment of $249 million is correctly calculated. (2) Quantitative accuracy is perfect: all dollar amounts ($149M, $100M, $249M) are correct, and the calculation is accurate. The date (December 28, 2024) is correctly referenced, and the additional detail about the loan being entered on October 9, 2024, adds context without contradicting the ground truth. (3) The multi-hop reasoning is sound—information about both the equity investment and the loan is synthesized correctly into a total investment figure. (4) The answer is semantically equivalent to the original, with clear, well-structured presentation and no factual or contextual errors. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 283,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What was the total financial impact on Danaher from the disposition of Envista Holdings Corporation, including the gain on disposition, the foreign currency translation adjustment loss, and the IPO and Separation-related costs?",
      "original_answer": "The total financial impact on Danaher from the disposition of Envista Holdings Corporation was $387 million. This includes a $451 million gain on disposition, reduced by $109 million in reclassified foreign currency translation adjustment losses and $69 million in IPO and Separation-related costs.",
      "llm_answer": "Danaher’s Envista disposition generated a $451 million pre‑tax gain, was offset by a $109 million foreign‑currency translation‑adjustment loss, and incurred $69 million of IPO‑ and separation‑related costs.  The net effect of those three items was therefore about **$273 million** of positive impact.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the individual components of the financial impact: a $451 million gain on disposition, a $109 million foreign currency translation adjustment loss, and $69 million in IPO and separation-related costs — all of which match the ground truth. However, the final calculated net impact is incorrect. The LLM states the net effect was '$273 million of positive impact', which results from incorrectly subtracting both the $109 million and $69 million from the $451 million gain: 451 - 109 - 69 = 273. But the original answer states the total financial impact was $387 million, implying the $451 million gain was reduced by $109 million and $69 million, but still represents a net positive impact of $387 million (451 - 109 - 69 = 273 is mathematically correct, but contradicts the stated total in the ground truth). This reveals a critical inconsistency: either the ground truth total ($387M) is wrong, or the components are misstated. However, since the task is to evaluate the LLM against the provided ground truth, and the ground truth explicitly states the total impact was $387 million (not $273 million), the LLM's calculation contradicts this. Therefore, the LLM fails on quantitative accuracy despite correct inputs. The reasoning is logically consistent (it performs the arithmetic correctly based on its interpretation), but the final number does not match the ground truth's explicitly stated total. This suggests either a data inconsistency in the ground truth or a misinterpretation by the model. Given the instructions to follow the ground truth strictly, the LLM is marked incorrect for the final figure. The model addresses all parts of the question and uses correct entities and context, so relevance and completeness are high. However, the core numerical conclusion is wrong, which heavily penalizes correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 507,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, impact the overall EBIT performance of the Converse segment, considering the 130 basis point gross margin contraction linked to unfavorable foreign currency exchange rates?",
      "original_answer": "The 15% currency-neutral revenue decline in Converse, primarily due to drops in North America and Western Europe, contributed to a 30% decrease in reported EBIT. This was exacerbated by a 130 basis point gross margin contraction caused in part by unfavorable changes in standard foreign currency exchange rates, which further reduced profitability.",
      "llm_answer": "The 15 % currency‑neutral revenue decline in Converse (down from $2.43 bn to $2.08 bn) translated into a **30 % drop in Converse EBIT**, falling from $676 million in fiscal 2023 to $474 million in fiscal 2024.  This steep EBIT decline was amplified by a **gross‑margin contraction of about 130 basis points** caused by unfavorable foreign‑currency rates, lower full‑price ASP and higher other costs, which reduced profitability beyond the revenue loss alone【page_46】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the 15% currency-neutral revenue decline and its impact on EBIT, stating a 30% drop in EBIT, which matches the original answer. The dollar amounts provided ($2.43B revenue decline to $2.08B, EBIT falling from $676M to $474M) are consistent with a ~30% EBIT decline and plausible given the context, though these specific figures are not in the ground truth; however, such elaboration is acceptable as long as it doesn't contradict. (2) The 130 basis point gross margin contraction is accurately cited and correctly attributed in part to unfavorable foreign currency exchange rates. The mention of 'lower full-price ASP and higher other costs' adds detail not in the original but does not contradict it and may reflect additional context from the source (e.g., page 46). (3) Multi-hop reasoning is sound: the model connects revenue decline, margin pressure, and their combined effect on EBIT performance. (4) Semantic equivalence is maintained—core facts, percentages, and causal logic match the ground truth. The only minor deviation is the inclusion of specific dollar figures not present in the original answer, but these are reasonable and do not introduce errors. Thus, the answer earns a 9/10 for correctness due to slight over-elaboration without factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 378,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the adoption of the new TDR accounting guidance on January 1, 2023, specifically impact JPMorgan Chase's allowance for credit losses in 2023, and what was the resulting effect on the Firm's financial position given the changes in trial modifications and Chapter 7 loans?",
      "original_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan Chase's allowance for credit losses. This change was driven by the elimination of the TDR 'reasonably expected' and 'concession assessment' criteria, which reclassified $69 million of loans subject to trial modification and $9 million of loans subject to discharge under Chapter 7 bankruptcy proceedings as non-FDMs (Financial Disincentive Modifications), although they were still considered TDRs. This reclassification reduced the allowance requirement, reflecting a change in how credit losses were estimated for these categories of loans, thereby improving the Firm's reported financial position by lowering the required reserves.",
      "llm_answer": "The new TDR accounting guidance that took effect on January 1 2023 caused JPMorgan Chase to cut the allowance for loan losses by $487 million for consumer loans, $100 million for credit‑card loans and $2 million for wholesale loans – a total reduction of **$587 million** (see the “cumulative effect of a change in accounting principle” line in the 2023 allowance‑for‑loan‑losses table).  Because the guidance eliminated the “reasonably‑expected” and concession‑assessment criteria, the $69 million of residential loans under trial modification and the $9 million of Chapter 7 bankruptcies were re‑classified as TDRs rather than as fully‑developed modifications, which lowered the allowance and consequently boosted the firm’s net income and equity (i.e., improved its financial position) despite the overall $3.1 billion increase in total credit‑loss allowance for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $587 million reduction in the allowance for credit losses, which matches the ground truth. It accurately breaks this down into $487 million (consumer), $100 million (credit card), and $2 million (wholesale), summing to $587 million—this level of detail is not in the original answer but is factually consistent and adds precision. The dates (January 1, 2023) and the $69 million (trial modifications) and $9 million (Chapter 7) figures are all correct. (2) All numeric values are accurate and correctly formatted; the total reduction is properly calculated. The mention of the 'cumulative effect of a change in accounting principle' line in the financials adds contextual support. (3) The reasoning is largely sound: the elimination of the 'reasonably expected' and 'concession assessment' criteria is correctly linked to the reclassification of loans. However, there is a minor error in stating that the loans were reclassified 'as TDRs rather than as fully-developed modifications'—this reverses the logic. In fact, they were reclassified as *non-FDMs* (not as TDRs), even though they remained TDRs under the old definition. This is a subtle but important distinction in terminology. The original answer correctly states they were reclassified as non-FDMs. Despite this, the overall impact (lower allowance, improved financial position) is correctly inferred. (4) The answer is highly relevant, addressing both the quantitative impact on the allowance and the resulting effect on financial position (via net income and equity). The extra detail on loan categories enhances completeness. The one qualitative inaccuracy prevents a perfect score, but the core facts, numbers, and synthesis are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 478,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What is the total amount invested in Level 2 assets by UNP's pension plan, and which specific investment categories use bid evaluation with independent pricing sources as their valuation methodology?",
      "original_answer": "The total amount invested in Level 2 assets by UNP's pension plan is $1,111 million. These Level 2 assets are specifically composed of investments in Corporate Stock, Federal Government Securities, and Bonds and Debentures, all of which use bid evaluation processes with independent pricing sources as their valuation methodology.",
      "llm_answer": "- The pension plan’s Level 2 assets total **$3,209 million** (Federal government securities $1,508 m + Bonds and debentures $1,696 m + Preferred stock $5 m).  \n\n- The investment categories that are valued **using a bid‑evaluation process with independent pricing sources** are: **Federal Government Securities, Bonds and Debentures, and Preferred Stock** (the latter is part of the Corporate Stock category).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its total amount for Level 2 assets: it reports $3,209 million, whereas the ground truth is $1,111 million. This major quantitative error undermines the core of the answer. The breakdown provided (Federal government securities $1,508M + Bonds and debentures $1,696M + Preferred stock $5M) sums to $3,209M, which is factually wrong and not supported by the ground truth. Additionally, the ground truth specifies Corporate Stock, Federal Government Securities, and Bonds and Debentures as the Level 2 categories, but the LLM answer incorrectly includes Preferred Stock (a subset of Corporate Stock) as a separate category and omits Corporate Stock as a distinct entity. (2) The calculation in the LLM answer is mathematically correct (1,508 + 1,696 + 5 = 3,209), but the inputs are factually wrong per the knowledge graph. The correct composition should total $1,111 million across the three categories, though the exact breakdown is not provided in the ground truth. (3) The multi-hop reasoning fails because the model incorrectly identifies the components of Level 2 assets and misattributes the valuation methodology to Preferred Stock instead of correctly identifying Corporate Stock as a whole. It also conflates subcategories, suggesting Preferred Stock is part of Corporate Stock while listing it separately, which introduces confusion. (4) Despite these issues, the answer is contextually relevant—it addresses both parts of the question (total Level 2 assets and valuation methodology) and correctly associates bid evaluation with independent pricing sources for Federal Government Securities and Bonds and Debentures. However, the inclusion of Preferred Stock and exclusion of Corporate Stock as a named category reduces qualitative accuracy. The contextual relevance is moderate because the structure and intent align with the question, but factual correctness is severely lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 526,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the growth rate of DHR's research and medical products segment revenue between 2019 and 2021 compare to the company's total revenue growth over the same period, and what does this suggest about the segment's role in DHR's overall financial performance?",
      "original_answer": "DHR's research and medical products segment grew from $13,512 million in 2019 to $24,802 million in 2021, representing a 83.5% increase over two years. Meanwhile, DHR's total revenue increased from $17,911 million in 2019 to $29,453 million in 2021, a 64.4% increase. This indicates that the research and medical products segment outperformed the company's overall growth, suggesting it was a key driver of DHR's financial performance during this period.",
      "llm_answer": "The research‑and‑medical products line grew from $13.5 billion in 2019 to $24.8 billion in 2021 – an increase of about **84 %**.  Over the same period total company sales rose from $17.9 billion to $29.5 billion, a growth of roughly **65 %**.  Because the segment’s revenue grew markedly faster than overall revenue, it was a primary driver of DHR’s top‑line expansion and underscores the segment’s outsized contribution to the company’s financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. The revenue figures for the research and medical products segment ($13.5B in 2019, $24.8B in 2021) and total DHR revenue ($17.9B in 2019, $29.5B in 2021) are accurate when converted from millions to billions (e.g., $13,512 million ≈ $13.5 billion). The calculated growth rates (~84% and ~65%) are correctly rounded from the ground truth values of 83.5% and 64.4%, respectively. Minor rounding is acceptable and common in financial communication. (2) All calculations are sound: (24,802 - 13,512) / 13,512 ≈ 83.5%, and (29,453 - 17,911) / 17,911 ≈ 64.4%. The LLM’s approximations (84%, 65%) are reasonable and do not misrepresent the data. (3) The multi-hop reasoning is correct: the model compares segment growth to total revenue growth and draws the logical conclusion that the segment outpaced overall company growth, acting as a primary driver. This matches the ground truth’s inference about the segment’s strategic importance. (4) The answer is semantically equivalent to the original, with slightly more concise phrasing (e.g., 'top-line expansion' instead of 'financial performance'), but the core message and implications are preserved. No critical information is omitted. The only reason for not scoring 10 is the slight rounding of percentages without indicating approximation in the original data, though this is minor and contextually acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 396,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the adoption of the revised TDR accounting guidance on January 1, 2023, specifically affect JPMorgan's allowance for credit losses and the classification of trial modifications for credit card loans during the year ended December 31, 2023?",
      "original_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan's allowance for credit losses. Additionally, the changes eliminated the TDR reasonably expected and concession assessment criteria, which affected the classification of credit card loan modifications. As a result, trial modifications were considered TDRs but not FDMs (formally distressed modifications), whereas in the prior year, credit card TDRs totaled $418 million. For the year ended December 31, 2023, credit card FDMs were $648 million, and there were $27 million of loans subject to trial modifications.",
      "llm_answer": "The January 1 2023 adoption of the revised TDR guidance lowered JPMorgan’s total allowance for credit losses by $587 million – $100 million of that reduction came from the credit‑card allowance (the table shows a cumulative accounting‑principle effect of –$587 million, with –$100 million for credit cards). Because the new guidance eliminated the “reasonably‑expected” and concession‑assessment criteria, the $27 million of credit‑card loans that were in trial modification during 2023 were no longer treated as FDMs; they were re‑classified as TDRs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $587 million reduction in the allowance for credit losses and the $27 million of trial modifications, which aligns with the ground truth. However, it introduces a specific breakdown of $100 million reduction attributed to credit-card allowance, which is not present in the original answer and cannot be verified from the provided ground truth. This unsupported detail undermines quantitative accuracy. (2) The date of adoption (January 1, 2023) and the year-end reference (2023) are correct. The $27 million in trial modifications matches the ground truth. However, the claim about $100 million reduction in credit-card allowance appears to be an inference from a table not available in the context and is not stated in the original answer, making it factually unsupported. Additionally, the original answer states that trial modifications were considered TDRs but not FDMs, and reports $648 million in FDMs and $418 million in prior-year TDRs—none of which are mentioned in the LLM answer, leading to incompleteness. (3) The reasoning around the elimination of the 'reasonably expected' and concession-assessment criteria is correctly linked to the reclassification of trial modifications, showing sound qualitative understanding of the accounting change. However, the model fails to mention the key comparison to prior-year TDRs ($418 million) and the total FDM amount in 2023 ($648 million), indicating incomplete multi-hop synthesis across time periods and categories. (4) The contextual relevance is high because the answer addresses the core impact on allowance and classification. However, the addition of unverified granular data and omission of key figures from the ground truth reduces correctness. The answer is partially accurate but lacks completeness and introduces unverified numbers, justifying a score of 6 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 514,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did 3M's adoption and subsequent introduction of a new accounting principle for determining net periodic pension and postretirement plan cost impact the presentation of its pension-related financial metrics across reporting periods?",
      "original_answer": "3M adopted a new accounting principle in the first quarter of 2021 that changed how it calculates the market-related value of fixed income securities in its pension and postretirement plans. Previously, the company used a calculated value approach that deferred asset gains or losses over three years, but it switched to a fair value approach that immediately reflects changes in asset values. This change was applied retrospectively, impacting the expected return on plan assets and the amortization of net unamortized actuarial gains or losses. As a result, the presentation of pension-related financial metrics such as net periodic benefit cost, non-operating other expense (income), net income, and earnings per share was altered. Additionally, this change affected consolidated other comprehensive income, retained earnings, and accumulated other comprehensive income (loss). The fair value approach aligns the expected return on plan assets more closely with the plans' funded status and liability-driven investment strategy, resulting in a more current reflection of asset value changes in financial reporting.",
      "llm_answer": "3M’s switch in the first quarter of 2021 from the calculated‑value to the fair‑value method for the fixed‑income portion of its pension‑ and post‑retirement‑plan assets was applied retrospectively, so the 2020 and 2019 statements now present both “under prior method” and “as‑adjusted” figures. The adjustment moved a portion of net periodic pension and post‑retirement cost out of non‑operating other expense (income) into operating results, lowering the reported pension expense (e.g., from $406 million to $322 million in 2020) and reducing the defined‑benefit OCI adjustment (e.g., from $171 million to $106 million in 2020), which in turn changed retained earnings, accumulated other‑comprehensive‑income and the related cash‑flow presentation.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core event—3M's 2021 adoption of a fair value method for fixed income securities in pension and postretirement plans, applied retrospectively—but introduces significant factual inaccuracies, particularly in quantitative details. The claim that 2020 and 2019 statements now present both 'under prior method' and 'as-adjusted' figures is not supported in the ground truth, which does not mention dual presentation. More critically, the LLM provides specific dollar amounts (e.g., pension expense dropping from $406M to $322M in 2020, OCI adjustment from $171M to $106M) that are not present in the original answer and cannot be verified; these numbers are likely fabricated or misattributed, severely undermining quantitative accuracy. While the direction of impact (lower pension expense, reduced OCI adjustment) aligns with the general effect of such a change, the ground truth does not specify these figures or confirm the reclassification of costs into operating results. The qualitative reasoning about retrospective application, impact on retained earnings, AOCI, and financial statement presentation is sound and relevant. The entity (3M), time frame (Q1 2021), and accounting change (calculated value to fair value for fixed income) are correctly identified. The answer addresses the impact on financial metrics but adds unsupported specifics. Thus, while the conceptual and contextual understanding is strong (high contextual relevance and decent qualitative accuracy), the inclusion of unverified numerical data results in a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 433,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did the adoption of the new TDR accounting guidance impact JPMorgan's allowance for credit losses in 2023, and what was the specific dollar amount of this impact?",
      "original_answer": "The adoption of the changes to the TDR accounting guidance on January 1, 2023, resulted in a reduction of $587 million in JPMorgan's allowance for credit losses. This reduction occurred because the new guidance eliminated the TDR 'reasonably expected' and 'concession' assessment criteria, which affected how trial modifications were classified. Previously, trial modifications were considered TDRs (Troubled Debt Restructurings), but under the new guidance, they are no longer classified as FDMs (Financial Difficulty Modifications), leading to a lower allowance requirement.",
      "llm_answer": "The new TDR accounting guidance, which took effect on January 1 2023, lowered JPMorgan’s allowance for credit losses by **$587 million** for the year 2023. This reduction is shown as the cumulative effect of the accounting‑principle change in the 2023 allowance‑for‑loan‑losses table.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative impact of the new TDR accounting guidance: a $587 million reduction in JPMorgan's allowance for credit losses effective January 1, 2023, which matches the ground truth exactly. The date and dollar amount are accurate, satisfying the quantitative accuracy criterion fully. The answer addresses both parts of the question—impact on allowance and the specific dollar amount—making it contextually relevant and complete on the surface. However, while the LLM mentions the reduction is due to the 'cumulative effect of the accounting-principle change,' it omits the underlying reasoning provided in the original answer: that the new guidance eliminated the 'reasonably expected' and 'concession' criteria for TDRs, and that trial modifications are no longer classified as FDMs. This explanatory mechanism represents a minor gap in qualitative depth and multi-hop synthesis, though the core facts and financial impact are correctly conveyed. Thus, the qualitative accuracy is slightly reduced due to missing mechanistic reasoning, but not enough to undermine the correctness of the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 322,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the combined impact on goodwill and operating profit specifically in the Africa/Eurasia region for Colgate-Palmolive in 2023, and how does this compare to the capital expenditures made in the same region during the year?",
      "original_answer": "In 2023, Colgate-Palmolive experienced a decrease in goodwill of $19 million due to foreign currency translation in the Africa/Eurasia region, bringing the ending goodwill balance to $88 million from $107 million. At the same time, the company reported an operating profit of $254 million for the region. Capital expenditures in Africa/Eurasia totaled $10 million in 2023. Therefore, the combined impact of the goodwill decrease and capital expenditures was $29 million, which is significantly lower than the region's operating profit of $254 million.",
      "llm_answer": "In 2023 Colgate‑Palmolive’s Africa/Eurasia segment saw goodwill fall by **$19 million** (a foreign‑currency translation adjustment) while generating **$254 million** of operating profit – a net positive impact of roughly **$235 million**.  By contrast, the company’s capital expenditures in that same region were only **$10 million** for the year.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $19 million decrease in goodwill due to foreign currency translation and the $254 million operating profit in the Africa/Eurasia region for 2023, which matches the ground truth. It also accurately reports capital expenditures of $10 million. These numeric values are all correct, earning high marks for quantitative accuracy. (2) However, the LLM calculates a 'net positive impact of roughly $235 million' (operating profit minus goodwill decrease), which is not what the question asked. The original answer computes the 'combined impact' of goodwill decrease and capital expenditures — $19M + $10M = $29M — and compares that to operating profit. The LLM instead combines goodwill change with operating profit, which misrepresents the required synthesis. This is a critical error in reasoning. (3) The multi-hop reasoning is partially sound — it pulls correct data from different parts (goodwill change, operating profit, capex) — but fails to synthesize them as requested. The comparison between $29M (combined outflow/decline) and $254M (profit) is missing. (4) Despite accurate numbers, the incorrect interpretation of 'combined impact' reduces qualitative accuracy. Contextual relevance is full, as all data pertains directly to the question. A score of 7 is justified due to correct data but flawed synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 379,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the impact on 3M's goodwill reporting structure as a result of the 2021 business segment reporting changes, and how was this evaluated in terms of impairment risk?",
      "original_answer": "As a result of the 2021 business segment reporting changes, 3M applied the relative fair value method to determine the impact on goodwill for any reporting unit changes, and these changes were found to be immaterial. Despite these changes, the Company completed its annual goodwill impairment test in the fourth quarter of 2021 and determined that no impairment existed. This indicates that the restructuring did not negatively affect the fair value of reporting units to the extent that impairment would occur.",
      "llm_answer": "The first‑quarter 2021 change to 3M’s business‑segment reporting required the company to re‑assign goodwill to the newly defined reporting units; it used the relative‑fair‑value method for the re‑allocation, and the resulting adjustment to goodwill was immaterial.  After the re‑allocation, 3M performed its normal fourth‑quarter 2021 goodwill‑impairment test (and continued to monitor for triggering events) and concluded that no goodwill impairment existed for any reporting unit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 2021 business segment changes required reassignment of goodwill using the relative fair value method, the adjustment was immaterial, and no impairment was found in the 2021 annual test. (2) Quantitative accuracy is perfect—dates (first-quarter and fourth-quarter 2021), methods (relative fair value), and outcomes (immaterial adjustment, no impairment) match the original answer exactly. Format variations (e.g., 're-assign' vs 're-assign') are stylistic and do not affect meaning. (3) Multi-hop reasoning is sound: the model correctly links the segment change to goodwill reallocation, explains the method used, and connects it to the subsequent impairment test. The only minor shortcoming is that the original answer explicitly states that the changes were evaluated and found immaterial in the context of reporting unit changes, while the LLM implies it by saying the adjustment was immaterial—semantically very close but slightly less explicit. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: impact on goodwill reporting structure and impairment risk evaluation. Overall, the answer is factually complete and well-reasoned, warranting a 9 due to slight difference in emphasis on the immateriality assessment process.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 386,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the strategic rationale behind AMD's investment in Silo AI, and how does it connect to AMD's goals for AI model deployment and software development?",
      "original_answer": "AMD's investment in Silo AI was strategically aimed at leveraging Silo AI's workforce to accelerate the deployment and development of AI models and software solutions on AMD hardware. This partnership aligns with AMD's broader objective to strengthen its capabilities in the AI space, particularly within its Data Center segment, by integrating Silo AI's expertise in AI research and development.",
      "llm_answer": "AMD bought Finland‑based AI lab Silo AI to bring in a team of AI experts who can “help the Company accelerate the deployment and development of AI models and software solutions on AMD hardware” (see page 71). The acquisition therefore serves AMD’s broader strategy of strengthening its Data‑Center AI portfolio—providing the talent and know‑how needed to get AI models up and running quickly and to build the accompanying software stack that runs on AMD’s CPUs, GPUs, APUs and other AI accelerators.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. It correctly identifies the strategic rationale behind AMD's investment in Silo AI: to accelerate AI model deployment and software development on AMD hardware by leveraging Silo AI's expertise. The answer accurately reflects that this supports AMD's broader goals in the Data Center segment and AI portfolio. The mention of 'acquisition' instead of 'investment' is a minor semantic deviation—while the original answer refers to an investment, the LLM interprets it as a full acquisition, which may not be factually precise but does not significantly distort the strategic intent. There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable but assumed correct. The reasoning is sound, with proper multi-hop synthesis connecting Silo AI's capabilities to AMD's strategic objectives in AI software and hardware integration. The contextual relevance is excellent, directly addressing both parts of the question: the rationale and the connection to AMD's AI goals. The answer adds useful detail (e.g., specific hardware types like CPUs, GPUs, APUs) that enriches the response without introducing errors. Thus, the correctness score is 9 due to the slight overstatement of 'bought' implying acquisition, while all other aspects are factually and semantically aligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 392,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many amendments were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015?",
      "original_answer": "6 amendments were made to the agreement during the specified period.",
      "llm_answer": "Six amendments were made to the Amended and Restated Agreement for Research & Development Alliance on Triex Module Technology with effective dates ranging from October 31 2014 through September 1 2015【page_109】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) The number of amendments is accurately stated as six, matching the original answer. (2) The date range provided (October 31, 2014, to September 1, 2015) falls within the question's specified period (September 2, 2014, to September 1, 2015), and all six amendments occurred in this window—thus the count is factually accurate. The slight discrepancy in the start date (October 31 vs. September 2) does not affect correctness because the answer does not claim amendments occurred before October 31, only that six occurred by September 1, 2015, which is consistent with the total count. (3) The reasoning is sound and correctly synthesizes the relevant information from the document (cited page 109), indicating proper multi-hop extraction. (4) All entities—the agreement name and time frame—are correctly identified. The answer is concise, relevant, and fully aligned with the question's requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1078,
        "completion_tokens": 283,
        "total_tokens": 1361
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did the timing of PM's acquisition of Swedish Match impact its operational reporting scope in the 2023 10-K, and what does the separate shipment volume commentary suggest about the integration timeline?",
      "original_answer": "PMI acquired a majority position in Swedish Match on November 11, 2022, which resulted in Swedish Match's results being included in PM's financials only from that date through December 31, 2022. This limited inclusion period affected the operational reporting scope in the 2023 10-K, as Swedish Match's business operations were managed and evaluated separately from PM's geographical segments. Additionally, the separate shipment volume commentary for Swedish Match indicates that integration efforts had not yet reached a stage where its operations were fully consolidated with PM’s existing business units, suggesting a phased or ongoing integration process.",
      "llm_answer": "The 10‑K notes that PMI only acquired a majority stake in Swedish Match on Nov. 11 2022, so the filing begins to include Swedish Match results only from that date and reports the business as a stand‑alone operating segment rather than folding it into the geographic segments. Because the filing also presents a separate “Swedish Match shipment‑volume” table and explicitly says the commentary assumes inclusion of Swedish Match’s 2022 volume for comparability, the volume figures are still reported apart from PMI’s consolidated shipment data, indicating that full integration of Swedish Match’s operations (including volume reporting) is still underway.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key date of PMI's acquisition of Swedish Match on November 11, 2022, which matches the ground truth. It accurately states that Swedish Match’s results were included only from that date forward, aligning with the limited reporting scope in the 2023 10-K. The answer correctly notes that Swedish Match was reported as a stand-alone operating segment rather than integrated into PM’s geographic segments, which reflects the actual reporting structure. It also correctly interprets the separate shipment volume commentary as evidence that integration is still ongoing. (2) All dates and events are factually accurate—acquisition date (Nov 11, 2022) is correct, and there are no numerical inaccuracies. The answer does not introduce any false figures and correctly references the comparative shipment volume treatment without misrepresenting data. (3) The multi-hop reasoning is sound: the model connects the timing of the acquisition to the reporting scope, infers the operational segmentation from the 10-K structure, and uses the separate shipment volume table as evidence of incomplete integration. This demonstrates proper synthesis across time, structure, and commentary. (4) The only minor shortcoming is that the LLM does not explicitly state that the 2023 10-K reflects a full year of Swedish Match’s operations (2023), but the implication is present. The ground truth emphasizes that the 2022 inclusion was partial, which the LLM captures, but could have contrasted more clearly with 2023’s full-year inclusion. Despite this, the core facts, logic, and implications are correct and well-articulated, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 460,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What was the total notional amount of interest rate swaps entered into by 3M in 2021, and how does this compare to the combined principal amount of the fixed-rate notes due in 2049 and 2050 that these swaps were designed to hedge?",
      "original_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million. These swaps were applied to a combined principal amount of $1.65 billion of fixed-rate notes due in 2049 and 2050, meaning the swaps covered approximately 48.5% of the total principal for those notes.",
      "llm_answer": "In 2021 3M entered into interest‑rate swaps with a total notional amount of **$800 million**. These swaps were used to hedge the fixed‑rate debt that comprised **$500 million of the 2049 notes and $300 million of the 2050 notes**, for a combined principal amount of **$800 million**—the same amount as the swaps’ notional value.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $800 million notional amount of interest rate swaps entered into by 3M in 2021, which matches the ground truth. However, it incorrectly states that the combined principal amount of the fixed-rate notes due in 2049 and 2050 is $800 million, breaking it down as $500 million (2049) and $300 million (2050). The ground truth specifies a combined principal of $1.65 billion, meaning the LLM significantly underreports this figure. This error leads to an incorrect conclusion that the swaps covered 100% of the hedged debt, when in reality they covered only about 48.5%. (2) The $800 million swap amount is accurate, but the $800 million principal is wrong—should be $1.65 billion. The individual note amounts are not supported by the ground truth, which does not specify how much of the $1.65 billion was issued in 2049 vs. 2050. (3) The multi-hop reasoning fails because the model incorrectly equates the notional amount with full hedge coverage, when the ground truth explicitly states partial coverage (48.5%). The synthesis between swaps and the notes they hedge is flawed due to incorrect principal amount. (4) Correctness and quantitative accuracy are low due to major factual and numerical errors in the principal amount and resulting coverage percentage. Qualitative accuracy is moderate because the model understands the hedging relationship and correct year/company/metric types. Contextual relevance is high as the answer addresses the right entities and intent of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 422,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What was the total consideration transferred by AbbVie for both the acquisition of Allergan and Soliton, Inc., and how much of this combined amount was attributed to cash payments?",
      "original_answer": "The total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was $64,619 million, of which $40,210 million was attributed to cash payments.",
      "llm_answer": "AbbVie transferred a total of **$64.6 billion** for the two deals – $64.084 billion for the Allergan acquisition and $0.535 billion for the Soliton acquisition.  Of that combined amount, **$40.210 billion** was paid in cash ($39.675 billion for Allergan plus $0.535 billion for Soliton).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with minor formatting differences. (1) Quantitatively: The total consideration is reported as $64.6 billion, which matches $64,619 million when rounded ($64.619 billion). The LLM breaks this into $64.084 billion for Allergan and $0.535 billion for Soliton, summing to $64.619 billion—correct. Cash payments are stated as $40.210 billion, matching the ground truth of $40,210 million. The cash breakdown ($39.675B + $0.535B) also correctly sums to $40.210B. (2) Completeness: The answer addresses both parts of the question—total consideration and cash portion—and correctly attributes the amounts to the two acquisitions. (3) Entity accuracy: AbbVie, Allergan, and Soliton, Inc. are correctly identified. (4) Reasoning: The multi-hop synthesis across both acquisitions is sound, with accurate summation and attribution of cash. (5) Semantic equivalence: The use of 'billion' instead of 'million' is appropriate and equivalent. The only minor point is that $64.6 billion is a rounded figure (vs. $64.619B), but this is acceptable per format variation rules. No factual or calculation errors are present. Thus, the answer is correct with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 345,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does Bank of America's adherence to Basel 3 capital requirements influence its ability to execute its $25 billion stock repurchase program authorized in 2024?",
      "original_answer": "Bank of America's adherence to Basel 3 capital requirements directly influences its ability to execute its $25 billion stock repurchase program because the program is subject to the Corporation's capital position and regulatory requirements. As of December 31, 2024, the Corporation's Common Equity Tier 1 (CET1) capital ratio under the Standardized approach was 11.9 percent, exceeding the minimum requirement of 10.7 percent, which includes a capital conservation buffer and G-SIB surcharge. This capital adequacy allows the Corporation to proceed with repurchasing $13.1 billion of common stock in 2024, as it remains above the thresholds that would trigger restrictions on capital distributions.",
      "llm_answer": "Bank of America’s 2024 capital metrics are comfortably above the Basel III minima – its CET1 ratio of 11.9 % (Standardized) exceeds the 10.7 % regulatory floor, its Tier 1 and total‑capital ratios are also well‑above the required 12.2 % and 14.2 %, and its leverage‑based ratios (6.9 % Tier 1 leverage, 5.0 % supplementary leverage) surpass the 3.0 % + 2.0 % buffer. Because the firm meets (and exceeds) all Basel III capital‑ratio and buffer requirements, it faces no regulatory restriction on capital distributions, giving it the headroom to fund the $25 billion stock‑repurchase program authorized in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Bank of America's CET1 ratio of 11.9% under the Standardized approach and the 10.7% regulatory minimum, which aligns with the ground truth. However, it introduces additional metrics not present in the original answer—specifically Tier 1 and total-capital ratios (12.2%, 14.2%) and leverage ratios (6.9%, 5.0%) with buffer details—that are unsupported by the provided ground truth. These values may be accurate in reality but are not part of the knowledge graph's verified data, making their inclusion factually unverifiable and thus incorrect in this evaluation context. (2) The dollar amount of the repurchase program ($25 billion) is correctly stated, but the LLM claims the full amount can be funded due to capital adequacy, whereas the ground truth specifies only $13.1 billion was repurchased in 2024. This overstatement misrepresents the execution level and implies full authorization usage without evidence. (3) The reasoning is logically sound—exceeding Basel III requirements allows for capital distributions—but extends beyond the documented outcome. The multi-hop synthesis between capital ratios and repurchase capacity is valid, but the conclusion overreaches by not acknowledging the actual $13.1 billion figure, which tempers the implied full execution. (4) Scores reflect high contextual relevance and solid qualitative reasoning, but quantitative accuracy is reduced due to unsupported metrics and the omission of the actual repurchase amount, which is a key factual detail in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 429,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the total carrying value in millions of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 as reported in the MMM 2022 10-K filing?",
      "original_answer": "The total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 is $1,287 million.",
      "llm_answer": "The 10‑K shows a $650 million medium‑term note maturing in 2023 with a carrying value of **$649 million**, and a $650 million medium‑term note maturing in 2048 with a carrying value of **$638 million**. Together, they represent a total carrying value of **approximately $1,287 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately identifies two medium-term notes of $650 million each, with maturity dates in 2023 and 2048, and reports their respective carrying values as $649 million and $638 million. (2) The sum of these values ($649M + $638M) equals $1,287 million, which matches the ground truth total carrying value exactly. Minor wording variation ('approximately') is acceptable given rounding conventions and does not affect accuracy. (3) The reasoning correctly synthesizes information from the MMM 2022 10-K filing across both maturities, demonstrating proper multi-hop logic by identifying separate notes and aggregating their carrying values. (4) All entities (MMM, 2022 10-K, medium-term notes, maturity years) are correctly identified, and the response directly addresses the question. All scores are maximized due to complete factual accuracy, correct calculation, and clear contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1105,
        "completion_tokens": 277,
        "total_tokens": 1382
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the difference in interest rates between IBM's 2.900% Notes due 2030 and the highest-yielding debt instrument listed in IBM's 2024 10-K filing?",
      "original_answer": "The highest-yielding debt instrument listed in IBM's 2024 10-K filing is the 7.125% Debentures due 2096. The difference in interest rates between these instruments and the 2.900% Notes due 2030 is 4.225 percentage points.",
      "llm_answer": "IBM’s 2.900 % Notes due 2030 carry an interest rate that is **4.225 percentage points lower** than the highest‑yielding debt instrument listed in the filing—the 7.125 % Debentures due 2096.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the 2.900% Notes due 2030 and the 7.125% Debentures due 2096 are correctly identified as the relevant instruments. (2) The quantitative calculation is correct: 7.125% - 2.900% = 4.225 percentage points, and the answer correctly states this difference. Minor formatting variations (e.g., use of thin spaces, % symbol placement) do not affect accuracy. (3) The multi-hop reasoning—identifying the highest-yielding debt instrument from IBM's 2024 10-K and computing the interest rate difference—is sound and complete. (4) The answer is contextually precise, directly addressing the question with no extraneous or missing information. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1103,
        "completion_tokens": 240,
        "total_tokens": 1343
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "What was the total financial value of AbbVie's acquisition of Allergan, and how much in right-of-use assets did AbbVie acquire as part of the lease obligations assumed during the acquisition?",
      "original_answer": "The total financial value of AbbVie's acquisition of Allergan was $64,084 million, which included $453 million in right-of-use assets acquired in the transaction as of December 31, 2020.",
      "llm_answer": "AbbVie’s acquisition of Allergan was valued at **$64.084 billion** in total consideration (cash $39.675 billion + stock $23.979 billion + equity awards $0.430 billion). As part of the lease obligations assumed in the deal, AbbVie acquired **about $453 million of right‑of‑use assets**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the total financial value of AbbVie's acquisition of Allergan is correctly stated as $64.084 billion (equivalent to $64,084 million in the original answer), and the right-of-use assets acquired are accurately reported as $453 million. The breakdown of consideration (cash, stock, equity awards) adds up to $64.084 billion ($39.675B + $23.979B + $0.430B = $64.084B), which matches the total value. (2) Quantitative accuracy is perfect—numbers are correct, properly formatted, and consistent with the source, allowing for unit variation (billion vs million). (3) Entity accuracy is correct: AbbVie, Allergan, right-of-use assets, lease obligations, and the context of the acquisition are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly combines total consideration and specific asset details from the acquisition, likely drawing from multiple parts of a 10-K or acquisition disclosure. (5) The answer addresses both parts of the question completely and with precise, relevant details. No factual or interpretive errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 337,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How many shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan according to the 2024 10-K filing, and why are no future awards or deferrals possible under this plan?",
      "original_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it has been closed to new deferrals and awards, as explicitly stated in the filing.",
      "llm_answer": "The 2024 Form 10‑K shows that **391 shares of common stock were issuable upon distribution under the Norwest Corporation Directors’ Formula Stock Award Plan**. The plan is effectively closed – the filing states that “no future stock awards or deferrals may be made under this plan,” meaning the company will not grant any additional awards or allow further deferrals under it.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of shares—391—is accurately reported, with no calculation required. (2) The answer addresses both parts of the multi-hop question: it correctly states the number of shares issuable upon distribution and explains that no future awards or deferrals are possible because the plan is closed, directly citing the filing's language. (3) Entity accuracy is correct: the plan name 'Norwest Corporation Directors’ Formula Stock Award Plan' and the 2024 10-K source are properly identified. (4) The reasoning is sound and synthesizes the necessary information from the filing, accurately interpreting the closure of the plan as preventing future activity. (5) The semantic meaning is equivalent to the original answer, with slightly rephrased but factually consistent wording. No errors in facts, logic, or completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 266,
        "total_tokens": 1462
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did the amortization of intangible assets associated with the Allergan acquisition impact AbbVie's gross margin in 2021, and what was the total amortization expense for definite-lived intangible assets in that same year?",
      "original_answer": "The amortization of intangible assets associated with the Allergan acquisition negatively impacted AbbVie's gross margin in 2021, as noted in the 10-K filing. Although lower amortization of inventory fair value step-up adjustments and favorable product mix contributed to an increase in gross margin, the expense from amortizing intangible assets related to the Allergan acquisition partially offset these gains. In 2021, the total amortization expense for definite-lived intangible assets was $7.7 billion.",
      "llm_answer": "The 2021 gross‑margin increase was helped by lower amortization of the inventory fair‑value step‑up from the Allergan deal, but that gain was partially offset by higher amortization of the intangible assets acquired with Allergan. In 2021 AbbVie recorded $7.7 billion of amortization expense for its definite‑lived intangible assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the $7.7 billion amortization expense for definite-lived intangible assets in 2021 is correct, matching the original answer exactly. (2) The answer correctly identifies that the amortization of intangible assets from the Allergan acquisition negatively impacted gross margin, even though other factors (lower inventory step-up amortization and favorable product mix) helped increase gross margin—this multi-hop reasoning is sound and aligns with the original. (3) The only minor omission is that the LLM does not explicitly mention 'favorable product mix' as a contributing factor to the gross margin increase, which slightly reduces completeness in qualitative terms. However, the key causal relationship—higher intangible asset amortization partially offsetting margin gains—is clearly and correctly stated. (4) All entities (AbbVie, Allergan acquisition, 2021, definite-lived intangible assets) are correctly identified and contextualized. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 350,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the specific purpose of the Restoration Plans as it relates to the Benefit Plans, and how does The Home Depot fund these Restoration Plans according to the 2023 10-K filing?",
      "original_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that they would have received as a matching contribution under the Benefit Plans if not for the maximum compensation limits set by the Internal Revenue Code. The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_answer": "The Restoration Plans exist to give eligible associates the deferred compensation they would have earned as a matching contribution under the defined‑contribution Benefit Plans if the Internal Revenue Code’s compensation limits did not apply. The Home Depot funds those plans by making cash contributions to grantor trusts, which then buy shares of the company’s common stock on the open market 【page_69】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes the purpose of the Restoration Plans: providing deferred compensation in the form of matching contributions that would have been made under the Benefit Plans but for the IRS compensation limits. (2) It correctly states that The Home Depot funds these plans through cash contributions to grantor trusts, which then purchase company stock in the open market—this matches the funding mechanism in the original answer. (3) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable but does not detract. (4) The reasoning is sound and reflects proper multi-hop synthesis: connecting the IRS limits to the need for Restoration Plans and explaining the funding mechanism via grantor trusts and stock purchases. (5) All entities—The Home Depot, Restoration Plans, Benefit Plans, grantor trusts, common stock—are correctly identified and logically linked. The inclusion of the citation 【page_69】 adds contextual support. Wording differs slightly (e.g., 'defined-contribution Benefit Plans' adds specificity not contradicted by the source), but the meaning is preserved. No factual errors, omissions, or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 363,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the percentage change in the value of Variable Rate Notes from December 31, 2023, to December 31, 2024, and how does this reflect in the overall change in total borrowings over the same period?",
      "original_answer": "The value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024. However, total borrowings increased from $20,443 million to $31,099 million, representing a $10,656 million increase. Therefore, the percentage change in Variable Rate Notes is 0%, while the overall percentage increase in total borrowings is approximately 52.1%.",
      "llm_answer": "The Variable Rate Notes balance was $22 million at both year‑end dates, so the change is zero – a 0 % percentage change.  In contrast, total borrowings grew from $20.443 billion in 2023 to $31.099 billion in 2024, an increase of about $10.7 billion, or roughly a 52 % rise over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only minor rounding differences. (1) All key facts are correct: Variable Rate Notes remained at $22 million, resulting in a 0% change. Total borrowings increased from $20,443 million ($20.443 billion) to $31,099 million ($31.099 billion), which is accurately reflected. The increase is correctly characterized as about $10.7 billion (actual: $10,656 million), and the percentage increase is stated as roughly 52%, while the exact value is 52.1% — this minor rounding is acceptable. (2) Quantitative accuracy is excellent: all dollar amounts match when accounting for unit formatting (million vs billion), and the 0% change is exact. The percentage increase is calculated as (31,099 - 20,443) / 20,443 ≈ 0.521 or 52.1%; stating 'roughly 52%' is a reasonable approximation. (3) Reasoning is sound: the model correctly identifies that Variable Rate Notes did not change while total borrowings increased significantly, implying that the growth in total borrowings came from other debt components. This reflects proper multi-hop synthesis between two related but distinct financial metrics across the same time period. (4) The answer is contextually perfect, directly addressing both parts of the question. The only reason for not giving a full 10 is the slight rounding down of 52.1% to 52%, which, while common and acceptable, represents a minor loss in precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 399,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, according to the provided financial data?",
      "original_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,726 million.",
      "llm_answer": "The filing shows that, as of January 28 2024, the net carrying amount of the 4.95 % senior notes due September 2026 was **$744 million**, and the net carrying amount of the 4.95 % senior notes due September 2052 was **$980 million**. Together, these two series of notes had a total carrying amount of **approximately $1.724 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net carrying amounts of HD's 4.95% Senior Notes due in September 2026 ($744 million) and September 2052 ($980 million), which align with the ground truth data. The sum of these amounts is $744M + $980M = $1,724 million, which the model reports as approximately $1.724 billion—this is numerically accurate and semantically equivalent to $1,724 million. The ground truth states $1,726 million, indicating a $2 million discrepancy. This minor difference could stem from rounding in reporting or intermediate calculations not visible in the summary. Given the closeness and the use of 'approximately,' this does not constitute a major error. (2) All dates (January 28, 2024; September 2026; September 2052), percentages (4.95%), and entities (HD's Senior Notes) are correct. (3) The multi-hop reasoning—identifying two tranches of notes, retrieving their respective carrying amounts, and summing them—is sound and complete. (4) The answer is contextually fully relevant, directly addressing the question with precise financial data. The correctness score is 9 due to the $2M variance in total; however, this is within reasonable rounding tolerance. Quantitative accuracy is slightly penalized for this small discrepancy, while qualitative and contextual scores remain perfect due to accurate reasoning and entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 382,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What percentage decrease did PM experience in its net derivative asset position from 2022 to 2023, and how does this align with the changes in its total gross amount of derivative contracts?",
      "original_answer": "PM experienced a 45.7% decrease in its net derivative asset position from $186 million in 2022 to $101 million in 2023. This aligns with a reduction in the total gross amount of derivative contracts from $873 million in 2022 to $584 million in 2023, indicating a strategic reduction in overall derivative exposure.",
      "llm_answer": "PMI’s net derivative‑asset balance fell from $186 million at 12/31/2022 to $101 million at 12/31/2023 – a decline of $85 million, or roughly **46 %** year‑over‑year. At the same time, the **total gross notional amount of derivative contracts rose** from $40.4 billion in 2022 to $43.3 billion in 2023, an increase of about **7 %**. Thus, even though the overall size of the derivative portfolio grew modestly, the net asset position associated with those contracts dropped sharply.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. While it correctly states the net derivative asset decrease from $186 million in 2022 to $101 million in 2023 and calculates a roughly 46% decline (which is close to the exact 45.7%), it completely misrepresents the total gross amount of derivative contracts. The ground truth states this decreased from $873 million to $584 million, but the LLM claims it increased from $40.4 billion to $43.3 billion — a figure over 45 times larger than the correct value and with the opposite trend. This invalidates the core comparison. (2) The quantitative inaccuracies are severe: the gross derivative amounts are off by billions of dollars and show an increase instead of a decrease. The percentage change in gross contracts is reported as +7% when it should reflect a ~33% decrease. Only the net asset values and their percentage drop are approximately correct. (3) The multi-hop reasoning fails because the LLM draws an incorrect conclusion — that net exposure decreased while gross exposure increased — when in fact both net and gross exposures decreased, indicating a broad reduction in derivative activity. The model thus misaligns the two trends rather than correctly aligning them. (4) Due to fundamental errors in key financial figures and directional trends, the correctness score is very low. The answer gets partial credit only for the net asset values and approximate percentage decline. Quantitative and qualitative accuracy scores are low due to massive discrepancies in scale and direction of change. Contextual relevance is slightly higher because the structure and intent of the response match the question, but the substance is largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 467,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, and how does this compare to the number of shares of Common Stock to be issued for options and RSUs under these plans?",
      "original_answer": "The total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, is 27.9 million (27.1 million from the 2016 Stock Incentive Plan and 0.8 million from the 2016 Stock Plan for Non-Employee Directors). This is in addition to 10,221,113 shares of Common Stock to be issued for options and 2,005,555 RSUs subject to continued employment under the 2016 Stock Incentive Plan, as well as 129,854 shares of Common Stock to be issued for options under the 2016 Stock Plan for Non-Employee Directors.",
      "llm_answer": "As of December 31 2024 the two plans together had **≈27.9 million shares** of Honeywell common stock available for future grants (27.1 million under the 2016 Stock Incentive Plan plus 0.8 million under the 2016 Stock Plan for Non‑Employee Directors).  \n\nBy contrast, the same plans already have **≈12.8 million shares** of common stock slated to be issued on the exercise of outstanding options and the settlement of RSUs (10.35 million option shares + 2.42 million RSU shares = 12,767,488 shares).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total shares available for future issuance (27.9 million: 27.1M + 0.8M), which matches the ground truth. However, it inaccurately calculates the number of shares to be issued for options and RSUs. The ground truth specifies 10,221,113 option shares and 2,005,555 RSUs under the 2016 Stock Incentive Plan, plus 129,854 option shares under the Non-Employee Directors plan, totaling 12,356,522 shares (10,221,113 + 2,005,555 + 129,854). The LLM reports ≈12.8 million (12,767,488), which is incorrect. It appears to have inflated both the option and RSU figures (10.35M options vs. actual 10.351M, and 2.42M RSUs vs. actual 2.006M), possibly due to incorrect data aggregation or misattribution across plans. (2) The calculation of total shares to be issued is off by ~411,000 shares, which is a significant quantitative error. While the available shares are correct, the comparison component fails due to this miscalculation. (3) The multi-hop reasoning is partially sound—correctly separating the two plans and aggregating available shares—but fails in accurately synthesizing the committed shares (options and RSUs) across both plans. The model combines figures but does not correctly reflect the breakdown by plan or the actual values from the source. (4) The contextual relevance is high as the answer addresses both parts of the question and uses appropriate terminology. The qualitative accuracy is moderate because the structure and intent are correct, but the factual synthesis is flawed. The correctness score is 6 due to the major error in the second part of the answer, despite getting the first and more prominent part right.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 459,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What was the growth in Dynamics 365 revenue in fiscal year 2022, and how does this contribute to the overall Dynamics products and cloud services revenue growth of 25%?",
      "original_answer": "Dynamics 365 revenue grew by 39% in fiscal year 2022, which significantly contributed to the overall Dynamics products and cloud services revenue growth of 25%. This indicates that Dynamics 365 was a key driver behind the broader Dynamics suite's performance, suggesting strong adoption and demand for Microsoft's integrated business applications platform.",
      "llm_answer": "In fiscal 2022, Dynamics 365 revenue grew **about 39 %**. That strong expansion was the key driver behind the broader **25 % increase** in Microsoft’s “Dynamics products and cloud services” revenue line.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states that Dynamics 365 revenue grew by about 39% in fiscal year 2022 and that this contributed to the overall Dynamics products and cloud services revenue growth of 25%. These figures match the ground truth exactly, with only minor formatting differences (e.g., 'about 39 %' vs '39%'), which are semantically equivalent. 2) Quantitatively, both percentages (39% and 25%) are accurate and correctly attributed to the right fiscal year and product lines. There are no calculation errors. 3) The multi-hop reasoning is sound: the model correctly infers that the strong growth in Dynamics 365 was a key driver of the broader Dynamics suite's growth, which aligns with the causal relationship implied in the original answer. While the LLM answer does not explicitly mention 'strong adoption and demand' or 'integrated business applications platform' as in the original, it captures the core logical connection. 4) The answer is fully contextually relevant, directly addressing both parts of the question—Dynamics 365's growth and its contribution to overall growth. The slight omission of descriptive context (e.g., 'significantly contributed', 'key driver behind strong adoption') prevents a perfect qualitative score, but the factual and reasoning core is intact. Overall, this is a highly accurate and well-reasoned response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 374,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "By how much did Tesla's Energy Generation and Storage revenue increase specifically due to the deployment of Megapack in 2021 compared to 2020, and what role does Megapack play in Tesla's broader energy storage product portfolio?",
      "original_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million, or 40%, in 2021 compared to 2020, primarily driven by the deployment of Megapack along with growth in solar cash and loan jobs, Powerwall, and Solar Roof. Megapack is a key component of Tesla's energy storage product lineup, designed for commercial, industrial, utility, and energy generation customers, and can be grouped to form large-scale installations of gigawatt hours or greater capacity.",
      "llm_answer": "Tesla’s Energy Generation and Storage revenue grew by **$795 million (a 40 % increase) in 2021 versus 2020**, and the filing notes that this rise was “primarily due to an increase in deployments of **Megapack**” (along with solar and Powerwall growth). Megapack is Tesla’s large‑scale lithium‑ion battery system designed for commercial, industrial, utility and renewable‑energy customers, and it now serves as the flagship, higher‑capacity offering that is replacing the older Powerpack and sits alongside the smaller‑scale Powerwall in the company’s energy‑storage portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $795 million increase in Tesla's Energy Generation and Storage revenue from 2020 to 2021, along with the 40% growth rate, matching the ground truth exactly. These figures are accurately reported with acceptable formatting (e.g., $795 million vs $795 million). 2) The qualitative description of Megapack’s role is largely accurate: it is correctly described as a large-scale battery system for commercial, industrial, utility, and renewable-energy customers. The answer adds contextual detail not in the original—namely that Megapack is replacing Powerpack and sits alongside Powerwall—which is factually correct and consistent with Tesla's product evolution, though not explicitly stated in the ground truth. This does not detract from accuracy but represents a minor expansion. 3) Multi-hop reasoning is sound: the answer links the revenue increase to Megapack deployment while acknowledging other contributing factors (solar, Powerwall), correctly interpreting 'primarily due to Megapack' as the main driver without excluding others. 4) All entities (Tesla, Megapack, 2020–2021 timeframe, revenue metric) are correct. The only reason for not scoring a 10 is that the original answer emphasizes Megapack as a 'key component' without explicitly stating it replaces Powerpack—this addition, while accurate, slightly exceeds the provided ground truth. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 405,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What was the total pre-tax loss recognized by Walmart in fiscal 2021 and 2022 related to the divestiture of Asda, including both the initial loss estimate and the additional adjustments upon closing, and how does this reflect the financial impact of pension-related obligations tied to the disposal group?",
      "original_answer": "Walmart recognized a total pre-tax loss of $5.7 billion related to the divestiture of Asda. This includes the $5.5 billion estimated pre-tax loss recognized in the fourth quarter of fiscal 2021, which incorporated $2.3 billion of accumulated pension components, and an additional $0.2 billion loss recorded in the first quarter of fiscal 2022 upon closing, primarily due to changes in net assets, currency exchange rate fluctuations, and purchase price adjustments. The pension-related obligations significantly contributed to the overall loss, illustrating the financial impact of legacy liabilities in international divestitures.",
      "llm_answer": "Walmart recorded a $5.5 billion pre‑tax loss on the Asda disposal in the fourth quarter of fiscal 2021 and an additional $0.2 billion pre‑tax loss in the first quarter of fiscal 2022, for a combined pre‑tax loss of about **$5.7 billion**. Approximately **$2.3 billion** of that amount reflected the derecognition of accumulated pension components for the Asda pension plan, illustrating that pension‑related obligations accounted for a sizable portion of the overall loss tied to the disposal group.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $5.5 billion loss in fiscal 2021, $0.2 billion additional loss in fiscal 2022, totaling $5.7 billion, with $2.3 billion attributed to pension components. These figures match the original answer exactly, and the sum ($5.5B + $0.2B = $5.7B) is correct. (2) The answer addresses both parts of the question: the total pre-tax loss over two fiscal years and the role of pension-related obligations. (3) Entities are correctly identified: Walmart, Asda, fiscal 2021 and 2022, and the pension components are accurately tied to the disposal group. (4) The reasoning is sound and reflects proper multi-hop synthesis: it combines information from two reporting periods and correctly attributes a significant portion of the loss to pension liabilities, highlighting their financial impact. The wording differs slightly but maintains semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 289,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 was represented by the combined revenue from Surface devices and Windows OEM licensing, given that the segment reported $56.5 billion in revenue and Windows OEM contributed 42% of that segment's revenue?",
      "original_answer": "The combined revenue from Surface devices and Windows OEM licensing represented 58% of the More Personal Computing segment's $56.5 billion in fiscal year 2022. Windows OEM contributed 42% ($23.73 billion) and Devices (primarily Surface) contributed 16% ($9.04 billion), totaling $32.77 billion or 58% of the segment's total revenue.",
      "llm_answer": "Windows OEM licensing accounts for 42 % of the More Personal Computing segment’s revenue. That equals 0.42 × $56.5 billion ≈ $23.7 billion. Adding the $6.991 billion of Devices (Surface) revenue gives a combined total of roughly $30.7 billion, which is about 30.7 / 56.5 ≈ 54 % of the segment’s revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly identifies that Windows OEM contributed 42% of the More Personal Computing segment revenue ($23.7 billion, correctly calculated from 0.42 × $56.5 billion), it uses an incorrect value for Surface (Devices) revenue. The LLM states $6.991 billion, but the ground truth is $9.04 billion (16% of $56.5 billion). This leads to an incorrect combined total of $30.7 billion instead of $32.77 billion, and thus a wrong percentage of 54% instead of the correct 58%. (2) Calculations are internally consistent but based on incorrect input data—Surface revenue should be 16% of $56.5 billion = $9.04 billion, not $6.991 billion. The sum $23.7B + $6.991B = $30.7B is accurate, but the inputs are flawed. (3) The reasoning process is sound—multi-hop synthesis is attempted by calculating OEM revenue, adding Surface revenue, and computing the combined percentage—but it fails due to reliance on incorrect data for Surface. The model appears to have used an incorrect or outdated figure for Devices revenue. (4) Scores reflect that core logic and structure are correct (hence moderate qualitative and high contextual relevance), but the answer is factually wrong on key numbers, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 369,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale, combining the $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda?",
      "original_answer": "The total financial impact on Walmart from the Asda pension-related activities was $3.3 billion, combining the $1.0 billion cash contribution made by Asda to its pension plan in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda. This amount reflects the full pension-related exposure transferred as part of the divestiture.",
      "llm_answer": "Walmart’s pension‑related impact from the Asda transaction equals the $1.0 billion cash contribution that Asda made to the UK pension plan in fiscal 2020 plus the $2.3 billion of accumulated pension components that were included in the disposal group when Asda was sold – a combined effect of roughly **$3.3 billion**【page_78†L1-L4】【page_79†L9-L12】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $1.0 billion cash contribution by Asda in fiscal 2020 and the $2.3 billion of accumulated pension components included in the disposal group are correctly stated, and their sum—$3.3 billion—is accurately calculated. Minor formatting differences ($1.0 billion vs $1.0 billion) are acceptable and do not affect meaning. (2) The answer is complete, addressing both components of the multi-part financial impact: the pension contribution and the pension elements in the disposal group. (3) Entity accuracy is correct: Walmart is the parent company, Asda is the subsidiary involved, fiscal 2020 is the correct time period, and the pension-related obligations are properly contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking Asda’s contribution to Walmart’s overall pension exposure and recognizing that both amounts were transferred upon sale, resulting in a total impact. The citations (page_78, page_79) further support the factual grounding. (5) The semantic meaning is equivalent to the original answer, with clear, precise language conveying the same conclusion: a $3.3 billion total pension-related financial impact on Walmart from the Asda divestiture.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 366,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "By how much did the value of pre-owned aircraft inventories increase from December 31, 2023, to December 31, 2024, and what specific valuation method does the company use for these pre-owned aircraft?",
      "original_answer": "The value of pre-owned aircraft inventories increased by $8 million from December 31, 2023 ($15 million) to December 31, 2024 ($23 million). The company values pre-owned aircraft at the lower of the trade-in value or the estimated net realizable value.",
      "llm_answer": "The pre‑owned aircraft line grew from $15 million at 12/31/2023 to $23 million at 12/31/2024 – an increase of **$8 million**.  The company records these aircraft at the **lower of the trade‑in value or the estimated net realizable value** (i.e., the lower‑of‑cost‑or‑NRV rule).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values for pre-owned aircraft inventories are accurate: $15 million on December 31, 2023, and $23 million on December 31, 2024, resulting in an $8 million increase, which is correctly calculated. (2) The valuation method is accurately stated as 'lower of the trade-in value or the estimated net realizable value,' with the added clarification of 'lower-of-cost-or-NRV rule,' which is semantically equivalent and adds helpful context without altering the meaning. (3) The answer addresses both parts of the multi-hop question: the quantitative change over time and the specific accounting method used. (4) All entities (pre-owned aircraft inventories, correct dates, valuation method) are correctly identified and synthesized from the source data. The wording differs slightly from the original answer but maintains full semantic equivalence. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 286,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the growth in Xbox Game Pass's curated game library relate to the 3% increase in Xbox content and services revenue, and what broader strategic investments does Microsoft highlight that could influence this gaming segment's performance?",
      "original_answer": "The Xbox Game Pass, which offers access to a curated library of over 100 first- and third-party titles, contributes to the 3% increase in Xbox content and services revenue. This growth is tied to Microsoft's broader strategic investments in gaming, including the acquisition of ZeniMax Media and the planned acquisition of Activision Blizzard, both of which expand the company's content portfolio and community engagement. These investments align with Microsoft's focus on transforming gaming through cloud services like Xbox Cloud Gaming, which enhances accessibility and user engagement across multiple platforms.",
      "llm_answer": "Microsoft notes that Xbox Game Pass now offers a “curated library of over 100 first‑ and third‑party console and PC titles” (page 6), a growth that helps drive higher subscription and usage activity and is reflected in the “Xbox content and services revenue increased 3%” year‑over‑year (page 40).  The company says this performance is underpinned by broader strategic bets – heavy investment in gaming content and community, the acquisition of studios such as ZeniMax (and the pending Activision Blizzard deal), expansion of Xbox Cloud Gaming, and the use of Windows, Azure and AI to create new, cross‑device gaming experiences (page 6).  These investments are intended to deepen engagement and fuel future growth of the Xbox segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3% year-over-year increase in Xbox content and services revenue and links it to the growth of Xbox Game Pass's curated library of over 100 titles, which matches the ground truth. All key entities—Xbox Game Pass, ZeniMax Media, Activision Blizzard, Xbox Cloud Gaming—are accurately named and correctly contextualized. (2) Quantitatively, the 3% revenue increase and the 'over 100' titles in the library are correctly reported. The LLM adds minor detail (console and PC titles) not in the original but consistent with it, and cites page numbers plausibly, though these were not part of the ground truth and don't affect accuracy. (3) The multi-hop reasoning is sound: the answer connects Game Pass growth to revenue, then links that to broader strategic investments (acquisitions, cloud gaming, AI, Azure), correctly synthesizing across multiple layers of the original answer. The only minor shortcoming is that it does not explicitly mention 'community engagement' or 'transformation of gaming through cloud services' in the same structured way as the original, slightly reducing qualitative precision. (4) The answer is fully contextually relevant, directly addressing both parts of the question—how Game Pass growth relates to revenue and what strategic investments are highlighted. Overall, the response is factually accurate, well-reasoned, and semantically equivalent to the ground truth, warranting a high score with only a small deduction in qualitative accuracy for slightly less precise framing of strategic goals.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 433,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How much revenue did Eli Lilly recognize in 2023 specifically from the sale of rights for the olanzapine portfolio, and how does this transaction factor into the broader collaboration and other revenue category for the same year?",
      "original_answer": "Eli Lilly recognized revenue from the 2023 sale of rights for the olanzapine portfolio, including Zyprexa, which is part of the broader 'collaboration and other revenue' category. This category includes revenue from collaborations such as the one with Boehringer Ingelheim and the sale of rights for the olanzapine portfolio and Baqsimi. The sale of the olanzapine portfolio rights directly contributed to the collaboration and other revenue in 2023.",
      "llm_answer": "In 2023 Eli Lilly recognized **about $1.7 billion** ( $79.4 million + $1,615.4 million ≈ $1,694.8 million ) from the July 2023 sale of the rights to its olanzapine portfolio (Zyprexa). That amount is rolled into the company’s **Collaboration and other revenue** line, which totaled **$5.31 billion** for 2023, so the olanzapine‑rights sale represents a component of that broader revenue category.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The original answer (ground truth) does not specify any dollar amount for the sale of the olanzapine portfolio rights in 2023—it only confirms that such a sale occurred and was included in the 'collaboration and other revenue' category. The LLM fabricates a figure of approximately $1.7 billion, breaking it down into $79.4 million and $1,615.4 million, which are not present in the ground truth and have no supporting evidence. This makes the quantitative claims entirely incorrect. (2) The calculation of $79.4M + $1,615.4M = $1,694.8M (~$1.7B) is mathematically correct, but since the inputs are fabricated, the result is invalid. Additionally, the stated total 'Collaboration and other revenue' of $5.31 billion is not confirmed in the ground truth, which only states that the olanzapine sale contributed to this category without providing a total. (3) The qualitative reasoning partially aligns with the ground truth: the model correctly identifies that the olanzapine rights sale is part of the 'collaboration and other revenue' category and mentions relevant context like Zyprexa and the broader category including other collaborations (e.g., Baqsimi). However, it fails to demonstrate valid multi-hop synthesis from actual data, instead inventing specifics. (4) Contextual relevance is high because the answer addresses the right categories and transaction type, but correctness is severely undermined by hallucinated numbers. Thus, while the structure and intent are reasonable, the factual foundation is flawed, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 456,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the structure of Tesla's 5.45% Solar Bonds, as evidenced by multiple Supplemental Indentures in 2015, reflect Tesla's (via SolarCity) financing strategy for solar energy projects, and what does this imply about the role of bond-specific trustee agreements in supporting recurring capital needs?",
      "original_answer": "Tesla, through its acquisition of SolarCity, issued multiple tranches of 5.45% Solar Bonds in 2015 (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15), each governed by distinct Supplemental Indentures (4.72, 4.74, 4.76, and 4.78) dated at different points in November through December 2015. This repeated issuance of the same interest rate bond with separate indentures suggests a deliberate financing strategy to raise capital in tranches, allowing SolarCity to match funding with project deployment timelines and investor demand. The use of multiple Supplemental Indentures under the same bond rate indicates that Tesla (via SolarCity) prioritized flexibility in structuring solar project financing, with trustee agreements playing a critical role in enabling discrete funding events while maintaining consistent yield terms for investors.",
      "llm_answer": "The 5.45 % Solar Bonds were not issued as a single, one‑time transaction; the 2015 filing lists a succession of “Supplemental Indentures” (e.g., Exhibit 4.50, 4.52, 4.54, 4.56, 4.60, 4.61, 4.62, 4.64, 4.66, 4.72, 4.74, 4.76, 4.78) that each amend the original indenture and create a new tranche of the same 5.45 % series. This tranche‑by‑tranche structure lets SolarCity (now part of Tesla) draw down capital repeatedly as new solar projects are funded, turning the bond issue into a revolving financing pool rather than a single‑shot loan. Because each tranche is governed by its own trustee‑administered supplemental indenture, the trustee agreements serve as the contractual conduit that enforces covenants, protects investors and authorizes incremental draws, thereby providing the ongoing, project‑level funding Tesla needs to sustain its solar‑energy rollout.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its interpretation and reasoning, but contains a minor quantitative inaccuracy in the listing of Supplemental Indentures. The ground truth specifies four tranches (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15) with corresponding Supplemental Indentures 4.72, 4.74, 4.76, and 4.78. However, the LLM lists a broader set of exhibit numbers (e.g., 4.50, 4.52, etc.), some of which are not mentioned in the ground truth and may refer to earlier or unrelated amendments. While it's plausible that multiple supplemental indentures were filed, the LLM overstates the number directly tied to the 5.45% Solar Bonds in question, introducing potential confusion. Despite this, the core financial percentage (5.45%) and the tranche-based issuance strategy are correctly identified. The qualitative analysis is strong: the LLM accurately infers that the structure enabled incremental capital draws aligned with project deployment, reflecting a flexible, recurring financing model. It correctly identifies the role of trustee agreements in enabling discrete funding events under consistent yield terms, demonstrating sound multi-hop reasoning across bond structure, financing strategy, and governance mechanisms. The answer is contextually excellent, directly addressing both the structural implications and the role of trustee agreements. Minor deduction in quantitative accuracy due to incorrect enumeration of exhibits; otherwise, the answer is semantically equivalent and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 419,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "By how much did the increase in Megapack deployments contribute to Tesla's Energy generation and storage revenue growth in 2021 compared to 2020, and what other product's decline partially offset this growth?",
      "original_answer": "The increase in Megapack deployments contributed to a $795 million, or 40%, growth in Tesla's Energy generation and storage revenue in 2021 compared to 2020. This growth was partially offset by a decrease in Powerpack deployments as Tesla phased out the product following the introduction of Megapack.",
      "llm_answer": "The rise in Megapack deployments was a key driver of the Energy generation and storage segment’s revenue jump of **$795 million (a 40% increase) in 2021 versus 2020**.  That growth was **partially offset by a decline in Powerpack deployments**, as Tesla began phasing out the Powerpack product after introducing the Megapack.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately reports the $795 million increase and 40% growth in Tesla's Energy generation and storage revenue from 2020 to 2021, with correct formatting (bold for emphasis is acceptable). (2) The answer correctly identifies that the growth was partially offset by a decline in Powerpack deployments, which aligns with the phasing out of the product following Megapack's introduction. (3) The multi-hop reasoning is sound: it connects Megapack's increased deployments to revenue growth and contrasts it with Powerpack's decline, synthesizing information across product lines and time periods. (4) All entities—Tesla, Megapack, Powerpack, and the relevant financial metric—are correctly identified and contextualized. The answer is semantically equivalent to the original, with no factual, numerical, or reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 266,
        "total_tokens": 1438
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "What was the combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024?",
      "original_answer": "$20 million",
      "llm_answer": "The Africa/Eurasia segment recorded **$12 million** of capital expenditures in 2024 (page 116) and **$8 million** of depreciation and amortization in the same year (page 117). Together, these amount to a combined total of **$20 million** for the region in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: capital expenditures for Africa/Eurasia in 2024 are correctly stated as $12 million (page 116), and depreciation and amortization are correctly stated as $8 million (page 117). (2) The calculation is accurate: $12 million + $8 million = $20 million, which matches the ground truth. Minor formatting differences (e.g., use of thin space in '$12 million') do not affect correctness. (3) The multi-hop reasoning is sound—information from two different pages and two different financial metrics is correctly synthesized to compute the combined total. (4) The entities (Africa/Eurasia region, 2024 fiscal year, correct financial metrics) are accurately identified and applied. The answer is semantically equivalent to the original and fully addresses the question with precise, well-supported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1062,
        "completion_tokens": 261,
        "total_tokens": 1324
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does TI's policy regarding retiree health care benefit plan investments compare to the actual TI common stock holdings in non-U.S. defined contribution plans as of December 31, 2024?",
      "original_answer": "TI maintains a policy that none of the assets related to the retiree health care benefit plan are directly invested in TI common stock, as stated in the disclosures. In contrast, TI's non-U.S. defined contribution plans held TI common stock valued at $34 million as of December 31, 2024. This highlights a clear distinction in investment strategy, where the retiree health care benefit plan avoids direct company stock investment, while the non-U.S. defined contribution plans do include TI stock holdings.",
      "llm_answer": "TI’s retiree‑health‑care benefit plan is invested almost entirely in broad‑market index funds – about 80 % in fixed‑income/cash and roughly 20 % in equity – and the plan “does not hold TI common stock directly.” In contrast, the company’s non‑U.S. defined‑contribution plans did hold TI common stock, valued at about **$34 million** as of December 31 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the retiree health care benefit plan does not hold TI common stock directly, and the non-U.S. defined contribution plans held $34 million in TI common stock as of December 31, 2024—this matches the original answer exactly in both amount and date. (2) Quantitative accuracy is perfect: the $34 million figure is correctly reported, and no erroneous calculations are present. (3) The multi-hop reasoning is sound—correctly contrasting two distinct plans (retiree health care vs. non-U.S. defined contribution) and their investment strategies regarding TI stock. (4) The LLM adds minor additional detail (80% fixed-income, 20% equity) not present in the ground truth, but this does not contradict it and may reflect broader knowledge from the filing; however, since the original answer does not confirm these percentages, this slight over-specification prevents a perfect 10 on qualitative accuracy. Otherwise, the semantic meaning and comparison are equivalent, and the response fully addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 314,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did LLY's revenue from Baqsimi change between 2023 and 2024, considering both U.S. and Outside U.S. sales, and what does the collaboration and other arrangements disclosure indicate about the shift in revenue recognition for Baqsimi?",
      "original_answer": "LLY's total revenue from Baqsimi dropped significantly from $677.6 million in 2023 (U.S. $645.7 million + Outside U.S. $31.9 million) to only $29.2 million in 2024 (U.S. $2.5 million + Outside U.S. $26.7 million). This sharp decline is explained by the company's disclosure that it sold the rights for Baqsimi in 2023, shifting the revenue recognition from product sales to collaboration and other arrangements, which typically involve milestone payments or profit-sharing agreements.",
      "llm_answer": "Baqsimi’s total revenue fell sharply from ≈ $678 million in 2023 (U.S. $645.7 m + Outside U.S. $31.9 m) to ≈ $29 million in 2024 (U.S. $2.5 m + Outside U.S. $26.7 m)【page_68】.  \n\nThe 2024 10‑K notes explain that the 2023 Baqsimi figures were recorded as “collaboration and other revenue” because Lilly sold the rights to the product; revenue from such sales of intellectual‑property rights is recognized in the collaboration‑and‑other‑arrangements line when control of the asset transfers【page_64】【page_67】. This disclosure shows that Baqsimi’s earnings have shifted from ongoing product‑sale revenue to a one‑time collaboration‑type recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for Baqsimi in 2023 and 2024, both for U.S. and Outside U.S. sales, with accurate totals ($677.6M ≈ $678M and $29.2M ≈ $29M — acceptable rounding). All individual components match the ground truth: $645.7M (U.S. 2023), $31.9M (Outside U.S. 2023), $2.5M (U.S. 2024), and $26.7M (Outside U.S. 2024). (2) Calculations are correct: 645.7 + 31.9 = 677.6 ≈ 678; 2.5 + 26.7 = 29.2 ≈ 29. The sharp decline is accurately characterized. (3) The reasoning about revenue recognition shift is substantively correct — the LLM correctly identifies that the sale of Baqsimi rights led to revenue being recognized under 'collaboration and other arrangements' in 2023, not 2024. However, there is a minor misstatement: the LLM says 'the 2023 Baqsimi figures were recorded as collaboration and other revenue', but in the ground truth, the 2023 revenue was still reported as product sales; the shift occurred *after* the sale, meaning future revenues would be collaboration-based. The disclosure indicates that *post-sale* revenue recognition changed, not that 2023 product revenue was collaboration revenue. This is a subtle but important distinction in timing and accounting treatment. (4) Despite this nuance, the core multi-hop synthesis — connecting the revenue drop to the rights sale and explaining the change in revenue recognition model — is sound and contextually appropriate. The answer is highly relevant and factually precise, warranting a correctness score of 9 due to the minor mischaracterization of when the revenue recognition shift took effect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 442,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What classification of revenue does Mastercard specifically include for its 'Processing and Gateway' services, and how does this align with the broader categories of revenue generation described in the company's 10-K filing?",
      "original_answer": "Mastercard classifies revenue from its 'Processing and Gateway' services under the broader category of 'value-added services and solutions,' which are distinct from its primary 'payment network' revenue source. This classification includes revenues generated through either fixed or transaction-based fees and is recognized in the period in which the related services are performed or transactions occur.",
      "llm_answer": "Mastercard reports the fees it earns from “Processing and gateway” activities as **value‑added services and solutions** revenue. This falls under the second of the two net‑revenue categories the 10‑K discloses – (i) payment‑network revenue and (ii) value‑added services and solutions – so the processing‑gateway income is grouped with the broader suite of value‑added offerings rather than with the core payment‑network fees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies that Mastercard classifies 'Processing and Gateway' revenue under 'value-added services and solutions,' distinguishing it from the primary 'payment-network revenue.' This matches the original answer's classification and structural explanation. The LLM correctly reflects the two-category revenue framework disclosed in the 10-K, demonstrating sound multi-hop reasoning by linking a specific service (Processing and Gateway) to its broader financial reporting category. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The only minor limitation is that the LLM does not explicitly mention the recognition method (i.e., revenue recognized when services are performed or transactions occur) or the fee structure (fixed or transaction-based), which are included in the original answer. However, the core classification and alignment with broader revenue categories are fully correct, making the response semantically nearly equivalent. Thus, the correctness and qualitative accuracy scores are slightly reduced to 9 to reflect the small omission, while contextual relevance remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 348,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the year-over-year change in CL's pension plan investments in international common stocks, and how does this shift reflect in the total international investments across both reporting periods?",
      "original_answer": "CL's pension plan investments in international common stocks increased by $5 million year-over-year, from $15 million to $20 million. This increase contributed to a broader rise in total international investments, which grew from $537 million to $566 million, reflecting a $29 million year-over-year change. The growth in international common stocks accounted for 17.2% of the total year-over-year increase in international investments.",
      "llm_answer": "Colgate‑Palmolive’s pension‑plan holdings of international common‑stock fell from $20 million at year‑end 2023 to $15 million at year‑end 2024 – a $5 million (‑25 %) reduction.  That decline helped drive the overall value of the international side of the pension plans down from $566 million in 2023 to $537 million in 2024, a total drop of $29 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of change. (1) The original answer states that CL's pension plan investments in international common stocks *increased* by $5 million, from $15 million to $20 million. The LLM incorrectly claims a *decrease* from $20 million to $15 million, reversing the year-over-year trend. (2) The total international investments grew from $537 million to $566 million (a $29 million increase), but the LLM reports a decrease of $29 million, again reversing the direction. (3) The LLM also misattributes the change in international common stocks as a driver of a decline, when in fact it contributed positively to growth. (4) The calculation of the percentage contribution (17.2%) is missing from the LLM answer, and the incorrect direction of change invalidates any derived insights. All core quantitative facts are wrong, and the multi-hop reasoning (linking the change in international common stocks to total international investment shifts) is flawed due to incorrect data synthesis. While the entities (CL/Colgate-Palmolive, pension plan, international investments) are contextually relevant, the factual inaccuracies render the response highly incorrect. Minor formatting like '$5 million' is acceptable, but directional errors in financial trends are severe. Thus, the correctness, quantitative, and qualitative accuracy scores are very low. Contextual relevance is moderate because the answer addresses the right topic and structure but with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 416,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the total increase in General Dynamics' (GD) Restricted Stock/RSUs expense from 2022 to 2024, and how did this trend contribute to the overall change in equity-based compensation expense during the same period?",
      "original_answer": "The total increase in Restricted Stock/RSUs expense from 2022 ($59M) to 2024 ($85M) was $26M. Over the same period, total equity-based compensation expense increased from $130M to $145M, an increase of $15M. Therefore, the rise in Restricted Stock/RSUs expense accounted for more than the total increase in overall equity-based compensation, indicating that the increase in RSUs was a primary driver of the overall compensation expense growth.",
      "llm_answer": "The Restricted‑stock/RSU expense rose from $59 million in 2022 to $85 million in 2024 – an increase of **$26 million**.  During the same period total equity‑based compensation expense grew from $130 million to $145 million, a **$15 million** rise, meaning the jump in RSU expense accounted for most of the overall increase (the rise in RSU cost more than offset the $11 million decline in stock‑option expense).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: Restricted Stock/RSUs expense increased from $59M in 2022 to $85M in 2024, a $26M increase; total equity-based compensation rose from $130M to $145M, a $15M increase—both match the original answer. (2) Calculations are accurate: $85M - $59M = $26M; $145M - $130M = $15M. (3) The multi-hop reasoning is sound: the model correctly infers that the $26M increase in RSUs exceeded the $15M total increase in equity compensation, implying RSUs were the primary driver. It adds contextual insight not in the original—mentioning an $11M decline in stock-option expense—which is consistent with the logic (since $26M increase in RSUs minus $11M decrease in options ≈ $15M net increase), though this specific $11M figure is not in the ground truth. However, as it's a plausible inference and does not contradict the data, it doesn't reduce correctness. (4) The answer addresses both parts of the question: the increase in RSU expense and its contribution to overall equity compensation trends. Wording differs slightly (e.g., 'most of the overall increase' vs 'more than the total increase'), but the semantic meaning is equivalent. The only minor gap is that the original emphasizes RSUs 'accounted for more than the total increase,' which the LLM captures in spirit but slightly understates with 'most.' Overall, this is a factually correct, complete, and well-reasoned response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 406,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "Given Amazon's use of an $8.0 billion unsecured 364-day term loan in early 2023, how does this borrowing decision reflect a strategic preference in short-term liquidity management considering the availability of its $20.0 billion Commercial Paper Programs?",
      "original_answer": "Amazon's decision to enter into an $8.0 billion unsecured 364-day term loan in January 2023, despite having access to a $20.0 billion Commercial Paper Program, suggests a strategic choice in liquidity management. The term loan, classified as short-term debt and fully repaid by December 31, 2023, was likely used to meet specific funding needs with a defined maturity, offering more certainty in repayment terms. In contrast, the Commercial Paper Program provides flexibility with variable issuance and maturities up to 397 days, but as of the reporting period, no borrowings had been drawn. This indicates that Amazon opted for a committed term facility for this particular financing need rather than tapping into its broader commercial paper capacity, possibly to preserve flexibility under the program for other short-term obligations.",
      "llm_answer": "Amazon’s January 2023 financing choice – an $8.0 billion unsecured 364‑day term loan that was fully repaid by year‑end – shows that the company preferred to tap a short‑term bank facility rather than draw on its much larger $20.0 billion commercial‑paper programs (which remained unused at that time)【page_57】. By using the term loan, Amazon diversified its near‑term funding sources and preserved the commercial‑paper capacity for other liquidity needs, reflecting a strategic emphasis on flexible, short‑term liquidity management while keeping its low‑cost CP option available.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: Amazon's $8.0 billion unsecured 364-day term loan in January 2023, its full repayment by year-end, the existence of a $20.0 billion Commercial Paper (CP) Program, and the fact that no borrowings were drawn under it at the time. These match the ground truth exactly. (2) Quantitative accuracy is perfect: dollar amounts ($8.0 billion, $20.0 billion), time frame (364-day, repaid by December 31, 2023), and timing (January 2023) are all accurate. Format variations (e.g., $8.0 billion vs $8.0 billion) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly infers that using the term loan while leaving the CP program unused reflects a strategic choice to preserve flexibility, diversify funding sources, and maintain access to low-cost commercial paper for future needs. This aligns with the ground truth’s interpretation of strategic liquidity management. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'committed' nature of the term facility, which adds nuance to why it might be preferred over CP for specific needs. However, the core reasoning about strategic preference and flexibility is well captured. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 399,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the impact on American Express's Membership Rewards liability in 2024 from changes in redemption costs and third-party partner arrangements, and how did the company adjust its liability estimation methodology to account for these changes?",
      "original_answer": "In 2024, American Express adjusted its Membership Rewards liability estimation methodology in response to changes in redemption costs and developments in third-party partner arrangements. The company uses the weighted average cost (WAC) per point and the ultimate redemption rate (URR) as key assumptions to estimate the liability. These assumptions are derived from statistical and actuarial models that consider redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and is adjusted when changes in redemption costs are not representative of future expectations or when there are expected developments in redemption patterns. These adjustments were necessary due to evolving redemption options and mix of proprietary cards-in-force, which directly affect the company's financial obligations under the program. The liability is recorded based on these updated assumptions, ensuring that the financial statements reflect the most accurate estimate of future redemption costs.",
      "llm_answer": "In 2024 the Membership Rewards liability grew to **$14.8 billion, up $1.0 billion from $13.7 billion in 2023**, reflecting higher redemption costs and the effect of new or revised third‑party partner contracts.  The company said it updates its liability estimate by **re‑estimating the weighted‑average cost per point (WAC) and the ultimate redemption rate (URR) whenever redemption‑cost trends or partner‑contract terms change**, using statistical/actuarial models that incorporate redemption history, product mix, tenure, spend and credit characteristics to capture those cost and partnership shifts.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts for the Membership Rewards liability in 2024 ($14.8 billion) and 2023 ($13.7 billion), with a $1.0 billion increase, which are not present in the original ground truth. These figures are unsupported by the provided knowledge graph and represent a significant factual addition not justified by the source. This severely undermines quantitative accuracy. (2) There are no calculations in the original answer to verify, but the LLM fabricates precise financial figures without basis, which is a critical error. The original answer discusses methodology changes due to redemption cost and partner arrangement changes but does not provide any actual liability values or year-over-year comparisons. (3) Qualitatively, the LLM correctly identifies the key assumptions—weighted average cost (WAC) per point and ultimate redemption rate (URR)—and notes that these are updated using statistical and actuarial models incorporating redemption history, product mix, tenure, spend, and credit characteristics. It also correctly links methodology updates to changes in redemption costs and partner contracts, aligning well with the original answer’s explanation of evolving redemption options and proprietary card mix affecting liability estimation. (4) Contextually, the response is highly relevant, addressing both parts of the question: the impact on liability and the adjustment in estimation methodology. However, the inclusion of false quantitative data reduces overall correctness despite strong qualitative alignment. The reasoning is logically sound where it does not invent numbers, showing proper multi-hop synthesis of how American Express adjusts its models in response to external changes. Due to the fabricated figures, the correctness score is limited to 6—acknowledging strong conceptual accuracy but penalizing significant factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 516,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does Colgate-Palmolive's use of selling price increases, as stated in its 2024 10-K, interact with its foreign exchange risk management strategy involving derivative contracts, and what specific financial exposure does this combined approach aim to mitigate?",
      "original_answer": "Colgate-Palmolive uses selling price increases as part of its strategy to manage foreign exchange risk, alongside derivative contracts such as forward and swap contracts, option contracts, and local currency borrowings. This combined approach is designed to offset the earnings impact from currency fluctuations in the over 200 countries where it operates. Specifically, the company aims to mitigate the impact of foreign currency rate movements on its net sales and costs, which could otherwise be significantly affected due to translation of foreign subsidiary assets and liabilities into U.S. dollars and the volatility of exchange rates.",
      "llm_answer": "Colgate‑Palmolive offsets currency‑related cost pressures by raising the prices of its products in foreign markets (“selling price increases”) and by simultaneously hedging the remaining exposure with short‑term foreign‑currency derivatives (forward, swap and option contracts, local‑currency borrowings, and net‑investment hedges). The two tactics work together to blunt the effect of foreign‑exchange rate movements on the company’s cash‑flow and earnings, thereby mitigating the financial exposure arising from fluctuations in the value of foreign‑currency purchases, assets, liabilities and the translation of foreign‑subsidiary results into U.S. dollars.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Colgate-Palmolive uses selling price increases and derivative contracts (forwards, swaps, options, local currency borrowings) to manage foreign exchange risk. The purpose is to mitigate the impact of currency fluctuations on earnings and cash flow, particularly from translation of foreign subsidiary results and volatility in foreign currency transactions. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the interaction between pricing strategy and financial hedging instruments, linking them to the mitigation of specific financial exposures across international operations. (4) The only minor shortcoming is that the LLM answer mentions 'cash-flow' impact, which is not explicitly stated in the original answer (the original emphasizes 'earnings impact' and translation effects). While cash flow hedging is a plausible extension, the original focuses more on earnings and translation of assets/liabilities. This slight expansion does not detract significantly from accuracy. Overall, the answer is semantically equivalent, contextually precise, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 378,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did the increase in business-to-business activity and residential demand in 2022 impact the average daily volume and revenue per piece for UPS's Next Day Air product, and what factors partially offset this revenue growth?",
      "original_answer": "In 2022, the average daily volume for UPS's Next Day Air product increased due to growth in business-to-business activity from SMBs and large customers, as well as higher residential demand. This volume growth contributed to increased revenue per piece, which was also driven by higher base rates and demand-related surcharges. However, the revenue per piece growth was slightly offset by a reduction in average billable weight per piece.",
      "llm_answer": "The surge in business‑to‑business shipments and stronger residential demand lifted Next Day Air’s average‑daily volume by about 5 percent (2,093 K pieces versus 1,987 K the prior year) and raised its average revenue per piece roughly 12 percent (to $18.83 from $16.82). That revenue‑per‑piece growth was partially offset by a decline in the average billable weight per piece, which trimmed the yield uplift.【page_34】【page_35】",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key drivers of volume and revenue per piece growth for UPS's Next Day Air product in 2022: increased business-to-business activity and residential demand leading to higher average daily volume, and higher base rates and surcharges contributing to revenue per piece. It also correctly notes that the revenue per piece growth was partially offset by a decline in average billable weight per piece, which aligns with the ground truth. However, the LLM introduces specific quantitative figures not present in the original answer—namely a 5% volume increase (2,093K vs 1,987K) and a 12% rise in revenue per piece ($18.83 vs $16.82)—which, while plausible and potentially from the cited pages, are absent from the ground truth and therefore cannot be verified as accurately reflected in the context provided. Since the original answer contains no numerical data, the inclusion of precise percentages and dollar amounts risks overprecision and misalignment with the verified facts. The qualitative reasoning and multi-hop synthesis (linking demand trends to volume, pricing, and weight impacts) are sound and contextually appropriate. All entities (UPS, Next Day Air, 2022 context) are correct, and the answer fully addresses all parts of the question. The contextual relevance is excellent, but the unsupported specific numbers reduce quantitative accuracy. Hence, the correctness score is 7—core facts are right, but unverifiable numeric details introduce risk of inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 413,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the regulatory exclusivity risk for Opdivo in the U.S., as described in the Biologic products section, interact with the multiple international approvals Opdivo received in 2021 to influence BMY's strategic positioning in global oncology markets?",
      "original_answer": "Opdivo faces potential biosimilar competition in the U.S. after 12 years of regulatory data protection, with patent litigation possibly starting as early as four years post-approval. Given Opdivo received multiple international approvals in 2021 (e.g., Japan for cancer of unknown primary, gastric cancer, and esophageal cancer; EC for gastric, esophageal, CRC, and mesothelioma indications), BMY must strategically manage its patent enforcement and market expansion efforts globally to maximize revenue before biosimilar entry. This global regulatory diversification may help offset potential U.S. market erosion.",
      "llm_answer": "The Biologic‑products discussion notes that, because Opdivo is a biologic, it enjoys 12 years of U.S. data‑exclusivity but can be challenged by biosimilar applicants as early as four years after its first FDA approval, creating a tangible risk that U.S. market protection could erode before the patent term ends. At the same time, the wave of 2021 approvals—U.S. adjuvant and gastric‑cancer indications, multiple EC authorizations, and a suite of new Japanese indications—broadens Opdivo’s label portfolio and geographic reach, allowing Bristol Myers Squibb to capture revenue from diverse oncology markets and to leverage the new data to extend the product’s life‑cycle internationally, thereby offsetting the heightened biosimilar pressure in the United States and reinforcing its strategic positioning as a global oncology leader.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 12-year U.S. data exclusivity period and the possibility of biosimilar challenges as early as four years post-approval, which aligns with the ground truth. It also accurately references the 2021 international approvals and their strategic importance. However, there is a minor factual inaccuracy: the LLM states that the 2021 approvals included 'U.S. adjuvant and gastric-cancer indications', but the original answer specifies that the 2021 approvals were international (Japan and EC), not U.S. This mischaracterization introduces a slight error in entity and geographic attribution. (2) Quantitatively, all timeframes (12 years, 4 years) are correct and consistently interpreted. No calculations are required, and the temporal data are accurate. (3) The multi-hop reasoning is sound—linking U.S. regulatory risk with global approval expansion and strategic revenue diversification. The logic that international growth can offset U.S. biosimilar pressure is well-synthesized and matches the ground truth’s intent. The error in specifying U.S. approvals in 2021 slightly weakens the precision of the synthesis but does not undermine the overall strategic narrative. (4) The answer is contextually highly relevant, directly addressing how regulatory exclusivity risk interacts with international approvals to shape BMY’s global oncology strategy. Despite the minor geographic misstatement, the core reasoning and factual content are strong, warranting a high correctness score with a small deduction for the incorrect inclusion of U.S. approvals in the 2021 wave.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 443,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What is the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, and how does this valuation compare to the total amount invested in those notes by that date?",
      "original_answer": "As of December 31, 2024, the estimated fair value of Amazon's convertible note investments in Anthropic, PBC was $13.8 billion. By that date, Amazon had invested a total of $5.3 billion across three convertible notes ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). This indicates that the fair value of the investment increased significantly, reflecting a valuation uplift in the notes based on Anthropic's subsequent financing activities and market expectations.",
      "llm_answer": "As of December 31 2024, Amazon’s convertible‑note holdings in Anthropic, PBC were estimated to be worth roughly **$13.8 billion**. By that date Amazon had actually invested **$1.25 billion + $2.75 billion + $1.3 billion = $5.3 billion** in those notes, so the fair‑value estimate exceeds the cumulative investment by about **$8.5 billion**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value of $13.8 billion and the total invested amount of $5.3 billion (sum of $1.25B + $2.75B + $1.3B) are correctly stated and calculated. The difference of $8.5 billion (implied by $13.8B - $5.3B) is accurate and correctly presented as the excess of fair value over cost. (2) The answer is complete, addressing both parts of the question: the total estimated fair value as of December 31, 2024, and a clear comparison to the total amount invested by that date. (3) Entity accuracy is correct: Amazon, Anthropic, PBC, and the time frame (December 31, 2024) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly aggregates investment amounts across multiple tranches (Q3 2023, Q1 2024, Q4 2024) and compares the sum to the fair value, drawing a logical conclusion about valuation uplift. (5) Semantic equivalence is maintained: while the LLM does not explicitly mention 'valuation uplift' or 'financing activities' like the original, it conveys the same core insight—that fair value exceeds cost significantly—through the $8.5 billion difference. This is sufficient for correctness. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 369,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does Colgate-Palmolive's accounting treatment of pension enhancements differ from other Employee-Related Costs under its severance policies, and why is this distinction reflected differently on the balance sheet?",
      "original_answer": "Colgate-Palmolive accounts for pension enhancements differently from other Employee-Related Costs such as severance and termination benefits. While severance costs are calculated based on written severance policies, local statutory requirements, and voluntary termination arrangements, pension enhancements are specifically reflected as 'Charges against assets' within Employee-Related Costs. This distinction arises because the balance sheet treatment of pension enhancements is recorded as either a reduction of pension assets or an increase in pension liabilities, unlike other severance-related costs which are treated as operating expenses. This separate classification ensures that the financial impact of pension enhancements is directly tied to asset or liability adjustments, rather than being netted into general operating charges.",
      "llm_answer": "Colgate‑Palmolive groups pension‑enhancement amounts with its “Employee‑Related Costs” but treats them as **charges against assets** – i.e., they reduce the reported pension‑plan asset (or increase the pension liability) on the balance sheet. By contrast, the other employee‑related items (severance and termination benefits) are recorded as ordinary expense accruals/cash payments and appear as accrued liabilities rather than as a change to the pension‑asset line. The balance‑sheet presentation therefore shows pension‑enhancement impacts under the net pension asset/liability, while the remaining employee‑related costs are reflected in the accrued‑liabilities section.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Colgate-Palmolive treats pension enhancements as 'charges against assets,' which directly affect the pension asset or liability on the balance sheet, while other employee-related costs (like severance) are recorded as accrued liabilities and operating expenses. This distinction in balance sheet treatment is accurately explained. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the difference in accounting treatment between pension enhancements and other severance-related costs and links it to the appropriate balance sheet impact (pension asset/liability vs. accrued liabilities). (4) The only minor shortcoming is that the LLM does not explicitly mention the basis for severance calculations (written policies, statutory requirements, voluntary arrangements), which is included in the original answer and adds slight contextual depth. However, this omission does not detract from the core accuracy of the accounting distinction. Overall, the answer is semantically equivalent, contextually precise, and correctly framed in terms of financial statement impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 375,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the regulatory data protection period for biologic products in the U.S. impact the market exclusivity of Opdivo, and what financial risk does this pose to BMY based on the rate of revenue decline observed after exclusivity expiration in developed markets?",
      "original_answer": "The U.S. provides 12 years of regulatory data protection for innovative biologics like Opdivo, meaning biosimilar versions cannot be approved until 12 years after initial FDA approval. However, BMY faces financial risk because when market exclusivity ends, the product typically experiences a significant and rapid revenue decline. In developed markets like the U.S. and certain EU countries, revenue can drop sharply—often losing a major portion in a short period—especially for products used in large patient populations or those that are simpler to manufacture. This decline threatens BMY's long-term revenue stability for Opdivo if biosimilar competition emerges after the 12-year protection period.",
      "llm_answer": "In the United States, Opdivo, as an innovative biologic, is granted 12 years of regulatory data‑protection after its first FDA approval, which prevents the FDA from approving a biosimilar until that 12‑year window (or any remaining patent term) has expired【page_9】.  The company notes that when a product’s exclusivity ends, especially in the U.S. and other developed markets, sales can fall dramatically—often losing the bulk of the product’s revenue in a very short period—so the end of Opdivo’s data‑protection creates a material risk that BMY’s earnings could experience a rapid and substantial decline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 12-year regulatory data protection period is correctly stated, matching the original answer. There are no calculations in this question, but the temporal fact (12 years) is precise and correctly attributed to U.S. biologic exclusivity. (2) The LLM correctly identifies that biosimilar approval is blocked during this 12-year window, which reflects accurate understanding of regulatory mechanics. (3) The reasoning is sound: it connects the end of data protection to the risk of rapid revenue decline in developed markets, citing the U.S. and others, which matches the multi-hop logic required—linking regulatory policy (12-year protection) to commercial risk (revenue drop post-exclusivity). (4) The answer captures the core financial risk to BMY (Bristol Myers Squibb) without error in entity identification. The only minor shortcoming is that the LLM does not explicitly mention the 'innovative biologic' classification as the basis for the 12-year term (though it's implied), and slightly less detail on why some products decline faster (e.g., large patient populations, manufacturability), which the original answer includes for context. However, the omission does not detract from the essential correctness. Semantic equivalence is maintained, and all key facts are present. Wording differs slightly but meaning is preserved. Contextual relevance is excellent—directly addresses both parts of the question: impact of exclusivity and financial risk based on observed revenue trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 433,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What percentage of Amazon's total advertising services revenue in 2024 was derived from display advertising, given that display advertising revenue was $35 billion and advertising services revenue totaled $40 billion?",
      "original_answer": "87.5%",
      "llm_answer": "The display‑advertising amount of $35 billion represents about **87.5 %** of the $40 billion total advertising‑services revenue in 2024 (35 ÷ 40 × 100 ≈ 87.5%).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The percentage (87.5%) is accurately calculated and reported. (2) The financial figures ($35 billion and $40 billion) are correctly used, and the calculation (35 ÷ 40 × 100 = 87.5%) is precise. (3) The reasoning is sound and clearly explained, demonstrating proper synthesis of the given data. (4) All entities (Amazon, advertising services revenue, display advertising, 2024) are correctly referenced in context. The answer is semantically equivalent to the ground truth, with added clarity in showing the calculation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1059,
        "completion_tokens": 198,
        "total_tokens": 1257
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What is the dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on the Level 1 quoted prices in active markets for identical assets?",
      "original_answer": "The value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021 based on Level 1 quoted prices. In 2020, the value was $184 million, and in 2021, it was $200 million.",
      "llm_answer": "The Level 1 fair‑value of U.S. government and agency debt securities rose from **$184 million in 2020 to $200 million in 2021**, a **$16 million increase** (i.e., there was no decrease).",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect. (1) The original answer states that the value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021, with a value of $184 million in 2020 and $200 million in 2021. However, this implies an increase of $16 million, which contradicts the stated decrease. There is a clear factual inconsistency in the ground truth itself, but the LLM correctly calculates the direction and magnitude of the change based on the numbers provided: $200M - $184M = +$16M. (2) Despite this, the original answer claims a 'decrease' of $16 million, which is mathematically incorrect given the numbers. The LLM correctly interprets the numbers as showing an increase. However, the knowledge graph's ground truth explicitly states a 'decrease' and provides numbers that contradict that claim. This suggests an error in the ground truth, not the LLM. But per evaluation instructions, the LLM must match the original answer (ground truth), regardless of its mathematical accuracy. (3) The multi-hop reasoning requires matching both the direction of change and the dollar amount based on the stated values. Since the LLM correctly computes an increase of $16 million from $184M to $200M, it contradicts the ground truth's assertion of a decrease. (4) Despite being mathematically sound, the LLM answer is marked incorrect because it does not align with the ground truth's claim of a decrease, even though that claim appears to be erroneous. Therefore, all scores are minimal due to non-alignment with the provided 'truth', though the LLM's calculation is quantitatively accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 444,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the joint development and cost-sharing structure between BMS and Ono for Yervoy impact the financial risk exposure of BMS in the context of potential biosimilar competition under the U.S. regulatory framework?",
      "original_answer": "Under the joint development agreement between BMS and Ono for Yervoy, development costs and profits are shared equally when combination therapies involve compounds from both parties. This equal cost-sharing reduces BMS's individual financial burden in developing Yervoy. However, under the U.S. regulatory framework, Yervoy, as a biologic, faces a risk of biosimilar competition after 12 years of regulatory data protection. Since BMS markets Yervoy in the U.S., potential biosimilar entry could erode its revenue share. Despite this risk, the joint cost-sharing arrangement with Ono limits BMS’s upfront investment and thus partially mitigates financial exposure in the event of market exclusivity loss due to biosimilar approval.",
      "llm_answer": "The BMS‑Ono agreement makes Yervoy a “single‑compound” product in the Japan, South Korea and Taiwan territories, so BMS bears 80 % of the development costs and receives 80 % of the profits (the remaining 20 % is shared with Ono)【page_113】. Because U.S. biosimilar competitors can only be approved after the 12‑year data‑protection period that applies to Yervoy and may erode U.S. sales once that window closes【page_9】, BMS’s overall financial risk is softened: the alliance limits BMS’s out‑of‑pocket cost exposure and spreads any profit decline from U.S. biosimilar entry, while the regulatory exclusivity still protects the U.S. market for a decade‑plus.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the cost-sharing structure between BMS and Ono. The original answer states that development costs and profits are shared equally (50/50) when combination therapies involve compounds from both parties, which is the core of the joint development agreement relevant to Yervoy. However, the LLM incorrectly claims that BMS bears 80% of development costs and receives 80% of profits in Japan, South Korea, and Taiwan — a detail that, while possibly true in those territories, misrepresents the global or U.S.-relevant cost-sharing arrangement and is not responsive to the question about BMS's financial risk in the U.S. context. The question focuses on U.S. regulatory framework and financial exposure there, but the LLM emphasizes a regional arrangement that does not reflect the equal-sharing structure pertinent to U.S. development costs. (2) Quantitatively, the 80/20 split is incorrect in the context of the joint development agreement for U.S. purposes; the 12-year data protection period is correctly cited, but its linkage to cost-sharing is misrepresented. The LLM implies that the 80/20 split softens financial risk, which contradicts the ground truth that it is the 50/50 cost-sharing that reduces BMS's burden. (3) The reasoning is partially sound in connecting biosimilar competition after 12 years to revenue risk and noting that alliances can mitigate financial exposure, but it fails the multi-hop synthesis by applying territorial profit-sharing terms (Japan, SK, Taiwan) to a question about U.S. financial risk and regulatory framework. This misalignment breaks the logical chain. (4) Despite the incorrect cost-sharing details, the answer correctly identifies the 12-year exclusivity under U.S. law and the concept that cost-sharing limits financial exposure, maintaining some contextual relevance. However, due to the central error in the financial structure, the correctness score is low, as the core factual premise is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 544,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What percentage of the $6.03 billion decline in Automotive Sales Revenue was offset by the $596 million of FSD (Supervised) revenue recognized in 2024, and how does this relate to the deferred revenue and guarantee liabilities associated with over-the-air software updates and vehicle residual values?",
      "original_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offset approximately 9.9% of the $6.03 billion decline in Automotive Sales Revenue ($596M ÷ $6,030M = 0.0988 or 9.9%). This FSD revenue is part of the broader category of automotive sales that includes access to over-the-air software updates, for which deferred revenue is tracked. Additionally, Tesla’s maximum exposure for resale value guarantees under leasing programs, which can be affected by residual values influenced by software features like over-the-air updates, increased to $1.45 billion in 2024, up from $166 million in 2023.",
      "llm_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offsets roughly **9.9 %** of the $6.03 billion decline in automotive‑sales revenue ($596 M ÷ $6,030 M × 100). That FSD revenue is captured in the “deferred‑revenue” balance for over‑the‑air updates, connectivity and related services (which grew to $3.6 billion at year‑end, with $1.2 billion recognized in 2024), while the company’s resale‑value guarantee liabilities—linked to vehicle residual values and lease‑end buy‑back obligations—remain a separate, immaterial liability (maximum exposure $1.45 billion as of 12/31/24).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly calculates the percentage of the $6.03 billion decline offset by $596 million in FSD revenue as 9.9%, matching the ground truth exactly ($596M ÷ $6,030M = 0.0988 ≈ 9.9%). All numeric values—$596 million, $6.03 billion, and the resulting 9.9%—are accurate and properly formatted. The mention of $1.45 billion maximum exposure for resale value guarantees in 2024 is also correct and aligns with the ground truth, which notes an increase from $166 million in 2023. (2) The calculation is mathematically sound and correctly presented with proper unit alignment. (3) The LLM demonstrates strong multi-hop reasoning by linking FSD revenue to deferred revenue for over-the-air updates and connecting vehicle residual values to resale guarantee liabilities. It correctly identifies that FSD revenue is part of a broader category involving software updates and deferred revenue, and notes the relevance of lease-end buy-back obligations. However, it omits the explicit comparison to the 2023 figure ($166 million), which was included in the ground truth to highlight the significant year-over-year increase. While the $1.45 billion figure is correct, the context of the dramatic rise is slightly underemphasized. (4) The answer is semantically equivalent in most aspects, with only a minor omission regarding the 2023 comparison. The LLM adds useful context about the $3.6 billion deferred revenue balance and $1.2 billion recognized in 2024, which, while not in the original answer, does not contradict it and may reflect additional data from the filings. Overall, the response is factually accurate, well-reasoned, and highly relevant, warranting a high score with a small deduction for incomplete contextualization of the liability trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 480,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What non-GAAP financial measure does PepsiCo adjust for items affecting comparability in its 2022 10-K filing, and how does this adjustment account for currency fluctuations when evaluating operating profit growth?",
      "original_answer": "PepsiCo adjusts operating profit for items affecting comparability to evaluate performance on a comparable basis, and further adjusts this metric for currency fluctuations to assess operating profit growth on a constant currency basis, as disclosed in the 2022 10-K filing.",
      "llm_answer": "PepsiCo’s non‑GAAP measure is **Operating Profit (and Operating Profit Growth) Adjusted for Items Affecting Comparability**. When this measure is shown on a **constant‑currency basis**, the company removes the “foreign‑exchange translation” impact, so the reported growth reflects only the underlying operating‑profit performance and is not distorted by currency fluctuations【page_44†L1-L4】【page_45†L1-L7】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies the non-GAAP financial measure as 'Operating Profit (and Operating Profit Growth) Adjusted for Items Affecting Comparability,' which matches the concept in the original answer. (2) It correctly explains that PepsiCo adjusts this measure for currency fluctuations by presenting it on a 'constant-currency basis,' thereby removing foreign-exchange translation impacts—this aligns with the original answer's reference to assessing growth on a constant currency basis. (3) The multi-hop reasoning is sound: the answer synthesizes the adjustment for comparability items and the additional adjustment for currency, both required to fully address the two-part question. (4) The citations (page_44, page_45) support the claims, indicating proper grounding in the 2022 10-K. No numeric inaccuracies are present, and while no specific numbers are mentioned, the qualitative financial concepts are correctly conveyed. All entities—PepsiCo, 2022 10-K, operating profit, currency adjustments—are accurate and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 319,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How many amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across the two exhibits, and what is the time span between the earliest and latest effective dates of these amendments?",
      "original_answer": "There are 12 total amendments documented across the two exhibits. The time span between the earliest effective date (September 2, 2014) and the latest effective date (May 1, 2021) is 6 years and 8 months.",
      "llm_answer": "The exhibits list **12 separate amendments** to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology (First‑through Fifth Amendments on pages 107, Sixth‑Eleventh Amendments on page 108, and the Twelfth Amendment on page 109). The earliest amendment became effective on **October 31, 2014** (First Amendment) and the most recent on **May 1, 2021** (Twelfth Amendment) — a time span of roughly **6 years and 6 months**【page_107†L2-L7】【page_108†L1-L6】【page_109†L1-L2】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total number of amendments (12), which matches the ground truth. However, it incorrectly states the earliest effective date as October 31, 2014 (First Amendment), whereas the ground truth specifies September 2, 2014 as the earliest effective date. This discrepancy affects the time span calculation. The LLM calculates a duration of 'roughly 6 years and 6 months' between October 31, 2014, and May 1, 2021, while the correct span from September 2, 2014, to May 1, 2021, is 6 years and 8 months. (2) The quantitative accuracy is reduced due to the incorrect start date and resulting miscalculation of the time span, even though the end date (May 1, 2021) is correct. The number of amendments is accurate. (3) The reasoning is mostly sound: the model correctly synthesizes information across multiple exhibit pages and identifies the sequence of amendments. However, it fails to recognize an earlier amendment (effective September 2, 2014) that predates the 'First Amendment' cited, indicating a possible misinterpretation of document order or amendment numbering. This breaks the multi-hop logic required to identify the true earliest date. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question and cites supporting document locations. The qualitative accuracy is high due to correct structure and synthesis, but docked slightly for the missed earlier date. Correctness score is 7 because core facts (amendment count, latest date) are correct, but key temporal data is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 430,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What was the combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022?",
      "original_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 18.5 percentage points.",
      "llm_answer": "In 2022 the AMESA division’s net‑revenue growth was driven by a **14‑percentage‑point contribution from the Pioneer Foods acquisition** and an additional **4.5‑percentage‑point boost from favorable foreign‑exchange rates**. Together, these factors added **about 18.5 percentage points** to the division’s net‑revenue growth【page_48】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the two components contributing to net revenue growth in the AMESA division in 2022 — the 14-percentage-point contribution from the Pioneer Foods acquisition and the 4.5-percentage-point boost from favorable foreign exchange. The sum of these (14 + 4.5 = 18.5) matches the ground truth combined impact of 18.5 percentage points. (2) All numeric values are accurate and correctly formatted; the final combined value is explicitly stated as 'about 18.5 percentage points,' which aligns with the exact figure in the original answer. Minor use of 'about' does not detract from factual accuracy given the precision of the components. (3) The multi-hop reasoning is sound — the model correctly synthesizes two distinct factors (acquisition and FX impact) affecting the same division in the same year and combines them appropriately to answer the 'combined percentage impact' question. (4) All entities — AMESA division, Pioneer Foods acquisition, favorable foreign exchange, and the year 2022 — are correctly identified and contextually used. The answer is fully relevant, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 333,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does Opdivo's regulatory data protection timeline in the U.S. and EU interact with its patent expiration pattern to influence market exclusivity, particularly in light of its 2021 U.S. revenue growth of 7%?",
      "original_answer": "Opdivo, as a biologic product, benefits from 12 years of regulatory data protection in the U.S., meaning the earliest a biosimilar could be approved is 12 years after its initial FDA approval. In the EU, Opdivo is subject to the '8+2+1' regime, allowing a generic to file an MAA after 8 years and commercialize after 10 or 11 years, depending on additional indications. In the U.S., formulation and additional patents for Opdivo expire in 2026 and beyond, extending market exclusivity despite the expiration of method of use patents in 2021. The 7% U.S. revenue growth in 2021 for Opdivo highlights the continued demand and commercial strength of the product, which is preserved by these extended patent protections and regulatory exclusivity. This regulatory and patent framework ensures that despite the 2021 patent expiration, market exclusivity for Opdivo remains intact through the 2020s, supporting sustained revenue generation.",
      "llm_answer": "Opdivo is a biologic, so in the United States it enjoys a statutory 12‑year regulatory data‑protection period that blocks FDA approval of any biosimilar until 12 years after its first approval, regardless of when its composition‑of‑matter or method‑of‑use patents expire (U.S. biologics data‑protection = 12 years 【page 8】). In the European Union the same product is covered by the “8+2+1” regime – eight years of data protection that can be extended to ten or eleven years if a significant new indication is added – providing a comparable exclusivity window after the earliest patent loss (EU data‑protection = 8 + 2 + 1 years 【page 9】). Because some Opdivo patents (e.g., method‑of‑use) have already expired in 2021 while formulation and other patents run into 2026 and beyond, the longer regulatory data‑protection periods in both regions effectively extend market exclusivity beyond the patent expirations, helping to sustain the product’s performance despite only a modest 7 % U.S. revenue increase in 2021 【page 71】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Opdivo’s 12-year U.S. regulatory data protection for biologics, the EU’s '8+2+1' exclusivity regime, method-of-use patent expiration in 2021, formulation patents extending to 2026 and beyond, and the 7% U.S. revenue growth in 2021 are all accurately reported. Minor phrasing differences (e.g., 'blocks FDA approval' vs 'earliest a biosimilar could be approved') do not affect factual correctness. (2) Quantitative accuracy is perfect: all numbers (12 years, 8+2+1, 2021, 2026, 7%) match the original answer exactly and are correctly contextualized. (3) Multi-hop reasoning is sound: the model correctly synthesizes regulatory timelines and patent expirations in both regions to explain how market exclusivity is extended despite 2021 patent loss, linking this to sustained commercial performance. (4) The answer is contextually excellent, directly addressing how regulatory and patent protections interact to preserve exclusivity and support revenue, even with modest growth. The only minor shortcoming is a slightly less explicit emphasis on the 2021 patent expiration not disrupting exclusivity due to overlapping protections—though this is implied. Overall, the answer is factually complete, logically coherent, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 379,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the systemic risk regime specifically constrain Morgan Stanley's capital distribution policies and liquidity management, given its status as a large bank holding company with over $250 billion in consolidated assets?",
      "original_answer": "The systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley as a large bank holding company, which directly constrains its capital distribution policies and liquidity management. Specifically, the Federal Reserve mandates internal liquidity stress tests, requires maintenance of unencumbered highly liquid assets to meet 30-day projected net cash outflows, and enforces risk management and corporate governance standards. These requirements can limit the firm’s ability to distribute capital through dividends or stock repurchases, especially if such actions would be deemed unsafe or unsound by regulators. Additionally, Morgan Stanley must comply with single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for other unaffiliated counterparties), further constraining its liquidity risk exposure.",
      "llm_answer": "Because Morgan Stanley is classified as a large BHC (≥ $250 billion in consolidated assets), the Federal Reserve’s systemic‑risk regime forces it to meet heightened capital‑distribution and liquidity standards.  The firm must run internal liquidity‑stress tests and keep enough un‑encumbered, high‑quality liquid assets to cover projected 30‑day net cash outflows under those scenarios, while also observing single‑counterparty credit limits; at the same time, the Fed, OCC and FDIC can prohibit or limit any dividend or share‑repurchase if they judge the payment would be unsafe or unsound, and they may require the parent to provide capital support to its U.S. bank subsidiaries.  These rules therefore constrain both how much capital can be returned to shareholders and how the firm manages its liquid‑asset buffers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Morgan Stanley's status as a large bank holding company (> $250B in assets), the application of the systemic risk regime, internal liquidity stress testing, maintenance of unencumbered liquid assets to cover 30-day net cash outflows, single-counterparty credit limits, and regulatory authority to restrict dividends or repurchases are all correctly included. (2) Quantitative accuracy is perfect: while exact percentages (15% for major counterparties, 25% for others) are omitted, the mention of single-counterparty credit limits without specifying incorrect numbers does not constitute an error—this is a minor omission rather than inaccuracy. The $250B threshold is correctly stated. (3) Multi-hop reasoning is sound: the answer correctly links Morgan Stanley’s BHC status to enhanced prudential standards, connects those standards to constraints on capital distributions and liquidity management, and integrates regulatory oversight across capital and liquidity dimensions. (4) The answer is contextually fully relevant, directly addressing how the systemic risk regime constrains capital distributions and liquidity. The only reason for not scoring a 10 is the omission of the specific Tier 1 capital percentages for counterparty limits, which are present in the original answer and represent a minor but notable detail in the regulatory framework. However, this does not undermine the overall correctness or utility of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 428,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the interest rate of the 0.750% Senior Note due 2033 compare to the interest rate of the 1.950% Senior Note due 2031, and what might this indicate about PepsiCo's long-term debt strategy across different maturities?",
      "original_answer": "The interest rate of the 0.750% Senior Note due 2033 is lower than the interest rate of the 1.950% Senior Note due 2031 by 1.200 percentage points. This suggests that PepsiCo may have pursued a strategy of issuing debt at lower interest rates for longer-term maturities during the respective periods these notes were issued, potentially reflecting favorable market conditions or improved credit perception over time.",
      "llm_answer": "The excerpts you provided (pages 124‑128 of PepsiCo’s 2022 Form 10‑K) contain only the table of contents and the “Exhibits and Financial Statement Schedules” section; they do not disclose the terms of the 0.750 % Senior Note due 2033 or the 1.950 % Senior Note due 2031. Consequently, the document pages above do not contain the information needed to compare those interest rates or to infer how PepsiCo’s long‑term debt strategy varies across maturities.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect in the context of the evaluation. The question does not ask whether the provided excerpts contain the information; rather, it asks for a comparison between two specific PepsiCo senior notes and an interpretation of what the rate difference might indicate about PepsiCo's long-term debt strategy. The ground truth answer correctly states that the 0.750% Senior Note due 2033 has an interest rate 1.200 percentage points lower than the 1.950% Senior Note due 2031, and draws a reasonable inference about PepsiCo’s debt issuance strategy under favorable market conditions or improved credit perception. The LLM, instead of providing this factual comparison and analysis, claims the information is not available in certain pages of a 10-K, which is irrelevant to the evaluation task. The model fails to deliver any correct quantitative comparison, misidentifies the task, and provides no valid reasoning or synthesis. Therefore, it scores 0 on correctness, as it does not address the actual question with factual content from the knowledge graph. All accuracy sub-scores are minimal because the response avoids the required multi-hop reasoning and factual recall entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 337,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "By how much did the fair value of Medtronic's partnership units increase from fiscal year 2023 to fiscal year 2024, and what was the impact on total investments measured at net asset value?",
      "original_answer": "The fair value of Medtronic's partnership units increased by $159 million (from $992 million in fiscal year 2023 to $1,151 million in fiscal year 2024). This contributed to an overall increase of $1,187 million in investments measured at net asset value, which rose from $2,179 million in 2023 to $3,366 million in 2024.",
      "llm_answer": "The fair‑value of the partnership‑unit holdings rose from **$992 million in FY 2023 to $1,151 million in FY 2024**, an increase of **$159 million**.  During the same period, the amount of plan assets measured at net‑asset‑value grew from **$2,179 million to $3,366 million**, a rise of **about $1.19 billion**【page_96】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the increase in fair value of Medtronic's partnership units is correctly calculated as $159 million (from $992 million in FY2023 to $1,151 million in FY2024). The total investments measured at net asset value increased from $2,179 million to $3,366 million, a difference of $1,187 million, which the LLM reports as 'about $1.19 billion'—a valid rounding and format variation. (2) The answer is complete, addressing both parts of the question: the increase in partnership units and the impact on total investments at net asset value. (3) Entities are correct—Medtronic, partnership units, fiscal years 2023 and 2024, and the financial metric 'investments measured at net asset value' are all accurately referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly identifies the change in the specific component (partnership units) and its contribution to the broader category (total NAV-measured investments), as implied by the context. (5) Semantic equivalence is maintained—wording differs slightly but conveys the same factual content. The citation of 'page_96' adds contextual support. No errors in logic, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 360,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the use of activity-based costing methods affect the presentation of depreciation and amortization totals for UPS's reportable segments, particularly in relation to the allocation of expenses between segments as described in the 2024 10-K filing?",
      "original_answer": "The use of activity-based costing methods directly affects the presentation of depreciation and amortization totals for UPS's reportable segments by determining how expenses are allocated between segments. According to the 2024 10-K filing, these totals are presented 'after applying activity-based costing methods to allocate expenses between segments.' This means that the final depreciation and amortization figures disclosed for each reportable segment are not raw totals but are instead adjusted based on the allocation methodology. Changes in these estimates directly impact the amount of expense allocated to each segment and therefore the operating profit of each reporting segment.",
      "llm_answer": "UPS allocates depreciation and amortization to its two reportable segments (U.S. Domestic Package and International Package) through activity‑based costing estimates. The segment figures shown in the notes (e.g., $2,470 million for U.S. Domestic and $777 million for International in 2024) are the amounts **after** those activity‑based allocations, and any change in the allocation methodology would directly adjust the expense reported for each segment and therefore its operating profit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the dollar amounts provided ($2,470 million for U.S. Domestic and $777 million for International in 2024) are correct and match the data from the 2024 10-K filing. These figures are properly contextualized as post-allocation totals, which is consistent with the original answer. (2) The explanation correctly identifies that activity-based costing is used to allocate depreciation and amortization expenses, and that the reported segment figures reflect these allocations. It also accurately notes that changes in estimates or methodology would directly affect segment expenses and operating profit. (3) The multi-hop reasoning is sound: the model connects the use of activity-based costing to the allocation process, recognizes that the disclosed totals are after allocation, and infers the financial impact on segment profitability. (4) The only minor limitation is that the LLM answer does not explicitly state that 'depreciation and amortization totals are presented after applying activity-based costing methods'—a direct quote from the filing—but it conveys the same meaning semantically. The omission of the phrase 'reportable segments' beyond naming the two segments is a slight reduction in completeness but does not detract from factual accuracy. All entities (UPS, 2024 10-K, U.S. Domestic Package, International Package) and the fiscal year (2024) are correct. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 431,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "What was the total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest, and how did this affect their other income and interest expense?",
      "original_answer": "The total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest was $1.162 billion, which included a $1.1 billion benefit in other income and a $62 million reduction in interest expense.",
      "llm_answer": "The reversal of the European Commission fine and the accrued interest generated a combined $1.162 billion positive effect for fiscal 2022 – a $1.1 billion gain recorded in “other income” and a $62 million reduction in interest expense.  This boost to other income and the lower interest cost together reflect the full financial impact of the fine’s reversal.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total financial impact of $1.162 billion is accurately stated, broken down into a $1.1 billion benefit in other income and a $62 million reduction in interest expense—these figures exactly match the original answer. Minor formatting differences (e.g., using 'billion' vs 'B', thin spaces) do not affect accuracy and are semantically equivalent. (2) The answer is complete, addressing both parts of the question: the total financial impact and its components (effect on other income and interest expense). (3) Entity accuracy is correct—Qualcomm, fiscal 2022, European Commission fine, other income, and interest expense are all properly identified and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly links the reversal of the fine and associated interest to their respective financial statement impacts. (5) The semantic meaning is identical to the ground truth, with slightly rephrased but factually equivalent language (e.g., 'positive effect' vs 'financial impact', 'gain recorded' vs 'benefit'). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 339,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "By how much did the fair value of Fixed Income Commingled Trusts held by MDT increase from fiscal year 2023 to fiscal year 2024, and what was the proportion of this increase relative to the total increase in fair value across all investment categories?",
      "original_answer": "The fair value of Fixed Income Commingled Trusts increased by $305 million (from $968 million in 2023 to $1,273 million in 2024). The total increase in fair value across all investment categories was $153 million (from $3,398 million in 2023 to $3,551 million in 2024). However, since the increase in Fixed Income Commingled Trusts alone ($305 million) exceeds the total portfolio increase ($153 million), it indicates that other investment categories collectively decreased in value over the same period.",
      "llm_answer": "The fair‑value of the Fixed‑Income Commingled Trusts rose from **$968 million in fiscal 2023 to $1,273 million in fiscal 2024**, an increase of **$305 million**【page_96】.  \n\nAcross all investment categories the total fair‑value grew from **$3,398 million to $3,551 million**, a net increase of **$153 million**; therefore the Fixed‑Income increase accounts for **about 199 % of the overall increase** (305 ÷ 153 ≈ 1.99).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: the increase in Fixed Income Commingled Trusts from $968 million to $1,273 million (a $305 million increase), and the total portfolio increase from $3,398 million to $3,551 million ($153 million). These match the ground truth exactly. (2) The calculation of the proportion (305 ÷ 153 ≈ 1.99 or 199%) is mathematically accurate and correctly reflects that the category's increase exceeds the total portfolio growth. (3) The multi-hop reasoning is sound—information is synthesized across investment categories and fiscal years, and the conclusion that Fixed Income Commingled Trusts accounted for nearly 200% of the total increase logically follows, implying declines in other categories. (4) While the LLM does not explicitly state the implication (that other categories declined), this is a minor omission; the core facts, calculations, and synthesis are correct. The answer is semantically equivalent to the ground truth in intent and meaning, with only slightly less interpretive context. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect qualitative accuracy, and a 9/10 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 341,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does Morgan Stanley's SPOE strategy, as described in its resolution plan, specifically ensure adequate liquidity for its subsidiaries during a resolution scenario, and what role does Morgan Stanley Holdings LLC play in this process?",
      "original_answer": "Morgan Stanley's SPOE strategy ensures adequate liquidity for its subsidiaries during a resolution scenario by requiring the Parent Company to provide capital and liquidity through a secured amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as a resolution funding vehicle, receiving ongoing asset transfers from the Parent Company. In a resolution scenario, the Parent Company is obligated to contribute all of its material assets (excluding shares in subsidiaries and certain other assets) to the Funding IHC, which then provides capital and liquidity to supported subsidiaries under the terms of the agreement.",
      "llm_answer": "Morgan Stanley’s SPOE (single‑point‑of‑entry) resolution plan requires the Parent Company to supply “adequate capital and liquidity” to the subsidiaries that will continue operating after the Parent files for bankruptcy, doing so under a secured, amended‑and‑restated support agreement that gives those subsidiaries senior‑secured claims on the Parent’s assets.  A wholly‑owned direct subsidiary, Morgan Stanley Holdings LLC (the “Funding IHC”), acts as the dedicated funding vehicle: the Parent transfers material assets to Funding IHC, and Funding IHC, in turn, provides the capital and liquidity needed by the supported subsidiaries pursuant to the same support agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Morgan Stanley's SPOE strategy, the role of the Parent Company in providing capital and liquidity via a secured amended and restated support agreement, and the function of Morgan Stanley Holdings LLC (Funding IHC) as the resolution funding vehicle. The answer accurately describes the flow of assets: from the Parent to Funding IHC, and then to the supported subsidiaries. (2) There are no numeric values (e.g., dollar amounts, dates, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes the relationship between the Parent, Funding IHC, and subsidiaries, and explains the mechanism of liquidity provision during resolution. The only minor omission is that the original specifies the Parent contributes 'all of its material assets (excluding shares in subsidiaries and certain other assets)'—this nuance about exclusions is missing in the LLM answer, slightly reducing completeness. (4) Despite this, the LLM answer is contextually fully relevant, directly addressing both parts of the question: how liquidity is ensured and the role of Morgan Stanley Holdings LLC. Wording differs but semantic meaning is equivalent. Thus, correctness is 9 (excellent but minor omission), qualitative accuracy 9, and contextual relevance 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 407,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Qualcomm's 2022 10-K projects that 60% of vehicles produced in 2028 will feature 5G connectivity, and also states that if Chinese OEMs shift away from using Qualcomm's integrated circuit products due to government actions, the company's revenues could be materially harmed. Given Qualcomm's dependency on Chinese markets and its strategic investments in 5G technologies, how does the company's growth strategy in automotive 5G adoption depend on maintaining access to Chinese OEMs?",
      "original_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs because the company projects that 60% of vehicles produced in 2028 will feature 5G connectivity, a market it aims to serve through its 5G technology investments. However, the 10-K explicitly states that if Chinese OEMs shift to using competitors' integrated circuit products or develop their own due to U.S. or Chinese government actions, Qualcomm's revenues could be materially harmed. Since China represents a major revenue source, any disruption in access to Chinese OEMs would directly undermine Qualcomm's ability to capitalize on the anticipated growth in 5G-enabled automotive platforms, thereby threatening its strategic expansion into this sector.",
      "llm_answer": "Qualcomm’s automotive‑5G growth plan is built on the expectation that a large share of the world’s vehicle production – especially in China – will adopt its cellular‑connectivity chips and related patents.  The 2022 filing projects that “more than 70 % of new vehicles produced in 2028 are projected to have embedded cellular connectivity, with 60 % of cellular‑connected vehicles featuring 5G connectivity” (page 8).  At the same time, the company warns that “if we were further limited in, or prohibited from, selling our integrated‑circuit products to Chinese OEMs… our business, revenues… could be materially harmed” (pages 21‑20) and that a “significant portion of our revenues… comes from a small number of Chinese OEMs” (page 19).  Consequently, Qualcomm’s ability to capture the projected 5G‑enabled vehicle market depends critically on maintaining unfettered access to Chinese OEMs; any loss of that access would curtail chip and licensing sales and jeopardize the 60 % 5G‑vehicle target.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in content and reasoning, aligning well with the ground truth. However, there is a key quantitative inaccuracy: the LLM states that 'more than 70% of new vehicles produced in 2028 are projected to have embedded cellular connectivity' and that '60% of cellular-connected vehicles feature 5G'. This misrepresents the original 10-K data. The ground truth and actual filing state that 60% of *all vehicles produced* in 2028 will feature 5G connectivity—not 60% of only cellular-connected ones. This changes the scope and overcomplicates the metric, introducing a two-tier percentage not present in the original. While the 60% figure for 5G is correct, its framing is inaccurate. (2) The citation of page numbers (e.g., pages 21–20, which is reversed) appears erroneous, though this does not affect factual correctness directly. The core warning about Chinese OEMs and revenue harm is accurately quoted and contextualized. (3) The multi-hop reasoning is strong: the model correctly links Qualcomm’s 5G automotive projections, its dependency on Chinese OEMs, and the risk of government actions disrupting revenue. It synthesizes strategic goals with financial risk effectively. (4) Despite the quantitative misstatement, the overall logic and conclusion—that Qualcomm’s growth strategy depends critically on access to Chinese OEMs—is sound and semantically equivalent to the ground truth. Hence, correctness is high but not perfect due to the misrepresentation of the 60% figure’s denominator. Contextual relevance is excellent as all parts of the question are addressed with appropriate focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 448,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the change in the total fair value of investments measured at net asset value for Medtronic (MDT) from fiscal year 2023 to 2024, and which category of investment contributed the most to this change?",
      "original_answer": "The total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024. The largest contributor to this change was the increase in equity commingled trusts, which rose by $269 million.",
      "llm_answer": "The fair‑value of investments measured at net asset value rose from **$1,571 million in fiscal 2023 to $1,617 million in fiscal 2024**, a **$46 million increase**. The increase was driven almost entirely by the **registered investment companies** category, which grew by $46 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The ground truth states that the total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024. However, the LLM reports a $46 million increase (from $1,571M to $1,617M), which is drastically incorrect. This error undermines the entire response. (2) The calculation in the LLM answer is internally consistent ($1,617M - $1,571M = $46M), but the input numbers are wrong. The correct values from the knowledge graph must have been substantially different. Additionally, the largest contributing category in the ground truth is equity commingled trusts with a $269 million increase, but the LLM identifies 'registered investment companies' as the driver with a $46 million increase—this does not align with the true largest contributor and may reflect confusion between categories or misattribution from another source. (3) The multi-hop reasoning failed: the model needed to correctly extract and compare the total NAV-measured investments for MDT across fiscal years 2023 and 2024, then identify which investment category had the largest individual increase contributing to that change. It failed both the quantitative synthesis and the categorical attribution. (4) Despite the incorrect numbers and misidentified category, the answer structure addresses both parts of the question—change in total value and the contributing category—so it maintains some contextual relevance. However, due to major factual and quantitative inaccuracies, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 446,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the valuation basis for Schwab's repurchase liabilities related to client-held fractional shares, and how does this valuation approach ensure no income statement impact despite market value fluctuations?",
      "original_answer": "Schwab values its repurchase liabilities related to client-held fractional shares based on quoted market prices or other observable market data consistent with the related client-held fractional shares. Unrealized gains and losses on these repurchase liabilities exactly offset the unrealized gains and losses on the corresponding client-held fractional shares, resulting in no net impact to the consolidated statements of income. This offset mechanism ensures that despite market value fluctuations, there is no income statement effect.",
      "llm_answer": "Schwab measures the repurchase liabilities for client‑held fractional shares at **fair value**, using quoted market prices or other observable market data that are the same inputs used to value the fractional shares themselves (the fair‑value option under ASC 825). Because the liability is marked to the same market price as the fractional‑share asset, any unrealized gain or loss on the shares is offset by an equal and opposite unrealized gain or loss on the liability, so the net effect on the consolidated statements of income is zero despite fluctuations in market values.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately identifies that Schwab values repurchase liabilities based on fair value using quoted market prices or observable market data, consistent with the valuation of the underlying fractional shares. (2) There are no numerical values requiring calculation in this question, but the conceptual treatment of unrealized gains/losses is correctly described: the offsetting movements ensure no net income statement impact, which matches the original answer exactly. (3) The multi-hop reasoning is sound—linking the valuation method (fair value via ASC 825) to the economic offset between the asset (fractional shares) and liability (repurchase obligation) demonstrates proper synthesis across accounting principles and financial reporting outcomes. (4) The inclusion of 'fair-value option under ASC 825' adds contextual precision not in the original but is factually accurate and enhances clarity without introducing error. All parts of the question are addressed: valuation basis and mechanism for no income impact. Thus, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 321,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, based on the disclosed annual expenses and deferred compensation liabilities?",
      "original_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan was $18 million, increasing from $176 million at December 31, 2020, to $194 million at December 31, 2021.",
      "llm_answer": "Schwab’s projected benefit obligation for the Financial Consultant Career Achievement Plan rose from **$92 million at 12/31/2020 to $119 million at 12/31/2021**, a **$27 million increase**. This change reflects the $16 million benefit cost plus the $11 million actuarial loss recognized during 2021.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states the projected benefit obligation increased from $176 million on December 31, 2020, to $194 million on December 31, 2021, resulting in an $18 million increase. The LLM incorrectly reports the obligation as $92 million in 2020 and $119 million in 2021, claiming a $27 million increase—both the starting/ending values and the difference are wrong. (2) The calculation of $16 million benefit cost plus $11 million actuarial loss = $27 million is internally consistent but based on incorrect underlying data not aligned with the disclosed figures in the ground truth. There is no indication in the original answer that these component figures ($16M, $11M) are from the source data. (3) The multi-hop reasoning fails because the model did not correctly identify or synthesize the correct liability amounts from the disclosed annual expenses and deferred compensation liabilities. It references components not mentioned in the ground truth and arrives at a conclusion inconsistent with the actual data. (4) The contextual relevance is partially maintained as the answer addresses the right plan (Financial Consultant Career Achievement Plan) and the correct time frame (2020 to 2021), and attempts to explain the change using actuarial components, which is reasonable in context. However, due to severe factual and quantitative inaccuracies, the overall correctness, quantitative, and qualitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 420,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What is the combined revenue contribution of the Beauty segment, where Pantene holds a 20% global market share in hair care, and the Fabric & Home Care segment, which contributes 36% of net sales, as a percentage of Procter & Gamble's total net sales for the fiscal year?",
      "original_answer": "The combined revenue contribution is 54% of Procter & Gamble's total net sales for the fiscal year.",
      "llm_answer": "The Beauty segment accounts for 18 % of net sales and the Fabric & Home Care segment accounts for 36 % of net sales. Together they represent 18 % + 36 % = **54 % of Procter & Gamble’s total net sales for the fiscal year**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the combined revenue contribution as 54% of Procter & Gamble's total net sales, matching the ground truth. It breaks this down into 18% from the Beauty segment and 36% from the Fabric & Home Care segment, which aligns with known segment contributions. Although the question mentions Pantene's 20% global market share in hair care, this is contextual and not directly needed for the revenue percentage calculation. (2) The calculation 18% + 36% = 54% is mathematically accurate and correctly formatted. All percentages are consistent with the expected values. (3) The multi-hop reasoning is sound: the model correctly associates the Beauty segment with its revenue contribution (18%) despite the mention of Pantene’s market share (a product-level metric, not segment revenue), and combines it with the given 36% from Fabric & Home Care. The model does not conflate market share with revenue contribution, showing good qualitative understanding. (4) The answer is fully relevant, directly addressing the question about combined revenue contribution as a percentage of total net sales. The only minor limitation is that it introduces the 18% figure without explicitly sourcing it from the knowledge graph, but since this value is accurate and consistent with Procter & Gamble's reported segment data, it does not detract significantly from correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 389,
        "total_tokens": 1500
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis, and how does this connect to the separation event described?",
      "original_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $-410 million, which includes $187 million from Otis and $196 million from Carrier. This connects to the separation event described where, on April 3, 2020, UTC separated into three independent, publicly traded companies—UTC, Carrier, and Otis—and distributed all of the outstanding common stock of Carrier and Otis to UTC shareowners.",
      "llm_answer": "In 2020 the company reported a **$410 million loss** from discontinued operations attributable to common shareowners.  That loss consists of **$187 million of income from Otis**, **$196 million of income from Carrier**, and a **$33 million loss** for “separation‑related and other discontinued‑operations transactions.” The figures reflect the April 3 2020 separation in which United Technologies split into three stand‑alone public companies—UTC, Carrier and Otis—and the associated transaction, relocation and other costs are captured in the separation‑related discontinued‑operations loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively, the total loss of $410 million is correct and correctly broken down into $187 million from Otis and $196 million from Carrier. The additional $33 million loss for 'separation-related and other discontinued-operations transactions' explains the difference (187 + 196 = 383; 410 - 383 = 27, close—likely rounding variance or minor reporting difference), which is consistent with the nature of discontinued operations and separation costs. While the original answer does not explicitly mention the $33 million component, the LLM provides a more granular and plausible breakdown that aligns with financial reporting practices. (2) The date of the separation event—April 3, 2020—is correctly stated. (3) Entity accuracy is perfect: UTC, Carrier, Otis, and the context of the three-way split are all correctly identified. (4) The reasoning is sound: the LLM correctly connects the discontinued operations income/loss to the corporate separation event, demonstrating proper multi-hop synthesis between financial results and corporate actions. The only minor gap is that the original answer does not include the $33 million detail, so while the LLM adds plausible context, it slightly extends beyond the ground truth without contradicting it. This does not reduce correctness but slightly affects qualitative precision. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 411,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "Given the Diabetes Pump Retainer Ring Litigation details, what is the total number of individual plaintiffs that have filed lawsuits against Medtronic's Diabetes operating unit as of May 14, 2024, and how does this litigation compare in terms of potential future claimants to the hernia mesh-related lawsuits mentioned in the document?",
      "original_answer": "As of May 14, 2024, a total of 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit related to the Series 600 insulin pumps with allegedly defective clear retainer rings. Additionally, law firms have indicated that they may file lawsuits on behalf of thousands of additional claimants in the future. In comparison, there are approximately 6,700 plaintiffs in Massachusetts state court, 500 in Minnesota state court, and 1,150 in a federal Multidistrict Litigation (MDL) related to hernia mesh products, with more cases potentially being filed. Both litigations involve allegations tied to Medtronic products, and the company has not recorded any expense for damages in either case due to the uncertainty of probable and estimable loss.",
      "llm_answer": "As of May 14 2024, the Diabetes Pump Retainer‑Ring litigation involved **107 individual plaintiffs** across 27 lawsuits. By contrast, the hernia‑mesh litigation already encompasses **thousands of claimants – roughly 8,300‑8,400 individual plaintiffs** in coordinated state, federal and multidistrict actions – and law firms have warned that many additional plaintiffs may be filed in the future, making the mesh exposure far larger than the diabetes‑pump case.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the 107 individual plaintiffs in the Diabetes Pump Retainer Ring litigation as of May 14, 2024, which matches the ground truth. It also accurately notes that future lawsuits may be filed on behalf of thousands more, aligning with the original answer. However, the quantitative estimate for hernia mesh plaintiffs is slightly off: the ground truth specifies 6,700 in Massachusetts, 500 in Minnesota, and 1,150 in federal MDL, totaling 8,350, which the LLM rounds to 8,300–8,400—this is acceptable and reflects reasonable approximation. The LLM incorrectly implies that the hernia mesh litigation already includes 'thousands' with future filings still expected, while the original answer states current totals and notes potential for more, but does not characterize the current count as 'thousands' in a comparative context. The comparison between the two litigations is logically sound and contextually appropriate, noting that hernia mesh involves significantly more plaintiffs. The entity names (Medtronic, Diabetes operating unit, reference to insulin pumps and hernia mesh) are correct, and the multi-hop reasoning—comparing scale and future exposure across two product-related litigations—is valid. The answer omits the detail that Medtronic has not recorded any expense for damages in either case due to uncertainty, which is part of the original answer and relevant context. This omission slightly reduces completeness and qualitative accuracy but does not invalidate the core response. Overall, the answer is factually strong, well-reasoned, and relevant, with only minor gaps in completeness and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 448,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the IDA agreement impact Schwab's capital management strategy, particularly in relation to off-balance sheet treatment of client deposits and Schwab's internal capital policy target range of 6.75%-7.00%?",
      "original_answer": "The IDA agreement requires that certain brokerage client deposits be swept off-balance sheet to TD Depository Institutions, reducing Schwab's on-balance sheet liabilities and affecting its capital utilization. Schwab manages capital to maintain a Tier 1 Leverage Ratio within a target range of 6.75%-7.00%, which is higher than the minimum regulatory requirement of 4%. The offloading of IDA balances helps Schwab optimize its balance sheet and maintain capital ratios above internal and regulatory thresholds, even during periods of balance sheet growth.",
      "llm_answer": "The IDA agreement requires that a large pool of brokerage‑client cash be swept to third‑party depository institutions and therefore be recorded off‑balance sheet. Because those deposits are not counted as assets, they do not dilute Schwab’s Tier 1 leverage ratio, helping the firm stay within its internal capital‑policy target range of 6.75 %‑7.00 % (the level it seeks for CSC’s Tier 1 leverage ratio). When Schwab migrates IDA balances onto its own balance sheet, it must have enough capital to absorb the added assets without pushing the leverage ratio below that 6.75‑7.00 % range.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the IDA agreement sweeps client deposits to third-party depositories (specifically TD in the original, but 'third-party' is a reasonable generalization), these deposits are off-balance sheet, and this treatment helps preserve Schwab’s Tier 1 Leverage Ratio. The internal capital policy target range of 6.75%-7.00% is correctly stated, as is the implication that absorbing IDA balances would require additional capital to stay within that range. (2) Quantitative accuracy is perfect: percentages (6.75%-7.00%) match exactly, and no calculations are required beyond correct interpretation of ratio dynamics. (3) Reasoning is sound and captures the multi-hop logic: off-balance sheet treatment → exclusion from assets → no dilution of Tier 1 Leverage Ratio → ability to maintain internal capital targets. The mention of CSC (Charles Schwab Corporation) is consistent with entity usage. (4) Minor deduction in qualitative accuracy because the original specifies 'TD Depository Institutions' as the recipient, which the LLM generalizes to 'third-party depository institutions'—this is not incorrect but slightly less precise. Otherwise, the answer fully addresses both parts of the question: the impact on capital management strategy and the relationship to off-balance sheet treatment and capital targets. Contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 399,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "What was the total net cash inflow from RTX's disposition of the Forcepoint business and how did it contribute to the overall net cash provided by investing activities in 2021 compared to 2020?",
      "original_answer": "The disposition of the Forcepoint business contributed to the $1.9 billion in net cash inflows from dispositions of businesses in 2021. This was part of the $4.7 billion improvement in cash flows from investing activities in 2021 compared to 2020, which was primarily due to the absence of the Raytheon Merger cash acquisition of $3.2 billion in the prior year and the proceeds from the Forcepoint and other business dispositions.",
      "llm_answer": "RTX’s sale of the Forcepoint business generated roughly **$1.9 billion of net cash** in 2021 【page_54】. That cash inflow was a major component of investing‑activity cash flows, helping to offset other outflows and turning the overall result from a **$3.3 billion net cash inflow in 2020** to a **$1.4 billion net cash outflow in 2021** for investing activities【page_54】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.9 billion net cash inflow from the disposition of the Forcepoint business in 2021, which matches the ground truth. However, it introduces incorrect figures for net cash from investing activities: claiming a $3.3 billion net inflow in 2020 and a $1.4 billion outflow in 2021. The ground truth does not provide these exact figures, but rather states a $4.7 billion improvement in cash flows from investing activities in 2021 vs 2020, primarily due to the absence of the $3.2 billion Raytheon Merger cash acquisition in 2020 and proceeds from dispositions like Forcepoint. The LLM’s characterization of a shift from $3.3B inflow to $1.4B outflow implies a $4.7B swing, which aligns numerically but misattributes the cause and misrepresents the actual cash flow figures. (2) The $1.9B from Forcepoint is correct. However, the $3.3B (2020) and $1.4B outflow (2021) are not supported by the original answer and appear to be fabricated or misread. The original answer does not state the absolute levels of net cash from investing activities, only the year-over-year improvement of $4.7B. (3) The multi-hop reasoning is flawed: while the model correctly links Forcepoint proceeds to investing cash inflows, it incorrectly infers the absolute values of net cash from investing activities and misrepresents the comparative dynamics between 2020 and 2021. It fails to mention the key factor—the absence of the $3.2B merger-related inflow in 2020—as a primary driver of the improvement, instead implying that Forcepoint alone caused a reversal in cash flow sign. (4) The correctness score is 4 due to partial factual accuracy on the Forcepoint proceeds but major errors in the comparative investing cash flow figures and reasoning. Quantitative accuracy is 5 because one major number is correct but two others are not. Qualitative accuracy is 4 due to flawed logic and incomplete synthesis. Contextual relevance is 8 because the answer addresses the right topic and direction of impact, even if the details are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 552,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Oracle's reliance on third-party colocation suppliers for global data centers impact the financial risk associated with Oracle Cloud Services, especially considering the long-term lease commitments and potential contract termination fees?",
      "original_answer": "Oracle delivers Oracle Cloud Services through global data centers, substantially all of which are leased through third-party colocation suppliers. Oracle has entered into long-term operating lease commitments with these providers, which often include significant contract termination fees if Oracle needs to exit these obligations early due to strategic changes. This creates financial risk, as Oracle may be locked into costly lease agreements even if demand for Oracle Cloud Services does not meet expectations or if market conditions change unfavorably. Additionally, Oracle depreciates these leased assets over their estimated useful lives, which could be shortened if Oracle's cloud strategy shifts, further impacting profitability.",
      "llm_answer": "Oracle’s cloud platform is built on global data‑centers that are “substantially all… leased through colocation suppliers” (p. 37). Because these facilities are obtained under long‑term operating leases, Oracle is obligated to pay “significant contract termination fees to early exit such obligations” (p. 22), so any change in strategy or need to relocate would hurt cash flow and profitability. The dependence on third‑party providers also means Oracle cannot control interruptions at those sites, adding further financial risk to its Oracle Cloud Services business.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of factual content and context. (1) It accurately captures Oracle's reliance on third-party colocation suppliers for its global data centers and correctly identifies the financial risks associated with long-term lease commitments and significant contract termination fees. The citations to page numbers (p. 37, p. 22) suggest grounding in source material, though the exact source is not evaluated here. (2) There are no numeric values, dates, or calculations in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model connects Oracle’s leasing model to strategic inflexibility and financial exposure, which is consistent with the ground truth. However, the LLM omits a key point from the original answer: that Oracle depreciates leased assets over their useful lives, and that a shift in cloud strategy could shorten these lives and further impact profitability. This missing element slightly weakens the completeness and qualitative accuracy. (4) Despite this omission, the answer remains contextually relevant and conveys the core financial risks accurately. Wording differs but semantic meaning is preserved on the main points. The answer would have scored higher with inclusion of the depreciation risk.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 383,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "What is the total number of shares available for future grants under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan as of December 31, 2021, and how does this availability support UnitedHealth Group's share-based compensation strategy?",
      "original_answer": "As of December 31, 2021, UnitedHealth Group had 64 million shares available under the 2020 Stock Incentive Plan and 18 million shares available under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available for future grants. This availability supports the company's share-based compensation strategy by ensuring sufficient shares are available for future stock options, restricted stock, and other equity awards, which are key tools in compensating employees and aligning their interests with shareholders.",
      "llm_answer": "UnitedHealth Group had **82 million shares** available for future grants as of December 31 2021 – 64 million under the 2020 Stock Incentive Plan and 18 million under the 1993 Employee Stock Purchase Plan【page_77†L31-L38】. This sizable pool gives the company flexibility to issue new stock options, SARs, restricted‑stock units, performance awards and ESPP purchases, supporting its strategy of using share‑based compensation to attract and retain talent while offsetting dilution from other equity awards【page_67†L9-L15】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 64 million shares under the 2020 Stock Incentive Plan and 18 million under the 1993 Employee Stock Purchase Plan, totaling 82 million shares as of December 31, 2021—this matches the original answer exactly. The sum (64M + 18M = 82M) is correct. (2) The answer is complete, addressing both the total number of shares available and how this supports UnitedHealth Group’s share-based compensation strategy. (3) Entity accuracy is perfect: correct plan names, correct company (UnitedHealth Group), and correct date. (4) The reasoning is sound and reflects multi-hop synthesis: it correctly pulls data from two different plans and explains the strategic purpose of maintaining available shares—aligning with the original answer’s emphasis on employee compensation and talent retention. The LLM adds slightly more detail (e.g., listing specific award types like SARs and performance awards) and cites supporting document pages, enhancing credibility without introducing error. The semantic meaning and factual content are equivalent to the ground truth. All scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 336,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Schwab account for client-held fractional shares and their corresponding repurchase liabilities under GAAP, and where are these liabilities reflected on the consolidated balance sheet according to the 2022 10-K filing?",
      "original_answer": "Schwab accounts for client-held fractional shares as part of 'other securities owned' on the consolidated balance sheets, recording them at fair value based on quoted market prices or other observable market data. These shares are included in other assets, and unrealized gains and losses are recognized in earnings. For client-held fractional shares where off-balance sheet treatment under ASC 940 or derecognition criteria under ASC 860 are not met, Schwab recognizes related repurchase liabilities that are accounted for at fair value. These repurchase liabilities are reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet, as disclosed in the 2022 10-K filing.",
      "llm_answer": "Schwab records client‑held fractional shares as “other securities owned at fair value” because the shares do not meet the derecognition criteria of ASC 860 (and off‑balance‑sheet treatment under ASC 940 is not applicable).  An equal‑amount repurchase liability is recognized at fair value, and this liability is presented in the “accrued expenses and other liabilities” line item of the consolidated balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) It correctly identifies that Schwab accounts for client-held fractional shares under ASC 860 and ASC 940, noting that derecognition criteria are not met and off-balance-sheet treatment does not apply—this aligns with the original answer. It accurately states that these shares are recorded at fair value as 'other securities owned' and that a corresponding repurchase liability is recognized, also at fair value. The liability's placement in 'accrued expenses and other liabilities' on the consolidated balance sheet is correctly reported. (2) There are no numeric values in this question, so quantitative accuracy is not applicable in terms of calculations or figures; however, all referenced standards (ASC 860, ASC 940) and account line items are correct, satisfying factual precision. (3) The multi-hop reasoning is sound: the model connects accounting treatment (GAAP/ASC) to balance sheet presentation via appropriate recognition criteria and liability classification. (4) The only minor omission is that the original answer adds that fractional shares are included in 'other assets' and that unrealized gains/losses are recognized in earnings—this contextual detail about income statement impact and asset classification is missing in the LLM response, slightly reducing completeness. However, the core of the question—accounting treatment under GAAP and balance sheet location—is fully addressed with semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 453,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Oracle's integration of Autonomous Database with OCI enable both cost reduction for customers and strategic growth in its cloud and license business?",
      "original_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by automating routine database administration tasks such as maintenance, tuning, patching, scaling, security, and backup, while also using machine learning-driven diagnostics to reduce human error and operational costs. This automation and efficiency lowers labor costs and allows for consumption-based pricing, where customers pay only for resources used. These cost-saving features directly support Oracle's strategic growth in its cloud and license business by encouraging customer migration to Oracle Cloud, particularly among existing Oracle customers using on-premise applications. The integration with other Oracle Cloud services like Java Cloud and Oracle APEX further enhances this migration by offering developers a modern, open platform for building cloud-native applications. As a result, Oracle can expand its cloud and license business by leveraging these technical capabilities to attract both new customers and a broader ecosystem of developers and partners.",
      "llm_answer": "Oracle ties its Autonomous Database to Oracle Cloud Infrastructure so the database runs as a fully managed, self‑driving service that automatically scales and is billed only for the compute, storage and I/O actually consumed. Because the service eliminates manual administration, reduces labor‑hour and over‑provisioning costs, and uses consumption‑based pricing, customers can lower total‑cost‑of‑ownership (see page 12). At the same time, the Autonomous Database is delivered only through OCI and is a cornerstone of Oracle’s “cloud‑and‑license” strategy—its usage drives migration from on‑premise licenses to subscription‑based cloud services, expanding OCI revenue and the overall cloud‑and‑license business (see pages 6, 7, 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Oracle's Autonomous Database on OCI reduces customer costs through automation of administration, elimination of manual labor, reduced over-provisioning, and consumption-based pricing—directly matching the cost-reduction mechanisms in the original answer. It also accurately links this to Oracle's strategic growth via migration from on-premise to cloud, expanding the cloud-and-license business. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; the LLM correctly avoids inventing any. (3) The multi-hop reasoning is sound: it connects Autonomous Database features → customer cost savings → migration incentive → growth in cloud and license revenue, which reflects the correct causal chain. It also correctly notes that the service is only available via OCI, reinforcing strategic lock-in. (4) The only minor omission is that the LLM does not mention integration with specific Oracle Cloud services like Java Cloud or APEX, nor machine learning-driven diagnostics for reducing human error—details present in the original that enhance completeness. However, the core facts, entities (Oracle, OCI, Autonomous Database, cloud-and-license strategy), and logic are correct. Wording differs but meaning is semantically equivalent. Contextual relevance is perfect as it directly addresses both cost reduction and strategic growth as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 418,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the financial implication for UnitedHealth Group if the AARP Program contract is transferred to another entity, considering the management and classification of AARP Program assets as described in the 10-K filing?",
      "original_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would be required to transfer cash equal to the fair value of the AARP Program assets at the date of transfer. These assets, which are managed separately from the company's general investment portfolio and used to fund medical costs payable and other related liabilities, are classified as current assets consistent with the liabilities they support. This would result in a direct reduction of both the company's current assets and the associated liabilities tied to the AARP Program, potentially impacting short-term liquidity depending on the fair value of the investments at the time of transfer.",
      "llm_answer": "If UnitedHealth were to transfer the AARP Program contract to another entity, it must remit cash equal to the fair‑value of the program’s investment assets on the transfer date. Because those assets are recorded as current assets (to match the related rate‑stabilization‑fund and other liabilities), the transfer would create a cash outflow that reduces UnitedHealth’s current‑asset balance by that fair‑value amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core financial implication described in the ground truth. It correctly states that UnitedHealth must transfer cash equal to the fair value of the AARP Program assets upon contract transfer, and that these assets are classified as current assets, leading to a reduction in current assets. The reasoning around matching asset classification with related liabilities (referred to as 'rate-stabilization-fund and other liabilities') aligns with the original answer's mention of liabilities the assets support. The only minor omission is that the original answer adds context about the assets being managed separately from the general investment portfolio and their specific use in funding medical costs, which adds depth to the risk and liquidity impact. However, this does not detract from the essential correctness. All entities (UnitedHealth, AARP Program) and financial classifications are accurate. There are no numerical inaccuracies (no specific dollar amounts in question, but the conceptual treatment of fair value is correct). The multi-hop reasoning—linking contract transfer → obligation to transfer cash → impact on current assets due to asset classification—is sound and properly synthesized. Wording differs slightly but maintains semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 365,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the fair value of Card Member and Other Loans, and how does it compare to the carrying value in relation to the Level 3 fair value hierarchy classification?",
      "original_answer": "The fair value of Card Member and Other Loans is $113 billion, while the carrying value is $110 billion. This fair value is entirely classified under Level 3 of the fair value hierarchy, indicating that it is based on unobservable inputs rather than market data.",
      "llm_answer": "The 2023 filing shows that the fair‑value of Card Member and Other Loans (excluding interest accruals) was **about $45.6 billion**, which is essentially the same as the **carrying amount of roughly $45.5 billion**.  These loans are classified in **Level 3 of the fair‑value hierarchy**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states the fair value is $113 billion and carrying value is $110 billion, whereas the LLM reports approximately $45.6 billion and $45.5 billion, which are less than half the correct values. These numbers are not within an acceptable margin of error and represent a major quantitative discrepancy. (2) The quantitative accuracy is very low because both the fair value and carrying value figures are incorrect. Although the LLM correctly identifies that fair value and carrying value are nearly equal (a qualitative observation), the actual numbers are factually wrong. The Level 3 classification is correctly identified, which is a key qualitative point. (3) The multi-hop reasoning appears flawed—either the model retrieved data from the wrong entity, year, or financial category. The question likely refers to American Express based on the ground truth knowledge graph, but the LLM may have pulled data from a different company or misclassified the loan category. While it correctly associates Card Member and Other Loans with Level 3, the numerical foundation is unsound. (4) Contextual relevance is moderate because the answer addresses the right components—fair value, carrying value, Level 3 classification—and uses appropriate terminology. However, due to the severe numerical inaccuracies, the correctness score is low. The qualitative accuracy is slightly higher because the conceptual understanding (e.g., Level 3 classification, proximity of fair and carrying values) is partially sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 435,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How many shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan as of December 31, 2021, and what types of awards can these shares become the subject of?",
      "original_answer": "As of December 31, 2021, 64 million shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31 2021, the UnitedHealth Group 2020 Stock Incentive Plan had **approximately 64 million shares** available for future issuance. These shares may be issued as future awards such as **stock options, stock‑appreciation rights, restricted stock, restricted stock units, performance awards, and other stock‑based awards**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the number of shares available — 64 million as of December 31, 2021 — is accurately reported, with acceptable use of 'approximately' given that the original data may be rounded. The date and entity (UnitedHealth Group 2020 Stock Incentive Plan) are correct. (2) The types of awards listed — stock options, stock-appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards — match the ground truth exactly in substance and completeness. (3) The reasoning is sound, with no multi-hop errors; the answer correctly synthesizes a single factual point from the plan's disclosure without requiring inference or calculation across multiple documents. (4) The wording differs slightly (e.g., 'may be issued as' vs. 'can become the subject of'), but the meaning is identical. All evaluation criteria are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 283,
        "total_tokens": 1462
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total estimated fair value of foreign government bonds and obligations held by the company in 2023, and how did this compare to the estimated fair value of the same category in 2022 for maturities of 12 months or more?",
      "original_answer": "The company held foreign government bonds and obligations with a total estimated fair value of $770 million in 2023. In comparison, the estimated fair value of the same category for maturities of 12 months or more in 2022 was $549 million, showing an increase of $221 million.",
      "llm_answer": "In 2023 the company held foreign government bonds and obligations with an **estimated fair value of $770 million**, all of which were classified as “due within 1 year” (i.e., less than 12 months). Consequently, the estimated fair value for the 12‑months‑or‑more bucket was **$0 million**.\n\nIn 2022 the same category had an **estimated fair value of $632 million**, of which **$549 million** was for securities with maturities of **12 months or more**.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly states that the estimated fair value of foreign government bonds and obligations in 2023 was $770 million and that in 2022, the value for maturities of 12 months or more was $549 million. However, it incorrectly claims that all $770 million in 2023 were due within 1 year, resulting in a $0 value for maturities of 12 months or more — this directly contradicts the ground truth, which implies the $770 million refers to the 12+ months maturity bucket (as it is being compared to the 2022 $549 million figure for the same maturity category). Additionally, the LLM introduces a figure of $632 million for the total 2022 value, which is not present in the ground truth and appears extraneous. (2) Quantitative accuracy is partially correct: $770 million (2023) and $549 million (2022, 12+ months) are accurate, but the $632 million and $0 million figures are unsupported or incorrect. The increase of $221 million (implied in the original answer) is accurate mathematically ($770M - $549M), but the LLM fails to compute or acknowledge this. (3) The multi-hop reasoning is flawed: the model fails to correctly align the 2023 value with the same maturity category (12+ months) as in 2022, instead misclassifying it as all short-term, which breaks the comparison. This undermines the core of the question, which asks for a year-over-year comparison of the same category. (4) Scores reflect that while some numbers are correct, the key comparison is invalidated by incorrect categorization and unsupported data, leading to a mostly incorrect conclusion despite partial factual grounding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 457,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total capital expenditure in the Africa/Eurasia region in 2021, and how does this compare to the capital expenditure in the same region in 2019?",
      "original_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019. This represents an increase of $25 million over the two-year period.",
      "llm_answer": "The Africa/Eurasia segment recorded **$33 million** of capital expenditures in 2021. In 2019 the same region’s capital expenditures were **$8 million**, so the 2021 amount was **$25 million higher** (more than three times the 2019 level).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: capital expenditure in Africa/Eurasia was $33 million in 2021 and $8 million in 2019, with an increase of $25 million, which is correctly stated. (2) Quantitative accuracy is perfect: the numbers match exactly, and the calculation of the $25 million difference is correct. The additional observation that the 2021 amount is 'more than three times' the 2019 level is a valid qualitative comparison and does not contradict the ground truth. (3) Multi-hop reasoning is sound—information from two different years is correctly synthesized to compute the change. (4) The answer is semantically equivalent to the original, with no omissions or distortions. All entities (region, metric, years) are correctly identified and used. The response fully addresses both parts of the question: the 2021 expenditure and its comparison to 2019.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1106,
        "completion_tokens": 269,
        "total_tokens": 1375
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the percentage change in Johnson & Johnson's worldwide sales of Contact Lenses/Other within the Vision segment from 2020 to 2021, and how did this performance compare to the overall growth rate of the broader Vision segment during the same period?",
      "original_answer": "The worldwide sales of Contact Lenses/Other grew by 14.9% from 2020 to 2021, while the broader Vision segment grew by 19.6% during the same period. This indicates that the Contact Lenses/Other category underperformed relative to the overall Vision segment's growth rate.",
      "llm_answer": "Johnson & Johnson’s worldwide Contact Lenses/Other sales rose from $2.994 billion in 2020 to $3.440 billion in 2021 – a **14.9 % increase**.  The broader Vision franchise grew from $3.919 billion to $4.688 billion in the same period, a **19.6 % increase**.  Thus, Contact Lenses/Other grew, but its rate of growth was about 5 percentage points lower than the overall Vision segment’s growth.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts for Contact Lenses/Other sales ($2.994B in 2020 and $3.440B in 2021) and Vision segment sales ($3.919B to $4.688B) are accurate. The calculated percentage changes—14.9% for Contact Lenses/Other and 19.6% for the broader Vision segment—are correct and match the original answer. Minor formatting differences (e.g., spacing in '14.9 %') do not affect accuracy. (2) The answer is complete, addressing both parts of the question: the percentage change in Contact Lenses/Other sales and the comparison to the overall Vision segment growth. (3) Entities are correctly identified: Johnson & Johnson, the Vision segment, the Contact Lenses/Other category, and the correct time period (2020 to 2021). (4) The reasoning is sound: the LLM correctly infers that Contact Lenses/Other grew at a slower rate than the overall segment (14.9% vs 19.6%), noting a ~5 percentage point difference, which aligns with the conclusion in the ground truth that it underperformed relative to the segment. (5) The semantic meaning is equivalent to the original answer, with slightly more detail (exact dollar figures), enhancing clarity without introducing error. All multi-hop elements—pulling data from two different product lines across two years and comparing growth rates—are handled accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 384,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the total weighted-average grant price for Service and Performance-Based RSUs that were outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year?",
      "original_answer": "$114.22 million for the outstanding shares as of December 31, 2021, which includes the impact of new grants at $125.02 million during the year.",
      "llm_answer": "The weighted‑average grant price for the Service‑ and Performance‑Based RSUs that were outstanding on December 31 2021 – reflecting the balance carried forward from the prior year plus the RSUs granted during 2021 – was **$114.22 per share**【page_130】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the weighted-average grant price as $114.22 per share, while the original answer refers to $114.22 million as the total value (not per share) of outstanding RSUs as of December 31, 2021. This is a critical error in unit interpretation—'per share' vs. 'total value in millions'. Additionally, the original answer mentions new grants during the year were at $125.02 million, which the LLM omits entirely. (2) Quantitatively, the LLM misrepresents $114.22 million as $114.22 per share, which is factually incorrect unless the number of shares is specified (which it isn't in the response). The new grant value of $125.02 million is also missing, making the quantitative response incomplete and misleading. (3) The reasoning correctly identifies that the answer should reflect both beginning balances and new grants, showing sound multi-hop logic in intent, but fails in execution by misrepresenting the nature of the data (total value vs. per-share price). (4) Contextual relevance is high because the response addresses the correct metric, time period, and type of RSUs. However, due to the significant quantitative error in both magnitude and unit, the correctness score is reduced to 6—partially correct but with major factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 361,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "By how much did Boeing's outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decrease from 2023 to 2024, and what percentage did this tranche represent of the company's total debt in 2024?",
      "original_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million (from $10,135 million in 2023 to $6,159 million in 2024). In 2024, this tranche represented approximately 11.43% of Boeing's total debt of $53,864 million.",
      "llm_answer": "Boeing’s outstanding balance of the 1.43 %‑2.50 % unsecured bonds due 2032 fell from **$10.135 billion in 2023 to $6.159 billion in 2024**, a decline of **about $3.98 billion**. In 2024 that tranche accounted for **roughly 11.4 % of Boeing’s total debt of $53.864 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only minor rounding differences. (1) All key numbers are correct: the 2023 balance ($10.135 billion = $10,135 million), 2024 balance ($6.159 billion = $6,159 million), and total debt in 2024 ($53.864 billion = $53,864 million) match exactly when adjusted for unit format. The decrease is correctly calculated: $10,135M - $6,159M = $3,976M, which the LLM reports as 'about $3.98 billion'—a perfectly acceptable rounding to three significant figures. The percentage is reported as 'roughly 11.4%', while the ground truth calculates 11.43%; this minor rounding difference (within 0.03 percentage points) does not affect factual correctness. (2) Quantitative accuracy is excellent: all values are either exact or appropriately rounded, and the calculation logic is sound. (3) The multi-hop reasoning—comparing two years' bond balances, computing the difference, and determining the proportion of total debt—is correctly executed. The LLM synthesizes data across time and debt categories accurately. (4) The answer is fully relevant and addresses both parts of the question: the decrease in bond balance and the percentage of total debt in 2024. The slight rounding in the percentage and use of 'billion' instead of 'million' is a presentational choice, not an error. Thus, the answer is semantically equivalent to the ground truth, warranting a high correctness score of 9 (not 10 due to the small imprecision in the percentage).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 415,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What was the combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021, and what percentage did this represent of the total Orthopaedics revenue for that year?",
      "original_answer": "The combined revenue from Knees and Hips in 2021 was $2,810 million ($1,325 million from Knees and $1,485 million from Hips). This represented 32.7% of the total Orthopaedics revenue of $8,588 million in 2021.",
      "llm_answer": "In 2021 the Orthopaedics franchise generated $8.588 billion in sales. The Hips ($1.485 billion) and Knees ($1.325 billion) lines together contributed $2.810 billion, which is roughly 33 percent of total Orthopaedics revenue for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: total Orthopaedics revenue ($8.588 billion = $8,588 million), Hips revenue ($1.485 billion = $1,485 million), Knees revenue ($1.325 billion = $1,325 million), and combined Knees and Hips revenue ($2.810 billion = $2,810 million). The percentage is reported as 'roughly 33 percent', which is a reasonable approximation of the exact 32.7% in the ground truth. (2) All numeric values match the ground truth in substance, with acceptable format variation (billions vs. millions). The sum $1,485M + $1,325M = $2,810M is accurate. The percentage calculation (2,810 / 8,588 ≈ 32.7%) is correct; rounding to 33% is acceptable in context. (3) The multi-hop reasoning is sound: the model correctly identifies the relevant product lines (Hips and Knees), extracts their revenues, sums them, and computes their share of total Orthopaedics revenue. (4) The answer is fully relevant and addresses both parts of the question. The only minor deduction is for the slight rounding of 32.7% to 'roughly 33%', which, while reasonable, is not exact. Hence, a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 329,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What is the total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing, and why were these shares excluded?",
      "original_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 20.8 million. These shares were excluded because the effect would have been antidilutive due to Boeing incurring a net loss in those periods.",
      "llm_answer": "The filing shows that Boeing excluded **about 25.8 million potential common shares** from the diluted‑loss‑per‑share calculation for the three years (≈ 13.6 m for 2024, 6.5 m for 2023 and 5.7 m for 2022).  \n\nThese shares were left out because their inclusion would have been **antidilutive** – either the exercise price/strike price was above the market price or the performance conditions were not met, and for the larger blocks (11.6 m, 5.7 m and 3.5 m) the company was incurring a net loss, making the effect of those shares antidilutive.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its total number of excluded shares. The ground truth states 20.8 million total shares were excluded over the three fiscal years, but the LLM claims approximately 25.8 million (13.6M + 6.5M + 5.7M = 25.8M), which is a significant overstatement. This error undermines the core quantitative claim. (2) The individual yearly breakdowns (13.6M, 6.5M, 5.7M) do not match the ground truth, which does not provide annual splits but gives a cumulative total of 20.8M. There is no verification that these annual numbers sum to the correct total, and their inclusion suggests a level of detail not supported by the source. Additionally, the LLM introduces sub-components like '11.6M, 5.7M, and 3.5M' without clear linkage to the main total, creating confusion and lack of traceability. (3) The reasoning for exclusion—antidilution due to net loss—is partially correct and aligns with the ground truth. The LLM adds extra detail about exercise prices and performance conditions, which may be generally true for such exclusions but are not specified in the original answer and thus introduce unverified information. While the concept of antidilution during loss periods is sound multi-hop reasoning, the incorrect numbers invalidate the synthesis. (4) The contextual relevance is high because the answer addresses both parts of the question—number of shares and reason for exclusion—and uses appropriate financial terminology. However, the substantial quantitative inaccuracy severely reduces overall correctness, warranting a low score of 3. The qualitative accuracy is moderate due to correct conceptual reasoning, but the numbers are too far off for a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 466,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "By how much did the amendment to the Retirement Value formula in 2021 reduce the Projected Benefit Obligation as of January 3, 2021, and how does this change affect the calculation of pension benefits for U.S. non-union employees hired before 2015?",
      "original_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021 by approximately $1.8 billion. This change affects the calculation of pension benefits for U.S. non-union employees hired before 2015 by transitioning them from the Final Average Pay formula to the Retirement Value formula for benefits earned after January 1, 2026, while preserving the Final Average Pay formula for service before that date.",
      "llm_answer": "The amendment lowered the projected benefit obligation on the January 3 2021 balance sheet by roughly **$1.8 billion** (see the “Amendments” line in the change‑in‑obligation table). For U.S. non‑union employees hired before January 1 2015, the change does **not** alter the benefits already earned under the Final‑Average‑Pay formula; those employees will continue to accrue benefits under that formula for service before January 1 2026, and only after that date will any new service be credited under the Retirement‑Value formula.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.8 billion reduction in the Projected Benefit Obligation as of January 3, 2021, matching the ground truth exactly. The date and dollar amount are accurate, and format (bolded $1.8 billion) is acceptable. (2) All quantitative elements are correct—no calculations required beyond accurate reporting of the $1.8 billion figure, which is properly attributed to the amendment's impact on the balance sheet as of the specified date. (3) The reasoning is sound: the LLM accurately explains that U.S. non-union employees hired before 2015 retain benefits earned under the Final Average Pay formula for service before January 1, 2026, and that new service after that date will be credited under the Retirement Value formula. This reflects correct multi-hop synthesis of the transition rule and grandfathering provision. (4) The only minor deviation from the original answer is the phrasing 'does not alter the benefits already earned' versus the ground truth's 'preserving the Final Average Pay formula for service before that date'—semantically equivalent but slightly less precise in describing the ongoing accrual under the old formula up to 2026. However, the core meaning and all key facts are preserved. Thus, the answer is factually complete and accurate with only negligible wording differences, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 381,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "Given that American Express's financial assets and liabilities carried at amortized cost are based on market conditions and perceived risks as of specific dates, why does the filing state that the fair value of the company cannot be estimated by aggregating these figures?",
      "original_answer": "The filing explains that the fair value figures for financial assets and liabilities measured at amortized cost are estimates based on market conditions and perceived risks as of December 31, 2021 and 2020. These estimates require management judgment and are not indicative of future fair values. Furthermore, the filing explicitly states that the fair value of American Express as a whole cannot be estimated by aggregating the fair values of individual financial instruments because doing so would not capture the company's overall valuation, which includes non-financial factors and the complexities of the business as a whole.",
      "llm_answer": "The table on page 141 shows only the estimated fair‑value amounts for the specific financial assets and liabilities that American Express carries at amortized cost. Those estimates are based on management’s judgment of market conditions and perceived risks as of the balance‑sheet dates and are not forward‑looking or comprehensive of all of the company’s assets, liabilities, off‑balance‑sheet items and other value drivers. Consequently, the filing notes that adding those line‑item fair‑value figures together would not produce a meaningful estimate of American Express’s overall fair value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly explains that the fair value estimates for financial assets and liabilities carried at amortized cost are based on management judgment and market conditions as of the balance-sheet dates (implied to be December 31, 2021 and 2020, though not explicitly stated—minor omission). (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable in terms of numbers; however, the reference to 'page 141' is consistent with typical 10-K structure and does not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes that aggregating individual fair value figures does not reflect the company’s overall fair value because it omits non-financial factors, off-balance-sheet items, and broader business complexities. (4) The LLM uses slightly different phrasing (e.g., 'not forward-looking or comprehensive') but captures the semantic meaning of the original answer. The only minor gap is the lack of explicit mention of 'non-financial factors' or 'business as a whole' in precisely those terms, though the concept is implied through 'other value drivers' and 'not comprehensive.' Overall, the answer is factually correct, contextually appropriate, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 378,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How many amendments to the Benefits Plan for Members of the Board of Directors are explicitly listed in the exhibit index, and what were the effective dates of the original plan and its first amendment?",
      "original_answer": "There are two explicitly listed amendments to the Benefits Plan for Members of the Board of Directors. The original plan was effective on April 14, 2004, and the first amendment was dated December 16, 2005.",
      "llm_answer": "The exhibit index lists **one amendment** to the Benefits Plan for Members of the Board of Directors (Item 10.13.1).  \nThe original plan is shown as “as amended and restated through April 14, 2004,” indicating an effective date of **April 14, 2004**.  \nThe first amendment is recorded as **Amendment Number One, dated December 16, 2005**.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the effective date of the original plan (April 14, 2004) and the date of the first amendment (December 16, 2005), which matches the ground truth. However, it incorrectly stated that only one amendment is listed, while the ground truth confirms there are two explicitly listed amendments. This is a significant factual omission affecting completeness. (2) Quantitatively, the dates are accurate and properly formatted; the dollar amounts or numerical counts are not involved beyond the amendment count, which is off by one. The reference to Item 10.13.1 may be contextually accurate but does not compensate for missing the second amendment. (3) The reasoning is partially sound—correctly extracting the original plan date and first amendment date shows accurate interpretation of 'as amended and restated' and amendment labeling. However, the failure to identify the second amendment suggests incomplete synthesis or oversight in scanning the exhibit index, undermining full multi-hop accuracy. (4) Despite the error in amendment count, the answer is contextually relevant and well-structured, addressing all parts of the question with mostly correct data. The core facts are present but incomplete, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 359,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Oracle's hybrid deployment model contribute to the cloud and license business representing 84% of total revenues in fiscal 2024?",
      "original_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based deployment options, provides customers with flexibility and choice, enabling them to select the deployment model that best suits their needs. This flexibility enhances customer retention and satisfaction, as evidenced by the high renewal rate of license support contracts. The cloud and license business, which includes these support contracts priced as a percentage of the net fees paid by customers, accounted for 84% of Oracle's total revenues in fiscal 2024. This indicates that the hybrid model not only supports customer adoption but also directly drives a significant portion of Oracle's revenue through recurring license support streams.",
      "llm_answer": "Oracle’s hybrid‑deployment approach—offering customers the ability to run applications and infrastructure both on‑premise and in Oracle‑hosted cloud environments—gave them the flexibility to choose the mix that best fits their needs.  By letting customers “pivot” existing software licenses and related support contracts to the Oracle Cloud and to expand those workloads over time, the model drove strong adoption of cloud‑service subscriptions and license‑support renewals, which in turn pushed the cloud‑and‑license segment to represent **84 % of Oracle’s total fiscal‑2024 revenue**【page_41】.  The hybrid‑deployment flexibility therefore directly fueled the growth of the cloud and license business that now dominates Oracle’s revenue mix【page_42】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Oracle's hybrid deployment model combines on-premise and cloud options, supports customer flexibility, and drives adoption and renewals. The cloud and license business represented 84% of total revenues in fiscal 2024—this number is correctly stated and matches the original answer. (2) Quantitative accuracy is perfect: the percentage (84%) and fiscal year (2024) are correct, with no calculation errors. (3) The reasoning is sound and captures the multi-hop logic: the hybrid model enables license portability and support renewals, which contribute to recurring revenue in the cloud and license segment. The LLM correctly infers that this model directly fuels revenue dominance. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'pricing of support contracts as a percentage of net fees'—a detail present in the original that strengthens the revenue linkage. However, the core causal chain (flexibility → adoption/renewals → revenue concentration) is preserved. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing how the hybrid model contributed to the revenue figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 351,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How much of American Express's December 31, 2021 deferred fees are specifically tied to Membership Rewards program participants, and how does this relate to the methodology used to estimate the future redemption liability for these points?",
      "original_answer": "The deferred fees tied to Membership Rewards program participants are specifically called out in the $8,737 million total deferred card and other fees as of December 31, 2021. This connects to the methodology used to estimate the future redemption liability, which relies on statistical and actuarial models using the weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR) based on factors like redemption trends, card product type, and credit attributes.",
      "llm_answer": "American Express reported **$2.838 billion** of “Deferred card and other fees (a)” on its December 31 2021 balance sheet, and the footnote clarifies that this line **includes the deferred fees attributable to Membership Rewards program participants**. The company values the associated future redemption liability by applying a **weighted‑average cost per point** (derived from the most recent 12 months of redemptions) together with an **Ultimate Redemption Rate** that is projected with statistical/actuarial models based on redemption trends, card type, enrollment tenure, spend levels and credit attributes.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the amount of deferred fees tied to Membership Rewards program participants as $2.838 billion, which is factually wrong. The ground truth does not specify a separate dollar amount for Membership Rewards within the $8,737 million total deferred fees—it only confirms that the Membership Rewards portion is included in that total. Thus, the LLM fabricates a precise figure not present in the original data. (2) The quantitative inaccuracy is severe: $2.838 billion is not mentioned in the ground truth, and no breakdown of the $8,737 million is provided, making this a significant error. The date (December 31, 2021) and the total deferred fees context are correct, but the key number requested—specifically the portion tied to Membership Rewards—is misrepresented. (3) The qualitative reasoning is partially sound: the LLM correctly describes the methodology involving weighted average cost per point and Ultimate Redemption Rate (URR), and references appropriate factors like redemption trends, card type, and credit attributes. This shows correct multi-hop understanding of how the liability is estimated. (4) Contextual relevance is high because the answer addresses both parts of the question—amount and methodology—even though the first part is numerically incorrect. The explanation of actuarial models and valuation approach aligns well with the ground truth. However, due to the critical error in asserting an unsupported dollar amount, the correctness and quantitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 426,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How many different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021, based on filings listed in the 2024 10-K report?",
      "original_answer": "16 different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021.",
      "llm_answer": "The 2024 10‑K lists **19 distinct award‑agreement forms** for the 2014 Equity Plan that were adopted between February 18 2015 and February 17 2021 (items 10.5.1 through 10.5.21, excluding the claw‑back policy and plan‑amendment entries).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim: it states that 19 distinct award-agreement forms were documented under The Coca-Cola Company 2014 Equity Plan between February 18, 2015, and February 17, 2021, while the ground truth is 16. This is a significant quantitative error. The LLM references 'items 10.5.1 through 10.5.21, excluding the claw-back policy and plan-amendment entries' to justify 19 forms, but this reasoning does not align with the verified knowledge graph data, which confirms 16 as the correct count. While the time period and plan name are correctly identified (showing contextual understanding), the failure to report the correct number undermines the answer’s validity. The multi-hop synthesis appears flawed—either due to miscounting or incorrect inclusion/exclusion of filings. Although the answer attempts to provide a rationale and is relevant to the question’s context, the major factual inaccuracy in the key numeric result leads to a low correctness score. Format variation is not an issue here, but the number itself is definitively wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 306,
        "total_tokens": 1417
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "Considering AMD's purchases from and equity gains with the ATMP JV in 2021, what was the total financial value of AMD's relationship with the ATMP JV that year, and how does this reflect the strategic importance of the joint venture?",
      "original_answer": "The total financial value of AMD's relationship with the ATMP JV in 2021 was $1.106 billion, combining $1.1 billion in purchases and a $6 million equity gain. This reflects the strategic importance of the joint venture as AMD relies on ATMP JV for critical assembly, test, mark, and packaging (ATMP) services, and maintains a 15% equity stake that gives it significant influence without the obligation to fund further investments.",
      "llm_answer": "In 2021 AMD bought $1.1 billion of inventory from the ATMP joint‑venture and recorded a $6 million equity‑method gain on its 15 % stake – a combined financial relationship of roughly **$1.106 billion**. This sizable purchase volume, together with a positive equity return, underscores how critical the ATMP JV is to AMD’s supply‑chain (assembly, test, mark‑and‑packaging) and demonstrates the strategic value AMD places on its influence over the venture.【page_64†L1-L9】【page_64†L10-L13】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately reports AMD's $1.1 billion in purchases and $6 million equity gain, correctly summing to $1.106 billion total financial value. The numbers match the original answer exactly, with acceptable formatting variations (e.g., '1.1 billion' vs '1.1 billion'). (2) The answer is complete, addressing both the total financial value and the strategic importance of the ATMP JV. (3) Entity accuracy is perfect: AMD, ATMP JV, 2021, 15% equity stake, and the nature of services (assembly, test, mark, and packaging) are all correctly identified. (4) The reasoning is sound and reflects multi-hop synthesis: it connects procurement volume with equity returns to infer strategic supply chain importance and influence, mirroring the original conclusion. The semantic meaning and factual content are equivalent to the ground truth, with only minor rewording. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 288,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Given that DARZALEX and DARZALEX FASPRO together accounted for 6.4% of Johnson & Johnson's total revenues in fiscal 2021 and their respective patent protections expire in 2029 (U.S.) and 2032 (Europe) for DARZALEX and are covered by a separate Janssen-owned portfolio for DARZALEX FASPRO, what is the earliest year that patent expiration could begin to materially impact this combined revenue stream?",
      "original_answer": "The earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is 2029, when the U.S. patents for DARZALEX expire, potentially allowing competitors to introduce biosimilars in the U.S. market, which accounts for a significant portion of Johnson & Johnson's global sales.",
      "llm_answer": "The first loss of patent protection for the DARZALEX family occurs in the United States in 2029; that is the earliest date at which the combined DARZALEX / DARZALEX FASPRO revenue stream could begin to feel a material impact. (The DARZALEX U.S. composition‑of‑matter patents expire in 2029, while the European patents run to 2032 and DARZALEX FASPRO is covered by a separate Janssen‑owned portfolio.)【page_9】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It correctly identifies 2029 as the earliest year of patent expiration for DARZALEX in the U.S., which aligns with the original answer. The mention of U.S. composition-of-matter patents expiring in 2029 and European patents lasting until 2032 is accurate. (2) All dates (2029, 2032) are correct and match the ground truth; no calculations were required, but the synthesis of timing across geographies is precise. (3) The multi-hop reasoning is sound: the model correctly infers that since DARZALEX FASPRO is covered by a separate portfolio and the earliest patent expiry is for DARZALEX in the U.S. in 2029, that is the first point at which biosimilar competition could emerge and materially impact revenue. (4) The answer is contextually relevant, complete, and directly addresses the question without extraneous information. Minor wording differences (e.g., 'feel a material impact' vs 'begin to materially impact') do not affect meaning. The citation of [page_9] suggests source grounding. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 318,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "What is the total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018, as disclosed in the 2022 10-K filing?",
      "original_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in the 2022 10-K filing for the years 2015 and 2018 is two: one amendment effective June 30, 2015, and another effective November 1, 2018.",
      "llm_answer": "The 2022 Form 10‑K lists one amendment to the Excess Benefit Plan for 2015 (effective June 30, 2015) and one amendment for 2018 (effective Nov. 1, 2018), for a total of **two amendments**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately identifies two amendments: one effective June 30, 2015, and another effective November 1, 2018, which aligns exactly with the original answer. (2) All dates and the total count (two amendments) are factually correct; there are no calculation errors. (3) The reasoning correctly synthesizes information from the 2022 10-K filing across two years (2015 and 2018) for the specific plan mentioned, demonstrating sound multi-hop logic. (4) The answer is semantically equivalent to the ground truth, using slightly different phrasing but preserving all key facts and context. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 214,
        "total_tokens": 1327
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How do FedEx's Network 2.0 optimization expenditures and European workforce reduction costs relate to the company's overall 2025 capital expenditure plan and strategic DRIVE transformation program?",
      "original_answer": "FedEx's 2025 capital expenditure plan totals $5.2 billion, with a portion allocated to Network 2.0 optimization. Specifically, the company is investing in network optimization and facility modernization as part of this initiative. Additionally, FedEx Express announced a European workforce reduction plan tied to cost-cutting efforts, with expected cash expenditures ranging from $250 million to $375 million through fiscal 2026. These workforce reduction costs are classified as business optimization expenses and support the DRIVE transformation program, which aims to improve long-term profitability. The capital allocation for Network 2.0 and the European workforce reductions are strategic components of FedEx's broader efforts under the DRIVE initiative to enhance operational efficiency and reduce structural costs.",
      "llm_answer": "FedEx’s 2025 capital‑expenditure budget of roughly $5.2 billion explicitly includes continued investment in the Network 2.0 optimization effort—the same initiative that generated $582 million of business‑optimization costs in 2024 and is a core component of the DRIVE transformation program. The European workforce‑reduction plan, which is expected to require $250 million‑$375 million of cash severance and professional‑fee outlays through fiscal 2026, is classified as a DRIVE‑related business‑optimization expense and is funded in addition to the $5.2 billion capex plan, supporting the overall transformation while being accounted for separately from the capital‑spending budget.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies FedEx's $5.2 billion 2025 capital expenditure plan and the $250 million to $375 million expected cash outlays for the European workforce reduction through fiscal 2026, which matches the ground truth. However, it introduces a figure of $582 million in business-optimization costs from 2024 related to Network 2.0, which is not present in the original answer and cannot be verified from the provided ground truth. This number, while possibly accurate, is extraneous and not supported by the reference, reducing quantitative accuracy. (2) All other numeric values—$5.2 billion capex, $250M–$375M workforce reduction costs—are correctly stated with appropriate timeframes (fiscal 2025 and through 2026). The distinction that workforce reduction costs are separate from capital expenditures is accurately conveyed and logically sound. (3) The multi-hop reasoning is strong: the LLM correctly links Network 2.0 to the DRIVE program, identifies that workforce reductions are part of DRIVE-related optimization expenses, and clarifies that these are non-capital, cash-based costs outside the capex budget. This reflects proper synthesis across financial categories (capital vs. restructuring expenses) and strategic initiatives. (4) The answer is contextually excellent—directly addressing how both expenditures relate to the capex plan and DRIVE—though the unsupported $582M figure prevents a top score in correctness and quantitative accuracy. Overall, the core facts and relationships are accurately conveyed with only one unverified data addition.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 437,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How does AMD's dependency on third-party suppliers for graphics cards and AIB partners affect its financial risk exposure in terms of inventory management and price protection obligations?",
      "original_answer": "AMD's dependency on third-party suppliers for graphics cards and its reliance on AIB partners exposes it to significant financial risk due to price protection obligations. If there is a significant decline in product prices, AMD must honor price protection rights for AIB partners' inventory, which can materially reduce revenue and gross margins. Additionally, AIB partners can return products removed from the price book within 12 months of manufacturing, further impacting financial stability during market fluctuations.",
      "llm_answer": "AMD’s reliance on external manufacturers for its graphics‑card and AIB‑partner‑built products means that most of the finished‑goods inventory is held by those distributors and partners, not by AMD itself. Under the distribution and AIB agreements, the partners’ inventory is protected against price cuts and they receive limited return rights, so if AMD’s product prices fall sharply it must honor those price‑protection and return provisions, which can erode revenue and gross margin and expose AMD to excess‑or‑obsolete‑inventory write‑downs. Thus, the third‑party supply chain creates a financial‑risk exposure tied to inventory management and price‑protection obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies AMD's reliance on third-party suppliers and AIB partners, explains the financial risks related to price protection and return rights, and links these obligations to impacts on revenue, gross margin, and inventory write-downs. All entities (AMD, AIB partners, third-party suppliers) and financial concepts (price protection, inventory management, gross margin) are correctly used. There are no numeric values in the original or LLM answer, so quantitative accuracy is scored as 10 by default. The only minor omission is that the original specifies AIB partners can return products within 12 months of manufacturing, which the LLM answer mentions in general terms ('limited return rights') but does not specify the 12-month window. This does not undermine the overall correctness but slightly reduces qualitative accuracy. The reasoning is sound and multi-hop: it connects AMD's supply chain model to contractual obligations and then to financial risk exposure. Contextual relevance is perfect—the response directly addresses inventory management and price protection as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 332,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What is AbbVie's total cost of products sold related to Venclexta, considering both its shared U.S. profits with Genentech and the royalties paid on net revenues outside the United States?",
      "original_answer": "AbbVie's total cost of products sold related to Venclexta includes Genentech's 50% share of U.S. profits from Venclexta and the royalties paid on net revenues outside the United States. Both components are explicitly included in AbbVie's cost of products sold, as stated in the filing.",
      "llm_answer": "AbbVie’s cost of products sold attributable to Venclexta consists of Genentech’s U.S. profit share plus the royalties paid on Venclexta net revenues earned outside the United States.  For 2023, those combined amounts total **$869 million**, which is reported as “Genentech’s share of profits, including royalties (included in cost of products sold).**",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer attempts to address the question and correctly identifies the two components of AbbVie's cost of products sold related to Venclexta: Genentech’s U.S. profit share and royalties on non-U.S. net revenues. This aligns with the ground truth in terms of conceptual structure, supporting contextual relevance and partial qualitative accuracy. However, the major flaw lies in quantitative accuracy—the LLM asserts a specific figure of $869 million for 2023 without any such number appearing in the original answer (ground truth). The ground truth does not provide any numerical value, only a qualitative explanation of what is included in the cost of products sold. Therefore, the inclusion of a precise dollar amount constitutes a significant factual overreach and inaccuracy. Additionally, the original answer does not mention 2023 or any fiscal year, so the temporal attribution is unsupported. While the reasoning framework is logically sound—correctly identifying that both components are included in cost of products sold—the introduction of unverified quantitative data undermines the correctness. The model fails the multi-hop verification because it fabricates a sum rather than stating that the total cost includes those two components without specifying an amount. Thus, despite correct entity identification (AbbVie, Genentech, Venclexta, cost of products sold), the addition of unsupported numerical data reduces the correctness score substantially.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 403,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What specific governance document related to board members does BNY make publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and who is this document explicitly applicable to?",
      "original_answer": "BNY makes its Directors' Code of Conduct publicly available in addition to the Corporate Governance Guidelines and Committee Charters, and this document is explicitly applicable to all directors of BNY.",
      "llm_answer": "BNY also posts its **Directors’ Code of Conduct** on its website. The Code is expressly **applicable to all directors of BNY**【page_3】【page_13】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It correctly identifies the additional governance document as the 'Directors’ Code of Conduct', which matches the original answer. It also accurately states that this document is 'applicable to all directors of BNY', which is consistent with the ground truth. (2) There are no numerical values, dates, or financial metrics in this question, so quantitative accuracy is not applicable, but the absence of such data is consistent with the original. (3) The reasoning is sound and demonstrates correct synthesis: the LLM correctly infers that in addition to Committee Charters and Corporate Governance Guidelines, the Directors’ Code of Conduct is the additional document, and correctly specifies its applicability. (4) The answer is contextually precise, directly addressing both parts of the question—naming the document and identifying whom it applies to. Minor formatting differences (bold emphasis, citation tags like 【page_3】) do not affect factual accuracy and are acceptable under semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 310,
        "total_tokens": 1414
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "Given AMD's 68% year-over-year revenue growth and 3 percentage-point gross margin improvement in 2021, how did the launch of the AMD Radeon RX 6600 XT and broader gaming-focused graphics strategy specifically contribute to these financial outcomes?",
      "original_answer": "The launch of the AMD Radeon RX 6600 XT in July 2021, designed for high-frame rate 1080p gaming, was part of a broader product strategy that contributed to AMD's 68% revenue growth from $9.8 billion in 2020 to $16.4 billion in 2021. This gaming-focused graphics strategy, which included the Radeon RX 6000M series for laptops and the AMD Advantage Design Framework, helped drive strong demand in the gaming segment. The improved gross margin from 45% to 48% reflects the company's success in scaling high-performance product lines like RDNA 2-based GPUs, which delivered both performance and power efficiency gains that enhanced AMD's competitive positioning and pricing power in the gaming market.",
      "llm_answer": "AMD’s 2021 results show a 68 % jump in net revenue to $16.4 billion and a three‑point rise in gross margin to 48 % (up from 45 % in 2020)【page_43】.  The company attributes much of that growth to its “high‑performance graphics” push, highlighted by the July‑2021 launch of the Radeon RX 6600 XT – a 1080p‑focused, high‑frame‑rate GPU built on the power‑efficient RDNA 2 architecture – and the broader rollout of Radeon RX 6700 XT, RX 6000M mobile GPUs and the AMD Advantage design framework for gaming laptops【page_43】【page_8】.  These new gaming‑centric products generated strong consumer and OEM demand for higher‑margin discrete graphics solutions, directly fueling the year‑over‑year revenue surge and lifting overall gross margin by three percentage points.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: AMD's 68% year-over-year revenue growth, increase from $9.8 billion in 2020 to $16.4 billion in 2021, gross margin improvement from 45% to 48% (a 3-percentage-point rise), and the July 2021 launch of the Radeon RX 6600 XT are all correctly stated. (2) Quantitative accuracy is perfect: the dollar amounts, percentages, and timeframes match the original answer exactly, with acceptable formatting (e.g., $16.4 billion, 68%, 48%). (3) The multi-hop reasoning is sound—the LLM correctly links the product launches (RX 6600 XT, RX 6700 XT, RX 6000M mobile GPUs, AMD Advantage) to increased demand in the gaming segment, which in turn drove revenue growth and margin expansion. It identifies the RDNA 2 architecture as a contributor to power efficiency and performance, which supports pricing power and margin improvement. (4) The answer addresses both parts of the question: how the RX 6600 XT launch and broader gaming graphics strategy contributed to revenue growth and gross margin improvement. The use of citations (e.g., page_43, page_8) suggests proper grounding in source material. No factual errors, omissions, or misattributions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 351,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was AbbVie's net revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta sales in the United States did Genentech receive as part of their collaboration agreement?",
      "original_answer": "AbbVie reported total net revenue of $2,288 million from Venclexta in 2023. As part of the collaboration agreement with Genentech, the pre-tax profit from Venclexta sales in the United States is shared equally between AbbVie and Genentech. Therefore, Genentech received 50% of the United States pre-tax profit from Venclexta, which is included in AbbVie's cost of products sold.",
      "llm_answer": "In 2023 AbbVie recorded total net revenue of **$2.288 billion** from Venclexta (U.S. $1.087 billion + international $1.201 billion). Under the AbbVie‑Genentech collaboration, Genentech’s share of the pre‑tax profit from U.S. Venclexta sales was **$869 million** for 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing the correct question and demonstrating an understanding of the collaboration structure. (1) The total net revenue for Venclexta in 2023 is correctly stated as $2.288 billion (equivalent to $2,288 million), which matches the ground truth and is accurately represented in billion format. However, the breakdown into U.S. ($1.087 billion) and international ($1.201 billion) is not present in the original answer and introduces unsupported specificity. (2) The critical error lies in the claim that Genentech received $869 million as its share of U.S. pre-tax profit. The ground truth states that Genentech receives 50% of the U.S. pre-tax profit, but no dollar amount is provided or calculable from the given information (e.g., cost of goods sold, gross margin, or pre-tax profit figures are not disclosed). Therefore, asserting a specific dollar amount ($869 million) is a fabrication not supported by the source data. (3) The multi-hop reasoning is partially sound—recognizing the 50% profit share under the collaboration agreement—but fails in execution by inventing a precise financial figure without basis. (4) While the answer is contextually relevant and attempts a detailed synthesis, the inclusion of a specific, unverifiable dollar amount for Genentech’s profit share severely undermines factual correctness. A correct answer would have stated the 50% sharing arrangement without quantifying the dollar amount of Genentech’s share, as the exact profit figure is not publicly itemized in the ground truth. Thus, the quantitative accuracy is low due to the incorrect specific figure, qualitative accuracy is moderate due to correct conceptual understanding but flawed inference, and overall correctness is reduced to partial credit.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 489,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "Despite issuing 48 million new Class C common shares in the May 2024 exchange offer, why does Visa's 10-K report only 10 Class C common shares outstanding as of September 30, 2024?",
      "original_answer": "Visa issued 48 million new Class C common shares in the May 2024 exchange offer in connection with the exchange of 241 million Class B-1 shares. However, the 10-K filing shows only 10 Class C common shares outstanding as of September 30, 2024. This discrepancy is explained by the fact that the 10 shares figure in the equity section is presented in millions, as noted in the table's header (\"millions, except per share data\"). Therefore, the 10 shares reported actually represent 10 million shares outstanding. This means that although 48 million Class C shares were newly issued in May 2024, the total outstanding amount was subsequently reduced by 38 million shares, likely through share repurchases, retirements, or other corporate actions not detailed in the provided excerpts.",
      "llm_answer": "Visa’s May 2024 exchange offer did not add permanent class C shares to the capital structure.  The company accepted 241 million class B‑1 shares, retired those B‑1 shares and, in return, “issued approximately 120 million shares of class B‑2 common stock and 48 million shares of class C common stock.” The newly‑issued class C shares were cancelled (treated as “authorized but unissued”) when the B‑1 shares were retired, so they are not counted as outstanding at period‑end. Therefore the balance‑sheet and share‑count tables still show only the original 10 class C shares that remained outstanding as of September 30, 2024 (see the equity summary on page 58 and the share‑count table on page 87).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that the 48 million newly issued Class C shares were 'cancelled' or 'treated as authorized but unissued' when the B-1 shares were retired, which contradicts the ground truth. The ground truth states that the 10 reported shares represent 10 million (due to the 'millions' unit in the table), implying that 38 million of the 48 million issued shares were likely repurchased or retired post-issuance—not that the issued shares were automatically cancelled as part of the exchange. The LLM incorrectly frames the mechanics of the exchange offer, suggesting the Class C shares were never outstanding, which is not supported. (2) Quantitatively, the LLM correctly cites 48 million Class C shares issued and 241 million Class B-1 shares exchanged, aligning with the ground truth. However, it fails to recognize that the '10 shares' in the 10-K are in millions, a critical point in the original answer. Instead, it treats the 10 shares as literal, which is a major error. (3) The multi-hop reasoning is flawed: the LLM does not correctly synthesize the unit clarification (millions) from the table header, which is central to resolving the apparent discrepancy. It invents a mechanism (automatic cancellation) not present in the ground truth. (4) Contextual relevance is moderate—the response addresses the exchange offer and share counts but misattributes the reason for low outstanding shares. The mention of page 58 and 87 adds apparent specificity but does not align with the correct explanation. Overall, core facts and reasoning are incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 453,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How much total cost did FedEx incur in 2024 for both Network 2.0 implementation and DRIVE transformation-related business optimization activities, and what is the expected range of future costs for the European workforce reduction plan announced in June 2024?",
      "original_answer": "FedEx incurred $582 million in 2024 for business optimization activities related to Network 2.0 and the DRIVE transformation. The European workforce reduction plan announced in June 2024 is expected to cost between $250 million and $375 million in cash expenditures through fiscal 2026.",
      "llm_answer": "FedEx recorded **$582 million** of costs in 2024 for its Network 2.0 implementation and other DRIVE‑transformation business‑optimization activities.  \n\nThe European workforce‑reduction plan announced in June 2024 is expected to generate **pre‑tax cash outlays of roughly $250 million to $375 million** through fiscal 2026.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $582 million cost for 2024 related to Network 2.0 and DRIVE transformation is accurately reported, and the expected future cash outlays of $250 million to $375 million for the European workforce reduction are correctly stated. Minor wording differences (e.g., 'pre-tax cash outlays' vs 'cash expenditures') do not affect factual accuracy and are semantically equivalent. (2) The timeframes—2024 for incurred costs and through fiscal 2026 for future costs—are correct. (3) The multi-hop reasoning is sound: the answer synthesizes costs from two distinct initiatives (Network 2.0/DRIVE optimization and European workforce reduction) as required by the question. (4) All entities (FedEx, Network 2.0, DRIVE transformation, European workforce reduction plan, June 2024 announcement) are correctly identified and contextualized. The answer is complete, factually precise, and contextually appropriate, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 297,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was the total value of AMD's (AMD) unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021?",
      "original_answer": "$329 million was the total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021.",
      "llm_answer": "In fiscal 2021, AMD reported that its net accounts‑receivable balance included **$329 million of unbilled accounts receivable**. These unbilled amounts represent work completed on custom‑product and development‑services contracts for which revenue had already been recognized but had not yet been invoiced.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) The quantitative value of $329 million matches exactly with the original answer, and the fiscal year 2021 is correctly identified. (2) The number is accurate and properly formatted ($329 million), with no calculation required beyond correct retrieval. (3) The reasoning is sound: the LLM correctly identifies that the unbilled receivables are tied to custom products and development services where revenue was recognized over time but not yet invoiced, demonstrating accurate synthesis of the financial context. (4) All entities—AMD, fiscal year 2021, unbilled accounts receivable, custom products, and development services—are correctly referenced. The answer is complete, factually precise, and directly addresses the multi-hop nature of the question by linking revenue recognition timing to specific contract types. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 278,
        "total_tokens": 1407
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was AbbVie's total revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta's U.S. sales did AbbVie share with Genentech as part of their collaboration agreement?",
      "original_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million. As part of the collaboration agreement with Genentech, AbbVie shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech, which is included in AbbVie's cost of products sold.",
      "llm_answer": "- **Total 2023 Venclexta revenue:** $2.288 billion (world‑wide net revenues)【page_42】  \n- **Share of U.S. pre‑tax profit with Genentech:** AbbVie splits the U.S. pre‑tax profit equally with Genentech, i.e., **50 %** of the profit is shared【page_68】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the total 2023 revenue from Venclexta is reported as $2.288 billion, which matches the ground truth of $2,288 million (format variation is acceptable: $2.288B = $2,288M). The profit-sharing percentage with Genentech is correctly stated as 50%, matching the original answer. (2) The answer addresses both parts of the multi-part question completely: total revenue and the profit-sharing arrangement. (3) Entities are accurate—AbbVie, Genentech, Venclexta, and the 2023 time frame are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the LLM correctly links AbbVie’s revenue reporting and its collaboration agreement with Genentech, noting that the 50% profit share is related to U.S. pre-tax profits and is reflected in cost of products sold (implied in the source context on page 68). The inclusion of citation markers 【page_42】 and 【page_68】 further supports accurate grounding. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 306,
        "total_tokens": 1444
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was the change in the aggregate principal balance of the 3.650% notes due 2023 between December 31, 2022, and December 15, 2023, and how does this compare to the balance of the 3.700% notes due 2023 on December 15, 2023?",
      "original_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from December 31, 2022 ($171 million) to December 15, 2023 ($0). On the same date, the 3.700% notes due 2023 had an aggregate principal balance of $400 million.",
      "llm_answer": "The 3.650% notes due 2023 fell from a $171 million aggregate principal balance at December 31 2022 to $0 million after the $171 million repayment recorded on December 15 2023 – a $171 million decrease. On December 15 2023, the 3.700% notes due 2023 carried a $400 million balance, which is $229 million larger than the (now‑zero) balance of the 3.650% notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 3.650% notes started at $171 million on December 31, 2022, decreased by $171 million to $0 on December 15, 2023, and the 3.700% notes had a $400 million balance on that same date. The calculation of the decrease ($171M - $0 = $171M) is correct. (2) The answer addresses both parts of the question: the change in principal balance for the 3.650% notes and the comparison to the 3.700% notes' balance. (3) Entities are correctly identified: note types (3.650% and 3.700%), maturity year (2023), and exact dates (December 31, 2022, and December 15, 2023) are all accurate. (4) The reasoning is sound: it correctly infers full repayment of the 3.650% notes and makes a valid comparison showing the 3.700% notes' balance is $229 million higher. Wording differs slightly from the original answer but maintains full semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 287,
        "total_tokens": 1458
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How could adverse litigation outcomes requiring Visa to modify its interchange reimbursement rates impact its transaction volumes and financial position, considering the protections provided by its U.S. and Europe retrospective responsibility plans and ongoing tax disputes?",
      "original_answer": "Adverse litigation outcomes could force Visa to reduce interchange reimbursement rates, which may lead some issuers to decrease promotion or use of Visa products, reduce cardholder benefits, or impose new fees, all of which could lower consumer usage and transaction volumes. This would directly harm Visa's net revenue. While Visa has U.S. and Europe retrospective responsibility plans that provide financial protections against certain litigation-related losses, these protections vary in scope and may not fully cover the financial impact of settlements, judgments, or changes in operating rules. At the same time, ongoing tax disputes with the IRS and foreign jurisdictions, combined with potential changes in global tax laws such as the OECD’s global minimum tax, could increase Visa’s effective tax rate and reduce cash flows. Therefore, even with partial mitigation from the retrospective plans, the combined effect of reduced interchange income and unfavorable tax outcomes could significantly harm Visa’s financial position.",
      "llm_answer": "If a court or regulator forces Visa to lower its default interchange reimbursement rates, the fee Visa earns on each payment would drop and merchants‑or‑issuer incentives to route transactions through Visa could weaken, leading to lower transaction volumes and reduced net‑revenue and profit. Although Visa’s U.S. and Europe retrospective responsibility plans are designed to absorb some settlement exposure from such litigation, a failure or limitation of those plans would still leave the company liable for cash outlays, and the additional cash‑flow strain would be compounded by the ongoing U.S. and foreign tax examinations that could further erode liquidity and its overall financial position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor omissions. (1) All factual elements are correct: adverse litigation leading to lower interchange rates, reduced transaction volumes, lower net revenue, and profit are accurately described. The existence and purpose of Visa’s U.S. and Europe retrospective responsibility plans are correctly noted, as is their potential limitation in fully covering losses. The compounding impact of ongoing tax disputes on liquidity and financial position is also properly highlighted. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is 10 by default—no discrepancies. (3) The multi-hop reasoning is sound: the LLM correctly links litigation → interchange rate reductions → lower issuer incentives → reduced transaction volumes → lower revenue → financial exposure, while also integrating the partial mitigation from retrospective plans and the added strain from tax disputes. The only minor shortcoming is that the LLM does not explicitly mention the potential for issuers to reduce cardholder benefits or impose new fees (a behavioral response mentioned in the original), which slightly weakens the completeness of the issuer-side impact. It also omits reference to the OECD global minimum tax, a specific risk factor in the original. (4) Despite these small gaps, the LLM captures the essential synthesis across litigation, interchange economics, risk-mitigation mechanisms, and tax-related financial risks, maintaining strong semantic equivalence and contextual relevance. Thus, correctness is 9 due to minor completeness issues, not factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 460,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "What are the effective dates of the Performance Share Unit award schedules under the United Technologies Corporation Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, and how do these dates reflect distinct governance updates to each plan as disclosed in the filings?",
      "original_answer": "The effective date of the Performance Share Unit award schedule under the United Technologies Corporation Long-Term Incentive Plan is January 1, 2020, while the effective date under the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan is March 31, 2021. These distinct effective dates reflect separate governance updates to each plan, with UTC’s update specifically tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, and Raytheon’s update tied to the amended Schedule of Terms filed on March 31, 2021, indicating discrete strategic and administrative adjustments within each company’s incentive structure.",
      "llm_answer": "- **United Technologies Corporation Long‑Term Incentive Plan** – the Schedule of Terms for performance‑share‑unit awards (Exhibit 10.15) was revised **January 2016** (the filing notes “Rev. January 2016”)【page_119†L3-L5】.  \n\n- **Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan** – the Schedule of Terms for performance‑share‑unit awards (Exhibit 10.5) reflects the plan’s first amendment, which became effective **December 6, 2020**【page_119†L21-L23】.  \n\nThese dates show that each company updated its governance of long‑term equity awards at different times: United Technologies revised its LTIP schedule in early 2016, while Raytheon Technologies incorporated a later 2020 amendment to its 2018 LTIP.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of key dates. The ground truth states the effective date for United Technologies' PSU award schedule is January 1, 2020, but the LLM incorrectly cites January 2016 based on a revision note in the filing. Similarly, for Raytheon, the correct effective date is March 31, 2021, but the LLM reports December 6, 2020, referencing the amendment date rather than the effective date of the Schedule of Terms. These are critical factual errors. (2) Quantitative accuracy is low: both dates are wrong, and no correct calculation or timeline alignment is presented. The format of dates is correct, but the values themselves are not. (3) The reasoning is flawed in the multi-hop synthesis: the LLM fails to connect the Raytheon update to the March 31, 2021 filing of the amended Schedule of Terms and instead focuses on an earlier amendment date. It also does not mention the governance rationale tied to the amendment and restatement of the UTC LTIP Performance Share Unit Deferral Plan effective January 1, 2020, missing the distinct strategic updates emphasized in the original answer. (4) Contextual relevance is moderate because the answer addresses the right plans and attempts to compare governance updates, but the incorrect dates and lack of correct supporting details severely undermine the accuracy. The answer discusses the right topic and structure but with incorrect factual grounding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 400,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "Which products were the primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022, and how did their performance compare to other product categories within the same segment?",
      "original_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were the Apple Watch and AirPods. These products contributed significantly to the segment's overall increase in net sales compared to 2021. In contrast, other categories such as HomePod mini and Beats products were not specifically cited as growth contributors, suggesting they either underperformed or remained flat relative to the strong performance of Apple Watch and AirPods. This indicates that the segment's growth was concentrated in two key product lines rather than being broadly distributed across all categories.",
      "llm_answer": "Apple’s Wearables, Home and Accessories segment grew because sales of the **Apple Watch and AirPods** rose sharply in 2022. The 10‑K notes that the segment’s net sales increased 7% to $41.2 billion “due primarily to higher net sales of Apple Watch and AirPods,” while other items in the group (Apple TV, Beats, HomePod mini and accessories) contributed far less to the growth. Thus, the Watch and AirPods outperformed the rest of the product mix within the segment.【page_24】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Apple Watch and AirPods as the primary growth drivers in the Wearables, Home and Accessories segment for 2022, which matches the original answer. It also correctly contrasts their strong performance with other categories (Beats, HomePod mini, Apple TV, accessories) that contributed less, implying they underperformed or were flat—consistent with the ground truth's assertion. (2) Quantitatively, the LLM cites a 7% increase in net sales to $41.2 billion, which is factually correct per Apple’s 2022 10-K (page 24), and correctly attributes the growth to Apple Watch and AirPods. No calculation errors are present. (3) The multi-hop reasoning is sound: the model synthesizes segment-level financial performance with product-level drivers from the filing, correctly inferring that growth was concentrated in specific products. (4) The only minor shortcoming is that the original answer emphasizes that HomePod mini and Beats were 'not specifically cited as growth contributors,' while the LLM slightly strengthens this to say they 'contributed far less,' which is a reasonable interpretation but slightly more definitive. This does not undermine correctness but slightly affects nuance in qualitative reasoning. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 393,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does the impact of insurance reverification on Otezla's 2025 sales expectations compare with its effect on ENBREL's projected sales pattern, and what specific historical trend do both products follow?",
      "original_answer": "Both Otezla and ENBREL are expected to follow the historical trend of experiencing lower sales in the first quarter due to insurance reverification and increased co-pay expenses as U.S. patients work through deductibles. This pattern is specifically mentioned for both products in the context of their 2025 sales expectations.",
      "llm_answer": "Both Otezla and ENBREL are expected to see their 2025 sales dampened in the first quarter because insurance‑reverification (along with benefit‑plan changes and higher co‑pays) reduces patient utilization early in the year. Each product is projected to follow the same historical pattern — the first quarter typically records the lowest sales of the year, with higher volumes in the subsequent quarters.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that both Otezla and ENBREL are expected to experience lower sales in Q1 2025 due to insurance reverification and higher co-pays, aligning with the historical trend of lowest sales in the first quarter. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the temporal reference (first quarter of 2025) is correctly implied and consistent. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both products follow the same seasonal pattern driven by U.S. insurance dynamics, despite being different drugs, and links this to patient utilization behavior. (4) All entities (Otezla, ENBREL, 2025 sales expectations, insurance reverification, co-pays, historical trend) are correctly identified and contextualized. The answer is complete, factually accurate, and conveys the same information as the original with slightly expanded but accurate phrasing (e.g., mentioning benefit-plan changes, which is consistent with reverification impacts). No factual or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 325,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "What is the total number of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K filing for both the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan?",
      "original_answer": "RTX disclosed 2 distinct exhibits related to stock appreciation rights awards: one for the United Technologies Corporation 2005 Long-Term Incentive Plan and one for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan.",
      "llm_answer": "RTX’s 2023 Form 10‑K lists two separate stock‑appreciation‑rights exhibits:  \n\n* Exhibit 10.16 – Schedule of Terms for stock appreciation rights awards under the United Technologies Corporation 2005 Long‑Term Incentive Plan.  \n* Exhibit 10.24 – Schedule of Terms for stock appreciation right awards under the Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan.  \n\nTherefore, the filing discloses **a total of two distinct stock‑appreciation‑rights‑related exhibits**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number 'two' is accurate and correctly reflects the total count of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K. (2) The answer is complete, addressing both incentive plans specified in the question: the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan. (3) Entity accuracy is perfect—company names, plan names, exhibit numbers (10.16 and 10.24), and the context of stock appreciation rights are all correctly identified. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by identifying two separate exhibits tied to two distinct incentive plans under RTX’s 2023 10-K, then correctly aggregating them into a total count. (5) The semantic meaning is equivalent to the original answer, with added detail (exhibit numbers and titles) that enhance clarity without introducing error. All formatting variations (e.g., 'stock appreciation rights' vs. 'stock-appreciation-rights') are acceptable and do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 329,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How does the recurring impact of insurance reverification in the first quarter affect the combined sales performance of ENBREL and Otezla in 2025, based on their respective historical patterns and expected net selling price trends?",
      "original_answer": "The recurring impact of insurance reverification in the first quarter is expected to depress the combined sales performance of ENBREL and Otezla in 2025, following their historical pattern of lower sales during this period. For ENBREL, the expectation is for relatively flat volumes but continued declines in net selling price, which will contribute to reduced sales. Similarly, Otezla experienced an 8% decrease in net selling price in 2024, and it is expected to follow the same seasonal pattern in 2025. While Otezla saw 3% volume growth in 2024, this was not enough to offset the price declines, and a similar dynamic is expected in 2025, leading to a compounded negative impact on total sales for both drugs.",
      "llm_answer": "Both ENBREL and Otezla are expected to repeat the historical pattern of the first‑quarter being the weakest sales period in 2025 because benefit‑plan changes, insurance reverification and higher patient co‑pays suppress demand early in the year. ENBREL’s 2025 outlook calls for flat volumes and a continued decline in net‑selling price, whereas Otezla is projected to see only modest net‑selling‑price declines (after an 8 % price drop in 2024). Together, these dynamics will produce a modest overall dip in their combined 2025 sales, anchored by a pronounced first‑quarter slowdown for both products.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the recurring impact of insurance reverification in Q1 2025 on ENBREL and Otezla, aligning with the ground truth's emphasis on seasonal suppression of sales due to benefit-plan changes and patient co-pays. It accurately notes flat volumes for ENBREL and continued net selling price declines, as well as Otezla’s 8% price drop in 2024 and expected modest declines in 2025. However, the LLM understates the severity of the impact by describing the combined sales effect as a 'modest overall dip,' whereas the original answer emphasizes a 'compounded negative impact' due to price declines outweighing volume growth, which was only 3% in 2024 and insufficient to offset price erosion—this nuance is missing. (2) Quantitatively, all numbers are correct: Otezla’s 8% net selling price decline in 2024 is accurately cited; no incorrect figures are introduced. The LLM does not quantify the expected 2025 price declines but correctly references the trend, which is acceptable given the forward-looking nature. (3) The multi-hop reasoning is sound: the model connects insurance reverification to Q1 seasonality, applies historical patterns to 2025 projections, and synthesizes price and volume trends across both drugs. However, it fails to explicitly mention that Otezla’s volume growth in 2024 did not offset price declines—a key point in the ground truth that supports the expectation of continued sales decline. (4) The answer is contextually relevant and well-structured, addressing all components of the question. The slight deduction in correctness and qualitative accuracy is due to the softened characterization of the sales impact and omission of the volume-price imbalance in Otezla’s case, which weakens the completeness of the synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 487,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Considering the impact of increased co-pay expenses and Medicare price setting timelines, by how much could AMGN's revenue from Otezla and ENBREL be affected starting in 2025 and 2026 respectively, and how does this reflect a pattern in the company's revenue forecasting for its key drugs?",
      "original_answer": "AMGN's Otezla revenue is expected to face lower first-quarter sales in 2025 due to increased co-pay expenses and benefit plan changes, following a historical pattern. ENBREL will also see continued declines in net selling price starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act. These impacts reflect a pattern where AMGN's revenue forecasting for both drugs incorporates predictable first-quarter declines driven by insurance dynamics and co-pay expenses, followed by gradual recovery in subsequent quarters. The combined effect suggests a recurring revenue compression risk tied to U.S. patient deductibles and regulatory-driven pricing.",
      "llm_answer": "Amgen says that Otezla’s 2025 sales will be hit by the usual first‑quarter dip that comes from higher patient co‑pays as beneficiaries work through deductibles, and that the drug was placed on the CMS Medicare‑price‑setting track (the price will be fixed beginning 1 Jan 2027). For ENBREL, the company foresees “relatively flat volumes with continued declines in net‑selling price” once the IRA‑driven Medicare Part D price set by CMS starts in 2026. Both forecasts illustrate the same pattern in Amgen’s outlook: each flagship product is expected to face a measurable revenue drag—either a quarterly sales dip (Otezla) or ongoing price‑erosion (ENBREL)—as reimbursement and pricing changes take effect.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key impacts on AMGN's Otezla and ENBREL revenues starting in 2025 and 2026, respectively, and links them to co-pay expenses and Medicare pricing under the Inflation Reduction Act (IRA). It accurately notes Otezla’s expected first-quarter 2025 sales dip due to higher co-pays and deductible resets, and ENBREL’s net selling price declines beginning in 2026 due to IRA-driven Medicare Part D pricing. However, it incorrectly states that Otezla’s CMS price will be fixed beginning January 1, 2027—this is not in the original answer and introduces a specific date not supported by the ground truth, which only mentions 2026 for ENBREL and general 2025 impact for Otezla. This minor factual overreach affects quantitative accuracy. (2) The original answer does not specify a 2027 price freeze for Otezla; thus, this detail is extraneous and potentially incorrect. All other dates (2025 for Otezla, 2026 for ENBREL) are correctly used. No numerical values (e.g., dollar amounts, percentages) are provided in either answer, so scoring focuses on temporal and mechanistic accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes the pattern in AMGN’s revenue forecasting—recurring first-quarter declines due to insurance dynamics (Otezla) and structural price erosion (ENBREL)—and ties both to broader U.S. reimbursement and regulatory trends. The conclusion about 'revenue drag' aligns semantically with the original’s 'recurring revenue compression risk.' (4) Scores reflect high qualitative and contextual accuracy, with a slight deduction in quantitative accuracy due to the unsupported 2027 date. The answer fully addresses both sub-questions and captures the intended pattern in forecasting, making it largely correct with one minor factual deviation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 495,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What is the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, and how does Schwab account for the unrealized gains and losses associated with these liabilities in its consolidated statements of income?",
      "original_answer": "The total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is equal to the value of the corresponding client-held fractional shares, which Schwab includes in accrued expenses and other liabilities. Schwab accounts for the unrealized gains and losses on these repurchase liabilities by offsetting them against the unrealized gains and losses on the related client-held fractional shares, resulting in no net impact to the consolidated statements of income.",
      "llm_answer": "The fair‑value of the repurchase liabilities that correspond to client‑held fractional shares was **$2.543 billion** as of December 31 2024 (the same amount reported for “Other securities owned at fair value”).  Schwab records these liabilities at fair value under ASC 825 and the unrealized gains and losses on the fractional shares are offset by equal unrealized gains and losses on the repurchase liabilities, so **no net gain or loss is recognized in the consolidated statements of income (or comprehensive income)**.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the fair value of repurchase liabilities as $2.543 billion, which is not supported by the ground truth. The original answer does not provide a specific dollar amount, only stating that the fair value equals the value of the corresponding client-held fractional shares included in accrued expenses and other liabilities. Introducing a precise figure like $2.543 billion without grounding in the source data is a significant factual error. (2) There is no verification possible for the $2.543 billion figure since the ground truth does not include a numerical value; thus, the quantitative accuracy is low due to the fabrication of a specific amount. (3) The reasoning about accounting treatment is largely correct: Schwab does offset unrealized gains and losses on repurchase liabilities against those on the related fractional shares, resulting in no net impact to income. This reflects accurate multi-hop understanding of the accounting logic under ASC 825 and consolidation principles. (4) Contextually, the answer is relevant and addresses both parts of the question—value of liabilities and income statement treatment—even though the first part contains an unsupported number. The qualitative reasoning and structure are sound, but the inclusion of a false quantitative figure severely undermines factual correctness, warranting a moderate overall score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 391,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What was the total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares, and how does this compare to AspenTech's 2023 net sales?",
      "original_answer": "The implied fully diluted market capitalization of AspenTech was $15.3 billion according to Emerson's proposal. This is significantly higher than AspenTech's 2023 net sales of $1.04 billion, indicating a substantial valuation multiple of approximately 14.7x net sales.",
      "llm_answer": "Emerson’s November 5 2024 proposal to buy the AspenTech shares it does not already own at $240 per share values AspenTech at an implied fully‑diluted market capitalization of **about $15.3 billion**.  AspenTech’s 2023 net sales were **approximately $1.04 billion**, so the implied market cap is roughly **15‑times** its annual sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the implied fully diluted market capitalization is accurately stated as $15.3 billion, and AspenTech's 2023 net sales are correctly reported as $1.04 billion. (2) The calculation of the valuation multiple is sound: $15.3B / $1.04B ≈ 14.71, which rounds to approximately 15x — the LLM's 'roughly 15-times' is a reasonable approximation and semantically equivalent to the ground truth's 'approximately 14.7x'. (3) The multi-hop reasoning is correct: the model synthesizes the market cap from Emerson's acquisition proposal and compares it to AspenTech's 2023 net sales, which requires combining data from different contexts. (4) Minor wording differences (e.g., 'about $15.3 billion' vs 'approximately $1.04 billion') are acceptable under semantic equivalence. The only slight deviation is the rounding of 14.7x to 15x, which is common in financial communication but slightly less precise than the ground truth. However, this does not undermine factual correctness. All entities (Emerson, AspenTech, 2023 net sales, implied market cap) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 337,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "What is the total potential additional federal tax liability, including penalties, that AMGN faces from the IRS Notices for the years 2010-2012 and 2013-2015, and how would previously accrued repatriation taxes affect this amount?",
      "original_answer": "The total potential additional federal tax liability from the IRS Notices for the years 2010–2012 and 2013–2015 is $8.7 billion ($3.6 billion for 2010–2012 and $5.1 billion for 2013–2015), plus penalties of $2.0 billion, totaling $10.7 billion. However, this amount would be reduced by up to $3.1 billion in previously accrued repatriation taxes ($900 million for 2010–2012 and $2.2 billion for 2013–2015), resulting in a net potential liability of $7.6 billion before interest.",
      "llm_answer": "Amgen says the IRS notices could increase its federal tax bill by roughly **$3.6 billion for 2010‑2012** (plus interest) and **$5.1 billion for 2013‑2015** (plus interest) and also add **about $2.0 billion in penalties** for the 2013‑2015 period – a combined potential exposure of **≈ $10.7 billion** (interest not quantified).  The company notes that **up to $900 million** of previously accrued repatriation tax for 2010‑2012 and **up to $2.2 billion** for 2013‑2015 could be credited against these amounts, potentially reducing the net liability by **≈ $3.1 billion** to about **$7.6 billion** (plus any interest).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $3.6 billion for 2010–2012, $5.1 billion for 2013–2015, totaling $8.7 billion in additional tax, plus $2.0 billion in penalties, resulting in a total potential liability of $10.7 billion. The reduction of up to $3.1 billion from previously accrued repatriation taxes ($900 million for 2010–2012 and $2.2 billion for 2013–2015) is correctly stated, leading to a net liability of $7.6 billion before interest. (2) The calculations are accurate: 3.6 + 5.1 = 8.7; 8.7 + 2.0 = 10.7; 0.9 + 2.2 = 3.1; 10.7 - 3.1 = 7.6. (3) The multi-hop reasoning is sound—information across two IRS notice periods is correctly synthesized, and the impact of previously accrued repatriation taxes is properly applied to reduce the total exposure. (4) All entities (AMGN/Amgen, IRS notices, tax years 2010–2012 and 2013–2015, penalties, repatriation taxes) are correctly identified and contextualized. (5) The answer is semantically equivalent to the original, with minor wording differences (e.g., '≈ $10.7 billion' vs '$10.7 billion') that do not affect factual accuracy. The inclusion of 'plus any interest' appropriately reflects that interest is not included in the $7.6 billion net figure, consistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 369,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does the inclusion of ENBREL in the Medicare price setting program, as detailed in the 2024 10-K filing, affect Amgen's financial outlook, and what additional risk does the potential inclusion of Otezla pose in the future?",
      "original_answer": "Amgen expects the government-mandated price reduction for ENBREL, effective January 1, 2026, to negatively impact its profitability in Medicare. This is due to the significantly lower price set by CMS under Medicare Part D. Additionally, Otezla has been selected for Medicare price setting beginning January 1, 2027, which could further reduce revenues if Amgen is required to accept a government-determined price. The Inflation Reduction Act (IRA) allows for up to 100 drugs to be subject to price setting by 2031, and Amgen notes that other products may be selected in future cycles, compounding the material adverse effect on sales and operations.",
      "llm_answer": "The filing states that CMS has already set a Medicare Part D price for ENBREL that is “significantly lower” than the current price and will apply beginning January 1 2026, and Amgen expects this to “negatively impact its profitability in Medicare” and to weigh on the company’s overall earnings outlook. In addition, the 10‑K warns that Otezla has been named among the next 15 drugs slated for mandatory Medicare price‑setting beginning January 1 2027, creating the further risk that Amgen could be forced to accept a government‑set price (and related rebate/penalty obligations) that would further reduce Otezla’s margins and could materially affect future sales and results of operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: ENBREL's government-mandated price reduction begins January 1, 2026, and will negatively impact Amgen's Medicare profitability and overall earnings outlook. Otezla has been selected for price setting starting January 1, 2027, posing additional risk. (2) Quantitative accuracy is perfect: dates (2026 and 2027) are correctly stated, and there are no numerical errors. Format variations are not needed as all data is in consistent date format. (3) Multi-hop reasoning is sound—LLM correctly synthesizes the impact of the Inflation Reduction Act (IRA) mechanism via CMS price setting across two drugs (ENBREL and Otezla) and anticipates future risks, even mentioning potential rebate/penalty obligations implied in the regulatory framework. (4) The answer addresses both parts of the question: the current impact of ENBREL’s inclusion and the future risk from Otezla. It also captures the broader implication of material adverse effects on sales and operations, consistent with the original answer. Wording differs slightly but maintains semantic equivalence. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 335,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares impact the consolidated statements of income, given the company's election of the fair value option under ASC 825?",
      "original_answer": "Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares results in unrealized gains and losses on these liabilities, which are offset by unrealized gains and losses on the corresponding client-held fractional shares. This offsetting mechanism ensures there is no net impact on the consolidated statements of income. Additionally, since the repurchase liabilities do not carry credit risk, Schwab has not recognized any gains or losses attributable to instrument-specific credit risk in the consolidated statements of income or comprehensive income.",
      "llm_answer": "Schwab measures the repurchase liabilities for client‑held fractional shares at fair value using quoted market prices and has elected the ASC 825 fair‑value option. Because the liability’s fair value moves opposite to the fractional‑share assets, unrealized gains and losses on the shares are offset by equal and opposite gains and losses on the liability, producing **no net effect on the consolidated statements of income (or comprehensive income)**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core mechanism described in the ground truth: Schwab uses quoted market prices to measure repurchase liabilities for client-held fractional shares under the fair value option (ASC 825), and the resulting unrealized gains/losses on the liabilities are offset by equal and opposite movements in the client-held fractional shares, leading to no net impact on the consolidated statements of income. The answer correctly emphasizes the offsetting effect and extends it to comprehensive income, which aligns with the absence of credit risk-related adjustments. The only minor omission is the explicit mention that 'the repurchase liabilities do not carry credit risk' and therefore no gains/losses from instrument-specific credit risk are recognized—this detail is present in the original answer but not in the LLM response. However, this does not affect the primary conclusion about income statement impact. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes the multi-hop logic involving fair value measurement, offsetting, and financial statement impact. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent as all parts of the question are addressed directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 364,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the use of the market multiple method in conjunction with the discounted cash flow method contribute to the determination of the $431 million goodwill impairment charge for the LTC reporting unit in 2021, and what specific store closure strategy announced in 2021 impacted the Retail/LTC segment's long-lived asset impairment analysis?",
      "original_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using a combination of the discounted cash flow method and the market multiple method. These valuation techniques revealed that the LTC reporting unit's fair value was lower than its carrying value, primarily due to deteriorating financial forecasts driven by lower net facility admissions, customer losses, and the prolonged impact of the COVID-19 pandemic. Separately, in the Retail/LTC segment, the Company announced in November 2021 that it would close approximately 900 stores over three years (300 per year from 2022 to 2024), which triggered a long-lived asset impairment test. This led to a $1.4 billion store impairment charge in Q4 2021, including $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment, also within the Retail/LTC segment.",
      "llm_answer": "The goodwill impairment was recorded because the fair‑value estimate for the LTC reporting unit – derived from **both a discounted‑cash‑flow analysis and a market‑multiple valuation** – was lower than the unit’s carrying amount, leading management to conclude that the $431 million goodwill balance was not recoverable【page_104】.  \n\nIn the same year, CVS announced a **store‑closure plan to shut about 900 retail locations (roughly 300 per year from 2022‑2024)**, which created indicators of impairment for the affected store asset groups and drove the $1.4 billion long‑lived‑asset write‑down in the Retail/LTC segment【page_103】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $431 million goodwill impairment for the LTC reporting unit in 2021 and accurately attributes it to the use of both the discounted cash flow and market multiple methods, which showed fair value below carrying value. It also correctly states the store closure strategy—approximately 900 stores to be closed at a rate of 300 per year from 2022 to 2024—announced in 2021, which triggered the long-lived asset impairment. The $1.4 billion impairment charge is accurately mentioned, though the breakdown into $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment is omitted. This is a minor omission that does not undermine the core accuracy. (2) All numeric values—$431 million, 900 stores, 300 per year, 2022–2024 timeframe, and $1.4 billion—are correct and match the ground truth. No calculations are required beyond accurate reporting, which is done properly. (3) The multi-hop reasoning is sound: the model correctly links the valuation methods to the goodwill impairment conclusion and separately connects the store closure announcement to the long-lived asset impairment in the Retail/LTC segment. It synthesizes information across different parts of the filing appropriately. (4) The answer is semantically equivalent to the original, with only minor contextual details missing (the specific components of the $1.4B charge). Wording is concise and accurate, with proper use of financial terminology and correct entities (LTC reporting unit, Retail/LTC segment, CVS). Thus, the answer earns a high score with only a slight deduction in qualitative accuracy for the omitted breakdown of the impairment charge.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 466,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "What is the dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, and what portion of this increase is attributable to Level 2 assets?",
      "original_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023 ($11,438 million) to December 31, 2024 ($12,416 million) is $978 million. Of this increase, Level 2 assets contributed $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024), indicating that the entire increase in this category came from growth in Level 2 assets.",
      "llm_answer": "The “Cash and investments segregated and on deposit for regulatory purposes” rose from **$11,438 million** at 12/31/2023 to **$12,416 million** at 12/31/2024 – an increase of **$978 million**.  \n\nOf that rise, the Level 2 component grew from **$8,810 million** to **$10,015 million**, a **$1,205 million** increase (the Level 1 portion fell by $227 million, offsetting part of the total change).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: the starting balance ($11,438 million), ending balance ($12,416 million), total increase ($978 million), Level 2 increase from $8,810 million to $10,015 million ($1,205 million), and even correctly notes that Level 1 assets decreased by $227 million. These figures match the ground truth exactly. (2) Calculations are accurate: $12,416M - $11,438M = $978M; $10,015M - $8,810M = $1,205M. The answer correctly infers that the increase in Level 2 assets exceeds the total category increase, implying that Level 2 growth more than accounts for the net increase. (3) Multi-hop reasoning is sound: the model synthesizes data across two time points and two asset levels (Level 1 and Level 2) to explain the net change, demonstrating correct understanding of component contributions. (4) While the original answer concludes that 'the entire increase...came from growth in Level 2 assets,' the LLM answer adds the nuance that Level 1 fell by $227 million, which is factually consistent and actually provides deeper insight. This does not contradict the ground truth but enhances it. The only reason for not giving a perfect 10 is that the LLM does not explicitly restate that Level 2 growth fully accounts for (and exceeds) the total increase, which was a key interpretive point in the original answer. However, the provided information allows the reader to reach that conclusion. All entities, dates, and metrics are correct. Semantic equivalence is high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 420,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How does Emerson allocate AspenTech's stock-based compensation expense between pre- and post-combination periods under ASC 805, and what specific valuation inputs and ownership figures from the acquisition are used in this allocation?",
      "original_answer": "Under ASC 805, Emerson allocates the fair value of AspenTech's stock-based compensation awards between pre- and post-combination service periods. The portion attributable to the pre-combination service period is included in the purchase price of the acquisition, while the post-combination portion is recognized as stock-based compensation expense over the remaining service period. This allocation uses the fair value of AspenTech stock at the time of the acquisition on May 16, 2022, determined using the closing market price per share, and Emerson's 55% ownership stake in AspenTech post-transaction.",
      "llm_answer": "Emerson first measured the fair value of the AspenTech awards that replaced the Heritage AspenTech awards using a Black‑Scholes model – the model incorporates AspenTech’s market price, a zero dividend yield, the risk‑free rate from the U.S. Treasury yield curve, the expected option life (based on historic exercise/cancellation patterns) and expected stock‑price volatility (derived from historic AspenTech prices).  Under ASC 805 the total fair value of those awards is then split: the portion attributable to service rendered before the closing (the “pre‑combination” share‑based compensation) is treated as part of the purchase price, while the remainder (the “post‑combination” portion) is recorded as stock‑based compensation expense over the remaining vesting period.  The allocation uses the acquisition ownership numbers – Emerson beneficially owned 55 % of AspenTech on a fully‑diluted basis (45 % non‑controlling) – and the purchase‑consideration table, which shows 66,662,482 Heritage AspenTech shares at $166.30 per share and a $102 million value of stock‑based compensation awards attributed to the pre‑combination service period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces significant inaccuracies. The core concept of allocating stock-based compensation under ASC 805 between pre- and post-combination periods is correctly explained. However, the LLM incorrectly states that Emerson used a Black-Scholes model to value the awards, which is not supported by the ground truth; instead, the fair value was based on the closing market price of AspenTech stock on May 16, 2022. This is a critical factual error affecting quantitative and qualitative accuracy. (2) The LLM provides specific numbers: 55% ownership (correct), $166.30 per share (plausible but not confirmed in ground truth), 66,662,482 shares, and $102 million for pre-combination compensation. The ground truth does not mention these exact figures (e.g., $102M, 66.66M shares), so their accuracy cannot be verified and they appear to be fabricated or inferred beyond available data. The date of the acquisition (May 16, 2022) is correct but not mentioned in the LLM response, weakening completeness. (3) The multi-hop reasoning is partially sound—linking ASC 805 treatment, purchase price allocation, and post-combination expense recognition—but the reliance on an incorrect valuation method (Black-Scholes vs. market price) undermines the reasoning foundation. The use of ownership percentage (55%) is correct and relevant. (4) The answer is contextually relevant and well-structured, addressing both parts of the question, but the introduction of unverified numbers and an incorrect valuation model reduces factual reliability. Correctness score is 6 due to partial accuracy with significant factual flaws in valuation methodology and unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 472,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What was the percentage change in the value of CVS's investments in 'States, Municipalities and Political Subdivisions' from December 31, 2021, to December 31, 2022, and how did this shift affect the overall composition of CVS's debt securities portfolio?",
      "original_answer": "The value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million on December 31, 2021, to $170 million on December 31, 2022, representing a 94.5% decrease. This significant reduction altered the overall composition of CVS's debt securities portfolio, where in 2021 these securities accounted for approximately 13.3% of total debt securities ($3,091 million out of $23,240 million), compared to only 4.9% in 2022 ($170 million out of $3,462 million).",
      "llm_answer": "The 2022 filing does not provide a separate amount for the “States, municipalities and political subdivisions” line‑item, so the percentage change from December 31 2021 to December 31 2022 cannot be calculated from the excerpts you supplied. Consequently, we cannot determine how any shift in that holding altered the overall composition of CVS’s debt‑securities portfolio. (The only disclosed figure is $3.091 billion at 12/31/2021 – Level 2 $3,086 m + Level 3 $5 m【page 149】.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) It claims the 2022 value is not disclosed, but the ground truth confirms it is $170 million, and this figure is essential to calculating the 94.5% decrease. The 2021 value of $3,091 million is correctly cited, but the LLM fails to use the 2022 data, which contradicts the provided ground truth. (2) Quantitative accuracy is extremely low: the correct values are $3,091 million (2021) and $170 million (2022), yielding a 94.5% decrease [(3,091 - 170)/3,091 ≈ 0.945], and the portfolio composition shifts from 13.3% to 4.9%—all of which the LLM ignores. (3) The reasoning is flawed: the model fails to perform the multi-hop synthesis of comparing two time points and assessing portfolio composition change, instead asserting insufficient data when the ground truth provides full data. (4) Contextual relevance is low because the answer denies the possibility of calculation rather than addressing the actual shift. The LLM appears to have misread or lacked access to the 2022 figure, leading to a complete factual breakdown. Minor credit is given for correctly citing the 2021 number.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 318,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the potential conversion of class B common stock, tied to the final resolution of U.S. covered litigation under the U.S. retrospective responsibility plan, depend on the accrual activity related to that litigation, and what financial uncertainty does this create for Visa's class A common stockholders?",
      "original_answer": "Under the U.S. retrospective responsibility plan, class B common stock will become convertible into class A common stock upon the final resolution of U.S. covered litigation. However, the accrual activity for U.S. covered litigation, which includes a charge to the litigation provision when a loss is deemed probable and reasonably estimable, affects the timing and certainty of that resolution. The accrual could be higher or lower than the escrow account balance, introducing uncertainty about when the litigation will be resolved and thus when the conversion will occur. This uncertainty impacts the potential dilution for class A common stockholders, as the market price of class A stock could fall if the conversion happens at a higher valuation that later decreases. Therefore, the financial exposure and timing of litigation resolution directly influence the dilutive effect and stock value risk for existing class A shareholders.",
      "llm_answer": "The conversion of Visa’s class B common stock is triggered only after the U.S. covered litigation is finally resolved under the U.S. retrospective‑responsibility plan.  The amount that must be settled before conversion is tied to the U.S.‑covered‑litigation accrual – the provision rose from a $881 million balance at the start of 2022 to $1.44 billion at year‑end after an $861 million provision and $301 million of payments (see the “Accrual Summary‑U.S. Covered Litigation” table).  Because that accrual is an estimate that could be higher or lower than the escrow balance, Visa cannot determine the exact conversion value, creating material uncertainty for class A shareholders about the size of any dilution and the potential impact on the market price of their shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that class B stock conversion depends on the final resolution of U.S. covered litigation under the U.S. retrospective responsibility plan, and that accrual activity introduces uncertainty about timing and conversion value. The impact on class A shareholders—specifically dilution risk and potential market price impact—is accurately described. (2) Quantitatively, the LLM provides specific figures: the accrual increased from $881 million to $1.44 billion in 2022, with an $861 million provision and $301 million in payments. These numbers are consistent with known 10-K disclosures (e.g., Visa’s 2022 10-K), and the arithmetic checks out: 881M + 861M - 301M = 1,441M ≈ 1.44B. While the ground truth does not include these specific numbers, their inclusion is factually correct and enhances precision. (3) The multi-hop reasoning is sound: the model connects litigation accruals, escrow balance uncertainty, conversion timing, and shareholder dilution—synthesizing financial reporting, legal provisions, and equity impacts. (4) The answer is semantically equivalent to the original, with slightly more numerical detail. The only minor limitation is that it doesn’t explicitly state that the accrual estimate vs. escrow balance affects *when* resolution occurs (not just conversion value), but this is implied. No factual errors; excellent contextual relevance and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 405,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what was the corresponding change in net losses on these investments year-over-year?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million in 2023 to $9,865 million in 2024), and the net losses on these investments increased by $46 million (from $21 million loss in 2023 to $67 million loss in 2024).",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio fell from **$15.6 billion** at July 29 2023 to **$9.9 billion** at July 27 2024 – a **decrease of about $5.7 billion**.  In the same period the loss on those investments grew from **$21 million** to **$67 million**, a **worsening of $46 million** year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same information as the ground truth with only minor formatting differences in number presentation. (1) All key facts are correct: the fair value decrease is accurately reflected as approximately $5.7 billion (exact value $5,727 million), and the net loss increase is correctly stated as $46 million (from $21M to $67M). (2) Numeric values are correct within acceptable rounding: $15.6 billion ≈ $15,592 million and $9.9 billion ≈ $9,865 million; the difference of $5.7 billion is a properly rounded version of $5,727 million. The loss change is exactly $46 million, which matches the ground truth. (3) Multi-hop reasoning is sound—LLM correctly synthesized data across two fiscal years and two financial metrics (fair value and net loss), linking them to the same investment category and time period. (4) Entities (Cisco, available-for-sale debt investments, correct fiscal dates) are accurately referenced. Wording is concise and semantically equivalent. The only reason for not scoring a 10 is the use of rounded figures rather than exact values, but this is acceptable under the guidelines as format variation. No factual or logical errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 337,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did the changes in ExtraBucks Rewards and gift card liabilities during 2021 impact CVS's revenue recognition, particularly in relation to breakage and redemption patterns?",
      "original_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 directly affected CVS's revenue recognition by reducing the contract liability balance as customers redeemed rewards and gift cards. Additionally, CVS recognized breakage revenue based on historical redemption patterns. As customers failed to redeem a portion of the issued rewards and gift cards, CVS reclassified these amounts from liabilities to revenue, reflecting the fulfillment of the obligation to provide goods or services. This process aligns with the company's accounting policy that recognizes breakage on unredeemed gift cards and expired rewards, which contributes to revenue as the likelihood of redemption diminishes over time.",
      "llm_answer": "In 2021 the contract‑liability balance for ExtraBucks Rewards and company gift cards grew from $71 million to $87 million because CVS earned $387 million of new rewards and issued the same amount of gift cards, while $371 million was removed through customer redemptions and the recognition of breakage. Revenue related to ExtraBucks Rewards is recorded only when the points are redeemed, so the $371 million reduction reflects the amount of revenue that was earned during the year as customers used their rewards; the portion attributed to breakage (the portion of gift‑card balances that CVS expects will never be redeemed, based on historical redemption patterns) is also recognized as revenue at the time the breakage estimate is updated. Thus, the net increase in liabilities ($16 million) represents the amount of rewards and gift‑card value still unredeemed, while the redemption and breakage activity directly boosted recognized revenue for the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that changes in liabilities affected revenue recognition through redemptions and breakage, but does not provide specific dollar amounts such as a rise from $71M to $87M, $387M in new rewards, or $371M in redemptions and breakage. These figures are entirely fabricated and not present in the original answer, making the quantitative claims false. (2) There is no verification possible for the calculations because the numbers do not appear in the ground truth; the net increase of $16M is based on incorrect inputs. The original answer does not mention any specific dollar amounts related to liabilities or redemptions in 2021. (3) The reasoning about breakage and revenue recognition aligns partially with the ground truth—CVS does recognize breakage revenue based on historical patterns and reclassifies unredeemed balances to revenue. However, the LLM invents a detailed financial narrative unsupported by the source, failing the multi-hop synthesis requirement since it introduces data not present in the knowledge base. (4) While the LLM captures the general concept of breakage and redemption impacting revenue (hence moderate contextual relevance and some qualitative accuracy), the inclusion of false quantitative data severely undermines correctness. The answer appears plausible but is factually incorrect, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 407,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does the funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan affect the conversion rate of class B common stock into class A common stock, and what financial impact does this have on Visa Inc.'s litigation provision based on the fiscal 2022 accrual activity?",
      "original_answer": "Funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the conversion rate of class B common stock to class A common stock, diluting the value of class B shares. This dilution mechanism is directly tied to the Company’s funding actions. According to the fiscal 2022 data, there was a measurable reduction in the number of as-converted class B shares following escrow deposits, and concurrently, the litigation provision was charged based on the accrual activity for U.S. covered litigation, which was deemed probable and reasonably estimable.",
      "llm_answer": "Funding the U.S. litigation escrow account triggers a downward adjustment to the class B‑to‑class A conversion rate; the $850 million deposited in fiscal 2022 reduced the conversion rate enough to eliminate the equivalent of 4 million class A shares (valued at $205.06 per share). At the same time, Visa recorded a $861 million accrual for U.S. covered litigation, which, after $301 million of payments, left the U.S. litigation provision balance at $1.44 billion—about $560 million higher than the beginning‑of‑year balance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific quantitative claims not present in the original answer, such as a $850 million deposit, elimination of 4 million class A shares, a share price of $205.06, a $861 million accrual, $301 million in payments, and a final provision balance of $1.44 billion. These numbers are not found in the ground truth and cannot be verified against it. Since the original answer does not provide specific dollar amounts or calculations, the introduction of these figures introduces unverifiable and potentially incorrect data. (2) While the general direction of the financial impact (increased litigation provision, downward adjustment in conversion rate) aligns with the original, the specific calculations and figures lack support. For example, the claim that the $850 million deposit eliminated 4 million shares implies a calculation that is not corroborated by the ground truth. Similarly, the accrual and payment figures result in a net increase of $560 million ($861M - $301M = $560M), which matches the stated increase in the provision, but this level of detail is absent from the original and thus cannot be confirmed. (3) The multi-hop reasoning is partially sound: the model correctly identifies the causal chain—funding the escrow account leads to a downward adjustment in the conversion rate and concurrently affects the litigation provision via accrual activity. This reflects understanding of the structural relationship between the escrow funding, stock conversion mechanics, and accounting for litigation provisions. (4) The contextual relevance is high because the answer addresses both parts of the question: the effect on conversion rate and the impact on the litigation provision. However, the quantitative accuracy is low due to the inclusion of unsupported numbers. The qualitative accuracy is moderate because the reasoning framework is correct, but the answer goes beyond the available evidence with precise figures. The correctness score is 6 because the core conceptual explanation is aligned with the ground truth, but the answer is significantly undermined by unverified numerical claims that affect factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 583,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what would be the impact on total investments if a 100 basis point interest rate increase occurred in each of those years?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million, from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. If a 100 basis point interest rate increase had occurred in 2023, the valuation would have been $15,386 million, and in 2024 it would have been $9,736 million. The difference between these two adjusted values is $5,650 million, which reflects the same general trend of decline in investment value over the period even under interest rate stress.",
      "llm_answer": "- The fair‑value of Cisco’s available‑for‑sale debt investments fell from **$15.592 billion** on July 29 2023 to **$9.865 billion** on July 27 2024 – a decline of **$5.727 billion**.  \n\n- If market rates were 100 basis points higher, the fair‑value would be lower by the amount shown in the “+ 100 bps” column of the sensitivity table:  \n\n  * 2024: $9 865 m – $9 736 m = **$129 million** lower.  \n  * 2023: $15 592 m – $15 386 m = **$206 million** lower.  \n\n  Consequently, total investments (cash + cash equivalents + AFS debt + marketable equity) would be reduced by roughly **$129 million** in 2024 (to about **$17.7 billion**) and by **$206 million** in 2023 (to about **$25.9 billion**).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fair value decrease of Cisco's available-for-sale debt investments from $15,592 million to $9,865 million, and calculates the $5,727 million decline accurately (matching ground truth). However, it misinterprets the second part of the question. The question asks for the impact on total investments under a 100 bps rate increase in each year, but more specifically, the ground truth expects the adjusted fair values under stress ($15,386M in 2023 and $9,736M in 2024) and the resulting difference of $5,650M as a comparison point. Instead, the LLM reports the absolute sensitivity impact ($206M and $129M reductions) and extrapolates to total investments (e.g., $17.7B and $25.9B), which are not supported by the ground truth and introduce unverified assumptions about other investment components. (2) While the core numbers from the AFS debt investments are correct (allowing for format variations like $15.592B = $15,592M), the derived total investment figures are speculative and not in the original answer. The sensitivity impacts ($129M and $206M) are numerically correct based on the difference in the +100bps column, but the use of these to estimate total investment levels goes beyond the provided data. (3) The multi-hop reasoning is partially sound—correctly pulling values across years and applying sensitivity—but fails to synthesize the intended comparison: the trend in AFS debt value decline under interest rate stress. Instead, it shifts focus to total investments, which requires additional data not referenced in the ground truth. (4) The contextual relevance is high because the LLM addresses both parts of the question and uses appropriate financial logic, but correctness is significantly reduced due to misalignment with the expected synthesis and unsupported extrapolation to total investment values.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 506,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "What was the financial impact on Visa Inc.'s litigation provision as a result of the U.S. Covered Litigation, and how does the accrual activity relate to the mechanisms outlined in the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa Inc. records a charge to the litigation provision when a loss from U.S. Covered Litigation is deemed probable and reasonably estimable. The accrual activity related to this litigation is directly tied to the mechanisms within the U.S. Retrospective Responsibility Plan, such as the litigation escrow agreement and indemnification obligations from Visa U.S.A. members. These mechanisms are designed to address potential liabilities, and the total accrual could be either higher or lower than the escrow account balance, depending on the resolution of the litigation.",
      "llm_answer": "Visa’s litigation provision jumped dramatically in 2022 because the company recorded a new $861 million provision for the interchange multidistrict litigation that is part of the U.S. covered litigation (the “Provision for covered legal matters” rose from $125 million in 2021 to $885 million in 2022)【page_102】. This accrual was made under the U.S. Retrospective Responsibility Plan – the plan’s escrow agreement, conversion‑feature and loss‑sharing mechanisms require the company to fund an escrow account (Visa deposited $850 million in 2022) and to record an accrual when a loss is probable and reasonably estimable, which is exactly what the $861 million provision reflects【page_72】【page_71】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific numerical data about Visa's litigation provision increase in 2022, citing a rise from $125 million in 2021 to $885 million in 2022, with a new $861 million provision. However, the original answer (ground truth) does not include any of these specific numbers or years. The ground truth focuses on the general accounting policy and structural mechanisms (e.g., escrow agreement, indemnification) under the U.S. Retrospective Responsibility Plan, without referencing actual dollar amounts or fiscal years. Therefore, while the LLM answer is factually detailed and internally consistent, it introduces quantitative claims not present in the ground truth, making them unverifiable against the provided source. (2) The numbers cited—$861 million provision, $885 million total, $850 million deposit—are specific and referenced to pages, but since the ground truth does not confirm or deny these, they cannot be considered 'correct' in the evaluation context. The jump from $125M to $885M implies a $760M increase, not $861M, so there is a potential inconsistency in how the figures relate. (3) The multi-hop reasoning is strong: the LLM correctly links the accrual activity to the U.S. Retrospective Responsibility Plan mechanisms (escrow, loss-sharing), aligning with the ground truth’s emphasis on these structures. It correctly identifies the triggering condition (probable and reasonably estimable loss) for recording a provision, which matches the original answer. (4) The contextual relevance is perfect—the response directly addresses both parts of the question: financial impact and relation to the Plan’s mechanisms. However, the correctness score is reduced due to unsupported quantitative claims. While plausible, the numbers introduce a level of specificity absent from the ground truth, risking overprecision. Thus, the answer is qualitatively accurate and well-reasoned but scores lower on quantitative accuracy due to unverifiable figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 537,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How much did the Heritage AspenTech acquisition contribute to the increase in Emerson's (EMR) gross margin percentage in 2023, and what was the total gross margin percentage for that year as a result of that contribution?",
      "original_answer": "The Heritage AspenTech acquisition contributed 0.6 percentage points to the increase in Emerson's gross margin in 2023. As a result, Emerson's gross margin for 2023 reached 49.0 percent.",
      "llm_answer": "The Heritage AspenTech acquisition added **0.6 percentage points** to Emerson’s gross‑margin improvement in 2023. As a result, Emerson’s overall gross‑margin for 2023 was **49.0 percent**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values '0.6 percentage points' and '49.0 percent' are accurately reported with correct units and precision. (2) The answer addresses both parts of the question: the contribution of the Heritage AspenTech acquisition to gross margin improvement (0.6 pp) and the resulting total gross margin percentage for 2023 (49.0%). (3) Entities are correctly identified: 'Heritage AspenTech acquisition', 'Emerson (EMR)', and the year '2023' are all accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking the acquisition's impact to the overall margin outcome. The wording differs slightly (e.g., 'gross-margin improvement' vs 'increase in gross margin percentage') but maintains semantic equivalence. No calculation errors or factual inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 256,
        "total_tokens": 1368
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does Cisco's guarantee of channel partner financing arrangements potentially affect its credit loss exposure as described in the financing receivables section, given the risk of channel partner financial instability?",
      "original_answer": "Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because it could be required to make payments if channel partners default on short-term financing with third parties. According to the filing, Cisco facilitates revolving short-term financing for channel partners with payment terms ranging from 60 to 90 days and, in some cases, guarantees a portion of these arrangements. If channel partners face financial instability, Cisco may be obligated to cover unpaid amounts under these guarantees. This exposure is compounded by the fact that Cisco already records allowances for credit losses based on internal credit risk ratings, historical default rates, and macroeconomic conditions. If financial instability among channel partners rises, Cisco could experience higher credit losses tied to these financing guarantees, directly impacting its financial position.",
      "llm_answer": "Cisco’s financing receivables include loan and lease arrangements it makes directly with customers and, separately, short‑term “revolving” financing it extends to its channel partners. In many of those partner programs Cisco also **guarantees a portion of the receivable**, so if a partner fails to pay, Cisco may have to make the payment itself. Because those guarantees expose Cisco to the partner’s credit risk, the company must treat the guaranteed amounts as part of its **financing‑receivable portfolio when estimating its allowance for credit losses**, potentially increasing the allowance and any actual loss if a partner’s financial instability leads to non‑payment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core mechanism by which Cisco's guarantee of channel partner financing increases its credit loss exposure. (1) It correctly identifies that Cisco guarantees a portion of short-term revolving financing for channel partners and that this exposes Cisco to credit risk if partners default—this aligns with the ground truth. The statement that Cisco must include guaranteed amounts in its financing-receivable portfolio for allowance estimation is factually correct and reflects proper synthesis. (2) There are no numeric values (e.g., dollar amounts, percentages, time periods like 60–90 days) in the LLM answer, so no quantitative inaccuracies exist; however, it omits the specific detail from the original answer that payment terms range from 60 to 90 days. This is a minor omission but does not affect the correctness of the reasoning. (3) The multi-hop reasoning is sound: the model connects Cisco’s guarantee practice → exposure to partner credit risk → inclusion in financing receivables → impact on allowance for credit losses. It correctly infers the financial statement implication without misrepresenting causality. (4) The answer is contextually fully relevant, directly addressing how guarantees increase credit loss exposure due to partner instability. The only reason it doesn’t score a 10 is the omission of the 60–90 day payment term context, which adds granularity to the risk profile. Overall, the semantic meaning and financial logic are equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 420,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "Given Emerson's 55% ownership stake in AspenTech and the reported $1,093 million in total revenue from AspenTech for 2024, what portion of this revenue is proportionally attributable to Emerson's controlling interest, and how does this stake influence Emerson's overall software and control revenue of $5,399 million?",
      "original_answer": "Emerson's 55% ownership in AspenTech gives it control over a majority of AspenTech's revenue. With AspenTech generating $1,093 million in total revenue for 2024, Emerson's proportionally attributable share is $601.15 million (55% of $1,093 million). AspenTech's revenue is a component of Emerson’s broader 'Software and Control' segment, which reported $5,399 million in revenue for the year. This indicates that AspenTech contributes significantly to Emerson's software and control offerings, representing over 10% of that segment's revenue.",
      "llm_answer": "Emerson’s 55 % ownership of AspenTech translates to roughly **$1,093 million × 55 % ≈ $601 million** of AspenTech’s 2024 revenue being attributable to Emerson. That $601 million is included in Emerson’s “Software and Control” segment, which reported $5,399 million in total sales, so the AspenTech stake accounts for about **11 % of the segment’s revenue** ( $601 million ÷ $5,399 million ≈ 0.11 ).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly calculates Emerson's attributable share of AspenTech's revenue as $601 million (55% of $1,093 million), which matches the ground truth of $601.15 million—rounding to $601 million is acceptable and common in financial reporting. The percentage contribution to Emerson's Software and Control segment is calculated as approximately 11% ($601M / $5,399M), which aligns with the ground truth statement that AspenTech represents 'over 10%' of the segment's revenue. (2) All numeric values are accurate: ownership stake (55%), AspenTech revenue ($1,093 million), Emerson's segment revenue ($5,399 million), proportional share (~$601 million), and derived percentage (~11%). Calculations are correct and clearly shown. (3) The multi-hop reasoning is sound: the model correctly links Emerson's ownership stake to revenue attribution, performs the proportional calculation, and integrates this into the broader context of Emerson’s segment reporting. It synthesizes ownership, revenue attribution, and segment contribution appropriately. (4) The only minor shortcoming is that the LLM does not explicitly state that 55% confers 'control' or 'majority control', which is mentioned in the original answer and relevant for accounting context (e.g., consolidation). However, this does not affect the quantitative or core qualitative accuracy. All other elements are semantically equivalent and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 398,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Pfizer's divestiture of Meridian and the Upjohn spin-off impact its overall cash position and financial restructuring in 2020 and 2021?",
      "original_answer": "Pfizer received $51 million in cash from the sale of Meridian in 2021 and recognized a $167 million loss from the transaction, which was recorded in Discontinued operations—net of tax. In contrast, the Upjohn spin-off in 2020 involved a much larger financial restructuring: Viatris paid Pfizer $12.0 billion in cash as part of the Reverse Morris Trust transaction, which Pfizer used to pay down commercial paper borrowings and redeem $1.492 billion in senior unsecured notes. The Upjohn transaction also resulted in Pfizer distributing $1.6 billion in net assets as part of the spin-off, including $412 million in cash transferred to the Upjohn Business. While the Meridian divestiture had a minimal cash inflow and a negative impact due to the loss, the Upjohn spin-off significantly affected Pfizer’s capital structure by reducing debt and providing a substantial cash infusion, illustrating a strategic shift toward focusing on core growth areas.",
      "llm_answer": "- **Upjohn spin‑off (2020)** – The reverse‑Morris‑Trust transaction gave Pfizer a **$12 billion cash payment** from the newly formed Viatris. Pfizer used that cash to **pay down commercial‑paper borrowings and to redeem $1.15 billion of 1.95 % senior notes (due 2021) and $342 million of 5.80 % senior notes (due 2023)**, thereby reducing debt and strengthening its liquidity position. In addition, the spin‑off involved a **$1.6 billion distribution of net assets (including $412 million of cash)** and incurred **$434 million of separation‑related costs** in 2020.\n\n- **Meridian divestiture (2021)** – The sale of the Meridian subsidiary brought **about $51 million of cash** and generated a **post‑sale loss of roughly $167 million (net of tax)**. The transaction had only a modest impact on cash compared with the Upjohn restructuring, but it was reflected in discontinued‑operations results and a $345 million pre‑tax legal charge in 2021.\n\nOverall, the Upjohn spin‑off provided a large cash infusion that was used to retire debt and improve Pfizer’s cash position, while the Meridian sale contributed a relatively small cash amount and a loss, having limited effect on the company’s broader financial restructuring.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the core financial impacts of both the Upjohn spin-off and Meridian divestiture, with accurate high-level characterization: the Upjohn transaction provided a major cash infusion used for debt reduction, while the Meridian sale had minimal cash impact and resulted in a loss. The entities (Pfizer, Upjohn, Viatris, Meridian), years (2020 for Upjohn, 2021 for Meridian), and financial concepts (Reverse Morris Trust, discontinued operations, debt redemption) are correctly used.\n\n2) Quantitative accuracy has minor but notable discrepancies: \n   - The Upjohn-related senior note redemptions are broken down as $1.15B + $342M = $1.492B total, which matches the ground truth. However, the LLM incorrectly attributes these as separate redemptions with specific interest rates and maturities (1.95% due 2021, 5.80% due 2023), which are not present in the original answer. While these details may be factually true, they go beyond the ground truth and introduce unverified specifics.\n   - The LLM mentions $434 million in separation-related costs and a $345 million pre-tax legal charge for Meridian—details not present in the ground truth. These figures, while possibly accurate, are not supported by the provided answer and represent over-specificity that risks misalignment.\n   - The $12 billion cash from Viatris and $51 million from Meridian are correct. The $1.6 billion net assets (including $412 million cash) transferred in the Upjohn spin-off are also accurately reported.\n\n3) Multi-hop reasoning is strong: the LLM correctly contrasts the scale and strategic impact of the two transactions, linking cash inflows to debt reduction and financial restructuring. It synthesizes the implications for Pfizer’s capital structure and strategic focus, aligning with the ground truth’s conclusion about a shift toward core growth areas.\n\n4) The answer is contextually excellent—directly addressing the question about cash position and financial restructuring in 2020 and 2021. The structure is clear, comparative, and focused. The minor over-specification of debt redemptions and addition of unmentioned charges prevent a top score in quantitative accuracy, but the qualitative and contextual understanding is robust. Hence, correctness is 8: core facts and synthesis are correct, but with some unsupported numerical details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 628,
        "total_tokens": 2169
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022, combining both the Amended Settlement Agreement payment and the annual deposit, and how does this reflect the plan's role in managing litigation liabilities?",
      "original_answer": "Visa contributed a total of $1.45 billion under the U.S. Retrospective Responsibility Plan in 2022. This includes Visa's $600 million payment as part of the Amended Settlement Agreement and the company's annual deposit of $850 million under the plan. This demonstrates the plan's function in systematically funding potential litigation liabilities.",
      "llm_answer": "Visa contributed $600 million under the Amended Settlement Agreement plus an additional $850 million deposited into the U.S. litigation escrow account in fiscal 2022, for a combined total of roughly $1.45 billion. These outlays illustrate how the U.S. Retrospective Responsibility Plan channels settlement payments and regular escrow deposits into a dedicated fund, enabling Visa to manage and contain the financial impact of the ongoing litigation liabilities. 【page_104】【page_102】【page_91】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $600 million from the Amended Settlement Agreement and $850 million in annual deposits sum to $1.45 billion, which matches the original answer. Minor phrasing differences (e.g., 'roughly $1.45 billion') are acceptable and do not affect factual accuracy. (2) The answer is complete, addressing both components of the financial contribution and the plan's role in managing litigation liabilities. (3) Entities are correctly identified: Visa, the U.S. Retrospective Responsibility Plan, the Amended Settlement Agreement, and fiscal 2022 are all accurately referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis—linking the two payments to the total and explaining how the plan functions to manage litigation risk through dedicated funding. The inclusion of source citations (e.g., page references) further supports contextual grounding. Semantic equivalence is maintained throughout, with no factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 301,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was the percentage change in the allocation to equity securities for the U.S. Retiree Health Care Plan between 2022 and 2023, and how did this shift affect the total value of equity securities in the plan by the end of 2023?",
      "original_answer": "The allocation to equity securities for the U.S. Retiree Health Care Plan decreased by 15 percentage points from 35% in 2022 to 20% in 2023. Despite this lower allocation percentage, the total value of equity securities in the plan increased slightly to $54 million by the end of 2023, as shown in the asset breakdown.",
      "llm_answer": "The U.S. Retiree Health Care plan cut its equity‑security allocation from 35 % in 2022 to 20 % in 2023 – a drop of 15 percentage points, or roughly a **42.9 % decrease** in the equity allocation.  As a result, the dollar amount of equity securities held in the plan fell to **about $54 million at year‑end 2023**, down from roughly $98 million at the end of 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the percentage point decrease in equity allocation (from 35% to 20%, a 15 percentage point drop), which matches the ground truth. However, it introduces a misleading calculation of a '42.9% decrease' in allocation, which is not requested and misrepresents the nature of the change. More critically, the LLM states that the dollar amount of equity securities 'fell to about $54 million' from 'roughly $98 million', implying a decline in value. This directly contradicts the ground truth, which states that despite the lower allocation percentage, the total value of equity securities *increased slightly* to $54 million. The original answer does not mention a prior value of $98 million, and such an inference is unsupported. (2) The $54 million figure for 2023 is correct, but the fabricated $98 million for 2022 is not in the ground truth and leads to an incorrect conclusion about the trend in dollar value. The calculation of a 42.9% relative decrease (15/35) is mathematically correct but contextually inappropriate and not asked for in the question. (3) The multi-hop reasoning fails: the model incorrectly infers that a lower allocation percentage must mean a lower dollar amount, failing to recognize that total plan assets may have changed, allowing equity values to rise in dollar terms even as their percentage share fell. This breaks the synthesis required between allocation percentage and absolute value. (4) The contextual relevance is moderate because the answer addresses the right plan and time period and discusses allocation and value, but the core conclusion about the dollar value trend is factually wrong, severely undermining correctness. Quantitative and qualitative accuracy are low due to the incorrect dollar figures and flawed reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 491,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did the adoption of the CECL accounting standard influence the differences in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, and what specific capital component drove this difference?",
      "original_answer": "The adoption of the CECL accounting standard influenced the differences in total capital between the Advanced approaches and the Standardized approach due to variations in the amount permitted in Tier 2 capital related to the qualifying allowance for credit losses. Specifically, under the Standardized approach, total capital increased by $12.6 billion in 2023, partly due to an increase in the adjusted allowance for credit losses included in Tier 2 capital. This component is treated differently under the two approaches, contributing to the observed capital disparity.",
      "llm_answer": "The CECL transition reduced the amount of Tier 2 capital that can be counted under the Advanced approaches. Because the qualifying allowance for credit losses is limited in the Advanced approaches, Bank of America’s total capital under the Advanced approaches is $9.95 billion lower than under the Standardized approach ($241.4 billion vs. $251.4 billion as of 12/31/2023). The driver of the gap is the **qualifying allowance for credit losses** component of Tier 2 capital 【page_52†L1-L9】【page_51†L31-L34】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key capital component driving the difference—the qualifying allowance for credit losses in Tier 2 capital—and links it to the CECL adoption, which aligns with the ground truth. However, the quantitative values are partially incorrect. The LLM states that total capital under Advanced approaches is $9.95 billion lower than under Standardized ($241.4B vs $251.4B), but the ground truth does not provide these exact figures or the $9.95B difference. Instead, it states that Standardized total capital increased by $12.6B in 2023 due to the allowance adjustment. There is no mention of Bank of America in the original answer, which the LLM introduces without grounding. (2) The $12.6B increase in the original is not matched by the LLM’s $9.95B difference; these are different metrics and not directly comparable. The LLM may be citing actual capital levels, while the original focuses on the change due to CECL. This is a significant quantitative discrepancy. (3) The reasoning is sound in connecting CECL to differences in Tier 2 capital treatment between approaches, showing correct multi-hop synthesis of accounting standards and regulatory capital rules. The core logic about differential treatment of allowances under the two approaches is accurate and well-reasoned. (4) The contextual relevance is high as the answer addresses the mechanism of CECL’s impact and the specific capital component. However, the correctness score is reduced due to unsupported numerical claims and introduction of a specific bank not in the original. The qualitative accuracy is strong in reasoning but docked slightly for entity over-specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 458,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Using the midpoint of the stated percentage ranges for each plan, what weighted average percentage allocation to Fixed Income Securities and Cash Equivalents should be applied across all defined benefit and retiree health care plans based on their respective total asset values as reported?",
      "original_answer": "The weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all plans is approximately 72.3%, calculated using the midpoints of the percentage ranges and the total asset values for each plan.",
      "llm_answer": "Using the mid‑points of the target ranges (U.S. DB = 72.5 %, U.S. retiree health = 80 %, non‑U.S. DB = 80 %) and the year‑end fair‑value assets (U.S. DB $418 m, U.S. retiree $264 m, non‑U.S. DB $1,866 m), the weighted‑average allocation to Fixed‑Income Securities and Cash Equivalents is:\n\n\\[\n\\frac{0.725(418)+0.80(264)+0.80(1,866)}{418+264+1,866}\\approx 78.9\\%\n\\]\n\nSo, about **79 %** of the total plan assets should be allocated to Fixed‑Income Securities and Cash Equivalents.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and calculation errors. The ground truth states the weighted average allocation is approximately 72.3%, but the LLM calculates 78.9%, a substantial deviation. The midpoints used by the LLM (72.5%, 80%, 80%) may be correct for each plan, but the final weighted average is miscalculated or based on incorrect asset weights. (2) The dollar amounts used—$418M (U.S. DB), $264M (U.S. retiree), and $1,866M (non-U.S. DB)—appear to match the knowledge graph data. However, the weighted calculation is incorrect: the correct computation should be (0.725 * 418 + 0.80 * 264 + 0.80 * 1866) / (418 + 264 + 1866) = (303.05 + 211.2 + 1492.8) / 2548 = 2007.05 / 2548 ≈ 78.76%, which rounds to 78.8% or 79%, matching the LLM’s result. However, since the ground truth is 72.3%, either the midpoints or the underlying asset values in the knowledge graph differ from what the LLM used, indicating a failure in multi-hop data retrieval or entity alignment. (3) The reasoning process is logically sound—using midpoints and weighting by asset values—but it synthesizes incorrect or misaligned data, suggesting a failure to retrieve the correct percentage ranges or asset values from the actual filings. (4) The contextual relevance is high because the LLM addresses the exact question structure and uses appropriate methodology. However, due to the large numerical discrepancy, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the method is correct, but the inputs or data sourcing are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 435,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the implementation of Basel 3 capital calculations influence the composition and risk profile of Bank of America's covered trading positions as reflected in its Value at Risk (VaR) metrics?",
      "original_answer": "Basel 3 capital calculations require Bank of America to maintain specific capital ratios, including a capital conservation buffer of 2.5% and a stress capital buffer of 2.5% at December 31, 2023. These regulatory requirements influence the Corporation’s risk appetite and capital allocation decisions, particularly in its Global Markets segment, which holds the majority of the market-based portfolio. As a result, the Corporation manages its covered trading positions—such as foreign exchange and commodity positions—under Basel 3 guidelines, which directly affect the risk profile and VaR metrics of these positions. In 2023, the annual average of total covered positions and less liquid trading positions portfolio VaR decreased compared to 2022, primarily due to the roll off of March 2020 market volatility from the historical data window used in the VaR model calibration, aligning with the Basel 3 capital framework.",
      "llm_answer": "Basel III requires Bank of America to calculate market‑risk capital only on “covered positions” – the most liquid, hedgeable trades that meet a regulatory definition – while foreign‑exchange and commodity trades are always treated as covered and less‑liquid or structurally‑restricted positions are excluded. Because the VaR tables (Table 41 and Table 42) are reported on the Basel III covered‑position view, the 2023 average VaR for total covered positions fell to $64 million (99 % confidence) from $70 million in 2022, and the combined covered‑plus‑less‑liquid portfolio VaR dropped to $84 million from $108 million, reflecting a composition shift toward more liquid, lower‑volatility exposures and the removal of the March‑2020 volatility window from the historical‑simulation model.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the impact of Basel III on covered positions and links it to VaR metrics, noting the exclusion of less-liquid positions and the use of covered positions for capital calculations. It accurately states that foreign exchange and commodity positions are included as covered, which aligns with the original answer. However, the LLM introduces specific dollar amounts—$64 million for total covered positions and $84 million for covered-plus-less-liquid portfolio VaR in 2023, down from $70 million and $108 million in 2022—that are not present in the original (ground truth) answer. The ground truth confirms a decrease in VaR due to the roll-off of March 2020 volatility but does not provide exact VaR figures or mention Table 41/Table 42. These specific numbers cannot be verified against the ground truth and appear to be either hallucinated or drawn from an external source not in the provided context. (2) While the directional change (decrease in VaR) matches the original answer, the absence of these figures in the ground truth means quantitative accuracy is compromised. The mention of 99% confidence level is plausible but also unverified in the original. (3) The reasoning is sound: the LLM correctly connects Basel III’s focus on covered positions to the composition of trading portfolios and VaR reporting, and it accurately explains the effect of removing the March 2020 volatility window from the historical simulation model. It synthesizes the regulatory framework with risk measurement practices appropriately, showing good multi-hop logic. (4) Despite strong qualitative reasoning and contextual relevance, the inclusion of unsupported numerical data reduces the correctness score. The answer goes beyond the original information with precise figures, which risks inaccuracy even if the trend is correct. Hence, the correctness score is 7—core facts and logic are right, but significant unverified numbers reduce confidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 535,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "What is the total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express, and how does this compare to the amount of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance?",
      "original_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is $1.8 billion. This compares to the $5.8 billion of outstanding debt eliminated through redemptions paid using proceeds from the $3.25 billion senior unsecured debt issuance, which also included $393 million in associated redemption premiums.",
      "llm_answer": "The 19 Boeing aircraft that back the Pass‑Through Certificates have a combined net book value of **about $1.8 billion** at May 31 2022. In contrast, FedEx used the proceeds from its senior unsecured debt issuance to **redeem roughly $5.8 billion of debt**, so the debt eliminated is more than three times the aircrafts’ net book value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net book value of the 19 Boeing aircraft as $1.8 billion and the amount of debt eliminated as $5.8 billion, both of which match the ground truth. It also correctly notes that the debt eliminated is more than three times the aircrafts' net book value, which is a valid comparison. However, the LLM omits mention of the $393 million in redemption premiums, which is part of the full picture in the original answer, though not directly part of the core comparison asked. (2) All numeric values—$1.8 billion (net book value), $5.8 billion (debt eliminated)—are accurate and correctly formatted. The date 'May 31, 2022' is contextually appropriate and aligns with typical FedEx fiscal reporting, though not explicitly stated in the ground truth; this is a reasonable inference and not a factual error. (3) The multi-hop reasoning is sound: the model connects the asset value (aircraft) to the debt structure (Pass-Through Certificates) and contrasts it with the refinancing activity using proceeds from senior unsecured debt. The synthesis across financial instruments is logically presented. (4) The omission of the redemption premium detail prevents a perfect score, but since the question focuses on the comparison between net book value and debt eliminated (not total cash outlay), the core answer remains factually correct and highly complete. Wording is clear and semantically equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 404,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How much did TI contribute to U.S. defined contribution plans in 2023, and what is notable about the investment of plan assets in TI common stock for the retiree health care benefit plan?",
      "original_answer": "TI contributed $75 million to U.S. defined contribution plans in 2023. Notably, none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock.",
      "llm_answer": "TI’s expense (i.e., employer contribution) to its U.S. defined‑contribution plans was **$75 million in 2023**. Notably, **the retiree health‑care benefit plan does not hold any of its assets directly in TI common stock**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the $75 million contribution amount for 2023 is accurate and matches the original answer exactly. (2) The qualitative response correctly identifies that no assets of the retiree health care benefit plan are directly invested in TI common stock, which is the key notable fact. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly separates the contribution to defined contribution plans from the investment policy of the retiree health care plan, two distinct but related components. (4) All entities—TI, U.S. defined contribution plans, retiree health care benefit plan, TI common stock—are accurately referenced with correct context. Wording differs slightly (e.g., 'does not hold any' vs 'none were invested') but conveys the same factual meaning. No errors in facts, numbers, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 268,
        "total_tokens": 1382
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "Apple's 10-K filing emphasizes its strategic focus on services as a key growth area. Given that Services revenue increased from $85.2 billion in 2023 to $96.169 billion in 2024, and total net sales rose from $383.285 billion in 2023 to $391.035 billion in 2024, what percentage of the total net sales growth between 2023 and 2024 was attributable to the increase in Services revenue?",
      "original_answer": "The increase in Services revenue contributed approximately 121% of the total net sales growth between 2023 and 2024. This is calculated as follows: Services revenue increased by $10.969 billion ($96.169B - $85.2B), while total net sales increased by $7.75 billion ($391.035B - $383.285B). Therefore, the Services growth alone accounted for $10.969B / $7.75B = 121% of the total net sales growth.",
      "llm_answer": "Apple’s Services net‑sales rose by $10.969 billion (from $85.2 billion in 2023 to $96.169 billion in 2024)【page_38】.  Total net‑sales grew by only $7.75 billion (from $383.285 billion to $391.035 billion)【page_38】.  Thus, the Services increase accounts for about \\(10.969 ÷ 7.75 ≈ 1.415\\) or **141 %** of the overall net‑sales growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical calculation error. While it correctly identifies the Services revenue increase ($96.169B - $85.2B = $10.969B) and the total net sales increase ($391.035B - $383.285B = $7.75B), it incorrectly computes the percentage contribution as 141% (10.969 ÷ 7.75 ≈ 1.415), whereas the correct value is approximately 141.5%, which should round to about 142%, but the ground truth states 121%, indicating a fundamental discrepancy. However, upon rechecking: 10.969 / 7.75 = 1.415 → 141.5%, not 121%. This suggests either the ground truth is incorrect or there was a typo in the original answer. But assuming the ground truth is accurate per the knowledge graph, the LLM must be wrong. However, recalculating: 10.969 / 7.75 = 1.415 → 141.5%, so the LLM's 141% is numerically correct. The original answer claiming 121% appears to be factually incorrect. This creates a conflict: the LLM performed the correct calculation, but it contradicts the provided 'ground truth'. Given the instructions prioritize alignment with the stated ground truth, the LLM is marked incorrect despite doing the math right. (2) All input numbers are accurate: $85.2B, $96.169B, $383.285B, $391.035B, and derived deltas ($10.969B and $7.75B) are correct. The final percentage is mathematically sound but diverges from the expected 121%. (3) The multi-hop reasoning is sound: the model correctly isolated Services growth, computed total sales growth, and derived the proportional contribution. The logic is valid and complete. (4) Due to the contradiction between actual calculation and provided ground truth, the correctness score is low because the answer does not match the expected result, even though it may be mathematically accurate. Quantitative accuracy is penalized due to the mismatch with the 'truth', despite correct arithmetic. Qualitative reasoning is solid. Contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 518,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "What is the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months, and how does the existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 contribute to the uncertainty surrounding these tax positions?",
      "original_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million. This uncertainty is influenced by the fact that the IRS has issued Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015, which Pfizer is currently appealing. These RARs represent formal audit findings that the company disputes, contributing to the ongoing uncertainty in tax positions and the potential for significant changes in unrecognized tax benefits.",
      "llm_answer": "Pfizer says it is “reasonably possible” that its gross unrecognized tax benefits (excluding interest) could fall by up to **$75 million** in the next 12 months as a result of settlements or statutes‑of‑limitations expirations. The uncertainty is heightened because the IRS has issued Revenue Agent’s Reports (RARs) for tax years 2011‑2013 and 2014‑2015; Pfizer is contesting those RARs and is appealing the disputed issues, so the ultimate outcome of those positions remains unknown and could materially affect the amount of unrecognized tax benefits.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the $75 million estimated maximum potential decrease in gross unrecognized tax benefits is accurately reported, matching the original answer exactly. The time frame of 'next 12 months' is correctly included. (2) The explanation of uncertainty due to the IRS Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 is complete and accurate. The LLM correctly notes that Pfizer is appealing these RARs, which introduces uncertainty—this aligns with the ground truth. (3) Multi-hop reasoning is sound: the answer synthesizes the numerical impact ($75M decrease) with the procedural context (ongoing appeals of RARs) to explain the uncertainty in tax positions. (4) All entities—Pfizer, IRS, RARs, tax years, and the term 'unrecognized tax benefits'—are correctly identified and used in context. Wording differs slightly (e.g., 'contest' vs 'disputes') but meaning is preserved. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 297,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the five-year transition period related to the adoption of the CECL accounting standard impact the calculation of BAC's TLAC ratios and CET1 capital as of December 31, 2023?",
      "original_answer": "The five-year transition period related to the adoption of the CECL accounting standard impacts the calculation of BAC's TLAC ratios by allowing the use of the regulatory capital rule that predates CECL, which affects how capital is measured and reported. As of December 31, 2023, BAC's CET1 capital was $194.9 billion, an increase of $14.9 billion from the prior year, influenced in part by the CECL transition's effect on capital calculations.",
      "llm_answer": "Both the TLAC ratios and the CET1‑capital ratios shown for December 31 2023 are computed under the “five‑year CECL transition” rule. The rule lets Bank of America use the transitional CECL amount (the $1.3 billion CECL‑transition provision shown in Table 11) when measuring regulatory capital, so the TLAC ratios (29 % of risk‑weighted assets and 13 % of supplementary leverage exposure) and the CET1 ratio (11.8 % under the Standardized approach) are calculated on a capital base that still includes the CECL transition adjustment rather than the full post‑CECL amount. This transitional treatment softens the impact of the new CECL accounting standard on the reported TLAC and CET1 figures.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly explains that the five-year CECL transition period allows Bank of America (BAC) to use a transitional approach in calculating regulatory capital metrics like TLAC and CET1 as of December 31, 2023. This matches the original answer’s claim about the use of pre-CECL capital rules softening the impact on reported capital. (2) Quantitatively, the LLM introduces specific figures not in the original answer—such as the $1.3 billion CECL-transition provision and the exact TLAC and CET1 ratios (29%, 13%, 11.8%)—which are plausible and consistent with BAC’s 2023 reporting, though not present in the ground truth. Since these numbers are not contradicted by the original answer and are contextually appropriate, they do not constitute errors but reflect deeper detail. The original answer mentions BAC’s CET1 capital of $194.9 billion (absolute amount), while the LLM discusses the CET1 *ratio* (11.8%), indicating complementary but not conflicting information. (3) The multi-hop reasoning is sound: the model correctly links the CECL transition rule to its effect on regulatory capital calculations for both TLAC and CET1, synthesizing accounting policy with capital adequacy metrics. (4) The LLM answer is semantically equivalent and adds precision (ratios, specific provision amount) without introducing inaccuracies. The only minor gap is the absence of the $194.9 billion CET1 capital figure from the ground truth, but since the question asks about the *impact* of the transition (not the absolute value), this omission does not undermine correctness. Overall, the response is factually solid, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 474,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How do the implementation dates and fuel surcharge adjustment mechanisms differ between FedEx Ground and FedEx Freight in response to fluctuating fuel prices?",
      "original_answer": "FedEx Ground adjusts its fuel surcharge on a weekly basis using fuel price data from two weeks prior, with updates to the fuel surcharge tables occurring on June 21, 2021, November 1, 2021, and April 4, 2022. FedEx Freight, on the other hand, adjusts its fuel surcharge weekly using fuel price data from two days prior, with updates to the fuel surcharge tables occurring on November 1, 2021, and April 4, 2022. These differences in timing and data lag reflect how each segment tailors its fuel surcharge mechanism to address fuel cost fluctuations.",
      "llm_answer": "FedEx Ground’s fuel surcharge is indexed and revised weekly using the fuel price that was published **two weeks earlier**; its surcharge tables were updated on **June 21 2021, November 1 2021 and April 4 2022**. In contrast, FedEx Freight also applies a weekly‑adjusted indexed surcharge but bases it on the fuel price **two days earlier**, and its tables were only updated on **November 1 2021 and April 4 2022**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: All dates (June 21, 2021, November 1, 2021, April 4, 2022) and time lags (two weeks prior for FedEx Ground, two days prior for FedEx Freight) are accurately reported. The answer correctly notes that FedEx Ground had three table updates while FedEx Freight had two, omitting only the June 21, 2021 update for Freight, which aligns with the original answer. (2) Completeness: The response addresses both parts of the question—implementation dates and adjustment mechanisms—for both FedEx Ground and FedEx Freight. (3) Entity accuracy: Correctly identifies 'FedEx Ground' and 'FedEx Freight' and associates each with the correct fuel surcharge logic and update dates. (4) Reasoning: The multi-hop synthesis is sound—comparing the two divisions’ approaches to fuel surcharge adjustments, highlighting differences in data lag (two weeks vs. two days) and update history. (5) Semantic equivalence: Though phrased differently, the LLM conveys the same factual content as the original answer, including the operational distinction in timing and the specific update dates. No factual errors, omissions, or misstatements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 340,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the reorganization of the Ventilator Product Line impact the reporting structure of MDT's Medical Surgical segment in fiscal year 2023, and what does this indicate about the strategic positioning of the retained Acute Care & Monitoring business?",
      "original_answer": "The Ventilator Product Line was moved out of the Medical Surgical segment and into the 'Other' line as part of a reorganization. This reorganization also involved the Renal Care Solutions business and led to the formation of a new unit called Acute Care & Monitoring within Medical Surgical, which combined retained PMRI businesses. This indicates a strategic refocusing of the Medical Surgical segment around core PMRI capabilities, while separating out businesses either being exited or transitioned.",
      "llm_answer": "The February 2024 decision to exit the ventilator product line removed that business from the Medical Surgical portfolio and placed it in the “Other” line; the remaining PMRI (patient‑monitoring and respiratory‑care) assets were bundled into a single **Acute Care & Monitoring** unit that stayed inside the Medical Surgical segment, and Medtronic restated FY 2023 results to reflect this new reporting structure【page 35】. By keeping the Acute Care & Monitoring businesses together within Medical Surgical, Medtronic is signaling that this combined unit is a strategic, core therapeutic platform that it intends to grow, while the ventilator line is being wound down.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that the Ventilator Product Line was removed from the Medical Surgical segment and moved to the 'Other' line, and that the remaining PMRI businesses (patient monitoring and respiratory care) were consolidated into a new Acute Care & Monitoring unit within Medical Surgical. This aligns with the original answer’s description of the reorganization. (2) The date mentioned—February 2024—is consistent with the timing of the decision, and although the original answer does not specify a month, it references the reorganization affecting FY2023 reporting, which the LLM correctly notes was restated to reflect the new structure. There are no numeric inaccuracies; the focus is on structural changes rather than financial figures. (3) The multi-hop reasoning is sound: the LLM correctly infers that retaining Acute Care & Monitoring within the segment signals strategic importance, while exiting ventilators indicates a divestiture or wind-down—this interpretation is logically supported by the ground truth’s statement about refocusing on core PMRI capabilities. (4) Minor deduction in qualitative and quantitative scores due to the introduction of 'February 2024' which, while plausible, is more specific than the original (which doesn’t specify timing), but this does not contradict the truth. Overall, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 410,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "What was the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over the fiscal years 2022 and 2023, based on the amounts disclosed in both tables?",
      "original_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over fiscal years 2022 and 2023 was $252 million.",
      "llm_answer": "Medtronic reported medical‑device‑regulation expenses of **$150 million for fiscal 2023** and **$102 million for fiscal 2022**. Combined, these charges reduced income before income taxes by **approximately $252 million** over the two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the medical device regulation expenses for both fiscal years 2022 ($102 million) and 2023 ($150 million), which match the ground truth values. The total impact of $252 million is accurately calculated by summing these two amounts. (2) All numeric values are correct and properly formatted; minor variations in presentation (e.g., $252 million vs $252M) are acceptable and do not affect accuracy. The calculation (150 + 102 = 252) is mathematically sound. (3) The reasoning is logically sound and demonstrates proper multi-hop synthesis by combining data from two fiscal years to arrive at the total financial impact. The model correctly identifies Medtronic as the company, the relevant fiscal years, and the correct financial metric (impact on income before income taxes). (4) All scores are 10 because the answer is factually accurate, complete, contextually relevant, and demonstrates correct reasoning with no errors in entities, numbers, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 290,
        "total_tokens": 1408
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How many different forms of Long-Term Incentive Restricted Stock Units, including both U.S. and International versions, are disclosed in Boeing's 2023 10-Q filings?",
      "original_answer": "Boeing disclosed four different forms of Long-Term Incentive Restricted Stock Units in their 2023 10-Q filings. These include: (1) U.S. Long-Term Incentive Restricted Stock Units (Exhibit 10.3), (2) U.S. Long-Term Incentive Performance Restricted Stock Units (Exhibit 10.5), (3) International Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.4), and (4) International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled) (Exhibit 10.6).",
      "llm_answer": "Boeing’s 2023 Form 10‑Q includes **nine distinct exhibit forms** that relate to Long‑Term Incentive Restricted Stock Units (LT‑RSUs), covering both U.S. and International versions, and including regular, CEO‑specific and performance‑based formats【page_127†L24-L38】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is significantly incorrect in terms of quantitative accuracy and completeness. The ground truth states that Boeing disclosed **four** different forms of Long-Term Incentive Restricted Stock Units in their 2023 10-Q filings, with specific breakdowns: two U.S. versions (regular and performance-based) and two International versions (both stock-settled, including performance-based). The LLM incorrectly claims there are **nine distinct exhibit forms**, which contradicts the verified data. This major numerical error undermines the core of the question. Additionally, the LLM introduces unverified categories such as 'CEO-specific' formats, which are not mentioned in the original answer or supported by the cited exhibit references. While the LLM correctly identifies the topic (LT-RSUs in Boeing’s 2023 10-Q) and acknowledges the U.S./International distinction, it fails to accurately enumerate the forms or reference the correct exhibits (10.3, 10.4, 10.5, 10.6). The citation [page_127†L24-L38] does not justify the claim of nine forms, suggesting either misinterpretation or hallucination. Multi-hop reasoning is flawed because the model did not correctly synthesize the disclosed forms from the exhibits. Thus, despite some contextual relevance, the answer is factually inaccurate on key points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 364,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "Given Apple's reliance on third-party developers and digital content providers for its product ecosystem, and considering the 12.9% year-over-year growth in Services revenue from 2022 to 2023, how might ongoing challenges in securing third-party software and content affect the sustainability of this growth trajectory for services like Apple Music?",
      "original_answer": "Apple's Services revenue grew from $78,129 million in 2022 to $85,200 million in 2023, representing a 12.9% increase. This growth includes revenue from services like Apple Music. However, the company's own disclosures indicate that its ability to maintain and grow this revenue depends on continued access to third-party software applications and digital content. Specifically, if developers choose not to maintain or update their applications due to Apple's minority market share or changes in App Store policies, or if content providers restrict access or raise costs, the attractiveness and functionality of Apple Music and other services could be compromised. This could lead to customer dissatisfaction and reduced demand, directly threatening the sustainability of the 12.9% growth rate seen in Services revenue.",
      "llm_answer": "Apple’s Services segment grew 12.9 % year‑over‑year (from $78.1 bn in 2022 to $85.2 bn in 2023) 【page_38】, but that growth rests heavily on the continued availability of third‑party apps, software and licensed digital content.  The 2023 filing notes that Apple “depends on the continued availability and development of compelling…software applications” and on “licensing…digital content…which can be short‑term and may not be renewed on commercially reasonable terms” 【page_13】; it also warns that failure to obtain or maintain these licenses could have a material adverse impact on the business.  Consequently, if developers pull back or content owners impose higher fees or restrict access, services such as Apple Music could lose key titles or features, dampening subscriber appeal and making the recent Services‑revenue growth harder to sustain.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Services revenue grew from $78.129 billion in 2022 to $85.200 billion in 2023, which is a 12.9% increase—correctly reported as $78.1bn and $85.2bn (acceptable rounding). (2) The answer correctly identifies the reliance on third-party developers and content providers, citing Apple's own risk disclosures about licensing digital content on short-term, non-renewable, or costly terms. (3) The multi-hop reasoning is sound: it connects the revenue growth to the dependency on external software and content, then logically infers that disruptions (e.g., developers withdrawing apps or content providers raising fees) could impair service quality (e.g., Apple Music losing titles), reduce subscriber appeal, and threaten sustained growth. (4) The answer cites specific risk factors from the 10-K (page 13 and page 38), aligning with the knowledge graph's sourcing. Wording differs but meaning is preserved, and all entities (Apple, Services revenue, Apple Music, third-party developers, content providers) are accurately referenced with correct years and metrics. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 344,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do MetLife's cash buffer needs, as influenced by reinsurance and derivative counterparty risks, affect its ability to manage liquidity under stress scenarios, particularly in light of the $12.4 billion short-term liquidity position at the end of 2021?",
      "original_answer": "MetLife maintains a $12.4 billion short-term liquidity position as of December 31, 2021, to manage business requirements under current and stress market conditions. However, its cash buffer needs are influenced by exposure to reinsurance and derivative counterparties, where failure to pay guaranteed benefits could result in liquidity strain. Although these agreements are largely collateralized and subject to netting agreements, which reduce counterparty risk, the potential ineffectiveness of hedging strategies or unexpected policyholder behavior combined with market volatility could exceed the risk management framework. This dynamic directly ties MetLife's cash buffer needs (as a capital risk factor) to its liquidity management strategy, where the $12.4 billion short-term liquidity buffer serves as a safeguard against such risks.",
      "llm_answer": "MetLife must keep a cash‑buffer to cover possible shortfalls if a reinsurer fails to pay or if a derivative counter‑party demands additional collateral; both of these exposures can tie up cash that would otherwise be free for other uses and therefore shrink the amount of unpledged liquidity available in a stress event. Nevertheless, the company’s short‑term liquidity pool of $12.4 billion at year‑end 2021 (plus $223 billion of overall liquid assets) and its practice of collateralizing reinsurance agreements and netting derivative positions are intended to absorb those buffer demands, allowing MetLife to meet its cash‑flow needs even under reasonably severe stress scenarios.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies MetLife's $12.4 billion short-term liquidity position as of year-end 2021, which matches the ground truth. It accurately describes how reinsurance and derivative counterparty risks influence cash buffer needs by potentially tying up liquidity during stress scenarios. The mention of collateralization and netting agreements aligns with the original answer’s point about risk mitigation. However, the LLM introduces a figure of '$223 billion of overall liquid assets' that is not present in the original answer or implied by the knowledge graph; this is a factual addition not supported by the ground truth and could mislead. 2) Quantitatively, the $12.4 billion figure is correct in amount and date. The $223 billion figure lacks verification from the original answer and appears to be either hallucinated or pulled from external context not provided, which reduces quantitative accuracy slightly. No calculations are performed, so no errors there. 3) The reasoning is sound: the model correctly synthesizes the relationship between counterparty risk (reinsurance and derivatives), cash buffer demands, and liquidity management under stress. It captures the multi-hop logic—how structural protections (collateral, netting) help manage risk and support the adequacy of the $12.4 billion buffer. The only gap is overemphasizing unverified asset totals, which slightly weakens the qualitative accuracy. 4) Despite the extraneous $223 billion figure, the answer remains highly relevant and focused on the core question about how cash buffer needs interact with liquidity under stress. The core message aligns semantically with the original: MetLife’s liquidity buffer is designed to withstand counterparty-related stresses due to risk controls. The score is reduced slightly due to the unsupported number, but the essential multi-hop reasoning and factual core are intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 513,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What is the total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, and how are these securities classified on the balance sheet according to the 2023 10-K filing?",
      "original_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is $33 million, and these securities are classified under 'Other Assets' on the balance sheet.",
      "llm_answer": "As of April 26 2024, Medtronic’s Level 3 auction‑rate securities had a fair‑value of **$33 million**. On the balance sheet they are **recorded as “Other assets”** (they are not shown under investments).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total fair value of Level 3 auction rate securities as $33 million as of April 26, 2024, which matches the ground truth. It also accurately states that these securities are classified under 'Other assets' on the balance sheet, consistent with the original answer. (2) The numeric value ($33 million) is correct and presented in an acceptable format (bolded but semantically equivalent). The date (April 26, 2024) is correctly stated. (3) The reasoning is sound and reflects proper synthesis from the 2023 10-K filing, correctly interpreting both the valuation level (Level 3) and classification of the securities. The clarification that they are not shown under investments adds contextual accuracy without contradicting the ground truth. (4) All aspects—factual, quantitative, and qualitative—are accurate and fully aligned with the question's requirements. The answer is complete, precise, and contextually appropriate, warranting top scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1108,
        "completion_tokens": 295,
        "total_tokens": 1403
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact the recognition and measurement of credit losses on mortgage loans and fixed maturity securities AFS, based on the impairment losses reported for 2019 and the ACL methodologies described?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition and measurement of credit losses from an incurred loss model to an expected lifetime credit loss model. For fixed maturity securities AFS, the impairment (loss) for foreign government, consumer corporate, industrial corporate, RMBS, and finance corporate securities in 2019 were ($81) million, ($23) million, ($22) million, ($2) million, and ($1) million, respectively, under the prior OTTI model. After adoption, impairment (loss) was comprised of intent-to-sell and direct write-down losses, rather than OTTI and intent-to-sell losses. For mortgage loans, the ACL is now established based on expected lifetime credit losses over the contractual term, adjusted for expected prepayments and extensions, incorporating past events, current conditions, and forecasted economic conditions. This represents a shift from the previous model where credit loss was recognized only when it was probable that all amounts due would not be collected.",
      "llm_answer": "The January 1 2020 adoption replaced the “other‑than‑temporary‑impairment” (OTTI) approach with an allowance‑for‑credit‑loss (ACL) model that records an allowance for the expected lifetime loss on both mortgage loans and Fixed‑Maturity Securities AFS, using judgment about pre‑payments, economic forecasts and discounted‑cash‑flow recoveries (see page 69 for mortgage loans and page 68 for Fixed‑Maturity Securities).  Consequently, the 2019 OTTI loss on Fixed‑Maturity Securities AFS of $129 million was restated as an “impairment (loss)” and, under the new ACL method, the 2020 impairment fell to $63 million (page 241), while mortgage‑loan losses moved from a $11 million loss in 2019 to a $213 million loss in 2020 (page 240), reflecting the shift to upfront expected‑loss recognition.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies the shift from OTTI to the ACL model based on expected lifetime credit losses (contextually relevant and qualitatively sound on the conceptual change), it fabricates or misrepresents key financial figures. The original answer reports 2019 impairment losses for specific AFS securities totaling $129 million in aggregate (e.g., $81M for foreign government, $23M consumer corporate, etc.), which the LLM correctly sums as $129 million. However, the LLM then claims that 'under the new ACL method, the 2020 impairment fell to $63 million' and that mortgage loan losses increased from $11M in 2019 to $213M in 2020 — these numbers are not present in the original answer and cannot be verified from the provided ground truth. The original answer does not provide any 2020 impairment amounts post-adoption, nor does it mention a $213 million mortgage loan loss or a drop to $63 million. Thus, the quantitative accuracy is low due to unsupported numerical claims. Additionally, the LLM introduces 'page 240' and 'page 241' references not present in the original, suggesting potential hallucination. While the qualitative shift in methodology is described reasonably well — including the use of forecasts, prepayments, and expected losses — the answer fails to describe the specific ACL methodology components mentioned in the original (e.g., contractual term adjusted for prepayments and extensions, incorporating past events, current conditions, and forecasts). The reasoning is partially sound but lacks fidelity to the source data. The answer is contextually relevant and addresses both mortgage loans and AFS securities, but the inclusion of fabricated post-adoption figures severely compromises factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 495,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does Lockheed Martin's obligation to provide consulting support under international offset agreements impact its ability to recover costs on U.S. government contractual commitments in 2024?",
      "original_answer": "Lockheed Martin's international offset agreements, which may include obligations to provide consulting support to in-country projects, require cash outlays and investments that are often outside the company’s control, such as those tied to joint ventures. These investments are only recoverable if the joint ventures operate successfully. Simultaneously, Lockheed Martin has $64.3 billion in purchase obligations related to U.S. government contracts, where cost recovery is only guaranteed if the government terminates the contract for convenience under the FAR. Therefore, if Lockheed Martin incurs significant costs fulfilling consulting support obligations under offset agreements but cannot recover those costs through successful joint ventures or offset reimbursements, it may not be able to recover those expenses under U.S. government contracts unless those contracts are terminated for convenience. This creates a financial risk in cost recovery when international obligations do not align with domestic reimbursement mechanisms.",
      "llm_answer": "Lockheed Martin’s offset agreements with foreign customers require it to provide in‑country consulting support (along with other technology‑transfer and investment activities) that is built into the “total cost to complete” estimates for those contracts (see page 16). Because those consulting‑support costs are part of the offset obligations and are not always allowable under FAR cost‑allowability rules, they reduce the amount of expense that can be charged to U.S. government contracts, limiting the company’s ability to recover those costs in 2024 (see page 45).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key elements of the multi-hop reasoning required by the question. (1) It correctly identifies that Lockheed Martin's offset obligations (including consulting support) are not always allowable under FAR rules and thus cannot be charged to U.S. government contracts, which limits cost recovery—this aligns with the ground truth. However, it omits the critical financial risk arising from the $64.3 billion in U.S. government purchase obligations, where cost recovery is only guaranteed upon termination for convenience. This quantitative detail is central to the original answer and was not mentioned, though no incorrect numbers were presented. (2) Quantitative accuracy is perfect: no numerical claims were made that contradict the ground truth, and the absence of the $64.3B figure does not introduce inaccuracy—just incompleteness. (3) The reasoning is sound within its scope but fails to synthesize across both international offset risks and domestic U.S. government contract limitations. The original answer hinges on the misalignment between non-recoverable offset costs and constrained recovery mechanisms on $64.3B in contracts—a core multi-hop link the LLM answer does not make. (4) Contextual relevance is high because the response directly addresses the mechanism (FAR cost allowability) that limits cost recovery. However, the omission of the scale of U.S. contractual exposure significantly weakens the completeness and qualitative accuracy. Thus, while the logic is valid, it provides an incomplete picture of the financial risk, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 443,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did TMO's pharma services business drive segment revenue and margin performance in 2021, considering both pandemic-related demand and the impact of inventory accounting changes?",
      "original_answer": "TMO's pharma services business significantly contributed to segment revenue and margin performance in 2021. The business experienced increased demand, particularly driven by its role in supporting customers with vaccine and therapy development during the ongoing COVID-19 pandemic. This led to strong sales growth and a positive sales mix, which boosted segment income margins. Additionally, a $20 million credit to cost of product revenue, resulting from a change in inventory accounting method, further improved margins. However, this positive impact was partially offset by strategic growth investments. Together, pandemic-related demand and the inventory accounting change were key contributors to the segment's financial performance.",
      "llm_answer": "In 2021 the Laboratory Products & Biopharma Services segment grew revenue 21% to $14.9 billion, largely because its pharma‑services business captured heightened pandemic‑related demand for vaccine‑ and therapy‑development work. That surge in higher‑margin services lifted the segment’s income margin from 10.4% to 12.4%, a gain that was further bolstered by a $20 million credit to cost of product revenue from a change in inventory accounting (which reduced product‑cost expense and helped offset strategic‑investment outlays).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key drivers of TMO's pharma services business in 2021—pandemic-related demand and the $20 million inventory accounting change—and accurately describes their positive impact on revenue and margins. All quantitative figures are correct: 21% revenue growth to $14.9 billion, margin increase from 10.4% to 12.4%, and the $20 million credit. These match the ground truth contextually and numerically, even though the original answer does not explicitly state the 21% growth or $14.9 billion figure. However, since the ground truth does not contradict these numbers and they align with the described strong sales growth and margin improvement, their inclusion is acceptable and likely inferred from external data consistent with the knowledge graph. (2) Quantitative accuracy is perfect: percentages, dollar amounts, and margin changes are correctly stated and internally consistent. The $20 million credit is accurately described as reducing cost of product revenue, which improves margins. (3) Multi-hop reasoning is sound: the model synthesizes pandemic-driven demand, its effect on sales mix and margins, the accounting change, and the offsetting effect of strategic investments. The logic flow connecting these elements is coherent and matches the causal relationships in the ground truth. (4) The only minor gap is that the LLM answer refers to the 'Laboratory Products & Biopharma Services' segment, while the original answer focuses specifically on the pharma services business within it. However, this is a reasonable aggregation, and the core facts about the pharma services driver are preserved. The answer is fully contextually relevant, addressing both parts of the question: pandemic demand and inventory accounting impact. Thus, the answer is factually excellent with only slight abstraction in segment labeling, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 523,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does MetLife's participation in Supervisory Colleges, both in the U.S. and Europe, influence its regulatory oversight and risk profile given the involvement of NYDFS and EIOPA?",
      "original_answer": "MetLife's participation in Supervisory Colleges in both the U.S. and Europe enhances regulatory oversight and shapes its risk profile through coordinated supervision. In the U.S., the NYDFS annually chairs Supervisory College meetings attended by MetLife's key U.S. and non-U.S. regulators, facilitating cooperation and coordination among insurance supervisors to better understand the risk profile of MetLife's international operations. Similarly, in Europe, EIOPA requires European regulators, such as the Central Bank of Ireland, to establish Supervisory Colleges for EEA-based insurance groups with significant European operations like MetLife. These colleges enhance understanding of the group's risk profile through collaboration among European supervisors. This dual participation ensures that both U.S. and European regulators have a comprehensive view of MetLife's operations and risk exposures, thereby influencing its regulatory environment and risk management practices.",
      "llm_answer": "MetLife’s lead regulator, the New York Department of Financial Services (NYDFS), chairs a U.S. Supervisory College that brings together the NYDFS and the other state and federal supervisors of MetLife’s U.S. and non‑U.S. insurers, giving regulators a “group‑wide” view of the company’s operations, capital, reserves and risk‑management practices. In Europe, EIOPA and the relevant national supervisors (e.g., the Central Bank of Ireland) have created a European Supervisory College for MetLife’s EEA‑based businesses, which coordinates oversight and shares information so that European regulators can more fully assess the group’s risk profile. Together, these colleges deepen regulatory scrutiny and promote coordinated supervision, thereby shaping MetLife’s risk‑management framework and potentially influencing capital and reserve requirements across both jurisdictions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NYDFS chairs the U.S. Supervisory College involving U.S. and non-U.S. regulators, and EIOPA collaborates with national regulators like the Central Bank of Ireland to form a European Supervisory College for MetLife’s EEA-based operations. Both colleges enhance regulatory coordination and risk assessment. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes MetLife’s regulatory environment across U.S. and European jurisdictions, linking NYDFS and EIOPA roles to group-wide supervision and risk management. The only minor omission is that the original answer specifies NYDFS holds these meetings annually, which the LLM answer does not mention—this slight lack of detail prevents a perfect 10 on qualitative accuracy. (4) The response is fully contextually relevant, directly addressing how participation in both colleges influences regulatory oversight and risk profile through coordinated supervision. Overall, the LLM captures the essence and factual basis of the ground truth with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 362,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, impact Citi's Net Income in 2024, and what was the resulting percentage change in total Net Income?",
      "original_answer": "The reduction in the ACL build for transfer risk outside the U.S., driven by U.S. banking law, contributed to a lower provision expense of $295 million in 2024 compared to $406 million in the prior year. This $111 million decrease in provision expense positively impacted Net Income, which increased by 27% to $4.9 billion in 2024.",
      "llm_answer": "The lower ACL build – the net ACL build fell to $228 million in 2024 from $910 million a year earlier, mainly because the transfer‑risk provision for exposures outside the United States was sharply reduced under U.S. banking‑law safety‑and‑soundness rules 【page_20】 – cut credit‑loss expense and helped lift Citi’s 2024 net income to $4.93 billion.  That earnings increase translated into a **27 % rise in total net income** compared with 2023 【page_21】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 27% increase in total net income and the resulting $4.93 billion net income in 2024, which aligns closely with the ground truth value of $4.9 billion. However, the LLM cites a net ACL build of $228 million in 2024 and $910 million in the prior year, implying a decrease of $682 million in ACL build, whereas the ground truth states a lower provision expense of $295 million in 2024 vs. $406 million in 2023 — a $111 million decrease. These figures are materially different and not reconcilable, indicating a quantitative discrepancy. (2) The calculation of the impact on net income is not directly verifiable from the LLM’s numbers, and the $111 million decrease in provision expense (ground truth) is not reflected in the LLM’s narrative. The LLM’s use of $228M and $910M may reflect gross vs. net provision differences or misinterpretation of the filing, but it leads to a significant numerical inconsistency. (3) The multi-hop reasoning is otherwise sound: the LLM correctly attributes the reduced ACL build to U.S. banking law affecting transfer risk outside the U.S., links this to lower credit loss expense, and connects it to the 27% increase in net income — which matches the ground truth percentage and final income figure (within rounding). (4) Despite the incorrect intermediate ACL figures, the final outcome (27% increase, ~$4.9B net income) is accurate, and the causal logic is preserved. Hence, the answer is substantially correct in outcome and reasoning but flawed in key quantitative details, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 439,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "Given that Lockheed Martin's FMS sales account for 73% of its international sales and the U.S. government may face funding disruptions due to the debt ceiling expiration in mid-January 2025, how might these potential disruptions specifically affect Lockheed Martin's Aeronautics segment, considering that international customers accounted for 32% of its net sales in 2024 and the F-35 program involves commitments from twelve FMS customers?",
      "original_answer": "Lockheed Martin's Aeronautics segment, which saw 32% of its 2024 net sales come from international customers, is significantly exposed to potential U.S. government funding disruptions due to the debt ceiling expiration. Since 73% of Lockheed Martin's international sales are conducted through FMS contracts with the U.S. government, any delay or reduction in U.S. defense funding could directly impact FMS orders for programs like the F-35, which has commitments from twelve FMS customers. This could result in delayed or reduced production schedules for the F-35, a key international platform, thereby affecting the Aeronautics segment’s revenue and margins. Given the long-cycle nature of defense contracts, such disruptions could have a prolonged effect on Lockheed Martin’s financial performance.",
      "llm_answer": "If a debt‑ceiling impasse forces the U.S. government to delay or curtail defense appropriations, the foreign‑military‑sales (FMS) contracts that fund most of Lockheed’s international business could become unfunded or postponed. Because ≈73 % of Lockheed’s international sales are FMS and 32 % of Aeronautics net sales come from overseas customers—including the F‑35 program, which relies on commitments from twelve FMS nations—any U.S. funding gap would likely delay F‑35 deliveries, reduce funded backlog, and depress Aeronautics revenue and cash flow in the near term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: 73% of Lockheed Martin's international sales are through FMS, 32% of Aeronautics net sales come from international customers, and the F-35 program has commitments from twelve FMS customers. These numbers match the ground truth exactly. (2) Quantitative accuracy is perfect—percentages (73%, 32%), the number of FMS customers (12), and the time context (implied 2024 data) are all accurate. No calculations are required, but the use of approximation symbol (≈) before 73% is acceptable and does not misrepresent the data. (3) The multi-hop reasoning is sound: the model correctly links U.S. government funding disruptions due to the debt ceiling → impact on FMS appropriations → effect on Lockheed’s international sales → specific impact on the F-35 program and Aeronautics segment revenue, backlog, and cash flow. It captures the causal chain and segment-level implications. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'prolonged effect' due to the 'long-cycle nature of defense contracts,' which is a nuance present in the original answer. However, the mention of reduced backlog and near-term revenue impact implies ongoing consequences. Otherwise, the semantic meaning and factual content are equivalent. Contextual relevance is full—every part of the question is addressed with precise, focused reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 393,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How many shares of common stock were available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and its related plans as of December 31, 2023, and how does this compare to the number of shares underlying stock options assumed through acquisitions?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan for future awards. Additionally, 17 million shares were available for future issuance under the ESPP, bringing the total to 70 million shares. Separately, 191,000 shares were underlying stock options assumed through acquisitions. Therefore, the total shares available for future issuance under the active plans was significantly larger than the assumed stock options from acquisitions.",
      "llm_answer": "As of December 31 2023, UnitedHealth Group had **about 70 million shares of common stock** still available for future issuance under its shareholder‑approved equity compensation plans – 53 million of those were reserved for the 2020 Stock Incentive Plan and another 17 million for the 1993 Employee Stock Purchase Plan. By contrast, the company only had **approximately 191,000 shares** of common stock underlying stock options that were assumed in connection with acquisitions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 53 million shares under the 2020 Stock Incentive Plan, 17 million under the ESPP (specifically named as the 1993 Employee Stock Purchase Plan, which aligns with UnitedHealth's actual plan), totaling approximately 70 million shares available for future issuance. The 191,000 shares underlying assumed stock options from acquisitions are also correctly reported. (2) The calculations and comparisons are sound: the total of 70 million is correctly implied as the sum of 53M and 17M, and the contrast with the much smaller 191,000 assumed options is accurately presented. (3) Multi-hop reasoning is properly executed: the answer synthesizes data from two different plans (2020 SIP and ESPP) and contrasts them with a separate pool of acquisition-related options, which requires correct identification and segregation of distinct share pools. (4) Entity accuracy is perfect: UnitedHealth Group is correctly identified, the plan names and years are accurate, and the time reference (December 31, 2023) is preserved. (5) The semantic meaning and completeness fully match the original answer, with slightly enhanced clarity in naming the ESPP. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 365,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What is the total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards, and how does this compare to the total unrecognized compensation cost as of November 3, 2024?",
      "original_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards is $1,746 million ($794 million in 2022 + $596 million in 2023 + $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was $11,259 million. This indicates that the majority of the compensation cost associated with these awards is yet to be recognized over the remaining weighted-average service period of 3.0 years.",
      "llm_answer": "The Multi‑Year Equity Awards generated **$356 million (2024) + $596 million (2023) + $794 million (2022) = $1.746 billion** of stock‑based compensation expense.  \n\nAs of November 3 2024, the company reported **$11.259 billion** of total unrecognized compensation cost for all unvested stock‑based awards.  \n\nThus, the expense recognized for the Multi‑Year Equity Awards over the three‑year period is roughly **15 %** of the remaining unrecognized compensation cost.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $794 million (2022), $596 million (2023), and $356 million (2024) are correctly summed to $1,746 million (expressed as $1.746 billion, which is semantically equivalent). The unrecognized compensation cost of $11,259 million is correctly reported as $11.259 billion. (2) The calculation of the sum is accurate and explicitly shown. (3) The multi-hop reasoning is sound: the model correctly aggregates compensation expense across three fiscal years for the Multi-Year Equity Awards and compares it to the total unrecognized cost as of a specific date, synthesizing information that spans multiple reporting periods and award types. (4) The LLM adds value by computing the percentage ($1.746B / $11.259B ≈ 15%), which is a reasonable interpretation and enhances the comparison without distorting the facts. All entities (Multi-Year Equity Awards, fiscal years 2022–2024, unrecognized cost as of November 3, 2024) are correctly identified and used. The answer is complete, factually precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 322,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total minimum LTD requirement for Citi in 2024 as a percentage of RWA, and how is this value calculated based on the components described in the TLAC section?",
      "original_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of RWA. This is calculated by adding Citi's capital surcharge under method 2 of the GSIB surcharge rule (3.5%) to the base minimum LTD requirement of 6% of RWA.",
      "llm_answer": "Citi’s binding minimum long‑term debt (LTD) requirement for 2024 is **9.5 % of its consolidated risk‑weighted assets (RWA)**. The figure is derived by taking the base component of **6 % of RWA** and adding the GSIB surcharge calculated under method 2 ( 3.5 % for Citi in 2024 ), giving 6 % + 3.5 % = 9.5 % of RWA, which exceeds the alternative benchmark of 4.5 % of total leverage exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total minimum LTD requirement for Citi in 2024 as 9.5% of RWA, which matches the ground truth. It accurately breaks this down into the base requirement of 6% and the GSIB surcharge under method 2 of 3.5%, with the correct calculation (6% + 3.5% = 9.5%). All numeric values and the year 2024 are correct. (2) Quantitative accuracy is perfect: percentages are correctly stated and summed; the addition is accurate. Format variations (e.g., spacing in '9.5 %') do not affect meaning. (3) The reasoning is sound and reflects proper multi-hop synthesis: combining the base LTD requirement with the GSIB surcharge from the TLAC framework. The mention of the alternative benchmark (4.5% of leverage exposure) adds context not required by the question but does not detract from correctness. (4) The answer is semantically equivalent to the ground truth and fully addresses both parts of the question: the total percentage and its calculation. The only minor point reducing qualitative accuracy slightly is the inclusion of extra information (leverage exposure benchmark) that, while accurate, is not asked for and could distract if incorrect. However, it does not undermine the core correctness. Scores reflect high accuracy with near-perfect reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 367,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade, and how does the pattern of annual increases from 2025 to 2029 inform the trend in pension obligations?",
      "original_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade is $19,510 million. This includes $1,800 million in 2025, increasing to $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, $1,990 million in 2029, and $9,990 million from 2030 to 2034. The annual increases from 2025 to 2029 show a consistent upward trend, indicating a growing financial obligation in the near term before a larger, cumulative payment in the final five years.",
      "llm_answer": "Lockheed Martin projects that its qualified defined‑benefit pension plans will require about **$19.5 billion** in benefit payments from 2025 through 2034 (the sum of $1.8 bn + $1.86 bn + $1.91 bn + $1.96 bn + $1.99 bn for 2025‑2029 plus $9.99 bn for 2030‑2034).  \n\nFrom 2025 to 2029 the annual payment amount rises each year (‑ $60 m from 2025‑26, then $50 m, $50 m and $30 m), showing a **steady upward trend** in pension obligations, though the incremental increase modestly tapers as the decade progresses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values are correct: $1.8B (2025), $1.86B (2026), $1.91B (2027), $1.96B (2028), $1.99B (2029), and $9.99B (2030–2034) sum to $19.51B, which matches the ground truth total of $19,510 million ($19.51 billion). The formatting variation (e.g., $19.5 billion vs $19,510 million) is acceptable. (2) Calculations are accurate: the incremental increases of $60M (2025–2026), $50M (2026–2027), $50M (2027–2028), and $30M (2028–2029) are correctly derived and described as a tapering upward trend. (3) The multi-hop reasoning is sound—information across years and segments (2025–2029 vs 2030–2034) is correctly synthesized. (4) The qualitative assessment of a 'steady upward trend' with a 'modestly tapering' increase is consistent with the ground truth’s 'consistent upward trend' and adds slightly more nuance. The only minor shortcoming is the omission of explicitly stating that the $9.99 billion covers five years (2030–2034), though this is implied. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 322,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "What was the total combined value of Mortgage/Asset-backed securities held by Honeywell in both 2020 and 2021, and how did this investment category rank in terms of proportion to total fixed income investments in each year?",
      "original_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell in 2020 and 2021 was $1,072 million + $982 million = $2,054 million. In 2020, Mortgage/Asset-backed securities represented approximately 8.1% of total fixed income investments ($982 million / $12,106 million total fixed income). In 2021, this category represented approximately 8.9% of total fixed income investments ($1,072 million / $12,041 million total fixed income).",
      "llm_answer": "Honeywell’s mortgage‑ and asset‑backed securities totaled **$1.075 billion in 2020** (U.S. $982 m + Non‑U.S. $93 m) and **$1.151 billion in 2021** (U.S. $1,072 m + Non‑U.S. $79 m).  \n\nThese holdings represented **about 5.5 % of total fixed‑income assets in 2020 (≈$1,075 m / $19,598 m)** and **about 5.7 % in 2021 (≈$1,151 m / $20,155 m)**, making mortgage/asset‑backed securities the **smallest‑weighted fixed‑income category** (lowest proportion) in both years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both values and calculations. According to the ground truth, Honeywell held $1,072 million in 2021 and $982 million in 2020 in Mortgage/Asset-backed securities, totaling $2,054 million. The LLM incorrectly reports $1.075 billion (i.e., $1,075 million) for 2020 and $1.151 billion ($1,151 million) for 2021, reversing the years and using incorrect totals. The LLM appears to have added U.S. and Non-U.S. components incorrectly—assigning $982m to 2020 U.S. and $1,072m to 2021 U.S., but then mislabeling the years in the summary. (2) The percentages are also wrong: the LLM calculates 5.5% for 2020 and 5.7% for 2021 using incorrect total fixed income figures ($19.6B and $20.2B), whereas the ground truth uses $12,106 million (2020) and $12,041 million (2021). Correct percentages are ~8.1% (2020) and ~8.9% (2021). The LLM’s totals and denominators are factually incorrect. (3) The multi-hop reasoning fails: the model must correctly identify the security type, extract values for two years, sum them, and compute proportions relative to total fixed income. The LLM uses wrong years, wrong numerators, and wrong denominators. It also incorrectly concludes this category was the 'smallest-weighted'—a claim not supported by the ground truth, which does not provide ranking data. (4) Contextual relevance is moderate—it addresses the right company and investment category and attempts both parts of the question. However, due to severe quantitative and qualitative errors, the answer is largely incorrect. Minor credit is given for attempting the right structure and using plausible financial logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 455,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Broadcom's shift from annual equity awards to multi-year awards with 4-7 year vesting periods affect its stock-based compensation expense recognition pattern?",
      "original_answer": "Broadcom's shift from annual equity awards to multi-year equity awards changes the stock-based compensation expense recognition pattern by extending the recognition period from a 4-year vesting cycle per annual grant to a longer 7-year period in total for the multi-year awards. Previously, annual grants were issued each year and recognized over 4 years. Now, the Multi-Year Equity Awards encompass four annual grant cycles into one award, with compensation expense recognized from the grant date through the vesting date, which spans up to 7 years. This change results in a more prolonged and overlapping expense recognition timeline compared to the prior annual model.",
      "llm_answer": "Broadcom replaced its once‑a‑year equity awards with “Multi‑Year Equity Awards” that vest over four to seven years. Consequently, stock‑based compensation expense is now recorded from the grant date through the entire vesting period rather than being concentrated in a single fiscal year, spreading the expense over multiple years and leaving a larger unrecognized compensation‑cost balance on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core change in Broadcom's stock-based compensation expense recognition pattern. It correctly identifies the shift from annual equity awards to Multi-Year Equity Awards with 4- to 7-year vesting periods (quantitatively accurate: matches the 7-year maximum vesting in the ground truth). The explanation that expenses are now recognized from grant date through the full vesting period, spreading costs over multiple years, aligns with the ground truth's description of a prolonged and overlapping recognition timeline. The mention of a larger unrecognized compensation cost on the balance sheet is a reasonable inference, though not explicitly stated in the original answer. The only minor shortcoming is that the LLM does not explicitly mention that the multi-year awards consolidate four annual grant cycles into one award, which is a key structural detail in the ground truth. However, the overall reasoning is sound, entities (Broadcom, Multi-Year Equity Awards) are correct, and the answer fully addresses the question about the impact on expense recognition pattern. Semantic equivalence is achieved with slightly less detail on the multi-grant consolidation aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 342,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does the application of U.S. banking law specifically influence the credit loss provisions in both Legacy Franchises and the Markets segment, and what is the combined impact on Citi's total provision for credit losses in 2024?",
      "original_answer": "The application of U.S. banking law led to a smaller ACL build for transfer risk associated with exposures outside the U.S. in both Legacy Franchises and the Markets segment. In Legacy Franchises, this contributed to a decrease in provisions from $1.3 billion in 2023 to $1.1 billion in 2024. In the Markets segment, it contributed to a lower net ACL build of $295 million compared to $406 million in the prior year. The combined impact of these reductions under U.S. banking law contributed to a total provision decrease from $1.738 billion in 2023 ($1.3 billion + $438 million) to $1.563 billion in 2024 ($1.1 billion + $463 million), a reduction of $175 million.",
      "llm_answer": "U.S. banking‑law safety‑and‑soundness rules require a smaller allowance‑for‑credit‑loss (ACL) build for “transfer‑risk” exposures that lie outside the United States; that rule trimmed the ACL build – and therefore the provision – for both the Legacy Franchises (included in All Other, managed‑basis) and the Markets businesses in 2024. The two segments together accounted for a $1.1 billion provision in All Other (Legacy Franchises) plus a $463 million provision in Markets, yielding a combined 2024 credit‑loss provision of roughly **$1.56 billion**.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the influence of U.S. banking law on credit loss provisions in both Legacy Franchises and the Markets segment, noting the reduced ACL build due to transfer risk for non-U.S. exposures. It accurately reports the 2024 provisions: $1.1 billion for Legacy Franchises and $463 million for Markets, aligning with the ground truth. The combined total of $1.56 billion is correct and matches the ground truth calculation ($1.1B + $463M = $1.563B, rounded appropriately). However, the LLM omits the 2023 figures and the year-over-year change, which are key to fully answering the question about the 'combined impact' on Citi's total provision. Specifically, it fails to mention the 2023 total of $1.738 billion or the $175 million reduction, which is a significant part of the original answer. (2) Quantitatively, all provided numbers are accurate: $1.1B (Legacy Franchises 2024), $463M (Markets 2024), and the sum of $1.563B (correctly rounded to $1.56B). The ground truth confirms these values. However, the absence of prior-year data and the delta reduces completeness. (3) The reasoning is sound in linking U.S. banking law to reduced ACL builds and lower provisions, and the synthesis across segments is correct. But the multi-hop aspect—comparing 2023 to 2024 and deriving the combined impact—is incomplete, as the LLM only reports 2024 outcomes without the change. (4) The answer is highly contextually relevant, using correct entities (Legacy Franchises, Markets, ACL, transfer risk, U.S. banking law) and correct financial terminology. The omission of comparative data prevents a higher score, but core facts are accurate and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 462,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "What was the total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021, and what percentage of the total assets at fair value did this combined amount represent?",
      "original_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021 was $1,458 million ($767 million in 2020 + $691 million in 2021). This represented approximately 8.66% of the total assets at fair value across both years ($1,458 million ÷ ($8,450 million + $8,396 million)).",
      "llm_answer": "The Honeywell UK pension scheme held **$691 million** of insurance‑buy‑in contracts at 12/31/2021 and **$767 million** at 12/31/2020, for a combined total of **$1.458 billion**.  Together these contracts represent roughly **8.7 %** of the combined fair‑value assets of the non‑U.S. pension plans for the two years ($1.458 billion ÷ ($8,396 million + $8,450 million) ≈ 8.7%).【page_112】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values for insurance buy-in contracts in 2020 ($767 million) and 2021 ($691 million) are accurate, and their sum ($1.458 billion or $1,458 million) is correctly calculated. The total fair value of assets for the two years ($8,450 million in 2020 and $8,396 million in 2021) is correctly used in the denominator. The percentage calculation is accurate: $1,458 million ÷ ($8,450 million + $8,396 million) = $1,458 million ÷ $16,846 million ≈ 8.655%, which rounds to 8.7% as stated (equivalent to the ground truth's 8.66% when rounded differently). (2) The answer is complete, addressing both parts of the question: the total value across two years and the percentage of total assets at fair value. (3) Entity accuracy is correct: HON (Honeywell) is properly identified, and the context of Non-U.S. Plans (specifically the UK pension scheme) is appropriate. (4) The multi-hop reasoning—aggregating values across years and calculating a percentage of total assets—is sound and clearly explained. (5) Semantic equivalence is maintained: dollar amounts are presented in consistent formats (million vs. billion), and the slight difference in rounding (8.7% vs. 8.66%) does not affect factual correctness. The citation to page_112 adds contextual support.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 374,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does Broadcom's (AVGO) emphasis on internal research and development, as part of its broader business strategy, influence its semiconductor segment's ability to maintain technology leadership in AI-related markets?",
      "original_answer": "Broadcom's focus on internal research and development plays a central role in maintaining its technology leadership in semiconductor markets, particularly in AI-related applications. The company explicitly states that its strategy involves 'extensive internal research and development' to ensure its products retain their technology market leadership. This R&D emphasis directly supports its semiconductor solutions segment, which includes products used in AI networking and connectivity. By investing in R&D, Broadcom is able to develop high-performance semiconductor devices such as complex digital and mixed-signal CMOS-based devices and analog III-V based products like gallium arsenide (GaAs) and indium phosphide (InP), which are critical for high-speed RF and optoelectronic applications in AI systems. This innovation enables Broadcom to deliver category-leading infrastructure technology products to major business and government customers, reinforcing its competitive edge in AI-driven markets.",
      "llm_answer": "Broadcom’s strategy links “extensive internal research and development” directly to preserving technology‑market leadership. The company channels R&D dollars into designing high‑capacity, low‑latency Ethernet switching, routing and custom ASIC platforms that are optimized for AI data‑center and high‑performance‑computing workloads. That internal innovation pipeline lets the semiconductor segment continuously launch cutting‑edge silicon that meets the rapidly growing bandwidth and compute demands of AI applications, keeping Broadcom at the forefront of AI‑related markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth. It correctly identifies Broadcom's (AVGO) emphasis on 'extensive internal research and development' as a strategic driver for maintaining technology leadership, particularly in AI-related semiconductor markets. The answer accurately reflects that R&D investments are directed toward high-performance products such as Ethernet switching, routing, and custom ASICs tailored for AI data centers and high-performance computing—applications that demand high bandwidth and low latency. While the original answer includes more technical detail about specific semiconductor technologies (e.g., CMOS, GaAs, InP), the LLM response captures the functional outcome of R&D (cutting-edge silicon for AI workloads) and correctly links internal innovation to market leadership. There are no numeric values in either response, so quantitative accuracy is not applicable but assumed perfect. The reasoning is sound and multi-hop: it connects Broadcom's R&D strategy to its semiconductor segment and then to AI market competitiveness. The only minor shortcoming is the omission of specific material technologies mentioned in the ground truth, which slightly reduces qualitative completeness but does not undermine the core correctness. Contextual relevance is excellent, as the response directly addresses how R&D influences technology leadership in AI-related markets.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 395,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "What is the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements, and how does this compare to the total advance payments made under its multi-year capacity purchase commitments as of September 29, 2024?",
      "original_answer": "Qualcomm is expected to pay $9.6 billion in the next 12 months under its purchase agreements, which primarily relate to integrated circuit product inventory obligations. This amount is part of the total $12.8 billion in obligations under purchase agreements. The total advance payments made under multi-year capacity purchase commitments as of September 29, 2024, were $3.0 billion. Therefore, the amount expected to be paid in the next 12 months is significantly higher than the advance payments made, indicating a substantial upcoming cash outflow relative to the prepayments already made.",
      "llm_answer": "Qualcomm’s purchase‑agreement obligations total $12.8 billion, of which **$9.6 billion is expected to be paid in the next 12 months** (Note 8, page 82).  The company has already recorded **$3.0 billion in advance payments** for its multi‑year capacity‑purchase commitments as of September 29, 2024 (same note, page 82).  Thus, the amount slated for payment over the coming year is about **$6.6 billion greater—more than three times—the total advance payments already made.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Qualcomm expects to pay $9.6 billion in the next 12 months under purchase agreements, which is part of a total $12.8 billion obligation, and $3.0 billion in advance payments were made under multi-year capacity purchase commitments as of September 29, 2024. These numbers match the original answer exactly. (2) The quantitative accuracy is perfect—values are correctly reported, and the comparison correctly calculates the difference as $6.6 billion ($9.6B - $3.0B). The statement that the upcoming payment is 'more than three times' the advance payments is also accurate (since $9.6B / $3.0B = 3.2x). (3) The multi-hop reasoning is sound: the model correctly synthesizes data from the same footnote (Note 8, page 82) to compare near-term obligations with prepayments. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that the $9.6 billion relates primarily to integrated circuit product inventory obligations—a detail present in the original answer. While this adds context, its omission does not undermine the core correctness. Overall, the answer is factually precise, contextually relevant, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 349,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "By how much did the GTN adjustment reductions for 2024 differ from those of 2023, and what was the specific non-U.S. factor that contributed to this change?",
      "original_answer": "The GTN adjustment reductions for 2024 were $159 million, compared to $134 million for 2023, resulting in a $25 million difference. The specific non-U.S. factor that contributed to this change was revisions in clawback amounts driven by VAT recoverable estimates.",
      "llm_answer": "The reductions to GTN‑adjustment provisions rose by **$25 million** in 2024 versus 2023 ($159 million vs. $134 million). Both years’ reductions were attributed to **non‑U.S. revisions of clawback amounts that stem from VAT‑recoverable estimates**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the GTN adjustment reductions for both 2024 ($159 million) and 2023 ($134 million), and accurately calculated the difference as $25 million. These figures match the ground truth exactly, with acceptable formatting (e.g., $159 million). (2) The non-U.S. factor cited — 'revisions of clawback amounts that stem from VAT-recoverable estimates' — is semantically equivalent to the ground truth's 'revisions in clawback amounts driven by VAT recoverable estimates.' The wording differs slightly but conveys the same causal mechanism. (3) The multi-hop reasoning is sound: the model correctly compared two years of financial data and attributed the change to a specific non-U.S. operational factor, synthesizing across time and geography as required. (4) The answer is fully contextually relevant and factually accurate. A score of 9 is given for correctness and qualitative accuracy due to minor phrasing differences in explaining the non-U.S. factor, but no factual errors exist. Quantitative accuracy is perfect, and contextual relevance is complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 312,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does Mastercard Send, as part of Mastercard's disbursements and remittances strategy, contribute to the company's broader objective of capturing new payment flows, and what specific partner ecosystems are leveraged to enable this capability according to the 2022 10-K filing?",
      "original_answer": "Mastercard Send contributes to the company's broader objective of capturing new payment flows by enabling consumers, businesses, governments, and nonprofits to send and receive money more efficiently, both domestically and across borders. This platform is a key component of Mastercard's disbursements and remittances strategy, which is explicitly tied to the company's goal of expanding multi-rail capabilities and applications to penetrate key flows. The platform leverages partnerships with central banks, fintechs, and financial institutions to help governments and nonprofits distribute social and economic assistance and facilitate business-to-consumer (B2C) disbursements, thereby enhancing the reach and utility of Mastercard's payment network.",
      "llm_answer": "Mastercard Send is the engine Mastercard uses to turn disbursements and remittances into a new, non‑card‑based payment flow, expanding its multi‑rail network and helping the company “capture new payment flows” 【page_8†L1-L4】.  The service works by embedding money‑movement capabilities inside consumer‑facing apps and by letting governments, NGOs and businesses push social‑aid or B2C payouts through a network of partners that includes digital‑messaging and payment platforms, central banks, fintech firms and other financial‑institution partners 【page_13†L4-L9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Mastercard Send as a key component of Mastercard's disbursements and remittances strategy aimed at capturing new payment flows by enabling efficient domestic and cross-border money movement. The explanation that it expands Mastercard's multi-rail network matches the original answer's emphasis on 'multi-rail capabilities and applications to penetrate key flows.' (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how Mastercard Send supports broader strategic objectives and identifies the relevant partner ecosystems. It accurately lists central banks, fintech firms, financial institutions, and adds 'digital-messaging and payment platforms,' which is consistent with the 2022 10-K's description (page 13) and complements the ground truth without introducing inaccuracies. (4) The only minor gap is that the LLM answer does not explicitly mention nonprofits (NGOs are referenced, which is semantically equivalent) or the specific use case of economic assistance distribution, though 'social-aid' covers this. Wording differs slightly (e.g., 'non-card-based payment flow' is not in the original but is a reasonable interpretation), but the semantic meaning and factual content are equivalent. All key entities—Mastercard, Mastercard Send, central banks, fintechs, financial institutions—are correct. The citations to page 8 and 13 of the 10-K add credibility and context. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 468,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does Mastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, influence the composition and recognition timing of its 'Other revenues' category in 2022?",
      "original_answer": "Mastercard introduced Cyber and Intelligence Solutions as part of its value-added services, which directly contributes to the 'Other revenues' category. This category includes fees from cyber and intelligence solutions offered to prevent fraud and ensure transaction safety. These revenues are recognized in the period when the related services are performed or transactions occur, thereby affecting the timing and composition of 'Other revenues' within Mastercard’s net revenue structure.",
      "llm_answer": "Mastercard’s rollout of Cyber and Intelligence Solutions adds a new line‑item to its “Other revenues” bucket – the category that already contains data‑analytics, loyalty, program‑management, ACH‑related and other payment‑related services. Because the company states that “Other revenues consist of value‑added products and services … and are recognized in the period in which the related services are performed or transactions occur” (see page 80), the cyber‑and‑intelligence fees are booked in the same period the fraud‑prevention or safety services are delivered, expanding the composition of other revenues but not changing the timing of their recognition.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that Mastercard's Cyber and Intelligence Solutions are part of 'Other revenues' and expand its composition without altering recognition timing. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the reference to page 80 of the filing supports the timing of revenue recognition, which aligns with the ground truth. (3) The multi-hop reasoning is sound: the model correctly links the introduction of a new service (Cyber and Intelligence Solutions) to its classification within value-added services, maps that to the 'Other revenues' category, and correctly applies the revenue recognition principle (when services are performed or transactions occur). (4) The answer is contextually precise, directly addressing both the compositional impact (adding to 'Other revenues') and the timing of recognition, as required by the question. Wording differs slightly but conveys identical meaning. All entities—Mastercard, Cyber and Intelligence Solutions, 'Other revenues', and the service delivery context—are correctly identified and logically connected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 337,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What was the total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 and December 31, 2023, and how did this change compare to the change in unrealized losses on those securities over the same period?",
      "original_answer": "The total fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million at December 31, 2022 to $320 million at December 31, 2023, a decrease of $7 million. Meanwhile, unrealized losses on these securities increased from $31 million to $25 million, a decrease in unrealized losses of $6 million. This means that while the fair value slightly declined, the unrealized losses improved year-over-year.",
      "llm_answer": "The fair‑value of the mortgage‑backed debt securities rose from **$452 million at 12/31/2022 (agency $333 m + residential $2 m + commercial $117 m)** to **$540 million at 12/31/2023 (agency $410 m + residential $2 m + commercial $128 m)** – an **increase of $88 million**.\n\nDuring the same period the pretax unrealized loss on those securities fell from **$42 million (agency $31 m + residential $1 m + commercial $10 m)** to **$33 million (agency $23 m + residential $1 m + commercial $9 m)** – a **reduction of about $9 million** in unrealized losses.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that CAT's Mortgage-Backed Debt Securities fair value decreased from $327 million to $320 million (a $7 million decrease), while the LLM claims an increase from $452 million to $540 million ($88 million increase). These numbers are completely inconsistent with the ground truth. Similarly, unrealized losses decreased from $31 million to $25 million (a $6 million reduction in losses) according to the ground truth, but the LLM reports a drop from $42 million to $33 million (a $9 million reduction), which is factually wrong. (2) All key numerical values—fair value amounts, unrealized loss amounts, and resulting changes—are incorrect. Calculations based on the LLM's own numbers are internally consistent (e.g., $540M - $452M = $88M), but since the inputs are wrong, the outputs are not accurate. (3) The multi-hop reasoning structure is sound—the LLM identifies fair value and unrealized losses at two points in time and computes changes—but it fails at entity and data retrieval. It appears to have fabricated or misattributed data, possibly confusing CAT with another company or pulling figures from a different context. (4) The contextual relevance is partially preserved because the answer addresses the right types of metrics (fair value, unrealized losses, year-over-year change) and attempts correct comparisons, but the factual inaccuracies render the response misleading. Due to complete failure on quantitative correctness and entity accuracy, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 439,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What is the total fair value of Qualcomm's corporate bonds and notes, and how does this compare to the fair value of U.S. Treasury securities and government-related securities as a percentage of the total marketable securities?",
      "original_answer": "Qualcomm's corporate bonds and notes have a total fair value of $4,634 million, while the fair value of U.S. Treasury securities and government-related securities is $208 million. The total marketable securities amount to $5,451 million. Therefore, corporate bonds and notes represent approximately 85% of the total marketable securities, whereas U.S. Treasury securities and government-related securities account for about 3.8% of the total marketable securities.",
      "llm_answer": "Qualcomm’s fair‑value balance sheet shows **corporate bonds and notes of $4.6 billion** (Level 2) and **U.S. Treasury and other government‑related securities of $208 million**. The Treasury‑related securities represent roughly **3.8 % of the total marketable‑securities portfolio ($208 m ÷ $5.45 b ≈ 3.8 %)**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the fair value of corporate bonds and notes as $4.6 billion, which matches the ground truth of $4,634 million (rounded appropriately). The fair value of U.S. Treasury and government-related securities is accurately stated as $208 million. The total marketable securities are correctly implied as $5.45 billion, consistent with the ground truth of $5,451 million. The percentage calculation for Treasury-related securities (3.8%) is accurate and correctly derived ($208M / $5,451M ≈ 3.8%). (2) All numeric values and calculations are correct. The LLM uses rounded figures (e.g., $4.6B instead of $4,634M) but maintains quantitative precision within acceptable formatting variations. (3) The multi-hop reasoning is sound: the model correctly identifies the two asset categories, retrieves their fair values, references the total marketable securities, and computes the correct percentage for the Treasury portion. However, it omits the explicit calculation or statement that corporate bonds and notes represent approximately 85% of total marketable securities ($4,634M / $5,451M ≈ 85%), which was part of the original answer. This is a minor omission in completeness but does not invalidate the correctness of the provided information. (4) The answer is contextually relevant, clearly addressing the comparison requested. The qualitative accuracy is slightly reduced due to the missing 85% figure, but otherwise reasoning and entity identification (Qualcomm, correct security types) are accurate. Overall, the answer is factually correct and well-aligned with the ground truth, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 449,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does MRK use pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, and what financial impact could this have on the company's oncology revenue stream?",
      "original_answer": "MRK leverages six months of pediatric market exclusivity (as stated in evidence_source_a) to extend market protection for Keytruda beyond the expiration of its compound patent. Additionally, evidence_source_b explains that for drug candidates like Keytruda, the company may benefit from a future Patent Term Extension (PTE) of up to five years and/or six months of pediatric market exclusivity, depending on regulatory approvals. Since Keytruda is part of a global strategic oncology collaboration (mentioned in evidence_source_a), any extension of exclusivity directly impacts revenue by delaying generic competition and preserving market share in the oncology segment. This regulatory strategy enhances revenue predictability and supports long-term financial planning around one of MRK's key oncology products.",
      "llm_answer": "Merck adds the FDA’s six‑month pediatric‑exclusivity provision to Keytruda’s U.S. compound‑patent expiry in 2028 (see page 15, note 8 and page 14), so that, after completing the required pediatric studies, the drug enjoys an extra half‑year of market protection that pushes the effective exclusivity date into 2029 (and is reinforced by two later‑expiring patents that run to 2029). Because Keytruda is Merck’s flagship oncology product, that additional six‑month window postpones generic competition and preserves the high‑margin oncology sales that generate a multi‑hundred‑million‑to‑over‑billion‑dollar revenue stream for the company.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the use of six months of pediatric market exclusivity to extend Keytruda's market protection beyond its compound patent expiration, which aligns with the ground truth. It also correctly notes that this extension delays generic competition and preserves high-margin oncology revenue. However, the LLM introduces specific dates (2028 patent expiry, extension to 2029) and references to 'two later-expiring patents' that are not present in the original answer or supported by the cited evidence sources in the ground truth. These additions, while plausible, are not confirmed by the provided knowledge graph and represent over-specificity beyond the source material. (2) The quantitative accuracy is partially compromised because the original answer does not specify the 2028 or 2029 dates or exact revenue figures like 'multi-hundred-million-to-over-billion-dollar'; instead, it speaks generally about preserving oncology revenue streams. While such figures may be accurate in reality, they are not contained in the ground truth and thus constitute unsupported precision. (3) The multi-hop reasoning is sound in concept—linking pediatric exclusivity to delayed generics and revenue protection—and correctly synthesizes the strategic intent behind regulatory exclusivity extensions. However, it goes beyond the evidence by introducing unverified patent timelines and reinforcing patents not mentioned in the original. (4) Contextual relevance is perfect: the answer directly addresses how MRK uses pediatric exclusivity to extend protection and the financial impact on oncology revenue. The core reasoning and strategic implications match the ground truth, even if extra details reduce factual fidelity. Hence, a correctness score of 7 reflects accurate core logic with minor but notable factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 502,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the introduction of Mastercard Installments in 2022, as part of broader innovation efforts, support Mastercard's strategic goal of expanding digital payment services across multiple channels?",
      "original_answer": "The introduction of Mastercard Installments in 2022 directly supports Mastercard’s strategic goal of expanding digital payment services by offering a new open-loop buy-now-pay-later solution that connects lenders with merchants across the company's acceptance network. This aligns with Mastercard’s innovation focus on delivering better digital experiences everywhere, particularly through mobile and connected devices, as outlined in their 2022 10-K filing. Additionally, this initiative is part of a broader push to capture new payment flows and extend services, including multi-rail capabilities and digital currency solutions, which are key components of their strategy to diversify and strengthen their payments ecosystem.",
      "llm_answer": "Mastercard Installments, launched in 2022, adds an open‑loop “buy‑now‑pay‑later” product that links lenders with merchants on Mastercard’s acceptance network, giving consumers a new digital‑payment option that can be used in‑store, online, in‑app and on mobile devices. By embedding this BNPL capability into the same technology platform that powers its multi‑rail network, the installment solution broadens the range of digital‑payment experiences Mastercard can offer across all channels, directly supporting its strategic goal of expanding digital payment services. 【page_8】【page_14】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All key facts are correct: Mastercard Installments was introduced in 2022 as an open-loop buy-now-pay-later (BNPL) solution connecting lenders and merchants via Mastercard’s network. It supports digital payment expansion across channels (in-store, online, in-app, mobile), which directly addresses the strategic goal in question. (2) Quantitative accuracy is perfect: the year 2022 is correctly cited, and no financial figures are misstated. (3) The reasoning is sound and reflects multi-hop synthesis—linking the product launch to Mastercard’s broader innovation strategy, multi-rail infrastructure, and digital experience goals. The mention of embedding BNPL into the multi-rail platform adds technical depth consistent with the 10-K context. (4) The only minor omission is that the LLM answer does not explicitly reference Mastercard’s strategic focus on 'capturing new payment flows' or 'digital currency solutions' as part of ecosystem diversification—elements present in the original answer. However, the core strategic alignment with expanding digital payments across channels is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. Citations to page_8 and page_14 suggest grounding in source material. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 405,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "What portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP were recorded within Cost of sales in 2024, given that profits from the Lagevrio collaboration were split equally between the partners?",
      "original_answer": "Merck's profit-sharing payments to Ridgeback Biotherapeutics LP that were recorded within Cost of sales in 2024 corresponded to 50% of the profits generated from the Lagevrio collaboration, as the agreement stipulates that profits are split equally between Merck and Ridgeback.",
      "llm_answer": "Merck’s profit‑sharing amounts for the Ridgeback/Lagevrio collaboration are included in the “Cost of sales” line. For 2024, Cost of sales for this collaboration was **$554 million**, which reflects Ridgeback’s one‑half share of the profits.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount ($554 million) that is not present in the original answer or implied by the ground truth. The ground truth states only that Merck recorded 50% of the profits as Cost of sales due to the equal profit split, with no mention of a specific dollar figure. This makes the quantitative claim unsupported and likely incorrect. (2) There is no verification possible for the $554 million figure, as the ground truth does not provide any monetary totals for 2024 profits from the Lagevrio collaboration. Thus, the quantitative accuracy is low due to the introduction of a precise but unverified number. (3) The reasoning is partially sound: the model correctly infers that Ridgeback's share corresponds to 50% and that this would be reflected in Cost of sales. This shows correct multi-hop understanding of the profit-sharing arrangement and accounting treatment. However, it goes beyond the available information by asserting a specific cost of sales value. (4) The contextual relevance is high because the answer addresses the correct entities (Merck, Ridgeback Biotherapeutics, Lagevrio), the correct time frame (2024), and the correct financial line item (Cost of sales). The qualitative accuracy is moderate because while the logic is reasonable, the unsupported figure undermines reliability. The correctness score is 4 due to the major error in fabricating a specific financial amount not present in the ground truth, despite otherwise correct conceptual understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 421,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the Overseas Fund Regime (OFR) interact with BlackRock's European domicile structures to affect its ability to market funds in the UK, and what equivalence requirements must be met under this regime?",
      "original_answer": "Under the Overseas Fund Regime (OFR), BlackRock must ensure that the consumer protection regimes in EU countries where its funds are domiciled are found equivalent to the UK's regime in order to market those funds to UK retail investors. This requirement directly affects BlackRock's ability to distribute its European-domiciled funds in the UK market and may necessitate adjustments to its fund structures or compliance frameworks to meet UK regulatory expectations.",
      "llm_answer": "The Overseas Fund Regime (OFR) gives BlackRock a fast‑track FCA registration for funds that are domiciled outside the United Kingdom, but the regime only allows those funds to be marketed to UK retail investors if the consumer‑protection rules in the EU country where the fund is incorporated are judged “equivalent” to the UK’s own consumer‑protection regime. Consequently, BlackRock’s European‑domiciled funds (e.g., in Luxembourg, Ireland, the Netherlands) can be sold in the UK only after the FCA determines that the EU jurisdiction’s consumer‑protection framework meets the OFR equivalence standard.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly explains that under the Overseas Fund Regime (OFR), BlackRock can market its European-domiciled funds in the UK only if the consumer protection regime of the fund's EU domicile (e.g., Luxembourg, Ireland, Netherlands) is deemed 'equivalent' to the UK's regime by the FCA. This aligns with the original answer's core point about equivalence requirements affecting BlackRock's ability to market EU-domiciled funds to UK retail investors. The LLM adds useful context—such as the 'fast-track FCA registration' and specific examples of fund domiciles—that enhances clarity without introducing inaccuracies. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects correct multi-hop synthesis between the OFR, BlackRock’s fund structures, and UK marketing eligibility. The only minor limitation is that the original answer emphasizes the potential need for structural or compliance adjustments, which the LLM omits—hence a 9 on qualitative accuracy. Overall, the response is highly relevant, complete, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 338,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does Broadcom's (AVGO) internal manufacturing strategy for FBAR filters, as part of its RF semiconductor devices, support its competitive advantage in the cellular handset market?",
      "original_answer": "Broadcom's internal manufacturing strategy for FBAR filters enables it to protect its intellectual property and accelerate time to market, which directly supports its competitive advantage in the cellular handset market where FBAR technology holds significant market share.",
      "llm_answer": "Broadcom manufactures its FBAR (film‑bulk‑acoustic‑resonator) filters in‑house rather than outsourcing them.  By keeping the innovative, proprietary III‑V wafer processes inside its U.S. and Singapore facilities, Broadcom protects the filter IP, shortens development cycles and can rapidly introduce performance‑leading FBAR products.  This control over a key, high‑efficiency filter technology gives Broadcom a clear competitive edge in the crowded cellular‑handset market, where FBAR filters are essential for superior RF‑front‑end performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies Broadcom's in-house manufacturing of FBAR filters as a strategic advantage, emphasizing protection of intellectual property (IP) and faster time to market—key points in the original answer. The mention of 'proprietary III-V wafer processes' and facilities in the U.S. and Singapore adds contextual detail not in the ground truth but does not contradict it and aligns with known Broadcom operations. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and captures the multi-hop logic: internal manufacturing → IP protection and speed → competitive advantage in the cellular handset market where FBAR is critical. The only minor gap is that the LLM answer does not explicitly mention Broadcom's 'significant market share' in FBAR technology, which is part of the original competitive advantage claim, though it implies dominance by referencing 'performance-leading' products. This omission prevents a perfect 10 on qualitative accuracy. Contextual relevance is excellent, directly addressing Broadcom's strategy and its impact on market position.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 345,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does Merck utilize both patent term extensions and regulatory exclusivity to maximize market protection for its biologic products, and what specific exclusivity durations are available in the U.S. for such products?",
      "original_answer": "Merck leverages both patent term extensions and regulatory exclusivity to extend market protection for its biologic products. In the U.S., regulatory data exclusivity for biologic products lasts 12 years from the date of first marketing approval. Additionally, if pediatric studies are completed, an extra six months of market exclusivity can be added. These mechanisms work together to provide extended market protection, allowing Merck to maintain exclusivity beyond the initial approval period and delay potential competition.",
      "llm_answer": "Merck layers a statutory patent‑term restoration (PTE) of up to **five years** on its key product patents with the separate regulatory exclusivities that the FDA grants.  In the United States the agency provides a **data/marketing‑exclusivity term of five years for a new chemical entity, seven years for an orphan‑drug indication, and a **twelve‑year** data‑exclusivity period for a biologic product** (with an additional six‑month pediatric exclusivity where applicable).  By adding the PTE to the 12‑year biologic exclusivity, Merck can extend the effective market‑protection window well beyond the original patent life.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the core mechanisms Merck uses to extend market protection for its biologic products. It correctly identifies the 12-year U.S. data exclusivity period for biologics and the additional six-month pediatric exclusivity, which matches the ground truth. It also accurately notes that patent term extension (PTE) can be layered on top, enhancing market protection. However, the LLM introduces 'five years' of patent term restoration, which, while generally accurate under the Hatch-Waxman Act for small molecules, is not the primary mechanism for biologics and may not be directly applicable in the same way under the Biologics Price Competition and Innovation Act (BPCIA). The ground truth does not mention PTE duration, so including it with a specific number introduces a detail that, while plausible, is not confirmed for biologics in this context and could be misleading. The mention of 5-year exclusivity for new chemical entities and 7-year orphan drug exclusivity, while factually correct, is not directly relevant to biologics and slightly distracts from the focus. Despite this, the key quantitative facts (12-year biologic exclusivity + 6 months pediatric) are correct, and the reasoning about layering exclusivities is sound. The answer is contextually relevant and synthesizes the main point well, earning a high but not perfect score due to the inclusion of marginally relevant or unverified details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 399,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How do the 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, potentially affect BlackRock's client engagement and compliance costs in its UK operations?",
      "original_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 10-K filing, introduce tailored reporting requirements for proxy advisers and investment consultants. These changes may increase BlackRock's compliance costs and necessitate adjustments to its stewardship activities on behalf of clients. Since BlackRock's UK subsidiaries are subject to rigorous conduct regulation, including the Consumer Duty rules, failure to meet the FCA's expectations regarding these new stewardship reporting obligations could expose BlackRock to regulatory sanctions, reputational risk, and potential client asset withdrawals, thereby impacting client engagement and operational efficiency.",
      "llm_answer": "The 2024 UK Stewardship Code reforms add “tailored reporting requirements for proxy advisers and investment consultants,” meaning BlackRock must gather and disclose more detailed stewardship data on behalf of its UK clients. That extra reporting creates additional compliance work and costs, while also prompting BlackRock to engage more closely with clients to meet the new transparency expectations around proxy‑voting and stewardship activities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core elements of the original answer. It correctly identifies the 2024 UK Stewardship Code reforms, specifically the 'tailored reporting requirements for proxy advisers and investment consultants,' which aligns with the ground truth. It accurately notes that these changes increase compliance costs and require more detailed stewardship reporting, impacting client engagement due to heightened transparency expectations around proxy voting and stewardship. The quantitative accuracy is perfect—there are no numerical figures to verify, but the dates (2024) and entities (UK Stewardship Code, BlackRock, proxy advisers, investment consultants) are correct. The reasoning is sound and reflects multi-hop synthesis between the regulatory change and its operational impact on BlackRock’s UK business. However, the LLM answer omits key risks mentioned in the original answer: regulatory sanctions, reputational risk, and potential client asset withdrawals due to failure to meet FCA expectations under Consumer Duty rules. While it mentions increased client engagement, it does not fully convey the negative implications for client relationships or operational efficiency if compliance fails. This omission reduces completeness and depth in qualitative accuracy, but the core facts and logic remain correct. Contextual relevance is strong as it directly addresses the question about client engagement and compliance costs.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 404,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022, and how does the Heritage AspenTech acquisition directly factor into this change according to the evidence provided?",
      "original_answer": "The depreciation and amortization expenses for the AspenTech segment increased by $147 million (from $95 million in fiscal 2021 to $242 million in fiscal 2022). The Heritage AspenTech acquisition directly factors into this change because it is explicitly stated that the increase in backlog for the AspenTech segment in fiscal 2022 is related to this acquisition, which would lead to the recognition of additional intangible assets requiring amortization.",
      "llm_answer": "The AspenTech segment’s depreciation‑and‑amortization expense rose from **$95 million in fiscal 2021 to $242 million in fiscal 2022**, a **$147 million increase**【page_77】.  This jump is almost entirely due to the **$148 million of amortization of intangibles tied to the Heritage AspenTech acquisition** that was recorded for 2022【page_79】, indicating the acquisition’s intangible assets drove the higher expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the dollar increase in depreciation and amortization expenses as $147 million, rising from $95 million in fiscal 2021 to $242 million in fiscal 2022, which matches the ground truth exactly. The calculation is accurate and numbers are correctly cited with acceptable formatting (e.g., $95 million vs $95 million). (2) The LLM adds a specific detail from the evidence—$148 million of amortization of intangibles tied to the Heritage AspenTech acquisition—which aligns closely with the $147 million increase, suggesting the acquisition is the primary driver. While the $148M figure is $1M higher than the total increase, this minor discrepancy may stem from rounding or reporting timing but does not materially undermine accuracy. (3) The multi-hop reasoning is sound: the model connects the acquisition to the recognition of intangible assets, which leads to higher amortization expenses, directly addressing how the acquisition factors into the change. The original answer notes the acquisition's impact via backlog and intangible asset recognition, and the LLM strengthens this by citing the specific amortization amount. (4) All entities (AspenTech segment, fiscal years 2021–2022, Heritage AspenTech acquisition) are correctly identified. The answer is fully relevant and semantically equivalent to the ground truth, with slightly more precise evidence from the document. The qualitative score is 9 because while the reasoning is strong, it slightly overstates 'almost entirely due to' without acknowledging possible minor contributing factors, though the core logic is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 445,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and what percentage did this region contribute to the total global growth in this business segment?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million ($744 million in Fiscal Year 2022 from $720 million in Fiscal Year 2021). This regional increase contributed approximately 0.35% to the total global growth in the Subscriptions and Services segment, which grew by $362 million (from $6,564 million to $6,926 million).",
      "llm_answer": "Broadcom’s Subscriptions‑and‑Services revenue in the Asia Pacific region rose from **$720 million in FY 2021 to $744 million in FY 2022**, a **year‑over‑year increase of $24 million**. That $24 million accounts for roughly **6.6 % of the total global increase in Subscriptions‑and‑Services revenue (which grew by $362 million from FY 2021 to FY 2022).**",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the year-over-year increase in Subscriptions and Services revenue in the Asia Pacific region: $720 million in FY 2021 to $744 million in FY 2022, a $24 million increase, which matches the ground truth. This satisfies the first part of the question. However, the second part — the percentage contribution of this regional increase to the total global growth in the segment — is incorrect. The LLM states it is 'roughly 6.6%', but the correct value is approximately 0.35% (calculated as $24M / $362M). The model appears to have miscalculated or misinterpreted the contribution, likely confusing it with a different metric or applying incorrect logic. While the entities (Broadcom, Subscriptions and Services, Asia Pacific, correct fiscal years) and the direction of reasoning are accurate, the critical calculation error in the percentage severely undermines the multi-hop synthesis required. The contextual relevance is high as the answer addresses both parts of the question and uses appropriate financial terminology. However, due to the major quantitative error in the percentage contribution, the correctness and accuracy scores are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 334,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How do the 2023 joint merger guidelines issued by the FTC and DOJ negatively impact BlackRock's ability to expand through acquisitions and affect funds engaging in HSR-reportable transactions?",
      "original_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ increase regulatory scrutiny and impose additional compliance burdens on transactions reportable under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. These guidelines could negatively impact BlackRock’s ability to expand through strategic investments or acquisitions by making such transactions more costly, complex, and time-consuming. Additionally, funds engaging in HSR-reportable transactions may face increased pre-merger notification expenses and potential transaction delays due to the expanded information and documentation requirements introduced alongside the new guidelines.",
      "llm_answer": "The December 2023 joint merger guidelines from the FTC and DOJ broaden the antitrust review framework, requiring far more information and longer waiting periods for Hart‑Scott‑Rodino (HSR) filings. That added scrutiny and documentation cost makes BlackRock’s strategic investments and acquisitions harder to complete and can delay or block deals, while funds that must file HSR notifications face higher compliance burdens and longer transaction timelines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 2023 joint merger guidelines from the FTC and DOJ are accurately cited, and their impact on HSR-reportable transactions is correctly described. The December 2023 issuance date is consistent with the actual release timeline, though the original answer does not specify the month—this addition is accurate and not misleading. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is fully preserved. (3) The multi-hop reasoning is sound: the answer correctly links the new guidelines to increased scrutiny, documentation, and waiting periods, then connects this to BlackRock’s acquisition challenges and broader fund-level compliance burdens. It synthesizes the regulatory change with its operational and strategic implications for both BlackRock and funds engaging in HSR filings. (4) The answer is contextually precise, addressing both parts of the question: impact on BlackRock’s expansion and on funds with HSR-reportable transactions. The only minor limitation is slight brevity compared to the original answer’s detail on 'pre-merger notification expenses' and 'expanded information requirements,' but the core meaning—higher compliance costs and delays—is clearly conveyed. Wording differences do not affect factual equivalence. Overall, this is a highly accurate, complete, and relevant response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 407,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements influence its accounting treatment and financial statement classification?",
      "original_answer": "Goldman Sachs uses two forms of Non-Employee Director RSU Award Agreements: one that is stock-settled (Form 10.8 referenced in evidence_source_a) and another that is cash-settled (Form 10.32 referenced in evidence_source_b). These differing settlement terms directly affect accounting treatment — stock-settled RSUs are classified as equity instruments, while cash-settled RSUs are classified as liability instruments under GAAP. This distinction impacts both the timing and measurement of compensation expense, with liability-classified awards requiring remeasurement at each reporting date until settlement.",
      "llm_answer": "Goldman Sachs discloses that its non‑employee directors can receive either traditional (stock‑settled) RSUs or cash‑settled RSUs – the filing lists a “Form of Non‑Employee Director RSU Award Agreement” and a separate “Form of Non‑Employee Director RSU Award Agreement (Cash‑Settled)”【page_6†L31-L32】.  \n\nBecause of this mix, the company must apply two different accounting treatments:  \n\n* **Stock‑settled RSUs** are measured at grant‑date fair value, expensed over the vesting period and recorded in shareholders’ equity (additional‑paid‑in‑capital).  \n\n* **Cash‑settled RSUs** are treated as a liability; they are re‑measured to fair value at each reporting date, with the change recognized in earnings and the liability shown on the balance sheet.  \n\nThus, Goldman Sachs reports compensation expense for both award types, but classifies the stock‑settled portion in equity and the cash‑settled portion as a liability on its financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Goldman Sachs uses both stock-settled and cash-settled RSUs for non-employee directors, with distinct accounting treatments. The stock-settled RSUs are classified as equity and measured at grant-date fair value, while cash-settled RSUs are liability-classified and remeasured at each reporting date. These classifications and their impact on financial statements (equity vs. liability, timing of expense recognition) are correctly described. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable beyond correct reference to concepts; the LLM does not introduce any incorrect figures and thus scores perfectly in this dimension. (3) The multi-hop reasoning is sound: the model correctly infers that differing settlement terms lead to different GAAP classifications and financial statement impacts, synthesizing the implication from the two forms referenced in the evidence. (4) The only minor shortcoming is that the LLM does not explicitly name the specific forms (Form 10.8 and Form 10.32) cited in the original answer, which slightly reduces completeness in entity-level detail, but this does not affect the overall correctness of the accounting treatment explanation. Wording differs but semantic meaning matches the ground truth. Contextual relevance is perfect—the response directly addresses the influence on accounting treatment and financial statement classification as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 423,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How many shares were granted in the form of restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program in 2023, and what specific vesting condition is mentioned for these units in the program documentation?",
      "original_answer": "In 2023, Abbott granted 4,981,231 restricted stock units under the 2017 Incentive Stock Program. These restricted stock units vest over three years, and upon vesting, the recipient receives one share of Abbott stock for each vested unit.",
      "llm_answer": "In 2023 Abbott granted **4,981,231 restricted‑stock units (RSUs)** under its 2017 Incentive Stock Program. The program documentation states that **RSUs vest over three years**, and when they vest the recipient receives one share of Abbott stock for each vested unit【page_60】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of restricted stock units granted in 2023 — 4,981,231 — is accurate and correctly reported. (2) The vesting condition is accurately described: RSUs vest over three years, and each vested unit results in one share of Abbott stock, which aligns exactly with the original answer. (3) The response addresses both parts of the multi-hop question: the quantity of RSUs granted under the specific program (Abbott Laboratories 2017 Incentive Stock Program) in the correct year (2023), and the vesting terms from the program documentation. (4) The reasoning is sound, with correct entity identification (Abbott, 2017 Incentive Stock Program, RSUs), and proper synthesis of quantitative and qualitative information. Minor formatting differences (e.g., use of em dash, bolding, citation marker 【page_60】) do not affect factual accuracy or completeness. Semantic equivalence is maintained, and all key facts are present and correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 294,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "What percentage of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe, and how does this geographic distribution reflect the long-term strategic impact of acquiring Leica Microsystems in 2005?",
      "original_answer": "Danaher's Life Sciences segment generated 28% of its 2024 sales from high-growth markets and 7% from other developed markets, totaling 35% from regions outside North America (44%) and Western Europe (21%). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which served as the foundational platform for expanding the Life Sciences business through subsequent acquisitions such as Beckman Coulter (2011), Pall (2015), and Abcam (2023), enabling broader global reach and integration of complementary technologies.",
      "llm_answer": "In 2024, 35 % of Danaher’s Life Sciences segment revenue came from markets outside North America (44 %) and Western Europe (21 %)—the “other developed” (7 %) and “high‑growth” (28 %) regions combined (page 8). The segment was created in 2005 through the acquisition of Leica Microsystems (page 8), and the fact that more than one‑third of its sales now arise from non‑NA/Western‑Europe markets shows how that acquisition seeded a platform that Danaher has expanded globally through subsequent purchases, delivering a diversified, high‑growth geographic footprint as a long‑term strategic payoff.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that 35% of Danaher's 2024 Life Sciences segment sales came from regions outside North America (44%) and Western Europe (21%), accurately breaking this down into 28% from high-growth markets and 7% from other developed markets, which matches the ground truth. All percentages are factually correct and properly summed (28% + 7% = 35%). (2) The quantitative accuracy is perfect: the numbers align exactly with the original answer, including the regional splits and the implied calculation. Format variations (e.g., spacing in '44 %') do not affect correctness. (3) The reasoning correctly traces the strategic impact of the 2005 Leica Microsystems acquisition as the foundation for global expansion, noting its role in enabling subsequent acquisitions and geographic diversification. While the LLM mentions that the segment was 'created' in 2005 via Leica, which is a slight simplification (Leica was a foundational but not sole component), it does capture the core multi-hop logic: acquisition → platform building → global expansion → diversified sales. The ground truth emphasizes Leica as a 'foundational platform' rather than the sole origin, so this is a minor overstatement but not a factual error. (4) The answer is contextually fully relevant, addressing both the geographic sales distribution and the long-term strategic impact of the 2005 acquisition. The synthesis across time and entities (Leica → Beckman Coulter → Pall → Abcam) is implied through the concept of platform expansion, even if not named explicitly. Overall, the answer is semantically equivalent to the ground truth with excellent factual and logical fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 461,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What is the total number of acquisitions Danaher has made in the Life Sciences segment since its establishment in 2005, including the year of acquisition for Pall and the most recent acquisition mentioned in the filing?",
      "original_answer": "Danaher has made 8 acquisitions in the Life Sciences segment since its establishment in 2005. These include: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023).",
      "llm_answer": "Danaher has made **nine** acquisitions in its Life Sciences segment since the segment was created in 2005. The acquisition of **Pall occurred in 2015**, and the most recent acquisition noted in the filing is **Abcam in 2023**.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that Danaher made nine acquisitions, but the ground truth confirms only eight: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010 counted as one acquisition event), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023). The LLM overcounts by one, likely due to splitting a multi-part acquisition or including an incorrect entity. (2) The dates for Pall (2015) and the most recent acquisition, Abcam (2023), are correct, satisfying two key factual checkpoints. However, the total count is wrong, which is a critical error in quantitative accuracy. (3) The reasoning is partially sound—LLM correctly identifies the segment start year (2005), retrieves the correct year for Pall, and identifies Abcam as the most recent. However, it fails in complete and accurate synthesis across all acquisitions, missing the correct total count despite referencing accurate individual events. (4) Contextual relevance is high—the answer addresses all parts of the question in structure and intent. Due to the significant error in the total number of acquisitions, the correctness score is reduced to 6, reflecting partial accuracy with a major factual discrepancy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 350,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "What was the change in the fair value of Abbott's interest rate hedge contracts between December 31, 2020 and December 31, 2021, and how does this reflect the fluctuation in their receivable position for these contracts during the same period?",
      "original_answer": "The fair value of Abbott's interest rate hedge contracts decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, representing a decline of $123 million. This change is consistent with the drop in the receivable position for these contracts, which also fell from $210 million to $87 million over the same period, indicating a significant reduction in Abbott's exposure or valuation of these hedges.",
      "llm_answer": "The fair‑value of Abbott’s interest‑rate hedge contracts fell from **$210 million at 12/31/2020 to $87 million at 12/31/2021**, a **decrease of $123 million**【page_65】.  This $123 million drop mirrors the change in the contracts’ receivable balance, which also fell from **$210 million to $87 million** over the same period, showing that the hedge moved from a larger net receivable to a much smaller one.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, resulting in a $123 million decrease, which is correctly calculated ($210M - $87M = $123M). The receivable position is also correctly reported as declining from $210 million to $87 million. (2) The answer addresses both parts of the multi-part question: the change in fair value and how it reflects the fluctuation in the receivable position. (3) Entity accuracy is correct—'Abbott' is the right company, and the dates (December 31, 2020 and 2021) and financial instruments ('interest-rate hedge contracts') are accurately identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the LLM correctly infers that the drop in fair value mirrors the drop in the receivable balance, indicating a consistent movement in Abbott's hedge valuation and exposure. The semantic meaning is equivalent to the original answer, with only minor wording differences (e.g., 'mirrors the change' vs 'consistent with the drop'), which do not affect factual accuracy. All criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 343,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How does BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, align with the observed doubling of U.S. revenues for Breyanzi in 2023?",
      "original_answer": "BMY's 2023 strategy emphasized expanding its autologous CAR-T cell therapy franchise, including pursuing new indications for Breyanzi such as CLL, FL, and MCL, which aligns with the doubling of U.S. revenues for Breyanzi due to higher demand. This strategic investment in cell therapy innovation and expansion into new treatment areas is directly reflected in the significant revenue growth of Breyanzi.",
      "llm_answer": "BMS’s strategy explicitly calls for “expanding our pipeline of autologous CAR‑T cell therapies” and notes that it is “exploring new indications with Breyanzi to include the treatment of CLL, FL and MCL” (page 43).  That focus is already paying off – U.S. sales of Breyanzi “doubled in 2023, primarily due to higher demand” (page 52).  In other words, the company’s push to broaden Breyanzi’s label and its overall CAR‑T platform is directly reflected in the sharp increase in U.S. revenue for the product.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurately represented: BMY's (BMS's) strategic focus on expanding its autologous CAR-T pipeline, specifically exploring new indications for Breyanzi (CLL, FL, MCL), is correctly stated and directly tied to the doubling of U.S. revenues in 2023 due to higher demand. (2) Quantitative accuracy is precise: 'doubled in 2023' matches the ground truth, and no calculations are required beyond this correct comparison. (3) Multi-hop reasoning is sound—the model correctly synthesizes strategic intent (pipeline expansion) with financial outcome (revenue growth), citing specific evidence from the document (pages 43 and 52). (4) Semantic equivalence is maintained: though phrased slightly differently, the LLM conveys the same causal relationship between strategic investment and revenue performance as the original answer. All entities (Breyanzi, CLL, FL, MCL, 2023, U.S. revenues) are correctly identified. The answer is contextually complete and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 306,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What was the total cash outflow for the acquisition of The Binding Site Group in 2023, and how did it contribute to the total cash used for acquisitions in 2023, including CorEvitas, LLC?",
      "original_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion. This, combined with the $0.91 billion used for the acquisition of CorEvitas, LLC, contributed to a total of $3.61 billion in cash used for acquisitions during 2023.",
      "llm_answer": "The Binding Site Group purchase required a cash payment of **$2.4 billion** (cash paid $2,412 million, offset by a $20 million cash receipt).  In 2023 Thermo Fisher’s total cash used for acquisitions was **$3.6 billion** – $2.7 billion for The Binding Site (the cash‑payment component of $2.4 billion) plus $0.91 billion for CorEvitas, LLC.  Thus, the Binding Site outflow accounted for roughly two‑thirds of the year’s acquisition cash outflows.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in key financial figures. The ground truth states the cash outflow for The Binding Site Group was $2.70 billion, but the LLM incorrectly reports it as $2.4 billion (or $2,412 million), citing a $20 million cash receipt offset that does not appear in the ground truth. This misrepresents the core number. While the total cash used for acquisitions ($3.6 billion) is approximately correct (ground truth: $3.61 billion), the LLM attributes this total to $2.7 billion (referenced correctly later) plus $0.91 billion for CorEvitas, which contradicts its earlier statement of only $2.4 billion paid for The Binding Site. (2) Calculations are inconsistent: the LLM claims $2.4 billion was paid for The Binding Site, yet later says $2.7 billion was used for it—this internal contradiction undermines quantitative accuracy. The sum of $2.7B + $0.91B = $3.61B is correct, but the LLM rounds to $3.6B, which is acceptable. However, the erroneous breakdown and conflicting numbers reduce precision. (3) The multi-hop reasoning is partially sound—the model identifies both acquisitions (The Binding Site Group and CorEvitas, LLC) and attempts to aggregate their costs and assess contribution to total acquisition spending. However, due to incorrect input values and internal inconsistencies, the synthesis is flawed. The conclusion that The Binding Site accounted for 'roughly two-thirds' is based on incorrect inputs and is therefore unreliable. (4) Contextual relevance is high—the answer addresses both parts of the question (cash outflow for The Binding Site and its contribution to total 2023 acquisition spending) and references the correct companies and year. Despite this, major factual inaccuracies in the primary financial figure and inconsistent reasoning severely limit correctness. Minor formatting variations like $2.7 billion vs $2,700 million are acceptable, but $2.4B vs $2.7B is a material error. Thus, the correctness score is low due to critical number inaccuracies and logical inconsistencies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 550,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "What is the total estimated annual cost savings from restructuring charges incurred in 2024 and 2023, and how does the acquisition of The Binding Site Group in 2023 contribute to the Specialty Diagnostics segment's strategic growth in blood cancer diagnostics?",
      "original_answer": "The restructuring charges incurred in 2024 and 2023 are expected to yield total estimated annual cost savings of $0.8 billion ($0.2 billion from 2024 charges and $0.6 billion from 2023 charges). The acquisition of The Binding Site Group in 2023 enhances the Specialty Diagnostics segment's portfolio by adding pioneering diagnostic assays and instruments for blood cancers, specifically multiple myeloma, aligning with the company's strategy of high-impact innovation and expanding its capabilities in specialty diagnostics.",
      "llm_answer": "The company said that the restructuring actions generated charges of roughly $0.3 billion in both 2024 and 2023, and that those actions are expected to produce annual cost‑saving benefits of about $0.2 billion for 2024 and $0.6 billion for 2023 – a combined estimated saving of **approximately $0.8 billion per year**.  \n\nThe 2023 acquisition of The Binding Site Group added a suite of specialty diagnostic assays and instruments focused on multiple‑myeloma and other blood‑cancer indications, expanding the Specialty Diagnostics portfolio and positioning the segment for strategic growth in blood‑cancer diagnostics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total estimated annual cost savings of $0.8 billion, with accurate breakdowns of $0.2 billion from 2024 restructuring charges and $0.6 billion from 2023 charges. These figures match the ground truth exactly, despite the mention of restructuring charges being $0.3 billion in both years—which is not contradicted in the original answer and does not affect the correctness of the savings figures. (2) All numeric values related to cost savings are accurate: $0.2B (2024), $0.6B (2023), and combined $0.8B annual savings. Format variations (e.g., 'billion' vs 'B') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes cost savings across two years and links the 2023 acquisition to strategic growth in blood cancer diagnostics. It accurately identifies The Binding Site Group’s contribution—adding diagnostic assays and instruments for multiple myeloma and other blood cancers—enhancing the Specialty Diagnostics segment. (4) The only minor limitation is that the LLM mentions restructuring charges of $0.3 billion in each year, which is not present in the ground truth and could be extraneous or unverified, but since the question focuses on cost *savings* (not charges), and the savings numbers are correct, this does not significantly detract from accuracy. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 417,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "What is the longest-term debt instrument listed in Eli Lilly's 2023 10-K filing, and how does its maturity year compare to the other debt instruments listed in the same filing?",
      "original_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061. This instrument matures in 2061, which is significantly later than the other debt instruments listed, such as the 0.500% Notes due 2033 and the 1.125% Notes due 2051.",
      "llm_answer": "The longest‑term debt instrument disclosed is the **1.375 % Notes due 2061 (ticker LLY61)**【page_1†L13-L22】. Its 2061 maturity is later than all of the other listed notes, which mature between 2025 and 2051 (e.g., 1.125 % Notes due 2051 is the next‑furthest‑out).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the longest-term debt instrument as the 1.375% Notes due 2061, matching the ground truth exactly in terms of name, interest rate, and maturity year. The maturity date of 2061 is accurately compared to the other debt instruments, with correct mention that others mature between 2025 and 2051, including the 1.125% Notes due 2051 as the next latest. All numeric values (percentages, years) are correct and quantitatively accurate. The reasoning is sound: it correctly synthesizes information from Eli Lilly's 2023 10-K to identify the longest-term instrument and contextualize its maturity relative to others. The only minor shortcoming is the addition of 'ticker LLY61', which is not present in the original ground truth and may be inferred or labeled by the model but is not confirmed in the source; however, this does not detract from factual correctness. The answer is semantically equivalent and fully addresses both parts of the question: identifying the instrument and comparing its maturity. Thus, the answer is highly accurate with only negligible over-specification, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 328,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "What is the total number of distinct indications for which Donanemab is under development or review, and how does this compare to the number of indications for which Lebrikizumab has received approval or is under regulatory review?",
      "original_answer": "Donanemab is under development or review for two distinct indications: early Alzheimer's disease and preclinical Alzheimer's disease. Lebrikizumab has received approval for atopic dermatitis in the EU and Japan, and is under regulatory review in the U.S. for the same indication, making it one approved or under review indication. Therefore, Donanemab is being developed for more indications than Lebrikizumab.",
      "llm_answer": "Donanemab is being pursued for **two distinct indications** – early Alzheimer’s disease (submitted for review) and pre‑clinical Alzheimer’s disease (Phase III)【page_42】.  \n\nLebrikizumab is being pursued for **one indication** – atopic dermatitis, which has already been approved in the EU and Japan and is under regulatory review in the United States【page_42】.  \n\nSo Donanemab has twice as many indications under development/review as Lebrikizumab.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that Donanemab is under development or review for two distinct indications—early Alzheimer’s disease and preclinical Alzheimer’s disease—and that Lebrikizumab is associated with one indication (atopic dermatitis) that is approved in the EU and Japan and under review in the U.S. The quantitative comparison (two vs. one) is accurate, and the conclusion that Donanemab has more (specifically twice as many) indications is semantically equivalent to the ground truth. All entities, indications, and regulatory statuses are correctly identified. The reasoning is sound and synthesizes information correctly across the two drugs. The only minor limitation is that the answer says 'twice as many' rather than the more conservative 'more than,' which, while mathematically correct, slightly overemphasizes the comparison without acknowledging that both numbers are small integers. However, this does not constitute a factual error. All information aligns with the ground truth, and the citation of 'page_42' suggests proper grounding. No factual inaccuracies in numbers, entities, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 316,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the decline in Alimta's revenue in the U.S. in 2023, caused by the entry of generics, impact the overall U.S. volume growth, and what other oncology product contributed positively to volume growth in the U.S.?",
      "original_answer": "The decline in Alimta's revenue in the U.S. in 2023, due to the entry of multiple generics in the first half of 2022, negatively impacted the overall U.S. volume growth. However, this was partially offset by strong performance from other oncology products such as Verzenio and Trulicity, which contributed positively to U.S. volume growth.",
      "llm_answer": "The loss of Alimta volume – caused by the launch of multiple generics in the first half of 2022 – pulled down U.S. volume growth in 2023, offsetting part of the overall increase.  That negative impact was partially counter‑balanced by growth in the oncology drug **Verzenio**, which was one of the products that drove U.S. volume expansion that year.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the decline in Alimta's revenue in the U.S. in 2023—due to the entry of generics in the first half of 2022—negatively impacted U.S. volume growth. This aligns with the ground truth. It also correctly identifies Verzenio as a positive contributor to U.S. oncology volume growth. However, the LLM omits mention of Trulicity, which is explicitly listed in the original answer as another product that contributed positively. While Verzenio is correctly cited, the omission of Trulicity reduces completeness. (2) There are no numerical values or calculations in the question or answers, so quantitative accuracy is not applicable in terms of figures; however, the temporal reference (generics launched in first half of 2022 affecting 2023 performance) is accurate, earning full marks. (3) The multi-hop reasoning is sound: the model connects the generic entry of Alimta to reduced volume and then links other oncology products to offsetting growth. The logic and entity relationships are valid, though incomplete due to missing Trulicity. (4) The answer is contextually relevant and conveys most of the required information. The correctness score is 8 because the core facts and reasoning are accurate, but the answer is partially incomplete on the second part of the question asking for 'other oncology product(s)'—plural—implying more than one, which the LLM fails to fully address.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 396,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How much total financial commitment and shared development cost has Merck incurred or anticipated in relation to V940 (mRNA-4157), and how does this tie into Merck's broader immuno-oncology strategy as outlined in its 2023 10-K filing?",
      "original_answer": "Merck incurred a $250 million payment in 2022 upon exercising its option to jointly develop and commercialize V940 (mRNA-4157) with Moderna. Additionally, Merck is sharing development costs equally with Moderna for this investigational individualized neoantigen therapy, which is being evaluated in combination with Keytruda in multiple Phase 3 clinical trials. This commitment aligns with Merck's immuno-oncology strategy, which includes V940 (mRNA-4157) as a key program being tested in the INTerpath-001 and INTerpath-002 trials for melanoma and NSCLC, respectively. The therapy has received Breakthrough Therapy and PRIME designations, underscoring its strategic importance in Merck's oncology pipeline.",
      "llm_answer": "Merck’s V940 (mRNA‑4157) deal with Moderna required a **$250 million upfront option payment** that was charged to research‑and‑development expense in 2022, and the company now records **its 50 % share of the ongoing development costs** as part of R&D (the collaboration accounted for roughly $288 million of R&D expense in 2022 and $218 million in 2023).  This investment is embedded in Merck’s **immuno‑oncology pillar**, where V940 – an individualized neo‑antigen vaccine combined with Keytruda – is highlighted as a key “next‑generation” immuno‑oncology asset that expands the company’s portfolio beyond PD‑1 blockade.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $250 million upfront payment made by Merck in 2022 upon exercising its option to co-develop V940 (mRNA-4157) with Moderna, which matches the ground truth. It also accurately states that Merck shares 50% of ongoing development costs, aligning with the 'equally shared' cost structure in the original answer. The LLM adds specific financial details not in the ground truth—$288 million in 2022 and $218 million in 2023 in R&D expense from the collaboration—which are plausible and consistent with public filings, though not part of the provided ground truth. These additional figures do not contradict but enhance the response, assuming they are accurate from external knowledge. (2) All numeric values related to the upfront payment and cost-sharing are correct. The inclusion of annual R&D expenses attributed to the collaboration shows a higher level of quantitative detail than the ground truth, but since these numbers are not in the original answer, they cannot be verified from the knowledge graph provided. However, they do not introduce error, and their presence improves precision without compromising correctness. (3) The reasoning is sound: the LLM correctly ties the financial commitment to Merck’s broader immuno-oncology strategy, identifying V940 as a next-generation asset used in combination with Keytruda, which is consistent with Merck’s strategy of expanding beyond PD-1 inhibitors. While the LLM does not explicitly name the INTerpath-001 and INTerpath-002 trials or mention Breakthrough Therapy and PRIME designations—details present in the ground truth—it still captures the strategic significance of V940 in Merck’s pipeline. (4) The answer is contextually fully relevant, addressing both the financial commitments and the strategic rationale. The minor omission of trial names and regulatory designations prevents a perfect score, but the core multi-hop synthesis—linking a financial outlay to a strategic R&D priority in immuno-oncology—is executed accurately and insightfully. Thus, the answer is highly correct with only minor completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 570,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How many additional years of U.S. patent protection could MK-7962 (sotatercept) receive beyond the standard biologic data exclusivity period, based on the disclosed expiration year and the stated patent expiration date?",
      "original_answer": "MK-7962 (sotatercept) is eligible for 12 years of data exclusivity upon approval in the U.S., and its granted patents covering methods of treatment will expire in 2037. If the product receives approval in 2027, as indicated by the anticipated expiration year, then it could receive an additional 10 years of protection beyond the standard exclusivity period.",
      "llm_answer": "MK‑7962’s listed U.S. compound‑patent expiration is 2027, but the company notes that method patents covering its use in pulmonary arterial hypertension run until 2037 (absent any PTE). Thus, the product could enjoy as much as **10 additional years of U.S. patent protection beyond the 12‑year biologic data‑exclusivity period**.【page_16】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) It correctly identifies that MK-7962 has method patents expiring in 2037 and that the standard biologic data exclusivity period is 12 years. It concludes that there could be 10 additional years of patent protection beyond the exclusivity period, which matches the ground truth calculation. (2) Quantitatively, all numbers are accurate: 2037 patent expiration, implied 2027 approval year (from 'anticipated expiration year' in original), and 10-year difference (2037 - 2027 = 10) are correct. The mention of a 2027 compound patent expiration aligns with typical early patent filings and does not contradict the method-of-use patent extension. (3) The reasoning is sound: it distinguishes between compound and method-of-treatment patents and correctly infers extended protection based on later-expiring method patents. The only minor limitation is that it does not explicitly state the assumed approval year (2027) as a basis for the 10-year extension, though this is implied and consistent with the original answer. (4) The answer is highly relevant, directly addressing the question about additional years of protection beyond data exclusivity. Wording differs slightly (e.g., 'enjoy as much as' vs 'could receive'), but the semantic meaning and factual content are equivalent. No major omissions or inaccuracies affect the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 395,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What was the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements?",
      "original_answer": "The total increase in Emerging Markets Equities investments was $106 million. In the U.S. Pension Plans, Emerging Markets Equities increased by $33 million (from $707 million in 2022 to $740 million in 2023). In the International Pension Plans, Emerging Markets Equities increased by $73 million (from $59 million in 2022 to $66 million in 2023 for International Pension Plans' direct Emerging Markets Equities holdings, and from $111 million in 2022 to $110 million in 2023 for the Investment Funds category which includes Emerging Markets Equities).",
      "llm_answer": "The 10‑K excerpts you provided do not include the pension‑plan tables that disclose the fair‑value of Emerging‑Markets‑Equities holdings (by NAV) for either the U.S. or the International pension plans. Because those figures are not present in the pages you shared, the total increase from 2022 to 2023 cannot be calculated from the available information.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to provide the correct information. (1) The original answer contains specific, accurate numbers: U.S. Pension Plans increased by $33 million (from $707M to $740M), and International Pension Plans increased by $73 million (with detailed breakdowns across direct holdings and investment funds), totaling a $106 million increase. The LLM claims the data is not present, but the ground truth implies the information was available in the source documents. (2) No numbers or calculations were attempted, so quantitative accuracy is near zero. (3) The reasoning is flawed—the LLM asserts the data is missing rather than performing the required multi-hop synthesis across U.S. and International plans and categories (direct holdings and investment funds). (4) The response is irrelevant because it denies the availability of data instead of answering the question, despite the original answer being fully supported by the knowledge graph. Thus, all scores are extremely low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 289,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "What is the change in the estimated fair value of U.S. government agencies securities held by GILD from December 31, 2022, to December 31, 2023, and how does this compare to the change in the estimated fair value of U.S. treasury securities over the same period?",
      "original_answer": "The estimated fair value of U.S. government agencies securities increased by $106 million (from $21 million on December 31, 2022, to $127 million on December 31, 2023). The estimated fair value of U.S. treasury securities decreased by $34 million (from $379 million on December 31, 2022, to $426 million on December 31, 2023). Therefore, while U.S. government agencies securities appreciated significantly, U.S. treasury securities experienced a smaller decline in value.",
      "llm_answer": "Gilead’s estimated fair‑value of its U.S. government‑agency securities rose from **$35 million at 12/31/2022 to $127 million at 12/31/2023**, a **$92 million increase**.  \nIn the same period its U.S. treasury securities grew from **$410 million to $426 million**, a **$16 million increase**.  \n\nSo the agency‑security fair‑value jump was about **$76 million larger** than the rise in treasury‑security fair value.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers and misrepresents the direction of changes in fair value for both securities. According to the ground truth, U.S. government agencies securities increased from $21 million to $127 million (a $106 million increase), but the LLM reports a rise from $35 million to $127 million (a $92 million increase), which is incorrect on both starting value and magnitude. For U.S. treasury securities, the ground truth shows a decrease from $379 million to $426 million — this is a $47 million increase, not a decrease, indicating a clear data error in the original answer; however, the original answer claims a $34 million decrease, which contradicts the provided numbers. This suggests an internal inconsistency in the ground truth itself. Despite that, the LLM reports treasury securities increasing from $410 million to $426 million ($16 million increase), which is closer but still incorrect in both base values and change amount. (2) Calculations are flawed: the LLM computes a $92 million increase for agency securities (should be $106 million) and a $16 million increase for treasuries (should be +$47 million based on stated values, though original answer claims -$34 million). The comparison stating the agency jump was $76 million larger than the treasury rise is therefore also incorrect. (3) Multi-hop reasoning is partially present — the model attempts to compare changes across two asset classes over time — but due to incorrect input values, the synthesis fails. (4) Scores reflect major quantitative inaccuracies and flawed reasoning, though the structure and intent of the response are relevant and address the correct entities (GILD, U.S. government agencies securities, U.S. treasury securities) and time period (2022–2023).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 491,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the revenue performance of Biktarvy in 2023 compared to 2022, and what implications might this have on Gilead's long-term financial strategy given the patent expiration timeline for its principal HIV products?",
      "original_answer": "Biktarvy generated $11,850 million in total revenue in 2023, an increase from $10,390 million in 2022, representing a 14% growth. Given that Biktarvy is a key revenue driver, Gilead may need to prioritize extending its patent protection or developing follow-on therapies to maintain market exclusivity and revenue stability. The 10-K filing highlights that patent expiration dates for principal products, including those in fixed-dose combinations like Biktarvy, are critical for long-term revenue planning. If Biktarvy’s patent expires sooner than anticipated, the growth momentum may not be sustainable due to potential generic competition.",
      "llm_answer": "Biktarvy generated $11.9 billion of product revenue in 2023 versus $10.4 billion in 2022 – a 14 percent year‑over‑year increase (page 40). Because Biktarvy’s U.S. and EU patents run through 2033 (page 9) and its sales are still growing, the drug will continue to supply a sizable, protected cash stream for many years, allowing Gilead to fund R&D, acquisitions and diversification while it prepares for the eventual loss of exclusivity on its other HIV assets later in the 2030s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: Biktarvy revenue in 2023 is reported as $11.9 billion (vs. $11,850 million in ground truth), and $10.4 billion in 2022 (vs. $10,390 million), which correctly rounds the original figures. The 14% year-over-year growth is accurate: (11,850 - 10,390) / 10,390 ≈ 14%. These numeric values are within acceptable rounding tolerance and format variation ($11.9 billion = $11,900 million ≈ $11,850 million).\n\n2) The answer addresses both parts of the question: revenue performance (2023 vs. 2022) and implications for long-term financial strategy. It correctly identifies that Biktarvy’s patents extend to 2033 in the U.S. and EU, which aligns with the knowledge graph’s emphasis on patent expiration timelines affecting revenue planning. While the ground truth emphasizes the risk of generic competition if patents expire sooner, the LLM focuses on the current protection window enabling strategic investments—this is a valid, complementary interpretation.\n\n3) Entity accuracy is strong: Gilead is correctly identified, Biktarvy is the correct product, and years (2022, 2023) and financial metric (product revenue) are accurate. The mention of R&D, acquisitions, and diversification as strategic uses of cash flow is logically sound and contextually appropriate.\n\n4) Multi-hop reasoning is solid: the model connects revenue growth to patent protection timeline and infers strategic implications (funding innovation, preparing for loss of exclusivity). While the ground truth stresses vulnerability to early patent expiration, the LLM emphasizes the current stability—both are valid angles. The LLM adds specific geographic patent detail (U.S. and EU through 2033) not in the ground truth, suggesting deeper document insight, but does not contradict it.\n\nMinor deduction in qualitative accuracy because the LLM does not explicitly acknowledge the risk of unsustainable growth under potential early patent challenges or generic entry, which is a key nuance in the original answer. However, the overall reasoning is sound, complete, and contextually enriched.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 565,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "Given Gilead's single operating segment structure and centralized resource allocation, how might the impending U.S. patent expiration of Truvada in 2023 affect the company's ability to invest in lifecycle management initiatives for its HIV portfolio?",
      "original_answer": "Gilead's single operating segment structure enables centralized resource allocation across its HIV portfolio, including Truvada, which is a key part of its HIV prevention and treatment offerings. However, with Truvada's U.S. patent expiration in 2023, the loss of exclusivity could significantly reduce revenue from this product due to generic competition. This revenue decline may constrain the company's ability to invest in lifecycle management initiatives, such as developing next-generation formulations or combination therapies within the HIV portfolio, unless offset by cost reallocations or revenue from newer products.",
      "llm_answer": "Gilead’s 10‑K notes that the company operates as a single segment and that the chief operating decision‑maker “allocates resources on an entity‑wide basis” (page 58).  The loss of U.S. patent protection for Truvada in 2023 will cut a high‑volume, high‑margin HIV revenue stream, but the centralized budgeting process lets Gilead shift cash‑flow from other areas (e.g., the $8 billion of operating cash generated in 2023, page 57) into new “lifecycle‑management” projects for its remaining HIV products (which still have patents expiring through 2029‑2031, page 9).  Consequently, while the Truvada expiry will reduce overall funding, the single‑segment structure gives Gilead the flexibility to re‑prioritize and continue investing in extending the commercial life of its HIV portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Gilead's single operating segment and centralized resource allocation, citing the 10-K (page 58), which supports the structural flexibility in budgeting. (2) Quantitatively, it accurately references the $8 billion in operating cash flow from 2023 (page 57) and correctly notes patent expirations for the HIV portfolio extending to 2029–2031 (page 9). These numbers are correctly reported with valid source citations. (3) The reasoning is sound: it acknowledges the revenue impact of Truvada’s 2023 U.S. patent expiration but correctly emphasizes that centralized control allows reallocation of resources to lifecycle management initiatives, which matches the multi-hop logic in the ground truth. (4) The answer is semantically equivalent—while it adds specific financial data and page references not in the original, it does not contradict it and enhances completeness. The only minor limitation is that it slightly downplays the risk of constrained investment unless offset by reallocations (the original emphasizes this constraint more), but the core conclusion about flexibility is valid. Thus, the answer is factually correct, well-supported, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 355,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the 2023 IDA Agreement impact Schwab's capital management strategy and contract asset amortization in 2023, and what was the specific dollar amount of amortization associated with this agreement?",
      "original_answer": "The 2023 IDA Agreement allowed Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which supported its capital management strategy by reducing balance sheet pressure and enabling future migration of IDA balances as capital levels permit. Additionally, the agreement resulted in contract assets related to the buy-down of fixed-rate obligations, which were amortized over the contractual term as a reduction to bank deposit account fee revenue. The specific dollar amount of amortization associated with this agreement in 2023 was included in the broader amortization of capitalized contract costs, which totaled $85 million for the year ended December 31, 2023.",
      "llm_answer": "The 2023 IDA agreement required a portion of brokerage‑client deposits to be swept off‑balance‑sheet, and Schwab’s capital‑management plan now explicitly includes “management of the 2023 IDA agreement” and a future migration of those balances onto the balance sheet, which will be pursued only when the firm has sufficient capital to support the incremental deposits【page_59】.  The agreement also generated contract assets that represent the buy‑down of fixed‑rate obligations; these assets are amortized on a straight‑line basis and produced **$85 million** of amortization expense for 2023【page_96】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the impact of the 2023 IDA Agreement on Schwab's capital management strategy—specifically, sweeping brokerage client deposits off-balance sheet and planning for future migration when capital levels permit. It also accurately describes the creation of contract assets from the buy-down of fixed-rate obligations and their amortization over time. The dollar amount of amortization in 2023 is correctly stated as $85 million, matching the ground truth. (2) Quantitatively, the $85 million figure is accurate and correctly attributed to 2023 amortization. The format ($85 million) matches the ground truth in substance, though the LLM refers to it as 'amortization expense' while the original answer frames it as amortization reducing bank deposit account fee revenue. This is a minor semantic difference in presentation but does not contradict the fact. (3) The multi-hop reasoning is sound: the model connects the IDA Agreement to both capital management and contract asset amortization, synthesizing information across different sections of the filing. However, it slightly oversimplifies by not explicitly noting that the $85 million represents the total amortization of capitalized contract costs (of which the IDA-related amortization is a part), potentially implying the entire $85M is directly from the IDA agreement. The original answer is more precise in this nuance. (4) Despite this minor imprecision, the core facts, numbers, and reasoning are correct, warranting a high score. The answer is contextually complete and directly responsive to all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 446,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How do the changes in LTIP units and other unit issuances during 2023 affect the total equity of SPG as reported in its 2023 10-K filing?",
      "original_answer": "The changes in LTIP units and other unit issuances contributed to a net increase in total equity. Specifically, the issuance of limited partner units added $197,426 to equity, while the long-term incentive performance units added $14,739. These increases were partially offset by the redemption of limited partner units, which reduced equity by $13,524 and treasury unit purchases that reduced equity by $140,593. Overall, these transactions resulted in a net reduction of $139,378 in equity from unit-related activities.",
      "llm_answer": "In 2023 the company recorded **long‑term incentive performance (LTIP) units** that were issued to limited‑partner owners, which added **$14.7 million** ( $14,739 thousand) to total equity.  At the same time the company issued **unit equivalents and other common units (50,658 units)**, which reduced total equity by **$16.1 million** ( $16,119 thousand).  Consequently, the LTIP issuances increased equity, but the broader unit‑equivalent issuance produced a slightly larger offset, netting a modest overall decline of about **$1.4 million** in total equity from these two items.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the addition from LTIP units ($14,739 thousand = $14.7 million), it incorrectly states that 'unit equivalents and other common units' reduced equity by $16.1 million, which does not align with the ground truth. The ground truth specifies multiple distinct transactions: issuance of limited partner units (+$197,426), redemption of limited partner units (-$13,524), and treasury unit purchases (-$140,593), resulting in a net reduction of $139,378. The LLM answer omits these key components and introduces a non-matching figure of $16.1 million for a category not defined in the original data. (2) The calculation is therefore incorrect: the LLM suggests a net decline of $1.4 million from two items, whereas the actual net impact is a reduction of $139,378 (over 100x larger). Additionally, the LLM fails to mention the $197,426 equity increase from limited partner unit issuances, a major omission. (3) The multi-hop reasoning is flawed—the model does not synthesize all relevant unit-related transactions as reported in the 10-K. It conflates or misrepresents categories (e.g., 'unit equivalents and other common units') and misses critical offsets, especially the large issuance and redemption dynamics. (4) Contextual relevance is moderate because the answer addresses unit issuances and their equity impact, but due to major quantitative and qualitative errors, the overall correctness score is low. The answer misleads on the scale and nature of the equity changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 432,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does Linde's distribution of Process Gases through on-site plants influence its long-term contract structure and revenue recognition policy, based on the specific distribution and accounting practices described in the 2024 10-K filing?",
      "original_answer": "Linde's distribution of Process Gases through on-site plants leads to long-term contracts (typically 10–20 years) with minimum purchase requirements and price escalation provisions. These contracts are structured as total requirement agreements, where revenue is recognized over time as product is delivered and the company has the right to invoice. This method of revenue recognition aligns with the continuous delivery of gases through pipelines and ensures that revenue reflects the ongoing supply of Process Gases to large-volume customers.",
      "llm_answer": "Linde’s process‑gas on‑site distribution is done through cryogenic or process‑gas plants that it builds and operates at the customer’s location. These plants are covered by “total‑requirement” contracts that typically run 10‑20 years, contain minimum‑purchase commitments and price‑escalation clauses, and therefore create long‑term supply obligations. Because the performance obligation is satisfied continuously as gas is delivered, Linde applies ASC 606’s over‑time method (using the practical expedient that revenue is recognized when it has the right to invoice), which results in revenue being recognized incrementally with each delivery and generates contract assets or liabilities tied to those long‑term on‑site agreements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: Linde's on-site gas distribution uses long-term contracts (10–20 years), includes minimum purchase requirements and price escalation clauses, and operates under total requirement agreements. Revenue is recognized over time as gas is delivered, aligned with ASC 606 using the right-to-invoice practical expedient. (2) There are no numeric values requiring calculation, but the time frame '10–20 years' matches exactly between answers. (3) The multi-hop reasoning is sound—linking on-site distribution to long-term contracts, then to revenue recognition policy under ASC 606, demonstrating correct synthesis of operational and accounting practices from the 2024 10-K. (4) The LLM adds slightly more technical detail (e.g., reference to ASC 606 and 'contract assets or liabilities') that are consistent with the filing and enhance accuracy without introducing error. Wording differs but meaning is identical. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 309,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the difference in the fair value of corporate notes and obligations between the two disclosed tables, and how does this difference compare to the overall change in total marketable securities' fair value across the same disclosures?",
      "original_answer": "The fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million. The total marketable securities' fair value decreased from $5,492 million to $5,722 million, representing an overall increase of $230 million. Therefore, while corporate notes and obligations saw a significant decline, the overall portfolio of marketable securities increased in value.",
      "llm_answer": "The fair‑value of corporate notes and obligations fell from $3,354 million at January 31 2023 to $2,978 million at January 31 2024 – a decrease of **$376 million**. Over the same period the fair‑value of total marketable securities rose from $5,492 million to $5,722 million – an **increase of $230 million**. Thus, the drop in corporate‑notes fair value more than offset the overall rise in the marketable‑securities portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: the fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million, which matches the ground truth. The total marketable securities' fair value increased from $5,492 million to $5,722 million, a $230 million increase, also accurate. (2) All calculations are correct: $3,354M - $2,978M = $376M decrease; $5,722M - $5,492M = $230M increase. Number formats are consistent and acceptable. (3) The multi-hop reasoning is sound—information is synthesized across two disclosures (likely two years or tables), and the comparison between the decline in corporate notes and the overall increase in marketable securities is logically presented. (4) The only minor issue is a slight mischaracterization in the conclusion: stating that 'the drop in corporate-notes fair value more than offset the overall rise' is misleading because the corporate notes are a subset of the total marketable securities. The total portfolio increased, so the decline in one component did not 'offset' the overall rise—it was simply outweighed by gains in other components. This does not invalidate the facts but introduces a small logical inaccuracy. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative reasoning, resulting in a 9/10 overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 392,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the impact of changing provider behavior, as described in the Health Care Benefits segment, affect the accuracy of CVS's premium pricing forecasts and ultimately its operating results, given the fixed premium period and the sensitivity of profits to forecast accuracy?",
      "original_answer": "Changing provider behavior, such as hospitals and providers attempting to maintain revenue levels during economic downturns, increases CVS's medical costs and limits its ability to accurately forecast and price for medical cost trends. This is especially problematic because premiums for Insured Health Care Benefits products, which make up 94% of Health Care Benefits segment revenues, are set in advance based on forecasts and cannot be adjusted during the fixed premium period. Even small differences between predicted and actual costs can significantly affect operating results, as profits are highly sensitive to forecast accuracy. Therefore, unpredictable provider behavior amplifies the risk of adverse financial outcomes for CVS.",
      "llm_answer": "Changing provider behavior—such as hospitals and other providers raising utilization or shifting services to preserve revenue—creates volatility in health‑care costs and claim‑submission patterns. Because CVS prices its Insured Health‑Care Benefits premiums in advance for a fixed 12‑month period, any cost increases that exceed the forecasts cannot be recovered through higher premiums, making profits extremely sensitive to forecast accuracy. Consequently, mis‑judging provider‑driven cost trends can lead to larger‑than‑expected claim expenses and materially depress the Health Care Benefits segment’s operating results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: provider behavior (e.g., increasing utilization to maintain revenue) increases cost volatility; premiums are fixed in advance (12-month period mentioned, consistent with 'fixed premium period'); inability to adjust premiums during the term; and high sensitivity of profits to forecast accuracy. (2) Quantitative accuracy is perfect: while no specific numbers (e.g., 94%) are repeated, the omission does not distort meaning—the focus is on the structural risk, not statistical detail. The 94% revenue figure from the original is relevant context but not essential to answering the causal chain in the question. (3) Multi-hop reasoning is sound: the model correctly links provider behavior → cost volatility → forecasting difficulty → fixed premiums preventing adjustment → profit sensitivity → adverse operating results. This reflects proper synthesis across cause-effect链条. (4) Semantic equivalence is strong; wording differs (e.g., 'materially depress operating results' vs 'adverse financial outcomes') but meaning is preserved. One minor point preventing a 10 is the slightly less explicit connection to 'economic downturns' as the driver of provider behavior, though 'preserve revenue' implies it. Overall, the answer is factually correct, contextually appropriate, and logically coherent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 392,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does Chevron's acquisition of Noble in October 2020, which added 6,000 cubic feet of natural gas per barrel of crude oil in production capacity, support its ability to maintain high-quality debt ratings of AA- (S&P) and Aa2 (Moody's) during periods of low commodity prices?",
      "original_answer": "Chevron's acquisition of Noble added production capacity measured in oil-equivalent barrels, where 6,000 cubic feet of natural gas equals 1 barrel of crude oil. This expanded production base increases cash flow potential from upstream operations. Chevron stated that during periods of low crude oil and natural gas prices, it can adjust its capital spending and reduce stock repurchases to preserve financial flexibility. Given that Chevron's debt is rated AA- by S&P and Aa2 by Moody’s—indicating strong creditworthiness—the additional production from Noble enhances Chevron’s ability to generate cash and maintain its investment-grade credit profile, even in challenging market conditions.",
      "llm_answer": "The October 2020 purchase of Noble added roughly 6,000 cubic feet of natural‑gas production for every barrel of oil‑equivalent (the conversion factor used in Chevron’s production tables) 【page_8】.  That extra oil‑equivalent output increased operating cash flow (e.g., operating cash of $29.2 billion in 2021) and helped the company cut total debt by $12.9 billion in 2021, strengthening its balance sheet and liquidity 【page_44】.  Because the higher cash‑generating capacity lets Chevron trim capital spending, suspend share‑repurchases and still fund its dividend, rating agencies view the company as able to meet its obligations even when commodity prices are low, supporting its AA‑ / Aa2 high‑quality ratings 【page_45】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core facts: Chevron's acquisition of Noble in October 2020 added 6,000 cubic feet of natural gas per barrel of oil-equivalent, which aligns with the ground truth's explanation that 6,000 cubic feet of gas equals 1 barrel of crude oil in oil-equivalent terms. The mention of increased cash flow and financial flexibility supports the maintenance of high credit ratings (AA-/Aa2), which matches the original answer’s reasoning. (2) Quantitatively, the LLM introduces specific figures not in the ground truth—$29.2 billion in operating cash flow in 2021 and $12.9 billion debt reduction—but these are plausible and consistent with Chevron’s reported performance post-acquisition. Since the ground truth does not include these numbers, their inclusion is not incorrect but represents additional contextual detail likely drawn from the cited pages. No calculation errors are present. (3) The multi-hop reasoning is sound: the model connects the acquisition → increased production → higher cash flow → improved balance sheet → ability to maintain credit ratings during low commodity prices. It correctly synthesizes operational impact with financial policy (cutting capex, suspending buybacks) and links to creditworthiness. (4) The answer is semantically equivalent to the ground truth, with slightly more granular financial data. The only minor limitation is that it cites page references not available in the original, but this doesn’t affect factual accuracy. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 436,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How much did Schwab spend to buy down fixed-rate obligation amounts under the 2023 IDA agreement, and how is this amount classified on the consolidated balance sheet?",
      "original_answer": "Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount was capitalized as contract assets and included in other assets on the consolidated balance sheet.",
      "llm_answer": "Schwab elected to buy down the full $5 billion of fixed‑rate obligation amounts permitted under the 2023 IDA agreement, incurring market‑based fees of **$249 million**.  Those fees were **capitalized as contract assets** and are presented within **other assets** on the consolidated balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligations under the 2023 IDA agreement. The dollar amounts match exactly, with acceptable formatting ($249 million vs $249 million). (2) The classification on the balance sheet is correctly stated: the $249 million was capitalized as contract assets and included in other assets, which aligns precisely with the original answer. (3) The multi-hop reasoning is sound—this requires linking the IDA agreement (a specific contractual arrangement) to the financial outflow and its proper accounting treatment on the balance sheet. The model correctly synthesizes the transaction amount, its purpose, and its financial statement classification. (4) No factual, numerical, or conceptual errors are present. Wording differs slightly (e.g., 'incurring market-based fees' vs 'spent'), but the meaning is equivalent. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 301,
        "total_tokens": 1436
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How much in store impairment charges did CVS record in 2024 as part of its enterprise-wide restructuring plan, and how does this compare to the expected cost savings projected for 2025 from that same initiative?",
      "original_answer": "CVS recorded $483 million in store impairment charges in 2024 as part of its enterprise-wide restructuring plan. The company projected that this restructuring would generate over $500 million in cost savings for 2025. Therefore, the impairment charges represent a near-term financial cost that is expected to be offset by anticipated longer-term savings in the following year.",
      "llm_answer": "CVS recorded a **$483 million store‑impairment charge in 2024** tied to its enterprise‑wide restructuring plan. The same plan is projected to **deliver more than $500 million of cost savings in 2025**, so the anticipated savings exceed the 2024 impairment charge by roughly $17 million (or a greater amount, since the savings are described as “over $500 million”).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $483 million store impairment charge in 2024 and the 'over $500 million' projected cost savings in 2025 are accurately reported, with appropriate acknowledgment of the phrasing 'over $500 million' implying potential savings exceeding $500 million. The observation that savings exceed the charge by at least $17 million is a reasonable inference. (2) The answer is complete, addressing both parts of the question: the 2024 impairment amount and the 2025 projected savings comparison. (3) Entities—CVS, the enterprise-wide restructuring plan, the correct years (2024 and 2025), and financial metrics (impairment charges, cost savings)—are all correctly identified. (4) The multi-hop reasoning is sound: the model correctly synthesizes data across time (2024 charge vs. 2025 savings) and interprets the financial trade-off between near-term costs and anticipated future benefits. (5) The semantic meaning is equivalent to the original answer, with slightly enhanced analytical insight (explicit comparison of $17 million difference) without introducing error. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 337,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was Chevron's equity in earnings from Angola LNG Limited in 2021, and what does this indicate about Chevron's involvement in the liquefied natural gas market in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited was -$166 million in 2021, indicating that Chevron's 36.4% stake in the venture resulted in a loss that year, reflecting potential challenges in the liquefaction and processing of natural gas for international markets.",
      "llm_answer": "Chevron reported **$336 million** of equity‑in‑earnings from its 36.4 % interest in Angola LNG Limited for 2021. This sizable earnings contribution demonstrates that Chevron is actively involved in the Angolan liquefied natural gas market, earning substantial profit from the processing and export of Angolan natural gas.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Chevron had $336 million in equity earnings from Angola LNG Limited in 2021. The ground truth is -$166 million, indicating a loss, not a profit. This fundamental error undermines the entire response. The percentage stake (36.4%) is correct, but the financial outcome is completely misrepresented. (2) The quantitative inaccuracy is severe: $336 million vs. -$166 million is not only a sign error but also a magnitude difference of over $500 million. This suggests either a data retrieval or synthesis failure. No plausible calculation or formatting variation explains this discrepancy. (3) The multi-hop reasoning fails because the model incorrectly infers profitability and strong market involvement from a loss-making position. The correct reasoning would link the negative equity earnings to operational or market challenges in Angola’s LNG sector, such as underutilization of liquefaction capacity or high processing costs. Instead, the LLM draws an opposite and unsupported conclusion about 'substantial profit' and active success. (4) Scores are low because the core fact (earnings value) is wrong, leading to incorrect interpretation. Contextual relevance is moderate (6/10) because the answer addresses the right company, venture, stake percentage, and market context, but with flawed data and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 384,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What operational risks does NextEra Energy Resources face given the mismatch between the Duane Arnold decommissioning timeline (expected completion by 2080) and the expiration dates of its nuclear fuel supply contracts (through 2033)?",
      "original_answer": "NextEra Energy Resources faces the risk of managing nuclear fuel supply beyond the expiration of existing contracts in 2033 while maintaining safe and compliant decommissioning operations at Duane Arnold, which is expected to continue through 2080. This creates a planning challenge as NEER must secure alternative fuel sources or storage solutions for the spent nuclear fuel onsite, which remains in long-term dry storage until the DOE can take possession. The gap between the expiration of fuel supply contracts and the long-term decommissioning obligations could lead to increased operational costs, regulatory scrutiny, or the need for additional capital expenditures to maintain safe storage.",
      "llm_answer": "NextEra Energy Resources (NEER) notes that its nuclear fuel‑supply contracts for all of its reactors expire no later than 2033, while the de‑commissioning of the Duane Arnold plant – which is not expected to be recommissioned – is projected to be fully funded but not completed until roughly 2080. This creates an operational risk that, after the fuel contracts lapse, NEER could lack a secured source of uranium and fuel‑fabrication services should it decide to restart Duane Arnold, or it may have to negotiate new contracts at higher cost to support any future restart. In addition, the long‑term de‑commissioning horizon exposes the company to prolonged funding, storage and regulatory‑compliance obligations that extend far beyond the life of its existing fuel agreements, increasing the risk of cost overruns or financing shortfalls. (See page 16).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly identifies key dates (fuel contracts expiring by 2033 and decommissioning completion around 2080), which aligns with the ground truth. However, it introduces a significant factual inaccuracy by suggesting the possibility of restarting Duane Arnold, stating NEER 'could lack a secured source of uranium... should it decide to restart Duane Arnold.' This contradicts the original context, which clearly states Duane Arnold is not expected to be recommissioned and is in long-term decommissioning. The operational risk is not about potential restart but about managing spent fuel storage and compliance during the decades-long decommissioning process. 2) Quantitatively, the dates (2033 and 2080) are accurate and correctly referenced. No calculations are required, so numerical precision is not an issue. Format and presentation of years are consistent with ground truth. 3) The multi-hop reasoning is partially sound—linking fuel contract expiration with long-term decommissioning is valid. However, the reasoning misfires by focusing on fuel procurement for potential restart rather than the actual risk: long-term on-site storage of spent fuel after contracts end and the associated costs, regulatory burden, and DOE dependency. The ground truth emphasizes safe storage and lack of disposal pathway, not restart capability. 4) Contextual relevance is high because the answer addresses the timeline mismatch and associated risks like cost overruns and regulatory obligations. But the core qualitative error—framing the risk around restart—shifts the focus away from the real issue of spent fuel management. This undermines the qualitative accuracy despite otherwise coherent structure and sourcing (e.g., reference to page 16).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 474,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Linde's involvement in the Amur GPP project, including contingent liabilities and contract suspensions, contrast with its revenue recognition policies for on-site industrial gas contracts, and what does this reveal about the financial risk exposure in long-term on-site agreements?",
      "original_answer": "Linde faces a contingent liability of $0.7 billion related to the Amur GPP project, stemming from fires and subsequent legal claims in Russia, and had its contracts suspended due to sanctions. This highlights the financial risk in long-term engineering projects, especially those involving international legal exposure. In contrast, Linde's on-site industrial gas contracts, which often span 10–20 years and include minimum purchase requirements, recognize revenue over time as product is delivered, based on the right to invoice. These contracts are generally more stable and predictable, with revenue tied to ongoing delivery rather than one-time project completion. However, the Amur GPP case shows that long-term on-site or project-based involvement can lead to significant unforeseen liabilities, even if the company is not directly responsible for construction flaws. This contrast reveals that while on-site contracts provide steady revenue, they also carry latent risks when tied to large infrastructure projects with multiple stakeholders and geopolitical exposure.",
      "llm_answer": "Linde’s Amur GPP involvement is an engineering‑procurement‑construction subcontract that was lawfully suspended in May 2022 because of sanctions and now carries a $0.7 billion contingent liability (page 84). By contrast, its on‑site industrial‑gas contracts are long‑term “total‑requirement” supply agreements (10‑20 years) whose performance obligations are satisfied over time and revenue is recognized as product is delivered and invoiced (page 87), with contract assets and liabilities recorded for the timing differences (page 88). The juxtaposition shows that, although on‑site sales generate steady, recognized revenue, Linde remains exposed to substantial financial risk when such long‑term agreements are disrupted by external events – the same type of disruption that has produced the sizable contingent liabilities on the Amur GPP project.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: the $0.7 billion contingent liability and the May 2022 suspension date match the original answer. The reference to specific pages (84, 87, 88) adds precision, though not required, and does not detract from accuracy. (2) The answer correctly identifies Linde’s role in the Amur GPP project as a subcontractor and notes the suspension due to sanctions, which is consistent with the original. It accurately contrasts this with on-site industrial gas contracts, correctly describing their 10–20 year duration, revenue recognition over time based on delivery and invoicing, and the use of contract assets/liabilities for timing differences. (3) The multi-hop reasoning is sound: it synthesizes information about project-based risks (Amur GPP) with revenue recognition policies for long-term supply contracts and draws a logical conclusion about financial risk exposure. The only minor shortcoming is that it does not explicitly mention 'minimum purchase requirements' or 'geopolitical exposure' as clearly as the original, and the insight about construction flaws and indirect liability is slightly less developed. However, the core contrast—between stable revenue recognition and potential for large contingent liabilities when disrupted by external events—is well articulated. (4) The answer is fully contextually relevant, directly addressing all parts of the question: Linde's involvement in Amur GPP, contingent liabilities, contract suspensions, revenue recognition policies, and the implications for financial risk in long-term agreements. Overall, this is a factually correct, well-reasoned response with only slight room for deeper qualitative nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 480,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the expected increase in TAC paid to Google Network partners, driven by shifts in device and geographic mix, directly impact the gross advertising revenue recognition model described in the consolidated financial statements?",
      "original_answer": "The increase in TAC paid to Google Network partners, driven by changes in device mix, geographic mix, and partner mix, directly affects the gross advertising revenue recognition model by increasing the cost of revenues associated with ads placed on Google Network properties. Since Google reports advertising revenues from these properties on a gross basis—recording the full amount billed to customers as revenue and the amounts paid to partners as cost of revenues—an increase in TAC results in higher cost of revenues. This dynamic puts downward pressure on gross margins, even as total advertising revenues may grow. For example, the financial statements note that Google recognizes revenues for ads on Google Network properties on a gross basis, with partner payments recorded as cost of revenues, while the MD&A section indicates that TAC is expected to rise with revenue growth and will vary based on multiple factors, including partner agreement terms and geographic mix.",
      "llm_answer": "The filing says that, because the mix of devices, geographies and partners is shifting, the amount of **TAC (traffic‑acquisition costs) paid to Google Network partners will rise** (Item 7, p. 29).  Under the revenue‑recognition policy for Google Network ads, Alphabet records **advertising revenue on a gross basis** – the full amount billed to advertisers is recognized as revenue, while the payments to Network partners are booked separately as **cost of revenues (TAC)** (Note 1, p. 55‑56).  Consequently, a higher TAC does not change the timing or amount of gross advertising revenue recognized; it simply increases the cost‑of‑revenues line and compresses the gross‑margin on that revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) It correctly identifies that TAC increases due to shifts in device, geographic, and partner mix, and that this impacts the gross advertising revenue model by increasing cost of revenues without affecting gross revenue recognition. The key entities—Google Network partners, TAC, gross revenue recognition, cost of revenues—are all correctly identified and used in context. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or fabricated data earns a perfect score. (3) The reasoning is sound: the LLM correctly explains the multi-hop logic that because revenue is recognized on a gross basis, higher TAC does not reduce reported revenue but increases costs, thereby compressing gross margin. It references the correct accounting policy (gross reporting with TAC as cost of revenue) and links it to the impact of rising partner payments. The only minor omission is that the original answer explicitly mentions downward pressure on gross margins and ties TAC variability to agreement terms and revenue growth—details slightly more developed than in the LLM response, which mentions margin compression but less explicitly connects TAC to revenue growth. (4) The answer is fully relevant to the question, directly addressing how rising TAC affects the gross revenue recognition model. Overall, the LLM captures the essential financial mechanics accurately and concisely, warranting a high correctness score with only slight room for added contextual depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 452,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How much of Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is influenced by compliance with the Coal Ash Act, given that closure methods must align with state and federal regulations and the ultimate method and timetable will affect the recorded ARO amount?",
      "original_answer": "Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is directly influenced by compliance with the Coal Ash Act, as the ARO amount recorded on the Consolidated Balance Sheets is based on estimated closure costs for impacted ash impoundments under this regulation. The closure methods—such as excavation and relocation of ash to a lined landfill or beneficial reuse—must align with standards set by the Coal Ash Act and other federal regulations, and the ultimate method and timetable for closure will determine the actual costs incurred, which may result in a material change to the ARO balance.",
      "llm_answer": "Duke Energy’s recorded ARO for the closure of coal‑ash impoundments – the portion that is driven by the need to comply with the EPA CCR rule and the North Carolina Coal Ash Management Act (the “Coal Ash Act”) – totals **$5.293 billion** on the consolidated balance sheet【page_177】. The ARO amount reflects the discounted cash‑flows of estimated closure costs, which will change as the ultimate closure method and timetable (required to meet the Coal Ash Act and other federal and state regulations) are finalized【page_178】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a specific dollar amount ($5.293 billion) for Duke Energy’s ARO related to coal ash impoundment closure, which is not present in the original answer (ground truth). However, the ground truth does not include any numerical value for the ARO—only a qualitative explanation of how the ARO is influenced by the Coal Ash Act, closure methods, and regulatory requirements. Since the original answer contains no dollar figure, the inclusion of $5.293 billion cannot be verified as correct from the provided ground truth, making the quantitative claim unsupported and potentially incorrect. This significantly undermines the correctness score. The qualitative aspects of the LLM answer are strong: it correctly identifies the Coal Ash Act and federal regulations (like the EPA CCR rule) as key drivers of the ARO, explains that closure methods (e.g., excavation, relocation) affect costs, and notes that the timetable and final method will impact the recorded ARO—this aligns well with the multi-hop reasoning in the ground truth. The context and entities (Duke Energy, Coal Ash Act, ARO, closure methods) are accurate and relevant. While the reasoning is sound and the answer is contextually appropriate, the unsupported numerical figure leads to a moderate correctness score. The model may have pulled the number from an external source or a different part of the filing not reflected in the ground truth, but since the evaluation is based solely on alignment with the provided original answer, the number cannot be considered accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 424,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables in the 2023 10-K filing for CRM?",
      "original_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two tables is a decrease of $58 million, calculated by subtracting the fair value of $178 million in the second table from the fair value of $236 million in the first table.",
      "llm_answer": "The fair‑value of the Mortgage‑Backed Obligations increased from **$178 million** (as of January 31 2023) to **$236 million** (as of January 31 2024), a rise of **$58 million**【page_77†L23-L27】【page_79†L13-L17】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and magnitude of change. The ground truth states that the fair value decreased from $236 million to $178 million, resulting in a $58 million decrease. However, the LLM incorrectly claims an increase from $178 million to $236 million, which misrepresents the data and reverses the trend. While the numerical values ($178M and $236M) are correctly extracted and the $58M difference is arithmetically accurate, the reasoning is flawed because it uses the values in reverse order. This leads to an incorrect conclusion about the direction of change, which is critical for financial interpretation. The entity (Mortgage-Backed Obligations), company (CRM), and filing (2023 10-K) are correct, and the answer addresses the question's focus on change in fair value, so contextual relevance is high. However, due to the severe factual and logical error in the quantitative direction and resulting calculation, the correctness, quantitative, and qualitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 295,
        "total_tokens": 1409
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What percentage of Danaher's Diagnostics segment sales in 2023 were attributed to 'other developed markets', and which specific geographic regions does the company classify under this category?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to 'other developed markets'. According to the company's definitions, this category includes the regions of Japan, Australia, and New Zealand.",
      "llm_answer": "In 2023, 5 percent of Danaher’s Diagnostics segment sales were generated in “other developed markets.” The company classifies “other developed markets” as Japan, Australia and New Zealand.【page_9】【page_78】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that 5 percent of Danaher’s Diagnostics segment sales in 2023 were attributed to 'other developed markets,' which aligns with the original answer. (2) The numeric value (5%) is correct, and no calculations are required beyond what is directly reported. (3) The answer correctly identifies the geographic regions classified under 'other developed markets' as Japan, Australia, and New Zealand, which is consistent with the company's definitions in the source material. (4) The response addresses both parts of the multi-hop question: the percentage of sales and the specific regions included in the category. The inclusion of citation markers ['page_9']['page_78'] suggests proper grounding in the source documents. Semantic equivalence is maintained, with no factual discrepancies, omissions, or reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 262,
        "total_tokens": 1376
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad, given the carload volume and average revenue per car for that category?",
      "original_answer": "The total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad was $6,656,270,000, calculated by multiplying the 2021 Bulk carloads (1,920,000) by the average revenue per car in 2021 ($3,467).",
      "llm_answer": "Union Pacific’s Bulk shipments generated about **$6.66 billion** in 2021. This is derived from 2,014 thousand carloads × $3,305 average revenue per car = $6,656 million (≈ $6.66 billion).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key inputs despite arriving at a numerically close result. The ground truth uses 1,920,000 carloads and $3,467 average revenue per car, while the LLM uses 2,014,000 carloads and $3,305, both of which are incorrect. The final revenue figure is rounded to $6.66 billion, which is close to the correct $6.656 billion, but this appears to be coincidental due to offsetting errors in the inputs. (2) Calculation verification: 1,920,000 × $3,467 = $6,656,640,000 (matches ground truth within rounding). LLM calculation: 2,014,000 × $3,305 = $6,656,270,000 — same output due to different inputs, suggesting potential data hallucination or misattribution. (3) Multi-hop reasoning is structurally sound (carloads × revenue per car = total revenue), but the model fails to use the correct source data, indicating a failure in entity and data retrieval accuracy. (4) Scores reflect major quantitative inaccuracies (2/10) due to wrong base figures, moderate qualitative reasoning (3/10) for correct formula application, high contextual relevance (8/10) as it addresses the right metric and year, and low overall correctness (3/10) due to reliance on incorrect underlying data despite proximate final number.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1105,
        "completion_tokens": 351,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ, and how does this reflect a reduction from Duke Energy's initial estimate following the April 1, 2019 closure determination?",
      "original_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina is approximately $8 billion to $9 billion after the settlement agreement with NCDEQ. This represents a reduction of approximately $1.5 billion from Duke Energy's initial estimate of $9.5 billion to $10.5 billion that followed the April 1, 2019 closure determination requiring excavation of the nine remaining impoundments.",
      "llm_answer": "The settlement with the North Carolina Department of Environmental Quality lowered the undiscounted, undiscounted cost to permanently close every coal‑ash basin in North Carolina and South Carolina to roughly **$8 billion‑$9 billion** (about $3.1 billion of which had already been spent through 2021).  That figure is about **$1.5 billion less** than Duke Energy’s original post‑April 1 2019 estimate, which had projected a total of **$9.5 billion‑$10.5 billion** to close all basins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total estimated undiscounted cost to close coal ash basins as $8 billion–$9 billion after the settlement with NCDEQ, and accurately states this is a $1.5 billion reduction from Duke Energy’s initial post-April 1, 2019 estimate of $9.5 billion–$10.5 billion. All key numbers and ranges match the ground truth exactly. (2) Quantitative accuracy is perfect: the $1.5 billion reduction is correctly calculated as the midpoint difference (e.g., $10 billion initial minus $8.5 billion revised ≈ $1.5 billion), and the ranges are preserved. The additional detail about $3.1 billion spent by 2021 is not in the ground truth but does not contradict it and adds context without error. (3) The multi-hop reasoning is sound—LLM correctly links the April 1, 2019 closure determination to the initial estimate and contrasts it with the revised estimate post-settlement. The entities (Duke Energy, NCDEQ, coal ash basins, North Carolina and South Carolina) are correctly identified and used. (4) The answer is semantically equivalent to the ground truth, with only minor rephrasing. The only reason for not scoring a 10 in correctness is the slight redundancy in 'undiscounted, undiscounted' (likely a typo), which does not affect factual accuracy. All other dimensions are strong, with full contextual relevance and precise qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 386,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total cash consideration paid by Mastercard for both Dynamic Yield LTD in 2022 and Recorded Future in 2024, and how does this spending reflect the company's acquisition strategy?",
      "original_answer": "Mastercard paid a total cash consideration of $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The combined total is $3.025 billion. These acquisitions align with the company's strategy to grow, diversify, and build its business by integrating specialized capabilities, such as Dynamic Yield's personalization technology and Recorded Future's threat intelligence, into Mastercard's broader service offerings.",
      "llm_answer": "Mastercard paid $325 million in cash for Dynamic Yield LTD in 2022 and $2.7 billion in cash for Recorded Future in 2024 – a combined cash outlay of roughly $3.0 billion. These acquisitions underscore Mastercard’s strategy of using sizable cash purchases to expand beyond its core payments network into data‑driven, intelligence‑based services, diversifying its portfolio and strengthening its value‑added solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the cash consideration for both acquisitions: $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024, matching the ground truth. The combined total is stated as 'roughly $3.0 billion', which is a reasonable approximation of the exact $3.025 billion. While the rounding is acceptable in context, it slightly deviates from the precise sum, preventing a perfect quantitative score. (2) All numeric values and years are accurate, and the format variations (e.g., $2.7 billion vs $2,700 million) are acceptable. The calculation of the total is logically sound, though not explicitly stated as $3.025 billion. (3) The multi-hop reasoning is correct—information from two separate acquisitions across different years is synthesized properly. The entity names (Dynamic Yield LTD, Recorded Future), years (2022, 2024), and financial metric (cash consideration) are all accurately identified and linked to Mastercard. (4) The qualitative explanation reflects the company's acquisition strategy accurately, emphasizing expansion into data-driven and intelligence-based services, diversification, and value-added solutions—consistent with the ground truth's emphasis on integrating specialized capabilities. The wording differs but the semantic meaning and strategic insight are equivalent. Contextual relevance is excellent as all parts of the question are addressed with appropriate detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 403,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of International bonds held by VZ according to both tables, and how does the categorization of these bonds differ between the two disclosures?",
      "original_answer": "The total fair value of International bonds held by VZ is $540 million, with $12 million disclosed in the first table and $528 million disclosed in the second table. The categorization of these bonds differs significantly: in the first table, $9 million is classified as Level 1 and $3 million as Level 2, while in the second table, only $10 million is classified as Level 1 and $518 million is classified as Level 2.",
      "llm_answer": "- **Total fair‑value of International bonds**  \n  *Pension‑plan table (page 92):* $341 million (2023) / $528 million (2022)  \n  *Other post‑retirement‑benefit table (page 93):* $12 million (2023) / $12 million (2022)  \n\n  **Combined total:** $353 million for 2023 (and $540 million for 2022).\n\n- **Difference in categorization**  \n  In the pension‑plan disclosure the International bonds are shown as a distinct line‑item under **Fixed‑income securities** of the pension‑plan asset allocation, broken out by Level 1 and Level 2 holdings. In the other post‑retirement‑benefit disclosure the same “International bonds” appear under **Fixed‑income securities** of the other benefit‑plan assets, also split by Level 1 and Level 2, but they are part of a separate benefit‑plan asset pool rather than the pension‑plan pool.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. The ground truth states the total fair value is $540 million, with $12 million in the first table and $528 million in the second. The LLM incorrectly reports $341 million and $12 million as 2023 values, summing to $353 million for 2023, which contradicts the correct total of $540 million. It also introduces 2022 data not requested in the question, creating confusion. The correct total ($540M) only appears incidentally as a 2022 sum, but the question does not ask for historical data or differentiate by year. (2) The categorization details are entirely missing: the ground truth specifies $9M Level 1 and $3M Level 2 in the first table, and $10M Level 1 and $518M Level 2 in the second. The LLM fails to report any of these breakdowns, instead offering generic descriptions of where the bonds are categorized without the required quantitative split. (3) The multi-hop reasoning is partially sound in that the model identifies two tables and attempts to combine values, but it misidentifies which values to extract and incorrectly associates them with years not specified in the question. The synthesis fails because it uses incorrect source data. (4) The contextual relevance is moderate—structure and intent align with the question, and it recognizes the need to compare two disclosures—but the severe quantitative inaccuracies and missing categorization details drastically reduce correctness. The answer would be more accurate if it ignored years and correctly extracted the $12M and $528M as contemporaneous values summing to $540M, with proper Level 1/Level 2 breakdowns.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 454,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Mastercard's real-time account-based payments infrastructure support its global payment network operations, and what portion of transactions does it handle for domestic and cross-border Mastercard and Maestro-branded card transactions?",
      "original_answer": "Mastercard's real-time account-based payments infrastructure enables instant payments between bank accounts with enhanced data and messaging capabilities, supporting both domestic and cross-border transactions. This infrastructure is part of a globally integrated payment network that handles approximately 70% of all transactions for Mastercard and Maestro-branded cards, including nearly all cross-border transactions.",
      "llm_answer": "Mastercard’s real‑time account‑based payments capability builds, operates and enhances a global real‑time clearing‑and‑settlement infrastructure, payment platforms and direct‑debit systems that allow ACH‑type batch and instant (real‑time) account‑to‑account transfers in many countries.  By integrating this infrastructure with its four‑party network, Mastercard can route, authorize, clear and settle payments instantly for issuers, acquirers, merchants and cardholders worldwide.  As a result, Mastercard switches roughly **70 % of all transactions on its Mastercard and Maestro‑branded cards**, covering virtually all cross‑border transactions and the majority of domestic ones.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 70% figure for transactions handled by Mastercard's real-time infrastructure is correctly reported, matching the original answer. The phrasing 'roughly 70%' is semantically equivalent to 'approximately 70%' in the ground truth. (2) The answer correctly identifies that this infrastructure supports both domestic and cross-border transactions, noting it covers 'virtually all cross-border transactions and the majority of domestic ones,' which aligns with 'nearly all cross-border transactions' and implies the remainder are domestic—consistent with the original. (3) The reasoning is sound: the LLM explains how the real-time infrastructure integrates with the four-party model to enable instant routing, clearing, and settlement, which accurately reflects the operational support role of the system. (4) Minor deduction in qualitative accuracy due to slightly more verbose and technical phrasing (e.g., 'ACH-type batch', 'direct-debit systems') not present in the original, but these do not introduce inaccuracies and may provide additional context. No factual errors; semantic equivalence is strong across all key points. Contextual relevance is perfect—directly addresses both parts of the question: infrastructure functionality and transaction volume share.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 376,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much cash consideration did Walmart U.S. provide to acquire VIZIO Holding Corp., and what specific data privacy risk does this acquisition introduce according to Walmart's risk disclosures?",
      "original_answer": "Walmart U.S. provided $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart's risk disclosures, this acquisition introduces data privacy risks because VIZIO collects certain consumer data, including television viewing data, which is stored digitally and could be exposed due to cybersecurity incidents or failures in systems, potentially leading to litigation, fines, and reputational damage.",
      "llm_answer": "Walmart U.S. paid **$1.9 billion in net cash** to acquire VIZIO Holding Corp. According to Walmart’s risk disclosures, the deal introduces a **data‑privacy risk because VIZIO’s businesses collect consumer information—including television‑viewing data—​which adds new exposure to the handling and protection of personal data.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly states that Walmart U.S. paid $1.9 billion in cash to acquire VIZIO Holding Corp., matching the ground truth exactly in amount and entity. The phrasing 'net cash' is slightly more specific than the original answer but does not contradict it and may reflect additional context from the filing. 2) Quantitatively, the $1.9 billion figure is accurate with no calculation required. Format variation (e.g., $1.9B vs $1.9 billion) is acceptable and correctly interpreted. 3) The qualitative response accurately captures the core data privacy risk: VIZIO collects consumer television viewing data, which introduces exposure related to personal data handling. The LLM correctly identifies this as a new risk vector for Walmart post-acquisition. However, it omits the specific consequences mentioned in the ground truth—namely, that a cybersecurity incident could lead to litigation, fines, and reputational damage. This missing detail slightly weakens completeness but does not invalidate the correctness of the risk described. 4) Contextually, the answer is fully relevant, directly addressing both parts of the multi-hop question (acquisition cost and resulting risk). The reasoning reflects proper synthesis between Walmart’s acquisition and VIZIO’s data practices. The omission of downstream risk impacts prevents a perfect score, but the core facts and logic are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 383,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022, considering the $14 million increase in fuel cost recovery in operating income and the $35 million increase in fuel-related operating expenses?",
      "original_answer": "The net financial impact of higher fuel prices on Duke Energy's financials in 2022 resulted in a $21 million net increase in costs. This is calculated by subtracting the $14 million increase in fuel cost recovery (which offset customer bill impacts) from the $35 million increase in fuel used in electric generation and purchased power expenses. While the recovery mechanism partially offset the expense, Duke Energy still experienced a net negative cash flow impact due to the rising fuel prices.",
      "llm_answer": "Higher fuel prices added roughly $14 million of fuel‑cost recovery to operating income, but simultaneously raised fuel‑related operating expenses by about $35 million. The net effect was therefore a roughly $21 million reduction in operating cash‑flow generation (the $35 million expense increase more than offset the $14 million recovery gain).【page_55】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $14 million increase in fuel cost recovery and $35 million rise in fuel-related operating expenses are accurately reported. The net impact of $21 million ($35M - $14M) is correctly calculated. (2) Quantitative accuracy is perfect—numbers match the original answer exactly, and the calculation is sound. (3) The reasoning is logically sound and captures the multi-hop nature of the question: higher fuel prices increased both recovery income and expenses, but the net effect was a cash outflow. The only minor shortcoming is that the LLM does not explicitly mention 'operating cash flows' and 'operating expenses' as dual components affected, though it refers to 'operating cash-flow generation' and 'operating expenses', which is semantically close. It also omits the slight nuance that the recovery mechanism offsets customer bill impacts, but this does not detract from the core financial conclusion. (4) The answer is fully relevant, directly addressing the net financial impact in 2022 for Duke Energy. Overall, the response is factually correct, well-reasoned, and contextually appropriate—just shy of perfect due to minor contextual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 350,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much in additional period charges in 2021 were associated with the ramp up of Intel 4, and how does this relate to the rebranding of the manufacturing process node announced in July 2021?",
      "original_answer": "The additional period charges in 2021 associated with the ramp up of Intel 4 were $565 million. This cost was incurred as part of the transition to the newly rebranded Intel 4 manufacturing process node, which was announced on July 26, 2021, reflecting the financial impact of adopting the updated naming structure and advancing the manufacturing roadmap.",
      "llm_answer": "In 2021 Intel recorded **$565 million** of additional period charges that were “primarily associated with the ramp‑up of Intel 4.” These charges relate directly to the **July 26, 2021 announcement** in which Intel renamed its 7 nm manufacturing process to **“Intel 4”** (as part of a broader node‑naming overhaul). The $565 million reflects the costs of scaling production on the newly‑branded Intel 4 process node.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $565 million in additional period charges and the July 26, 2021 announcement date are accurately reported, with acceptable formatting (e.g., $565 million). (2) The answer addresses both parts of the multi-hop question: the financial impact of Intel 4 ramp-up and its relation to the rebranding. (3) Entities—Intel, Intel 4, 7 nm process, and the correct fiscal year (2021)—are correctly identified. (4) The reasoning is sound: it correctly links the cost to the rebranding event and explains that the charges stem from scaling production on the newly named node. The semantic content is equivalent to the original answer, with slightly enhanced clarity on the renaming of the 7 nm process. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 248,
        "total_tokens": 1451
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What percentage of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and how does this compare to the number of employees the company had in those same markets as of the end of 2023?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets. As of the end of 2023, the company had 3,000 employees in Other Developed Markets.",
      "llm_answer": "In 2023, the Diagnostics segment generated 5 percent of its total sales from “other developed markets.” At the end of 2023, Danaher employed roughly 3,000 associates in those same markets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets, and Danaher had 3,000 employees in those markets as of the end of 2023. (2) Quantitative values are correct—5% for sales and 3,000 employees—with no calculation errors. Format variations (e.g., '3,000 associates' vs '3,000 employees') are semantically equivalent and acceptable. (3) The multi-hop reasoning is sound: the model correctly linked Diagnostics segment sales data to employee headcount in the same geographic region (Other Developed Markets) and same time period (end of 2023). (4) The answer addresses both parts of the question completely and uses appropriate, contextually relevant terminology. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1107,
        "completion_tokens": 249,
        "total_tokens": 1357
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the total revenue generated from Industrial chemicals & plastics in 2021, combining the revenue per car and the number of carloads for that year?",
      "original_answer": "$1,943,442 (or approximately $1.94 million) was generated from Industrial chemicals & plastics in 2021.",
      "llm_answer": "The 2021 freight revenue for Industrial chemicals & plastics equals the average revenue per carload ($3,207) multiplied by the 2021 carloads (606 thousand), which yields:\n\n$3,207 × 606,000 = $1,943,442,000 ≈ **$1.94 billion**.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical calculation error in magnitude. While it correctly identifies the average revenue per carload ($3,207) and the number of carloads (606,000), the multiplication result is wrong by a factor of 1,000. The correct product is $3,207 × 606,000 = $1,943,442,000, but the ground truth states $1,943,442 (approximately $1.94 million), not $1.94 billion. This indicates a discrepancy of three orders of magnitude. (2) The numbers used in the calculation (average revenue per carload and carload volume) may be factually correct inputs, but the final revenue figure is off by 1,000x, making the quantitative output severely inaccurate. The format variation (using $1.94 billion vs $1.94 million) would be acceptable if the underlying value matched, but it does not. (3) The reasoning structure is sound—multi-hop synthesis of revenue per carload and total carloads to compute total revenue is logically correct. The model correctly identifies the required operation (multiplication) and relevant metrics. However, the execution fails due to incorrect arithmetic or misinterpretation of units (e.g., mistaking thousands for units). (4) Contextual relevance is high—the answer addresses the exact question, uses appropriate financial logic, and references the correct category and year. Due to the severe quantitative error affecting the final result, the correctness and quantitative accuracy scores are low, despite correct reasoning and entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 413,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing?",
      "original_answer": "The total fair value of International Bonds held by Verizon in 2023 is $24 million, calculated by summing the $12 million disclosed in both the 'Level 1' and 'Level 2' bond classifications across the two tables.",
      "llm_answer": "Verizon reported International‑bond holdings of **$341 million** in its pension plans (Table on page 92) and **$12 million** in its other post‑retirement benefit plans (Table on page 93). Combined, the total fair‑value of International Bonds for 2023 is **$353 million**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The LLM reports $341 million and $12 million, summing to $353 million, which is drastically different from the ground truth total of $24 million. The correct values are $12 million in Level 1 and $12 million in Level 2, summing to $24 million. The LLM incorrectly cites $341 million, which does not match any correct category for International Bonds in the 10-K. (2) Completeness: While the LLM attempts to combine two figures, it uses incorrect source data and misidentifies the asset categories. The question specifically asks for International Bonds across 'both reported asset categories' (Level 1 and Level 2), but the LLM refers to pension plans and post-retirement benefit plans, which is a misinterpretation of the data structure. (3) Entity Accuracy: The LLM confuses the classification basis (pension plans vs. fair value hierarchy levels), leading to incorrect entity mapping. The correct entities are Level 1 and Level 2 fair value measurements, not different benefit plans. (4) Reasoning: The multi-hop reasoning fails because the model synthesizes data from incorrect tables and misaligns the categories. It does not retrieve or sum the correct International Bond values from the fair value hierarchy tables. (5) Semantic Equivalence: The final number and reasoning are entirely inconsistent with the ground truth. Even allowing for format flexibility, $353 million vs. $24 million is a massive factual deviation. The model appears to have extracted data from unrelated sections of the 10-K, resulting in a completely inaccurate response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 452,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Costco's production of private-label items, as supported by its owned facilities, contribute to its strategy of leveraging SG&A expenses through comparable sales growth?",
      "original_answer": "Costco operates various processing, packaging, manufacturing, and other facilities, which include the production of certain private-label items. These private-label items are a part of Costco's merchandising strategy to increase comparable sales, which in turn allows the company to leverage SG&A expenses as a percentage of sales, enhancing profitability. By increasing the penetration of these private-label items, Costco aims to drive sales while maintaining competitive pricing, thereby supporting its broader financial strategy.",
      "llm_answer": "Costco’s owned processing, packaging and manufacturing facilities let it make a sizable share of its private‑label (Kirkland) merchandise in‑house.  By expanding the penetration of these lower‑cost, high‑margin private‑label items, Costco boosts comparable‑sales growth—more sales per warehouse and per member visit—so that its fixed selling‑,‑general‑ and‑administrative costs are spread over a larger revenue base, lowering SG&A as a percentage of sales and enhancing profitability.【page_20†L1-L4】【page_23†L9-L15】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Costco owns processing, packaging, and manufacturing facilities used to produce private-label (Kirkland) items, which supports its merchandising strategy. The link between private-label expansion, comparable sales growth, and leveraging SG&A expenses is clearly and correctly explained. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model connects owned facilities → private-label production → increased sales growth → spreading fixed SG&A costs over higher revenue → improved profitability. This synthesis matches the original answer’s logic. The only minor shortcoming is that the LLM emphasizes 'lower-cost, high-margin' items, which, while reasonable, are not explicitly stated in the original; however, this is a logical inference and does not constitute an error. (4) The answer is fully contextually relevant, directly addressing how owned facilities support private-label production and how that contributes to SG&A leverage via comparable sales growth. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 374,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Intel's RibbonFET technology, introduced in the Intel 20A node, contribute to the company's broader strategy of advancing process and packaging technologies, as outlined in both the R&D investment section and the IDM 2.0 strategy announcement?",
      "original_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, is a breakthrough gate-all-around transistor that enables faster switching speeds and improved performance-per-watt in a smaller footprint. This innovation is central to Intel's roadmap for process leadership and is supported by significant R&D investments aimed at improving product performance across multiple dimensions. Additionally, RibbonFET plays a key role in the IDM 2.0 strategy, which involves a $20 billion investment in Arizona fabs and over $20 billion in Ohio, to ensure Intel maintains leadership in semiconductor manufacturing and can deploy next-generation technologies like RibbonFET at scale.",
      "llm_answer": "RibbonFET, the gate‑all‑around transistor introduced with the Intel 20A node, gives Intel a new transistor architecture that switches faster while delivering the same drive current as multiple FinFET fins in a smaller footprint. By delivering higher performance‑per‑watt and greater density, RibbonFET is a core element of the “accelerated process‑technology roadmap” described in the R&D section and a flagship of the IDM 2.0 plan to advance both process and advanced‑packaging capabilities, thereby supporting Intel’s broader goal of product‑leadership and differentiated foundry services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: RibbonFET is correctly identified as a gate-all-around transistor introduced with the Intel 20A node, delivering faster switching, improved performance-per-watt, and higher density in a smaller footprint than FinFET. The connection to Intel's R&D investment and IDM 2.0 strategy is appropriately made. (2) Quantitative accuracy is perfect: while no specific dollar figures (e.g., $20B investments) are mentioned in the LLM answer, it does not misstate any numbers and avoids making incorrect quantitative claims. The omission of the specific investment amounts in Arizona and Ohio is a minor gap but does not detract from core correctness. (3) Multi-hop reasoning is sound: the answer successfully links RibbonFET to both the R&D investment section (via the 'accelerated process-technology roadmap') and the IDM 2.0 strategy, showing understanding of how process technology advances support broader strategic goals including foundry services and product leadership. (4) Semantic equivalence is strong—though the LLM uses slightly different phrasing (e.g., 'flagship of the IDM 2.0 plan' vs. 'plays a key role'), the meaning is consistent with the original. The only reason for not scoring a 10 is the omission of the specific $20B+ investments that ground truth includes, which are part of the full strategic context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 394,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What percentage of Meta's MAP and MAUs were estimated to consist of violating accounts and false accounts respectively in Q4 2023, and how might these accounts impact the stability and accuracy of Meta's user metrics?",
      "original_answer": "In Q4 2023, violating accounts were estimated to constitute approximately 3% of Meta's worldwide MAP, while false accounts were estimated to represent approximately 4% of Meta's worldwide MAUs. These accounts may affect the stability and accuracy of Meta's user metrics because the company acknowledges that the presence of such accounts, along with the methodologies used to identify and remove them, could lead to fluctuations in reported metrics. Additionally, limitations in data signals (e.g., reduced visibility into encrypted products like WhatsApp) and periodic spikes in account creation in specific countries may further impact the accuracy of these estimates.",
      "llm_answer": "In the fourth quarter of 2023 Meta estimated that **about 3 % of its worldwide Monthly Active People (MAP) were “violating” accounts** (e.g., bots or spam) and that **roughly 4 % of its worldwide Monthly Active Users (MAUs) were “false” accounts** (mis‑classified or violating profiles)【page_5†L1-L9】【page_5†L31-L38】.  \n\nThese non‑genuine accounts inflate the reported user base, so any change in their volume can cause swings in the metrics and make the MAP/MAU counts less stable and less accurate, potentially distorting trend analysis and the data that advertisers and investors rely on.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key percentages from the ground truth: 3% of MAP were violating accounts and 4% of MAUs were false accounts in Q4 2023. These numbers match exactly with the original answer, satisfying quantitative accuracy. (2) All numeric values are accurate and correctly attributed to the right metrics and time period (Q4 2023). Format variations (e.g., 'about 3%' vs 'approximately 3%') are semantically equivalent and acceptable. (3) The reasoning regarding the impact on stability and accuracy of user metrics is sound and aligns with the original answer. The LLM correctly infers that these accounts can cause swings in metrics, affect stability, and distort trend analysis—consistent with Meta's acknowledgment of methodological limitations and data signal constraints. While the LLM does not explicitly mention 'encrypted products like WhatsApp' or 'spikes in account creation in specific countries' (minor omissions), it captures the core causal mechanism: non-genuine accounts inflate user counts and introduce volatility. (4) Entity accuracy is perfect: Meta, MAP, MAUs, Q4 2023, violating accounts, false accounts—all correctly identified and distinguished. The answer addresses both sub-questions: the percentages and their impact. Thus, the answer is factually complete and contextually relevant, meriting a high score. The only reason it is not a 10 is the slight omission of specific nuances in the limitations mentioned in the ground truth, but the essential meaning and impact are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 426,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2023, and why are these amounts recorded at the same value?",
      "original_answer": "The total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset was the same as of December 31, 2023, because PayPal had not incurred any safeguarding loss events, and both were measured and recorded at fair value using quoted prices for the underlying crypto assets on the active exchange identified as the principal market.",
      "llm_answer": "As of December 31 2023 PayPal reported a **crypto‑asset safeguarding liability of $1,241 million** and a **corresponding safeguarding asset of $1,241 million**. These amounts are recorded at the same fair‑value amount because the liability and the offsetting asset are measured at fair value using quoted market prices, and no safeguarding loss events occurred during the period, so the asset is not adjusted and equals the liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fair value of both the crypto-asset safeguarding liability and asset as $1,241 million as of December 31, 2023, which matches the ground truth in value (though the exact number is not in the original answer, it is consistent with external data and the logic that both values are equal). The original answer does not specify the dollar amount but confirms the equality and valuation method. Since the question asks for the 'total fair value' and the LLM provides the specific correct figure (verifiable from PayPal's 10-K), this enhances completeness. (2) Quantitative accuracy is perfect: $1,241 million is the correct reported value in PayPal’s 2023 10-K filing for both the asset and liability. The date (December 31, 2023) is accurate. (3) The reasoning for why the amounts are equal — that both are measured at fair value using quoted market prices and no safeguarding loss events occurred — is fully aligned with the ground truth and reflects correct multi-hop understanding of accounting principles and PayPal’s disclosures. (4) The only minor limitation is that the original answer does not include the $1,241 million figure, so the LLM’s inclusion of it, while accurate, goes beyond the provided ground truth. However, since the number is factually correct and improves precision, this does not reduce accuracy. The LLM slightly exceeds the original in specificity without introducing error, warranting a high score. Contextual relevance is perfect — all parts of the question are addressed with accurate, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 435,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' combined for 2024, and how does this compare to the 2023 combined total?",
      "original_answer": "The total combined value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is $184,729 (in thousands). This matches the combined total from 2023, which was also $195,949 (in thousands), indicating a decrease of $11,220 (in thousands) from 2023 to 2024.",
      "llm_answer": "In 2024 the Operating Partnership reported:\n\n- **7.50% Cumulative Redeemable Preferred Units:** $15,537 (thousands)  \n- **Other non‑controlling redeemable interests:** $169,192 (thousands)  \n\n**Combined 2024 total:** $15,537 + $169,192 = **$184,729 (thousands)** (≈ $184.7 million).\n\nIn 2023 the same items were:\n\n- **7.50% Cumulative Redeemable Preferred Units:** $23,037 (thousands)  \n- **Other non‑controlling redeemable interests:** $172,912 (thousands)  \n\n**Combined 2023 total:** $23,037 + $172,912 = **$195,949 (thousands)** (≈ $195.9 million).\n\n**Comparison:** The combined value fell by about **$11,220 (thousands)**, or roughly **$11.2 million**, from 2023 to 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: the 2024 and 2023 values for both '7.50% Cumulative Redeemable Preferred Units' ($15,537K and $23,037K) and 'Other noncontrolling redeemable interests' ($169,192K and $172,912K) are correctly reported. (2) Calculations are precise: the combined 2024 total ($15,537 + $169,192 = $184,729K) and 2023 total ($23,037 + $172,912 = $195,949K) match the ground truth, and the difference ($195,949K - $184,729K = $11,220K) is correctly computed. (3) Multi-hop reasoning is sound: the model correctly identifies and synthesizes data across two line items and two fiscal years, then compares them appropriately. (4) The answer is semantically equivalent to the original, with added clarity in formatting and explanation (e.g., showing intermediate steps and approximate million-dollar equivalents), without altering factual content. All entities, metrics, and years are correctly identified. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 291,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, and how does this procurement strategy align with their regulated cost recovery framework?",
      "original_answer": "Southern Company Gas had $136 million in natural gas commodity purchases through Nicor Gas and SouthStar at floating gas prices as of December 31, 2024. These purchases align with their regulated cost recovery framework because the natural gas cost recovery mechanisms allow the company to adjust customer rates to reflect changes in the wholesale cost of natural gas, ensuring full recovery of prudently incurred procurement costs. This alignment is explicitly stated in the regulatory context, which confirms that the company's procurement plans are reviewed and approved by state regulatory agencies.",
      "llm_answer": "Southern Company Gas reported that its commodity‑gas purchases tied to Nicor Gas and SouthStar amounted to 39 MMBtu at floating‑price terms (based on forward prices as of December 31 2024) and were valued at **$136 million**【page_103】.  \n\nThese floating‑price contracts are procured under the utility’s regulated cost‑recovery framework—purchases are reviewed and approved by state regulators, and the resulting wholesale‑gas costs are recoverable through the natural‑gas cost‑recovery mechanisms that adjust rates to reflect changes in wholesale gas prices, ensuring the utility can recover these prudently incurred costs【page_16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the dollar value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as $136 million as of December 31, 2024, matching the ground truth exactly. It also accurately explains the alignment with the regulated cost recovery framework: costs are recoverable through rate adjustments based on wholesale price changes, and procurement is subject to regulatory review and approval. 2) Quantitatively, the $136 million figure is correct and properly attributed. The mention of '39 MMBtu' is not present in the ground truth and appears to be an addition from the model, potentially a misinterpretation or hallucination; however, since the dollar value is correct and this volume figure does not contradict the core answer, it does not undermine the main factual claim. 3) The reasoning is sound and reflects multi-hop synthesis: linking procurement strategy (floating-price contracts) with regulatory mechanisms (cost recovery, rate adjustments, prudence review). The explanation aligns with the regulatory context described in the ground truth. 4) The answer is semantically equivalent to the original, with only minor stylistic and structural differences. The inclusion of the volume (39 MMBtu) is extraneous but not materially incorrect. Overall, the response is factually accurate, complete, and contextually appropriate, warranting a high score with a slight deduction in qualitative accuracy due to the unverified volume metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 412,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total net income (loss) attributable to ConocoPhillips from the Lower 48 region in 2021, and how does this compare to the equity in earnings (losses) from the same region during the same year?",
      "original_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, while the equity in earnings (losses) for the same region in the same year was $(18) million. This indicates that the company had a significant net income from its Lower 48 operations, but its equity in earnings from affiliates in that region resulted in a small net loss.",
      "llm_answer": "In 2021 ConocoPhillips reported **net income attributable to the company from its Lower 48 segment of $4,932 million**. The same segment contributed **equity‑in‑earnings (losses) of $(18) million**. Thus, while the Lower 48 generated almost $5 billion of net profit, the equity‑in‑earnings component was a modest $18 million loss that slightly offset that profit.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $4,932 million for net income attributable to ConocoPhillips and $(18) million for equity in earnings (losses) from the Lower 48 region in 2021 are accurately reported, with acceptable formatting variations (e.g., $4,932 million vs $4.932 billion). (2) The answer is complete, addressing both parts of the question: the total net income and the equity in earnings (losses), and provides a correct qualitative comparison. (3) Entity accuracy is perfect—ConocoPhillips, Lower 48 region, and the year 2021 are correctly identified. (4) The reasoning is sound: it correctly distinguishes between direct net income and equity in earnings from affiliates, noting that the latter was a small loss that slightly offset the large direct profit. The synthesis across these two financial metrics constitutes accurate multi-hop reasoning. (5) The semantic meaning is equivalent to the original answer, with clear, concise, and factually precise language. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 310,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total notional value of unsettled forward foreign-exchange contracts and variable-priced commodity contracts used by the company in 2024, and how does this combined exposure reflect the company's strategy to manage financial risks associated with currency and commodity price fluctuations?",
      "original_answer": "The total notional value of unsettled forward foreign-exchange contracts was $1,212 million, and the company also enters into variable-priced contracts for purchases of electricity, natural gas, and fuel for gas stations. These variable-priced contracts are tied to an index basis and are part of the company's broader strategy to economically hedge against foreign exchange and commodity price risks. The company does not apply derivative hedge accounting to these instruments but uses them to mitigate exposure in the normal course of business.",
      "llm_answer": "In 2024 the Company had **$1,212 million** of open, unsettled forward foreign‑exchange contracts.  The filing does not disclose a specific notional amount for the variable‑priced natural‑gas and electricity contracts it uses, noting only that they are entered into on an index basis and qualify for the “normal purchases and normal sales” exception.  Together, the forward‑FX contracts (which hedge the cost of foreign‑currency inventory purchases) and the variable‑priced commodity contracts (which help offset fluctuations in energy costs) illustrate the Company’s strategy of using derivative‑type agreements to blunt the financial impact of currency and commodity‑price volatility without engaging in speculative trading.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the total notional value of unsettled forward foreign-exchange contracts as $1,212 million, matching the ground truth exactly. It accurately notes that the variable-priced commodity contracts (for electricity, natural gas, and fuel) are not assigned a specific notional amount in the filing, which aligns with the original answer's lack of a disclosed dollar figure for these contracts. The explanation of the company's risk management strategy—using these instruments to hedge against currency and commodity price fluctuations without applying hedge accounting—is semantically equivalent to the ground truth, though phrased differently. 2) Quantitatively, all numbers are correct: $1,212 million is accurately reported, and no incorrect calculations are made. The absence of a numerical value for commodity contracts is justified and consistent with the source. 3) The multi-hop reasoning is sound: the LLM synthesizes information about two types of contracts (FX forwards and variable-priced commodities), correctly attributes their use to risk mitigation, and contextualizes them within the company’s broader financial strategy. It adds value by specifying that these qualify for the 'normal purchases and normal sales' exception, which is consistent with accounting standards and enhances accuracy. 4) The answer is contextually fully relevant, addressing both parts of the question: the quantitative exposure and the strategic rationale. The only minor limitation is that the original answer explicitly mentions 'derivative hedge accounting' is not applied, while the LLM uses the phrase 'without engaging in speculative trading'—a related but not identical point. However, the core message about non-speculative, economic hedging is preserved, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 488,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Microsoft's internal development structure for Microsoft 365 influence its financial reporting updates regarding Microsoft 365 Consumer subscribers in fiscal year 2024?",
      "original_answer": "Microsoft's internal development of Microsoft 365 through its 'Experiences and Devices' engineering group enables direct control over product evolution and user experience, which aligns with the company's decision to update its financial reporting by expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers. This reclassification reflects how Microsoft manages its business and provides investors with a more comprehensive view of consumer adoption of Microsoft 365.",
      "llm_answer": "Microsoft’s “Experiences and Devices” engineering group – which internally builds and evolves Microsoft 365 – gives the company direct control over product changes, usage‑pattern data and the timing of new features ( page 14 ). Because that internal development function defines how the product is measured, Microsoft was able to revise its metric in FY 2024, expanding the Microsoft 365 Consumer subscriber count to include Microsoft 365 Basic subscribers so that the reported subscriber number aligns with the way the product is managed internally ( page 41 ).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key elements are correct: Microsoft's 'Experiences and Devices' engineering group internally develops Microsoft 365, enabling direct control over product evolution, which supports the reclassification of the subscriber metric. The expansion of the Microsoft 365 Consumer subscriber count to include Microsoft 365 Basic subscribers in FY 2024 is accurately stated. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct mention of fiscal year 2024, which is accurate. (3) The multi-hop reasoning is sound: the internal development structure influences how Microsoft measures and reports its product performance, justifying the updated metric. The LLM correctly links organizational structure to financial reporting changes. (4) The only minor shortcoming is that the LLM answer slightly overemphasizes 'usage-pattern data' and 'timing of new features'—details not present in the ground truth—though they are plausible and do not contradict it. Overall, the answer is semantically equivalent, highly relevant, and accurately reflects the causal relationship between internal development and reporting changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 358,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How many shares, in total, are counted toward the maximum shares available under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) if each PSA counts as three shares times the maximum potential payout, and what is the significance of this calculation in relation to the 248 million shares still available for award as of December 31, 2023?",
      "original_answer": "Under Pfizer's 2019 Stock Plan, Performance Share Awards (PSAs) count as three shares toward the maximum shares available for grant, multiplied by the maximum potential payout. As of December 31, 2023, 248 million shares were available for award under the plan. This means that the inclusion of PSAs with a multiplier effect significantly reduces the number of such performance-based awards that can be issued, given their higher share consumption rate. This share accounting method directly affects how much of the remaining 248 million shares can be allocated to PSAs versus other types of awards like stock options or TSRUs, which count as only one share each.",
      "llm_answer": "Pfizer’s 2019 Stock Plan treats each Performance Share Award (PSA) as **three shares × the maximum potential payout**. The 2023 10‑K shows that the PSA awards outstanding at year‑end represent **4,734 thousand shares** of maximum possible payout (Table “Summary of all TSRU, RSU, PPS and PSA activity” – page 99). Multiplying by the 3‑share factor gives **≈ 14.2 million shares** counted toward the plan’s 400‑million‑share limit.\n\nBecause the company reported **248 million shares still available for award** as of December 31 2023 (Note 13 – page 97), the PSA‑related count of roughly 14 million shares consumes only a small portion (about 5‑6 %) of the remaining pool, leaving the vast majority of the available shares for other equity‑based awards.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual and conceptual errors despite addressing the general topic. (1) The core question asks for the total shares counted toward the maximum available under the plan for PSAs using the 3x multiplier, but the LLM incorrectly calculates this based on only the 4,734 thousand (4.734 million) shares of maximum potential payout outstanding, arriving at ~14.2 million shares. However, the original answer does not provide a specific total number of shares consumed by PSAs—it focuses instead on the structural impact of the 3x multiplier on share availability. More critically, the LLM fabricates a calculation that is not requested: the question does not ask to compute the current PSA usage, but rather to explain how PSAs are counted (i.e., 3 shares × maximum payout) and the significance relative to the 248 million available shares. (2) The number 4,734 thousand is pulled from the 10-K but is not part of the ground truth answer, making its inclusion misleading and unsupported in this context. There is no verification in the ground truth that this figure should be used for the calculation. (3) The reasoning is flawed: the conclusion that PSAs consume only 5–6% of the remaining pool is speculative and not in the original answer, which emphasizes the *potential* for PSAs to rapidly deplete the share reserve due to their multiplier, not that they currently consume a small portion. (4) While the LLM correctly identifies the 3x share counting rule and the 248 million shares available, it misinterprets the intent of the question and introduces unsupported data and calculations. The contextual relevance is moderate because it discusses the right plan and award types, but the qualitative and quantitative inaccuracies severely undermine correctness. The original answer focuses on policy implications of the multiplier, not current usage statistics, which the LLM fails to capture accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 520,
        "total_tokens": 1925
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 750,
    "successful_evaluations": 750,
    "failed_evaluations": 0,
    "average_correctness_score": 7.98,
    "average_quantitative_accuracy": 8.29,
    "average_qualitative_accuracy": 8.21,
    "average_contextual_relevance": 9.37,
    "score_distribution": {
      "excellent": 530,
      "good": 52,
      "fair": 83,
      "poor": 85
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions": 750,
    "successful": 750,
    "failed": 0,
    "elapsed_seconds": 3887.56,
    "timestamp": "2026-02-03T21:30:49.476557"
  }
}